"spid"	"chid"	"casn"	"chnm"	"code"	"aeid"	"aenm"	"l6id"	"l4id"	"l5id"	"l6_mthd_id"	"flag"	"fval"	"fval_unit"	"resp_unit"
"MED00013"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	117	"ATG_ERa_TRANS_up"	50286	2171917	2037842	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"MED00024"	22366	"50-27-1"	"Estriol"	"C50271"	75	"ATG_ERE_CIS_up"	13707	2092531	1965593	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"MED00030"	22341	"1610-18-0"	"Prometon"	"C1610180"	75	"ATG_ERE_CIS_up"	13182	2092525	1965599	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"MED00030"	22341	"1610-18-0"	"Prometon"	"C1610180"	75	"ATG_ERE_CIS_up"	13705	2092525	1965599	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"MED00030"	22341	"1610-18-0"	"Prometon"	"C1610180"	117	"ATG_ERa_TRANS_up"	49647	2171900	2037825	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"MED00030"	22341	"1610-18-0"	"Prometon"	"C1610180"	117	"ATG_ERa_TRANS_up"	50283	2171900	2037825	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000008"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	117	"ATG_ERa_TRANS_up"	50089	2171877	2037802	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000012"	20440	"120-36-5"	"Dichlorprop"	"C120365"	75	"ATG_ERE_CIS_up"	13494	2092498	1965626	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000016"	40001	"4376-18-5"	"Monomethyl phthalate"	"C4376185"	75	"ATG_ERE_CIS_up"	13493	2092495	1965629	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000017"	32525	"149877-41-8"	"Bifenazate"	"C149877418"	117	"ATG_ERa_TRANS_up"	50088	2171869	2037794	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000018"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	75	"ATG_ERE_CIS_up"	13256	2092493	1965632	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000018"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	75	"ATG_ERE_CIS_up"	13492	2092493	1965632	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000020"	23881	"74115-24-5"	"Clofentezine"	"C74115245"	75	"ATG_ERE_CIS_up"	13491	2092491	1965633	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000021"	21248	"83-79-4"	"Rotenone"	"C83794"	117	"ATG_ERa_TRANS_up"	50087	2171865	2037790	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000039"	20792	"123-33-1"	"Maleic hydrazide"	"C123331"	75	"ATG_ERE_CIS_up"	13254	2092477	1965647	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000039"	20792	"123-33-1"	"Maleic hydrazide"	"C123331"	75	"ATG_ERE_CIS_up"	13490	2092477	1965647	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000040"	32365	"1194-65-6"	"Dichlobenil"	"C1194656"	75	"ATG_ERE_CIS_up"	13489	2092476	1965648	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000040"	32365	"1194-65-6"	"Dichlobenil"	"C1194656"	117	"ATG_ERa_TRANS_up"	50086	2171851	2037776	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000041"	20426	"99-30-9"	"Dicloran"	"C99309"	75	"ATG_ERE_CIS_up"	13703	2092475	1965649	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000044"	21105	"82-68-8"	"Pentachloronitrobenzene"	"C82688"	75	"ATG_ERE_CIS_up"	13702	2092472	1965652	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000044"	21105	"82-68-8"	"Pentachloronitrobenzene"	"C82688"	117	"ATG_ERa_TRANS_up"	49620	2171847	2037772	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000045"	21151	"90-43-7"	"2-Phenylphenol"	"C90437"	75	"ATG_ERE_CIS_up"	13701	2092471	1965654	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000051"	34625	"361377-29-9"	"Fluoxastrobin"	"C361377299"	75	"ATG_ERE_CIS_up"	13488	2092466	1965658	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000053"	34365	"134605-64-4"	"Butafenacil"	"C134605644"	75	"ATG_ERE_CIS_up"	13487	2092464	1965660	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000057"	34492	"120116-88-3"	"Cyazofamid"	"C120116883"	75	"ATG_ERE_CIS_up"	13486	2092460	1965664	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000058"	34590	"161326-34-7"	"Fenamidone"	"C161326347"	75	"ATG_ERE_CIS_up"	13700	2092459	1965665	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000059"	20022	"50594-66-6"	"Acifluorfen"	"C50594666"	75	"ATG_ERE_CIS_up"	13253	2092458	1965666	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000059"	20022	"50594-66-6"	"Acifluorfen"	"C50594666"	75	"ATG_ERE_CIS_up"	13485	2092458	1965666	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000059"	20022	"50594-66-6"	"Acifluorfen"	"C50594666"	117	"ATG_ERa_TRANS_up"	50085	2171833	2037758	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000062"	32393	"72490-01-8"	"Fenoxycarb"	"C72490018"	75	"ATG_ERE_CIS_up"	13699	2092455	1965669	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000062"	32393	"72490-01-8"	"Fenoxycarb"	"C72490018"	117	"ATG_ERa_TRANS_up"	50280	2171830	2037755	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000067"	34503	"122008-85-9"	"Cyhalofop-butyl"	"C122008859"	75	"ATG_ERE_CIS_up"	13252	2092450	1965674	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000067"	34503	"122008-85-9"	"Cyhalofop-butyl"	"C122008859"	75	"ATG_ERE_CIS_up"	13484	2092450	1965674	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000068"	24151	"35554-44-0"	"Imazalil"	"C35554440"	75	"ATG_ERE_CIS_up"	13698	2092449	1965675	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000068"	24151	"35554-44-0"	"Imazalil"	"C35554440"	117	"ATG_ERa_TRANS_up"	50279	2171824	2037749	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000069"	24159	"82558-50-7"	"Isoxaben"	"C82558507"	75	"ATG_ERE_CIS_up"	13251	2092448	1965676	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000069"	24159	"82558-50-7"	"Isoxaben"	"C82558507"	75	"ATG_ERE_CIS_up"	13483	2092448	1965676	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000076"	22448	"51218-45-2"	"Metolachlor"	"C51218452"	117	"ATG_ERa_TRANS_up"	50278	2171817	2037742	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000077"	24204	"21087-64-9"	"Metribuzin"	"C21087649"	75	"ATG_ERE_CIS_up"	13482	2092441	1965683	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000078"	32600	"113136-77-9"	"Cyclanilide"	"C113136779"	75	"ATG_ERE_CIS_up"	13481	2092440	1965684	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000080"	21086	"23135-22-0"	"Oxamyl"	"C23135220"	75	"ATG_ERE_CIS_up"	13697	2092438	1965686	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000083"	24259	"2310-17-0"	"Phosalone"	"C2310170"	75	"ATG_ERE_CIS_up"	13696	2092435	1965689	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000086"	37495	"1007-28-9"	"Deisopropylatrazine"	"C1007289"	75	"ATG_ERE_CIS_up"	13135	2092432	1965692	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000086"	37495	"1007-28-9"	"Deisopropylatrazine"	"C1007289"	75	"ATG_ERE_CIS_up"	13695	2092432	1965692	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000087"	20450	"115-32-2"	"Dicofol"	"C115322"	75	"ATG_ERE_CIS_up"	13250	2092431	1965693	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000087"	20450	"115-32-2"	"Dicofol"	"C115322"	75	"ATG_ERE_CIS_up"	13480	2092431	1965693	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000087"	20450	"115-32-2"	"Dicofol"	"C115322"	117	"ATG_ERa_TRANS_up"	50084	2171806	2037731	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000088"	20560	"115-29-7"	"Endosulfan"	"C115297"	117	"ATG_ERa_TRANS_up"	49619	2171805	2037730	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000089"	29221	"1702-17-6"	"Clopyralid"	"C1702176"	75	"ATG_ERE_CIS_up"	13249	2092429	1965695	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000089"	29221	"1702-17-6"	"Clopyralid"	"C1702176"	75	"ATG_ERE_CIS_up"	13479	2092429	1965695	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000090"	24002	"39515-41-8"	"Fenpropathrin"	"C39515418"	75	"ATG_ERE_CIS_up"	13358	2092428	1965696	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000094"	23869	"834-12-8"	"Ametryn"	"C834128"	75	"ATG_ERE_CIS_up"	13248	2092425	1965699	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000096"	20122	"86-50-0"	"Azinphos-methyl"	"C86500"	75	"ATG_ERE_CIS_up"	13246	2092423	1965701	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000096"	20122	"86-50-0"	"Azinphos-methyl"	"C86500"	75	"ATG_ERE_CIS_up"	13478	2092423	1965701	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000100"	23990	"21725-46-2"	"Cyanazine"	"C21725462"	75	"ATG_ERE_CIS_up"	13694	2092419	1965705	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000102"	20449	"62-73-7"	"Dichlorvos"	"C62737"	75	"ATG_ERE_CIS_up"	13477	2092417	1965707	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000106"	24102	"22224-92-6"	"Fenamiphos"	"C22224926"	117	"ATG_ERa_TRANS_up"	50083	2171788	2037713	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000112"	24270	"67747-09-5"	"Prochloraz"	"C67747095"	75	"ATG_ERE_CIS_up"	13475	2092407	1965717	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000113"	32464	"41198-08-7"	"Profenofos"	"C41198087"	75	"ATG_ERE_CIS_up"	13134	2092406	1965718	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000113"	32464	"41198-08-7"	"Profenofos"	"C41198087"	75	"ATG_ERE_CIS_up"	13693	2092406	1965718	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000113"	32464	"41198-08-7"	"Profenofos"	"C41198087"	117	"ATG_ERa_TRANS_up"	49618	2171781	2037706	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000113"	32464	"41198-08-7"	"Profenofos"	"C41198087"	117	"ATG_ERa_TRANS_up"	50277	2171781	2037706	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000115"	22111	"709-98-8"	"Propanil"	"C709988"	75	"ATG_ERE_CIS_up"	13474	2092404	1965720	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000118"	21948	"114-26-1"	"Propoxur"	"C114261"	75	"ATG_ERE_CIS_up"	13245	2092402	1965722	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000121"	24337	"28249-77-6"	"Thiobencarb"	"C28249776"	75	"ATG_ERE_CIS_up"	13473	2092399	1965725	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000122"	24338	"23564-05-8"	"Thiophanate-methyl"	"C23564058"	75	"ATG_ERE_CIS_up"	13244	2092398	1965726	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000122"	24338	"23564-05-8"	"Thiophanate-methyl"	"C23564058"	75	"ATG_ERE_CIS_up"	13472	2092398	1965726	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000124"	21389	"52-68-6"	"Trichlorfon"	"C52686"	75	"ATG_ERE_CIS_up"	13243	2092396	1965728	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000124"	21389	"52-68-6"	"Trichlorfon"	"C52686"	75	"ATG_ERE_CIS_up"	13471	2092396	1965728	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000124"	21389	"52-68-6"	"Trichlorfon"	"C52686"	117	"ATG_ERa_TRANS_up"	49617	2171771	2037696	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000124"	21389	"52-68-6"	"Trichlorfon"	"C52686"	117	"ATG_ERa_TRANS_up"	50276	2171771	2037696	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000127"	24235	"85509-19-9"	"Flusilazole"	"C85509199"	75	"ATG_ERE_CIS_up"	13242	2092393	1965731	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000127"	24235	"85509-19-9"	"Flusilazole"	"C85509199"	75	"ATG_ERE_CIS_up"	13470	2092393	1965731	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000128"	32463	"86209-51-0"	"Primisulfuron-methyl"	"C86209510"	75	"ATG_ERE_CIS_up"	13241	2092392	1965732	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000128"	32463	"86209-51-0"	"Primisulfuron-methyl"	"C86209510"	75	"ATG_ERE_CIS_up"	13469	2092392	1965732	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000130"	34545	"110488-70-5"	"Dimethomorph"	"C110488705"	117	"ATG_ERa_TRANS_up"	49772	2171765	2037690	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000131"	34877	"53112-28-0"	"Pyrimethanil"	"C53112280"	75	"ATG_ERE_CIS_up"	13468	2092389	1965735	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000132"	24242	"76738-62-0"	"Paclobutrazol"	"C76738620"	75	"ATG_ERE_CIS_up"	13240	2092388	1965736	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000132"	24242	"76738-62-0"	"Paclobutrazol"	"C76738620"	75	"ATG_ERE_CIS_up"	13467	2092388	1965736	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000132"	24242	"76738-62-0"	"Paclobutrazol"	"C76738620"	117	"ATG_ERa_TRANS_up"	49646	2171763	2037688	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000132"	24242	"76738-62-0"	"Paclobutrazol"	"C76738620"	117	"ATG_ERa_TRANS_up"	50275	2171763	2037688	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000135"	32548	"114369-43-6"	"Fenbuconazole"	"C114369436"	75	"ATG_ERE_CIS_up"	13239	2092385	1965739	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000135"	32548	"114369-43-6"	"Fenbuconazole"	"C114369436"	75	"ATG_ERE_CIS_up"	13466	2092385	1965739	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000135"	32548	"114369-43-6"	"Fenbuconazole"	"C114369436"	117	"ATG_ERa_TRANS_up"	49771	2171760	2037685	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000135"	32548	"114369-43-6"	"Fenbuconazole"	"C114369436"	117	"ATG_ERa_TRANS_up"	50082	2171760	2037685	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000140"	32355	"81777-89-1"	"Clomazone"	"C81777891"	75	"ATG_ERE_CIS_up"	13692	2092380	1965744	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000140"	32355	"81777-89-1"	"Clomazone"	"C81777891"	117	"ATG_ERa_TRANS_up"	49616	2171755	2037680	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000140"	32355	"81777-89-1"	"Clomazone"	"C81777891"	117	"ATG_ERa_TRANS_up"	49833	2171755	2037680	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000141"	32354	"105512-06-9"	"Clodinafop-propargyl mixt."	"C105512069"	75	"ATG_ERE_CIS_up"	13465	2092379	1965745	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000142"	32550	"111812-58-9"	"Fenpyroximate (Z,E)"	"C111812589"	75	"ATG_ERE_CIS_up"	13464	2092378	1965746	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000146"	32552	"142459-58-3"	"Flufenacet"	"C142459583"	75	"ATG_ERE_CIS_up"	13238	2092374	1965750	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000146"	32552	"142459-58-3"	"Flufenacet"	"C142459583"	75	"ATG_ERE_CIS_up"	13463	2092374	1965750	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000148"	32376	"87674-68-8"	"Dimethenamid"	"C87674688"	75	"ATG_ERE_CIS_up"	13237	2092372	1965752	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000152"	34212	"118134-30-8"	"Spiroxamine"	"C118134308"	75	"ATG_ERE_CIS_up"	13236	2092368	1965756	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000152"	34212	"118134-30-8"	"Spiroxamine"	"C118134308"	75	"ATG_ERE_CIS_up"	13462	2092368	1965756	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000153"	34609	"120068-37-3"	"Fipronil"	"C120068373"	75	"ATG_ERE_CIS_up"	13690	2092367	1965757	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000153"	34609	"120068-37-3"	"Fipronil"	"C120068373"	117	"ATG_ERa_TRANS_up"	50274	2171742	2037667	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000157"	24216	"1929-82-4"	"Nitrapyrin"	"C1929824"	75	"ATG_ERE_CIS_up"	13461	2092363	1965761	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000161"	32544	"136-45-8"	"Dipropyl pyridine-2,5-dicarboxylate"	"C136458"	75	"ATG_ERE_CIS_up"	13234	2092359	1965765	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000161"	32544	"136-45-8"	"Dipropyl pyridine-2,5-dicarboxylate"	"C136458"	75	"ATG_ERE_CIS_up"	13460	2092359	1965765	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000162"	34303	"81406-37-3"	"Fluroxypyr-meptyl"	"C81406373"	75	"ATG_ERE_CIS_up"	13688	2092358	1965766	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000166"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	75	"ATG_ERE_CIS_up"	13233	2092354	1965770	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000166"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	75	"ATG_ERE_CIS_up"	13459	2092354	1965770	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000167"	34402	"23184-66-9"	"Butachlor"	"C23184669"	117	"ATG_ERa_TRANS_up"	50080	2171728	2037653	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000175"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	75	"ATG_ERE_CIS_up"	13687	2092345	1965780	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000177"	23936	"2008-41-5"	"Butylate"	"C2008415"	75	"ATG_ERE_CIS_up"	13181	2092343	1965781	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000177"	23936	"2008-41-5"	"Butylate"	"C2008415"	75	"ATG_ERE_CIS_up"	13686	2092343	1965781	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000181"	21385	"133-07-3"	"Folpet"	"C133073"	75	"ATG_ERE_CIS_up"	13458	2092339	1965785	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000181"	21385	"133-07-3"	"Folpet"	"C133073"	117	"ATG_ERa_TRANS_up"	49614	2171714	2037639	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000181"	21385	"133-07-3"	"Folpet"	"C133073"	117	"ATG_ERa_TRANS_up"	50272	2171714	2037639	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000182"	32405	"23422-53-9"	"Formetanate hydrochloride"	"C23422539"	75	"ATG_ERE_CIS_up"	13133	2092338	1965786	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000182"	32405	"23422-53-9"	"Formetanate hydrochloride"	"C23422539"	75	"ATG_ERE_CIS_up"	13685	2092338	1965786	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000183"	24317	"5902-51-2"	"Terbacil"	"C5902512"	75	"ATG_ERE_CIS_up"	13180	2092337	1965787	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000183"	24317	"5902-51-2"	"Terbacil"	"C5902512"	75	"ATG_ERE_CIS_up"	13684	2092337	1965787	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000185"	20764	"101-21-3"	"Chlorpropham"	"C101213"	75	"ATG_ERE_CIS_up"	13457	2092335	1965789	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000186"	20420	"23950-58-5"	"Propyzamide"	"C23950585"	75	"ATG_ERE_CIS_up"	13456	2092334	1965790	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000187"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	75	"ATG_ERE_CIS_up"	13455	2092333	1965791	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000187"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	117	"ATG_ERa_TRANS_up"	50079	2171708	2037633	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000188"	32372	"119446-68-3"	"Difenoconazole"	"C119446683"	117	"ATG_ERa_TRANS_up"	50078	2171707	2037632	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000191"	32673	"123343-16-8"	"Pyrithiobac-sodium"	"C123343168"	75	"ATG_ERE_CIS_up"	13454	2092329	1965795	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000192"	34392	"188425-85-6"	"Boscalid"	"C188425856"	117	"ATG_ERa_TRANS_up"	49770	2171703	2037628	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000192"	34392	"188425-85-6"	"Boscalid"	"C188425856"	117	"ATG_ERa_TRANS_up"	50077	2171703	2037628	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000195"	22253	"10453-86-8"	"Resmethrin"	"C10453868"	75	"ATG_ERE_CIS_up"	13232	2092325	1965800	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000195"	22253	"10453-86-8"	"Resmethrin"	"C10453868"	75	"ATG_ERE_CIS_up"	13453	2092325	1965800	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000197"	32649	"7696-12-0"	"Tetramethrin"	"C7696120"	117	"ATG_ERa_TRANS_up"	49769	2171699	2037624	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000197"	32649	"7696-12-0"	"Tetramethrin"	"C7696120"	117	"ATG_ERa_TRANS_up"	50076	2171699	2037624	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000199"	32601	"94361-06-5"	"Cyproconazole"	"C94361065"	75	"ATG_ERE_CIS_up"	13132	2092322	1965802	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000199"	32601	"94361-06-5"	"Cyproconazole"	"C94361065"	75	"ATG_ERE_CIS_up"	13683	2092322	1965802	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000201"	34872	"1698-60-8"	"Chloridazon"	"C1698608"	75	"ATG_ERE_CIS_up"	13452	2092320	1965804	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000202"	24316	"34014-18-1"	"Tebuthiuron"	"C34014181"	75	"ATG_ERE_CIS_up"	13451	2092319	1965805	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000204"	32611	"13194-48-4"	"Ethoprop"	"C13194484"	75	"ATG_ERE_CIS_up"	13450	2092317	1965807	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000204"	32611	"13194-48-4"	"Ethoprop"	"C13194484"	117	"ATG_ERa_TRANS_up"	50075	2171692	2037617	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000206"	32547	"2593-15-9"	"Etridiazole"	"C2593159"	117	"ATG_ERa_TRANS_up"	50074	2171690	2037615	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000208"	32667	"66230-04-4"	"Esfenvalerate"	"C66230044"	75	"ATG_ERE_CIS_up"	13231	2092313	1965811	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000208"	32667	"66230-04-4"	"Esfenvalerate"	"C66230044"	75	"ATG_ERE_CIS_up"	13449	2092313	1965811	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000209"	24344	"2303-17-5"	"Tri-allate"	"C2303175"	75	"ATG_ERE_CIS_up"	13131	2092312	1965812	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000209"	24344	"2303-17-5"	"Tri-allate"	"C2303175"	75	"ATG_ERE_CIS_up"	13357	2092312	1965812	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000209"	24344	"2303-17-5"	"Tri-allate"	"C2303175"	75	"ATG_ERE_CIS_up"	13682	2092312	1965812	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000209"	24344	"2303-17-5"	"Tri-allate"	"C2303175"	117	"ATG_ERa_TRANS_up"	50073	2171687	2037612	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000210"	34580	"26225-79-6"	"Ethofumesate"	"C26225796"	75	"ATG_ERE_CIS_up"	13230	2092311	1965813	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000210"	34580	"26225-79-6"	"Ethofumesate"	"C26225796"	75	"ATG_ERE_CIS_up"	13448	2092311	1965813	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000211"	24206	"2212-67-1"	"Molinate"	"C2212671"	75	"ATG_ERE_CIS_up"	13447	2092310	1965814	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000212"	34364	"144651-06-9"	"Oxasulfuron"	"C144651069"	75	"ATG_ERE_CIS_up"	13130	2092309	1965815	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000215"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	75	"ATG_ERE_CIS_up"	13356	2092306	1965818	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000215"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	75	"ATG_ERE_CIS_up"	13681	2092306	1965818	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000219"	34723	"141112-29-0"	"Isoxaflutole"	"C141112290"	75	"ATG_ERE_CIS_up"	13229	2092302	1965822	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000221"	32327	"22781-23-3"	"Bendiocarb"	"C22781233"	117	"ATG_ERa_TRANS_up"	50072	2171675	2037600	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000224"	32562	"113-48-4"	"MGK-264"	"C113484"	117	"ATG_ERa_TRANS_up"	49613	2171672	2037597	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000224"	32562	"113-48-4"	"MGK-264"	"C113484"	117	"ATG_ERa_TRANS_up"	50271	2171672	2037597	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000230"	32555	"103361-09-7"	"Flumioxazin"	"C103361097"	75	"ATG_ERE_CIS_up"	13228	2092291	1965833	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000230"	32555	"103361-09-7"	"Flumioxazin"	"C103361097"	75	"ATG_ERE_CIS_up"	13446	2092291	1965833	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000232"	32359	"121552-61-2"	"Cyprodinil"	"C121552612"	75	"ATG_ERE_CIS_up"	13680	2092290	1965834	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000232"	32359	"121552-61-2"	"Cyprodinil"	"C121552612"	117	"ATG_ERa_TRANS_up"	50270	2171665	2037590	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000233"	34956	"112281-77-3"	"Tetraconazole"	"C112281773"	75	"ATG_ERE_CIS_up"	13445	2092289	1965835	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000233"	34956	"112281-77-3"	"Tetraconazole"	"C112281773"	117	"ATG_ERa_TRANS_up"	50269	2171664	2037589	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000237"	24239	"19666-30-9"	"Oxadiazon"	"C19666309"	75	"ATG_ERE_CIS_up"	13679	2092287	1965837	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000238"	32356	"1134-23-2"	"Cycloate"	"C1134232"	117	"ATG_ERa_TRANS_up"	49612	2171661	2037586	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000238"	32356	"1134-23-2"	"Cycloate"	"C1134232"	117	"ATG_ERa_TRANS_up"	49832	2171661	2037586	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000238"	32356	"1134-23-2"	"Cycloate"	"C1134232"	117	"ATG_ERa_TRANS_up"	50268	2171661	2037586	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000242"	24315	"88671-89-0"	"Myclobutanil"	"C88671890"	75	"ATG_ERE_CIS_up"	13678	2092282	1965842	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000242"	24315	"88671-89-0"	"Myclobutanil"	"C88671890"	117	"ATG_ERa_TRANS_up"	49611	2171657	2037582	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000242"	24315	"88671-89-0"	"Myclobutanil"	"C88671890"	117	"ATG_ERa_TRANS_up"	49831	2171657	2037582	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000242"	24315	"88671-89-0"	"Myclobutanil"	"C88671890"	117	"ATG_ERa_TRANS_up"	50267	2171657	2037582	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000245"	20819	"950-37-8"	"Methidathion"	"C950378"	75	"ATG_ERE_CIS_up"	13129	2092279	1965845	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000245"	20819	"950-37-8"	"Methidathion"	"C950378"	75	"ATG_ERE_CIS_up"	13677	2092279	1965845	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000245"	20819	"950-37-8"	"Methidathion"	"C950378"	117	"ATG_ERa_TRANS_up"	50071	2171654	2037579	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000246"	32482	"96182-53-5"	"Tebupirimfos"	"C96182535"	117	"ATG_ERa_TRANS_up"	49610	2171653	2037578	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000246"	32482	"96182-53-5"	"Tebupirimfos"	"C96182535"	117	"ATG_ERa_TRANS_up"	50266	2171653	2037578	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000249"	34653	"79983-71-4"	"Hexaconazole"	"C79983714"	75	"ATG_ERE_CIS_up"	13676	2092275	1965849	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000250"	34612	"69806-50-4"	"Fluazifop-butyl"	"C69806504"	75	"ATG_ERE_CIS_up"	13444	2092274	1965850	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000252"	32577	"79538-32-2"	"Tefluthrin"	"C79538322"	75	"ATG_ERE_CIS_up"	13443	2092272	1965852	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000252"	32577	"79538-32-2"	"Tefluthrin"	"C79538322"	117	"ATG_ERa_TRANS_up"	49609	2171647	2037572	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000252"	32577	"79538-32-2"	"Tefluthrin"	"C79538322"	117	"ATG_ERa_TRANS_up"	50265	2171647	2037572	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000255"	32554	"87546-18-7"	"Flumiclorac-pentyl"	"C87546187"	75	"ATG_ERE_CIS_up"	13227	2092269	1965855	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000255"	32554	"87546-18-7"	"Flumiclorac-pentyl"	"C87546187"	75	"ATG_ERE_CIS_up"	13442	2092269	1965855	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000255"	32554	"87546-18-7"	"Flumiclorac-pentyl"	"C87546187"	117	"ATG_ERa_TRANS_up"	50070	2171644	2037569	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000257"	32551	"79622-59-6"	"Fluazinam"	"C79622596"	75	"ATG_ERE_CIS_up"	13441	2092267	1965857	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000260"	34676	"42509-80-8"	"Isazofos"	"C42509808"	75	"ATG_ERE_CIS_up"	13675	2092264	1965860	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000262"	24902	"533-74-4"	"Dazomet"	"C533744"	75	"ATG_ERE_CIS_up"	13440	2092262	1965862	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000265"	32640	"95737-68-1"	"Pyriproxyfen"	"C95737681"	75	"ATG_ERE_CIS_up"	13674	2092259	1965865	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000268"	38666	"5598-15-2"	"Chlorpyrifos oxon"	"C5598152"	117	"ATG_ERa_TRANS_up"	49608	2171631	2037556	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000268"	38666	"5598-15-2"	"Chlorpyrifos oxon"	"C5598152"	117	"ATG_ERa_TRANS_up"	50264	2171631	2037556	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000273"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	75	"ATG_ERE_CIS_up"	13179	2092251	1965873	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000273"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	75	"ATG_ERE_CIS_up"	13673	2092251	1965873	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000273"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	117	"ATG_ERa_TRANS_up"	49830	2171626	2037551	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000273"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	117	"ATG_ERa_TRANS_up"	50263	2171626	2037551	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000277"	34855	"79241-46-6"	"Fluazifop-P-butyl"	"C79241466"	75	"ATG_ERE_CIS_up"	13128	2092247	1965877	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000278"	35180	"584-79-2"	"Allethrin"	"C584792"	75	"ATG_ERE_CIS_up"	13672	2092246	1965878	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000280"	40222	"199119-58-9"	"Trifloxysulfuron-sodium"	"C199119589"	75	"ATG_ERE_CIS_up"	13127	2092244	1965881	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000280"	40222	"199119-58-9"	"Trifloxysulfuron-sodium"	"C199119589"	75	"ATG_ERE_CIS_up"	13355	2092244	1965881	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000286"	34586	"153233-91-1"	"Etoxazole"	"C153233911"	75	"ATG_ERE_CIS_up"	13225	2092238	1965886	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000289"	32655	"131983-72-7"	"Triticonazole"	"C131983727"	75	"ATG_ERE_CIS_up"	13224	2092236	1965888	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000289"	32655	"131983-72-7"	"Triticonazole"	"C131983727"	75	"ATG_ERE_CIS_up"	13439	2092236	1965888	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000333"	32605	"51338-27-3"	"Diclofop-methyl"	"C51338273"	75	"ATG_ERE_CIS_up"	13223	2092228	1965896	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000341"	24272	"7287-19-6"	"Prometryn"	"C7287196"	75	"ATG_ERE_CIS_up"	13438	2092226	1965898	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000353"	20194	"10043-35-3"	"Boric acid"	"C10043353"	75	"ATG_ERE_CIS_up"	13437	2092223	1965902	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000354"	32580	"141517-21-7"	"Trifloxystrobin"	"C141517217"	117	"ATG_ERa_TRANS_up"	50067	2171597	2037522	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000363"	35957	"68359-37-5"	"Cyfluthrin"	"C68359375"	75	"ATG_ERE_CIS_up"	13436	2092215	1965909	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000371"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	117	"ATG_ERa_TRANS_up"	49829	2171584	2037509	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000373"	34496	"127277-53-6"	"Prohexadione-calcium"	"C127277536"	75	"ATG_ERE_CIS_up"	13435	2092207	1965917	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000374"	40755	"113776-20-8"	"Fenoxaprop-(2S)-ethyl"	"C113776208"	75	"ATG_ERE_CIS_up"	13434	2092206	1965918	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000376"	34737	"9006-42-2"	"Metiram"	"C9006422"	75	"ATG_ERE_CIS_up"	13222	2092205	1965919	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TV000382"	20790	"1634-78-2"	"Malaoxon"	"C1634782"	75	"ATG_ERE_CIS_up"	13124	2092203	1965921	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000391"	22325	"2971-36-0"	"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane"	"C2971360"	117	"ATG_ERa_TRANS_up"	49828	2171571	2037496	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TV000392"	20247	"63-25-2"	"Carbaryl"	"C63252"	75	"ATG_ERE_CIS_up"	13669	2092195	1965929	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000392"	20247	"63-25-2"	"Carbaryl"	"C63252"	117	"ATG_ERa_TRANS_up"	50262	2171570	2037495	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000393"	39336	"28434-00-6"	"S-Bioallethrin"	"C28434006"	75	"ATG_ERE_CIS_up"	13433	2092194	1965930	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TV000396"	32532	"128639-02-1"	"Carfentrazone-ethyl"	"C128639021"	75	"ATG_ERE_CIS_up"	13123	2092192	1965932	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TV000396"	32532	"128639-02-1"	"Carfentrazone-ethyl"	"C128639021"	75	"ATG_ERE_CIS_up"	13668	2092192	1965932	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000401"	31865	"335-67-1"	"PFOA"	"C335671"	117	"ATG_ERa_TRANS_up"	50261	2171565	2037490	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TV000512"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	708	"NVS_NR_bER"	516236	2706382	2695342	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000512"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	714	"NVS_NR_hER"	517859	2708546	2697823	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000514"	32358	"57966-95-7"	"Cymoxanil"	"C57966957"	714	"NVS_NR_hER"	517743	2708547	2697824	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000517"	28038	"55406-53-6"	"3-Iodo-2-propynyl-N-butylcarbamate"	"C55406536"	725	"NVS_NR_mERa"	517021	2709863	2699140	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000517"	28038	"55406-53-6"	"3-Iodo-2-propynyl-N-butylcarbamate"	"C55406536"	725	"NVS_NR_mERa"	517412	2709863	2699140	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000523"	32642	"122931-48-0"	"Rimsulfuron"	"C122931480"	714	"NVS_NR_hER"	517744	2708553	2697830	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000529"	21248	"83-79-4"	"Rotenone"	"C83794"	714	"NVS_NR_hER"	517745	2708556	2697833	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000539"	20440	"120-36-5"	"Dichlorprop"	"C120365"	714	"NVS_NR_hER"	517746	2708560	2697837	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000548"	23864	"74223-64-6"	"Metsulfuron-methyl"	"C74223646"	708	"NVS_NR_bER"	516359	2706402	2695362	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000548"	23864	"74223-64-6"	"Metsulfuron-methyl"	"C74223646"	714	"NVS_NR_hER"	517747	2708567	2697844	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000573"	20620	"55-38-9"	"Fenthion"	"C55389"	714	"NVS_NR_hER"	517861	2708580	2697857	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000574"	21268	"122-34-9"	"Simazine"	"C122349"	708	"NVS_NR_bER"	516237	2706416	2695376	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000574"	21268	"122-34-9"	"Simazine"	"C122349"	708	"NVS_NR_bER"	516360	2706416	2695376	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000590"	20479	"60-51-5"	"Dimethoate"	"C60515"	708	"NVS_NR_bER"	516223	2706425	2695385	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TV000590"	20479	"60-51-5"	"Dimethoate"	"C60515"	708	"NVS_NR_bER"	516338	2706425	2695385	11	"Borderline active"	NA	NA	"percent_activity"
"TV000590"	20479	"60-51-5"	"Dimethoate"	"C60515"	708	"NVS_NR_bER"	516425	2706425	2695385	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TV000590"	20479	"60-51-5"	"Dimethoate"	"C60515"	708	"NVS_NR_bER"	516472	2706425	2695385	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TV000597"	34818	"35575-96-3"	"Azamethiphos"	"C35575963"	714	"NVS_NR_hER"	517748	2708594	2697871	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000615"	32464	"41198-08-7"	"Profenofos"	"C41198087"	714	"NVS_NR_hER"	517749	2708604	2697881	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000621"	22455	"131-11-3"	"Dimethyl phthalate"	"C131113"	725	"NVS_NR_mERa"	517023	2709875	2699152	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000621"	22455	"131-11-3"	"Dimethyl phthalate"	"C131113"	725	"NVS_NR_mERa"	517413	2709875	2699152	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000622"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	708	"NVS_NR_bER"	516238	2706446	2695406	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000622"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	708	"NVS_NR_bER"	516362	2706446	2695406	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000622"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	714	"NVS_NR_hER"	517750	2708611	2697888	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000630"	20247	"63-25-2"	"Carbaryl"	"C63252"	725	"NVS_NR_mERa"	517024	2709878	2699155	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000641"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	708	"NVS_NR_bER"	516224	2706456	2695416	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TV000641"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	708	"NVS_NR_bER"	516339	2706456	2695416	11	"Borderline active"	NA	NA	"percent_activity"
"TV000641"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	708	"NVS_NR_bER"	516419	2706456	2695416	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TV000641"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	708	"NVS_NR_bER"	516426	2706456	2695416	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TV000641"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	708	"NVS_NR_bER"	516473	2706456	2695416	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TV000654"	21086	"23135-22-0"	"Oxamyl"	"C23135220"	714	"NVS_NR_hER"	517751	2708628	2697905	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000674"	24245	"40487-42-1"	"Pendimethalin"	"C40487421"	708	"NVS_NR_bER"	516363	2706473	2695433	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000705"	37495	"1007-28-9"	"Deisopropylatrazine"	"C1007289"	708	"NVS_NR_bER"	516225	2706491	2695451	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TV000705"	37495	"1007-28-9"	"Deisopropylatrazine"	"C1007289"	708	"NVS_NR_bER"	516420	2706491	2695451	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TV000705"	37495	"1007-28-9"	"Deisopropylatrazine"	"C1007289"	708	"NVS_NR_bER"	516427	2706491	2695451	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TV000716"	32442	"138261-41-3"	"Imidacloprid"	"C138261413"	714	"NVS_NR_hER"	517753	2708662	2697939	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000720"	34252	"149979-41-9"	"Tepraloxydim"	"C149979419"	708	"NVS_NR_bER"	516239	2706500	2695460	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000770"	24304	"74051-80-2"	"Sethoxydim"	"C74051802"	725	"NVS_NR_mERa"	517025	2709891	2699168	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TV000774"	40002	"131-70-4"	"Monobutyl phthalate"	"C131704"	714	"NVS_NR_hER"	517701	2708687	2697964	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TV000777"	32655	"131983-72-7"	"Triticonazole"	"C131983727"	725	"NVS_NR_mERa"	517414	2709892	2699169	12	"Borderline inactive"	NA	NA	"percent_activity"
"TV000781"	34803	"219714-96-2"	"Penoxsulam"	"C219714962"	714	"NVS_NR_hER"	517754	2708689	2697966	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000097"	47528	"58394-64-2"	"Benzyloctyl adipate"	"C58394642"	2	"ACEA_T47D_80hr_Positive"	10506	1777803	1781602	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000657"	34881	"124495-18-7"	"Quinoxyfen"	"C124495187"	751	"OT_ERa_EREGFP_0480"	116703	564474	567513	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000661"	24159	"82558-50-7"	"Isoxaben"	"C82558507"	742	"OT_ER_ERaERa_0480"	114975	554623	563564	10	"Noisy data"	NA	NA	"percent_activity"
"TX000667"	34653	"79983-71-4"	"Hexaconazole"	"C79983714"	746	"OT_ER_ERbERb_0480"	116585	548442	557657	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000667"	34653	"79983-71-4"	"Hexaconazole"	"C79983714"	746	"OT_ER_ERbERb_0480"	116618	548442	557657	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000669"	24235	"85509-19-9"	"Flusilazole"	"C85509199"	750	"OT_ERa_EREGFP_0120"	115556	571473	565541	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000669"	24235	"85509-19-9"	"Flusilazole"	"C85509199"	751	"OT_ERa_EREGFP_0480"	116704	564480	567519	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000671"	34303	"81406-37-3"	"Fluroxypyr-meptyl"	"C81406373"	742	"OT_ER_ERaERa_0480"	114925	554628	563569	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000671"	34303	"81406-37-3"	"Fluroxypyr-meptyl"	"C81406373"	744	"OT_ER_ERaERb_0480"	112872	2402528	2398608	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX000671"	34303	"81406-37-3"	"Fluroxypyr-meptyl"	"C81406373"	744	"OT_ER_ERaERb_0480"	112977	2402528	2398608	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX000671"	34303	"81406-37-3"	"Fluroxypyr-meptyl"	"C81406373"	746	"OT_ER_ERbERb_0480"	116619	548444	557659	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000677"	34625	"361377-29-9"	"Fluoxastrobin"	"C361377299"	2	"ACEA_T47D_80hr_Positive"	10729	1777813	1781592	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX000683"	34545	"110488-70-5"	"Dimethomorph"	"C110488705"	750	"OT_ERa_EREGFP_0120"	115557	571478	565546	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000689"	35957	"68359-37-5"	"Cyfluthrin"	"C68359375"	750	"OT_ERa_EREGFP_0120"	115558	571481	565549	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000689"	35957	"68359-37-5"	"Cyfluthrin"	"C68359375"	751	"OT_ERa_EREGFP_0480"	116705	564488	567527	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000691"	32605	"51338-27-3"	"Diclofop-methyl"	"C51338273"	746	"OT_ER_ERbERb_0480"	116620	548452	557667	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000691"	32605	"51338-27-3"	"Diclofop-methyl"	"C51338273"	750	"OT_ERa_EREGFP_0120"	115559	571482	565550	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000693"	22341	"1610-18-0"	"Prometon"	"C1610180"	2	"ACEA_T47D_80hr_Positive"	10247	1777820	1781585	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000693"	22341	"1610-18-0"	"Prometon"	"C1610180"	742	"OT_ER_ERaERa_0480"	114996	554637	563578	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000693"	22341	"1610-18-0"	"Prometon"	"C1610180"	742	"OT_ER_ERaERa_0480"	115057	554637	563578	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX000695"	20407	"333-41-5"	"Diazinon"	"C333415"	745	"OT_ER_ERaERb_1440"	115469	556611	535380	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000695"	20407	"333-41-5"	"Diazinon"	"C333415"	747	"OT_ER_ERbERb_1440"	114768	558579	559642	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000695"	20407	"333-41-5"	"Diazinon"	"C333415"	747	"OT_ER_ERbERb_1440"	114854	558579	559642	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000695"	20407	"333-41-5"	"Diazinon"	"C333415"	750	"OT_ERa_EREGFP_0120"	115560	571484	565552	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000695"	20407	"333-41-5"	"Diazinon"	"C333415"	751	"OT_ERa_EREGFP_0480"	116899	564491	567530	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000696"	24002	"39515-41-8"	"Fenpropathrin"	"C39515418"	744	"OT_ER_ERaERb_0480"	112975	2402517	2398616	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000698"	24152	"81335-37-7"	"Imazaquin"	"C81335377"	2	"ACEA_T47D_80hr_Positive"	10507	1777823	1781582	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000700"	32667	"66230-04-4"	"Esfenvalerate"	"C66230044"	747	"OT_ER_ERbERb_1440"	114769	558582	559645	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000708"	24234	"27314-13-2"	"Norflurazon"	"C27314132"	2	"ACEA_T47D_80hr_Positive"	10248	1777827	1781578	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000710"	32329	"741-58-2"	"Bensulide"	"C741582"	750	"OT_ERa_EREGFP_0120"	115561	571491	565559	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000710"	32329	"741-58-2"	"Bensulide"	"C741582"	751	"OT_ERa_EREGFP_0480"	116706	564498	567537	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000713"	23892	"71751-41-2"	"Abamectin"	"C71751412"	750	"OT_ERa_EREGFP_0120"	115562	571493	565561	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000713"	23892	"71751-41-2"	"Abamectin"	"C71751412"	751	"OT_ERa_EREGFP_0480"	116707	564500	567539	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000717"	37495	"1007-28-9"	"Deisopropylatrazine"	"C1007289"	2	"ACEA_T47D_80hr_Positive"	10249	1777832	1781573	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000717"	37495	"1007-28-9"	"Deisopropylatrazine"	"C1007289"	2	"ACEA_T47D_80hr_Positive"	10508	1777832	1781573	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000725"	34877	"53112-28-0"	"Pyrimethanil"	"C53112280"	2	"ACEA_T47D_80hr_Positive"	10509	1777836	1781570	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000728"	34665	"81334-34-1"	"Imazapyr"	"C81334341"	2	"ACEA_T47D_80hr_Positive"	10250	1777837	1781568	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000732"	34212	"118134-30-8"	"Spiroxamine"	"C118134308"	750	"OT_ERa_EREGFP_0120"	115563	571502	565570	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000732"	34212	"118134-30-8"	"Spiroxamine"	"C118134308"	751	"OT_ERa_EREGFP_0480"	116708	564509	567548	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000734"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	2	"ACEA_T47D_80hr_Positive"	10251	1777840	1781565	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000734"	24299	"78587-05-0"	"Hexythiazox"	"C78587050"	750	"OT_ERa_EREGFP_0120"	115564	571503	565571	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000736"	32569	"23103-98-2"	"Pirimicarb"	"C23103982"	2	"ACEA_T47D_80hr_Positive"	10222	1777841	1781564	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX000736"	32569	"23103-98-2"	"Pirimicarb"	"C23103982"	2	"ACEA_T47D_80hr_Positive"	10730	1777841	1781564	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX000736"	32569	"23103-98-2"	"Pirimicarb"	"C23103982"	750	"OT_ERa_EREGFP_0120"	115565	571504	565572	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000740"	34252	"149979-41-9"	"Tepraloxydim"	"C149979419"	2	"ACEA_T47D_80hr_Positive"	10510	1777843	1781562	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000750"	34818	"35575-96-3"	"Azamethiphos"	"C35575963"	751	"OT_ERa_EREGFP_0480"	116709	564516	567555	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000752"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	2	"ACEA_T47D_80hr_Positive"	10252	1777847	1781559	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000752"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	2	"ACEA_T47D_80hr_Positive"	10511	1777847	1781559	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000754"	23998	"52315-07-8"	"Cypermethrin"	"C52315078"	2	"ACEA_T47D_80hr_Positive"	10512	1777848	1781557	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000757"	32355	"81777-89-1"	"Clomazone"	"C81777891"	750	"OT_ERa_EREGFP_0120"	115566	571512	565580	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000761"	32549	"126833-17-8"	"Fenhexamid"	"C126833178"	2	"ACEA_T47D_80hr_Positive"	10223	1777851	1781554	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX000763"	21086	"23135-22-0"	"Oxamyl"	"C23135220"	2	"ACEA_T47D_80hr_Positive"	10253	1777852	1781553	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000765"	32580	"141517-21-7"	"Trifloxystrobin"	"C141517217"	2	"ACEA_T47D_80hr_Positive"	10224	1777853	1781552	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX000767"	32552	"142459-58-3"	"Flufenacet"	"C142459583"	750	"OT_ERa_EREGFP_0120"	115567	571517	565585	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000773"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	2	"ACEA_T47D_80hr_Positive"	10254	1777857	1781548	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000773"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	2	"ACEA_T47D_80hr_Positive"	10513	1777857	1781548	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000773"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	751	"OT_ERa_EREGFP_0480"	116710	564527	567566	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000777"	32551	"79622-59-6"	"Fluazinam"	"C79622596"	750	"OT_ERa_EREGFP_0120"	115539	571521	565589	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX000779"	32359	"121552-61-2"	"Cyprodinil"	"C121552612"	744	"OT_ER_ERaERb_0480"	112883	2402480	2398653	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000779"	32359	"121552-61-2"	"Cyprodinil"	"C121552612"	744	"OT_ER_ERaERb_0480"	112974	2402480	2398653	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000779"	32359	"121552-61-2"	"Cyprodinil"	"C121552612"	746	"OT_ER_ERbERb_0480"	116541	548492	557707	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX000781"	32392	"66441-23-4"	"Fenoxaprop-ethyl"	"C66441234"	2	"ACEA_T47D_80hr_Positive"	10255	1777860	1781545	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000781"	32392	"66441-23-4"	"Fenoxaprop-ethyl"	"C66441234"	2	"ACEA_T47D_80hr_Positive"	10514	1777860	1781545	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000783"	24337	"28249-77-6"	"Thiobencarb"	"C28249776"	746	"OT_ER_ERbERb_0480"	116621	548494	557709	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000785"	32372	"119446-68-3"	"Difenoconazole"	"C119446683"	2	"ACEA_T47D_80hr_Positive"	10515	1777862	1781544	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000785"	32372	"119446-68-3"	"Difenoconazole"	"C119446683"	750	"OT_ERa_EREGFP_0120"	115822	571525	565593	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000787"	32649	"7696-12-0"	"Tetramethrin"	"C7696120"	2	"ACEA_T47D_80hr_Positive"	10516	1777863	1781542	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000793"	22448	"51218-45-2"	"Metolachlor"	"C51218452"	2	"ACEA_T47D_80hr_Positive"	10517	1777865	1781541	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000793"	22448	"51218-45-2"	"Metolachlor"	"C51218452"	750	"OT_ERa_EREGFP_0120"	115568	571528	565596	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000801"	34300	"135410-20-7"	"Acetamiprid"	"C135410207"	2	"ACEA_T47D_80hr_Positive"	10518	1777868	1781537	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000803"	34590	"161326-34-7"	"Fenamidone"	"C161326347"	2	"ACEA_T47D_80hr_Positive"	10154	1777869	1781536	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX000803"	34590	"161326-34-7"	"Fenamidone"	"C161326347"	751	"OT_ERa_EREGFP_0480"	116711	564539	567578	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000811"	34664	"114311-32-9"	"Imazamox"	"C114311329"	751	"OT_ERa_EREGFP_0480"	116712	564541	567580	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000814"	23990	"21725-46-2"	"Cyanazine"	"C21725462"	2	"ACEA_T47D_80hr_Positive"	10519	1777872	1781533	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000814"	23990	"21725-46-2"	"Cyanazine"	"C21725462"	742	"OT_ER_ERaERa_0480"	114926	554689	563630	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000814"	23990	"21725-46-2"	"Cyanazine"	"C21725462"	742	"OT_ER_ERaERa_0480"	114997	554689	563630	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000815"	20370	"1596-84-5"	"Daminozide"	"C1596845"	743	"OT_ER_ERaERa_1440"	114362	550479	561662	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000815"	20370	"1596-84-5"	"Daminozide"	"C1596845"	744	"OT_ER_ERaERb_0480"	112882	2402466	2398672	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000815"	20370	"1596-84-5"	"Daminozide"	"C1596845"	744	"OT_ER_ERaERb_0480"	112973	2402466	2398672	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000815"	20370	"1596-84-5"	"Daminozide"	"C1596845"	750	"OT_ERa_EREGFP_0120"	115823	571536	565604	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000818"	23871	"33089-61-1"	"Amitraz"	"C33089611"	751	"OT_ERa_EREGFP_0480"	116713	564544	567583	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000826"	32553	"62924-70-3"	"Flumetralin"	"C62924703"	743	"OT_ER_ERaERa_1440"	114363	550484	561667	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000826"	32553	"62924-70-3"	"Flumetralin"	"C62924703"	743	"OT_ER_ERaERa_1440"	114481	550484	561667	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000826"	32553	"62924-70-3"	"Flumetralin"	"C62924703"	746	"OT_ER_ERbERb_0480"	116586	548511	557726	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000826"	32553	"62924-70-3"	"Flumetralin"	"C62924703"	746	"OT_ER_ERbERb_0480"	116622	548511	557726	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000832"	20089	"101-05-3"	"Anilazine"	"C101053"	2	"ACEA_T47D_80hr_Positive"	10387	1777880	1781525	10	"Noisy data"	NA	NA	"percent_activity"
"TX000834"	32638	"175013-18-0"	"Pyraclostrobin"	"C175013180"	751	"OT_ERa_EREGFP_0480"	116714	564551	567590	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000838"	34580	"26225-79-6"	"Ethofumesate"	"C26225796"	744	"OT_ER_ERaERb_0480"	112972	2402457	2398679	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000840"	22020	"314-40-9"	"Bromacil"	"C314409"	2	"ACEA_T47D_80hr_Positive"	10256	1777883	1781522	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000842"	32386	"55283-68-6"	"Ethalfluralin"	"C55283686"	2	"ACEA_T47D_80hr_Positive"	10520	1777884	1781521	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000842"	32386	"55283-68-6"	"Ethalfluralin"	"C55283686"	742	"OT_ER_ERaERa_0480"	114927	554701	563642	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000842"	32386	"55283-68-6"	"Ethalfluralin"	"C55283686"	751	"OT_ERa_EREGFP_0480"	116715	564554	567593	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000842"	32386	"55283-68-6"	"Ethalfluralin"	"C55283686"	751	"OT_ERa_EREGFP_0480"	116900	564554	567593	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000854"	23412	"6153-64-6"	"Oxytetracycline dihydrate"	"C6153646"	742	"OT_ER_ERaERa_0480"	114998	554705	563646	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000854"	23412	"6153-64-6"	"Oxytetracycline dihydrate"	"C6153646"	744	"OT_ER_ERaERb_0480"	112971	2402451	2398682	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000858"	20154	"120-32-1"	"Clorophene"	"C120321"	75	"ATG_ERE_CIS_up"	13666	2092179	1965945	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX000858"	20154	"120-32-1"	"Clorophene"	"C120321"	708	"NVS_NR_bER"	516199	2706542	2695502	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX000858"	20154	"120-32-1"	"Clorophene"	"C120321"	708	"NVS_NR_bER"	516474	2706542	2695502	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX000862"	23999	"66215-27-8"	"Cyromazine"	"C66215278"	2	"ACEA_T47D_80hr_Positive"	10521	1777891	1781514	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000862"	23999	"66215-27-8"	"Cyromazine"	"C66215278"	751	"OT_ERa_EREGFP_0480"	116931	564561	567600	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX000864"	24154	"36734-19-7"	"Iprodione"	"C36734197"	2	"ACEA_T47D_80hr_Positive"	10522	1777892	1781513	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000872"	24216	"1929-82-4"	"Nitrapyrin"	"C1929824"	2	"ACEA_T47D_80hr_Positive"	10257	1777895	1781510	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000872"	24216	"1929-82-4"	"Nitrapyrin"	"C1929824"	2	"ACEA_T47D_80hr_Positive"	10523	1777895	1781510	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000872"	24216	"1929-82-4"	"Nitrapyrin"	"C1929824"	747	"OT_ER_ERbERb_1440"	114770	558653	559716	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000880"	34232	"101-10-0"	"Cloprop"	"C101100"	2	"ACEA_T47D_80hr_Positive"	10258	1777898	1781508	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000884"	26523	"87-90-1"	"Symclosene"	"C87901"	2	"ACEA_T47D_80hr_Positive"	10259	1777900	1781505	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000884"	26523	"87-90-1"	"Symclosene"	"C87901"	2	"ACEA_T47D_80hr_Positive"	10524	1777900	1781505	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000892"	34676	"42509-80-8"	"Isazofos"	"C42509808"	2	"ACEA_T47D_80hr_Positive"	10525	1777903	1781502	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000892"	34676	"42509-80-8"	"Isazofos"	"C42509808"	744	"OT_ER_ERaERb_0480"	112970	2402437	2398700	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000892"	34676	"42509-80-8"	"Isazofos"	"C42509808"	750	"OT_ERa_EREGFP_0120"	115569	571565	565633	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000892"	34676	"42509-80-8"	"Isazofos"	"C42509808"	751	"OT_ERa_EREGFP_0480"	116716	564572	567611	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000902"	24160	"77501-63-4"	"Lactofen"	"C77501634"	2	"ACEA_T47D_80hr_Positive"	10260	1777908	1781497	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000904"	24245	"40487-42-1"	"Pendimethalin"	"C40487421"	751	"OT_ERa_EREGFP_0480"	116717	564578	567617	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000906"	32550	"111812-58-9"	"Fenpyroximate (Z,E)"	"C111812589"	750	"OT_ERa_EREGFP_0120"	115570	571572	565640	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000906"	32550	"111812-58-9"	"Fenpyroximate (Z,E)"	"C111812589"	751	"OT_ERa_EREGFP_0480"	116718	564579	567618	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000908"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	2	"ACEA_T47D_80hr_Positive"	10440	1777911	1781494	11	"Borderline active"	NA	NA	"percent_activity"
"TX000908"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	744	"OT_ER_ERaERb_0480"	112906	2402429	2398703	11	"Borderline active"	NA	NA	"percent_activity"
"TX000908"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	746	"OT_ER_ERbERb_0480"	116623	548543	557758	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000908"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	750	"OT_ERa_EREGFP_0120"	115571	571573	565641	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000910"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	2	"ACEA_T47D_80hr_Positive"	10261	1777912	1781493	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000910"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	2	"ACEA_T47D_80hr_Positive"	10526	1777912	1781493	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000910"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	742	"OT_ER_ERaERa_0480"	114928	554728	563669	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000912"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	2	"ACEA_T47D_80hr_Positive"	10388	1777913	1781492	10	"Noisy data"	NA	NA	"percent_activity"
"TX000912"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	2	"ACEA_T47D_80hr_Positive"	10731	1777913	1781492	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX000912"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	742	"OT_ER_ERaERa_0480"	114929	554729	563670	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000912"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	750	"OT_ERa_EREGFP_0120"	115572	571575	565643	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000912"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	750	"OT_ERa_EREGFP_0120"	115824	571575	565643	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000912"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	751	"OT_ERa_EREGFP_0480"	116719	564582	567621	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000918"	20794	"12427-38-2"	"Maneb"	"C12427382"	2	"ACEA_T47D_80hr_Positive"	10527	1777916	1781489	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000920"	21389	"52-68-6"	"Trichlorfon"	"C52686"	742	"OT_ER_ERaERa_0480"	114999	554733	563674	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000920"	21389	"52-68-6"	"Trichlorfon"	"C52686"	743	"OT_ER_ERaERa_1440"	114364	550522	561705	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000920"	21389	"52-68-6"	"Trichlorfon"	"C52686"	744	"OT_ER_ERaERb_0480"	112905	2402423	2398706	11	"Borderline active"	NA	NA	"percent_activity"
"TX000920"	21389	"52-68-6"	"Trichlorfon"	"C52686"	750	"OT_ERa_EREGFP_0120"	115825	571579	565647	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000926"	24280	"60207-90-1"	"Propiconazole"	"C60207901"	751	"OT_ERa_EREGFP_0480"	116720	564589	567628	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000934"	24239	"19666-30-9"	"Oxadiazon"	"C19666309"	2	"ACEA_T47D_80hr_Positive"	10528	1777923	1781483	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000939"	21248	"83-79-4"	"Rotenone"	"C83794"	2	"ACEA_T47D_80hr_Positive"	10389	1777924	1781481	10	"Noisy data"	NA	NA	"percent_activity"
"TX000939"	21248	"83-79-4"	"Rotenone"	"C83794"	2	"ACEA_T47D_80hr_Positive"	10732	1777924	1781481	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX000944"	20620	"55-38-9"	"Fenthion"	"C55389"	744	"OT_ER_ERaERb_0480"	112867	2402415	2398718	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX000944"	20620	"55-38-9"	"Fenthion"	"C55389"	744	"OT_ER_ERaERb_0480"	112904	2402415	2398718	11	"Borderline active"	NA	NA	"percent_activity"
"TX000944"	20620	"55-38-9"	"Fenthion"	"C55389"	746	"OT_ER_ERbERb_0480"	116624	548557	557772	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000949"	22292	"52645-53-1"	"Permethrin"	"C52645531"	2	"ACEA_T47D_80hr_Positive"	10529	1777928	1781478	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000951"	32354	"105512-06-9"	"Clodinafop-propargyl mixt."	"C105512069"	750	"OT_ERa_EREGFP_0120"	115573	571591	565659	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000951"	32354	"105512-06-9"	"Clodinafop-propargyl mixt."	"C105512069"	750	"OT_ERa_EREGFP_0120"	115826	571591	565659	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000953"	20560	"115-29-7"	"Endosulfan"	"C115297"	744	"OT_ER_ERaERb_0480"	112881	2402409	2398723	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000953"	20560	"115-29-7"	"Endosulfan"	"C115297"	750	"OT_ERa_EREGFP_0120"	115574	571593	565661	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000953"	20560	"115-29-7"	"Endosulfan"	"C115297"	750	"OT_ERa_EREGFP_0120"	115827	571593	565661	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000953"	20560	"115-29-7"	"Endosulfan"	"C115297"	751	"OT_ERa_EREGFP_0480"	116721	564600	567639	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000955"	24259	"2310-17-0"	"Phosalone"	"C2310170"	746	"OT_ER_ERbERb_0480"	116587	548564	557779	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000959"	32393	"72490-01-8"	"Fenoxycarb"	"C72490018"	746	"OT_ER_ERbERb_0480"	116625	548566	557781	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000966"	20160	"82657-04-3"	"Bifenthrin"	"C82657043"	2	"ACEA_T47D_80hr_Positive"	10530	1777936	1781470	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000966"	20160	"82657-04-3"	"Bifenthrin"	"C82657043"	751	"OT_ERa_EREGFP_0480"	116722	564605	567644	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000969"	32548	"114369-43-6"	"Fenbuconazole"	"C114369436"	750	"OT_ERa_EREGFP_0120"	115828	571600	565668	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000971"	24170	"24307-26-4"	"Mepiquat chloride"	"C24307264"	2	"ACEA_T47D_80hr_Positive"	10531	1777939	1781466	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000973"	32640	"95737-68-1"	"Pyriproxyfen"	"C95737681"	750	"OT_ERa_EREGFP_0120"	115575	571602	565670	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000977"	34871	"129630-19-9"	"Pyraflufen-ethyl"	"C129630199"	2	"ACEA_T47D_80hr_Positive"	10532	1777941	1781464	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX000986"	23890	"3337-71-1"	"Asulam"	"C3337711"	750	"OT_ERa_EREGFP_0120"	115576	571605	565673	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX000999"	34816	"6923-22-4"	"Monocrotophos"	"C6923224"	750	"OT_ERa_EREGFP_0120"	115577	571609	565677	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001001"	24338	"23564-05-8"	"Thiophanate-methyl"	"C23564058"	2	"ACEA_T47D_80hr_Positive"	10262	1777948	1781458	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001019"	29600	"79-39-0"	"Methacrylamide"	"C79390"	2	"ACEA_T47D_80hr_Positive"	10263	1777951	1781455	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001019"	29600	"79-39-0"	"Methacrylamide"	"C79390"	2	"ACEA_T47D_80hr_Positive"	10533	1777951	1781455	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001025"	35288	"33956-49-9"	"Codlelure"	"C33956499"	75	"ATG_ERE_CIS_up"	13221	2092171	1965953	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001027"	41237	"99-86-5"	"alpha-Terpinene"	"C99865"	2	"ACEA_T47D_80hr_Positive"	10534	1777953	1781453	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001027"	41237	"99-86-5"	"alpha-Terpinene"	"C99865"	75	"ATG_ERE_CIS_up"	13431	2092170	1965954	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001027"	41237	"99-86-5"	"alpha-Terpinene"	"C99865"	117	"ATG_ERa_TRANS_up"	50064	2171545	2037470	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001027"	41237	"99-86-5"	"alpha-Terpinene"	"C99865"	744	"OT_ER_ERaERb_0480"	112866	2402387	2398746	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001027"	41237	"99-86-5"	"alpha-Terpinene"	"C99865"	744	"OT_ER_ERaERb_0480"	112903	2402387	2398746	11	"Borderline active"	NA	NA	"percent_activity"
"TX001029"	35175	"525-79-1"	"Kinetin"	"C525791"	743	"OT_ER_ERaERa_1440"	114365	550558	561741	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001029"	35175	"525-79-1"	"Kinetin"	"C525791"	745	"OT_ER_ERaERb_1440"	115396	556742	535511	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001029"	35175	"525-79-1"	"Kinetin"	"C525791"	745	"OT_ER_ERaERb_1440"	115470	556742	535511	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001031"	26252	"101-02-0"	"Triphenyl phosphite"	"C101020"	714	"NVS_NR_hER"	517865	2708712	2697989	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001031"	26252	"101-02-0"	"Triphenyl phosphite"	"C101020"	725	"NVS_NR_mERa"	517378	2709904	2699181	11	"Borderline active"	NA	NA	"percent_activity"
"TX001031"	26252	"101-02-0"	"Triphenyl phosphite"	"C101020"	725	"NVS_NR_mERa"	517611	2709904	2699181	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX001031"	26252	"101-02-0"	"Triphenyl phosphite"	"C101020"	744	"OT_ER_ERaERb_0480"	112969	2402385	2398748	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001031"	26252	"101-02-0"	"Triphenyl phosphite"	"C101020"	746	"OT_ER_ERbERb_0480"	116626	548587	557802	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001033"	42052	"95-13-6"	"Indene"	"C95136"	746	"OT_ER_ERbERb_0480"	116604	548588	557803	10	"Noisy data"	NA	NA	"percent_activity"
"TX001033"	42052	"95-13-6"	"Indene"	"C95136"	747	"OT_ER_ERbERb_1440"	114840	558712	559775	10	"Noisy data"	NA	NA	"percent_activity"
"TX001037"	40371	"140-56-7"	"Fenaminosulf"	"C140567"	75	"ATG_ERE_CIS_up"	13430	2092165	1965959	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001037"	40371	"140-56-7"	"Fenaminosulf"	"C140567"	751	"OT_ERa_EREGFP_0480"	116723	564627	567666	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001039"	40776	"654055-01-3"	"Morin hydrate"	"C654055013"	75	"ATG_ERE_CIS_up"	13328	2092164	1965961	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX001039"	40776	"654055-01-3"	"Morin hydrate"	"C654055013"	75	"ATG_ERE_CIS_up"	13665	2092164	1965961	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001039"	40776	"654055-01-3"	"Morin hydrate"	"C654055013"	117	"ATG_ERa_TRANS_up"	50258	2171539	2037464	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001039"	40776	"654055-01-3"	"Morin hydrate"	"C654055013"	708	"NVS_NR_bER"	516240	2706545	2695505	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001039"	40776	"654055-01-3"	"Morin hydrate"	"C654055013"	708	"NVS_NR_bER"	516365	2706545	2695505	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001055"	30060	"594-20-7"	"2,2-Dichloropropane"	"C594207"	75	"ATG_ERE_CIS_up"	13353	2092158	1965967	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX001055"	30060	"594-20-7"	"2,2-Dichloropropane"	"C594207"	117	"ATG_ERa_TRANS_up"	49606	2171533	2037458	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001059"	41550	"7540-51-4"	"(S)-(-)-beta-Citronellol"	"C7540514"	117	"ATG_ERa_TRANS_up"	49605	2171532	2037457	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001063"	35423	"571-58-4"	"1,4-Dimethylnaphthalene"	"C571584"	2	"ACEA_T47D_80hr_Positive"	10264	1777965	1781441	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001063"	35423	"571-58-4"	"1,4-Dimethylnaphthalene"	"C571584"	2	"ACEA_T47D_80hr_Positive"	10535	1777965	1781441	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001067"	41413	"6485-40-1"	"R-(-)-Carvone"	"C6485401"	2	"ACEA_T47D_80hr_Positive"	10441	1777966	1781439	11	"Borderline active"	NA	NA	"percent_activity"
"TX001067"	41413	"6485-40-1"	"R-(-)-Carvone"	"C6485401"	75	"ATG_ERE_CIS_up"	13121	2092154	1965970	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001067"	41413	"6485-40-1"	"R-(-)-Carvone"	"C6485401"	117	"ATG_ERa_TRANS_up"	50063	2171529	2037454	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001067"	41413	"6485-40-1"	"R-(-)-Carvone"	"C6485401"	708	"NVS_NR_bER"	516241	2706547	2695507	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001067"	41413	"6485-40-1"	"R-(-)-Carvone"	"C6485401"	750	"OT_ERa_EREGFP_0120"	115789	571628	565696	10	"Noisy data"	NA	NA	"percent_activity"
"TX001071"	25130	"28804-88-8"	"Dimethylnaphthalene"	"C28804888"	75	"ATG_ERE_CIS_up"	13120	2092152	1965972	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001071"	25130	"28804-88-8"	"Dimethylnaphthalene"	"C28804888"	75	"ATG_ERE_CIS_up"	13664	2092152	1965972	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001071"	25130	"28804-88-8"	"Dimethylnaphthalene"	"C28804888"	117	"ATG_ERa_TRANS_up"	49768	2171527	2037452	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001071"	25130	"28804-88-8"	"Dimethylnaphthalene"	"C28804888"	117	"ATG_ERa_TRANS_up"	50062	2171527	2037452	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001071"	25130	"28804-88-8"	"Dimethylnaphthalene"	"C28804888"	742	"OT_ER_ERaERa_0480"	115000	554784	563725	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001071"	25130	"28804-88-8"	"Dimethylnaphthalene"	"C28804888"	744	"OT_ER_ERaERb_0480"	112968	2402372	2398761	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001085"	20151	"140-11-4"	"Benzyl acetate"	"C140114"	2	"ACEA_T47D_80hr_Positive"	10442	1777970	1781436	11	"Borderline active"	NA	NA	"percent_activity"
"TX001111"	29304	"11099-07-3"	"Glyceryl stearates"	"C11099073"	2	"ACEA_T47D_80hr_Positive"	10265	1777972	1781433	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001117"	41492	"4468-42-2"	"3-Phenylhexane"	"C4468422"	744	"OT_ER_ERaERb_0480"	112967	2402367	2398766	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001131"	34929	"283594-90-1"	"Spiromesifen"	"C283594901"	75	"ATG_ERE_CIS_up"	13178	2092143	1965981	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001131"	34929	"283594-90-1"	"Spiromesifen"	"C283594901"	75	"ATG_ERE_CIS_up"	13662	2092143	1965981	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001131"	34929	"283594-90-1"	"Spiromesifen"	"C283594901"	743	"OT_ER_ERaERa_1440"	114366	550578	561761	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001133"	44865	"18924-66-8"	"2,2'-(Tetradecylimino)diethanol"	"C18924668"	708	"NVS_NR_bER"	516226	2706553	2695513	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX001133"	44865	"18924-66-8"	"2,2'-(Tetradecylimino)diethanol"	"C18924668"	708	"NVS_NR_bER"	516428	2706553	2695513	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001133"	44865	"18924-66-8"	"2,2'-(Tetradecylimino)diethanol"	"C18924668"	708	"NVS_NR_bER"	516475	2706553	2695513	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX001133"	44865	"18924-66-8"	"2,2'-(Tetradecylimino)diethanol"	"C18924668"	745	"OT_ER_ERaERb_1440"	115471	556763	535532	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001139"	42171	"1541-81-7"	"4-Dodecylmorpholine"	"C1541817"	75	"ATG_ERE_CIS_up"	13429	2092141	1965983	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001139"	42171	"1541-81-7"	"4-Dodecylmorpholine"	"C1541817"	750	"OT_ERa_EREGFP_0120"	115578	571638	565706	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001165"	32639	"55512-33-9"	"Pyridate"	"C55512339"	2	"ACEA_T47D_80hr_Positive"	10155	1777977	1781429	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001165"	32639	"55512-33-9"	"Pyridate"	"C55512339"	2	"ACEA_T47D_80hr_Positive"	10443	1777977	1781429	11	"Borderline active"	NA	NA	"percent_activity"
"TX001165"	32639	"55512-33-9"	"Pyridate"	"C55512339"	2	"ACEA_T47D_80hr_Positive"	10733	1777977	1781429	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001165"	32639	"55512-33-9"	"Pyridate"	"C55512339"	75	"ATG_ERE_CIS_up"	13428	2092139	1965985	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001165"	32639	"55512-33-9"	"Pyridate"	"C55512339"	743	"OT_ER_ERaERa_1440"	114367	550581	561764	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001165"	32639	"55512-33-9"	"Pyridate"	"C55512339"	743	"OT_ER_ERaERa_1440"	114482	550581	561764	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001177"	40360	"163520-33-0"	"Isoxadifen-ethyl"	"C163520330"	117	"ATG_ERa_TRANS_up"	50059	2171513	2037438	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001183"	41544	"21145-77-7"	"6-Acetyl-1,1,2,4,4,7-hexamethyltetralin"	"C21145777"	117	"ATG_ERa_TRANS_up"	50257	2171512	2037437	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001183"	41544	"21145-77-7"	"6-Acetyl-1,1,2,4,4,7-hexamethyltetralin"	"C21145777"	750	"OT_ERa_EREGFP_0120"	115579	571641	565709	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001183"	41544	"21145-77-7"	"6-Acetyl-1,1,2,4,4,7-hexamethyltetralin"	"C21145777"	750	"OT_ERa_EREGFP_0120"	115829	571641	565709	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001183"	41544	"21145-77-7"	"6-Acetyl-1,1,2,4,4,7-hexamethyltetralin"	"C21145777"	751	"OT_ERa_EREGFP_0480"	116724	564648	567687	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001221"	44815	"2917-73-9"	"Dibutyl nonanedioate"	"C2917739"	725	"NVS_NR_mERa"	517029	2709924	2699201	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001229"	44818	"3913-02-8"	"2-Butyloctan-1-ol"	"C3913028"	2	"ACEA_T47D_80hr_Positive"	10724	1777981	1781424	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX001229"	44818	"3913-02-8"	"2-Butyloctan-1-ol"	"C3913028"	75	"ATG_ERE_CIS_up"	13427	2092133	1965991	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001229"	44818	"3913-02-8"	"2-Butyloctan-1-ol"	"C3913028"	117	"ATG_ERa_TRANS_up"	50058	2171508	2037433	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001275"	21831	"99-08-1"	"3-Nitrotoluene"	"C99081"	714	"NVS_NR_hER"	517839	2708737	2698014	11	"Borderline active"	NA	NA	"percent_activity"
"TX001275"	21831	"99-08-1"	"3-Nitrotoluene"	"C99081"	714	"NVS_NR_hER"	517925	2708737	2698014	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001275"	21831	"99-08-1"	"3-Nitrotoluene"	"C99081"	714	"NVS_NR_hER"	517977	2708737	2698014	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX001280"	20913	"91-20-3"	"Naphthalene"	"C91203"	714	"NVS_NR_hER"	517756	2708738	2698015	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	2	"ACEA_T47D_80hr_Positive"	10536	1777986	1781419	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	714	"NVS_NR_hER"	517757	2708740	2698017	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	725	"NVS_NR_mERa"	517031	2709928	2699205	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	725	"NVS_NR_mERa"	517417	2709928	2699205	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	745	"OT_ER_ERaERb_1440"	115347	556774	535543	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	746	"OT_ER_ERbERb_0480"	116542	548618	557833	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	747	"OT_ER_ERbERb_1440"	114771	558742	559805	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001307"	22529	"99-76-3"	"Methylparaben"	"C99763"	747	"OT_ER_ERbERb_1440"	114855	558742	559805	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001309"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	2	"ACEA_T47D_80hr_Positive"	10266	1777987	1781418	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001309"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	725	"NVS_NR_mERa"	517542	2709929	2699206	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001309"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	747	"OT_ER_ERbERb_1440"	114772	558743	559806	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001309"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	750	"OT_ERa_EREGFP_0120"	115580	571649	565717	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001311"	20232	"58-08-2"	"Caffeine"	"C58082"	75	"ATG_ERE_CIS_up"	13425	2092095	1966029	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001311"	20232	"58-08-2"	"Caffeine"	"C58082"	117	"ATG_ERa_TRANS_up"	49644	2171470	2037395	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001311"	20232	"58-08-2"	"Caffeine"	"C58082"	117	"ATG_ERa_TRANS_up"	50254	2171470	2037395	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001334"	22510	"1570-64-5"	"4-Chloro-2-methylphenol"	"C1570645"	725	"NVS_NR_mERa"	517032	2709932	2699209	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001334"	22510	"1570-64-5"	"4-Chloro-2-methylphenol"	"C1570645"	725	"NVS_NR_mERa"	517418	2709932	2699209	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001334"	22510	"1570-64-5"	"4-Chloro-2-methylphenol"	"C1570645"	745	"OT_ER_ERaERb_1440"	115348	556779	535548	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001334"	22510	"1570-64-5"	"4-Chloro-2-methylphenol"	"C1570645"	746	"OT_ER_ERbERb_0480"	116543	548623	557838	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001346"	26525	"88-18-6"	"2-tert-Butylphenol"	"C88186"	747	"OT_ER_ERbERb_1440"	114773	558748	559811	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001349"	21847	"101-84-8"	"Diphenyl oxide"	"C101848"	2	"ACEA_T47D_80hr_Positive"	10734	1777993	1781412	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001353"	29677	"7631-86-9"	"Silica"	"C7631869"	751	"OT_ERa_EREGFP_0480"	116725	564663	567702	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001355"	20350	"120-71-8"	"2-Methoxy-5-methylaniline"	"C120718"	725	"NVS_NR_mERa"	517272	2709934	2699211	10	"Noisy data"	NA	NA	"percent_activity"
"TX001355"	20350	"120-71-8"	"2-Methoxy-5-methylaniline"	"C120718"	747	"OT_ER_ERbERb_1440"	114774	558751	559814	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001360"	25145	"95-87-4"	"2,5-Dimethylphenol"	"C95874"	750	"OT_ERa_EREGFP_0120"	115581	571658	565726	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001360"	25145	"95-87-4"	"2,5-Dimethylphenol"	"C95874"	751	"OT_ERa_EREGFP_0480"	116726	564665	567704	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001365"	40285	"118-93-4"	"2-Hydroxyacetophenone"	"C118934"	750	"OT_ERa_EREGFP_0120"	115582	571659	565727	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001366"	21774	"83-32-9"	"Acenaphthene"	"C83329"	2	"ACEA_T47D_80hr_Positive"	10537	1777997	1781408	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001366"	21774	"83-32-9"	"Acenaphthene"	"C83329"	745	"OT_ER_ERaERb_1440"	115397	556786	535555	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001366"	21774	"83-32-9"	"Acenaphthene"	"C83329"	747	"OT_ER_ERbERb_1440"	114775	558754	559817	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001370"	23878	"120-12-7"	"Anthracene"	"C120127"	2	"ACEA_T47D_80hr_Positive"	10538	1777998	1781407	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001370"	23878	"120-12-7"	"Anthracene"	"C120127"	75	"ATG_ERE_CIS_up"	13220	2092082	1966042	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001370"	23878	"120-12-7"	"Anthracene"	"C120127"	75	"ATG_ERE_CIS_up"	13424	2092082	1966042	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001370"	23878	"120-12-7"	"Anthracene"	"C120127"	117	"ATG_ERa_TRANS_up"	50253	2171457	2037382	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001370"	23878	"120-12-7"	"Anthracene"	"C120127"	745	"OT_ER_ERaERb_1440"	115472	556787	535556	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001370"	23878	"120-12-7"	"Anthracene"	"C120127"	747	"OT_ER_ERbERb_1440"	114776	558755	559818	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001370"	23878	"120-12-7"	"Anthracene"	"C120127"	747	"OT_ER_ERbERb_1440"	114856	558755	559818	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001382"	20716	"123-31-9"	"Hydroquinone"	"C123319"	117	"ATG_ERa_TRANS_up"	49604	2171452	2037377	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001382"	20716	"123-31-9"	"Hydroquinone"	"C123319"	117	"ATG_ERa_TRANS_up"	50252	2171452	2037377	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001382"	20716	"123-31-9"	"Hydroquinone"	"C123319"	714	"NVS_NR_hER"	517758	2708749	2698026	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001384"	20582	"91-53-2"	"Ethoxyquin"	"C91532"	75	"ATG_ERE_CIS_up"	13657	2092076	1966048	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001384"	20582	"91-53-2"	"Ethoxyquin"	"C91532"	714	"NVS_NR_hER"	517703	2708750	2698027	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001384"	20582	"91-53-2"	"Ethoxyquin"	"C91532"	714	"NVS_NR_hER"	517926	2708750	2698027	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001384"	20582	"91-53-2"	"Ethoxyquin"	"C91532"	714	"NVS_NR_hER"	517978	2708750	2698027	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX001402"	34588	"131807-57-3"	"Famoxadone"	"C131807573"	751	"OT_ERa_EREGFP_0480"	116727	564677	567716	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001404"	34773	"116714-46-6"	"Novaluron"	"C116714466"	2	"ACEA_T47D_80hr_Positive"	10539	1778009	1781397	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001404"	34773	"116714-46-6"	"Novaluron"	"C116714466"	750	"OT_ERa_EREGFP_0120"	115583	571671	565739	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001405"	32555	"103361-09-7"	"Flumioxazin"	"C103361097"	2	"ACEA_T47D_80hr_Positive"	10156	1778010	1781395	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001406"	32600	"113136-77-9"	"Cyclanilide"	"C113136779"	2	"ACEA_T47D_80hr_Positive"	10540	1778011	1781394	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001408"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	742	"OT_ER_ERaERa_0480"	114930	554828	563769	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001408"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	742	"OT_ER_ERaERa_0480"	115001	554828	563769	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001408"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	743	"OT_ER_ERaERa_1440"	114483	550616	561799	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001408"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	747	"OT_ER_ERbERb_1440"	114777	558768	559831	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001408"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	750	"OT_ERa_EREGFP_0120"	115584	571674	565742	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001408"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	751	"OT_ERa_EREGFP_0480"	116728	564681	567720	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001409"	32532	"128639-02-1"	"Carfentrazone-ethyl"	"C128639021"	750	"OT_ERa_EREGFP_0120"	115585	571675	565743	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001412"	34609	"120068-37-3"	"Fipronil"	"C120068373"	751	"OT_ERa_EREGFP_0480"	116729	564684	567723	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001414"	24304	"74051-80-2"	"Sethoxydim"	"C74051802"	750	"OT_ERa_EREGFP_0120"	115586	571678	565746	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001417"	32398	"131341-86-1"	"Fludioxonil"	"C131341861"	742	"OT_ER_ERaERa_0480"	114931	554835	563776	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001417"	32398	"131341-86-1"	"Fludioxonil"	"C131341861"	750	"OT_ERa_EREGFP_0120"	115587	571681	565749	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001419"	34365	"134605-64-4"	"Butafenacil"	"C134605644"	2	"ACEA_T47D_80hr_Positive"	10267	1778021	1781384	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001419"	34365	"134605-64-4"	"Butafenacil"	"C134605644"	2	"ACEA_T47D_80hr_Positive"	10541	1778021	1781384	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001419"	34365	"134605-64-4"	"Butafenacil"	"C134605644"	750	"OT_ERa_EREGFP_0120"	115588	571683	565751	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001420"	20450	"115-32-2"	"Dicofol"	"C115322"	742	"OT_ER_ERaERa_0480"	114990	554838	563779	11	"Borderline active"	NA	NA	"percent_activity"
"TX001420"	20450	"115-32-2"	"Dicofol"	"C115322"	744	"OT_ER_ERaERb_0480"	112865	2402318	2398818	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001420"	20450	"115-32-2"	"Dicofol"	"C115322"	746	"OT_ER_ERbERb_0480"	116544	548654	557869	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001421"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	743	"OT_ER_ERaERa_1440"	114368	550627	561810	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001421"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	745	"OT_ER_ERaERb_1440"	115398	556811	535580	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001421"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	745	"OT_ER_ERaERb_1440"	115473	556811	535580	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001429"	34223	"119168-77-3"	"Tebufenpyrad"	"C119168773"	750	"OT_ERa_EREGFP_0120"	115589	571692	565760	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001430"	34956	"112281-77-3"	"Tetraconazole"	"C112281773"	2	"ACEA_T47D_80hr_Positive"	10268	1778031	1781374	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001430"	34956	"112281-77-3"	"Tetraconazole"	"C112281773"	2	"ACEA_T47D_80hr_Positive"	10542	1778031	1781374	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001430"	34956	"112281-77-3"	"Tetraconazole"	"C112281773"	750	"OT_ERa_EREGFP_0120"	115540	571693	565761	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001431"	34503	"122008-85-9"	"Cyhalofop-butyl"	"C122008859"	751	"OT_ERa_EREGFP_0480"	116730	564701	567740	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001432"	32488	"117718-60-2"	"Thiazopyr"	"C117718602"	2	"ACEA_T47D_80hr_Positive"	10444	1778033	1781373	11	"Borderline active"	NA	NA	"percent_activity"
"TX001432"	32488	"117718-60-2"	"Thiazopyr"	"C117718602"	742	"OT_ER_ERaERa_0480"	114932	554848	563789	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001432"	32488	"117718-60-2"	"Thiazopyr"	"C117718602"	742	"OT_ER_ERaERa_0480"	115002	554848	563789	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001432"	32488	"117718-60-2"	"Thiazopyr"	"C117718602"	750	"OT_ERa_EREGFP_0120"	115590	571695	565763	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001432"	32488	"117718-60-2"	"Thiazopyr"	"C117718602"	750	"OT_ERa_EREGFP_0120"	115830	571695	565763	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001432"	32488	"117718-60-2"	"Thiazopyr"	"C117718602"	751	"OT_ERa_EREGFP_0480"	116731	564702	567741	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001433"	32673	"123343-16-8"	"Pyrithiobac-sodium"	"C123343168"	2	"ACEA_T47D_80hr_Positive"	10543	1778034	1781371	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001440"	24182	"109-86-4"	"2-Methoxyethanol"	"C109864"	2	"ACEA_T47D_80hr_Positive"	10157	1778037	1781369	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001440"	24182	"109-86-4"	"2-Methoxyethanol"	"C109864"	750	"OT_ERa_EREGFP_0120"	115591	571699	565767	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001441"	34855	"79241-46-6"	"Fluazifop-P-butyl"	"C79241466"	744	"OT_ER_ERaERb_0480"	112966	2402302	2398833	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001441"	34855	"79241-46-6"	"Fluazifop-P-butyl"	"C79241466"	751	"OT_ERa_EREGFP_0480"	116732	564707	567746	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001441"	34855	"79241-46-6"	"Fluazifop-P-butyl"	"C79241466"	751	"OT_ERa_EREGFP_0480"	116901	564707	567746	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001442"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	750	"OT_ERa_EREGFP_0120"	115592	571701	565769	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001442"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	751	"OT_ERa_EREGFP_0480"	116733	564708	567747	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001446"	32500	"68694-11-1"	"Triflumizole"	"C68694111"	746	"OT_ER_ERbERb_0480"	116627	548671	557886	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001449"	21332	"137-26-8"	"Thiram"	"C137268"	751	"OT_ERa_EREGFP_0480"	116902	564712	567751	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001450"	20601	"96-45-7"	"Ethylene thiourea"	"C96457"	2	"ACEA_T47D_80hr_Positive"	10544	1778044	1781361	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001533"	24085	"16672-87-0"	"Ethephon"	"C16672870"	2	"ACEA_T47D_80hr_Positive"	10269	1778045	1781360	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001535"	20440	"120-36-5"	"Dichlorprop"	"C120365"	2	"ACEA_T47D_80hr_Positive"	10545	1778047	1781358	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001537"	24195	"94-74-6"	"MCPA"	"C94746"	2	"ACEA_T47D_80hr_Positive"	10270	1778049	1781356	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001538"	24174	"78-48-8"	"Tribufos"	"C78488"	750	"OT_ERa_EREGFP_0120"	115593	571712	565780	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001538"	24174	"78-48-8"	"Tribufos"	"C78488"	751	"OT_ERa_EREGFP_0480"	116734	564719	567758	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001542"	40363	"83657-24-3"	"Diniconazole"	"C83657243"	750	"OT_ERa_EREGFP_0120"	115541	571716	565784	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001543"	32578	"59669-26-0"	"Thiodicarb"	"C59669260"	2	"ACEA_T47D_80hr_Positive"	10445	1778055	1781350	11	"Borderline active"	NA	NA	"percent_activity"
"TX001543"	32578	"59669-26-0"	"Thiodicarb"	"C59669260"	750	"OT_ERa_EREGFP_0120"	115831	571717	565785	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001543"	32578	"59669-26-0"	"Thiodicarb"	"C59669260"	751	"OT_ERa_EREGFP_0480"	116690	564724	567763	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001544"	21105	"82-68-8"	"Pentachloronitrobenzene"	"C82688"	750	"OT_ERa_EREGFP_0120"	115594	571718	565786	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001547"	20686	"58-89-9"	"Lindane"	"C58899"	744	"OT_ER_ERaERb_0480"	112965	2402281	2398848	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001550"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	2	"ACEA_T47D_80hr_Positive"	10158	1778062	1781343	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001550"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	2	"ACEA_T47D_80hr_Positive"	10446	1778062	1781343	11	"Borderline active"	NA	NA	"percent_activity"
"TX001550"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	750	"OT_ERa_EREGFP_0120"	115595	571724	565792	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001552"	22455	"131-11-3"	"Dimethyl phthalate"	"C131113"	2	"ACEA_T47D_80hr_Positive"	10546	1778064	1781341	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001553"	34612	"69806-50-4"	"Fluazifop-butyl"	"C69806504"	2	"ACEA_T47D_80hr_Positive"	10447	1778065	1781340	11	"Borderline active"	NA	NA	"percent_activity"
"TX001553"	34612	"69806-50-4"	"Fluazifop-butyl"	"C69806504"	746	"OT_ER_ERbERb_0480"	116605	548696	557911	10	"Noisy data"	NA	NA	"percent_activity"
"TX001553"	34612	"69806-50-4"	"Fluazifop-butyl"	"C69806504"	750	"OT_ERa_EREGFP_0120"	115596	571727	565795	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001555"	20242	"2425-06-1"	"Captafol"	"C2425061"	751	"OT_ERa_EREGFP_0480"	116735	564736	567775	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001557"	24276	"2312-35-8"	"Propargite"	"C2312358"	751	"OT_ERa_EREGFP_0480"	116736	564738	567777	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001569"	47527	"66456-53-9"	"Adipic acid, polypropyleneglycol, laurate"	"C66456539"	750	"OT_ERa_EREGFP_0120"	115597	571733	565801	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001572"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	2	"ACEA_T47D_80hr_Positive"	10725	1778074	1781332	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX001572"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	750	"OT_ERa_EREGFP_0120"	115598	571736	565804	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001577"	32615	"98967-40-9"	"Flumetsulam"	"C98967409"	2	"ACEA_T47D_80hr_Positive"	10448	1778075	1781330	11	"Borderline active"	NA	NA	"percent_activity"
"TX001577"	32615	"98967-40-9"	"Flumetsulam"	"C98967409"	2	"ACEA_T47D_80hr_Positive"	10735	1778075	1781330	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001580"	32683	"7786-34-7"	"Mevinphos"	"C7786347"	2	"ACEA_T47D_80hr_Positive"	10271	1778076	1781329	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001580"	32683	"7786-34-7"	"Mevinphos"	"C7786347"	2	"ACEA_T47D_80hr_Positive"	10547	1778076	1781329	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001582"	32344	"54593-83-8"	"Chlorethoxyfos"	"C54593838"	742	"OT_ER_ERaERa_0480"	114933	554892	563833	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001582"	32344	"54593-83-8"	"Chlorethoxyfos"	"C54593838"	744	"OT_ER_ERaERb_0480"	112864	2402263	2398878	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001582"	32344	"54593-83-8"	"Chlorethoxyfos"	"C54593838"	750	"OT_ERa_EREGFP_0120"	115599	571739	565807	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001582"	32344	"54593-83-8"	"Chlorethoxyfos"	"C54593838"	750	"OT_ERa_EREGFP_0120"	115832	571739	565807	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001588"	23900	"17804-35-2"	"Benomyl"	"C17804352"	2	"ACEA_T47D_80hr_Positive"	10548	1778080	1781325	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001592"	21100	"56-38-2"	"Parathion"	"C56382"	744	"OT_ER_ERaERb_0480"	112964	2402258	2398874	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001594"	32464	"41198-08-7"	"Profenofos"	"C41198087"	2	"ACEA_T47D_80hr_Positive"	10272	1778083	1781322	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001594"	32464	"41198-08-7"	"Profenofos"	"C41198087"	2	"ACEA_T47D_80hr_Positive"	10549	1778083	1781322	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001594"	32464	"41198-08-7"	"Profenofos"	"C41198087"	744	"OT_ER_ERaERb_0480"	112863	2402257	2398873	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001594"	32464	"41198-08-7"	"Profenofos"	"C41198087"	746	"OT_ER_ERbERb_0480"	116545	548714	557929	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001594"	32464	"41198-08-7"	"Profenofos"	"C41198087"	750	"OT_ERa_EREGFP_0120"	115600	571745	565813	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001601"	40362	"50-65-7"	"Niclosamide"	"C50657"	2	"ACEA_T47D_80hr_Positive"	10273	1778085	1781320	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001601"	40362	"50-65-7"	"Niclosamide"	"C50657"	751	"OT_ERa_EREGFP_0480"	116737	564754	567793	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001611"	22018	"298-04-4"	"Disulfoton"	"C298044"	744	"OT_ER_ERaERb_0480"	112862	2402250	2398876	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001611"	22018	"298-04-4"	"Disulfoton"	"C298044"	746	"OT_ER_ERbERb_0480"	116628	548721	557936	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001611"	22018	"298-04-4"	"Disulfoton"	"C298044"	750	"OT_ERa_EREGFP_0120"	115816	571752	565820	11	"Borderline active"	NA	NA	"percent_activity"
"TX001611"	22018	"298-04-4"	"Disulfoton"	"C298044"	751	"OT_ERa_EREGFP_0480"	116738	564759	567798	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001617"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	2	"ACEA_T47D_80hr_Positive"	10225	1778091	1781314	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX001617"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	2	"ACEA_T47D_80hr_Positive"	10449	1778091	1781314	11	"Borderline active"	NA	NA	"percent_activity"
"TX001617"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	742	"OT_ER_ERaERa_0480"	115003	554906	563847	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001617"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	744	"OT_ER_ERaERb_0480"	112871	2402249	2398887	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX001617"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	750	"OT_ERa_EREGFP_0120"	115601	571753	565821	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001617"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	750	"OT_ERa_EREGFP_0120"	115833	571753	565821	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001619"	25599	"6317-18-6"	"Methylene bis(thiocyanate)"	"C6317186"	2	"ACEA_T47D_80hr_Positive"	10274	1778092	1781313	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001619"	25599	"6317-18-6"	"Methylene bis(thiocyanate)"	"C6317186"	2	"ACEA_T47D_80hr_Positive"	10550	1778092	1781313	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001619"	25599	"6317-18-6"	"Methylene bis(thiocyanate)"	"C6317186"	750	"OT_ERa_EREGFP_0120"	115834	571754	565822	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001623"	32482	"96182-53-5"	"Tebupirimfos"	"C96182535"	751	"OT_ERa_EREGFP_0480"	116739	564762	567801	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001649"	21997	"140-31-8"	"1-(2-Aminoethyl)piperazine"	"C140318"	117	"ATG_ERa_TRANS_up"	49763	2171437	2037362	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001649"	21997	"140-31-8"	"1-(2-Aminoethyl)piperazine"	"C140318"	117	"ATG_ERa_TRANS_up"	50053	2171437	2037362	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001650"	27218	"579-66-8"	"2,6-Diethylaniline"	"C579668"	75	"ATG_ERE_CIS_up"	13119	2092061	1966063	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001650"	27218	"579-66-8"	"2,6-Diethylaniline"	"C579668"	75	"ATG_ERE_CIS_up"	13656	2092061	1966063	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001650"	27218	"579-66-8"	"2,6-Diethylaniline"	"C579668"	117	"ATG_ERa_TRANS_up"	49826	2171436	2037361	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX001650"	27218	"579-66-8"	"2,6-Diethylaniline"	"C579668"	117	"ATG_ERa_TRANS_up"	50251	2171436	2037361	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001650"	27218	"579-66-8"	"2,6-Diethylaniline"	"C579668"	714	"NVS_NR_hER"	517979	2708756	2698033	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX001693"	21871	"106-48-9"	"4-Chlorophenol"	"C106489"	75	"ATG_ERE_CIS_up"	13118	2092052	1966072	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001693"	21871	"106-48-9"	"4-Chlorophenol"	"C106489"	751	"OT_ERa_EREGFP_0480"	116740	564774	567813	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001694"	20605	"104-76-7"	"2-Ethyl-1-hexanol"	"C104767"	75	"ATG_ERE_CIS_up"	13423	2092051	1966073	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001694"	20605	"104-76-7"	"2-Ethyl-1-hexanol"	"C104767"	117	"ATG_ERa_TRANS_up"	49762	2171426	2037351	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001694"	20605	"104-76-7"	"2-Ethyl-1-hexanol"	"C104767"	117	"ATG_ERa_TRANS_up"	50052	2171426	2037351	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001699"	24922	"124-09-4"	"1,6-Hexanediamine"	"C124094"	743	"OT_ER_ERaERa_1440"	114369	550710	561893	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001700"	25132	"83-41-0"	"1,2-Dimethyl-3-nitrobenzene"	"C83410"	75	"ATG_ERE_CIS_up"	13117	2092048	1966076	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001712"	24913	"124-18-5"	"Decane"	"C124185"	75	"ATG_ERE_CIS_up"	13422	2092043	1966081	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001712"	24913	"124-18-5"	"Decane"	"C124185"	751	"OT_ERa_EREGFP_0480"	116741	564782	567821	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001714"	21643	"124-13-0"	"Octanal"	"C124130"	75	"ATG_ERE_CIS_up"	13219	2092042	1966082	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001714"	21643	"124-13-0"	"Octanal"	"C124130"	117	"ATG_ERa_TRANS_up"	49761	2171417	2037342	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001714"	21643	"124-13-0"	"Octanal"	"C124130"	708	"NVS_NR_bER"	516242	2706586	2695546	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001714"	21643	"124-13-0"	"Octanal"	"C124130"	708	"NVS_NR_bER"	516366	2706586	2695546	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001717"	21641	"112-05-0"	"Nonanoic acid"	"C112050"	75	"ATG_ERE_CIS_up"	13116	2092041	1966083	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001717"	21641	"112-05-0"	"Nonanoic acid"	"C112050"	75	"ATG_ERE_CIS_up"	13351	2092041	1966083	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX001717"	21641	"112-05-0"	"Nonanoic acid"	"C112050"	75	"ATG_ERE_CIS_up"	13655	2092041	1966083	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX001717"	21641	"112-05-0"	"Nonanoic acid"	"C112050"	117	"ATG_ERa_TRANS_up"	50051	2171416	2037341	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001732"	21726	"65-45-2"	"Salicylamide"	"C65452"	750	"OT_ERa_EREGFP_0120"	115603	571779	565847	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001735"	21106	"87-86-5"	"Pentachlorophenol"	"C87865"	75	"ATG_ERE_CIS_up"	13218	2092038	1966086	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001735"	21106	"87-86-5"	"Pentachlorophenol"	"C87865"	75	"ATG_ERE_CIS_up"	13421	2092038	1966086	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001745"	20121	"26628-22-8"	"Sodium azide"	"C26628228"	2	"ACEA_T47D_80hr_Positive"	10159	1778120	1781285	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001745"	20121	"26628-22-8"	"Sodium azide"	"C26628228"	117	"ATG_ERa_TRANS_up"	49760	2171410	2037335	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001745"	20121	"26628-22-8"	"Sodium azide"	"C26628228"	117	"ATG_ERa_TRANS_up"	50050	2171410	2037335	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001745"	20121	"26628-22-8"	"Sodium azide"	"C26628228"	714	"NVS_NR_hER"	517866	2708765	2698042	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001747"	20941	"7632-00-0"	"Sodium nitrite"	"C7632000"	117	"ATG_ERa_TRANS_up"	50049	2171409	2037334	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001760"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	725	"NVS_NR_mERa"	517034	2709948	2699225	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001760"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	725	"NVS_NR_mERa"	517273	2709948	2699225	10	"Noisy data"	NA	NA	"percent_activity"
"TX001760"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	745	"OT_ER_ERaERb_1440"	115399	556909	535678	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001760"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	746	"OT_ER_ERbERb_0480"	116629	548754	557969	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001769"	26118	"119-64-2"	"Tetralin"	"C119642"	2	"ACEA_T47D_80hr_Positive"	10551	1778124	1781281	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001785"	26879	"111-49-9"	"Hexamethyleneimine"	"C111499"	2	"ACEA_T47D_80hr_Positive"	10160	1778126	1781279	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001792"	22480	"620-17-7"	"3-Ethylphenol"	"C620177"	117	"ATG_ERa_TRANS_up"	50048	2171399	2037324	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001792"	22480	"620-17-7"	"3-Ethylphenol"	"C620177"	725	"NVS_NR_mERa"	517035	2709949	2699226	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001795"	27852	"25168-05-2"	"Chlorotoluene"	"C25168052"	743	"OT_ER_ERaERa_1440"	114370	550730	561913	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001795"	27852	"25168-05-2"	"Chlorotoluene"	"C25168052"	745	"OT_ER_ERaERb_1440"	115400	556914	535683	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001795"	27852	"25168-05-2"	"Chlorotoluene"	"C25168052"	747	"OT_ER_ERbERb_1440"	114778	558882	559945	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001801"	20877	"90-12-0"	"1-Methylnaphthalene"	"C90120"	75	"ATG_ERE_CIS_up"	13115	2092020	1966105	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX001816"	20523	"51-28-5"	"2,4-Dinitrophenol"	"C51285"	2	"ACEA_T47D_80hr_Positive"	10161	1778135	1781271	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001830"	21544	"95-57-8"	"2-Chlorophenol"	"C95578"	75	"ATG_ERE_CIS_up"	13420	2092014	1966110	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001847"	21932	"111-42-2"	"Diethanolamine"	"C111422"	743	"OT_ER_ERaERa_1440"	114443	550743	561926	10	"Noisy data"	NA	NA	"percent_activity"
"TX001865"	21426	"57-13-6"	"Urea"	"C57136"	2	"ACEA_T47D_80hr_Positive"	10552	1778142	1781263	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001904"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	714	"NVS_NR_hER"	517867	2708774	2698051	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001904"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	725	"NVS_NR_mERa"	517036	2709955	2699232	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001904"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	725	"NVS_NR_mERa"	517275	2709955	2699232	10	"Noisy data"	NA	NA	"percent_activity"
"TX001904"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	745	"OT_ER_ERaERb_1440"	115349	556932	535701	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001904"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	750	"OT_ERa_EREGFP_0120"	115542	571808	565876	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001906"	25363	"79-14-1"	"Glycolic acid"	"C79141"	2	"ACEA_T47D_80hr_Positive"	10275	1778147	1781258	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001906"	25363	"79-14-1"	"Glycolic acid"	"C79141"	2	"ACEA_T47D_80hr_Positive"	10553	1778147	1781258	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001907"	20515	"68-12-2"	"N,N-Dimethylformamide"	"C68122"	714	"NVS_NR_hER"	517759	2708775	2698052	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX001913"	20439	"120-83-2"	"2,4-Dichlorophenol"	"C120832"	708	"NVS_NR_bER"	516429	2706597	2695557	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001913"	20439	"120-83-2"	"2,4-Dichlorophenol"	"C120832"	708	"NVS_NR_bER"	516477	2706597	2695557	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX001913"	20439	"120-83-2"	"2,4-Dichlorophenol"	"C120832"	744	"OT_ER_ERaERb_0480"	112861	2402191	2398943	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001913"	20439	"120-83-2"	"2,4-Dichlorophenol"	"C120832"	746	"OT_ER_ERbERb_0480"	116546	548780	557995	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX001914"	25091	"119-90-4"	"3,3'-Dimethoxybenzidine"	"C119904"	117	"ATG_ERa_TRANS_up"	49759	2171370	2037295	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX001914"	25091	"119-90-4"	"3,3'-Dimethoxybenzidine"	"C119904"	117	"ATG_ERa_TRANS_up"	50045	2171370	2037295	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX001916"	26797	"108-67-8"	"1,3,5-Trimethylbenzene"	"C108678"	2	"ACEA_T47D_80hr_Positive"	10554	1778151	1781254	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX001920"	21124	"108-95-2"	"Phenol"	"C108952"	714	"NVS_NR_hER"	517927	2708778	2698055	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX001920"	21124	"108-95-2"	"Phenol"	"C108952"	714	"NVS_NR_hER"	517982	2708778	2698055	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002085"	21959	"118-79-6"	"2,4,6-Tribromophenol"	"C118796"	75	"ATG_ERE_CIS_up"	13652	2091986	1966138	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002085"	21959	"118-79-6"	"2,4,6-Tribromophenol"	"C118796"	117	"ATG_ERa_TRANS_up"	49825	2171361	2037286	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX002088"	20152	"100-51-6"	"Benzyl alcohol"	"C100516"	2	"ACEA_T47D_80hr_Positive"	10276	1778157	1781249	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002088"	20152	"100-51-6"	"Benzyl alcohol"	"C100516"	2	"ACEA_T47D_80hr_Positive"	10555	1778157	1781249	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002089"	20293	"532-27-4"	"2-Chloroacetophenone"	"C532274"	117	"ATG_ERa_TRANS_up"	49603	2171359	2037284	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002089"	20293	"532-27-4"	"2-Chloroacetophenone"	"C532274"	714	"NVS_NR_hER"	517760	2708780	2698057	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002089"	20293	"532-27-4"	"2-Chloroacetophenone"	"C532274"	750	"OT_ERa_EREGFP_0120"	115543	571819	565887	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002089"	20293	"532-27-4"	"2-Chloroacetophenone"	"C532274"	751	"OT_ERa_EREGFP_0480"	116691	564826	567865	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002091"	21815	"95-76-1"	"3,4-Dichloroaniline"	"C95761"	75	"ATG_ERE_CIS_up"	13419	2091983	1966141	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002091"	21815	"95-76-1"	"3,4-Dichloroaniline"	"C95761"	117	"ATG_ERa_TRANS_up"	49602	2171358	2037283	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002091"	21815	"95-76-1"	"3,4-Dichloroaniline"	"C95761"	117	"ATG_ERa_TRANS_up"	50248	2171358	2037283	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002091"	21815	"95-76-1"	"3,4-Dichloroaniline"	"C95761"	744	"OT_ER_ERaERb_0480"	112963	2402182	2398952	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002092"	20430	"95-50-1"	"1,2-Dichlorobenzene"	"C95501"	747	"OT_ER_ERbERb_1440"	114849	558913	559976	11	"Borderline active"	NA	NA	"percent_activity"
"TX002093"	21914	"110-12-3"	"5-Methyl-2-hexanone"	"C110123"	2	"ACEA_T47D_80hr_Positive"	10277	1778161	1781245	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002093"	21914	"110-12-3"	"5-Methyl-2-hexanone"	"C110123"	747	"OT_ER_ERbERb_1440"	114757	558914	559977	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002093"	21914	"110-12-3"	"5-Methyl-2-hexanone"	"C110123"	747	"OT_ER_ERbERb_1440"	114841	558914	559977	10	"Noisy data"	NA	NA	"percent_activity"
"TX002094"	23192	"50-21-5"	"Lactic acid"	"C50215"	751	"OT_ERa_EREGFP_0480"	116884	564830	567869	10	"Noisy data"	NA	NA	"percent_activity"
"TX002101"	21916	"110-43-0"	"2-Heptanone"	"C110430"	2	"ACEA_T47D_80hr_Positive"	10278	1778165	1781240	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002101"	21916	"110-43-0"	"2-Heptanone"	"C110430"	2	"ACEA_T47D_80hr_Positive"	10556	1778165	1781240	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002103"	20921	"91-59-8"	"2-Naphthylamine"	"C91598"	117	"ATG_ERa_TRANS_up"	50044	2171349	2037274	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002104"	21402	"95-63-6"	"1,2,4-Trimethylbenzene"	"C95636"	2	"ACEA_T47D_80hr_Positive"	10557	1778167	1781239	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002104"	21402	"95-63-6"	"1,2,4-Trimethylbenzene"	"C95636"	75	"ATG_ERE_CIS_up"	13418	2091973	1966151	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002105"	25148	"108-68-9"	"3,5-Dimethylphenol"	"C108689"	2	"ACEA_T47D_80hr_Positive"	10450	1778168	1781237	11	"Borderline active"	NA	NA	"percent_activity"
"TX002105"	25148	"108-68-9"	"3,5-Dimethylphenol"	"C108689"	2	"ACEA_T47D_80hr_Positive"	10736	1778168	1781237	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002108"	27454	"2044-64-6"	"N,N-Dimethylacetoacetamide"	"C2044646"	708	"NVS_NR_bER"	516243	2706601	2695561	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002108"	27454	"2044-64-6"	"N,N-Dimethylacetoacetamide"	"C2044646"	714	"NVS_NR_hER"	517761	2708783	2698060	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002108"	27454	"2044-64-6"	"N,N-Dimethylacetoacetamide"	"C2044646"	714	"NVS_NR_hER"	517868	2708783	2698060	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002108"	27454	"2044-64-6"	"N,N-Dimethylacetoacetamide"	"C2044646"	725	"NVS_NR_mERa"	517014	2709960	2699237	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX002108"	27454	"2044-64-6"	"N,N-Dimethylacetoacetamide"	"C2044646"	725	"NVS_NR_mERa"	517380	2709960	2699237	11	"Borderline active"	NA	NA	"percent_activity"
"TX002108"	27454	"2044-64-6"	"N,N-Dimethylacetoacetamide"	"C2044646"	725	"NVS_NR_mERa"	517544	2709960	2699237	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002108"	27454	"2044-64-6"	"N,N-Dimethylacetoacetamide"	"C2044646"	725	"NVS_NR_mERa"	517614	2709960	2699237	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002116"	27414	"1563-38-8"	"2,3-Dihydro-2,2-dimethyl-7-benzofuranol"	"C1563388"	2	"ACEA_T47D_80hr_Positive"	10279	1778171	1781234	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002119"	20759	"78-59-1"	"Isophorone"	"C78591"	708	"NVS_NR_bER"	516244	2706602	2695562	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002119"	20759	"78-59-1"	"Isophorone"	"C78591"	714	"NVS_NR_hER"	517762	2708784	2698061	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002119"	20759	"78-59-1"	"Isophorone"	"C78591"	714	"NVS_NR_hER"	517869	2708784	2698061	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002119"	20759	"78-59-1"	"Isophorone"	"C78591"	725	"NVS_NR_mERa"	517420	2709961	2699238	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002120"	21864	"105-67-9"	"2,4-Dimethylphenol"	"C105679"	117	"ATG_ERa_TRANS_up"	49601	2171341	2037266	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002133"	21993	"132-64-9"	"Dibenzofuran"	"C132649"	2	"ACEA_T47D_80hr_Positive"	10162	1778176	1781229	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002133"	21993	"132-64-9"	"Dibenzofuran"	"C132649"	117	"ATG_ERa_TRANS_up"	49600	2171338	2037263	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002133"	21993	"132-64-9"	"Dibenzofuran"	"C132649"	117	"ATG_ERa_TRANS_up"	50247	2171338	2037263	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002149"	20969	"79-24-3"	"Nitroethane"	"C79243"	2	"ACEA_T47D_80hr_Positive"	10451	1778178	1781228	11	"Borderline active"	NA	NA	"percent_activity"
"TX002149"	20969	"79-24-3"	"Nitroethane"	"C79243"	2	"ACEA_T47D_80hr_Positive"	10737	1778178	1781228	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002151"	21645	"124-07-2"	"Octanoic acid"	"C124072"	744	"OT_ER_ERaERb_0480"	112860	2402162	2398973	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002151"	21645	"124-07-2"	"Octanoic acid"	"C124072"	744	"OT_ER_ERaERb_0480"	112902	2402162	2398973	11	"Borderline active"	NA	NA	"percent_activity"
"TX002176"	21251	"81-07-2"	"Saccharin"	"C81072"	742	"OT_ER_ERaERa_0480"	114934	554994	563935	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002176"	21251	"81-07-2"	"Saccharin"	"C81072"	742	"OT_ER_ERaERa_0480"	115004	554994	563935	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002176"	21251	"81-07-2"	"Saccharin"	"C81072"	743	"OT_ER_ERaERa_1440"	114371	550781	561964	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002193"	24814	"106-43-4"	"4-Chlorotoluene"	"C106434"	75	"ATG_ERE_CIS_up"	13651	2091956	1966168	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002200"	21717	"59-50-7"	"4-Chloro-3-methylphenol"	"C59507"	2	"ACEA_T47D_80hr_Positive"	10280	1778185	1781219	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002200"	21717	"59-50-7"	"4-Chloro-3-methylphenol"	"C59507"	714	"NVS_NR_hER"	517983	2708789	2698066	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002200"	21717	"59-50-7"	"4-Chloro-3-methylphenol"	"C59507"	742	"OT_ER_ERaERa_0480"	115005	554999	563940	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002212"	25451	"14901-07-6"	"4-(2,6,6-Trimethyl-cyclohex-1-enyl)-but-3-en-2-one"	"C14901076"	117	"ATG_ERa_TRANS_up"	50246	2171325	2037250	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002215"	26307	"87-62-7"	"2,6-Dimethylaniline"	"C87627"	750	"OT_ERa_EREGFP_0120"	115604	571849	565917	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002225"	20915	"86-87-3"	"1-Naphthaleneacetic acid"	"C86873"	714	"NVS_NR_hER"	517763	2708792	2698069	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002253"	21961	"119-61-9"	"Benzophenone"	"C119619"	725	"NVS_NR_mERa"	517615	2709969	2699246	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002253"	21961	"119-61-9"	"Benzophenone"	"C119619"	742	"OT_ER_ERaERa_0480"	114991	555010	563951	11	"Borderline active"	NA	NA	"percent_activity"
"TX002253"	21961	"119-61-9"	"Benzophenone"	"C119619"	744	"OT_ER_ERaERb_0480"	112859	2402145	2398987	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002253"	21961	"119-61-9"	"Benzophenone"	"C119619"	747	"OT_ER_ERbERb_1440"	114779	558949	560012	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002253"	21961	"119-61-9"	"Benzophenone"	"C119619"	747	"OT_ER_ERbERb_1440"	114857	558949	560012	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002257"	22187	"2416-94-6"	"2,3,6-Trimethylphenol"	"C2416946"	750	"OT_ERa_EREGFP_0120"	115605	571858	565926	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002275"	22049	"527-60-6"	"2,4,6-Trimethylphenol"	"C527606"	75	"ATG_ERE_CIS_up"	13417	2091931	1966193	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002275"	22049	"527-60-6"	"2,4,6-Trimethylphenol"	"C527606"	117	"ATG_ERa_TRANS_up"	49599	2171306	2037231	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002275"	22049	"527-60-6"	"2,4,6-Trimethylphenol"	"C527606"	117	"ATG_ERa_TRANS_up"	50245	2171306	2037231	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002277"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	75	"ATG_ERE_CIS_up"	13416	2091930	1966194	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002277"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	117	"ATG_ERa_TRANS_up"	49758	2171305	2037230	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX002277"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	117	"ATG_ERa_TRANS_up"	50043	2171305	2037230	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002277"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	743	"OT_ER_ERaERa_1440"	114444	550803	561986	10	"Noisy data"	NA	NA	"percent_activity"
"TX002277"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	745	"OT_ER_ERaERb_1440"	115474	556987	535756	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002283"	36299	"7378-99-6"	"N,N-Dimethyloctylamine"	"C7378996"	2	"ACEA_T47D_80hr_Positive"	10281	1778203	1781203	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002283"	36299	"7378-99-6"	"N,N-Dimethyloctylamine"	"C7378996"	75	"ATG_ERE_CIS_up"	13415	2091928	1966196	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002283"	36299	"7378-99-6"	"N,N-Dimethyloctylamine"	"C7378996"	750	"OT_ERa_EREGFP_0120"	115606	571864	565932	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002287"	22113	"760-23-6"	"3,4-Dichloro-1-butene"	"C760236"	75	"ATG_ERE_CIS_up"	13414	2091926	1966198	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002287"	22113	"760-23-6"	"3,4-Dichloro-1-butene"	"C760236"	117	"ATG_ERa_TRANS_up"	50042	2171301	2037226	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002295"	21653	"110-62-3"	"Pentanal"	"C110623"	75	"ATG_ERE_CIS_up"	13413	2091922	1966202	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002295"	21653	"110-62-3"	"Pentanal"	"C110623"	117	"ATG_ERa_TRANS_up"	50244	2171297	2037222	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002297"	21832	"99-97-8"	"N,N,4-Trimethylaniline"	"C99978"	75	"ATG_ERE_CIS_up"	13650	2091921	1966203	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002299"	25692	"123-35-3"	"Myrcene"	"C123353"	750	"OT_ERa_EREGFP_0120"	115607	571870	565938	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002301"	41426	"110-87-2"	"3,4-Dihydro-2H-pyran"	"C110872"	2	"ACEA_T47D_80hr_Positive"	10226	1778210	1781195	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX002301"	41426	"110-87-2"	"3,4-Dihydro-2H-pyran"	"C110872"	2	"ACEA_T47D_80hr_Positive"	10738	1778210	1781195	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002301"	41426	"110-87-2"	"3,4-Dihydro-2H-pyran"	"C110872"	75	"ATG_ERE_CIS_up"	13412	2091919	1966205	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002301"	41426	"110-87-2"	"3,4-Dihydro-2H-pyran"	"C110872"	117	"ATG_ERa_TRANS_up"	49757	2171294	2037219	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX002301"	41426	"110-87-2"	"3,4-Dihydro-2H-pyran"	"C110872"	117	"ATG_ERa_TRANS_up"	50041	2171294	2037219	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002303"	38795	"1873-88-7"	"1,1,1,3,5,5,5-Heptamethyltrisiloxane"	"C1873887"	117	"ATG_ERa_TRANS_up"	49756	2171293	2037218	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX002303"	38795	"1873-88-7"	"1,1,1,3,5,5,5-Heptamethyltrisiloxane"	"C1873887"	117	"ATG_ERa_TRANS_up"	50040	2171293	2037218	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002309"	26488	"79-92-5"	"2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane"	"C79925"	743	"OT_ER_ERaERa_1440"	114372	550814	561997	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002309"	26488	"79-92-5"	"2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane"	"C79925"	743	"OT_ER_ERaERa_1440"	114484	550814	561997	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002311"	34287	"104-67-6"	"5-Heptyldihydro-2(3H)-furanone"	"C104676"	75	"ATG_ERE_CIS_up"	13411	2091915	1966209	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002313"	22406	"131-56-6"	"2,4-Dihydroxybenzophenone"	"C131566"	725	"NVS_NR_mERa"	517616	2709974	2699251	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002317"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	708	"NVS_NR_bER"	516245	2706616	2695576	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002317"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	745	"OT_ER_ERaERb_1440"	115401	557001	535770	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002317"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	747	"OT_ER_ERbERb_1440"	114780	558969	560032	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002317"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	747	"OT_ER_ERbERb_1440"	114858	558969	560032	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002317"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	750	"OT_ERa_EREGFP_0120"	115608	571877	565945	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002327"	21969	"121-33-5"	"4-Hydroxy-3-methoxybenzaldehyde"	"C121335"	2	"ACEA_T47D_80hr_Positive"	10558	1778218	1781187	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002327"	21969	"121-33-5"	"4-Hydroxy-3-methoxybenzaldehyde"	"C121335"	714	"NVS_NR_hER"	517704	2708803	2698080	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002327"	21969	"121-33-5"	"4-Hydroxy-3-methoxybenzaldehyde"	"C121335"	725	"NVS_NR_mERa"	517038	2709976	2699253	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002327"	21969	"121-33-5"	"4-Hydroxy-3-methoxybenzaldehyde"	"C121335"	725	"NVS_NR_mERa"	517421	2709976	2699253	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002329"	32630	"1214-39-7"	"N-Benzyladenine"	"C1214397"	117	"ATG_ERa_TRANS_up"	50038	2171283	2037208	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002333"	22055	"540-88-5"	"tert-Butyl acetate"	"C540885"	2	"ACEA_T47D_80hr_Positive"	10559	1778221	1781184	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002339"	21195	"1120-71-4"	"1,3-Propane sultone"	"C1120714"	2	"ACEA_T47D_80hr_Positive"	10282	1778222	1781183	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002339"	21195	"1120-71-4"	"1,3-Propane sultone"	"C1120714"	745	"OT_ER_ERaERb_1440"	115402	557007	535776	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002341"	26080	"100-21-0"	"Terephthalic acid"	"C100210"	743	"OT_ER_ERaERa_1440"	114373	550824	562007	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002341"	26080	"100-21-0"	"Terephthalic acid"	"C100210"	747	"OT_ER_ERbERb_1440"	114781	558976	560039	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002341"	26080	"100-21-0"	"Terephthalic acid"	"C100210"	747	"OT_ER_ERbERb_1440"	114859	558976	560039	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002345"	36690	"141-04-8"	"Diisobutyl adipate"	"C141048"	75	"ATG_ERE_CIS_up"	13350	2091903	1966221	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX002345"	36690	"141-04-8"	"Diisobutyl adipate"	"C141048"	75	"ATG_ERE_CIS_up"	13649	2091903	1966221	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002345"	36690	"141-04-8"	"Diisobutyl adipate"	"C141048"	750	"OT_ERa_EREGFP_0120"	115609	571885	565953	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002357"	20375	"50-29-3"	"p,p'-DDT"	"C50293"	2	"ACEA_T47D_80hr_Positive"	10560	1778225	1781180	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002357"	20375	"50-29-3"	"p,p'-DDT"	"C50293"	708	"NVS_NR_bER"	516246	2706619	2695579	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002357"	20375	"50-29-3"	"p,p'-DDT"	"C50293"	751	"OT_ERa_EREGFP_0480"	116885	564893	567932	10	"Noisy data"	NA	NA	"percent_activity"
"TX002359"	21798	"91-22-5"	"Quinoline"	"C91225"	2	"ACEA_T47D_80hr_Positive"	10561	1778226	1781179	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002361"	25017	"80-43-3"	"Dicumyl peroxide"	"C80433"	714	"NVS_NR_hER"	517764	2708805	2698082	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002361"	25017	"80-43-3"	"Dicumyl peroxide"	"C80433"	743	"OT_ER_ERaERa_1440"	114374	550828	562011	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002361"	25017	"80-43-3"	"Dicumyl peroxide"	"C80433"	743	"OT_ER_ERaERa_1440"	114485	550828	562011	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002369"	26665	"100-54-9"	"3-Pyridinecarbonitrile"	"C100549"	2	"ACEA_T47D_80hr_Positive"	10562	1778228	1781177	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002377"	20805	"89-78-1"	"dl-Menthol"	"C89781"	2	"ACEA_T47D_80hr_Positive"	10563	1778231	1781175	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002377"	20805	"89-78-1"	"dl-Menthol"	"C89781"	750	"OT_ERa_EREGFP_0120"	115610	571892	565960	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002379"	25607	"93-15-2"	"Methyleugenol"	"C93152"	117	"ATG_ERa_TRANS_up"	50036	2171267	2037192	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002379"	25607	"93-15-2"	"Methyleugenol"	"C93152"	725	"NVS_NR_mERa"	517039	2709979	2699256	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002387"	26623	"98-52-2"	"4-tert-Butylcyclohexanol"	"C98522"	117	"ATG_ERa_TRANS_up"	49824	2171264	2037189	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX002387"	26623	"98-52-2"	"4-tert-Butylcyclohexanol"	"C98522"	744	"OT_ER_ERaERb_0480"	112962	2402108	2399023	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002389"	41516	"4940-11-8"	"2-Ethyl-3-hydroxy-4H-pyran-4-one"	"C4940118"	75	"ATG_ERE_CIS_up"	13648	2091888	1966236	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002399"	42490	"2031-67-6"	"Triethoxymethylsilane"	"C2031676"	117	"ATG_ERa_TRANS_up"	49642	2171258	2037183	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002399"	42490	"2031-67-6"	"Triethoxymethylsilane"	"C2031676"	117	"ATG_ERa_TRANS_up"	49823	2171258	2037183	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX002399"	42490	"2031-67-6"	"Triethoxymethylsilane"	"C2031676"	117	"ATG_ERa_TRANS_up"	50242	2171258	2037183	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002399"	42490	"2031-67-6"	"Triethoxymethylsilane"	"C2031676"	743	"OT_ER_ERaERa_1440"	114375	550839	562022	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002399"	42490	"2031-67-6"	"Triethoxymethylsilane"	"C2031676"	743	"OT_ER_ERaERa_1440"	114486	550839	562022	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002403"	20654	"105-87-3"	"Geranyl acetate"	"C105873"	75	"ATG_ERE_CIS_up"	13216	2091882	1966241	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX002403"	20654	"105-87-3"	"Geranyl acetate"	"C105873"	75	"ATG_ERE_CIS_up"	13408	2091882	1966241	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002403"	20654	"105-87-3"	"Geranyl acetate"	"C105873"	750	"OT_ERa_EREGFP_0120"	115611	571900	565968	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002407"	20425	"117-80-6"	"Dichlone"	"C117806"	750	"OT_ERa_EREGFP_0120"	115612	571902	565970	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002407"	20425	"117-80-6"	"Dichlone"	"C117806"	750	"OT_ERa_EREGFP_0120"	115835	571902	565970	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002415"	38788	"1076-97-7"	"1,4-Cyclohexanedicarboxylic acid"	"C1076977"	708	"NVS_NR_bER"	516227	2706624	2695584	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX002415"	38788	"1076-97-7"	"1,4-Cyclohexanedicarboxylic acid"	"C1076977"	708	"NVS_NR_bER"	516340	2706624	2695584	11	"Borderline active"	NA	NA	"percent_activity"
"TX002415"	38788	"1076-97-7"	"1,4-Cyclohexanedicarboxylic acid"	"C1076977"	708	"NVS_NR_bER"	516421	2706624	2695584	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX002415"	38788	"1076-97-7"	"1,4-Cyclohexanedicarboxylic acid"	"C1076977"	708	"NVS_NR_bER"	516430	2706624	2695584	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002415"	38788	"1076-97-7"	"1,4-Cyclohexanedicarboxylic acid"	"C1076977"	708	"NVS_NR_bER"	516478	2706624	2695584	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002425"	26900	"112-00-5"	"Dodecyltrimethylammonium chloride"	"C112005"	725	"NVS_NR_mERa"	517381	2709983	2699260	11	"Borderline active"	NA	NA	"percent_activity"
"TX002425"	26900	"112-00-5"	"Dodecyltrimethylammonium chloride"	"C112005"	725	"NVS_NR_mERa"	517617	2709983	2699260	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002425"	26900	"112-00-5"	"Dodecyltrimethylammonium chloride"	"C112005"	750	"OT_ERa_EREGFP_0120"	115613	571908	565976	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002425"	26900	"112-00-5"	"Dodecyltrimethylammonium chloride"	"C112005"	751	"OT_ERa_EREGFP_0480"	116742	564915	567954	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002429"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	708	"NVS_NR_bER"	516341	2706626	2695586	11	"Borderline active"	NA	NA	"percent_activity"
"TX002429"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	708	"NVS_NR_bER"	516479	2706626	2695586	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002429"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	714	"NVS_NR_hER"	517984	2708811	2698088	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002429"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	725	"NVS_NR_mERa"	517618	2709984	2699261	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002429"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	742	"OT_ER_ERaERa_0480"	114935	555063	564004	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002429"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	742	"OT_ER_ERaERa_0480"	115006	555063	564004	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002429"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	743	"OT_ER_ERaERa_1440"	114487	550850	562033	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002435"	21152	"92-69-3"	"4-Phenylphenol"	"C92693"	708	"NVS_NR_bER"	516318	2706627	2695587	10	"Noisy data"	NA	NA	"percent_activity"
"TX002439"	22479	"90-00-6"	"2-Ethylphenol"	"C90006"	708	"NVS_NR_bER"	516431	2706628	2695588	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002439"	22479	"90-00-6"	"2-Ethylphenol"	"C90006"	708	"NVS_NR_bER"	516480	2706628	2695588	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002453"	22008	"143-08-8"	"1-Nonanol"	"C143088"	742	"OT_ER_ERaERa_0480"	115007	555069	564010	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002470"	20354	"461-58-5"	"Cyanoguanidine"	"C461585"	2	"ACEA_T47D_80hr_Positive"	10163	1778257	1781148	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002472"	24621	"111-96-6"	"Bis(2-methoxyethyl) ether"	"C111966"	2	"ACEA_T47D_80hr_Positive"	10283	1778258	1781147	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002472"	24621	"111-96-6"	"Bis(2-methoxyethyl) ether"	"C111966"	2	"ACEA_T47D_80hr_Positive"	10564	1778258	1781147	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002474"	21946	"112-30-1"	"1-Decanol"	"C112301"	117	"ATG_ERa_TRANS_up"	50035	2171234	2037159	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002496"	26076	"1401-55-4"	"Tannic acid"	"C1401554"	744	"OT_ER_ERaERb_0480"	112858	2402078	2399056	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002498"	29170	"141-79-7"	"4-Methylpent-3-en-2-one"	"C141797"	742	"OT_ER_ERaERa_0480"	114936	555078	564019	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002498"	29170	"141-79-7"	"4-Methylpent-3-en-2-one"	"C141797"	744	"OT_ER_ERaERb_0480"	112961	2402077	2399055	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002498"	29170	"141-79-7"	"4-Methylpent-3-en-2-one"	"C141797"	750	"OT_ERa_EREGFP_0120"	115790	571925	565993	10	"Noisy data"	NA	NA	"percent_activity"
"TX002506"	42187	"109-46-6"	"N,N'-Dibutylthiourea"	"C109466"	117	"ATG_ERa_TRANS_up"	50034	2171226	2037151	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002508"	20220	"1948-33-0"	"tert-Butylhydroquinone"	"C1948330"	75	"ATG_ERE_CIS_up"	13407	2091850	1966274	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002508"	20220	"1948-33-0"	"tert-Butylhydroquinone"	"C1948330"	744	"OT_ER_ERaERb_0480"	112880	2402074	2399059	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002508"	20220	"1948-33-0"	"tert-Butylhydroquinone"	"C1948330"	744	"OT_ER_ERaERb_0480"	112960	2402074	2399059	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002508"	20220	"1948-33-0"	"tert-Butylhydroquinone"	"C1948330"	746	"OT_ER_ERbERb_0480"	116547	548897	558112	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002526"	24072	"957-51-7"	"Diphenamid"	"C957517"	2	"ACEA_T47D_80hr_Positive"	10565	1778268	1781137	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002526"	24072	"957-51-7"	"Diphenamid"	"C957517"	750	"OT_ERa_EREGFP_0120"	115614	571931	565999	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002530"	40788	"121-00-6"	"2-tert-Butyl-4-methoxyphenol"	"C121006"	75	"ATG_ERE_CIS_up"	13406	2091844	1966280	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002530"	40788	"121-00-6"	"2-tert-Butyl-4-methoxyphenol"	"C121006"	744	"OT_ER_ERaERb_0480"	112857	2402069	2399068	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002545"	21519	"112-34-5"	"2-(2-Butoxyethoxy)ethanol"	"C112345"	2	"ACEA_T47D_80hr_Positive"	10164	1778272	1781133	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002553"	21126	"92-84-2"	"Phenothiazine"	"C92842"	2	"ACEA_T47D_80hr_Positive"	10227	1778273	1781131	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX002567"	26773	"107-88-0"	"1,3-Butanediol"	"C107880"	708	"NVS_NR_bER"	516367	2706633	2695593	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002569"	20144	"119-53-9"	"Benzoin"	"C119539"	2	"ACEA_T47D_80hr_Positive"	10566	1778275	1781130	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002577"	26647	"99-96-7"	"4-Hydroxybenzoic acid"	"C99967"	75	"ATG_ERE_CIS_up"	13177	2091835	1966289	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002577"	26647	"99-96-7"	"4-Hydroxybenzoic acid"	"C99967"	75	"ATG_ERE_CIS_up"	13646	2091835	1966289	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002577"	26647	"99-96-7"	"4-Hydroxybenzoic acid"	"C99967"	117	"ATG_ERa_TRANS_up"	49641	2171210	2037135	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002577"	26647	"99-96-7"	"4-Hydroxybenzoic acid"	"C99967"	117	"ATG_ERa_TRANS_up"	50239	2171210	2037135	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002581"	22332	"99-71-8"	"4-(Butan-2-yl)phenol"	"C99718"	725	"NVS_NR_mERa"	517040	2709993	2699270	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002581"	22332	"99-71-8"	"4-(Butan-2-yl)phenol"	"C99718"	725	"NVS_NR_mERa"	517422	2709993	2699270	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002587"	21793	"90-15-3"	"1-Naphthol"	"C90153"	743	"OT_ER_ERaERa_1440"	114488	550883	562066	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002591"	24466	"150-13-0"	"4-Aminobenzoic acid"	"C150130"	2	"ACEA_T47D_80hr_Positive"	10165	1778281	1781125	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002599"	21771	"80-46-6"	"4-(2-Methylbutan-2-yl)phenol"	"C80466"	708	"NVS_NR_bER"	516368	2706637	2695597	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002599"	21771	"80-46-6"	"4-(2-Methylbutan-2-yl)phenol"	"C80466"	714	"NVS_NR_hER"	517766	2708826	2698103	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002599"	21771	"80-46-6"	"4-(2-Methylbutan-2-yl)phenol"	"C80466"	714	"NVS_NR_hER"	517870	2708826	2698103	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002599"	21771	"80-46-6"	"4-(2-Methylbutan-2-yl)phenol"	"C80466"	725	"NVS_NR_mERa"	517620	2709995	2699272	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002603"	42299	"99-89-8"	"4-Isopropylphenol"	"C99898"	714	"NVS_NR_hER"	517928	2708827	2698104	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002603"	42299	"99-89-8"	"4-Isopropylphenol"	"C99898"	714	"NVS_NR_hER"	517985	2708827	2698104	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002603"	42299	"99-89-8"	"4-Isopropylphenol"	"C99898"	725	"NVS_NR_mERa"	517041	2709996	2699273	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002603"	42299	"99-89-8"	"4-Isopropylphenol"	"C99898"	725	"NVS_NR_mERa"	517423	2709996	2699273	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002611"	21922	"110-73-6"	"2-(Ethylamino)ethanol"	"C110736"	2	"ACEA_T47D_80hr_Positive"	10166	1778287	1781119	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002615"	20179	"110-97-4"	"Diisopropanolamine"	"C110974"	750	"OT_ERa_EREGFP_0120"	115791	571951	566019	10	"Noisy data"	NA	NA	"percent_activity"
"TX002615"	20179	"110-97-4"	"Diisopropanolamine"	"C110974"	750	"OT_ERa_EREGFP_0120"	115836	571951	566019	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002625"	20932	"59-67-6"	"Nicotinic acid"	"C59676"	2	"ACEA_T47D_80hr_Positive"	10284	1778289	1781116	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002625"	20932	"59-67-6"	"Nicotinic acid"	"C59676"	2	"ACEA_T47D_80hr_Positive"	10567	1778289	1781116	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002639"	22405	"131-57-7"	"2-Hydroxy-4-methoxybenzophenone"	"C131577"	2	"ACEA_T47D_80hr_Positive"	10452	1778291	1781114	11	"Borderline active"	NA	NA	"percent_activity"
"TX002639"	22405	"131-57-7"	"2-Hydroxy-4-methoxybenzophenone"	"C131577"	742	"OT_ER_ERaERa_0480"	114903	555107	564048	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002639"	22405	"131-57-7"	"2-Hydroxy-4-methoxybenzophenone"	"C131577"	745	"OT_ER_ERaERb_1440"	115350	557078	535847	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002639"	22405	"131-57-7"	"2-Hydroxy-4-methoxybenzophenone"	"C131577"	747	"OT_ER_ERbERb_1440"	114860	559046	560109	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002641"	26974	"120-95-6"	"2,4-Bis(2-methylbutan-2-yl)phenol"	"C120956"	744	"OT_ER_ERaERb_0480"	112959	2402047	2399089	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002641"	26974	"120-95-6"	"2,4-Bis(2-methylbutan-2-yl)phenol"	"C120956"	747	"OT_ER_ERbERb_1440"	114782	559047	560110	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002641"	26974	"120-95-6"	"2,4-Bis(2-methylbutan-2-yl)phenol"	"C120956"	747	"OT_ER_ERbERb_1440"	114861	559047	560110	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002641"	26974	"120-95-6"	"2,4-Bis(2-methylbutan-2-yl)phenol"	"C120956"	750	"OT_ERa_EREGFP_0120"	115615	571955	566023	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002641"	26974	"120-95-6"	"2,4-Bis(2-methylbutan-2-yl)phenol"	"C120956"	750	"OT_ERa_EREGFP_0120"	115837	571955	566023	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002649"	21853	"103-76-4"	"1-Piperazineethanol"	"C103764"	2	"ACEA_T47D_80hr_Positive"	10568	1778293	1781113	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002649"	21853	"103-76-4"	"1-Piperazineethanol"	"C103764"	747	"OT_ER_ERbERb_1440"	114783	559048	560111	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002649"	21853	"103-76-4"	"1-Piperazineethanol"	"C103764"	750	"OT_ERa_EREGFP_0120"	115817	571956	566024	11	"Borderline active"	NA	NA	"percent_activity"
"TX002663"	42130	"587-85-9"	"Diphenylmercury(II)"	"C587859"	2	"ACEA_T47D_80hr_Positive"	10569	1778295	1781110	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002665"	36226	"142-31-4"	"Sodium octyl sulfate"	"C142314"	75	"ATG_ERE_CIS_up"	13327	2091811	1966313	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX002665"	36226	"142-31-4"	"Sodium octyl sulfate"	"C142314"	75	"ATG_ERE_CIS_up"	13645	2091811	1966313	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002665"	36226	"142-31-4"	"Sodium octyl sulfate"	"C142314"	117	"ATG_ERa_TRANS_up"	50238	2171186	2037111	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002669"	27052	"128-39-2"	"2,6-Di-tert-butylphenol"	"C128392"	745	"OT_ER_ERaERb_1440"	115475	557085	535854	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002669"	27052	"128-39-2"	"2,6-Di-tert-butylphenol"	"C128392"	746	"OT_ER_ERbERb_0480"	116588	548930	558145	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002669"	27052	"128-39-2"	"2,6-Di-tert-butylphenol"	"C128392"	746	"OT_ER_ERbERb_0480"	116630	548930	558145	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002673"	37494	"6190-65-4"	"Deethylatrazine"	"C6190654"	2	"ACEA_T47D_80hr_Positive"	10167	1778299	1781106	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002699"	41275	"142-18-7"	"1-Monolaurin"	"C142187"	117	"ATG_ERa_TRANS_up"	50033	2171179	2037104	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002699"	41275	"142-18-7"	"1-Monolaurin"	"C142187"	725	"NVS_NR_mERa"	517545	2710004	2699281	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002699"	41275	"142-18-7"	"1-Monolaurin"	"C142187"	725	"NVS_NR_mERa"	517621	2710004	2699281	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002713"	41567	"141-22-0"	"9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-"	"C141220"	117	"ATG_ERa_TRANS_up"	50032	2171177	2037102	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002723"	24081	"145-73-3"	"Endothal"	"C145733"	75	"ATG_ERE_CIS_up"	13349	2091799	1966325	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX002723"	24081	"145-73-3"	"Endothal"	"C145733"	75	"ATG_ERE_CIS_up"	13644	2091799	1966325	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002739"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	75	"ATG_ERE_CIS_up"	13113	2091798	1966326	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002739"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	75	"ATG_ERE_CIS_up"	13643	2091798	1966326	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002739"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	744	"OT_ER_ERaERb_0480"	112856	2402032	2399104	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002739"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	745	"OT_ER_ERaERb_1440"	115476	557094	535863	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002739"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	746	"OT_ER_ERbERb_0480"	116631	548939	558154	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002739"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	750	"OT_ERa_EREGFP_0120"	115616	571970	566038	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002739"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	751	"OT_ERa_EREGFP_0480"	116743	564977	568016	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002741"	42154	"493-52-7"	"Methyl red"	"C493527"	708	"NVS_NR_bER"	516247	2706652	2695612	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002741"	42154	"493-52-7"	"Methyl red"	"C493527"	725	"NVS_NR_mERa"	517382	2710010	2699287	11	"Borderline active"	NA	NA	"percent_activity"
"TX002741"	42154	"493-52-7"	"Methyl red"	"C493527"	725	"NVS_NR_mERa"	517622	2710010	2699287	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002741"	42154	"493-52-7"	"Methyl red"	"C493527"	751	"OT_ERa_EREGFP_0480"	116744	564978	568017	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002747"	24836	"5392-40-5"	"3,7-Dimethyl-2,6-octadienal"	"C5392405"	75	"ATG_ERE_CIS_up"	13112	2091795	1966329	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002747"	24836	"5392-40-5"	"3,7-Dimethyl-2,6-octadienal"	"C5392405"	117	"ATG_ERa_TRANS_up"	50031	2171170	2037095	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002749"	35160	"127-41-3"	"alpha-Ionone"	"C127413"	742	"OT_ER_ERaERa_0480"	114937	555127	564068	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002749"	35160	"127-41-3"	"alpha-Ionone"	"C127413"	742	"OT_ER_ERaERa_0480"	115008	555127	564068	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002751"	21940	"111-87-5"	"1-Octanol"	"C111875"	117	"ATG_ERa_TRANS_up"	49754	2171168	2037093	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX002751"	21940	"111-87-5"	"1-Octanol"	"C111875"	117	"ATG_ERa_TRANS_up"	50030	2171168	2037093	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002753"	29105	"70-55-3"	"4-Toluenesulfonamide"	"C70553"	2	"ACEA_T47D_80hr_Positive"	10454	1778313	1781092	11	"Borderline active"	NA	NA	"percent_activity"
"TX002753"	29105	"70-55-3"	"4-Toluenesulfonamide"	"C70553"	2	"ACEA_T47D_80hr_Positive"	10740	1778313	1781092	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002763"	37028	"57-09-0"	"Hexadecyltrimethylammonium bromide"	"C57090"	714	"NVS_NR_hER"	517705	2708846	2698123	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002771"	20014	"520-45-6"	"Dehydroacetic acid"	"C520456"	2	"ACEA_T47D_80hr_Positive"	10571	1778317	1781088	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002771"	20014	"520-45-6"	"Dehydroacetic acid"	"C520456"	725	"NVS_NR_mERa"	517046	2710013	2699290	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002771"	20014	"520-45-6"	"Dehydroacetic acid"	"C520456"	725	"NVS_NR_mERa"	517425	2710013	2699290	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002775"	27429	"1724-39-6"	"Cyclododecanol"	"C1724396"	75	"ATG_ERE_CIS_up"	13642	2091787	1966337	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002775"	27429	"1724-39-6"	"Cyclododecanol"	"C1724396"	745	"OT_ER_ERaERb_1440"	115403	557105	535874	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002784"	34972	"89-83-8"	"Thymol"	"C89838"	744	"OT_ER_ERaERb_0480"	112957	2402019	2399119	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002796"	24123	"69806-40-2"	"Haloxyfop-methyl"	"C69806402"	2	"ACEA_T47D_80hr_Positive"	10286	1778322	1781083	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002796"	24123	"69806-40-2"	"Haloxyfop-methyl"	"C69806402"	2	"ACEA_T47D_80hr_Positive"	10572	1778322	1781083	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002798"	24955	"110-05-4"	"Di-tert-butyl peroxide"	"C110054"	2	"ACEA_T47D_80hr_Positive"	10573	1778323	1781082	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002802"	32376	"87674-68-8"	"Dimethenamid"	"C87674688"	2	"ACEA_T47D_80hr_Positive"	10574	1778324	1781081	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002804"	32562	"113-48-4"	"MGK-264"	"C113484"	746	"OT_ER_ERbERb_0480"	116633	548957	558172	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002805"	34265	"57754-85-5"	"Clopyralid-olamine"	"C57754855"	2	"ACEA_T47D_80hr_Positive"	10287	1778326	1781080	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002805"	34265	"57754-85-5"	"Clopyralid-olamine"	"C57754855"	2	"ACEA_T47D_80hr_Positive"	10575	1778326	1781080	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002806"	24048	"43222-48-6"	"Difenzoquat metilsulfate"	"C43222486"	750	"OT_ERa_EREGFP_0120"	115617	571990	566058	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002823"	24344	"2303-17-5"	"Tri-allate"	"C2303175"	746	"OT_ER_ERbERb_0480"	116590	548964	558179	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002823"	24344	"2303-17-5"	"Tri-allate"	"C2303175"	746	"OT_ER_ERbERb_0480"	116634	548964	558179	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002825"	24266	"29232-93-7"	"Pirimiphos-methyl"	"C29232937"	2	"ACEA_T47D_80hr_Positive"	10288	1778333	1781072	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002825"	24266	"29232-93-7"	"Pirimiphos-methyl"	"C29232937"	742	"OT_ER_ERaERa_0480"	114992	555149	564090	11	"Borderline active"	NA	NA	"percent_activity"
"TX002844"	21151	"90-43-7"	"2-Phenylphenol"	"C90437"	744	"OT_ER_ERaERb_0480"	112855	2402002	2399129	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002844"	21151	"90-43-7"	"2-Phenylphenol"	"C90437"	746	"OT_ER_ERbERb_0480"	116548	548969	558184	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002857"	41909	"10025-74-8"	"Dysprosium(III) chloride"	"C10025748"	2	"ACEA_T47D_80hr_Positive"	10576	1778340	1781065	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002857"	41909	"10025-74-8"	"Dysprosium(III) chloride"	"C10025748"	746	"OT_ER_ERbERb_0480"	116635	548972	558187	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002857"	41909	"10025-74-8"	"Dysprosium(III) chloride"	"C10025748"	750	"OT_ERa_EREGFP_0120"	115838	572003	566071	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002857"	41909	"10025-74-8"	"Dysprosium(III) chloride"	"C10025748"	751	"OT_ERa_EREGFP_0480"	116692	565010	568049	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002857"	41909	"10025-74-8"	"Dysprosium(III) chloride"	"C10025748"	751	"OT_ERa_EREGFP_0480"	116894	565010	568049	11	"Borderline active"	NA	NA	"percent_activity"
"TX002857"	41909	"10025-74-8"	"Dysprosium(III) chloride"	"C10025748"	751	"OT_ERa_EREGFP_0480"	116932	565010	568049	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002865"	42062	"2756-56-1"	"Isobornyl propanoate"	"C2756561"	75	"ATG_ERE_CIS_up"	13405	2091775	1966349	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002865"	42062	"2756-56-1"	"Isobornyl propanoate"	"C2756561"	117	"ATG_ERa_TRANS_up"	49822	2171150	2037075	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX002889"	42196	"138-22-7"	"Butyl lactate"	"C138227"	2	"ACEA_T47D_80hr_Positive"	10289	1778343	1781063	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002889"	42196	"138-22-7"	"Butyl lactate"	"C138227"	750	"OT_ERa_EREGFP_0120"	115792	572006	566074	10	"Noisy data"	NA	NA	"percent_activity"
"TX002891"	41955	"139-87-7"	"Ethyl diethanolamine"	"C139877"	743	"OT_ER_ERaERa_1440"	114376	550947	562130	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002893"	20068	"117-79-3"	"2-Aminoanthraquinone"	"C117793"	725	"NVS_NR_mERa"	517281	2710022	2699299	10	"Noisy data"	NA	NA	"percent_activity"
"TX002893"	20068	"117-79-3"	"2-Aminoanthraquinone"	"C117793"	750	"OT_ERa_EREGFP_0120"	115618	572008	566076	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002893"	20068	"117-79-3"	"2-Aminoanthraquinone"	"C117793"	751	"OT_ERa_EREGFP_0480"	116745	565015	568054	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002903"	41289	"4574-04-3"	"Myristyltrimethylammonium chlorideN,N,N-Trimethyltetradecan-1-aminium chloride"	"C4574043"	714	"NVS_NR_hER"	517706	2708860	2698137	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002903"	41289	"4574-04-3"	"Myristyltrimethylammonium chlorideN,N,N-Trimethyltetradecan-1-aminium chloride"	"C4574043"	725	"NVS_NR_mERa"	517624	2710024	2699301	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002905"	41250	"14233-37-5"	"1,4-Bis(N-isopropylamino)anthraquinone"	"C14233375"	751	"OT_ERa_EREGFP_0480"	116746	565019	568058	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	117	"ATG_ERa_TRANS_up"	49752	2171138	2037063	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	117	"ATG_ERa_TRANS_up"	50028	2171138	2037063	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	714	"NVS_NR_hER"	517707	2708861	2698138	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	714	"NVS_NR_hER"	517931	2708861	2698138	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	714	"NVS_NR_hER"	517989	2708861	2698138	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	725	"NVS_NR_mERa"	517282	2710025	2699302	10	"Noisy data"	NA	NA	"percent_activity"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	745	"OT_ER_ERaERb_1440"	115477	557137	535906	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	750	"OT_ERa_EREGFP_0120"	115839	572013	566081	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002907"	41357	"3025-30-7"	"Ethyl (2E,4Z)-deca-2,4-dienoate"	"C3025307"	751	"OT_ERa_EREGFP_0480"	116693	565020	568059	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002915"	35152	"116-25-6"	"1-(Hydroxymethyl)-5,5-dimethylhydantoin"	"C116256"	75	"ATG_ERE_CIS_up"	13111	2091760	1966364	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002915"	35152	"116-25-6"	"1-(Hydroxymethyl)-5,5-dimethylhydantoin"	"C116256"	75	"ATG_ERE_CIS_up"	13640	2091760	1966364	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002915"	35152	"116-25-6"	"1-(Hydroxymethyl)-5,5-dimethylhydantoin"	"C116256"	117	"ATG_ERa_TRANS_up"	49598	2171135	2037060	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002917"	20221	"98-54-4"	"4-tert-Butylphenol"	"C98544"	714	"NVS_NR_hER"	517768	2708864	2698141	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002917"	20221	"98-54-4"	"4-tert-Butylphenol"	"C98544"	725	"NVS_NR_mERa"	517002	2710027	2699304	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002917"	20221	"98-54-4"	"4-tert-Butylphenol"	"C98544"	725	"NVS_NR_mERa"	517546	2710027	2699304	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002917"	20221	"98-54-4"	"4-tert-Butylphenol"	"C98544"	725	"NVS_NR_mERa"	517625	2710027	2699304	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002921"	21164	"110-85-0"	"Piperazine"	"C110850"	2	"ACEA_T47D_80hr_Positive"	10168	1778354	1781051	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002921"	21164	"110-85-0"	"Piperazine"	"C110850"	2	"ACEA_T47D_80hr_Positive"	10455	1778354	1781051	11	"Borderline active"	NA	NA	"percent_activity"
"TX002933"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	742	"OT_ER_ERaERa_0480"	114938	555172	564113	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002933"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	742	"OT_ER_ERaERa_0480"	115009	555172	564113	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002933"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	746	"OT_ER_ERbERb_0480"	116591	548988	558203	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002933"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	746	"OT_ER_ERbERb_0480"	116636	548988	558203	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002933"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	747	"OT_ER_ERbERb_1440"	114785	559111	560174	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002933"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	750	"OT_ERa_EREGFP_0120"	115619	572019	566087	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002933"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	751	"OT_ERa_EREGFP_0480"	116747	565026	568065	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002953"	20617	"97-53-0"	"Eugenol"	"C97530"	2	"ACEA_T47D_80hr_Positive"	10290	1778359	1781046	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002953"	20617	"97-53-0"	"Eugenol"	"C97530"	75	"ATG_ERE_CIS_up"	13348	2091752	1966372	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX002959"	23723	"77-86-1"	"Tromethamine"	"C77861"	708	"NVS_NR_bER"	516249	2706674	2695634	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002963"	21754	"77-71-4"	"5,5-Dimethylhydantoin"	"C77714"	75	"ATG_ERE_CIS_up"	13639	2091749	1966375	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002963"	21754	"77-71-4"	"5,5-Dimethylhydantoin"	"C77714"	117	"ATG_ERa_TRANS_up"	49640	2171124	2037049	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX002963"	21754	"77-71-4"	"5,5-Dimethylhydantoin"	"C77714"	117	"ATG_ERa_TRANS_up"	50237	2171124	2037049	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX002965"	21485	"121-91-5"	"1,3-Benzenedicarboxylic acid"	"C121915"	743	"OT_ER_ERaERa_1440"	114515	550965	562148	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX002967"	21986	"126-73-8"	"Tributyl phosphate"	"C126738"	117	"ATG_ERa_TRANS_up"	49751	2171122	2037047	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX002967"	21986	"126-73-8"	"Tributyl phosphate"	"C126738"	117	"ATG_ERa_TRANS_up"	50027	2171122	2037047	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX002967"	21986	"126-73-8"	"Tributyl phosphate"	"C126738"	750	"OT_ERa_EREGFP_0120"	115620	572026	566094	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002967"	21986	"126-73-8"	"Tributyl phosphate"	"C126738"	751	"OT_ERa_EREGFP_0480"	116748	565033	568072	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002971"	21640	"123-99-9"	"Nonanedioic acid"	"C123999"	708	"NVS_NR_bER"	516250	2706675	2695635	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002971"	21640	"123-99-9"	"Nonanedioic acid"	"C123999"	725	"NVS_NR_mERa"	517049	2710034	2699311	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002977"	26500	"80-54-6"	"3-(4-tert-Butylphenyl)-2-methylpropanal"	"C80546"	745	"OT_ER_ERaERb_1440"	115351	557152	535921	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX002977"	26500	"80-54-6"	"3-(4-tert-Butylphenyl)-2-methylpropanal"	"C80546"	745	"OT_ER_ERaERb_1440"	115462	557152	535921	11	"Borderline active"	NA	NA	"percent_activity"
"TX002985"	22527	"94-13-3"	"Propylparaben"	"C94133"	725	"NVS_NR_mERa"	517547	2710037	2699314	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX002985"	22527	"94-13-3"	"Propylparaben"	"C94133"	725	"NVS_NR_mERa"	517627	2710037	2699314	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX002985"	22527	"94-13-3"	"Propylparaben"	"C94133"	750	"OT_ERa_EREGFP_0120"	115621	572029	566097	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX002985"	22527	"94-13-3"	"Propylparaben"	"C94133"	750	"OT_ERa_EREGFP_0120"	115840	572029	566097	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX002985"	22527	"94-13-3"	"Propylparaben"	"C94133"	751	"OT_ERa_EREGFP_0480"	116895	565036	568075	11	"Borderline active"	NA	NA	"percent_activity"
"TX003065"	26640	"99-62-7"	"1,3-Diisopropylbenzene"	"C99627"	744	"OT_ER_ERaERb_0480"	112956	2401969	2399170	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003067"	25293	"149-57-5"	"2-Ethylhexanoic acid"	"C149575"	2	"ACEA_T47D_80hr_Positive"	10577	1778371	1781034	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003079"	21575	"75-99-0"	"Dalapon"	"C75990"	75	"ATG_ERE_CIS_up"	13401	2091730	1966394	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003079"	21575	"75-99-0"	"Dalapon"	"C75990"	725	"NVS_NR_mERa"	517050	2710040	2699317	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003079"	21575	"75-99-0"	"Dalapon"	"C75990"	725	"NVS_NR_mERa"	517426	2710040	2699317	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003085"	21286	"96-09-3"	"Styrene oxide"	"C96093"	2	"ACEA_T47D_80hr_Positive"	10578	1778377	1781029	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003091"	26691	"102-76-1"	"Triacetin"	"C102761"	708	"NVS_NR_bER"	516319	2706682	2695642	10	"Noisy data"	NA	NA	"percent_activity"
"TX003091"	26691	"102-76-1"	"Triacetin"	"C102761"	725	"NVS_NR_mERa"	517051	2710041	2699318	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003099"	20634	"51-21-8"	"5-Fluorouracil"	"C51218"	75	"ATG_ERE_CIS_up"	13176	2091726	1966398	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003099"	20634	"51-21-8"	"5-Fluorouracil"	"C51218"	75	"ATG_ERE_CIS_up"	13347	2091726	1966398	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003099"	20634	"51-21-8"	"5-Fluorouracil"	"C51218"	75	"ATG_ERE_CIS_up"	13638	2091726	1966398	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003099"	20634	"51-21-8"	"5-Fluorouracil"	"C51218"	117	"ATG_ERa_TRANS_up"	49639	2171101	2037026	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003099"	20634	"51-21-8"	"5-Fluorouracil"	"C51218"	117	"ATG_ERa_TRANS_up"	50236	2171101	2037026	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003107"	27131	"288-88-0"	"1H-1,2,4-Triazole"	"C288880"	725	"NVS_NR_mERa"	517052	2710042	2699319	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003117"	26602	"96-76-4"	"2,4-Di-tert-butylphenol"	"C96764"	746	"OT_ER_ERbERb_0480"	116592	549013	558228	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003117"	26602	"96-76-4"	"2,4-Di-tert-butylphenol"	"C96764"	746	"OT_ER_ERbERb_0480"	116637	549013	558228	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003117"	26602	"96-76-4"	"2,4-Di-tert-butylphenol"	"C96764"	750	"OT_ERa_EREGFP_0120"	115622	572044	566112	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003117"	26602	"96-76-4"	"2,4-Di-tert-butylphenol"	"C96764"	750	"OT_ERa_EREGFP_0120"	115841	572044	566112	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003127"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	2	"ACEA_T47D_80hr_Positive"	10579	1778382	1781023	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003127"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	725	"NVS_NR_mERa"	517628	2710044	2699321	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003127"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	742	"OT_ER_ERaERa_0480"	115010	555198	564139	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003127"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	746	"OT_ER_ERbERb_0480"	116549	549014	558229	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003127"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	750	"OT_ERa_EREGFP_0120"	115623	572045	566113	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003133"	25892	"90-30-2"	"N-Phenyl-1-naphthylamine"	"C90302"	2	"ACEA_T47D_80hr_Positive"	10580	1778383	1781022	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003153"	42273	"2934-05-6"	"2,4-Diisopropylphenol"	"C2934056"	714	"NVS_NR_hER"	517933	2708887	2698164	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003153"	42273	"2934-05-6"	"2,4-Diisopropylphenol"	"C2934056"	714	"NVS_NR_hER"	517990	2708887	2698164	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003153"	42273	"2934-05-6"	"2,4-Diisopropylphenol"	"C2934056"	744	"OT_ER_ERaERb_0480"	112955	2401953	2399177	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003153"	42273	"2934-05-6"	"2,4-Diisopropylphenol"	"C2934056"	746	"OT_ER_ERbERb_0480"	116550	549018	558233	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003155"	42189	"4107-98-6"	"N,N-Diisopropylaniline"	"C4107986"	2	"ACEA_T47D_80hr_Positive"	10291	1778387	1781019	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003159"	42094	"23089-26-1"	"Levomenol"	"C23089261"	743	"OT_ER_ERaERa_1440"	114377	550992	562175	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003159"	42094	"23089-26-1"	"Levomenol"	"C23089261"	750	"OT_ERa_EREGFP_0120"	115842	572052	566120	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003159"	42094	"23089-26-1"	"Levomenol"	"C23089261"	751	"OT_ERa_EREGFP_0480"	116750	565059	568098	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003161"	21554	"334-48-5"	"Decanoic acid"	"C334485"	708	"NVS_NR_bER"	516252	2706691	2695651	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003163"	41514	"21662-09-9"	"(4Z)-4-Decenal"	"C21662099"	75	"ATG_ERE_CIS_up"	13213	2091709	1966415	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003163"	41514	"21662-09-9"	"(4Z)-4-Decenal"	"C21662099"	75	"ATG_ERE_CIS_up"	13400	2091709	1966415	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003163"	41514	"21662-09-9"	"(4Z)-4-Decenal"	"C21662099"	117	"ATG_ERa_TRANS_up"	49750	2171084	2037009	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003163"	41514	"21662-09-9"	"(4Z)-4-Decenal"	"C21662099"	117	"ATG_ERa_TRANS_up"	50025	2171084	2037009	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003169"	20766	"122-42-9"	"Propham"	"C122429"	714	"NVS_NR_hER"	517875	2708889	2698166	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003169"	20766	"122-42-9"	"Propham"	"C122429"	725	"NVS_NR_mERa"	517629	2710051	2699328	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003171"	20512	"79-44-7"	"Dimethylcarbamoyl chloride"	"C79447"	2	"ACEA_T47D_80hr_Positive"	10169	1778394	1781010	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003172"	20286	"95-74-9"	"3-Chloro-4-methylaniline"	"C95749"	743	"OT_ER_ERaERa_1440"	114347	550998	562181	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003172"	20286	"95-74-9"	"3-Chloro-4-methylaniline"	"C95749"	745	"OT_ER_ERaERb_1440"	115352	557182	535951	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003183"	42074	"499-75-2"	"Isopropyl-o-cresol"	"C499752"	744	"OT_ER_ERaERb_0480"	112854	2401942	2399189	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003183"	42074	"499-75-2"	"Isopropyl-o-cresol"	"C499752"	745	"OT_ER_ERaERb_1440"	115478	557184	535953	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003183"	42074	"499-75-2"	"Isopropyl-o-cresol"	"C499752"	746	"OT_ER_ERbERb_0480"	116551	549029	558244	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003187"	25502	"78-70-6"	"Linalool"	"C78706"	2	"ACEA_T47D_80hr_Positive"	10581	1778399	1781006	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003187"	25502	"78-70-6"	"Linalool"	"C78706"	117	"ATG_ERa_TRANS_up"	50024	2171075	2037000	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003187"	25502	"78-70-6"	"Linalool"	"C78706"	725	"NVS_NR_mERa"	517053	2710052	2699329	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003197"	25523	"118-71-8"	"Maltol"	"C118718"	2	"ACEA_T47D_80hr_Positive"	10582	1778402	1781003	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003197"	25523	"118-71-8"	"Maltol"	"C118718"	714	"NVS_NR_hER"	517841	2708891	2698168	11	"Borderline active"	NA	NA	"percent_activity"
"TX003197"	25523	"118-71-8"	"Maltol"	"C118718"	714	"NVS_NR_hER"	517934	2708891	2698168	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003197"	25523	"118-71-8"	"Maltol"	"C118718"	714	"NVS_NR_hER"	517991	2708891	2698168	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003197"	25523	"118-71-8"	"Maltol"	"C118718"	750	"OT_ERa_EREGFP_0120"	115624	572065	566133	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003203"	41265	"2425-77-6"	"2-Hexyl-1-decanol"	"C2425776"	743	"OT_ER_ERaERa_1440"	114360	551006	562189	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX003203"	41265	"2425-77-6"	"2-Hexyl-1-decanol"	"C2425776"	745	"OT_ER_ERaERb_1440"	115479	557190	535959	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003203"	41265	"2425-77-6"	"2-Hexyl-1-decanol"	"C2425776"	747	"OT_ER_ERbERb_1440"	114786	559158	560221	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003203"	41265	"2425-77-6"	"2-Hexyl-1-decanol"	"C2425776"	747	"OT_ER_ERbERb_1440"	114862	559158	560221	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003203"	41265	"2425-77-6"	"2-Hexyl-1-decanol"	"C2425776"	750	"OT_ERa_EREGFP_0120"	115793	572066	566134	10	"Noisy data"	NA	NA	"percent_activity"
"TX003207"	42415	"657-84-1"	"Sodium 4-methylbenzenesulfonate"	"C657841"	751	"OT_ERa_EREGFP_0480"	116751	565074	568113	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003213"	41232	"717-74-8"	"1,3,5-Triisopropylbenzene"	"C717748"	75	"ATG_ERE_CIS_up"	13110	2091692	1966432	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003213"	41232	"717-74-8"	"1,3,5-Triisopropylbenzene"	"C717748"	75	"ATG_ERE_CIS_up"	13346	2091692	1966432	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003213"	41232	"717-74-8"	"1,3,5-Triisopropylbenzene"	"C717748"	75	"ATG_ERE_CIS_up"	13636	2091692	1966432	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003215"	29320	"21245-02-3"	"2-Ethylhexyl 4-(dimethylamino)benzoate"	"C21245023"	2	"ACEA_T47D_80hr_Positive"	10741	1778407	1780998	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003217"	27833	"24549-06-2"	"2-Ethyl-6-methylaniline"	"C24549062"	745	"OT_ER_ERaERb_1440"	115353	557195	535964	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003217"	27833	"24549-06-2"	"2-Ethyl-6-methylaniline"	"C24549062"	745	"OT_ER_ERaERb_1440"	115463	557195	535964	11	"Borderline active"	NA	NA	"percent_activity"
"TX003229"	42209	"4455-26-9"	"N-Methyldioctylamine"	"C4455269"	725	"NVS_NR_mERa"	517054	2710054	2699331	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003229"	42209	"4455-26-9"	"N-Methyldioctylamine"	"C4455269"	725	"NVS_NR_mERa"	517427	2710054	2699331	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003229"	42209	"4455-26-9"	"N-Methyldioctylamine"	"C4455269"	750	"OT_ERa_EREGFP_0120"	115625	572073	566141	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003231"	38924	"6259-76-3"	"Hexyl salicylate"	"C6259763"	2	"ACEA_T47D_80hr_Positive"	10228	1778411	1780994	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX003231"	38924	"6259-76-3"	"Hexyl salicylate"	"C6259763"	2	"ACEA_T47D_80hr_Positive"	10742	1778411	1780994	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003231"	38924	"6259-76-3"	"Hexyl salicylate"	"C6259763"	117	"ATG_ERa_TRANS_up"	49597	2171060	2036985	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003231"	38924	"6259-76-3"	"Hexyl salicylate"	"C6259763"	744	"OT_ER_ERaERb_0480"	112853	2401928	2399213	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003235"	41643	"1008-72-6"	"Sodium 2-formylbenzenesulfonate"	"C1008726"	2	"ACEA_T47D_80hr_Positive"	10456	1778412	1780993	11	"Borderline active"	NA	NA	"percent_activity"
"TX003235"	41643	"1008-72-6"	"Sodium 2-formylbenzenesulfonate"	"C1008726"	75	"ATG_ERE_CIS_up"	13212	2091684	1966441	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003235"	41643	"1008-72-6"	"Sodium 2-formylbenzenesulfonate"	"C1008726"	75	"ATG_ERE_CIS_up"	13399	2091684	1966441	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003237"	41274	"941-69-5"	"1-Phenyl-1H-pyrrole-2,5-dione"	"C941695"	750	"OT_ERa_EREGFP_0120"	115626	572076	566144	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003237"	41274	"941-69-5"	"1-Phenyl-1H-pyrrole-2,5-dione"	"C941695"	751	"OT_ERa_EREGFP_0480"	116694	565083	568122	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003239"	24598	"118-58-1"	"Benzyl salicylate"	"C118581"	742	"OT_ER_ERaERa_0480"	114904	555230	564171	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003249"	21311	"732-26-3"	"2,4,6-Tris(tert-butyl)phenol"	"C732263"	75	"ATG_ERE_CIS_up"	13211	2091680	1966444	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003249"	21311	"732-26-3"	"2,4,6-Tris(tert-butyl)phenol"	"C732263"	75	"ATG_ERE_CIS_up"	13398	2091680	1966444	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003249"	21311	"732-26-3"	"2,4,6-Tris(tert-butyl)phenol"	"C732263"	744	"OT_ER_ERaERb_0480"	112852	2401923	2399208	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003255"	24097	"111-76-2"	"2-Butoxyethanol"	"C111762"	2	"ACEA_T47D_80hr_Positive"	10583	1778418	1780987	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003255"	24097	"111-76-2"	"2-Butoxyethanol"	"C111762"	75	"ATG_ERE_CIS_up"	13109	2091677	1966447	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003261"	29157	"122-40-7"	"Pentylcinnamaldehyde"	"C122407"	117	"ATG_ERa_TRANS_up"	49821	2171049	2036974	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003261"	29157	"122-40-7"	"Pentylcinnamaldehyde"	"C122407"	750	"OT_ERa_EREGFP_0120"	115627	572082	566150	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003265"	22247	"7212-44-4"	"Nerolidol"	"C7212444"	117	"ATG_ERa_TRANS_up"	49749	2171047	2036972	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003265"	22247	"7212-44-4"	"Nerolidol"	"C7212444"	117	"ATG_ERa_TRANS_up"	50023	2171047	2036972	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003265"	22247	"7212-44-4"	"Nerolidol"	"C7212444"	746	"OT_ER_ERbERb_0480"	116638	549053	558268	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003267"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	2	"ACEA_T47D_80hr_Positive"	10292	1778422	1780984	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003267"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	2	"ACEA_T47D_80hr_Positive"	10584	1778422	1780984	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003267"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	75	"ATG_ERE_CIS_up"	13108	2091671	1966453	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003267"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	75	"ATG_ERE_CIS_up"	13345	2091671	1966453	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003267"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	75	"ATG_ERE_CIS_up"	13635	2091671	1966453	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003273"	24873	"108-80-5"	"Cyanuric acid"	"C108805"	75	"ATG_ERE_CIS_up"	13396	2091670	1966454	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003275"	42276	"94-71-3"	"2-Ethoxyphenol"	"C94713"	75	"ATG_ERE_CIS_up"	13107	2091669	1966455	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003279"	21943	"112-12-9"	"2-Undecanone"	"C112129"	75	"ATG_ERE_CIS_up"	13106	2091668	1966456	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003279"	21943	"112-12-9"	"2-Undecanone"	"C112129"	75	"ATG_ERE_CIS_up"	13634	2091668	1966456	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003279"	21943	"112-12-9"	"2-Undecanone"	"C112129"	743	"OT_ER_ERaERa_1440"	114378	551028	562211	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003279"	21943	"112-12-9"	"2-Undecanone"	"C112129"	751	"OT_ERa_EREGFP_0480"	116903	565095	568134	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003281"	41491	"104-54-1"	"3-Phenyl-2-propen-1-ol"	"C104541"	2	"ACEA_T47D_80hr_Positive"	10170	1778426	1780979	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003285"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	75	"ATG_ERE_CIS_up"	13633	2091666	1966458	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003285"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	743	"OT_ER_ERaERa_1440"	114348	551030	562213	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003285"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	743	"OT_ER_ERaERa_1440"	114445	551030	562213	10	"Noisy data"	NA	NA	"percent_activity"
"TX003285"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	745	"OT_ER_ERaERb_1440"	115354	557214	535983	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003285"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	745	"OT_ER_ERaERb_1440"	115464	557214	535983	11	"Borderline active"	NA	NA	"percent_activity"
"TX003285"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	745	"OT_ER_ERaERb_1440"	115538	557214	535983	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003289"	21597	"111-71-7"	"Heptanal"	"C111717"	75	"ATG_ERE_CIS_up"	13632	2091664	1966460	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003289"	21597	"111-71-7"	"Heptanal"	"C111717"	117	"ATG_ERa_TRANS_up"	49820	2171039	2036964	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003289"	21597	"111-71-7"	"Heptanal"	"C111717"	743	"OT_ER_ERaERa_1440"	114379	551031	562214	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003289"	21597	"111-71-7"	"Heptanal"	"C111717"	747	"OT_ER_ERbERb_1440"	114850	559183	560246	11	"Borderline active"	NA	NA	"percent_activity"
"TX003291"	21483	"122-78-1"	"Phenylacetaldehyde"	"C122781"	2	"ACEA_T47D_80hr_Positive"	10293	1778429	1780976	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003291"	21483	"122-78-1"	"Phenylacetaldehyde"	"C122781"	117	"ATG_ERa_TRANS_up"	49748	2171038	2036963	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003291"	21483	"122-78-1"	"Phenylacetaldehyde"	"C122781"	117	"ATG_ERa_TRANS_up"	50022	2171038	2036963	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003293"	40794	"6152-33-6"	"Sodium 2-phenylphenate tetrahydrate"	"C6152336"	75	"ATG_ERE_CIS_up"	13631	2091662	1966462	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003293"	40794	"6152-33-6"	"Sodium 2-phenylphenate tetrahydrate"	"C6152336"	744	"OT_ER_ERaERb_0480"	112954	2401909	2399229	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003297"	41302	"68169-03-9"	"2-(Dihydrocyclopentadienyloxy)ethyl methacrylate"	"C68169039"	75	"ATG_ERE_CIS_up"	13395	2091660	1966464	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003297"	41302	"68169-03-9"	"2-(Dihydrocyclopentadienyloxy)ethyl methacrylate"	"C68169039"	117	"ATG_ERa_TRANS_up"	50021	2171035	2036960	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003297"	41302	"68169-03-9"	"2-(Dihydrocyclopentadienyloxy)ethyl methacrylate"	"C68169039"	742	"OT_ER_ERaERa_0480"	115011	555248	564189	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003297"	41302	"68169-03-9"	"2-(Dihydrocyclopentadienyloxy)ethyl methacrylate"	"C68169039"	744	"OT_ER_ERaERb_0480"	112953	2401907	2399227	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003297"	41302	"68169-03-9"	"2-(Dihydrocyclopentadienyloxy)ethyl methacrylate"	"C68169039"	745	"OT_ER_ERaERb_1440"	115355	557219	535988	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003297"	41302	"68169-03-9"	"2-(Dihydrocyclopentadienyloxy)ethyl methacrylate"	"C68169039"	747	"OT_ER_ERbERb_1440"	114787	559187	560250	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003297"	41302	"68169-03-9"	"2-(Dihydrocyclopentadienyloxy)ethyl methacrylate"	"C68169039"	747	"OT_ER_ERbERb_1440"	114863	559187	560250	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003301"	21894	"108-93-0"	"Cyclohexanol"	"C108930"	714	"NVS_NR_hER"	517770	2708899	2698176	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003301"	21894	"108-93-0"	"Cyclohexanol"	"C108930"	714	"NVS_NR_hER"	517817	2708899	2698176	10	"Noisy data"	NA	NA	"percent_activity"
"TX003301"	21894	"108-93-0"	"Cyclohexanol"	"C108930"	725	"NVS_NR_mERa"	517055	2710060	2699337	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003301"	21894	"108-93-0"	"Cyclohexanol"	"C108930"	725	"NVS_NR_mERa"	517428	2710060	2699337	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003301"	21894	"108-93-0"	"Cyclohexanol"	"C108930"	742	"OT_ER_ERaERa_0480"	114939	555250	564191	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003303"	21885	"107-41-5"	"2-Methyl-2,4-pentanediol"	"C107415"	2	"ACEA_T47D_80hr_Positive"	10171	1778435	1780971	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003307"	22179	"2176-62-7"	"Pentachloropyridine"	"C2176627"	750	"OT_ERa_EREGFP_0120"	115628	572100	566168	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003313"	26251	"603-35-0"	"Triphenylphosphine"	"C603350"	725	"NVS_NR_mERa"	517056	2710061	2699338	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003313"	26251	"603-35-0"	"Triphenylphosphine"	"C603350"	747	"OT_ER_ERbERb_1440"	114788	559195	560258	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003313"	26251	"603-35-0"	"Triphenylphosphine"	"C603350"	747	"OT_ER_ERbERb_1440"	114864	559195	560258	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003315"	20828	"150-76-5"	"4-Methoxyphenol"	"C150765"	2	"ACEA_T47D_80hr_Positive"	10457	1778441	1780964	11	"Borderline active"	NA	NA	"percent_activity"
"TX003315"	20828	"150-76-5"	"4-Methoxyphenol"	"C150765"	714	"NVS_NR_hER"	517771	2708901	2698178	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003315"	20828	"150-76-5"	"4-Methoxyphenol"	"C150765"	714	"NVS_NR_hER"	517876	2708901	2698178	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003315"	20828	"150-76-5"	"4-Methoxyphenol"	"C150765"	725	"NVS_NR_mERa"	517057	2710062	2699339	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003319"	25857	"66-71-7"	"1,10-Phenanthroline"	"C66717"	2	"ACEA_T47D_80hr_Positive"	10294	1778442	1780963	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003319"	25857	"66-71-7"	"1,10-Phenanthroline"	"C66717"	725	"NVS_NR_mERa"	517003	2710063	2699340	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003319"	25857	"66-71-7"	"1,10-Phenanthroline"	"C66717"	725	"NVS_NR_mERa"	517548	2710063	2699340	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003319"	25857	"66-71-7"	"1,10-Phenanthroline"	"C66717"	725	"NVS_NR_mERa"	517630	2710063	2699340	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003323"	22519	"59-30-3"	"Folic acid"	"C59303"	750	"OT_ERa_EREGFP_0120"	115629	572106	566174	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003325"	41421	"487-06-9"	"5,7-Dimethoxy-2H-chromen-2-one"	"C487069"	744	"OT_ER_ERaERb_0480"	112952	2401895	2399240	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003327"	42390	"3811-73-2"	"Sodium (2-pyridylthio)-N-oxide"	"C3811732"	747	"OT_ER_ERbERb_1440"	114758	559200	560263	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003327"	42390	"3811-73-2"	"Sodium (2-pyridylthio)-N-oxide"	"C3811732"	747	"OT_ER_ERbERb_1440"	114851	559200	560263	11	"Borderline active"	NA	NA	"percent_activity"
"TX003331"	21217	"58-14-0"	"Pyrimethamine"	"C58140"	75	"ATG_ERE_CIS_up"	13175	2091644	1966480	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003331"	21217	"58-14-0"	"Pyrimethamine"	"C58140"	75	"ATG_ERE_CIS_up"	13630	2091644	1966480	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003337"	41409	"587-65-5"	"2-Chloro-N-phenylacetamide"	"C587655"	708	"NVS_NR_bER"	516253	2706706	2695666	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003337"	41409	"587-65-5"	"2-Chloro-N-phenylacetamide"	"C587655"	708	"NVS_NR_bER"	516372	2706706	2695666	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003337"	41409	"587-65-5"	"2-Chloro-N-phenylacetamide"	"C587655"	751	"OT_ERa_EREGFP_0480"	116695	565119	568158	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003347"	20966	"62-23-7"	"4-Nitrobenzoic acid"	"C62237"	2	"ACEA_T47D_80hr_Positive"	10585	1778451	1780954	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003349"	22409	"80-09-1"	"4,4'-Sulfonyldiphenol"	"C80091"	2	"ACEA_T47D_80hr_Positive"	10391	1778452	1780953	10	"Noisy data"	NA	NA	"percent_activity"
"TX003349"	22409	"80-09-1"	"4,4'-Sulfonyldiphenol"	"C80091"	725	"NVS_NR_mERa"	517058	2710065	2699342	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003349"	22409	"80-09-1"	"4,4'-Sulfonyldiphenol"	"C80091"	725	"NVS_NR_mERa"	517429	2710065	2699342	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003357"	21094	"101-80-4"	"4,4'-Oxydianiline"	"C101804"	743	"OT_ER_ERaERa_1440"	114380	551057	562240	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003357"	21094	"101-80-4"	"4,4'-Oxydianiline"	"C101804"	744	"OT_ER_ERaERb_0480"	112851	2401885	2399247	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003357"	21094	"101-80-4"	"4,4'-Oxydianiline"	"C101804"	745	"OT_ER_ERaERb_1440"	115356	557241	536010	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003359"	25816	"144-62-7"	"Oxalic acid"	"C144627"	750	"OT_ERa_EREGFP_0120"	115794	572118	566186	10	"Noisy data"	NA	NA	"percent_activity"
"TX003359"	25816	"144-62-7"	"Oxalic acid"	"C144627"	751	"OT_ERa_EREGFP_0480"	116886	565125	568164	10	"Noisy data"	NA	NA	"percent_activity"
"TX003363"	32337	"33629-47-9"	"Butralin"	"C33629479"	744	"OT_ER_ERaERb_0480"	112951	2401883	2399245	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003363"	32337	"33629-47-9"	"Butralin"	"C33629479"	746	"OT_ER_ERbERb_0480"	116639	549088	558303	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003365"	20122	"86-50-0"	"Azinphos-methyl"	"C86500"	2	"ACEA_T47D_80hr_Positive"	10586	1778457	1780948	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003369"	21590	"143-07-7"	"Dodecanoic acid"	"C143077"	2	"ACEA_T47D_80hr_Positive"	10295	1778458	1780947	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003369"	21590	"143-07-7"	"Dodecanoic acid"	"C143077"	2	"ACEA_T47D_80hr_Positive"	10392	1778458	1780947	10	"Noisy data"	NA	NA	"percent_activity"
"TX003373"	26228	"78-40-0"	"Triethyl phosphate"	"C78400"	2	"ACEA_T47D_80hr_Positive"	10458	1778459	1780946	11	"Borderline active"	NA	NA	"percent_activity"
"TX003373"	26228	"78-40-0"	"Triethyl phosphate"	"C78400"	2	"ACEA_T47D_80hr_Positive"	10743	1778459	1780946	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003375"	20959	"99-55-8"	"2-Methyl-5-nitroaniline"	"C99558"	117	"ATG_ERa_TRANS_up"	50020	2171004	2036929	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003383"	25453	"123-92-2"	"3-Methylbutyl acetate"	"C123922"	714	"NVS_NR_hER"	517818	2708909	2698186	10	"Noisy data"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	2	"ACEA_T47D_80hr_Positive"	10587	1778464	1780942	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	75	"ATG_ERE_CIS_up"	13105	2091625	1966499	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	714	"NVS_NR_hER"	517709	2708910	2698187	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	714	"NVS_NR_hER"	517935	2708910	2698187	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	714	"NVS_NR_hER"	517992	2708910	2698187	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	743	"OT_ER_ERaERa_1440"	114489	551067	562250	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	744	"OT_ER_ERaERb_0480"	112850	2401875	2399256	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	745	"OT_ER_ERaERb_1440"	115357	557251	536020	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	746	"OT_ER_ERbERb_0480"	116552	549096	558311	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	747	"OT_ER_ERbERb_1440"	114865	559219	560282	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003387"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	751	"OT_ERa_EREGFP_0480"	116904	565134	568173	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003389"	27837	"24800-44-0"	"Tripropylene glycol"	"C24800440"	2	"ACEA_T47D_80hr_Positive"	10296	1778465	1780940	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003389"	27837	"24800-44-0"	"Tripropylene glycol"	"C24800440"	2	"ACEA_T47D_80hr_Positive"	10588	1778465	1780940	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003389"	27837	"24800-44-0"	"Tripropylene glycol"	"C24800440"	750	"OT_ERa_EREGFP_0120"	115630	572128	566196	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003395"	26727	"106-24-1"	"Geraniol"	"C106241"	75	"ATG_ERE_CIS_up"	13104	2091623	1966501	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003395"	26727	"106-24-1"	"Geraniol"	"C106241"	75	"ATG_ERE_CIS_up"	13343	2091623	1966501	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003395"	26727	"106-24-1"	"Geraniol"	"C106241"	75	"ATG_ERE_CIS_up"	13628	2091623	1966501	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003403"	42436	"4065-45-6"	"Sulisobenzone"	"C4065456"	2	"ACEA_T47D_80hr_Positive"	10589	1778467	1780938	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003405"	42206	"2687-96-9"	"1-Dodecyl-2-pyrrolidinone"	"C2687969"	117	"ATG_ERa_TRANS_up"	50019	2170996	2036921	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003405"	42206	"2687-96-9"	"1-Dodecyl-2-pyrrolidinone"	"C2687969"	725	"NVS_NR_mERa"	517060	2710070	2699347	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003411"	25659	"119-36-8"	"Methyl salicylate"	"C119368"	117	"ATG_ERa_TRANS_up"	50235	2170994	2036919	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003411"	25659	"119-36-8"	"Methyl salicylate"	"C119368"	751	"OT_ERa_EREGFP_0480"	116752	565139	568178	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003417"	21947	"112-70-9"	"1-Tridecanol"	"C112709"	2	"ACEA_T47D_80hr_Positive"	10726	1778470	1780935	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX003423"	23602	"110-15-6"	"Butanedioic acid"	"C110156"	2	"ACEA_T47D_80hr_Positive"	10297	1778472	1780934	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003423"	23602	"110-15-6"	"Butanedioic acid"	"C110156"	2	"ACEA_T47D_80hr_Positive"	10590	1778472	1780934	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003427"	21984	"124-22-1"	"1-Dodecanamine"	"C124221"	75	"ATG_ERE_CIS_up"	13103	2091614	1966510	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003427"	21984	"124-22-1"	"1-Dodecanamine"	"C124221"	746	"OT_ER_ERbERb_0480"	116583	549106	558321	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX003427"	21984	"124-22-1"	"1-Dodecanamine"	"C124221"	750	"OT_ERa_EREGFP_0120"	115631	572137	566205	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003433"	21238	"108-46-3"	"Resorcinol"	"C108463"	2	"ACEA_T47D_80hr_Positive"	10172	1778476	1780929	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003433"	21238	"108-46-3"	"Resorcinol"	"C108463"	2	"ACEA_T47D_80hr_Positive"	10459	1778476	1780929	11	"Borderline active"	NA	NA	"percent_activity"
"TX003433"	21238	"108-46-3"	"Resorcinol"	"C108463"	75	"ATG_ERE_CIS_up"	13210	2091611	1966513	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003433"	21238	"108-46-3"	"Resorcinol"	"C108463"	117	"ATG_ERa_TRANS_up"	50018	2170986	2036911	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003433"	21238	"108-46-3"	"Resorcinol"	"C108463"	744	"OT_ER_ERaERb_0480"	112950	2401863	2399277	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003433"	21238	"108-46-3"	"Resorcinol"	"C108463"	746	"OT_ER_ERbERb_0480"	116640	549108	558323	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003435"	22109	"706-14-9"	"gamma-Decanolactone"	"C706149"	750	"OT_ERa_EREGFP_0120"	115632	572140	566208	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003437"	25881	"95-54-5"	"1,2-Phenylenediamine"	"C95545"	725	"NVS_NR_mERa"	517286	2710074	2699351	10	"Noisy data"	NA	NA	"percent_activity"
"TX003443"	22312	"1806-26-4"	"4-Octylphenol"	"C1806264"	2	"ACEA_T47D_80hr_Positive"	10229	1778480	1780925	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX003443"	22312	"1806-26-4"	"4-Octylphenol"	"C1806264"	714	"NVS_NR_hER"	517877	2708919	2698196	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003443"	22312	"1806-26-4"	"4-Octylphenol"	"C1806264"	750	"OT_ERa_EREGFP_0120"	115633	572143	566211	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003443"	22312	"1806-26-4"	"4-Octylphenol"	"C1806264"	751	"OT_ERa_EREGFP_0480"	116753	565150	568189	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003451"	42191	"534-13-4"	"N,N'-Dimethylthiourea"	"C534134"	2	"ACEA_T47D_80hr_Positive"	10744	1778482	1780924	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003451"	42191	"534-13-4"	"N,N'-Dimethylthiourea"	"C534134"	75	"ATG_ERE_CIS_up"	13626	2091603	1966520	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003451"	42191	"534-13-4"	"N,N'-Dimethylthiourea"	"C534134"	117	"ATG_ERa_TRANS_up"	49638	2170978	2036903	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003451"	42191	"534-13-4"	"N,N'-Dimethylthiourea"	"C534134"	117	"ATG_ERa_TRANS_up"	50234	2170978	2036903	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003471"	25101	"99-07-0"	"3-Dimethylaminophenol"	"C99070"	725	"NVS_NR_mERa"	517062	2710076	2699353	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003471"	25101	"99-07-0"	"3-Dimethylaminophenol"	"C99070"	725	"NVS_NR_mERa"	517430	2710076	2699353	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003471"	25101	"99-07-0"	"3-Dimethylaminophenol"	"C99070"	751	"OT_ERa_EREGFP_0480"	116754	565155	568194	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003471"	25101	"99-07-0"	"3-Dimethylaminophenol"	"C99070"	751	"OT_ERa_EREGFP_0480"	116905	565155	568194	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003485"	22422	"101-77-9"	"4,4'-Methylenedianiline"	"C101779"	2	"ACEA_T47D_80hr_Positive"	10173	1778486	1780920	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003485"	22422	"101-77-9"	"4,4'-Methylenedianiline"	"C101779"	742	"OT_ER_ERaERa_0480"	115012	555302	564243	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003485"	22422	"101-77-9"	"4,4'-Methylenedianiline"	"C101779"	745	"OT_ER_ERaERb_1440"	115480	557273	536042	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003489"	25662	"122-57-6"	"Methyl styryl ketone"	"C122576"	75	"ATG_ERE_CIS_up"	13173	2091594	1966530	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003489"	25662	"122-57-6"	"Methyl styryl ketone"	"C122576"	75	"ATG_ERE_CIS_up"	13625	2091594	1966530	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003489"	25662	"122-57-6"	"Methyl styryl ketone"	"C122576"	117	"ATG_ERa_TRANS_up"	49819	2170969	2036894	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003489"	25662	"122-57-6"	"Methyl styryl ketone"	"C122576"	743	"OT_ER_ERaERa_1440"	114381	551090	562273	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003497"	26684	"101-86-0"	"2-Benzylideneoctanal"	"C101860"	75	"ATG_ERE_CIS_up"	13623	2091591	1966533	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003497"	26684	"101-86-0"	"2-Benzylideneoctanal"	"C101860"	747	"OT_ER_ERbERb_1440"	114789	559243	560306	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003499"	20402	"95-80-7"	"2,4-Diaminotoluene"	"C95807"	75	"ATG_ERE_CIS_up"	13209	2091590	1966534	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003499"	20402	"95-80-7"	"2,4-Diaminotoluene"	"C95807"	75	"ATG_ERE_CIS_up"	13392	2091590	1966534	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003503"	20663	"56-81-5"	"Glycerol"	"C56815"	714	"NVS_NR_hER"	517772	2708924	2698201	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003505"	41641	"609-54-1"	"2,5-Dimethylbenzenesulfonic acid"	"C609541"	2	"ACEA_T47D_80hr_Positive"	10591	1778491	1780914	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003509"	24666	"110-63-4"	"1,4-Butanediol"	"C110634"	2	"ACEA_T47D_80hr_Positive"	10592	1778492	1780913	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003515"	20108	"50-78-2"	"Aspirin"	"C50782"	117	"ATG_ERa_TRANS_up"	50017	2170959	2036884	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003523"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	2	"ACEA_T47D_80hr_Positive"	10298	1778495	1780910	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003523"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	2	"ACEA_T47D_80hr_Positive"	10593	1778495	1780910	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003523"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	75	"ATG_ERE_CIS_up"	13391	2091582	1966542	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003523"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	746	"OT_ER_ERbERb_0480"	116641	549127	558342	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003523"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	750	"OT_ERa_EREGFP_0120"	115634	572158	566226	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003539"	20458	"2921-88-2"	"Chlorpyrifos"	"C2921882"	725	"NVS_NR_mERa"	517431	2710080	2699357	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003539"	20458	"2921-88-2"	"Chlorpyrifos"	"C2921882"	742	"OT_ER_ERaERa_0480"	114905	555313	564254	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003539"	20458	"2921-88-2"	"Chlorpyrifos"	"C2921882"	746	"OT_ER_ERbERb_0480"	116553	549129	558344	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003540"	20194	"10043-35-3"	"Boric acid"	"C10043353"	2	"ACEA_T47D_80hr_Positive"	10594	1778498	1780907	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003549"	26171	"29385-43-1"	"Tolyltriazole"	"C29385431"	117	"ATG_ERa_TRANS_up"	50016	2170953	2036878	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003549"	26171	"29385-43-1"	"Tolyltriazole"	"C29385431"	725	"NVS_NR_mERa"	517549	2710082	2699359	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003549"	26171	"29385-43-1"	"Tolyltriazole"	"C29385431"	725	"NVS_NR_mERa"	517631	2710082	2699359	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003562"	32646	"4151-50-2"	"Sulfluramid"	"C4151502"	708	"NVS_NR_bER"	516254	2706728	2695688	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003562"	32646	"4151-50-2"	"Sulfluramid"	"C4151502"	750	"OT_ERa_EREGFP_0120"	115635	572164	566232	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003564"	32610	"80844-07-1"	"Etofenprox"	"C80844071"	75	"ATG_ERE_CIS_up"	13326	2094546	1963578	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003564"	32610	"80844-07-1"	"Etofenprox"	"C80844071"	75	"ATG_ERE_CIS_up"	13619	2094546	1963578	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003571"	40372	"133855-98-8"	"Epoxiconazole"	"C133855988"	2	"ACEA_T47D_80hr_Positive"	10299	1778503	1780902	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003571"	40372	"133855-98-8"	"Epoxiconazole"	"C133855988"	2	"ACEA_T47D_80hr_Positive"	10595	1778503	1780902	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003571"	40372	"133855-98-8"	"Epoxiconazole"	"C133855988"	117	"ATG_ERa_TRANS_up"	50014	2170948	2036873	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003571"	40372	"133855-98-8"	"Epoxiconazole"	"C133855988"	750	"OT_ERa_EREGFP_0120"	115636	572166	566234	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003571"	40372	"133855-98-8"	"Epoxiconazole"	"C133855988"	751	"OT_ERa_EREGFP_0480"	116755	565173	568212	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003698"	20319	"1897-45-6"	"Chlorothalonil"	"C1897456"	746	"OT_ER_ERbERb_0480"	116642	549137	558352	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003698"	20319	"1897-45-6"	"Chlorothalonil"	"C1897456"	750	"OT_ERa_EREGFP_0120"	115637	572168	566236	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003698"	20319	"1897-45-6"	"Chlorothalonil"	"C1897456"	751	"OT_ERa_EREGFP_0480"	116906	565175	568214	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003699"	21975	"122-39-4"	"Diphenylamine"	"C122394"	2	"ACEA_T47D_80hr_Positive"	10300	1778506	1780900	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003699"	21975	"122-39-4"	"Diphenylamine"	"C122394"	745	"OT_ER_ERaERb_1440"	115404	557293	536062	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003699"	21975	"122-39-4"	"Diphenylamine"	"C122394"	745	"OT_ER_ERaERb_1440"	115481	557293	536062	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003699"	21975	"122-39-4"	"Diphenylamine"	"C122394"	746	"OT_ER_ERbERb_0480"	116554	549138	558353	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003699"	21975	"122-39-4"	"Diphenylamine"	"C122394"	747	"OT_ER_ERbERb_1440"	114790	559261	560324	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003715"	34490	"420-04-2"	"Cyanamide"	"C420042"	2	"ACEA_T47D_80hr_Positive"	10596	1778512	1780893	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003725"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	117	"ATG_ERa_TRANS_up"	49596	2170944	2036869	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003725"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	117	"ATG_ERa_TRANS_up"	49818	2170944	2036869	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003725"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	117	"ATG_ERa_TRANS_up"	50233	2170944	2036869	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003725"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	708	"NVS_NR_bER"	516255	2706731	2695691	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003725"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	708	"NVS_NR_bER"	516373	2706731	2695691	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003725"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	725	"NVS_NR_mERa"	517064	2710087	2699364	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003731"	23645	"60-54-8"	"Tetracycline"	"C60548"	725	"NVS_NR_mERa"	517287	2710088	2699365	10	"Noisy data"	NA	NA	"percent_activity"
"TX003735"	29874	"49562-28-9"	"Fenofibrate"	"C49562289"	714	"NVS_NR_hER"	517773	2708938	2698215	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003735"	29874	"49562-28-9"	"Fenofibrate"	"C49562289"	725	"NVS_NR_mERa"	517066	2710090	2699367	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003758"	24000	"1861-32-1"	"Chlorthal-dimethyl"	"C1861321"	75	"ATG_ERE_CIS_up"	13618	2094535	1963589	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003786"	27047	"127-51-5"	"alpha-Isomethylionone"	"C127515"	2	"ACEA_T47D_80hr_Positive"	10597	1778519	1780886	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003786"	27047	"127-51-5"	"alpha-Isomethylionone"	"C127515"	725	"NVS_NR_mERa"	517068	2710094	2699371	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003786"	27047	"127-51-5"	"alpha-Isomethylionone"	"C127515"	725	"NVS_NR_mERa"	517433	2710094	2699371	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003786"	27047	"127-51-5"	"alpha-Isomethylionone"	"C127515"	746	"OT_ER_ERbERb_0480"	116643	549150	558365	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003786"	27047	"127-51-5"	"alpha-Isomethylionone"	"C127515"	751	"OT_ERa_EREGFP_0480"	116756	565188	568227	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003818"	31863	"375-95-1"	"PFNA"	"C375951"	725	"NVS_NR_mERa"	517550	2710098	2699375	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003818"	31863	"375-95-1"	"PFNA"	"C375951"	725	"NVS_NR_mERa"	517632	2710098	2699375	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003824"	42400	"1120-01-0"	"Sodium hexyldecyl sulfate"	"C1120010"	117	"ATG_ERa_TRANS_up"	50013	2170929	2036854	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003838"	21735	"67-68-5"	"Dimethyl sulfoxide"	"C67685"	725	"NVS_NR_mERa"	517435	2710102	2699379	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003844"	20807	"149-30-4"	"2-Mercaptobenzothiazole"	"C149304"	117	"ATG_ERa_TRANS_up"	49595	2170924	2036849	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003844"	20807	"149-30-4"	"2-Mercaptobenzothiazole"	"C149304"	117	"ATG_ERa_TRANS_up"	50229	2170924	2036849	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003844"	20807	"149-30-4"	"2-Mercaptobenzothiazole"	"C149304"	725	"NVS_NR_mERa"	517070	2710103	2699380	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003846"	40112	"106-30-9"	"Ethyl heptanoate"	"C106309"	708	"NVS_NR_bER"	516257	2706747	2695707	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003848"	41847	"109-43-3"	"Dibutyl decanedioate"	"C109433"	745	"OT_ER_ERaERb_1440"	115405	557313	536082	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003862"	41298	"695-06-7"	"gamma-Caprolactone"	"C695067"	2	"ACEA_T47D_80hr_Positive"	10745	1778529	1780876	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003870"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	117	"ATG_ERa_TRANS_up"	50012	2170915	2036840	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003870"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	742	"OT_ER_ERaERa_0480"	114940	555346	564287	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003870"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	743	"OT_ER_ERaERa_1440"	114382	551133	562316	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003870"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	744	"OT_ER_ERaERb_0480"	112949	2401809	2399325	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003870"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	745	"OT_ER_ERaERb_1440"	115406	557317	536086	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003870"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	747	"OT_ER_ERbERb_1440"	114791	559285	560348	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003876"	35001	"112-38-9"	"10-Undecenoic acid"	"C112389"	75	"ATG_ERE_CIS_up"	13617	2094510	1963614	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003876"	35001	"112-38-9"	"10-Undecenoic acid"	"C112389"	725	"NVS_NR_mERa"	517071	2710108	2699385	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003878"	41252	"128-95-0"	"1,4-Diaminoanthraquinone"	"C128950"	117	"ATG_ERa_TRANS_up"	50011	2170912	2036837	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	708	"NVS_NR_bER"	516200	2706752	2695712	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	708	"NVS_NR_bER"	516481	2706752	2695712	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	725	"NVS_NR_mERa"	517004	2710109	2699386	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	725	"NVS_NR_mERa"	517383	2710109	2699386	11	"Borderline active"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	725	"NVS_NR_mERa"	517551	2710109	2699386	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	725	"NVS_NR_mERa"	517633	2710109	2699386	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	743	"OT_ER_ERaERa_1440"	114446	551139	562322	10	"Noisy data"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	750	"OT_ERa_EREGFP_0120"	115843	572199	566267	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003890"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	751	"OT_ERa_EREGFP_0480"	116907	565206	568245	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	2	"ACEA_T47D_80hr_Positive"	10301	1778538	1780867	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	2	"ACEA_T47D_80hr_Positive"	10598	1778538	1780867	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	75	"ATG_ERE_CIS_up"	13616	2094505	1963619	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	708	"NVS_NR_bER"	516374	2706753	2695713	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	725	"NVS_NR_mERa"	517072	2710110	2699387	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	725	"NVS_NR_mERa"	517436	2710110	2699387	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	742	"OT_ER_ERaERa_0480"	115013	555353	564294	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	743	"OT_ER_ERaERa_1440"	114349	551140	562323	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	744	"OT_ER_ERaERb_0480"	112870	2401802	2399331	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	745	"OT_ER_ERaERb_1440"	115358	557324	536093	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	746	"OT_ER_ERbERb_0480"	116584	549169	558384	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX003892"	35708	"25155-18-4"	"Methylbenzethonium chloride"	"C25155184"	747	"OT_ER_ERbERb_1440"	114759	559292	560355	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003896"	42059	"106-27-4"	"Isopentyl butyrate"	"C106274"	750	"OT_ERa_EREGFP_0120"	115638	572201	566269	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003906"	24460	"60-09-3"	"4-Aminoazobenzene"	"C60093"	725	"NVS_NR_mERa"	517437	2710111	2699388	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003906"	24460	"60-09-3"	"4-Aminoazobenzene"	"C60093"	743	"OT_ER_ERaERa_1440"	114350	551142	562325	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003908"	21777	"83-88-5"	"Riboflavin"	"C83885"	2	"ACEA_T47D_80hr_Positive"	10302	1778541	1780864	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003908"	21777	"83-88-5"	"Riboflavin"	"C83885"	714	"NVS_NR_hER"	517994	2708959	2698236	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX003908"	21777	"83-88-5"	"Riboflavin"	"C83885"	725	"NVS_NR_mERa"	517073	2710112	2699389	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	2	"ACEA_T47D_80hr_Positive"	10599	1778542	1780863	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	75	"ATG_ERE_CIS_up"	13861	2094501	1963623	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	742	"OT_ER_ERaERa_0480"	114941	555357	564298	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	742	"OT_ER_ERaERa_0480"	115014	555357	564298	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	744	"OT_ER_ERaERb_0480"	112849	2401798	2399335	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	745	"OT_ER_ERaERb_1440"	115482	557328	536097	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	746	"OT_ER_ERbERb_0480"	116555	549173	558388	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003910"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	746	"OT_ER_ERbERb_0480"	116610	549173	558388	11	"Borderline active"	NA	NA	"percent_activity"
"TX003912"	42232	"107-75-5"	"7-Hydroxy-3,7-dimethyloctanal"	"C107755"	750	"OT_ERa_EREGFP_0120"	115639	572205	566273	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003916"	23588	"50-70-4"	"D-Glucitol"	"C50704"	75	"ATG_ERE_CIS_up"	13325	2094499	1963625	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003916"	23588	"50-70-4"	"D-Glucitol"	"C50704"	75	"ATG_ERE_CIS_up"	13341	2094499	1963625	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX003916"	23588	"50-70-4"	"D-Glucitol"	"C50704"	117	"ATG_ERa_TRANS_up"	49747	2170902	2036827	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003916"	23588	"50-70-4"	"D-Glucitol"	"C50704"	117	"ATG_ERa_TRANS_up"	49775	2170902	2036827	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX003948"	41891	"101-81-5"	"Diphenylmethane"	"C101815"	2	"ACEA_T47D_80hr_Positive"	10460	1778546	1780859	11	"Borderline active"	NA	NA	"percent_activity"
"TX003948"	41891	"101-81-5"	"Diphenylmethane"	"C101815"	75	"ATG_ERE_CIS_up"	13171	2094497	1963627	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003948"	41891	"101-81-5"	"Diphenylmethane"	"C101815"	117	"ATG_ERa_TRANS_up"	49817	2170900	2036825	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003948"	41891	"101-81-5"	"Diphenylmethane"	"C101815"	744	"OT_ER_ERaERb_0480"	112848	2401794	2399341	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003948"	41891	"101-81-5"	"Diphenylmethane"	"C101815"	750	"OT_ERa_EREGFP_0120"	115795	572208	566276	10	"Noisy data"	NA	NA	"percent_activity"
"TX003950"	25021	"84-61-7"	"Dicyclohexyl phthalate"	"C84617"	2	"ACEA_T47D_80hr_Positive"	10600	1778547	1780858	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003950"	25021	"84-61-7"	"Dicyclohexyl phthalate"	"C84617"	117	"ATG_ERa_TRANS_up"	49816	2170899	2036824	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003950"	25021	"84-61-7"	"Dicyclohexyl phthalate"	"C84617"	708	"NVS_NR_bER"	516258	2706758	2695718	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003950"	25021	"84-61-7"	"Dicyclohexyl phthalate"	"C84617"	750	"OT_ERa_EREGFP_0120"	115818	572209	566277	11	"Borderline active"	NA	NA	"percent_activity"
"TX003956"	41379	"489-01-0"	"2,6-Di-tert-butyl-4-methoxyphenol"	"C489010"	117	"ATG_ERa_TRANS_up"	49815	2170898	2036823	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003956"	41379	"489-01-0"	"2,6-Di-tert-butyl-4-methoxyphenol"	"C489010"	742	"OT_ER_ERaERa_0480"	114906	555363	564304	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX003956"	41379	"489-01-0"	"2,6-Di-tert-butyl-4-methoxyphenol"	"C489010"	742	"OT_ER_ERaERa_0480"	114976	555363	564304	10	"Noisy data"	NA	NA	"percent_activity"
"TX003956"	41379	"489-01-0"	"2,6-Di-tert-butyl-4-methoxyphenol"	"C489010"	742	"OT_ER_ERaERa_0480"	114993	555363	564304	11	"Borderline active"	NA	NA	"percent_activity"
"TX003956"	41379	"489-01-0"	"2,6-Di-tert-butyl-4-methoxyphenol"	"C489010"	742	"OT_ER_ERaERa_0480"	115062	555363	564304	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX003956"	41379	"489-01-0"	"2,6-Di-tert-butyl-4-methoxyphenol"	"C489010"	746	"OT_ER_ERbERb_0480"	116644	549179	558394	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003958"	41248	"88-58-4"	"2,5-Di-tert-butylbenzene-1,4-diol"	"C88584"	75	"ATG_ERE_CIS_up"	13860	2094494	1963630	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003958"	41248	"88-58-4"	"2,5-Di-tert-butylbenzene-1,4-diol"	"C88584"	117	"ATG_ERa_TRANS_up"	49746	2170897	2036822	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX003958"	41248	"88-58-4"	"2,5-Di-tert-butylbenzene-1,4-diol"	"C88584"	117	"ATG_ERa_TRANS_up"	50010	2170897	2036822	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX003958"	41248	"88-58-4"	"2,5-Di-tert-butylbenzene-1,4-diol"	"C88584"	714	"NVS_NR_hER"	517774	2708965	2698242	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003958"	41248	"88-58-4"	"2,5-Di-tert-butylbenzene-1,4-diol"	"C88584"	714	"NVS_NR_hER"	517879	2708965	2698242	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX003958"	41248	"88-58-4"	"2,5-Di-tert-butylbenzene-1,4-diol"	"C88584"	725	"NVS_NR_mERa"	517074	2710117	2699394	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX003962"	20939	"139-13-9"	"Nitrilotriacetic acid"	"C139139"	117	"ATG_ERa_TRANS_up"	49637	2170895	2036820	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX003962"	20939	"139-13-9"	"Nitrilotriacetic acid"	"C139139"	117	"ATG_ERa_TRANS_up"	49814	2170895	2036820	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX003962"	20939	"139-13-9"	"Nitrilotriacetic acid"	"C139139"	117	"ATG_ERa_TRANS_up"	50228	2170895	2036820	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX003962"	20939	"139-13-9"	"Nitrilotriacetic acid"	"C139139"	743	"OT_ER_ERaERa_1440"	114447	551153	562336	10	"Noisy data"	NA	NA	"percent_activity"
"TX003990"	22381	"84-16-2"	"meso-Hexestrol"	"C84162"	708	"NVS_NR_bER"	516320	2706763	2695723	10	"Noisy data"	NA	NA	"percent_activity"
"TX003990"	22381	"84-16-2"	"meso-Hexestrol"	"C84162"	725	"NVS_NR_mERa"	517288	2710119	2699396	10	"Noisy data"	NA	NA	"percent_activity"
"TX003998"	24063	"576-26-1"	"2,6-Dimethylphenol"	"C576261"	75	"ATG_ERE_CIS_up"	13615	2094484	1963640	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004006"	27525	"3164-85-0"	"Potassium 2-ethylhexanoate"	"C3164850"	2	"ACEA_T47D_80hr_Positive"	10174	1778557	1780848	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004016"	35616	"824-39-5"	"Sodium 2-nitrophenolate"	"C824395"	725	"NVS_NR_mERa"	517076	2710123	2699400	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004030"	20570	"6381-77-7"	"Sodium erythorbate (1:1)"	"C6381777"	714	"NVS_NR_hER"	517880	2708976	2698253	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004040"	25133	"99-51-4"	"1,2-Dimethyl-4-nitrobenzene"	"C99514"	117	"ATG_ERa_TRANS_up"	50007	2170880	2036805	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004042"	26156	"584-84-9"	"Toluene-2,4-diisocyanate"	"C584849"	2	"ACEA_T47D_80hr_Positive"	10601	1778562	1780843	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004046"	29214	"1335-46-2"	"Ionone, methyl-"	"C1335462"	744	"OT_ER_ERaERb_0480"	112948	2401776	2399358	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004046"	29214	"1335-46-2"	"Ionone, methyl-"	"C1335462"	746	"OT_ER_ERbERb_0480"	116645	549195	558410	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004050"	24143	"822-06-0"	"1,6-Diisocyanatohexane"	"C822060"	750	"OT_ERa_EREGFP_0120"	115640	572227	566295	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004050"	24143	"822-06-0"	"1,6-Diisocyanatohexane"	"C822060"	751	"OT_ERa_EREGFP_0480"	116757	565234	568273	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004056"	44697	"5877-42-9"	"4-Ethyloct-1-yn-3-ol"	"C5877429"	117	"ATG_ERa_TRANS_up"	49743	2170875	2036800	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004056"	44697	"5877-42-9"	"4-Ethyloct-1-yn-3-ol"	"C5877429"	117	"ATG_ERa_TRANS_up"	50006	2170875	2036800	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004058"	34583	"2122-70-5"	"Ethyl 1-naphthaleneacetate"	"C2122705"	744	"OT_ER_ERaERb_0480"	112847	2401772	2399365	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004058"	34583	"2122-70-5"	"Ethyl 1-naphthaleneacetate"	"C2122705"	746	"OT_ER_ERbERb_0480"	116646	549199	558414	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004062"	21032	"621-64-7"	"N-Nitrosodipropylamine"	"C621647"	2	"ACEA_T47D_80hr_Positive"	10602	1778567	1780838	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004062"	21032	"621-64-7"	"N-Nitrosodipropylamine"	"C621647"	725	"NVS_NR_mERa"	517384	2710129	2699406	11	"Borderline active"	NA	NA	"percent_activity"
"TX004062"	21032	"621-64-7"	"N-Nitrosodipropylamine"	"C621647"	725	"NVS_NR_mERa"	517552	2710129	2699406	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004062"	21032	"621-64-7"	"N-Nitrosodipropylamine"	"C621647"	725	"NVS_NR_mERa"	517634	2710129	2699406	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004078"	25292	"94-96-2"	"2-Ethyl-1,3-hexanediol"	"C94962"	742	"OT_ER_ERaERa_0480"	114942	555386	564327	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004104"	22353	"92-04-6"	"2-Chloro-4-phenylphenol"	"C92046"	714	"NVS_NR_hER"	517842	2708981	2698258	11	"Borderline active"	NA	NA	"percent_activity"
"TX004104"	22353	"92-04-6"	"2-Chloro-4-phenylphenol"	"C92046"	714	"NVS_NR_hER"	517996	2708981	2698258	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004104"	22353	"92-04-6"	"2-Chloro-4-phenylphenol"	"C92046"	750	"OT_ERa_EREGFP_0120"	115844	572235	566303	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004104"	22353	"92-04-6"	"2-Chloro-4-phenylphenol"	"C92046"	751	"OT_ERa_EREGFP_0480"	116696	565242	568281	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004120"	44576	"77-89-4"	"Acetyltriethyl citrate"	"C77894"	75	"ATG_ERE_CIS_up"	13170	2094458	1963666	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004160"	25478	"108-21-4"	"Isopropyl acetate"	"C108214"	725	"NVS_NR_mERa"	517439	2710138	2699415	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004160"	25478	"108-21-4"	"Isopropyl acetate"	"C108214"	750	"OT_ERa_EREGFP_0120"	115641	572239	566307	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004164"	40110	"105-37-3"	"Ethyl propionate"	"C105373"	2	"ACEA_T47D_80hr_Positive"	10603	1778575	1780830	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004170"	21888	"107-87-9"	"2-Pentanone"	"C107879"	2	"ACEA_T47D_80hr_Positive"	10461	1778576	1780829	11	"Borderline active"	NA	NA	"percent_activity"
"TX004170"	21888	"107-87-9"	"2-Pentanone"	"C107879"	745	"OT_ER_ERaERb_1440"	115407	557365	536134	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004170"	21888	"107-87-9"	"2-Pentanone"	"C107879"	745	"OT_ER_ERaERb_1440"	115483	557365	536134	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004188"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	117	"ATG_ERa_TRANS_up"	49594	2170846	2036771	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004188"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	725	"NVS_NR_mERa"	517553	2710140	2699417	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004188"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	725	"NVS_NR_mERa"	517635	2710140	2699417	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004188"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	744	"OT_ER_ERaERb_0480"	112947	2401760	2399372	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004188"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	746	"OT_ER_ERbERb_0480"	116556	549211	558426	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004188"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	750	"OT_ERa_EREGFP_0120"	115642	572242	566310	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004196"	29612	"138-86-3"	"Limonene"	"C138863"	747	"OT_ER_ERbERb_1440"	114792	559336	560399	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004208"	29262	"4130-42-1"	"2,6-Di-tert-butyl-4-ethylphenol"	"C4130421"	725	"NVS_NR_mERa"	517385	2710143	2699420	11	"Borderline active"	NA	NA	"percent_activity"
"TX004208"	29262	"4130-42-1"	"2,6-Di-tert-butyl-4-ethylphenol"	"C4130421"	725	"NVS_NR_mERa"	517554	2710143	2699420	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004208"	29262	"4130-42-1"	"2,6-Di-tert-butyl-4-ethylphenol"	"C4130421"	725	"NVS_NR_mERa"	517636	2710143	2699420	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004208"	29262	"4130-42-1"	"2,6-Di-tert-butyl-4-ethylphenol"	"C4130421"	744	"OT_ER_ERaERb_0480"	112879	2401756	2399377	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004208"	29262	"4130-42-1"	"2,6-Di-tert-butyl-4-ethylphenol"	"C4130421"	744	"OT_ER_ERaERb_0480"	112946	2401756	2399377	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004208"	29262	"4130-42-1"	"2,6-Di-tert-butyl-4-ethylphenol"	"C4130421"	746	"OT_ER_ERbERb_0480"	116647	549215	558430	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004214"	41815	"116-02-9"	"3,3,5-Trimethylcyclohexanol"	"C116029"	2	"ACEA_T47D_80hr_Positive"	10175	1778582	1780824	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004220"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	2	"ACEA_T47D_80hr_Positive"	10604	1778584	1780822	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004220"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	75	"ATG_ERE_CIS_up"	13611	2094431	1963693	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004220"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	746	"OT_ER_ERbERb_0480"	116593	549218	558433	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004220"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	746	"OT_ER_ERbERb_0480"	116648	549218	558433	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004220"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	750	"OT_ERa_EREGFP_0120"	115643	572249	566317	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004220"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	751	"OT_ERa_EREGFP_0480"	116758	565256	568295	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004224"	20240	"105-60-2"	"Caprolactam"	"C105602"	2	"ACEA_T47D_80hr_Positive"	10605	1778585	1780820	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004224"	20240	"105-60-2"	"Caprolactam"	"C105602"	75	"ATG_ERE_CIS_up"	13610	2094430	1963694	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004224"	20240	"105-60-2"	"Caprolactam"	"C105602"	117	"ATG_ERa_TRANS_up"	49636	2170833	2036758	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004224"	20240	"105-60-2"	"Caprolactam"	"C105602"	117	"ATG_ERa_TRANS_up"	50227	2170833	2036758	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004244"	42454	"589-68-4"	"Tetradecanoic acid, 2,3-dihydroxypropyl ester"	"C589684"	743	"OT_ER_ERaERa_1440"	114383	551192	562375	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004244"	42454	"589-68-4"	"Tetradecanoic acid, 2,3-dihydroxypropyl ester"	"C589684"	743	"OT_ER_ERaERa_1440"	114490	551192	562375	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004244"	42454	"589-68-4"	"Tetradecanoic acid, 2,3-dihydroxypropyl ester"	"C589684"	751	"OT_ERa_EREGFP_0480"	116759	565259	568298	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004246"	44564	"3855-32-1"	"2,6,10-Trimethyl-2,6,10-triazaundecane"	"C3855321"	117	"ATG_ERa_TRANS_up"	49635	2170827	2036752	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004246"	44564	"3855-32-1"	"2,6,10-Trimethyl-2,6,10-triazaundecane"	"C3855321"	117	"ATG_ERa_TRANS_up"	49813	2170827	2036752	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX004246"	44564	"3855-32-1"	"2,6,10-Trimethyl-2,6,10-triazaundecane"	"C3855321"	117	"ATG_ERa_TRANS_up"	50226	2170827	2036752	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004258"	40731	"605-45-8"	"Diisopropyl phthalate"	"C605458"	742	"OT_ER_ERaERa_0480"	114907	555407	564348	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004258"	40731	"605-45-8"	"Diisopropyl phthalate"	"C605458"	745	"OT_ER_ERaERb_1440"	115484	557378	536147	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004258"	40731	"605-45-8"	"Diisopropyl phthalate"	"C605458"	746	"OT_ER_ERbERb_0480"	116557	549223	558438	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004258"	40731	"605-45-8"	"Diisopropyl phthalate"	"C605458"	746	"OT_ER_ERbERb_0480"	116611	549223	558438	11	"Borderline active"	NA	NA	"percent_activity"
"TX004258"	40731	"605-45-8"	"Diisopropyl phthalate"	"C605458"	751	"OT_ERa_EREGFP_0480"	116760	565261	568300	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004278"	22000	"141-43-5"	"Ethanolamine"	"C141435"	2	"ACEA_T47D_80hr_Positive"	10606	1778590	1780815	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004280"	44742	"929-59-9"	"2,2'-[Ethane-1,2-diylbis(oxy)]diethanamine"	"C929599"	75	"ATG_ERE_CIS_up"	13169	2094416	1963708	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004280"	44742	"929-59-9"	"2,2'-[Ethane-1,2-diylbis(oxy)]diethanamine"	"C929599"	75	"ATG_ERE_CIS_up"	13390	2094416	1963708	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX004280"	44742	"929-59-9"	"2,2'-[Ethane-1,2-diylbis(oxy)]diethanamine"	"C929599"	75	"ATG_ERE_CIS_up"	13857	2094416	1963708	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004280"	44742	"929-59-9"	"2,2'-[Ethane-1,2-diylbis(oxy)]diethanamine"	"C929599"	117	"ATG_ERa_TRANS_up"	50001	2170819	2036744	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004280"	44742	"929-59-9"	"2,2'-[Ethane-1,2-diylbis(oxy)]diethanamine"	"C929599"	708	"NVS_NR_bER"	516432	2706792	2695752	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004280"	44742	"929-59-9"	"2,2'-[Ethane-1,2-diylbis(oxy)]diethanamine"	"C929599"	708	"NVS_NR_bER"	516483	2706792	2695752	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004300"	42394	"130-14-3"	"Sodium 1-naphthalenesulfonate"	"C130143"	750	"OT_ERa_EREGFP_0120"	115644	572258	566326	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004300"	42394	"130-14-3"	"Sodium 1-naphthalenesulfonate"	"C130143"	750	"OT_ERa_EREGFP_0120"	115845	572258	566326	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004316"	44663	"3734-67-6"	"C.I. Acid Red 1"	"C3734676"	2	"ACEA_T47D_80hr_Positive"	10303	1778593	1780812	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004316"	44663	"3734-67-6"	"C.I. Acid Red 1"	"C3734676"	2	"ACEA_T47D_80hr_Positive"	10607	1778593	1780812	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004316"	44663	"3734-67-6"	"C.I. Acid Red 1"	"C3734676"	75	"ATG_ERE_CIS_up"	13609	2094411	1963713	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004329"	29159	"123-17-1"	"2,6,8-Trimethyl-4-nonanol"	"C123171"	2	"ACEA_T47D_80hr_Positive"	10304	1778594	1780811	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004329"	29159	"123-17-1"	"2,6,8-Trimethyl-4-nonanol"	"C123171"	117	"ATG_ERa_TRANS_up"	49592	2170811	2036736	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004329"	29159	"123-17-1"	"2,6,8-Trimethyl-4-nonanol"	"C123171"	117	"ATG_ERa_TRANS_up"	49812	2170811	2036736	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX004329"	29159	"123-17-1"	"2,6,8-Trimethyl-4-nonanol"	"C123171"	117	"ATG_ERa_TRANS_up"	50224	2170811	2036736	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004329"	29159	"123-17-1"	"2,6,8-Trimethyl-4-nonanol"	"C123171"	743	"OT_ER_ERaERa_1440"	114448	551200	562383	10	"Noisy data"	NA	NA	"percent_activity"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	75	"ATG_ERE_CIS_up"	13389	2094407	1963717	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	117	"ATG_ERa_TRANS_up"	49811	2170810	2036735	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	117	"ATG_ERa_TRANS_up"	50223	2170810	2036735	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	742	"OT_ER_ERaERa_0480"	114943	555414	564355	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	742	"OT_ER_ERaERa_0480"	115015	555414	564355	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	745	"OT_ER_ERaERb_1440"	115485	557385	536154	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	750	"OT_ERa_EREGFP_0120"	115645	572261	566329	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004331"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	751	"OT_ERa_EREGFP_0480"	116761	565268	568307	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004333"	38808	"2554-06-5"	"1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane"	"C2554065"	725	"NVS_NR_mERa"	517080	2710148	2699425	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004333"	38808	"2554-06-5"	"1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane"	"C2554065"	725	"NVS_NR_mERa"	517440	2710148	2699425	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004333"	38808	"2554-06-5"	"1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane"	"C2554065"	747	"OT_ER_ERbERb_1440"	114793	559354	560417	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004333"	38808	"2554-06-5"	"1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane"	"C2554065"	747	"OT_ER_ERbERb_1440"	114866	559354	560417	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004333"	38808	"2554-06-5"	"1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane"	"C2554065"	751	"OT_ERa_EREGFP_0480"	116762	565269	568308	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004339"	21866	"105-99-7"	"Dibutyl hexanedioate"	"C105997"	117	"ATG_ERa_TRANS_up"	49741	2170808	2036733	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004339"	21866	"105-99-7"	"Dibutyl hexanedioate"	"C105997"	750	"OT_ERa_EREGFP_0120"	115646	572263	566331	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004355"	41610	"147-81-9"	"Arabinose"	"C147819"	708	"NVS_NR_bER"	516229	2706799	2695759	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX004355"	41610	"147-81-9"	"Arabinose"	"C147819"	708	"NVS_NR_bER"	516423	2706799	2695759	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX004355"	41610	"147-81-9"	"Arabinose"	"C147819"	708	"NVS_NR_bER"	516434	2706799	2695759	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004357"	41422	"87-01-4"	"7-(Dimethylamino)-4-methylcoumarin"	"C87014"	75	"ATG_ERE_CIS_up"	13608	2094402	1963722	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004359"	24436	"25956-17-6"	"Allura Red C.I.16035"	"C25956176"	744	"OT_ER_ERaERb_0480"	112846	2401735	2399399	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004359"	24436	"25956-17-6"	"Allura Red C.I.16035"	"C25956176"	746	"OT_ER_ERbERb_0480"	116558	549236	558451	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004361"	42006	"26402-26-6"	"Glyceryl monooctanoate"	"C26402266"	2	"ACEA_T47D_80hr_Positive"	10305	1778602	1780803	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004361"	42006	"26402-26-6"	"Glyceryl monooctanoate"	"C26402266"	2	"ACEA_T47D_80hr_Positive"	10608	1778602	1780803	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004363"	38888	"2390-60-5"	"Basic Blue 7"	"C2390605"	725	"NVS_NR_mERa"	517082	2710155	2699432	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004363"	38888	"2390-60-5"	"Basic Blue 7"	"C2390605"	725	"NVS_NR_mERa"	517293	2710155	2699432	10	"Noisy data"	NA	NA	"percent_activity"
"TX004363"	38888	"2390-60-5"	"Basic Blue 7"	"C2390605"	750	"OT_ERa_EREGFP_0120"	115647	572269	566337	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004363"	38888	"2390-60-5"	"Basic Blue 7"	"C2390605"	750	"OT_ERa_EREGFP_0120"	115846	572269	566337	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004363"	38888	"2390-60-5"	"Basic Blue 7"	"C2390605"	751	"OT_ERa_EREGFP_0480"	116763	565276	568315	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004365"	21224	"6459-94-5"	"C.I. Acid Red 114"	"C6459945"	708	"NVS_NR_bER"	516201	2706802	2695762	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004365"	21224	"6459-94-5"	"C.I. Acid Red 114"	"C6459945"	708	"NVS_NR_bER"	516485	2706802	2695762	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004371"	20161	"92-52-4"	"Biphenyl"	"C92524"	2	"ACEA_T47D_80hr_Positive"	10609	1778606	1780799	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004371"	20161	"92-52-4"	"Biphenyl"	"C92524"	117	"ATG_ERa_TRANS_up"	49810	2170799	2036724	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX004379"	36467	"27344-41-8"	"Disodium 4,4'-bis(2-sulfostyryl)biphenyl"	"C27344418"	725	"NVS_NR_mERa"	517083	2710157	2699434	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004379"	36467	"27344-41-8"	"Disodium 4,4'-bis(2-sulfostyryl)biphenyl"	"C27344418"	744	"OT_ER_ERaERb_0480"	112845	2401729	2399404	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004379"	36467	"27344-41-8"	"Disodium 4,4'-bis(2-sulfostyryl)biphenyl"	"C27344418"	746	"OT_ER_ERbERb_0480"	116559	549242	558457	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004391"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	2	"ACEA_T47D_80hr_Positive"	10610	1778608	1780797	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004391"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	117	"ATG_ERa_TRANS_up"	49591	2170796	2036721	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004391"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	117	"ATG_ERa_TRANS_up"	50222	2170796	2036721	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004391"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	747	"OT_ER_ERbERb_1440"	114794	559366	560429	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004391"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	747	"OT_ER_ERbERb_1440"	114867	559366	560429	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004391"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	750	"OT_ERa_EREGFP_0120"	115847	572274	566342	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004395"	44536	"13171-00-1"	"1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone"	"C13171001"	2	"ACEA_T47D_80hr_Positive"	10611	1778609	1780796	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004395"	44536	"13171-00-1"	"1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone"	"C13171001"	746	"OT_ER_ERbERb_0480"	116560	549244	558459	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004395"	44536	"13171-00-1"	"1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone"	"C13171001"	750	"OT_ERa_EREGFP_0120"	115648	572275	566343	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004395"	44536	"13171-00-1"	"1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone"	"C13171001"	751	"OT_ERa_EREGFP_0480"	116764	565282	568321	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	117	"ATG_ERa_TRANS_up"	49740	2170790	2036715	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	117	"ATG_ERa_TRANS_up"	50000	2170790	2036715	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	708	"NVS_NR_bER"	516435	2706807	2695767	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	708	"NVS_NR_bER"	516486	2706807	2695767	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	725	"NVS_NR_mERa"	517555	2710161	2699438	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	725	"NVS_NR_mERa"	517637	2710161	2699438	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	742	"OT_ER_ERaERa_0480"	115016	555433	564374	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	743	"OT_ER_ERaERa_1440"	114491	551220	562403	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	744	"OT_ER_ERaERb_0480"	112844	2401722	2399412	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	746	"OT_ER_ERbERb_0480"	116561	549249	558464	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004415"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	747	"OT_ER_ERbERb_1440"	114760	559372	560435	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004423"	37714	"1987-50-4"	"4-Heptylphenol"	"C1987504"	2	"ACEA_T47D_80hr_Positive"	10230	1778618	1780788	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX004437"	20278	"97-00-7"	"1-Chloro-2,4-dinitrobenzene"	"C97007"	708	"NVS_NR_bER"	516376	2706809	2695769	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004449"	20040	"309-00-2"	"Aldrin"	"C309002"	725	"NVS_NR_mERa"	517084	2710165	2699442	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004449"	20040	"309-00-2"	"Aldrin"	"C309002"	744	"OT_ER_ERaERb_0480"	112945	2401715	2399421	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004449"	20040	"309-00-2"	"Aldrin"	"C309002"	746	"OT_ER_ERbERb_0480"	116649	549256	558471	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004449"	20040	"309-00-2"	"Aldrin"	"C309002"	747	"OT_ER_ERbERb_1440"	114795	559379	560442	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004463"	24376	"1929-77-7"	"Vernolate"	"C1929777"	117	"ATG_ERa_TRANS_up"	49739	2170779	2036704	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004463"	24376	"1929-77-7"	"Vernolate"	"C1929777"	117	"ATG_ERa_TRANS_up"	49999	2170779	2036704	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004463"	24376	"1929-77-7"	"Vernolate"	"C1929777"	714	"NVS_NR_hER"	517999	2709020	2698297	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004467"	20930	"54-11-5"	"Nicotine"	"C54115"	725	"NVS_NR_mERa"	517086	2710168	2699445	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004478"	44571	"618-45-1"	"3-Isopropylphenol"	"C618451"	725	"NVS_NR_mERa"	517296	2710170	2699447	10	"Noisy data"	NA	NA	"percent_activity"
"TX004478"	44571	"618-45-1"	"3-Isopropylphenol"	"C618451"	742	"OT_ER_ERaERa_0480"	115017	555444	564385	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004478"	44571	"618-45-1"	"3-Isopropylphenol"	"C618451"	745	"OT_ER_ERaERb_1440"	115486	557415	536184	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004478"	44571	"618-45-1"	"3-Isopropylphenol"	"C618451"	746	"OT_ER_ERbERb_0480"	116562	549260	558475	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004484"	41794	"99607-70-2"	"Cloquintocet-mexyl"	"C99607702"	750	"OT_ERa_EREGFP_0120"	115650	572293	566361	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004498"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	117	"ATG_ERa_TRANS_up"	49634	2170770	2036695	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004498"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	117	"ATG_ERa_TRANS_up"	49809	2170770	2036695	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX004498"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	117	"ATG_ERa_TRANS_up"	50219	2170770	2036695	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004498"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	725	"NVS_NR_mERa"	517557	2710173	2699450	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004498"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	725	"NVS_NR_mERa"	517639	2710173	2699450	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004498"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	750	"OT_ERa_EREGFP_0120"	115849	572294	566362	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004506"	34598	"71283-80-2"	"Fenoxaprop-P-ethyl"	"C71283802"	2	"ACEA_T47D_80hr_Positive"	10612	1778629	1780776	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004506"	34598	"71283-80-2"	"Fenoxaprop-P-ethyl"	"C71283802"	725	"NVS_NR_mERa"	517088	2710175	2699452	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004506"	34598	"71283-80-2"	"Fenoxaprop-P-ethyl"	"C71283802"	750	"OT_ERa_EREGFP_0120"	115651	572295	566363	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004510"	32688	"26002-80-2"	"Phenothrin"	"C26002802"	751	"OT_ERa_EREGFP_0480"	116765	565303	568342	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004512"	34601	"67564-91-4"	"(2R,6S)-Fenpropimorph"	"C67564914"	117	"ATG_ERa_TRANS_up"	49590	2170767	2036692	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX004512"	34601	"67564-91-4"	"(2R,6S)-Fenpropimorph"	"C67564914"	117	"ATG_ERa_TRANS_up"	50218	2170767	2036692	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004524"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	2	"ACEA_T47D_80hr_Positive"	10746	1778632	1780773	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004524"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	75	"ATG_ERE_CIS_up"	13853	2094362	1963762	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004524"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	117	"ATG_ERa_TRANS_up"	49737	2170765	2036690	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004524"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	117	"ATG_ERa_TRANS_up"	49997	2170765	2036690	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004524"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	743	"OT_ER_ERaERa_1440"	114492	551238	562421	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004524"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	745	"OT_ER_ERaERb_1440"	115359	557422	536191	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004524"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	746	"OT_ER_ERbERb_0480"	116650	549267	558482	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004526"	32431	"87392-12-9"	"S-Metolachlor"	"C87392129"	75	"ATG_ERE_CIS_up"	13321	2094361	1963763	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004534"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	75	"ATG_ERE_CIS_up"	13320	2094360	1963764	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004534"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	75	"ATG_ERE_CIS_up"	13607	2094360	1963764	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004534"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	117	"ATG_ERa_TRANS_up"	49736	2170763	2036688	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004534"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	117	"ATG_ERa_TRANS_up"	49996	2170763	2036688	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004536"	24086	"563-12-2"	"Ethion"	"C563122"	708	"NVS_NR_bER"	516344	2706827	2695787	11	"Borderline active"	NA	NA	"percent_activity"
"TX004536"	24086	"563-12-2"	"Ethion"	"C563122"	708	"NVS_NR_bER"	516437	2706827	2695787	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004536"	24086	"563-12-2"	"Ethion"	"C563122"	708	"NVS_NR_bER"	516488	2706827	2695787	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004536"	24086	"563-12-2"	"Ethion"	"C563122"	714	"NVS_NR_hER"	517737	2709034	2698311	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX004536"	24086	"563-12-2"	"Ethion"	"C563122"	714	"NVS_NR_hER"	517939	2709034	2698311	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004536"	24086	"563-12-2"	"Ethion"	"C563122"	714	"NVS_NR_hER"	518002	2709034	2698311	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004536"	24086	"563-12-2"	"Ethion"	"C563122"	751	"OT_ERa_EREGFP_0480"	116766	565308	568347	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004538"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	2	"ACEA_T47D_80hr_Positive"	10231	1778636	1780769	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX004538"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	2	"ACEA_T47D_80hr_Positive"	10747	1778636	1780769	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004538"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	725	"NVS_NR_mERa"	517090	2710182	2699459	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004538"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	725	"NVS_NR_mERa"	517443	2710182	2699459	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004538"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	742	"OT_ER_ERaERa_0480"	114944	555455	564396	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004538"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	742	"OT_ER_ERaERa_0480"	115018	555455	564396	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004538"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	751	"OT_ERa_EREGFP_0480"	116767	565309	568348	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004540"	34324	"14816-18-3"	"Phoxim"	"C14816183"	2	"ACEA_T47D_80hr_Positive"	10232	1778637	1780768	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX004544"	24046	"311-45-5"	"Paraoxon"	"C311455"	2	"ACEA_T47D_80hr_Positive"	10613	1778638	1780767	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004544"	24046	"311-45-5"	"Paraoxon"	"C311455"	708	"NVS_NR_bER"	516438	2706829	2695789	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004544"	24046	"311-45-5"	"Paraoxon"	"C311455"	708	"NVS_NR_bER"	516489	2706829	2695789	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX004544"	24046	"311-45-5"	"Paraoxon"	"C311455"	714	"NVS_NR_hER"	517777	2709036	2698313	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004544"	24046	"311-45-5"	"Paraoxon"	"C311455"	725	"NVS_NR_mERa"	517091	2710183	2699460	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004544"	24046	"311-45-5"	"Paraoxon"	"C311455"	725	"NVS_NR_mERa"	517444	2710183	2699460	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004544"	24046	"311-45-5"	"Paraoxon"	"C311455"	742	"OT_ER_ERaERa_0480"	115019	555457	564398	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004546"	37539	"959-98-8"	"Endosulfan I"	"C959988"	742	"OT_ER_ERaERa_0480"	114945	555458	564399	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004546"	37539	"959-98-8"	"Endosulfan I"	"C959988"	742	"OT_ER_ERaERa_0480"	115020	555458	564399	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004546"	37539	"959-98-8"	"Endosulfan I"	"C959988"	744	"OT_ER_ERaERb_0480"	112944	2401697	2399435	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004546"	37539	"959-98-8"	"Endosulfan I"	"C959988"	746	"OT_ER_ERbERb_0480"	116563	549274	558489	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004546"	37539	"959-98-8"	"Endosulfan I"	"C959988"	750	"OT_ERa_EREGFP_0120"	115652	572305	566373	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004546"	37539	"959-98-8"	"Endosulfan I"	"C959988"	750	"OT_ERa_EREGFP_0120"	115850	572305	566373	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004572"	37185	"19774-82-4"	"Amiodarone hydrochloride"	"C19774824"	750	"OT_ERa_EREGFP_0120"	115653	572308	566376	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004572"	37185	"19774-82-4"	"Amiodarone hydrochloride"	"C19774824"	751	"OT_ERa_EREGFP_0480"	116768	565315	568354	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004614"	20047	"57-06-7"	"Allyl isothiocyanate"	"C57067"	117	"ATG_ERa_TRANS_up"	49735	2170747	2036672	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004614"	20047	"57-06-7"	"Allyl isothiocyanate"	"C57067"	117	"ATG_ERa_TRANS_up"	49995	2170747	2036672	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004626"	29904	"678-39-7"	"1,1,2,2-Tetrahydroperfluoro-1-decanol"	"C678397"	117	"ATG_ERa_TRANS_up"	49994	2170745	2036670	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004626"	29904	"678-39-7"	"1,1,2,2-Tetrahydroperfluoro-1-decanol"	"C678397"	725	"NVS_NR_mERa"	517445	2710192	2699469	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004626"	29904	"678-39-7"	"1,1,2,2-Tetrahydroperfluoro-1-decanol"	"C678397"	742	"OT_ER_ERaERa_0480"	114977	555468	564409	10	"Noisy data"	NA	NA	"percent_activity"
"TX004626"	29904	"678-39-7"	"1,1,2,2-Tetrahydroperfluoro-1-decanol"	"C678397"	744	"OT_ER_ERaERb_0480"	112943	2401687	2399452	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004626"	29904	"678-39-7"	"1,1,2,2-Tetrahydroperfluoro-1-decanol"	"C678397"	746	"OT_ER_ERbERb_0480"	116651	549284	558499	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004626"	29904	"678-39-7"	"1,1,2,2-Tetrahydroperfluoro-1-decanol"	"C678397"	751	"OT_ERa_EREGFP_0480"	116769	565322	568361	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004630"	22366	"50-27-1"	"Estriol"	"C50271"	2	"ACEA_T47D_80hr_Positive"	10394	1778650	1780755	10	"Noisy data"	NA	NA	"percent_activity"
"TX004638"	44784	"1189-08-8"	"1,3-Butyleneglycol dimethacrylate"	"C1189088"	2	"ACEA_T47D_80hr_Positive"	10395	1778651	1780754	10	"Noisy data"	NA	NA	"percent_activity"
"TX004638"	44784	"1189-08-8"	"1,3-Butyleneglycol dimethacrylate"	"C1189088"	2	"ACEA_T47D_80hr_Positive"	10463	1778651	1780754	11	"Borderline active"	NA	NA	"percent_activity"
"TX004638"	44784	"1189-08-8"	"1,3-Butyleneglycol dimethacrylate"	"C1189088"	2	"ACEA_T47D_80hr_Positive"	10748	1778651	1780754	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX004638"	44784	"1189-08-8"	"1,3-Butyleneglycol dimethacrylate"	"C1189088"	742	"OT_ER_ERaERa_0480"	114946	555470	564411	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004808"	37754	"101-37-1"	"2,4,6-Tris(allyloxy)-1,3,5-triazine"	"C101371"	725	"NVS_NR_mERa"	517093	2710196	2699473	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004808"	37754	"101-37-1"	"2,4,6-Tris(allyloxy)-1,3,5-triazine"	"C101371"	751	"OT_ERa_EREGFP_0480"	116770	565325	568364	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004808"	37754	"101-37-1"	"2,4,6-Tris(allyloxy)-1,3,5-triazine"	"C101371"	751	"OT_ERa_EREGFP_0480"	116908	565325	568364	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004824"	32459	"298-02-2"	"Phorate"	"C298022"	744	"OT_ER_ERaERb_0480"	112843	2401683	2399446	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004824"	32459	"298-02-2"	"Phorate"	"C298022"	746	"OT_ER_ERbERb_0480"	116652	549288	558503	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004824"	32459	"298-02-2"	"Phorate"	"C298022"	750	"OT_ERa_EREGFP_0120"	115654	572319	566387	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004844"	44888	"2457-01-4"	"Barium bis(2-ethylhexanoate)"	"C2457014"	2	"ACEA_T47D_80hr_Positive"	10614	1778655	1780750	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004844"	44888	"2457-01-4"	"Barium bis(2-ethylhexanoate)"	"C2457014"	743	"OT_ER_ERaERa_1440"	114384	551261	562444	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004844"	44888	"2457-01-4"	"Barium bis(2-ethylhexanoate)"	"C2457014"	746	"OT_ER_ERbERb_0480"	116564	549290	558505	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004844"	44888	"2457-01-4"	"Barium bis(2-ethylhexanoate)"	"C2457014"	750	"OT_ERa_EREGFP_0120"	115655	572321	566389	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004890"	37749	"4638-48-6"	"5-Chlorosalicylanilide"	"C4638486"	75	"ATG_ERE_CIS_up"	13318	2094327	1963797	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004890"	37749	"4638-48-6"	"5-Chlorosalicylanilide"	"C4638486"	75	"ATG_ERE_CIS_up"	13605	2094327	1963797	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004890"	37749	"4638-48-6"	"5-Chlorosalicylanilide"	"C4638486"	751	"OT_ERa_EREGFP_0480"	116771	565332	568371	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004902"	28022	"51632-16-7"	"1-(Bromomethyl)-3-phenoxybenzene"	"C51632167"	2	"ACEA_T47D_80hr_Positive"	10464	1778660	1780745	11	"Borderline active"	NA	NA	"percent_activity"
"TX004902"	28022	"51632-16-7"	"1-(Bromomethyl)-3-phenoxybenzene"	"C51632167"	743	"OT_ER_ERaERa_1440"	114351	551266	562449	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004942"	41709	"5850-86-2"	"C.I. Acid Orange 8, monosodium salt"	"C5850862"	75	"ATG_ERE_CIS_up"	13317	2094322	1963802	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004942"	41709	"5850-86-2"	"C.I. Acid Orange 8, monosodium salt"	"C5850862"	75	"ATG_ERE_CIS_up"	13604	2094322	1963802	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004942"	41709	"5850-86-2"	"C.I. Acid Orange 8, monosodium salt"	"C5850862"	117	"ATG_ERa_TRANS_up"	49733	2170725	2036650	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX004942"	41709	"5850-86-2"	"C.I. Acid Orange 8, monosodium salt"	"C5850862"	117	"ATG_ERa_TRANS_up"	49992	2170725	2036650	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX004946"	37730	"31519-22-9"	"1,4-Dihydroxy-2-naphthoic acid"	"C31519229"	708	"NVS_NR_bER"	516263	2706850	2695810	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX004946"	37730	"31519-22-9"	"1,4-Dihydroxy-2-naphthoic acid"	"C31519229"	708	"NVS_NR_bER"	516378	2706850	2695810	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004946"	37730	"31519-22-9"	"1,4-Dihydroxy-2-naphthoic acid"	"C31519229"	714	"NVS_NR_hER"	517819	2709059	2698336	10	"Noisy data"	NA	NA	"percent_activity"
"TX004951"	44788	"120-18-3"	"Naphthalene-2-sulfonic acid"	"C120183"	751	"OT_ERa_EREGFP_0480"	116887	565337	568376	10	"Noisy data"	NA	NA	"percent_activity"
"TX004954"	29162	"126-06-7"	"3-Bromo-1-chloro-5,5-dimethylhydantoin"	"C126067"	708	"NVS_NR_bER"	516323	2706851	2695811	10	"Noisy data"	NA	NA	"percent_activity"
"TX004972"	41653	"4707-47-5"	"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate"	"C4707475"	75	"ATG_ERE_CIS_up"	13850	2094317	1963807	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX004972"	41653	"4707-47-5"	"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate"	"C4707475"	742	"OT_ER_ERaERa_0480"	115021	555485	564426	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004972"	41653	"4707-47-5"	"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate"	"C4707475"	744	"OT_ER_ERaERb_0480"	112841	2401670	2399466	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX004972"	41653	"4707-47-5"	"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate"	"C4707475"	745	"OT_ER_ERaERb_1440"	115488	557456	536225	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX004972"	41653	"4707-47-5"	"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate"	"C4707475"	747	"OT_ER_ERbERb_1440"	114868	559424	560487	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005026"	27955	"29590-42-9"	"Isooctyl acrylate"	"C29590429"	725	"NVS_NR_mERa"	517451	2710211	2699488	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005044"	25110	"78-63-7"	"2,5-Dimethyl-2,5-di-(tert-butylperoxy)hexane"	"C78637"	2	"ACEA_T47D_80hr_Positive"	10616	1778668	1780738	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005044"	25110	"78-63-7"	"2,5-Dimethyl-2,5-di-(tert-butylperoxy)hexane"	"C78637"	708	"NVS_NR_bER"	516264	2706859	2695819	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005044"	25110	"78-63-7"	"2,5-Dimethyl-2,5-di-(tert-butylperoxy)hexane"	"C78637"	725	"NVS_NR_mERa"	517098	2710214	2699491	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005044"	25110	"78-63-7"	"2,5-Dimethyl-2,5-di-(tert-butylperoxy)hexane"	"C78637"	725	"NVS_NR_mERa"	517452	2710214	2699491	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005052"	44825	"585-34-2"	"3-tert-Butylphenol"	"C585342"	2	"ACEA_T47D_80hr_Positive"	10617	1778669	1780736	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005052"	44825	"585-34-2"	"3-tert-Butylphenol"	"C585342"	75	"ATG_ERE_CIS_up"	13849	2094312	1963812	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005054"	27466	"2386-87-0"	"UT-632"	"C2386870"	725	"NVS_NR_mERa"	517099	2710217	2699494	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005054"	27466	"2386-87-0"	"UT-632"	"C2386870"	743	"OT_ER_ERaERa_1440"	114385	551276	562459	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005054"	27466	"2386-87-0"	"UT-632"	"C2386870"	743	"OT_ER_ERaERa_1440"	114516	551276	562459	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX005060"	23581	"79902-63-9"	"Simvastatin"	"C79902639"	750	"OT_ERa_EREGFP_0120"	115657	572337	566405	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005060"	23581	"79902-63-9"	"Simvastatin"	"C79902639"	751	"OT_ERa_EREGFP_0480"	116772	565344	568383	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005068"	20870	"119-47-1"	"2,2'-Methylenebis(4-methyl-6-tert-butylphenol)"	"C119471"	75	"ATG_ERE_CIS_up"	13848	2094309	1963815	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005068"	20870	"119-47-1"	"2,2'-Methylenebis(4-methyl-6-tert-butylphenol)"	"C119471"	117	"ATG_ERa_TRANS_up"	49589	2170712	2036637	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005068"	20870	"119-47-1"	"2,2'-Methylenebis(4-methyl-6-tert-butylphenol)"	"C119471"	725	"NVS_NR_mERa"	517300	2710218	2699495	10	"Noisy data"	NA	NA	"percent_activity"
"TX005068"	20870	"119-47-1"	"2,2'-Methylenebis(4-methyl-6-tert-butylphenol)"	"C119471"	750	"OT_ERa_EREGFP_0120"	115658	572338	566406	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005068"	20870	"119-47-1"	"2,2'-Methylenebis(4-methyl-6-tert-butylphenol)"	"C119471"	751	"OT_ERa_EREGFP_0480"	116773	565345	568384	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005078"	27581	"4904-61-4"	"1,5,9-Cyclododecatriene"	"C4904614"	117	"ATG_ERa_TRANS_up"	50214	2170710	2036635	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005078"	27581	"4904-61-4"	"1,5,9-Cyclododecatriene"	"C4904614"	714	"NVS_NR_hER"	517780	2709074	2698351	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005080"	37712	"27955-94-8"	"4,4',4-Ethane-1,1,1-triyltriphenol"	"C27955948"	75	"ATG_ERE_CIS_up"	13847	2094306	1963818	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005080"	37712	"27955-94-8"	"4,4',4-Ethane-1,1,1-triyltriphenol"	"C27955948"	117	"ATG_ERa_TRANS_up"	50213	2170709	2036634	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005086"	40742	"124-94-7"	"Triamcinolone"	"C124947"	714	"NVS_NR_hER"	517711	2709076	2698353	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005086"	40742	"124-94-7"	"Triamcinolone"	"C124947"	714	"NVS_NR_hER"	517942	2709076	2698353	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005086"	40742	"124-94-7"	"Triamcinolone"	"C124947"	714	"NVS_NR_hER"	518006	2709076	2698353	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005086"	40742	"124-94-7"	"Triamcinolone"	"C124947"	743	"OT_ER_ERaERa_1440"	114386	551280	562463	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005086"	40742	"124-94-7"	"Triamcinolone"	"C124947"	750	"OT_ERa_EREGFP_0120"	115659	572340	566408	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005086"	40742	"124-94-7"	"Triamcinolone"	"C124947"	751	"OT_ERa_EREGFP_0480"	116774	565347	568386	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005106"	21322	"97-77-8"	"Disulfiram"	"C97778"	2	"ACEA_T47D_80hr_Positive"	10618	1778677	1780728	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005106"	21322	"97-77-8"	"Disulfiram"	"C97778"	117	"ATG_ERa_TRANS_up"	49989	2170706	2036631	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005109"	25080	"108-83-8"	"Diisobutyl ketone"	"C108838"	2	"ACEA_T47D_80hr_Positive"	10306	1778678	1780727	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005109"	25080	"108-83-8"	"Diisobutyl ketone"	"C108838"	742	"OT_ER_ERaERa_0480"	115022	555495	564436	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005109"	25080	"108-83-8"	"Diisobutyl ketone"	"C108838"	743	"OT_ER_ERaERa_1440"	114449	551282	562465	10	"Noisy data"	NA	NA	"percent_activity"
"TX005109"	25080	"108-83-8"	"Diisobutyl ketone"	"C108838"	745	"OT_ER_ERaERb_1440"	115360	557466	536235	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005130"	20143	"65-85-0"	"Benzoic acid"	"C65850"	725	"NVS_NR_mERa"	517100	2710225	2699502	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005130"	20143	"65-85-0"	"Benzoic acid"	"C65850"	750	"OT_ERa_EREGFP_0120"	115660	572344	566412	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005131"	20148	"98-07-7"	"Benzotrichloride"	"C98077"	2	"ACEA_T47D_80hr_Positive"	10177	1778681	1780724	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005131"	20148	"98-07-7"	"Benzotrichloride"	"C98077"	2	"ACEA_T47D_80hr_Positive"	10465	1778681	1780724	11	"Borderline active"	NA	NA	"percent_activity"
"TX005131"	20148	"98-07-7"	"Benzotrichloride"	"C98077"	2	"ACEA_T47D_80hr_Positive"	10749	1778681	1780724	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005131"	20148	"98-07-7"	"Benzotrichloride"	"C98077"	725	"NVS_NR_mERa"	517101	2710226	2699503	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005131"	20148	"98-07-7"	"Benzotrichloride"	"C98077"	725	"NVS_NR_mERa"	517453	2710226	2699503	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005134"	26513	"85-40-5"	"1,2,3,6-Tetrahydrophthalimide"	"C85405"	742	"OT_ER_ERaERa_0480"	115023	555499	564440	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005156"	25143	"526-75-0"	"2,3-Dimethylphenol"	"C526750"	2	"ACEA_T47D_80hr_Positive"	10307	1778685	1780720	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005156"	25143	"526-75-0"	"2,3-Dimethylphenol"	"C526750"	2	"ACEA_T47D_80hr_Positive"	10619	1778685	1780720	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005164"	24985	"118-52-5"	"1,3-Dichloro-5,5-dimethylhydantoin"	"C118525"	2	"ACEA_T47D_80hr_Positive"	10178	1778686	1780719	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005166"	25726	"88-74-4"	"2-Nitroaniline"	"C88744"	75	"ATG_ERE_CIS_up"	13167	2094290	1963834	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005166"	25726	"88-74-4"	"2-Nitroaniline"	"C88744"	75	"ATG_ERE_CIS_up"	13846	2094290	1963834	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005177"	26799	"108-77-0"	"2,4,6-Trichloro-s-triazine"	"C108770"	745	"OT_ER_ERaERb_1440"	115437	557476	536245	10	"Noisy data"	NA	NA	"percent_activity"
"TX005185"	32514	"643-79-8"	"1,2-Benzenedicarboxaldehyde"	"C643798"	725	"NVS_NR_mERa"	517102	2710230	2699507	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005191"	20737	"120-72-9"	"Indole"	"C120729"	75	"ATG_ERE_CIS_up"	13601	2094285	1963839	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005191"	20737	"120-72-9"	"Indole"	"C120729"	117	"ATG_ERa_TRANS_up"	49987	2170688	2036613	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005192"	21790	"88-75-5"	"2-Nitrophenol"	"C88755"	2	"ACEA_T47D_80hr_Positive"	10308	1778691	1780714	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005192"	21790	"88-75-5"	"2-Nitrophenol"	"C88755"	2	"ACEA_T47D_80hr_Positive"	10620	1778691	1780714	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005192"	21790	"88-75-5"	"2-Nitrophenol"	"C88755"	743	"OT_ER_ERaERa_1440"	114387	551295	562478	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005192"	21790	"88-75-5"	"2-Nitrophenol"	"C88755"	743	"OT_ER_ERaERa_1440"	114493	551295	562478	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005192"	21790	"88-75-5"	"2-Nitrophenol"	"C88755"	743	"OT_ER_ERaERa_1440"	114517	551295	562478	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX005193"	24062	"95-65-8"	"3,4-Dimethylphenol"	"C95658"	75	"ATG_ERE_CIS_up"	13166	2094283	1963841	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005193"	24062	"95-65-8"	"3,4-Dimethylphenol"	"C95658"	714	"NVS_NR_hER"	517713	2709088	2698365	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005193"	24062	"95-65-8"	"3,4-Dimethylphenol"	"C95658"	714	"NVS_NR_hER"	518008	2709088	2698365	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005193"	24062	"95-65-8"	"3,4-Dimethylphenol"	"C95658"	744	"OT_ER_ERaERb_0480"	112942	2401646	2399487	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005197"	24359	"95-95-4"	"2,4,5-Trichlorophenol"	"C95954"	744	"OT_ER_ERaERb_0480"	112840	2401645	2399488	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005197"	24359	"95-95-4"	"2,4,5-Trichlorophenol"	"C95954"	744	"OT_ER_ERaERb_0480"	112901	2401645	2399488	11	"Borderline active"	NA	NA	"percent_activity"
"TX005199"	21378	"76-03-9"	"Trichloroacetic acid"	"C76039"	2	"ACEA_T47D_80hr_Positive"	10309	1778694	1780712	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005206"	21764	"78-96-6"	"1-Amino-2-propanol"	"C78966"	725	"NVS_NR_mERa"	517558	2710233	2699510	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005206"	21764	"78-96-6"	"1-Amino-2-propanol"	"C78966"	725	"NVS_NR_mERa"	517640	2710233	2699510	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005206"	21764	"78-96-6"	"1-Amino-2-propanol"	"C78966"	743	"OT_ER_ERaERa_1440"	114388	551299	562482	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005206"	21764	"78-96-6"	"1-Amino-2-propanol"	"C78966"	743	"OT_ER_ERaERa_1440"	114494	551299	562482	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005206"	21764	"78-96-6"	"1-Amino-2-propanol"	"C78966"	745	"OT_ER_ERaERb_1440"	115489	557483	536252	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005210"	20224	"96-48-0"	"4-Butyrolactone"	"C96480"	2	"ACEA_T47D_80hr_Positive"	10621	1778696	1780709	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005215"	20137	"92-87-5"	"Benzidine"	"C92875"	725	"NVS_NR_mERa"	517103	2710234	2699511	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005215"	20137	"92-87-5"	"Benzidine"	"C92875"	747	"OT_ER_ERbERb_1440"	114796	559453	560516	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005237"	21386	"88-06-2"	"2,4,6-Trichlorophenol"	"C88062"	2	"ACEA_T47D_80hr_Positive"	10179	1778698	1780707	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005237"	21386	"88-06-2"	"2,4,6-Trichlorophenol"	"C88062"	75	"ATG_ERE_CIS_up"	13600	2094274	1963850	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005241"	21607	"142-62-1"	"Hexanoic acid"	"C142621"	2	"ACEA_T47D_80hr_Positive"	10622	1778699	1780706	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005256"	41472	"107-54-0"	"3,5-Dimethyl-1-hexyn-3-ol"	"C107540"	725	"NVS_NR_mERa"	517104	2710235	2699512	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005256"	41472	"107-54-0"	"3,5-Dimethyl-1-hexyn-3-ol"	"C107540"	750	"OT_ERa_EREGFP_0120"	115661	572364	566432	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005256"	41472	"107-54-0"	"3,5-Dimethyl-1-hexyn-3-ol"	"C107540"	750	"OT_ERa_EREGFP_0120"	115886	572364	566432	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX005260"	37752	"744-45-6"	"Diphenyl isophthalate"	"C744456"	745	"OT_ER_ERaERb_1440"	115408	557489	536258	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005260"	37752	"744-45-6"	"Diphenyl isophthalate"	"C744456"	750	"OT_ERa_EREGFP_0120"	115662	572365	566433	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005262"	44828	"692-86-4"	"Ethyl undec-10-enoate"	"C692864"	75	"ATG_ERE_CIS_up"	13599	2094270	1963854	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005392"	23430	"78-11-5"	"Pentaerythritol tetranitrate"	"C78115"	117	"ATG_ERa_TRANS_up"	49588	2170656	2036581	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005392"	23430	"78-11-5"	"Pentaerythritol tetranitrate"	"C78115"	714	"NVS_NR_hER"	517944	2709104	2698381	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005392"	23430	"78-11-5"	"Pentaerythritol tetranitrate"	"C78115"	714	"NVS_NR_hER"	518009	2709104	2698381	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005392"	23430	"78-11-5"	"Pentaerythritol tetranitrate"	"C78115"	725	"NVS_NR_mERa"	517304	2710246	2699523	10	"Noisy data"	NA	NA	"percent_activity"
"TX005392"	23430	"78-11-5"	"Pentaerythritol tetranitrate"	"C78115"	750	"OT_ERa_EREGFP_0120"	115663	572370	566438	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005392"	23430	"78-11-5"	"Pentaerythritol tetranitrate"	"C78115"	751	"OT_ERa_EREGFP_0480"	116775	565377	568416	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005404"	32648	"22248-79-9"	"Z-Tetrachlorvinphos"	"C22248799"	75	"ATG_ERE_CIS_up"	13843	2094251	1963873	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005404"	32648	"22248-79-9"	"Z-Tetrachlorvinphos"	"C22248799"	725	"NVS_NR_mERa"	517107	2710249	2699526	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005404"	32648	"22248-79-9"	"Z-Tetrachlorvinphos"	"C22248799"	725	"NVS_NR_mERa"	517454	2710249	2699526	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005404"	32648	"22248-79-9"	"Z-Tetrachlorvinphos"	"C22248799"	743	"OT_ER_ERaERa_1440"	114389	551311	562494	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005416"	42096	"6706-59-8"	"L-Glucitol"	"C6706598"	2	"ACEA_T47D_80hr_Positive"	10466	1778709	1780696	11	"Borderline active"	NA	NA	"percent_activity"
"TX005416"	42096	"6706-59-8"	"L-Glucitol"	"C6706598"	750	"OT_ERa_EREGFP_0120"	115664	572373	566441	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005422"	42086	"59227-89-3"	"Laurocapram"	"C59227893"	725	"NVS_NR_mERa"	517108	2710252	2699529	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005440"	35204	"2155-70-6"	"Tributyltin methacrylate"	"C2155706"	75	"ATG_ERE_CIS_up"	13316	2094246	1963878	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005440"	35204	"2155-70-6"	"Tributyltin methacrylate"	"C2155706"	75	"ATG_ERE_CIS_up"	13598	2094246	1963878	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005440"	35204	"2155-70-6"	"Tributyltin methacrylate"	"C2155706"	725	"NVS_NR_mERa"	517641	2710254	2699531	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005456"	41639	"827-21-4"	"Benzenesulfonic acid, 2,4-dimethyl-, sodium salt"	"C827214"	750	"OT_ERa_EREGFP_0120"	115666	572377	566445	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005464"	29223	"1742-14-9"	"1,1-Bis(3,4-dimethylphenyl)ethane"	"C1742149"	75	"ATG_ERE_CIS_up"	13207	2094243	1963881	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005464"	29223	"1742-14-9"	"1,1-Bis(3,4-dimethylphenyl)ethane"	"C1742149"	75	"ATG_ERE_CIS_up"	13842	2094243	1963881	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005468"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	725	"NVS_NR_mERa"	517559	2710258	2699535	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005468"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	725	"NVS_NR_mERa"	517642	2710258	2699535	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005468"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	742	"OT_ER_ERaERa_0480"	115025	555532	564473	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005468"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	747	"OT_ER_ERbERb_1440"	114761	559471	560534	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005468"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	750	"OT_ERa_EREGFP_0120"	115667	572379	566447	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005468"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	751	"OT_ERa_EREGFP_0480"	116777	565386	568425	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005468"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	751	"OT_ERa_EREGFP_0480"	116909	565386	568425	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005472"	41715	"6625-46-3"	"C.I. Acid Violet 12, disodium salt"	"C6625463"	117	"ATG_ERa_TRANS_up"	49587	2170643	2036568	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005472"	41715	"6625-46-3"	"C.I. Acid Violet 12, disodium salt"	"C6625463"	117	"ATG_ERa_TRANS_up"	49807	2170643	2036568	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX005472"	41715	"6625-46-3"	"C.I. Acid Violet 12, disodium salt"	"C6625463"	117	"ATG_ERa_TRANS_up"	50212	2170643	2036568	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005477"	29353	"32388-55-9"	"1-Cedr-8-en-9-ylethanone"	"C32388559"	75	"ATG_ERE_CIS_up"	13339	2094239	1963885	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX005477"	29353	"32388-55-9"	"1-Cedr-8-en-9-ylethanone"	"C32388559"	75	"ATG_ERE_CIS_up"	13841	2094239	1963885	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005477"	29353	"32388-55-9"	"1-Cedr-8-en-9-ylethanone"	"C32388559"	745	"OT_ER_ERaERb_1440"	115490	557506	536275	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005477"	29353	"32388-55-9"	"1-Cedr-8-en-9-ylethanone"	"C32388559"	750	"OT_ERa_EREGFP_0120"	115819	572382	566450	11	"Borderline active"	NA	NA	"percent_activity"
"TX005477"	29353	"32388-55-9"	"1-Cedr-8-en-9-ylethanone"	"C32388559"	751	"OT_ERa_EREGFP_0480"	116778	565389	568428	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005478"	42356	"2110-18-1"	"2-(3-Phenylpropyl)pyridine"	"C2110181"	75	"ATG_ERE_CIS_up"	13840	2094238	1963886	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005478"	42356	"2110-18-1"	"2-(3-Phenylpropyl)pyridine"	"C2110181"	744	"OT_ER_ERaERb_0480"	112941	2401619	2399512	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005482"	44833	"80-27-3"	"Terpinyl propionate"	"C80273"	708	"NVS_NR_bER"	516267	2706903	2695863	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005482"	44833	"80-27-3"	"Terpinyl propionate"	"C80273"	725	"NVS_NR_mERa"	517110	2710259	2699536	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005490"	32484	"3383-96-8"	"Temephos"	"C3383968"	2	"ACEA_T47D_80hr_Positive"	10750	1778722	1780683	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005490"	32484	"3383-96-8"	"Temephos"	"C3383968"	75	"ATG_ERE_CIS_up"	13315	2094235	1963889	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005490"	32484	"3383-96-8"	"Temephos"	"C3383968"	708	"NVS_NR_bER"	516379	2706906	2695866	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005500"	41877	"151-05-3"	"Dimethylbenzylcarbinyl acetate"	"C151053"	2	"ACEA_T47D_80hr_Positive"	10623	1778723	1780682	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005515"	38830	"10094-34-5"	"1,1-Dimethyl-2-phenylethyl butanoate"	"C10094345"	2	"ACEA_T47D_80hr_Positive"	10310	1778725	1780680	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005515"	38830	"10094-34-5"	"1,1-Dimethyl-2-phenylethyl butanoate"	"C10094345"	2	"ACEA_T47D_80hr_Positive"	10624	1778725	1780680	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005515"	38830	"10094-34-5"	"1,1-Dimethyl-2-phenylethyl butanoate"	"C10094345"	117	"ATG_ERa_TRANS_up"	49586	2170633	2036558	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005515"	38830	"10094-34-5"	"1,1-Dimethyl-2-phenylethyl butanoate"	"C10094345"	117	"ATG_ERa_TRANS_up"	50210	2170633	2036558	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005530"	44901	"2694-54-4"	"Triprop-2-en-1-yl benzene-1,2,4-tricarboxylate"	"C2694544"	75	"ATG_ERE_CIS_up"	13338	2094229	1963895	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX005530"	44901	"2694-54-4"	"Triprop-2-en-1-yl benzene-1,2,4-tricarboxylate"	"C2694544"	75	"ATG_ERE_CIS_up"	13838	2094229	1963895	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005530"	44901	"2694-54-4"	"Triprop-2-en-1-yl benzene-1,2,4-tricarboxylate"	"C2694544"	117	"ATG_ERa_TRANS_up"	49730	2170632	2036557	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005530"	44901	"2694-54-4"	"Triprop-2-en-1-yl benzene-1,2,4-tricarboxylate"	"C2694544"	751	"OT_ERa_EREGFP_0480"	116779	565397	568436	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005536"	44902	"27253-33-4"	"Calcium neodecanoate"	"C27253334"	117	"ATG_ERa_TRANS_up"	50209	2170631	2036556	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005545"	22253	"10453-86-8"	"Resmethrin"	"C10453868"	2	"ACEA_T47D_80hr_Positive"	10311	1778728	1780678	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	708	"NVS_NR_bER"	516269	2706909	2695869	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	708	"NVS_NR_bER"	516380	2706909	2695869	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	714	"NVS_NR_hER"	517820	2709123	2698400	10	"Noisy data"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	725	"NVS_NR_mERa"	517114	2710265	2699542	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	725	"NVS_NR_mERa"	517457	2710265	2699542	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	725	"NVS_NR_mERa"	517539	2710265	2699542	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	744	"OT_ER_ERaERb_0480"	112839	2401608	2399529	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	746	"OT_ER_ERbERb_0480"	116654	549363	558578	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005559"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	751	"OT_ERa_EREGFP_0480"	116780	565401	568440	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005561"	42198	"1907-65-9"	"N-Butyl-p-toluenesulfonamide"	"C1907659"	743	"OT_ER_ERaERa_1440"	114390	551335	562518	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005619"	32620	"86479-06-3"	"Hexaflumuron"	"C86479063"	2	"ACEA_T47D_80hr_Positive"	10625	1778732	1780673	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005619"	32620	"86479-06-3"	"Hexaflumuron"	"C86479063"	750	"OT_ERa_EREGFP_0120"	115668	572397	566465	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005621"	38939	"754-91-6"	"PFOSA"	"C754916"	117	"ATG_ERa_TRANS_up"	50208	2170622	2036547	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005621"	38939	"754-91-6"	"PFOSA"	"C754916"	725	"NVS_NR_mERa"	517644	2710269	2699546	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005621"	38939	"754-91-6"	"PFOSA"	"C754916"	742	"OT_ER_ERaERa_0480"	114908	555551	564492	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005621"	38939	"754-91-6"	"PFOSA"	"C754916"	744	"OT_ER_ERaERb_0480"	112838	2401604	2399525	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005621"	38939	"754-91-6"	"PFOSA"	"C754916"	746	"OT_ER_ERbERb_0480"	116565	549367	558582	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005664"	20373	"72-54-8"	"p,p'-DDD"	"C72548"	744	"OT_ER_ERaERb_0480"	112837	2401602	2399531	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005681"	47167	"79-16-3"	"N-Methylacetamide"	"C79163"	2	"ACEA_T47D_80hr_Positive"	10626	1778737	1780668	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005684"	22474	"50-22-6"	"Corticosterone"	"C50226"	75	"ATG_ERE_CIS_up"	13337	2094214	1963910	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX005701"	32303	"53939-28-9"	"(Z)-11-Hexadecenal"	"C53939289"	747	"OT_ER_ERbERb_1440"	114797	559496	560559	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005701"	32303	"53939-28-9"	"(Z)-11-Hexadecenal"	"C53939289"	747	"OT_ER_ERbERb_1440"	114869	559496	560559	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005701"	32303	"53939-28-9"	"(Z)-11-Hexadecenal"	"C53939289"	751	"OT_ERa_EREGFP_0480"	116781	565411	568450	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005727"	20107	"22839-47-0"	"Aspartame"	"C22839470"	2	"ACEA_T47D_80hr_Positive"	10751	1778740	1780665	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005736"	21240	"127-47-9"	"Retinol acetate"	"C127479"	75	"ATG_ERE_CIS_up"	13597	2094211	1963913	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005742"	25505	"60-33-3"	"Linoleic acid"	"C60333"	2	"ACEA_T47D_80hr_Positive"	10312	1778743	1780663	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005742"	25505	"60-33-3"	"Linoleic acid"	"C60333"	2	"ACEA_T47D_80hr_Positive"	10627	1778743	1780663	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005742"	25505	"60-33-3"	"Linoleic acid"	"C60333"	75	"ATG_ERE_CIS_up"	13314	2094208	1963916	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005742"	25505	"60-33-3"	"Linoleic acid"	"C60333"	75	"ATG_ERE_CIS_up"	13596	2094208	1963916	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005742"	25505	"60-33-3"	"Linoleic acid"	"C60333"	725	"NVS_NR_mERa"	517005	2710273	2699550	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005751"	20755	"54-85-3"	"Isoniazid"	"C54853"	2	"ACEA_T47D_80hr_Positive"	10180	1778744	1780661	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005751"	20755	"54-85-3"	"Isoniazid"	"C54853"	750	"OT_ERa_EREGFP_0120"	115669	572409	566477	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005757"	26261	"13674-87-8"	"Tris(1,3-dichloro-2-propyl)phosphate"	"C13674878"	117	"ATG_ERa_TRANS_up"	49729	2170609	2036534	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005757"	26261	"13674-87-8"	"Tris(1,3-dichloro-2-propyl)phosphate"	"C13674878"	117	"ATG_ERa_TRANS_up"	49980	2170609	2036534	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005759"	41267	"1569-02-4"	"1-Ethoxy-2-propanol"	"C1569024"	75	"ATG_ERE_CIS_up"	13165	2094205	1963919	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005759"	41267	"1569-02-4"	"1-Ethoxy-2-propanol"	"C1569024"	75	"ATG_ERE_CIS_up"	13388	2094205	1963919	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX005759"	41267	"1569-02-4"	"1-Ethoxy-2-propanol"	"C1569024"	75	"ATG_ERE_CIS_up"	13837	2094205	1963919	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005759"	41267	"1569-02-4"	"1-Ethoxy-2-propanol"	"C1569024"	725	"NVS_NR_mERa"	517562	2710277	2699554	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005764"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	2	"ACEA_T47D_80hr_Positive"	10233	1778747	1780657	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX005764"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	2	"ACEA_T47D_80hr_Positive"	10467	1778747	1780657	11	"Borderline active"	NA	NA	"percent_activity"
"TX005764"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	117	"ATG_ERa_TRANS_up"	50206	2170607	2036532	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005764"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	714	"NVS_NR_hER"	517714	2709140	2698417	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005764"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	714	"NVS_NR_hER"	518012	2709140	2698417	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005764"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	745	"OT_ER_ERaERb_1440"	115361	557536	536305	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005766"	20379	"53-43-0"	"Dehydroepiandrosterone"	"C53430"	2	"ACEA_T47D_80hr_Positive"	10396	1778748	1780658	10	"Noisy data"	NA	NA	"percent_activity"
"TX005766"	20379	"53-43-0"	"Dehydroepiandrosterone"	"C53430"	708	"NVS_NR_bER"	516492	2706924	2695884	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005766"	20379	"53-43-0"	"Dehydroepiandrosterone"	"C53430"	725	"NVS_NR_mERa"	517645	2710280	2699557	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005780"	22731	"298-46-4"	"Carbamazepine"	"C298464"	2	"ACEA_T47D_80hr_Positive"	10181	1778750	1780656	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005780"	22731	"298-46-4"	"Carbamazepine"	"C298464"	117	"ATG_ERa_TRANS_up"	49728	2170604	2036529	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005780"	22731	"298-46-4"	"Carbamazepine"	"C298464"	117	"ATG_ERa_TRANS_up"	49979	2170604	2036529	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005780"	22731	"298-46-4"	"Carbamazepine"	"C298464"	725	"NVS_NR_mERa"	517118	2710281	2699558	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005780"	22731	"298-46-4"	"Carbamazepine"	"C298464"	725	"NVS_NR_mERa"	517459	2710281	2699558	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005784"	21185	"53-03-2"	"Prednisone"	"C53032"	750	"OT_ERa_EREGFP_0120"	115670	572416	566484	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005784"	21185	"53-03-2"	"Prednisone"	"C53032"	750	"OT_ERa_EREGFP_0120"	115852	572416	566484	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005788"	33058	"584-13-4"	"4-Amino-1,2,4-triazole"	"C584134"	2	"ACEA_T47D_80hr_Positive"	10182	1778752	1780653	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005788"	33058	"584-13-4"	"4-Amino-1,2,4-triazole"	"C584134"	117	"ATG_ERa_TRANS_up"	50205	2170602	2036527	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005794"	26496	"80-26-2"	"alpha-Terpinyl acetate"	"C80262"	2	"ACEA_T47D_80hr_Positive"	10313	1778754	1780651	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005794"	26496	"80-26-2"	"alpha-Terpinyl acetate"	"C80262"	751	"OT_ERa_EREGFP_0480"	116910	565426	568465	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005813"	26102	"117-08-8"	"Tetrachlorophthalic anhydride"	"C117088"	2	"ACEA_T47D_80hr_Positive"	10628	1778758	1780647	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005816"	22171	"2016-57-1"	"1-Decanamine"	"C2016571"	714	"NVS_NR_hER"	517884	2709151	2698428	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005816"	22171	"2016-57-1"	"1-Decanamine"	"C2016571"	745	"OT_ER_ERaERb_1440"	115438	557549	536318	10	"Noisy data"	NA	NA	"percent_activity"
"TX005845"	29871	"23593-75-1"	"Clotrimazole"	"C23593751"	117	"ATG_ERa_TRANS_up"	50203	2170590	2036515	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005845"	29871	"23593-75-1"	"Clotrimazole"	"C23593751"	750	"OT_ERa_EREGFP_0120"	115671	572426	566494	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005845"	29871	"23593-75-1"	"Clotrimazole"	"C23593751"	750	"OT_ERa_EREGFP_0120"	115853	572426	566494	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005847"	23322	"84371-65-3"	"Mifepristone"	"C84371653"	708	"NVS_NR_bER"	516494	2706935	2695895	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005849"	34764	"111991-09-4"	"Nicosulfuron"	"C111991094"	75	"ATG_ERE_CIS_up"	13206	2094185	1963939	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005849"	34764	"111991-09-4"	"Nicosulfuron"	"C111991094"	75	"ATG_ERE_CIS_up"	13836	2094185	1963939	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005875"	21358	"1156-19-0"	"Tolazamide"	"C1156190"	2	"ACEA_T47D_80hr_Positive"	10629	1778766	1780639	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005885"	34518	"13684-56-5"	"Desmedipham"	"C13684565"	725	"NVS_NR_mERa"	517120	2710295	2699572	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005885"	34518	"13684-56-5"	"Desmedipham"	"C13684565"	725	"NVS_NR_mERa"	517461	2710295	2699572	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005897"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	2	"ACEA_T47D_80hr_Positive"	10183	1778769	1780636	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005897"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	75	"ATG_ERE_CIS_up"	13387	2094176	1963948	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX005897"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	75	"ATG_ERE_CIS_up"	13835	2094176	1963948	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005897"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	746	"OT_ER_ERbERb_0480"	116566	549403	558618	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005897"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	751	"OT_ERa_EREGFP_0480"	116782	565441	568480	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005897"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	751	"OT_ERa_EREGFP_0480"	116911	565441	568480	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005912"	41708	"1320-07-6"	"C.I. Acid Orange 24, monosodium salt"	"C1320076"	117	"ATG_ERa_TRANS_up"	49585	2170576	2036501	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005920"	42399	"14351-66-7"	"Sodium abietate"	"C14351667"	725	"NVS_NR_mERa"	517122	2710299	2699576	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005920"	42399	"14351-66-7"	"Sodium abietate"	"C14351667"	725	"NVS_NR_mERa"	517462	2710299	2699576	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005920"	42399	"14351-66-7"	"Sodium abietate"	"C14351667"	743	"OT_ER_ERaERa_1440"	114450	551376	562559	10	"Noisy data"	NA	NA	"percent_activity"
"TX005926"	23193	"63-42-3"	"Lactose"	"C63423"	2	"ACEA_T47D_80hr_Positive"	10314	1778772	1780633	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005926"	23193	"63-42-3"	"Lactose"	"C63423"	2	"ACEA_T47D_80hr_Positive"	10630	1778772	1780633	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005944"	44493	"23779-32-0"	"1-[3-(Triethoxysilyl)propyl]urea"	"C23779320"	744	"OT_ER_ERaERb_0480"	112940	2401564	2399563	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005944"	44493	"23779-32-0"	"1-[3-(Triethoxysilyl)propyl]urea"	"C23779320"	745	"OT_ER_ERaERb_1440"	115409	557562	536331	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005944"	44493	"23779-32-0"	"1-[3-(Triethoxysilyl)propyl]urea"	"C23779320"	747	"OT_ER_ERbERb_1440"	114798	559530	560593	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005944"	44493	"23779-32-0"	"1-[3-(Triethoxysilyl)propyl]urea"	"C23779320"	751	"OT_ERa_EREGFP_0480"	116783	565445	568484	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005944"	44493	"23779-32-0"	"1-[3-(Triethoxysilyl)propyl]urea"	"C23779320"	751	"OT_ERa_EREGFP_0480"	116912	565445	568484	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005970"	42491	"2761-24-2"	"Triethoxypentylsilane"	"C2761242"	2	"ACEA_T47D_80hr_Positive"	10631	1778775	1780631	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX005970"	42491	"2761-24-2"	"Triethoxypentylsilane"	"C2761242"	750	"OT_ERa_EREGFP_0120"	115672	572440	566508	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005974"	34997	"81741-28-8"	"Tributyltetradecylphosphonium chloride"	"C81741288"	708	"NVS_NR_bER"	516204	2706944	2695904	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX005974"	34997	"81741-28-8"	"Tributyltetradecylphosphonium chloride"	"C81741288"	725	"NVS_NR_mERa"	517388	2710300	2699577	11	"Borderline active"	NA	NA	"percent_activity"
"TX005974"	34997	"81741-28-8"	"Tributyltetradecylphosphonium chloride"	"C81741288"	725	"NVS_NR_mERa"	517648	2710300	2699577	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX005982"	41920	"1559-35-9"	"2-(2-Ethylhexyloxy)ethanol"	"C1559359"	2	"ACEA_T47D_80hr_Positive"	10468	1778778	1780628	11	"Borderline active"	NA	NA	"percent_activity"
"TX005982"	41920	"1559-35-9"	"2-(2-Ethylhexyloxy)ethanol"	"C1559359"	2	"ACEA_T47D_80hr_Positive"	10752	1778778	1780628	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX005982"	41920	"1559-35-9"	"2-(2-Ethylhexyloxy)ethanol"	"C1559359"	75	"ATG_ERE_CIS_up"	13205	2094163	1963961	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX005982"	41920	"1559-35-9"	"2-(2-Ethylhexyloxy)ethanol"	"C1559359"	75	"ATG_ERE_CIS_up"	13833	2094163	1963961	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005982"	41920	"1559-35-9"	"2-(2-Ethylhexyloxy)ethanol"	"C1559359"	117	"ATG_ERa_TRANS_up"	50201	2170566	2036491	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005982"	41920	"1559-35-9"	"2-(2-Ethylhexyloxy)ethanol"	"C1559359"	743	"OT_ER_ERaERa_1440"	114391	551383	562566	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX005992"	41623	"15310-01-7"	"Benodanil"	"C15310017"	117	"ATG_ERa_TRANS_up"	49726	2170563	2036488	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005992"	41623	"15310-01-7"	"Benodanil"	"C15310017"	117	"ATG_ERa_TRANS_up"	49977	2170563	2036488	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX005994"	20207	"88-85-7"	"Dinoseb"	"C88857"	75	"ATG_ERE_CIS_up"	13313	2094159	1963965	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX005994"	20207	"88-85-7"	"Dinoseb"	"C88857"	117	"ATG_ERa_TRANS_up"	50199	2170562	2036487	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX005994"	20207	"88-85-7"	"Dinoseb"	"C88857"	725	"NVS_NR_mERa"	517463	2710302	2699579	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006030"	40721	"92-68-2"	"4-Cyclohexylcyclohexanone"	"C92682"	725	"NVS_NR_mERa"	517124	2710307	2699584	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006044"	44718	"68555-86-2"	"Acid Orange 156"	"C68555862"	75	"ATG_ERE_CIS_up"	13832	2094154	1963970	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006044"	44718	"68555-86-2"	"Acid Orange 156"	"C68555862"	117	"ATG_ERa_TRANS_up"	49976	2170557	2036482	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006088"	22377	"57-91-0"	"17alpha-Estradiol"	"C57910"	708	"NVS_NR_bER"	516324	2706955	2695915	10	"Noisy data"	NA	NA	"percent_activity"
"TX006092"	44553	"15046-75-0"	"Sodium 2-methylbenzenesulfonate"	"C15046750"	2	"ACEA_T47D_80hr_Positive"	10184	1778788	1780618	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006092"	44553	"15046-75-0"	"Sodium 2-methylbenzenesulfonate"	"C15046750"	2	"ACEA_T47D_80hr_Positive"	10469	1778788	1780618	11	"Borderline active"	NA	NA	"percent_activity"
"TX006100"	44713	"67786-14-5"	"Acid Red 337"	"C67786145"	75	"ATG_ERE_CIS_up"	13831	2094144	1963980	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006104"	26033	"126-92-1"	"Sodium ethasulfate"	"C126921"	2	"ACEA_T47D_80hr_Positive"	10470	1778790	1780616	11	"Borderline active"	NA	NA	"percent_activity"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	117	"ATG_ERa_TRANS_up"	49724	2170544	2036469	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	117	"ATG_ERa_TRANS_up"	49974	2170544	2036469	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	714	"NVS_NR_hER"	517846	2709178	2698455	11	"Borderline active"	NA	NA	"percent_activity"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	714	"NVS_NR_hER"	517946	2709178	2698455	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	714	"NVS_NR_hER"	518016	2709178	2698455	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	725	"NVS_NR_mERa"	517126	2710313	2699590	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	743	"OT_ER_ERaERa_1440"	114392	551397	562580	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006112"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	746	"OT_ER_ERbERb_0480"	116613	549426	558641	11	"Borderline active"	NA	NA	"percent_activity"
"TX006120"	21103	"1825-21-4"	"Pentachloroanisole"	"C1825214"	75	"ATG_ERE_CIS_up"	13594	2094139	1963985	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006120"	21103	"1825-21-4"	"Pentachloroanisole"	"C1825214"	117	"ATG_ERa_TRANS_up"	49723	2170542	2036467	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006120"	21103	"1825-21-4"	"Pentachloroanisole"	"C1825214"	117	"ATG_ERa_TRANS_up"	49973	2170542	2036467	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006128"	32535	"95266-40-3"	"Trinexapac-ethyl"	"C95266403"	2	"ACEA_T47D_80hr_Positive"	10632	1778794	1780612	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006132"	22174	"2104-64-5"	"EPN"	"C2104645"	2	"ACEA_T47D_80hr_Positive"	10185	1778795	1780610	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006132"	22174	"2104-64-5"	"EPN"	"C2104645"	725	"NVS_NR_mERa"	517389	2710316	2699593	11	"Borderline active"	NA	NA	"percent_activity"
"TX006132"	22174	"2104-64-5"	"EPN"	"C2104645"	725	"NVS_NR_mERa"	517563	2710316	2699593	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006132"	22174	"2104-64-5"	"EPN"	"C2104645"	725	"NVS_NR_mERa"	517649	2710316	2699593	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006132"	22174	"2104-64-5"	"EPN"	"C2104645"	747	"OT_ER_ERbERb_1440"	114800	559553	560616	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006136"	21026	"924-16-3"	"N-Nitrosodibutylamine"	"C924163"	75	"ATG_ERE_CIS_up"	13593	2094134	1963990	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006138"	34531	"23564-06-9"	"Thiophanate"	"C23564069"	2	"ACEA_T47D_80hr_Positive"	10234	1778797	1780608	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX006138"	34531	"23564-06-9"	"Thiophanate"	"C23564069"	2	"ACEA_T47D_80hr_Positive"	10471	1778797	1780608	11	"Borderline active"	NA	NA	"percent_activity"
"TX006138"	34531	"23564-06-9"	"Thiophanate"	"C23564069"	2	"ACEA_T47D_80hr_Positive"	10754	1778797	1780608	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006138"	34531	"23564-06-9"	"Thiophanate"	"C23564069"	742	"OT_ER_ERaERa_0480"	114947	555616	564557	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006138"	34531	"23564-06-9"	"Thiophanate"	"C23564069"	742	"OT_ER_ERaERa_0480"	115026	555616	564557	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006138"	34531	"23564-06-9"	"Thiophanate"	"C23564069"	751	"OT_ERa_EREGFP_0480"	116785	565470	568509	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006143"	47246	"139340-56-0"	"Darbufelone mesylate"	"C139340560"	117	"ATG_ERa_TRANS_up"	49972	2170535	2036460	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006143"	47246	"139340-56-0"	"Darbufelone mesylate"	"C139340560"	725	"NVS_NR_mERa"	517128	2710317	2699594	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006144"	47248	"NOCAS_47248"	"CI-1018"	"CNOCAS47248"	117	"ATG_ERa_TRANS_up"	49971	2170534	2036459	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006144"	47248	"NOCAS_47248"	"CI-1018"	"CNOCAS47248"	750	"OT_ERa_EREGFP_0120"	115674	572465	566533	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006145"	47249	"221246-12-4"	"Fandosentan potassium salt"	"C221246124"	117	"ATG_ERa_TRANS_up"	49583	2170533	2036458	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006145"	47249	"221246-12-4"	"Fandosentan potassium salt"	"C221246124"	117	"ATG_ERa_TRANS_up"	49805	2170533	2036458	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006145"	47249	"221246-12-4"	"Fandosentan potassium salt"	"C221246124"	117	"ATG_ERa_TRANS_up"	50198	2170533	2036458	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006145"	47249	"221246-12-4"	"Fandosentan potassium salt"	"C221246124"	708	"NVS_NR_bER"	516271	2706963	2695923	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006146"	47251	"145742-28-5"	"CP-122721"	"C145742285"	75	"ATG_ERE_CIS_up"	13592	2094129	1963995	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006146"	47251	"145742-28-5"	"CP-122721"	"C145742285"	117	"ATG_ERa_TRANS_up"	49722	2170532	2036457	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006146"	47251	"145742-28-5"	"CP-122721"	"C145742285"	117	"ATG_ERa_TRANS_up"	49970	2170532	2036457	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006146"	47251	"145742-28-5"	"CP-122721"	"C145742285"	750	"OT_ERa_EREGFP_0120"	115675	572467	566535	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006147"	47252	"186392-65-4"	"Ingliforib"	"C186392654"	725	"NVS_NR_mERa"	517129	2710319	2699596	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006148"	47253	"199171-88-5"	"CP-401387"	"C199171885"	2	"ACEA_T47D_80hr_Positive"	10315	1778803	1780602	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006148"	47253	"199171-88-5"	"CP-401387"	"C199171885"	2	"ACEA_T47D_80hr_Positive"	10633	1778803	1780602	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006148"	47253	"199171-88-5"	"CP-401387"	"C199171885"	117	"ATG_ERa_TRANS_up"	49969	2170530	2036455	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006148"	47253	"199171-88-5"	"CP-401387"	"C199171885"	725	"NVS_NR_mERa"	517130	2710320	2699597	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006148"	47253	"199171-88-5"	"CP-401387"	"C199171885"	725	"NVS_NR_mERa"	517465	2710320	2699597	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006149"	47254	"220860-50-4"	"CP-457920"	"C220860504"	2	"ACEA_T47D_80hr_Positive"	10186	1778804	1780601	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006149"	47254	"220860-50-4"	"CP-457920"	"C220860504"	117	"ATG_ERa_TRANS_up"	49721	2170529	2036454	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006149"	47254	"220860-50-4"	"CP-457920"	"C220860504"	117	"ATG_ERa_TRANS_up"	49968	2170529	2036454	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006150"	47255	"NOCAS_47255"	"CP-465394"	"CNOCAS47255"	2	"ACEA_T47D_80hr_Positive"	10634	1778805	1780600	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006151"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	725	"NVS_NR_mERa"	517650	2710321	2699598	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006151"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	742	"OT_ER_ERaERa_0480"	114948	555625	564566	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006151"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	745	"OT_ER_ERaERb_1440"	115362	557596	536365	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006151"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	746	"OT_ER_ERbERb_0480"	116568	549441	558656	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006151"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	746	"OT_ER_ERbERb_0480"	116614	549441	558656	11	"Borderline active"	NA	NA	"percent_activity"
"TX006151"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	750	"OT_ERa_EREGFP_0120"	115676	572472	566540	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006151"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	751	"OT_ERa_EREGFP_0480"	116786	565479	568518	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006153"	47259	"149062-75-9"	"PharmaGSID_47259"	"C149062759"	75	"ATG_ERE_CIS_up"	13311	2094122	1964002	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006153"	47259	"149062-75-9"	"PharmaGSID_47259"	"C149062759"	75	"ATG_ERE_CIS_up"	13591	2094122	1964002	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006153"	47259	"149062-75-9"	"PharmaGSID_47259"	"C149062759"	117	"ATG_ERa_TRANS_up"	49720	2170525	2036450	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006153"	47259	"149062-75-9"	"PharmaGSID_47259"	"C149062759"	117	"ATG_ERa_TRANS_up"	49967	2170525	2036450	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	2	"ACEA_T47D_80hr_Positive"	10187	1778811	1780594	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	75	"ATG_ERE_CIS_up"	13590	2094119	1964005	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	744	"OT_ER_ERaERb_0480"	112939	2401525	2399613	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	745	"OT_ER_ERaERb_1440"	115491	557601	536370	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	747	"OT_ER_ERbERb_1440"	114801	559569	560632	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	747	"OT_ER_ERbERb_1440"	114870	559569	560632	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	750	"OT_ERa_EREGFP_0120"	115677	572477	566545	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006156"	47263	"349495-42-7"	"PharmaGSID_47263"	"C349495427"	751	"OT_ERa_EREGFP_0480"	116787	565484	568523	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006157"	47264	"171866-31-2"	"CP-283097"	"C171866312"	743	"OT_ER_ERaERa_1440"	114393	551418	562601	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006158"	47265	"NOCAS_47265"	"CP-471358"	"CNOCAS47265"	2	"ACEA_T47D_80hr_Positive"	10635	1778813	1780592	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006160"	47267	"NOCAS_47267"	"CP-642931"	"CNOCAS47267"	2	"ACEA_T47D_80hr_Positive"	10188	1778815	1780590	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006160"	47267	"NOCAS_47267"	"CP-642931"	"CNOCAS47267"	2	"ACEA_T47D_80hr_Positive"	10472	1778815	1780590	11	"Borderline active"	NA	NA	"percent_activity"
"TX006160"	47267	"NOCAS_47267"	"CP-642931"	"CNOCAS47267"	750	"OT_ERa_EREGFP_0120"	115678	572481	566549	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006161"	47268	"104795-68-8"	"CI-959"	"C104795688"	75	"ATG_ERE_CIS_up"	13830	2094114	1964010	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006161"	47268	"104795-68-8"	"CI-959"	"C104795688"	714	"NVS_NR_hER"	517782	2709188	2698465	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006161"	47268	"104795-68-8"	"CI-959"	"C104795688"	751	"OT_ERa_EREGFP_0480"	116788	565489	568528	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006162"	47270	"253450-09-8"	"Besonprodil"	"C253450098"	75	"ATG_ERE_CIS_up"	13310	2094113	1964011	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006162"	47270	"253450-09-8"	"Besonprodil"	"C253450098"	75	"ATG_ERE_CIS_up"	13589	2094113	1964011	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006162"	47270	"253450-09-8"	"Besonprodil"	"C253450098"	117	"ATG_ERa_TRANS_up"	49719	2170516	2036441	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006163"	47271	"676116-04-4"	"PD 0343701"	"C676116044"	75	"ATG_ERE_CIS_up"	13588	2094112	1964012	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006163"	47271	"676116-04-4"	"PD 0343701"	"C676116044"	117	"ATG_ERa_TRANS_up"	49718	2170515	2036440	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006163"	47271	"676116-04-4"	"PD 0343701"	"C676116044"	714	"NVS_NR_hER"	517947	2709189	2698466	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006163"	47271	"676116-04-4"	"PD 0343701"	"C676116044"	714	"NVS_NR_hER"	518017	2709189	2698466	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006163"	47271	"676116-04-4"	"PD 0343701"	"C676116044"	751	"OT_ERa_EREGFP_0480"	116697	565491	568530	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006164"	47272	"249296-43-3"	"CJ-013610"	"C249296433"	75	"ATG_ERE_CIS_up"	13309	2094111	1964013	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006164"	47272	"249296-43-3"	"CJ-013610"	"C249296433"	742	"OT_ER_ERaERa_0480"	115027	555638	564579	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006164"	47272	"249296-43-3"	"CJ-013610"	"C249296433"	744	"OT_ER_ERaERb_0480"	112836	2401517	2399616	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006164"	47272	"249296-43-3"	"CJ-013610"	"C249296433"	744	"OT_ER_ERaERb_0480"	112900	2401517	2399616	11	"Borderline active"	NA	NA	"percent_activity"
"TX006167"	47276	"194098-25-4"	"CP-409092"	"C194098254"	2	"ACEA_T47D_80hr_Positive"	10636	1778821	1780584	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006168"	47277	"361343-19-3"	"Elzasonan"	"C361343193"	117	"ATG_ERa_TRANS_up"	49966	2170511	2036436	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006168"	47277	"361343-19-3"	"Elzasonan"	"C361343193"	725	"NVS_NR_mERa"	517131	2710323	2699600	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006168"	47277	"361343-19-3"	"Elzasonan"	"C361343193"	725	"NVS_NR_mERa"	517310	2710323	2699600	10	"Noisy data"	NA	NA	"percent_activity"
"TX006169"	47278	"214535-77-0"	"CP-457677"	"C214535770"	117	"ATG_ERa_TRANS_up"	49717	2170510	2036435	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006169"	47278	"214535-77-0"	"CP-457677"	"C214535770"	117	"ATG_ERa_TRANS_up"	49965	2170510	2036435	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006170"	47279	"261947-38-0"	"CP-532623"	"C261947380"	117	"ATG_ERa_TRANS_up"	49582	2170509	2036434	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006170"	47279	"261947-38-0"	"CP-532623"	"C261947380"	117	"ATG_ERa_TRANS_up"	50197	2170509	2036434	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006171"	47280	"289716-94-5"	"CP-607366"	"C289716945"	751	"OT_ERa_EREGFP_0480"	116789	565498	568537	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006172"	47281	"353280-07-6"	"CP-612372"	"C353280076"	117	"ATG_ERa_TRANS_up"	49716	2170507	2036432	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006172"	47281	"353280-07-6"	"CP-612372"	"C353280076"	117	"ATG_ERa_TRANS_up"	49964	2170507	2036432	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006172"	47281	"353280-07-6"	"CP-612372"	"C353280076"	714	"NVS_NR_hER"	517886	2709194	2698471	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006172"	47281	"353280-07-6"	"CP-612372"	"C353280076"	751	"OT_ERa_EREGFP_0480"	116790	565499	568538	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006173"	47282	"445295-04-5"	"CP-671305"	"C445295045"	75	"ATG_ERE_CIS_up"	13587	2094103	1964021	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006173"	47282	"445295-04-5"	"CP-671305"	"C445295045"	117	"ATG_ERa_TRANS_up"	49715	2170506	2036431	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006174"	47283	"368832-42-2"	"CP-728663"	"C368832422"	75	"ATG_ERE_CIS_up"	13204	2094102	1964022	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006174"	47283	"368832-42-2"	"CP-728663"	"C368832422"	75	"ATG_ERE_CIS_up"	13386	2094102	1964022	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006174"	47283	"368832-42-2"	"CP-728663"	"C368832422"	75	"ATG_ERE_CIS_up"	13829	2094102	1964022	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006174"	47283	"368832-42-2"	"CP-728663"	"C368832422"	117	"ATG_ERa_TRANS_up"	49581	2170505	2036430	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006174"	47283	"368832-42-2"	"CP-728663"	"C368832422"	117	"ATG_ERa_TRANS_up"	49804	2170505	2036430	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006174"	47283	"368832-42-2"	"CP-728663"	"C368832422"	117	"ATG_ERa_TRANS_up"	50196	2170505	2036430	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006174"	47283	"368832-42-2"	"CP-728663"	"C368832422"	750	"OT_ERa_EREGFP_0120"	115679	572494	566562	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006175"	47284	"478149-53-0"	"PHA-00543613"	"C478149530"	750	"OT_ERa_EREGFP_0120"	115680	572495	566563	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006177"	47286	"123122-55-4"	"Candoxatril"	"C123122554"	2	"ACEA_T47D_80hr_Positive"	10637	1778831	1780574	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006178"	47287	"197077-55-7"	"UK-333747"	"C197077557"	2	"ACEA_T47D_80hr_Positive"	10638	1778832	1780573	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006179"	47288	"203942-49-8"	"UK-337312"	"C203942498"	708	"NVS_NR_bER"	516325	2706971	2695931	10	"Noisy data"	NA	NA	"percent_activity"
"TX006179"	47288	"203942-49-8"	"UK-337312"	"C203942498"	714	"NVS_NR_hER"	517716	2709196	2698473	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006179"	47288	"203942-49-8"	"UK-337312"	"C203942498"	725	"NVS_NR_mERa"	517390	2710325	2699602	11	"Borderline active"	NA	NA	"percent_activity"
"TX006179"	47288	"203942-49-8"	"UK-337312"	"C203942498"	725	"NVS_NR_mERa"	517564	2710325	2699602	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006179"	47288	"203942-49-8"	"UK-337312"	"C203942498"	725	"NVS_NR_mERa"	517651	2710325	2699602	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006179"	47288	"203942-49-8"	"UK-337312"	"C203942498"	750	"OT_ERa_EREGFP_0120"	115681	572499	566567	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006179"	47288	"203942-49-8"	"UK-337312"	"C203942498"	750	"OT_ERa_EREGFP_0120"	115855	572499	566567	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006180"	47289	"215297-27-1"	"UK-343664"	"C215297271"	2	"ACEA_T47D_80hr_Positive"	10639	1778834	1780571	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006180"	47289	"215297-27-1"	"UK-343664"	"C215297271"	75	"ATG_ERE_CIS_up"	13308	2094096	1964028	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006180"	47289	"215297-27-1"	"UK-343664"	"C215297271"	117	"ATG_ERa_TRANS_up"	49714	2170499	2036424	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006180"	47289	"215297-27-1"	"UK-343664"	"C215297271"	750	"OT_ERa_EREGFP_0120"	115682	572500	566568	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006181"	47290	"402910-27-4"	"UK-416244"	"C402910274"	117	"ATG_ERa_TRANS_up"	49713	2170498	2036423	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006181"	47290	"402910-27-4"	"UK-416244"	"C402910274"	117	"ATG_ERa_TRANS_up"	49963	2170498	2036423	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006181"	47290	"402910-27-4"	"UK-416244"	"C402910274"	725	"NVS_NR_mERa"	517565	2710326	2699603	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006181"	47290	"402910-27-4"	"UK-416244"	"C402910274"	725	"NVS_NR_mERa"	517652	2710326	2699603	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006181"	47290	"402910-27-4"	"UK-416244"	"C402910274"	750	"OT_ERa_EREGFP_0120"	115683	572501	566569	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006182"	47291	"NOCAS_47291"	"CI-1044"	"CNOCAS47291"	750	"OT_ERa_EREGFP_0120"	115684	572502	566570	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006184"	47294	"668981-02-0"	"CP-863187"	"C668981020"	2	"ACEA_T47D_80hr_Positive"	10640	1778838	1780567	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006185"	47295	"291305-06-1"	"UK-373911"	"C291305061"	725	"NVS_NR_mERa"	517132	2710328	2699605	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006185"	47295	"291305-06-1"	"UK-373911"	"C291305061"	725	"NVS_NR_mERa"	517466	2710328	2699605	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006185"	47295	"291305-06-1"	"UK-373911"	"C291305061"	750	"OT_ERa_EREGFP_0120"	115685	572505	566573	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006185"	47295	"291305-06-1"	"UK-373911"	"C291305061"	750	"OT_ERa_EREGFP_0120"	115856	572505	566573	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006187"	47297	"134002-60-1"	"CP-085958"	"C134002601"	117	"ATG_ERa_TRANS_up"	49962	2170492	2036417	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006187"	47297	"134002-60-1"	"CP-085958"	"C134002601"	708	"NVS_NR_bER"	516272	2706975	2695935	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006187"	47297	"134002-60-1"	"CP-085958"	"C134002601"	725	"NVS_NR_mERa"	517133	2710329	2699606	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006187"	47297	"134002-60-1"	"CP-085958"	"C134002601"	725	"NVS_NR_mERa"	517467	2710329	2699606	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006190"	47301	"210826-40-7"	"CP-456773"	"C210826407"	75	"ATG_ERE_CIS_up"	13586	2094087	1964037	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006190"	47301	"210826-40-7"	"CP-456773"	"C210826407"	117	"ATG_ERa_TRANS_up"	49712	2170490	2036415	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006190"	47301	"210826-40-7"	"CP-456773"	"C210826407"	744	"OT_ER_ERaERb_0480"	112938	2401493	2399640	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006190"	47301	"210826-40-7"	"CP-456773"	"C210826407"	750	"OT_ERa_EREGFP_0120"	115686	572509	566577	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006192"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	714	"NVS_NR_hER"	517783	2709201	2698478	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006192"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	714	"NVS_NR_hER"	517887	2709201	2698478	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006192"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	714	"NVS_NR_hER"	517922	2709201	2698478	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX006192"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	742	"OT_ER_ERaERa_0480"	114949	555663	564604	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006192"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	746	"OT_ER_ERbERb_0480"	116569	549479	558694	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006193"	47304	"135080-03-4"	"CP-100829"	"C135080034"	75	"ATG_ERE_CIS_up"	13585	2094085	1964039	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006193"	47304	"135080-03-4"	"CP-100829"	"C135080034"	117	"ATG_ERa_TRANS_up"	49711	2170488	2036413	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006193"	47304	"135080-03-4"	"CP-100829"	"C135080034"	117	"ATG_ERa_TRANS_up"	49961	2170488	2036413	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006193"	47304	"135080-03-4"	"CP-100829"	"C135080034"	708	"NVS_NR_bER"	516495	2706976	2695936	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006194"	47305	"NOCAS_47305"	"CP-608039"	"CNOCAS47305"	743	"OT_ER_ERaERa_1440"	114452	551452	562635	10	"Noisy data"	NA	NA	"percent_activity"
"TX006195"	47306	"290352-28-2"	"CP-634384"	"C290352282"	2	"ACEA_T47D_80hr_Positive"	10473	1778847	1780559	11	"Borderline active"	NA	NA	"percent_activity"
"TX006195"	47306	"290352-28-2"	"CP-634384"	"C290352282"	75	"ATG_ERE_CIS_up"	13584	2094083	1964041	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006195"	47306	"290352-28-2"	"CP-634384"	"C290352282"	117	"ATG_ERa_TRANS_up"	49580	2170486	2036411	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006195"	47306	"290352-28-2"	"CP-634384"	"C290352282"	117	"ATG_ERa_TRANS_up"	50195	2170486	2036411	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006196"	47307	"501027-49-2"	"PD-0333941"	"C501027492"	725	"NVS_NR_mERa"	517134	2710331	2699608	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006197"	47308	"158081-99-3"	"CP-105696"	"C158081993"	744	"OT_ER_ERaERb_0480"	112878	2401487	2399646	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006199"	47316	"461023-63-2"	"Aplaviroc hydrochloride"	"C461023632"	746	"OT_ER_ERbERb_0480"	116655	549486	558701	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006200"	47320	"180084-01-9"	"SB236057A"	"C180084019"	725	"NVS_NR_mERa"	517653	2710333	2699610	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006200"	47320	"180084-01-9"	"SB236057A"	"C180084019"	751	"OT_ERa_EREGFP_0480"	116698	565525	568564	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006203"	47311	"NOCAS_47311"	"GSK163929B"	"CNOCAS47311"	75	"ATG_ERE_CIS_up"	13583	2094075	1964049	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006203"	47311	"NOCAS_47311"	"GSK163929B"	"CNOCAS47311"	725	"NVS_NR_mERa"	517135	2710335	2699612	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006203"	47311	"NOCAS_47311"	"GSK163929B"	"CNOCAS47311"	725	"NVS_NR_mERa"	517311	2710335	2699612	10	"Noisy data"	NA	NA	"percent_activity"
"TX006203"	47311	"NOCAS_47311"	"GSK163929B"	"CNOCAS47311"	751	"OT_ERa_EREGFP_0480"	116791	565528	568567	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006204"	47322	"200940-23-4"	"SB243213A"	"C200940234"	75	"ATG_ERE_CIS_up"	13203	2094074	1964050	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006204"	47322	"200940-23-4"	"SB243213A"	"C200940234"	75	"ATG_ERE_CIS_up"	13828	2094074	1964050	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006204"	47322	"200940-23-4"	"SB243213A"	"C200940234"	708	"NVS_NR_bER"	516382	2706982	2695942	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006204"	47322	"200940-23-4"	"SB243213A"	"C200940234"	750	"OT_ERa_EREGFP_0120"	115687	572522	566590	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006204"	47322	"200940-23-4"	"SB243213A"	"C200940234"	751	"OT_ERa_EREGFP_0480"	116792	565529	568568	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006204"	47322	"200940-23-4"	"SB243213A"	"C200940234"	751	"OT_ERa_EREGFP_0480"	116914	565529	568568	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006205"	23719	"97322-87-7"	"Troglitazone"	"C97322877"	2	"ACEA_T47D_80hr_Positive"	10641	1778857	1780548	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006205"	23719	"97322-87-7"	"Troglitazone"	"C97322877"	117	"ATG_ERa_TRANS_up"	49633	2170476	2036401	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006205"	23719	"97322-87-7"	"Troglitazone"	"C97322877"	117	"ATG_ERa_TRANS_up"	50194	2170476	2036401	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006207"	47310	"196808-45-4"	"Farglitazar"	"C196808454"	75	"ATG_ERE_CIS_up"	13827	2094071	1964053	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006207"	47310	"196808-45-4"	"Farglitazar"	"C196808454"	714	"NVS_NR_hER"	517784	2709211	2698488	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006207"	47310	"196808-45-4"	"Farglitazar"	"C196808454"	714	"NVS_NR_hER"	517888	2709211	2698488	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006207"	47310	"196808-45-4"	"Farglitazar"	"C196808454"	725	"NVS_NR_mERa"	517312	2710338	2699615	10	"Noisy data"	NA	NA	"percent_activity"
"TX006208"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	2	"ACEA_T47D_80hr_Positive"	10189	1778860	1780545	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006208"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	2	"ACEA_T47D_80hr_Positive"	10474	1778860	1780545	11	"Borderline active"	NA	NA	"percent_activity"
"TX006208"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	2	"ACEA_T47D_80hr_Positive"	10755	1778860	1780545	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006208"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	117	"ATG_ERa_TRANS_up"	49710	2170473	2036398	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006208"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	117	"ATG_ERa_TRANS_up"	49960	2170473	2036398	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006208"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	745	"OT_ER_ERaERb_1440"	115492	557650	536419	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006208"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	750	"OT_ERa_EREGFP_0120"	115688	572526	566594	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006210"	47324	"219790-72-4"	"SB281832"	"C219790724"	750	"OT_ERa_EREGFP_0120"	115689	572528	566596	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006210"	47324	"219790-72-4"	"SB281832"	"C219790724"	751	"OT_ERa_EREGFP_0480"	116793	565535	568574	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006211"	47315	"444610-91-7"	"PharmaGSID_47315"	"C444610917"	75	"ATG_ERE_CIS_up"	13826	2094067	1964057	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006211"	47315	"444610-91-7"	"PharmaGSID_47315"	"C444610917"	708	"NVS_NR_bER"	516326	2706986	2695946	10	"Noisy data"	NA	NA	"percent_activity"
"TX006211"	47315	"444610-91-7"	"PharmaGSID_47315"	"C444610917"	725	"NVS_NR_mERa"	517313	2710340	2699617	10	"Noisy data"	NA	NA	"percent_activity"
"TX006213"	47328	"NOCAS_47328"	"MK-274"	"CNOCAS47328"	75	"ATG_ERE_CIS_up"	13825	2094065	1964059	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006213"	47328	"NOCAS_47328"	"MK-274"	"CNOCAS47328"	725	"NVS_NR_mERa"	517136	2710341	2699618	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006214"	47330	"NOCAS_47330"	"PharmaGSID_47330"	"CNOCAS47330"	725	"NVS_NR_mERa"	517314	2710342	2699619	10	"Noisy data"	NA	NA	"percent_activity"
"TX006214"	47330	"NOCAS_47330"	"PharmaGSID_47330"	"CNOCAS47330"	742	"OT_ER_ERaERa_0480"	115028	555685	564626	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006216"	47338	"262376-75-0"	"HMR1426"	"C262376750"	117	"ATG_ERa_TRANS_up"	49709	2170465	2036390	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006216"	47338	"262376-75-0"	"HMR1426"	"C262376750"	117	"ATG_ERa_TRANS_up"	49959	2170465	2036390	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006217"	47339	"181640-09-5"	"SR144190"	"C181640095"	75	"ATG_ERE_CIS_up"	13307	2094061	1964063	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006217"	47339	"181640-09-5"	"SR144190"	"C181640095"	75	"ATG_ERE_CIS_up"	13582	2094061	1964063	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006218"	47341	"264618-44-2"	"SSR146977"	"C264618442"	725	"NVS_NR_mERa"	517654	2710344	2699621	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006218"	47341	"264618-44-2"	"SSR146977"	"C264618442"	745	"OT_ER_ERaERb_1440"	115363	557660	536429	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006218"	47341	"264618-44-2"	"SSR146977"	"C264618442"	747	"OT_ER_ERbERb_1440"	114871	559628	560691	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006219"	47342	"NOCAS_47342"	"SR125047"	"CNOCAS47342"	725	"NVS_NR_mERa"	517137	2710345	2699622	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006219"	47342	"NOCAS_47342"	"SR125047"	"CNOCAS47342"	750	"OT_ERa_EREGFP_0120"	115690	572537	566605	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006220"	47344	"159138-81-5"	"Cariporide mesylate"	"C159138815"	2	"ACEA_T47D_80hr_Positive"	10642	1778872	1780533	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006222"	47347	"155990-20-8"	"SR271425"	"C155990208"	725	"NVS_NR_mERa"	517566	2710347	2699624	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006222"	47347	"155990-20-8"	"SR271425"	"C155990208"	725	"NVS_NR_mERa"	517655	2710347	2699624	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006223"	47348	"742693-38-5"	"SSR504734"	"C742693385"	75	"ATG_ERE_CIS_up"	13824	2094055	1964069	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006223"	47348	"742693-38-5"	"SSR504734"	"C742693385"	745	"OT_ER_ERaERb_1440"	115493	557665	536434	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006223"	47348	"742693-38-5"	"SSR504734"	"C742693385"	750	"OT_ERa_EREGFP_0120"	115691	572541	566609	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006224"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	75	"ATG_ERE_CIS_up"	13306	2094054	1964070	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006224"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	75	"ATG_ERE_CIS_up"	13581	2094054	1964070	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006224"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	725	"NVS_NR_mERa"	517567	2710348	2699625	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006224"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	725	"NVS_NR_mERa"	517656	2710348	2699625	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006225"	47351	"NOCAS_47351"	"SSR240612"	"CNOCAS47351"	117	"ATG_ERa_TRANS_up"	49579	2170456	2036381	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006225"	47351	"NOCAS_47351"	"SSR240612"	"CNOCAS47351"	117	"ATG_ERa_TRANS_up"	50193	2170456	2036381	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006225"	47351	"NOCAS_47351"	"SSR240612"	"CNOCAS47351"	725	"NVS_NR_mERa"	517468	2710349	2699626	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006225"	47351	"NOCAS_47351"	"SSR240612"	"CNOCAS47351"	751	"OT_ERa_EREGFP_0480"	116794	565549	568588	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006226"	47353	"NOCAS_47353"	"SSR241586"	"CNOCAS47353"	714	"NVS_NR_hER"	517717	2709222	2698499	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006226"	47353	"NOCAS_47353"	"SSR241586"	"CNOCAS47353"	714	"NVS_NR_hER"	518018	2709222	2698499	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006226"	47353	"NOCAS_47353"	"SSR241586"	"CNOCAS47353"	725	"NVS_NR_mERa"	517568	2710350	2699627	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006226"	47353	"NOCAS_47353"	"SSR241586"	"CNOCAS47353"	725	"NVS_NR_mERa"	517657	2710350	2699627	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006227"	47355	"189003-92-7"	"Trelanserin"	"C189003927"	2	"ACEA_T47D_80hr_Positive"	10316	1778879	1780526	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006227"	47355	"189003-92-7"	"Trelanserin"	"C189003927"	2	"ACEA_T47D_80hr_Positive"	10643	1778879	1780526	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006227"	47355	"189003-92-7"	"Trelanserin"	"C189003927"	750	"OT_ERa_EREGFP_0120"	115692	572544	566612	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006227"	47355	"189003-92-7"	"Trelanserin"	"C189003927"	750	"OT_ERa_EREGFP_0120"	115857	572544	566612	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006227"	47355	"189003-92-7"	"Trelanserin"	"C189003927"	751	"OT_ERa_EREGFP_0480"	116795	565551	568590	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006228"	47356	"473289-62-2"	"Ilepatril"	"C473289622"	747	"OT_ER_ERbERb_1440"	114802	559637	560700	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006229"	47357	"288104-79-0"	"Surinabant"	"C288104790"	750	"OT_ERa_EREGFP_0120"	115693	572546	566614	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006229"	47357	"288104-79-0"	"Surinabant"	"C288104790"	751	"OT_ERa_EREGFP_0480"	116796	565553	568592	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006230"	47358	"439687-69-1"	"Nelivaptan"	"C439687691"	75	"ATG_ERE_CIS_up"	13385	2094048	1964076	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006230"	47358	"439687-69-1"	"Nelivaptan"	"C439687691"	75	"ATG_ERE_CIS_up"	13823	2094048	1964076	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006230"	47358	"439687-69-1"	"Nelivaptan"	"C439687691"	714	"NVS_NR_hER"	517785	2709224	2698501	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006230"	47358	"439687-69-1"	"Nelivaptan"	"C439687691"	725	"NVS_NR_mERa"	517315	2710352	2699629	10	"Noisy data"	NA	NA	"percent_activity"
"TX006231"	47359	"298198-52-4"	"SSR180711"	"C298198524"	750	"OT_ERa_EREGFP_0120"	115694	572548	566616	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006232"	47360	"929601-09-2"	"SR58611"	"C929601092"	75	"ATG_ERE_CIS_up"	13580	2094046	1964078	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006232"	47360	"929601-09-2"	"SR58611"	"C929601092"	117	"ATG_ERa_TRANS_up"	49578	2170449	2036374	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006232"	47360	"929601-09-2"	"SR58611"	"C929601092"	117	"ATG_ERa_TRANS_up"	50192	2170449	2036374	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006233"	47362	"NOCAS_47362"	"SSR150106"	"CNOCAS47362"	75	"ATG_ERE_CIS_up"	13164	2094045	1964079	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006233"	47362	"NOCAS_47362"	"SSR150106"	"CNOCAS47362"	725	"NVS_NR_mERa"	517391	2710353	2699630	11	"Borderline active"	NA	NA	"percent_activity"
"TX006233"	47362	"NOCAS_47362"	"SSR150106"	"CNOCAS47362"	725	"NVS_NR_mERa"	517658	2710353	2699630	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006233"	47362	"NOCAS_47362"	"SSR150106"	"CNOCAS47362"	750	"OT_ERa_EREGFP_0120"	115695	572550	566618	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006234"	47363	"139290-65-6"	"Volinanserin"	"C139290656"	745	"OT_ER_ERaERb_1440"	115494	557675	536444	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006234"	47363	"139290-65-6"	"Volinanserin"	"C139290656"	750	"OT_ERa_EREGFP_0120"	115696	572551	566619	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006234"	47363	"139290-65-6"	"Volinanserin"	"C139290656"	751	"OT_ERa_EREGFP_0480"	116797	565558	568597	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006236"	47366	"NOCAS_47366"	"SAR115740"	"CNOCAS47366"	75	"ATG_ERE_CIS_up"	13579	2094042	1964082	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006236"	47366	"NOCAS_47366"	"SAR115740"	"CNOCAS47366"	751	"OT_ERa_EREGFP_0480"	116798	565560	568599	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006238"	47368	"344930-95-6"	"SSR69071"	"C344930956"	75	"ATG_ERE_CIS_up"	13305	2094040	1964084	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006238"	47368	"344930-95-6"	"SSR69071"	"C344930956"	75	"ATG_ERE_CIS_up"	13578	2094040	1964084	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006238"	47368	"344930-95-6"	"SSR69071"	"C344930956"	117	"ATG_ERa_TRANS_up"	49577	2170443	2036368	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006239"	47369	"221671-62-1"	"SR146131"	"C221671621"	2	"ACEA_T47D_80hr_Positive"	10727	1778891	1780514	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX006239"	47369	"221671-62-1"	"SR146131"	"C221671621"	75	"ATG_ERE_CIS_up"	13577	2094039	1964085	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006239"	47369	"221671-62-1"	"SR146131"	"C221671621"	708	"NVS_NR_bER"	516383	2706999	2695959	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006239"	47369	"221671-62-1"	"SR146131"	"C221671621"	725	"NVS_NR_mERa"	517316	2710357	2699634	10	"Noisy data"	NA	NA	"percent_activity"
"TX006240"	47371	"725228-45-5"	"AVE5638"	"C725228455"	75	"ATG_ERE_CIS_up"	13822	2094038	1964086	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006240"	47371	"725228-45-5"	"AVE5638"	"C725228455"	725	"NVS_NR_mERa"	517138	2710358	2699635	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006240"	47371	"725228-45-5"	"AVE5638"	"C725228455"	725	"NVS_NR_mERa"	517317	2710358	2699635	10	"Noisy data"	NA	NA	"percent_activity"
"TX006240"	47371	"725228-45-5"	"AVE5638"	"C725228455"	745	"OT_ER_ERaERb_1440"	115364	557680	536449	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006240"	47371	"725228-45-5"	"AVE5638"	"C725228455"	747	"OT_ER_ERbERb_1440"	114872	559648	560711	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006240"	47371	"725228-45-5"	"AVE5638"	"C725228455"	750	"OT_ERa_EREGFP_0120"	115697	572556	566624	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006241"	47372	"478263-98-8"	"AVE3295"	"C478263988"	75	"ATG_ERE_CIS_up"	13576	2094037	1964087	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006244"	47376	"648917-13-9"	"AVE2865"	"C648917139"	2	"ACEA_T47D_80hr_Positive"	10644	1778896	1780510	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006244"	47376	"648917-13-9"	"AVE2865"	"C648917139"	75	"ATG_ERE_CIS_up"	13304	2094034	1964090	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006244"	47376	"648917-13-9"	"AVE2865"	"C648917139"	75	"ATG_ERE_CIS_up"	13575	2094034	1964090	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006245"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	117	"ATG_ERa_TRANS_up"	49576	2170436	2036361	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006245"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	117	"ATG_ERa_TRANS_up"	50191	2170436	2036361	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006245"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	714	"NVS_NR_hER"	517786	2709233	2698510	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006245"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	714	"NVS_NR_hER"	517889	2709233	2698510	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006245"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	725	"NVS_NR_mERa"	517139	2710360	2699637	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006245"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	725	"NVS_NR_mERa"	517318	2710360	2699637	10	"Noisy data"	NA	NA	"percent_activity"
"TX006245"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	750	"OT_ERa_EREGFP_0120"	115698	572561	566629	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006246"	47379	"NOCAS_47379"	"SSR126768"	"CNOCAS47379"	75	"ATG_ERE_CIS_up"	13574	2094032	1964092	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006246"	47379	"NOCAS_47379"	"SSR126768"	"CNOCAS47379"	714	"NVS_NR_hER"	518019	2709234	2698511	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006246"	47379	"NOCAS_47379"	"SSR126768"	"CNOCAS47379"	725	"NVS_NR_mERa"	517319	2710361	2699638	10	"Noisy data"	NA	NA	"percent_activity"
"TX006247"	47381	"NOCAS_47381"	"AVE8923"	"CNOCAS47381"	117	"ATG_ERa_TRANS_up"	49958	2170434	2036359	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006247"	47381	"NOCAS_47381"	"AVE8923"	"CNOCAS47381"	725	"NVS_NR_mERa"	517392	2710362	2699639	11	"Borderline active"	NA	NA	"percent_activity"
"TX006247"	47381	"NOCAS_47381"	"AVE8923"	"CNOCAS47381"	725	"NVS_NR_mERa"	517569	2710362	2699639	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006247"	47381	"NOCAS_47381"	"AVE8923"	"CNOCAS47381"	725	"NVS_NR_mERa"	517659	2710362	2699639	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006249"	47385	"NOCAS_47385"	"SAR377142"	"CNOCAS47385"	75	"ATG_ERE_CIS_up"	13303	2094029	1964095	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006249"	47385	"NOCAS_47385"	"SAR377142"	"CNOCAS47385"	117	"ATG_ERa_TRANS_up"	49957	2170432	2036357	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006249"	47385	"NOCAS_47385"	"SAR377142"	"CNOCAS47385"	744	"OT_ER_ERaERb_0480"	112937	2401438	2399691	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006249"	47385	"NOCAS_47385"	"SAR377142"	"CNOCAS47385"	750	"OT_ERa_EREGFP_0120"	115699	572564	566632	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006250"	47387	"NOCAS_47387"	"SAR102779"	"CNOCAS47387"	75	"ATG_ERE_CIS_up"	13384	2094028	1964096	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006250"	47387	"NOCAS_47387"	"SAR102779"	"CNOCAS47387"	75	"ATG_ERE_CIS_up"	13821	2094028	1964096	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006250"	47387	"NOCAS_47387"	"SAR102779"	"CNOCAS47387"	725	"NVS_NR_mERa"	517140	2710363	2699640	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006250"	47387	"NOCAS_47387"	"SAR102779"	"CNOCAS47387"	725	"NVS_NR_mERa"	517469	2710363	2699640	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006251"	47389	"NOCAS_47389"	"SAR150640"	"CNOCAS47389"	2	"ACEA_T47D_80hr_Positive"	10645	1778903	1780502	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006251"	47389	"NOCAS_47389"	"SAR150640"	"CNOCAS47389"	750	"OT_ERa_EREGFP_0120"	115544	572566	566634	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006252"	47391	"1068967-96-3"	"SAR102608"	"C1068967963"	750	"OT_ERa_EREGFP_0120"	115700	572567	566635	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006252"	47391	"1068967-96-3"	"SAR102608"	"C1068967963"	750	"OT_ERa_EREGFP_0120"	115858	572567	566635	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006252"	47391	"1068967-96-3"	"SAR102608"	"C1068967963"	751	"OT_ERa_EREGFP_0480"	116915	565574	568613	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006253"	47333	"NOCAS_47333"	"PharmaGSID_47333"	"CNOCAS47333"	75	"ATG_ERE_CIS_up"	13302	2094025	1964099	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006253"	47333	"NOCAS_47333"	"PharmaGSID_47333"	"CNOCAS47333"	75	"ATG_ERE_CIS_up"	13573	2094025	1964099	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006254"	47334	"NOCAS_47334"	"MK-968"	"CNOCAS47334"	2	"ACEA_T47D_80hr_Positive"	10756	1778906	1780499	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006255"	47335	"851916-42-2"	"MK-812"	"C851916422"	75	"ATG_ERE_CIS_up"	13572	2094023	1964101	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006255"	47335	"851916-42-2"	"MK-812"	"C851916422"	750	"OT_ERa_EREGFP_0120"	115701	572570	566638	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006256"	47337	"1061517-62-1"	"PharmaGSID_47337"	"C1061517621"	75	"ATG_ERE_CIS_up"	13301	2094022	1964102	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006256"	47337	"1061517-62-1"	"PharmaGSID_47337"	"C1061517621"	725	"NVS_NR_mERa"	517320	2710365	2699642	10	"Noisy data"	NA	NA	"percent_activity"
"TX006293"	37208	"15307-79-6"	"Diclofenac sodium"	"C15307796"	2	"ACEA_T47D_80hr_Positive"	10190	1778909	1780496	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006293"	37208	"15307-79-6"	"Diclofenac sodium"	"C15307796"	725	"NVS_NR_mERa"	517141	2710366	2699643	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006293"	37208	"15307-79-6"	"Diclofenac sodium"	"C15307796"	725	"NVS_NR_mERa"	517470	2710366	2699643	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006295"	20740	"53-86-1"	"Indomethacin"	"C53861"	2	"ACEA_T47D_80hr_Positive"	10646	1778910	1780495	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006295"	20740	"53-86-1"	"Indomethacin"	"C53861"	75	"ATG_ERE_CIS_up"	13571	2094020	1964104	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006295"	20740	"53-86-1"	"Indomethacin"	"C53861"	725	"NVS_NR_mERa"	517471	2710367	2699644	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006299"	29879	"65277-42-1"	"Ketoconazole"	"C65277421"	2	"ACEA_T47D_80hr_Positive"	10728	1778911	1780494	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX006299"	29879	"65277-42-1"	"Ketoconazole"	"C65277421"	725	"NVS_NR_mERa"	517006	2710368	2699645	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006299"	29879	"65277-42-1"	"Ketoconazole"	"C65277421"	725	"NVS_NR_mERa"	517393	2710368	2699645	11	"Borderline active"	NA	NA	"percent_activity"
"TX006299"	29879	"65277-42-1"	"Ketoconazole"	"C65277421"	725	"NVS_NR_mERa"	517570	2710368	2699645	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006299"	29879	"65277-42-1"	"Ketoconazole"	"C65277421"	725	"NVS_NR_mERa"	517660	2710368	2699645	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006299"	29879	"65277-42-1"	"Ketoconazole"	"C65277421"	750	"OT_ERa_EREGFP_0120"	115545	572574	566642	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006301"	20784	"75330-75-5"	"Lovastatin"	"C75330755"	750	"OT_ERa_EREGFP_0120"	115702	572575	566643	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006303"	20822	"59-05-2"	"Methotrexate"	"C59052"	714	"NVS_NR_hER"	517822	2709244	2698521	10	"Noisy data"	NA	NA	"percent_activity"
"TX006463"	21123	"57-30-7"	"Phenobarbital sodium"	"C57307"	742	"OT_ER_ERaERa_0480"	115058	555730	564671	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX006463"	21123	"57-30-7"	"Phenobarbital sodium"	"C57307"	750	"OT_ERa_EREGFP_0120"	115703	572578	566646	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006463"	21123	"57-30-7"	"Phenobarbital sodium"	"C57307"	751	"OT_ERa_EREGFP_0480"	116799	565585	568624	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006533"	32647	"21564-17-0"	"2-(Thiocyanomethylthio)benzothiazole"	"C21564170"	750	"OT_ERa_EREGFP_0120"	115859	572580	566648	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006535"	34742	"NOCAS_34742"	"Milbemectin (mixture of 70% Milbemcin A4, 30% Milbemycin A3)"	"CNOCAS34742"	2	"ACEA_T47D_80hr_Positive"	10757	1778919	1780487	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006550"	21199	"1114-71-2"	"Pebulate"	"C1114712"	117	"ATG_ERa_TRANS_up"	49574	2170411	2036336	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006550"	21199	"1114-71-2"	"Pebulate"	"C1114712"	117	"ATG_ERa_TRANS_up"	49802	2170411	2036336	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006550"	21199	"1114-71-2"	"Pebulate"	"C1114712"	117	"ATG_ERa_TRANS_up"	50189	2170411	2036336	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006550"	21199	"1114-71-2"	"Pebulate"	"C1114712"	708	"NVS_NR_bER"	516327	2707012	2695972	10	"Noisy data"	NA	NA	"percent_activity"
"TX006550"	21199	"1114-71-2"	"Pebulate"	"C1114712"	725	"NVS_NR_mERa"	517142	2710370	2699647	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006550"	21199	"1114-71-2"	"Pebulate"	"C1114712"	725	"NVS_NR_mERa"	517472	2710370	2699647	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006552"	32579	"64700-56-7"	"Triclopyr-butotyl"	"C64700567"	2	"ACEA_T47D_80hr_Positive"	10317	1778922	1780484	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006552"	32579	"64700-56-7"	"Triclopyr-butotyl"	"C64700567"	2	"ACEA_T47D_80hr_Positive"	10647	1778922	1780484	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006552"	32579	"64700-56-7"	"Triclopyr-butotyl"	"C64700567"	75	"ATG_ERE_CIS_up"	13820	2094007	1964117	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006552"	32579	"64700-56-7"	"Triclopyr-butotyl"	"C64700567"	117	"ATG_ERa_TRANS_up"	49707	2170410	2036335	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006552"	32579	"64700-56-7"	"Triclopyr-butotyl"	"C64700567"	117	"ATG_ERa_TRANS_up"	49956	2170410	2036335	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006560"	23950	"55285-14-8"	"Carbosulfan"	"C55285148"	725	"NVS_NR_mERa"	517571	2710373	2699650	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006560"	23950	"55285-14-8"	"Carbosulfan"	"C55285148"	725	"NVS_NR_mERa"	517661	2710373	2699650	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006560"	23950	"55285-14-8"	"Carbosulfan"	"C55285148"	751	"OT_ERa_EREGFP_0480"	116800	565593	568632	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006577"	24124	"79277-27-3"	"Thifensulfuron-methyl"	"C79277273"	747	"OT_ER_ERbERb_1440"	114803	559677	560740	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006577"	24124	"79277-27-3"	"Thifensulfuron-methyl"	"C79277273"	747	"OT_ER_ERbERb_1440"	114873	559677	560740	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006588"	27390	"1333-39-7"	"Phenolsulfonic acid"	"C1333397"	2	"ACEA_T47D_80hr_Positive"	10318	1778925	1780480	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006588"	27390	"1333-39-7"	"Phenolsulfonic acid"	"C1333397"	2	"ACEA_T47D_80hr_Positive"	10648	1778925	1780480	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006588"	27390	"1333-39-7"	"Phenolsulfonic acid"	"C1333397"	708	"NVS_NR_bER"	516328	2707021	2695981	10	"Noisy data"	NA	NA	"percent_activity"
"TX006588"	27390	"1333-39-7"	"Phenolsulfonic acid"	"C1333397"	725	"NVS_NR_mERa"	517145	2710379	2699656	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006588"	27390	"1333-39-7"	"Phenolsulfonic acid"	"C1333397"	725	"NVS_NR_mERa"	517473	2710379	2699656	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006590"	24051	"1445-75-6"	"Diisopropyl methylphosphonate"	"C1445756"	2	"ACEA_T47D_80hr_Positive"	10649	1778926	1780479	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006600"	29302	"10042-59-8"	"2-Propyl-1-heptanol"	"C10042598"	2	"ACEA_T47D_80hr_Positive"	10319	1778927	1780478	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	75	"ATG_ERE_CIS_up"	13163	2093998	1964126	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	75	"ATG_ERE_CIS_up"	13383	2093998	1964126	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	708	"NVS_NR_bER"	516205	2707023	2695983	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	708	"NVS_NR_bER"	516497	2707023	2695983	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	714	"NVS_NR_hER"	517718	2709256	2698533	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	714	"NVS_NR_hER"	517948	2709256	2698533	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	714	"NVS_NR_hER"	518020	2709256	2698533	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	751	"OT_ERa_EREGFP_0480"	116801	565598	568637	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006606"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	751	"OT_ERa_EREGFP_0480"	116916	565598	568637	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006616"	21006	"684-93-5"	"N-Nitroso-N-methylurea"	"C684935"	2	"ACEA_T47D_80hr_Positive"	10475	1778930	1780475	11	"Borderline active"	NA	NA	"percent_activity"
"TX006622"	27364	"1118-92-9"	"N,N-Dimethyloctanamide"	"C1118929"	2	"ACEA_T47D_80hr_Positive"	10650	1778931	1780474	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006630"	41487	"20780-48-7"	"3,7-Dimethyloctan-3-yl acetate"	"C20780487"	2	"ACEA_T47D_80hr_Positive"	10651	1778932	1780473	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006644"	34150	"52-86-8"	"Haloperidol"	"C52868"	743	"OT_ER_ERaERa_1440"	114495	551535	562718	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006644"	34150	"52-86-8"	"Haloperidol"	"C52868"	745	"OT_ER_ERaERb_1440"	115365	557719	536488	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006644"	34150	"52-86-8"	"Haloperidol"	"C52868"	747	"OT_ER_ERbERb_1440"	114804	559687	560750	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006644"	34150	"52-86-8"	"Haloperidol"	"C52868"	747	"OT_ER_ERbERb_1440"	114874	559687	560750	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006662"	34576	"2491-38-5"	"2-Bromo-4-hydroxyacetophenone"	"C2491385"	725	"NVS_NR_mERa"	517574	2710387	2699664	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006662"	34576	"2491-38-5"	"2-Bromo-4-hydroxyacetophenone"	"C2491385"	725	"NVS_NR_mERa"	517664	2710387	2699664	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006662"	34576	"2491-38-5"	"2-Bromo-4-hydroxyacetophenone"	"C2491385"	745	"OT_ER_ERaERb_1440"	115366	557721	536490	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006662"	34576	"2491-38-5"	"2-Bromo-4-hydroxyacetophenone"	"C2491385"	747	"OT_ER_ERbERb_1440"	114805	559689	560752	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006666"	23216	"6893-02-3"	"3,5,3'-Triiodothyronine"	"C6893023"	744	"OT_ER_ERaERb_0480"	112835	2401403	2399731	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006666"	23216	"6893-02-3"	"3,5,3'-Triiodothyronine"	"C6893023"	744	"OT_ER_ERaERb_0480"	112899	2401403	2399731	11	"Borderline active"	NA	NA	"percent_activity"
"TX006672"	35748	"51229-78-8"	"Chloroallyl methenamine chloride"	"C51229788"	745	"OT_ER_ERaERb_1440"	115367	557723	536492	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006694"	41200	"94-91-7"	"N,N'-Disalicylidene-1,2-diaminopropane"	"C94917"	117	"ATG_ERa_TRANS_up"	49954	2170384	2036309	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006698"	24944	"35691-65-7"	"1,2-Dibromo-2,4-dicyanobutane"	"C35691657"	751	"OT_ERa_EREGFP_0480"	116802	565613	568652	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006698"	24944	"35691-65-7"	"1,2-Dibromo-2,4-dicyanobutane"	"C35691657"	751	"OT_ERa_EREGFP_0480"	116917	565613	568652	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006742"	42007	"1323-38-2"	"Glyceryl monoricinoleate"	"C1323382"	2	"ACEA_T47D_80hr_Positive"	10652	1778945	1780460	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006742"	42007	"1323-38-2"	"Glyceryl monoricinoleate"	"C1323382"	75	"ATG_ERE_CIS_up"	13382	2093975	1964149	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006742"	42007	"1323-38-2"	"Glyceryl monoricinoleate"	"C1323382"	117	"ATG_ERa_TRANS_up"	49706	2170378	2036303	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006742"	42007	"1323-38-2"	"Glyceryl monoricinoleate"	"C1323382"	117	"ATG_ERa_TRANS_up"	49953	2170378	2036303	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006742"	42007	"1323-38-2"	"Glyceryl monoricinoleate"	"C1323382"	743	"OT_ER_ERaERa_1440"	114395	551546	562729	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006745"	41691	"35256-85-0"	"Butam"	"C35256850"	725	"NVS_NR_mERa"	517147	2710392	2699669	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006745"	41691	"35256-85-0"	"Butam"	"C35256850"	744	"OT_ER_ERaERb_0480"	112834	2401394	2399738	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006754"	32516	"3547-33-9"	"2-Hydroxyethyl octyl sulfide"	"C3547339"	117	"ATG_ERa_TRANS_up"	49952	2170376	2036301	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006756"	27320	"824-78-2"	"Sodium 4-nitrophenolate"	"C824782"	725	"NVS_NR_mERa"	517148	2710393	2699670	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006762"	42169	"5116-94-9"	"Monotridecyl phosphate"	"C5116949"	708	"NVS_NR_bER"	516443	2707036	2695996	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006762"	42169	"5116-94-9"	"Monotridecyl phosphate"	"C5116949"	708	"NVS_NR_bER"	516500	2707036	2695996	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006762"	42169	"5116-94-9"	"Monotridecyl phosphate"	"C5116949"	725	"NVS_NR_mERa"	517007	2710394	2699671	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006792"	24553	"123-77-3"	"Azodicarbonamide"	"C123773"	747	"OT_ER_ERbERb_1440"	114806	559704	560767	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006822"	23875	"7773-06-0"	"Ammonium sulfamate"	"C7773060"	2	"ACEA_T47D_80hr_Positive"	10320	1778954	1780451	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006822"	23875	"7773-06-0"	"Ammonium sulfamate"	"C7773060"	2	"ACEA_T47D_80hr_Positive"	10653	1778954	1780451	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006834"	21272	"7758-19-2"	"Sodium chlorite"	"C7758192"	708	"NVS_NR_bER"	516230	2707039	2695999	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX006834"	21272	"7758-19-2"	"Sodium chlorite"	"C7758192"	708	"NVS_NR_bER"	516346	2707039	2695999	11	"Borderline active"	NA	NA	"percent_activity"
"TX006834"	21272	"7758-19-2"	"Sodium chlorite"	"C7758192"	708	"NVS_NR_bER"	516444	2707039	2695999	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006834"	21272	"7758-19-2"	"Sodium chlorite"	"C7758192"	708	"NVS_NR_bER"	516501	2707039	2695999	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006838"	24104	"206-44-0"	"Fluoranthene"	"C206440"	744	"OT_ER_ERaERb_0480"	112833	2401383	2399761	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006840"	29692	"7757-79-1"	"Potassium nitrate"	"C7757791"	2	"ACEA_T47D_80hr_Positive"	10321	1778957	1780448	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006849"	26214	"101-20-2"	"Triclocarban"	"C101202"	725	"NVS_NR_mERa"	517149	2710397	2699674	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006849"	26214	"101-20-2"	"Triclocarban"	"C101202"	751	"OT_ERa_EREGFP_0480"	116803	565629	568668	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006851"	47205	"83834-59-7"	"2-Ethylhexyl trans-4-methoxycinnamate"	"C83834597"	75	"ATG_ERE_CIS_up"	13298	2093959	1964165	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006851"	47205	"83834-59-7"	"2-Ethylhexyl trans-4-methoxycinnamate"	"C83834597"	75	"ATG_ERE_CIS_up"	13569	2093959	1964165	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006851"	47205	"83834-59-7"	"2-Ethylhexyl trans-4-methoxycinnamate"	"C83834597"	117	"ATG_ERa_TRANS_up"	49951	2170362	2036287	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006851"	47205	"83834-59-7"	"2-Ethylhexyl trans-4-methoxycinnamate"	"C83834597"	745	"OT_ER_ERaERb_1440"	115495	557745	536514	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006863"	21301	"54965-24-1"	"Tamoxifen citrate"	"C54965241"	2	"ACEA_T47D_80hr_Positive"	10322	1778961	1780444	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006863"	21301	"54965-24-1"	"Tamoxifen citrate"	"C54965241"	2	"ACEA_T47D_80hr_Positive"	10654	1778961	1780444	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006863"	21301	"54965-24-1"	"Tamoxifen citrate"	"C54965241"	744	"OT_ER_ERaERb_0480"	112894	2401378	2399756	10	"Noisy data"	NA	NA	"percent_activity"
"TX006863"	21301	"54965-24-1"	"Tamoxifen citrate"	"C54965241"	745	"OT_ER_ERaERb_1440"	115441	557747	536516	10	"Noisy data"	NA	NA	"percent_activity"
"TX006871"	27222	"586-62-9"	"Terpinolene"	"C586629"	744	"OT_ER_ERaERb_0480"	112936	2401375	2399753	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006873"	47127	"16587-71-6"	"4-(tert-Pentyl)-cyclohexanone"	"C16587716"	750	"OT_ERa_EREGFP_0120"	115860	572629	566697	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006883"	25506	"463-40-1"	"Linolenic acid"	"C463401"	75	"ATG_ERE_CIS_up"	13568	2093950	1964174	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006883"	25506	"463-40-1"	"Linolenic acid"	"C463401"	714	"NVS_NR_hER"	517719	2709283	2698560	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006883"	25506	"463-40-1"	"Linolenic acid"	"C463401"	714	"NVS_NR_hER"	517949	2709283	2698560	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006883"	25506	"463-40-1"	"Linolenic acid"	"C463401"	714	"NVS_NR_hER"	518023	2709283	2698560	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX006883"	25506	"463-40-1"	"Linolenic acid"	"C463401"	725	"NVS_NR_mERa"	517477	2710405	2699682	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006883"	25506	"463-40-1"	"Linolenic acid"	"C463401"	747	"OT_ER_ERbERb_1440"	114901	559720	560783	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX006883"	25506	"463-40-1"	"Linolenic acid"	"C463401"	750	"OT_ERa_EREGFP_0120"	115820	572630	566698	11	"Borderline active"	NA	NA	"percent_activity"
"TX006885"	20970	"1836-75-5"	"Nitrofen"	"C1836755"	75	"ATG_ERE_CIS_up"	13202	2093949	1964175	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006885"	20970	"1836-75-5"	"Nitrofen"	"C1836755"	75	"ATG_ERE_CIS_up"	13817	2093949	1964175	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006885"	20970	"1836-75-5"	"Nitrofen"	"C1836755"	117	"ATG_ERa_TRANS_up"	49801	2170352	2036277	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX006885"	20970	"1836-75-5"	"Nitrofen"	"C1836755"	751	"OT_ERa_EREGFP_0480"	116804	565638	568677	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006891"	21957	"118-55-8"	"Phenyl salicylate"	"C118558"	744	"OT_ER_ERaERb_0480"	112832	2401370	2399763	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006891"	21957	"118-55-8"	"Phenyl salicylate"	"C118558"	746	"OT_ER_ERbERb_0480"	116570	549601	558816	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006899"	20336	"637-07-0"	"Clofibrate"	"C637070"	75	"ATG_ERE_CIS_up"	13297	2093943	1964181	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006899"	20336	"637-07-0"	"Clofibrate"	"C637070"	75	"ATG_ERE_CIS_up"	13567	2093943	1964181	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006899"	20336	"637-07-0"	"Clofibrate"	"C637070"	744	"OT_ER_ERaERb_0480"	112877	2401369	2399769	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006899"	20336	"637-07-0"	"Clofibrate"	"C637070"	744	"OT_ER_ERaERb_0480"	112935	2401369	2399769	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006909"	27633	"6683-19-8"	"Irganox 1010"	"C6683198"	725	"NVS_NR_mERa"	517152	2710408	2699685	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006913"	24059	"119-93-7"	"3,3'-Dimethylbenzidine"	"C119937"	744	"OT_ER_ERaERb_0480"	112831	2401367	2399767	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006913"	24059	"119-93-7"	"3,3'-Dimethylbenzidine"	"C119937"	746	"OT_ER_ERbERb_0480"	116571	549604	558819	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006913"	24059	"119-93-7"	"3,3'-Dimethylbenzidine"	"C119937"	751	"OT_ERa_EREGFP_0480"	116896	565643	568682	11	"Borderline active"	NA	NA	"percent_activity"
"TX006925"	20894	"90-94-8"	"Michler's ketone"	"C90948"	725	"NVS_NR_mERa"	517478	2710412	2699689	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006929"	20352	"135-20-6"	"Cupferron"	"C135206"	2	"ACEA_T47D_80hr_Positive"	10476	1778974	1780431	11	"Borderline active"	NA	NA	"percent_activity"
"TX006929"	20352	"135-20-6"	"Cupferron"	"C135206"	747	"OT_ER_ERbERb_1440"	114807	559728	560791	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006939"	21209	"51-52-5"	"6-Propyl-2-thiouracil"	"C51525"	725	"NVS_NR_mERa"	517479	2710413	2699690	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006953"	27441	"1843-05-6"	"Octabenzone"	"C1843056"	750	"OT_ERa_EREGFP_0120"	115704	572643	566711	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006963"	27195	"544-76-3"	"Hexadecane"	"C544763"	75	"ATG_ERE_CIS_up"	13296	2093923	1964201	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX006963"	27195	"544-76-3"	"Hexadecane"	"C544763"	75	"ATG_ERE_CIS_up"	13565	2093923	1964201	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006965"	27774	"15708-41-5"	"Ethylenediaminetetraacetic acid ferric sodium salt"	"C15708415"	2	"ACEA_T47D_80hr_Positive"	10323	1778982	1780423	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006965"	27774	"15708-41-5"	"Ethylenediaminetetraacetic acid ferric sodium salt"	"C15708415"	2	"ACEA_T47D_80hr_Positive"	10655	1778982	1780423	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006965"	27774	"15708-41-5"	"Ethylenediaminetetraacetic acid ferric sodium salt"	"C15708415"	714	"NVS_NR_hER"	517890	2709294	2698571	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006973"	26529	"88-60-8"	"2-tert-Butyl-5-methylphenol"	"C88608"	75	"ATG_ERE_CIS_up"	13816	2093920	1964204	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX006973"	26529	"88-60-8"	"2-tert-Butyl-5-methylphenol"	"C88608"	742	"OT_ER_ERaERa_0480"	114950	555800	564741	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX006973"	26529	"88-60-8"	"2-tert-Butyl-5-methylphenol"	"C88608"	742	"OT_ER_ERaERa_0480"	115029	555800	564741	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006981"	24869	"80-15-9"	"Cumene hydroperoxide"	"C80159"	117	"ATG_ERa_TRANS_up"	49573	2170321	2036246	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX006981"	24869	"80-15-9"	"Cumene hydroperoxide"	"C80159"	751	"OT_ERa_EREGFP_0480"	116918	565656	568695	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX006984"	32113	"107534-96-3"	"Tebuconazole"	"C107534963"	117	"ATG_ERa_TRANS_up"	49949	2170320	2036245	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX006990"	24891	"69-74-9"	"Cytarabine hydrochloride"	"C69749"	714	"NVS_NR_hER"	517720	2709297	2698574	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX006990"	24891	"69-74-9"	"Cytarabine hydrochloride"	"C69749"	714	"NVS_NR_hER"	518024	2709297	2698574	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007109"	24049	"35367-38-5"	"Diflubenzuron"	"C35367385"	117	"ATG_ERa_TRANS_up"	49948	2170308	2036233	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007125"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	2	"ACEA_T47D_80hr_Positive"	10324	1778995	1780410	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007125"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	2	"ACEA_T47D_80hr_Positive"	10398	1778995	1780410	10	"Noisy data"	NA	NA	"percent_activity"
"TX007125"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	725	"NVS_NR_mERa"	517576	2710434	2699711	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007125"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	725	"NVS_NR_mERa"	517668	2710434	2699711	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007125"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	742	"OT_ER_ERaERa_0480"	114909	555811	564752	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007125"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	747	"OT_ER_ERbERb_1440"	114808	559749	560812	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007125"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	747	"OT_ER_ERbERb_1440"	114875	559749	560812	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007155"	21928	"111-15-9"	"2-Ethoxyethyl acetate"	"C111159"	117	"ATG_ERa_TRANS_up"	49705	2170301	2036226	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007155"	21928	"111-15-9"	"2-Ethoxyethyl acetate"	"C111159"	725	"NVS_NR_mERa"	517158	2710435	2699712	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007155"	21928	"111-15-9"	"2-Ethoxyethyl acetate"	"C111159"	725	"NVS_NR_mERa"	517482	2710435	2699712	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007161"	24031	"156-60-5"	"(E)-1,2-Dichloroethylene"	"C156605"	725	"NVS_NR_mERa"	517159	2710436	2699713	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007163"	34357	"103055-07-8"	"Lufenuron"	"C103055078"	75	"ATG_ERE_CIS_up"	13380	2093895	1964229	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX007163"	34357	"103055-07-8"	"Lufenuron"	"C103055078"	117	"ATG_ERa_TRANS_up"	49704	2170298	2036223	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007163"	34357	"103055-07-8"	"Lufenuron"	"C103055078"	117	"ATG_ERa_TRANS_up"	49947	2170298	2036223	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007178"	20372	"53-19-0"	"o,p'-DDD"	"C53190"	714	"NVS_NR_hER"	517951	2709317	2698594	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007178"	20372	"53-19-0"	"o,p'-DDD"	"C53190"	714	"NVS_NR_hER"	518027	2709317	2698594	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007178"	20372	"53-19-0"	"o,p'-DDD"	"C53190"	725	"NVS_NR_mERa"	517009	2710438	2699715	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	2	"ACEA_T47D_80hr_Positive"	10325	1779002	1780403	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	743	"OT_ER_ERaERa_1440"	114396	551604	562787	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	743	"OT_ER_ERaERa_1440"	114453	551604	562787	10	"Noisy data"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	743	"OT_ER_ERaERa_1440"	114497	551604	562787	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	745	"OT_ER_ERaERb_1440"	115410	557788	536557	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	746	"OT_ER_ERbERb_0480"	116606	549634	558849	10	"Noisy data"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	750	"OT_ERa_EREGFP_0120"	115546	572666	566734	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007180"	34005	"5329-14-6"	"Sulfamic acid"	"C5329146"	750	"OT_ERa_EREGFP_0120"	115797	572666	566734	10	"Noisy data"	NA	NA	"percent_activity"
"TX007182"	20811	"7487-94-7"	"Mercuric chloride"	"C7487947"	725	"NVS_NR_mERa"	517332	2710439	2699716	10	"Noisy data"	NA	NA	"percent_activity"
"TX007190"	20710	"122-66-7"	"1,2-Diphenylhydrazine"	"C122667"	742	"OT_ER_ERaERa_0480"	115059	555820	564761	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX007192"	20529	"121-14-2"	"2,4-Dinitrotoluene"	"C121142"	2	"ACEA_T47D_80hr_Positive"	10656	1779005	1780401	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007192"	20529	"121-14-2"	"2,4-Dinitrotoluene"	"C121142"	750	"OT_ERa_EREGFP_0120"	115705	572669	566737	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007194"	21427	"51-79-6"	"Urethane"	"C51796"	75	"ATG_ERE_CIS_up"	13162	2093887	1964237	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007194"	21427	"51-79-6"	"Urethane"	"C51796"	725	"NVS_NR_mERa"	517160	2710440	2699717	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007196"	20123	"103-33-3"	"Azobenzene"	"C103333"	117	"ATG_ERa_TRANS_up"	49946	2170289	2036214	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007202"	22959	"577-11-7"	"Docusate sodium"	"C577117"	117	"ATG_ERa_TRANS_up"	49945	2170286	2036211	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007202"	22959	"577-11-7"	"Docusate sodium"	"C577117"	714	"NVS_NR_hER"	517892	2709323	2698600	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007206"	21824	"97-23-4"	"Dichlorophen"	"C97234"	117	"ATG_ERa_TRANS_up"	49703	2170285	2036210	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007206"	21824	"97-23-4"	"Dichlorophen"	"C97234"	117	"ATG_ERa_TRANS_up"	49944	2170285	2036210	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007206"	21824	"97-23-4"	"Dichlorophen"	"C97234"	708	"NVS_NR_bER"	516207	2707084	2696044	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007206"	21824	"97-23-4"	"Dichlorophen"	"C97234"	708	"NVS_NR_bER"	516504	2707084	2696044	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007206"	21824	"97-23-4"	"Dichlorophen"	"C97234"	725	"NVS_NR_mERa"	517333	2710443	2699720	10	"Noisy data"	NA	NA	"percent_activity"
"TX007206"	21824	"97-23-4"	"Dichlorophen"	"C97234"	742	"OT_ER_ERaERa_0480"	114910	555826	564767	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007206"	21824	"97-23-4"	"Dichlorophen"	"C97234"	750	"OT_ERa_EREGFP_0120"	115706	572674	566742	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007214"	20453	"60-57-1"	"Dieldrin"	"C60571"	2	"ACEA_T47D_80hr_Positive"	10326	1779012	1780393	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007214"	20453	"60-57-1"	"Dieldrin"	"C60571"	2	"ACEA_T47D_80hr_Positive"	10657	1779012	1780393	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007214"	20453	"60-57-1"	"Dieldrin"	"C60571"	746	"OT_ER_ERbERb_0480"	116615	549644	558859	11	"Borderline active"	NA	NA	"percent_activity"
"TX007216"	20890	"56-04-2"	"6-Methyl-2-thiouracil"	"C56042"	751	"OT_ERa_EREGFP_0480"	116805	565684	568723	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007220"	27496	"2702-72-9"	"2,4-D sodium salt"	"C2702729"	75	"ATG_ERE_CIS_up"	13294	2093878	1964246	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007220"	27496	"2702-72-9"	"2,4-D sodium salt"	"C2702729"	75	"ATG_ERE_CIS_up"	13335	2093878	1964246	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX007220"	27496	"2702-72-9"	"2,4-D sodium salt"	"C2702729"	117	"ATG_ERa_TRANS_up"	49702	2170281	2036206	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007220"	27496	"2702-72-9"	"2,4-D sodium salt"	"C2702729"	117	"ATG_ERa_TRANS_up"	49943	2170281	2036206	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007222"	27522	"3147-75-9"	"Octrizole"	"C3147759"	117	"ATG_ERa_TRANS_up"	50185	2170280	2036205	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007222"	27522	"3147-75-9"	"Octrizole"	"C3147759"	750	"OT_ERa_EREGFP_0120"	115707	572679	566747	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007226"	27527	"3194-55-6"	"1,2,5,6,9,10-Hexabromocyclododecane"	"C3194556"	117	"ATG_ERa_TRANS_up"	49701	2170278	2036203	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007226"	27527	"3194-55-6"	"1,2,5,6,9,10-Hexabromocyclododecane"	"C3194556"	117	"ATG_ERa_TRANS_up"	49942	2170278	2036203	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007226"	27527	"3194-55-6"	"1,2,5,6,9,10-Hexabromocyclododecane"	"C3194556"	751	"OT_ERa_EREGFP_0480"	116806	565687	568726	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007238"	23902	"56-55-3"	"Benz(a)anthracene"	"C56553"	725	"NVS_NR_mERa"	517334	2710446	2699723	10	"Noisy data"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	708	"NVS_NR_bER"	516277	2707088	2696048	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	708	"NVS_NR_bER"	516387	2707088	2696048	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	744	"OT_ER_ERaERb_0480"	112934	2401319	2399814	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	746	"OT_ER_ERbERb_0480"	116594	549652	558867	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	746	"OT_ER_ERbERb_0480"	116656	549652	558867	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	750	"OT_ERa_EREGFP_0120"	115708	572684	566752	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	750	"OT_ERa_EREGFP_0120"	115861	572684	566752	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007242"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	751	"OT_ERa_EREGFP_0480"	116808	565691	568730	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007255"	20692	"100-97-0"	"Methenamine"	"C100970"	2	"ACEA_T47D_80hr_Positive"	10191	1779023	1780382	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007255"	20692	"100-97-0"	"Methenamine"	"C100970"	2	"ACEA_T47D_80hr_Positive"	10477	1779023	1780382	11	"Borderline active"	NA	NA	"percent_activity"
"TX007256"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	75	"ATG_ERE_CIS_up"	13813	2093865	1964259	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007256"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	117	"ATG_ERa_TRANS_up"	50183	2170268	2036193	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007256"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	725	"NVS_NR_mERa"	517161	2710449	2699726	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007256"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	725	"NVS_NR_mERa"	517483	2710449	2699726	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007263"	20961	"100-01-6"	"4-Nitroaniline"	"C100016"	708	"NVS_NR_bER"	516329	2707091	2696051	10	"Noisy data"	NA	NA	"percent_activity"
"TX007263"	20961	"100-01-6"	"4-Nitroaniline"	"C100016"	725	"NVS_NR_mERa"	517162	2710450	2699727	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007263"	20961	"100-01-6"	"4-Nitroaniline"	"C100016"	725	"NVS_NR_mERa"	517484	2710450	2699727	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007268"	24721	"464-49-3"	"D-Camphor"	"C464493"	743	"OT_ER_ERaERa_1440"	114397	551629	562812	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007270"	24065	"99-65-0"	"1,3-Dinitrobenzene"	"C99650"	2	"ACEA_T47D_80hr_Positive"	10659	1779028	1780378	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007272"	21464	"137-30-4"	"Ziram"	"C137304"	708	"NVS_NR_bER"	516278	2707093	2696053	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007272"	21464	"137-30-4"	"Ziram"	"C137304"	725	"NVS_NR_mERa"	517163	2710452	2699729	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007272"	21464	"137-30-4"	"Ziram"	"C137304"	725	"NVS_NR_mERa"	517485	2710452	2699729	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007278"	24489	"2835-95-2"	"5-Amino-2-methylphenol"	"C2835952"	75	"ATG_ERE_CIS_up"	13293	2093859	1964265	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007278"	24489	"2835-95-2"	"5-Amino-2-methylphenol"	"C2835952"	75	"ATG_ERE_CIS_up"	13563	2093859	1964265	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007282"	21952	"115-86-6"	"Triphenyl phosphate"	"C115866"	2	"ACEA_T47D_80hr_Positive"	10328	1779032	1780373	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007282"	21952	"115-86-6"	"Triphenyl phosphate"	"C115866"	2	"ACEA_T47D_80hr_Positive"	10660	1779032	1780373	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007282"	21952	"115-86-6"	"Triphenyl phosphate"	"C115866"	75	"ATG_ERE_CIS_up"	13812	2093857	1964267	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007282"	21952	"115-86-6"	"Triphenyl phosphate"	"C115866"	117	"ATG_ERa_TRANS_up"	49700	2170260	2036185	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007282"	21952	"115-86-6"	"Triphenyl phosphate"	"C115866"	117	"ATG_ERa_TRANS_up"	49941	2170260	2036185	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007282"	21952	"115-86-6"	"Triphenyl phosphate"	"C115866"	745	"OT_ER_ERaERb_1440"	115368	557818	536587	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007288"	25219	"25155-30-0"	"Sodium dodecylbenzenesulfonate"	"C25155300"	75	"ATG_ERE_CIS_up"	13562	2093854	1964270	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007288"	25219	"25155-30-0"	"Sodium dodecylbenzenesulfonate"	"C25155300"	708	"NVS_NR_bER"	516208	2707094	2696054	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007288"	25219	"25155-30-0"	"Sodium dodecylbenzenesulfonate"	"C25155300"	714	"NVS_NR_hER"	517722	2709336	2698613	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007288"	25219	"25155-30-0"	"Sodium dodecylbenzenesulfonate"	"C25155300"	714	"NVS_NR_hER"	517952	2709336	2698613	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007288"	25219	"25155-30-0"	"Sodium dodecylbenzenesulfonate"	"C25155300"	714	"NVS_NR_hER"	518028	2709336	2698613	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007288"	25219	"25155-30-0"	"Sodium dodecylbenzenesulfonate"	"C25155300"	750	"OT_ERa_EREGFP_0120"	115547	572699	566767	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007292"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	2	"ACEA_T47D_80hr_Positive"	10661	1779036	1780369	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007292"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	75	"ATG_ERE_CIS_up"	13201	2093853	1964272	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007292"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	75	"ATG_ERE_CIS_up"	13379	2093853	1964272	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX007292"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	75	"ATG_ERE_CIS_up"	13811	2093853	1964272	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007292"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	725	"NVS_NR_mERa"	517577	2710454	2699731	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007292"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	725	"NVS_NR_mERa"	517669	2710454	2699731	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007317"	38696	"93-89-0"	"Ethyl benzoate"	"C93890"	743	"OT_ER_ERaERa_1440"	114398	551641	562824	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007317"	38696	"93-89-0"	"Ethyl benzoate"	"C93890"	751	"OT_ERa_EREGFP_0480"	116809	565710	568749	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007349"	44394	"98-53-3"	"4-tert-Butylcyclohexanone"	"C98533"	714	"NVS_NR_hER"	517823	2709342	2698619	10	"Noisy data"	NA	NA	"percent_activity"
"TX007351"	41861	"762-04-9"	"Diethyl phosphite"	"C762049"	2	"ACEA_T47D_80hr_Positive"	10329	1779042	1780363	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007351"	41861	"762-04-9"	"Diethyl phosphite"	"C762049"	2	"ACEA_T47D_80hr_Positive"	10662	1779042	1780363	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007353"	32389	"4602-84-0"	"Farnesol"	"C4602840"	75	"ATG_ERE_CIS_up"	13161	2093834	1964290	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007353"	32389	"4602-84-0"	"Farnesol"	"C4602840"	725	"NVS_NR_mERa"	517165	2710460	2699737	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007353"	32389	"4602-84-0"	"Farnesol"	"C4602840"	744	"OT_ER_ERaERb_0480"	112933	2401296	2399837	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007353"	32389	"4602-84-0"	"Farnesol"	"C4602840"	746	"OT_ER_ERbERb_0480"	116657	549675	558890	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007353"	32389	"4602-84-0"	"Farnesol"	"C4602840"	751	"OT_ERa_EREGFP_0480"	116810	565714	568753	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007365"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	2	"ACEA_T47D_80hr_Positive"	10330	1779044	1780361	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007365"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	2	"ACEA_T47D_80hr_Positive"	10663	1779044	1780361	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007365"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	743	"OT_ER_ERaERa_1440"	114399	551646	562829	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007365"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	750	"OT_ERa_EREGFP_0120"	115709	572708	566776	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007365"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	751	"OT_ERa_EREGFP_0480"	116811	565715	568754	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007365"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	751	"OT_ERa_EREGFP_0480"	116919	565715	568754	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007383"	32316	"88-04-0"	"4-Chloro-3,5-dimethylphenol"	"C88040"	2	"ACEA_T47D_80hr_Positive"	10664	1779046	1780360	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007383"	32316	"88-04-0"	"4-Chloro-3,5-dimethylphenol"	"C88040"	75	"ATG_ERE_CIS_up"	13809	2093827	1964297	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007383"	32316	"88-04-0"	"4-Chloro-3,5-dimethylphenol"	"C88040"	708	"NVS_NR_bER"	516279	2707104	2696064	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007383"	32316	"88-04-0"	"4-Chloro-3,5-dimethylphenol"	"C88040"	714	"NVS_NR_hER"	517954	2709346	2698623	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007383"	32316	"88-04-0"	"4-Chloro-3,5-dimethylphenol"	"C88040"	714	"NVS_NR_hER"	518030	2709346	2698623	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007383"	32316	"88-04-0"	"4-Chloro-3,5-dimethylphenol"	"C88040"	745	"OT_ER_ERaERb_1440"	115369	557832	536601	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007405"	23745	"58-86-6"	"D-Xylose"	"C58866"	75	"ATG_ERE_CIS_up"	13160	2093821	1964304	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007423"	44391	"88-69-7"	"2-Isopropylphenol"	"C88697"	117	"ATG_ERa_TRANS_up"	49572	2170222	2036147	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007423"	44391	"88-69-7"	"2-Isopropylphenol"	"C88697"	744	"OT_ER_ERaERb_0480"	112932	2401291	2399845	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007423"	44391	"88-69-7"	"2-Isopropylphenol"	"C88697"	746	"OT_ER_ERbERb_0480"	116658	549680	558895	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007435"	34317	"8001-54-5"	"Benzalkonium chloride"	"C8001545"	708	"NVS_NR_bER"	516388	2707108	2696068	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007435"	34317	"8001-54-5"	"Benzalkonium chloride"	"C8001545"	714	"NVS_NR_hER"	517824	2709350	2698627	10	"Noisy data"	NA	NA	"percent_activity"
"TX007473"	41682	"115-39-9"	"Bromophenol blue"	"C115399"	75	"ATG_ERE_CIS_up"	13561	2093810	1964314	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007473"	41682	"115-39-9"	"Bromophenol blue"	"C115399"	725	"NVS_NR_mERa"	517488	2710472	2699749	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007473"	41682	"115-39-9"	"Bromophenol blue"	"C115399"	745	"OT_ER_ERaERb_1440"	115412	557837	536606	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007481"	36229	"142-87-0"	"Sodium decyl sulfate"	"C142870"	75	"ATG_ERE_CIS_up"	13292	2093809	1964315	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007481"	36229	"142-87-0"	"Sodium decyl sulfate"	"C142870"	75	"ATG_ERE_CIS_up"	13560	2093809	1964315	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007491"	20673	"2353-45-9"	"FD&C Green No. 3"	"C2353459"	2	"ACEA_T47D_80hr_Positive"	10331	1779054	1780352	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007491"	20673	"2353-45-9"	"FD&C Green No. 3"	"C2353459"	2	"ACEA_T47D_80hr_Positive"	10665	1779054	1780352	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007491"	20673	"2353-45-9"	"FD&C Green No. 3"	"C2353459"	75	"ATG_ERE_CIS_up"	13200	2093806	1964318	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007491"	20673	"2353-45-9"	"FD&C Green No. 3"	"C2353459"	75	"ATG_ERE_CIS_up"	13808	2093806	1964318	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007491"	20673	"2353-45-9"	"FD&C Green No. 3"	"C2353459"	117	"ATG_ERa_TRANS_up"	49632	2170209	2036134	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007491"	20673	"2353-45-9"	"FD&C Green No. 3"	"C2353459"	117	"ATG_ERa_TRANS_up"	49800	2170209	2036134	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX007491"	20673	"2353-45-9"	"FD&C Green No. 3"	"C2353459"	117	"ATG_ERa_TRANS_up"	50179	2170209	2036134	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007493"	23296	"61-73-4"	"Methylene blue"	"C61734"	117	"ATG_ERa_TRANS_up"	49698	2170208	2036133	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007493"	23296	"61-73-4"	"Methylene blue"	"C61734"	117	"ATG_ERa_TRANS_up"	49939	2170208	2036133	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007493"	23296	"61-73-4"	"Methylene blue"	"C61734"	743	"OT_ER_ERaERa_1440"	114400	551657	562840	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007493"	23296	"61-73-4"	"Methylene blue"	"C61734"	744	"OT_ER_ERaERb_0480"	112893	2401284	2399855	10	"Noisy data"	NA	NA	"percent_activity"
"TX007493"	23296	"61-73-4"	"Methylene blue"	"C61734"	746	"OT_ER_ERbERb_0480"	116607	549687	558902	10	"Noisy data"	NA	NA	"percent_activity"
"TX007495"	38881	"633-96-5"	"C.I. Acid Orange 7"	"C633965"	117	"ATG_ERa_TRANS_up"	49697	2170207	2036132	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX007495"	38881	"633-96-5"	"C.I. Acid Orange 7"	"C633965"	117	"ATG_ERa_TRANS_up"	49938	2170207	2036132	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007501"	41721	"8004-92-0"	"C.I. Acid Yellow 3 disodium salt"	"C8004920"	2	"ACEA_T47D_80hr_Positive"	10399	1779057	1780348	10	"Noisy data"	NA	NA	"percent_activity"
"TX007501"	41721	"8004-92-0"	"C.I. Acid Yellow 3 disodium salt"	"C8004920"	2	"ACEA_T47D_80hr_Positive"	10478	1779057	1780348	11	"Borderline active"	NA	NA	"percent_activity"
"TX007501"	41721	"8004-92-0"	"C.I. Acid Yellow 3 disodium salt"	"C8004920"	2	"ACEA_T47D_80hr_Positive"	10758	1779057	1780348	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007503"	40343	"5437-45-6"	"Benzyl bromoacetate"	"C5437456"	117	"ATG_ERa_TRANS_up"	49937	2170205	2036130	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007521"	44443	"56375-79-2"	"N,N-Dibutyl-N-methylbutan-1-aminium chloride"	"C56375792"	2	"ACEA_T47D_80hr_Positive"	10332	1779059	1780346	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007521"	44443	"56375-79-2"	"N,N-Dibutyl-N-methylbutan-1-aminium chloride"	"C56375792"	2	"ACEA_T47D_80hr_Positive"	10666	1779059	1780346	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007525"	42418	"3026-63-9"	"Sodium tridecyl sulfate"	"C3026639"	708	"NVS_NR_bER"	516209	2707115	2696075	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007525"	42418	"3026-63-9"	"Sodium tridecyl sulfate"	"C3026639"	714	"NVS_NR_hER"	517825	2709357	2698634	10	"Noisy data"	NA	NA	"percent_activity"
"TX007525"	42418	"3026-63-9"	"Sodium tridecyl sulfate"	"C3026639"	725	"NVS_NR_mERa"	517010	2710474	2699751	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007525"	42418	"3026-63-9"	"Sodium tridecyl sulfate"	"C3026639"	750	"OT_ERa_EREGFP_0120"	115710	572724	566792	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007547"	41661	"611-20-1"	"Benzonitrile, 2-hydroxy-"	"C611201"	746	"OT_ER_ERbERb_0480"	116659	549693	558908	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007555"	36286	"5146-66-7"	"2,6-Octadienenitrile, 3,7-dimethyl-"	"C5146667"	75	"ATG_ERE_CIS_up"	13159	2093789	1964335	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007555"	36286	"5146-66-7"	"2,6-Octadienenitrile, 3,7-dimethyl-"	"C5146667"	117	"ATG_ERa_TRANS_up"	49935	2170192	2036117	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007555"	36286	"5146-66-7"	"2,6-Octadienenitrile, 3,7-dimethyl-"	"C5146667"	725	"NVS_NR_mERa"	517015	2710477	2699754	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX007555"	36286	"5146-66-7"	"2,6-Octadienenitrile, 3,7-dimethyl-"	"C5146667"	725	"NVS_NR_mERa"	517396	2710477	2699754	11	"Borderline active"	NA	NA	"percent_activity"
"TX007555"	36286	"5146-66-7"	"2,6-Octadienenitrile, 3,7-dimethyl-"	"C5146667"	725	"NVS_NR_mERa"	517578	2710477	2699754	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007555"	36286	"5146-66-7"	"2,6-Octadienenitrile, 3,7-dimethyl-"	"C5146667"	725	"NVS_NR_mERa"	517670	2710477	2699754	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007557"	44435	"51-05-8"	"Procaine hydrochloride"	"C51058"	2	"ACEA_T47D_80hr_Positive"	10192	1779063	1780341	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007557"	44435	"51-05-8"	"Procaine hydrochloride"	"C51058"	2	"ACEA_T47D_80hr_Positive"	10479	1779063	1780341	11	"Borderline active"	NA	NA	"percent_activity"
"TX007557"	44435	"51-05-8"	"Procaine hydrochloride"	"C51058"	2	"ACEA_T47D_80hr_Positive"	10759	1779063	1780341	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007601"	38700	"97-52-9"	"2-Methoxy-4-nitroaniline"	"C97529"	747	"OT_ER_ERbERb_1440"	114876	559820	560883	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007618"	20683	"87-68-3"	"Hexachloro-1,3-butadiene"	"C87683"	2	"ACEA_T47D_80hr_Positive"	10193	1779068	1780337	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007618"	20683	"87-68-3"	"Hexachloro-1,3-butadiene"	"C87683"	2	"ACEA_T47D_80hr_Positive"	10480	1779068	1780337	11	"Borderline active"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	117	"ATG_ERa_TRANS_up"	49934	2170178	2036103	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	708	"NVS_NR_bER"	516447	2707121	2696081	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	708	"NVS_NR_bER"	516506	2707121	2696081	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	725	"NVS_NR_mERa"	517579	2710480	2699757	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	742	"OT_ER_ERaERa_0480"	114951	555885	564826	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	745	"OT_ER_ERaERb_1440"	115370	557855	536624	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	747	"OT_ER_ERbERb_1440"	114762	559823	560886	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	750	"OT_ERa_EREGFP_0120"	115711	572733	566801	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	750	"OT_ERa_EREGFP_0120"	115862	572733	566801	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	751	"OT_ERa_EREGFP_0480"	116812	565740	568779	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007630"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	751	"OT_ERa_EREGFP_0480"	116920	565740	568779	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007648"	23927	"101-55-3"	"p-Bromodiphenyl ether"	"C101553"	117	"ATG_ERa_TRANS_up"	49798	2170177	2036102	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX007648"	23927	"101-55-3"	"p-Bromodiphenyl ether"	"C101553"	117	"ATG_ERa_TRANS_up"	50177	2170177	2036102	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007648"	23927	"101-55-3"	"p-Bromodiphenyl ether"	"C101553"	744	"OT_ER_ERaERb_0480"	112830	2401269	2399862	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007648"	23927	"101-55-3"	"p-Bromodiphenyl ether"	"C101553"	746	"OT_ER_ERbERb_0480"	116660	549702	558917	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007664"	26141	"68-11-1"	"Thioglycolic acid"	"C68111"	75	"ATG_ERE_CIS_up"	13199	2093770	1964354	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007664"	26141	"68-11-1"	"Thioglycolic acid"	"C68111"	75	"ATG_ERE_CIS_up"	13807	2093770	1964354	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007664"	26141	"68-11-1"	"Thioglycolic acid"	"C68111"	117	"ATG_ERa_TRANS_up"	49631	2170173	2036098	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007664"	26141	"68-11-1"	"Thioglycolic acid"	"C68111"	117	"ATG_ERa_TRANS_up"	49797	2170173	2036098	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX007664"	26141	"68-11-1"	"Thioglycolic acid"	"C68111"	117	"ATG_ERa_TRANS_up"	50176	2170173	2036098	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007682"	20494	"756-79-6"	"Dimethyl methylphosphonate"	"C756796"	2	"ACEA_T47D_80hr_Positive"	10333	1779074	1780332	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007682"	20494	"756-79-6"	"Dimethyl methylphosphonate"	"C756796"	2	"ACEA_T47D_80hr_Positive"	10667	1779074	1780332	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007682"	20494	"756-79-6"	"Dimethyl methylphosphonate"	"C756796"	751	"OT_ERa_EREGFP_0480"	116813	565745	568784	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007694"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	75	"ATG_ERE_CIS_up"	13158	2093765	1964359	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007694"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	75	"ATG_ERE_CIS_up"	13806	2093765	1964359	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007694"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	745	"OT_ER_ERaERb_1440"	115413	557862	536631	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007694"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	745	"OT_ER_ERaERb_1440"	115497	557862	536631	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007694"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	747	"OT_ER_ERbERb_1440"	114842	559830	560893	10	"Noisy data"	NA	NA	"percent_activity"
"TX007696"	22254	"13071-79-9"	"Terbufos"	"C13071799"	742	"OT_ER_ERaERa_0480"	114952	555893	564834	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007696"	22254	"13071-79-9"	"Terbufos"	"C13071799"	750	"OT_ERa_EREGFP_0120"	115798	572741	566809	10	"Noisy data"	NA	NA	"percent_activity"
"TX007696"	22254	"13071-79-9"	"Terbufos"	"C13071799"	751	"OT_ERa_EREGFP_0480"	116814	565748	568787	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007708"	20168	"111-44-4"	"Bis(2-chloroethyl) ether"	"C111444"	75	"ATG_ERE_CIS_up"	13198	2093760	1964364	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX007708"	20168	"111-44-4"	"Bis(2-chloroethyl) ether"	"C111444"	75	"ATG_ERE_CIS_up"	13805	2093760	1964364	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX007708"	20168	"111-44-4"	"Bis(2-chloroethyl) ether"	"C111444"	751	"OT_ERa_EREGFP_0480"	116815	565751	568790	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007717"	22489	"140-10-3"	"Cinnamic acid"	"C140103"	743	"OT_ER_ERaERa_1440"	114479	551683	562866	11	"Borderline active"	NA	NA	"percent_activity"
"TX007717"	22489	"140-10-3"	"Cinnamic acid"	"C140103"	750	"OT_ERa_EREGFP_0120"	115712	572745	566813	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007737"	22991	"114-07-8"	"Erythromycin"	"C114078"	750	"OT_ERa_EREGFP_0120"	115713	572746	566814	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007745"	38732	"123-25-1"	"Diethyl butanedioate"	"C123251"	714	"NVS_NR_hER"	517790	2709367	2698644	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	708	"NVS_NR_bER"	516231	2707129	2696089	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	708	"NVS_NR_bER"	516347	2707129	2696089	11	"Borderline active"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	708	"NVS_NR_bER"	516448	2707129	2696089	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	708	"NVS_NR_bER"	516507	2707129	2696089	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	714	"NVS_NR_hER"	517893	2709370	2698647	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	725	"NVS_NR_mERa"	517490	2710487	2699764	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	742	"OT_ER_ERaERa_0480"	114979	555902	564843	10	"Noisy data"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	744	"OT_ER_ERaERb_0480"	112829	2401253	2399880	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007771"	25234	"17372-87-1"	"Eosin"	"C17372871"	744	"OT_ER_ERaERb_0480"	112892	2401253	2399880	10	"Noisy data"	NA	NA	"percent_activity"
"TX007783"	41663	"103-41-3"	"Benzyl cinnamate"	"C103413"	75	"ATG_ERE_CIS_up"	13558	2093741	1964383	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX007791"	44430	"451-40-1"	"1,2-Diphenylethanone"	"C451401"	2	"ACEA_T47D_80hr_Positive"	10334	1779089	1780316	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007791"	44430	"451-40-1"	"1,2-Diphenylethanone"	"C451401"	745	"OT_ER_ERaERb_1440"	115498	557875	536644	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007791"	44430	"451-40-1"	"1,2-Diphenylethanone"	"C451401"	747	"OT_ER_ERbERb_1440"	114809	559843	560906	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007791"	44430	"451-40-1"	"1,2-Diphenylethanone"	"C451401"	747	"OT_ER_ERbERb_1440"	114877	559843	560906	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007803"	22679	"58-85-5"	"Biotin"	"C58855"	750	"OT_ERa_EREGFP_0120"	115714	572754	566822	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007805"	42234	"29836-26-8"	"Octyl beta-D-glucopyranoside"	"C29836268"	750	"OT_ERa_EREGFP_0120"	115715	572755	566823	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007831"	22437	"500-38-9"	"Nordihydroguaiaretic acid"	"C500389"	2	"ACEA_T47D_80hr_Positive"	10481	1779092	1780313	11	"Borderline active"	NA	NA	"percent_activity"
"TX007831"	22437	"500-38-9"	"Nordihydroguaiaretic acid"	"C500389"	745	"OT_ER_ERaERb_1440"	115442	557878	536647	10	"Noisy data"	NA	NA	"percent_activity"
"TX007831"	22437	"500-38-9"	"Nordihydroguaiaretic acid"	"C500389"	747	"OT_ER_ERbERb_1440"	114763	559846	560909	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX007833"	44390	"6610-29-3"	"N-Methylhydrazinecarbothioamide"	"C6610293"	743	"OT_ER_ERaERa_1440"	114401	551695	562878	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007873"	41389	"93-08-3"	"2'-Acetonaphthone"	"C93083"	743	"OT_ER_ERaERa_1440"	114402	551696	562879	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX007873"	41389	"93-08-3"	"2'-Acetonaphthone"	"C93083"	743	"OT_ER_ERaERa_1440"	114454	551696	562879	10	"Noisy data"	NA	NA	"percent_activity"
"TX007873"	41389	"93-08-3"	"2'-Acetonaphthone"	"C93083"	743	"OT_ER_ERaERa_1440"	114498	551696	562879	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX007998"	24827	"69-09-0"	"Chlorpromazine hydrochloride"	"C69090"	725	"NVS_NR_mERa"	517672	2710496	2699773	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008000"	44487	"5137-55-3"	"Methyltrioctylammonium chloride"	"C5137553"	117	"ATG_ERa_TRANS_up"	49930	2170120	2036045	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008000"	44487	"5137-55-3"	"Methyltrioctylammonium chloride"	"C5137553"	751	"OT_ERa_EREGFP_0480"	116816	565767	568806	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008064"	41346	"533-23-3"	"2,4-D-ethyl ester"	"C533233"	745	"OT_ER_ERaERb_1440"	115414	557885	536654	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008064"	41346	"533-23-3"	"2,4-D-ethyl ester"	"C533233"	745	"OT_ER_ERaERb_1440"	115499	557885	536654	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008064"	41346	"533-23-3"	"2,4-D-ethyl ester"	"C533233"	750	"OT_ERa_EREGFP_0120"	115799	572763	566831	10	"Noisy data"	NA	NA	"percent_activity"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	2	"ACEA_T47D_80hr_Positive"	10668	1779100	1780306	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	75	"ATG_ERE_CIS_up"	13197	2093706	1964418	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	75	"ATG_ERE_CIS_up"	13377	2093706	1964418	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	75	"ATG_ERE_CIS_up"	13803	2093706	1964418	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	714	"NVS_NR_hER"	517723	2709386	2698663	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	714	"NVS_NR_hER"	517955	2709386	2698663	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	714	"NVS_NR_hER"	518033	2709386	2698663	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008066"	40352	"39300-45-3"	"Dinocap"	"C39300453"	725	"NVS_NR_mERa"	517011	2710503	2699780	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008068"	32412	"81405-85-8"	"Imazmethabenz"	"C81405858"	743	"OT_ER_ERaERa_1440"	114403	551703	562886	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008152"	44572	"647-42-7"	"3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol"	"C647427"	743	"OT_ER_ERaERa_1440"	114404	551707	562890	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008152"	44572	"647-42-7"	"3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol"	"C647427"	744	"OT_ER_ERaERb_0480"	112931	2401234	2399903	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008152"	44572	"647-42-7"	"3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol"	"C647427"	745	"OT_ER_ERaERb_1440"	115415	557891	536660	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008168"	27926	"27193-86-8"	"Dodecylphenol"	"C27193868"	714	"NVS_NR_hER"	518034	2709393	2698670	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008168"	27926	"27193-86-8"	"Dodecylphenol"	"C27193868"	750	"OT_ERa_EREGFP_0120"	115800	572771	566839	10	"Noisy data"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	2	"ACEA_T47D_80hr_Positive"	10194	1779109	1780296	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	708	"NVS_NR_bER"	516391	2707153	2696113	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	714	"NVS_NR_hER"	517847	2709394	2698671	11	"Borderline active"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	714	"NVS_NR_hER"	518035	2709394	2698671	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	725	"NVS_NR_mERa"	517397	2710511	2699788	11	"Borderline active"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	725	"NVS_NR_mERa"	517580	2710511	2699788	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	725	"NVS_NR_mERa"	517673	2710511	2699788	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008177"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	751	"OT_ERa_EREGFP_0480"	116897	565781	568820	11	"Borderline active"	NA	NA	"percent_activity"
"TX008213"	47535	"82469-79-2"	"Butyryl trihexyl citrate"	"C82469792"	2	"ACEA_T47D_80hr_Positive"	10195	1779111	1780294	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008217"	26967	"120-55-8"	"Diethylene glycol dibenzoate"	"C120558"	742	"OT_ER_ERaERa_0480"	115030	555929	564870	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008217"	26967	"120-55-8"	"Diethylene glycol dibenzoate"	"C120558"	744	"OT_ER_ERaERb_0480"	112930	2401226	2399908	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008217"	26967	"120-55-8"	"Diethylene glycol dibenzoate"	"C120558"	745	"OT_ER_ERaERb_1440"	115500	557899	536668	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008221"	47537	"2432-87-3"	"Dioctyl succinate"	"C2432873"	747	"OT_ER_ERbERb_1440"	114843	559868	560931	10	"Noisy data"	NA	NA	"percent_activity"
"TX008224"	47538	"6624-73-3"	"Pentane-1,5-diyl dibenzoate"	"C6624733"	745	"OT_ER_ERaERb_1440"	115371	557901	536670	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008224"	47538	"6624-73-3"	"Pentane-1,5-diyl dibenzoate"	"C6624733"	746	"OT_ER_ERbERb_0480"	116572	549747	558962	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008224"	47538	"6624-73-3"	"Pentane-1,5-diyl dibenzoate"	"C6624733"	746	"OT_ER_ERbERb_0480"	116616	549747	558962	11	"Borderline active"	NA	NA	"percent_activity"
"TX008226"	47539	"22915-73-7"	"Hexane-1,6-diyl dibenzoate"	"C22915737"	75	"ATG_ERE_CIS_up"	13555	2093679	1964445	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008226"	47539	"22915-73-7"	"Hexane-1,6-diyl dibenzoate"	"C22915737"	117	"ATG_ERa_TRANS_up"	49926	2170082	2036007	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008226"	47539	"22915-73-7"	"Hexane-1,6-diyl dibenzoate"	"C22915737"	744	"OT_ER_ERaERb_0480"	112828	2401223	2399913	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008226"	47539	"22915-73-7"	"Hexane-1,6-diyl dibenzoate"	"C22915737"	746	"OT_ER_ERbERb_0480"	116662	549748	558963	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008319"	25688	"110-91-8"	"Morpholine"	"C110918"	2	"ACEA_T47D_80hr_Positive"	10669	1779116	1780289	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008321"	27236	"602-01-7"	"2,3-Dinitrotoluene"	"C602017"	2	"ACEA_T47D_80hr_Positive"	10196	1779117	1780288	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008321"	27236	"602-01-7"	"2,3-Dinitrotoluene"	"C602017"	117	"ATG_ERa_TRANS_up"	49925	2170080	2036005	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008325"	20443	"94-80-4"	"2,4-D 1-butyl ester "	"C94804"	2	"ACEA_T47D_80hr_Positive"	10335	1779118	1780287	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008325"	20443	"94-80-4"	"2,4-D 1-butyl ester "	"C94804"	117	"ATG_ERa_TRANS_up"	49924	2170079	2036004	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008327"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	2	"ACEA_T47D_80hr_Positive"	10235	1779119	1780286	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX008327"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	2	"ACEA_T47D_80hr_Positive"	10482	1779119	1780286	11	"Borderline active"	NA	NA	"percent_activity"
"TX008327"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	2	"ACEA_T47D_80hr_Positive"	10760	1779119	1780286	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008349"	21392	"102-71-6"	"Triethanolamine"	"C102716"	2	"ACEA_T47D_80hr_Positive"	10197	1779121	1780284	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008349"	21392	"102-71-6"	"Triethanolamine"	"C102716"	75	"ATG_ERE_CIS_up"	13196	2093673	1964451	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX008349"	21392	"102-71-6"	"Triethanolamine"	"C102716"	75	"ATG_ERE_CIS_up"	13376	2093673	1964451	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX008349"	21392	"102-71-6"	"Triethanolamine"	"C102716"	75	"ATG_ERE_CIS_up"	13800	2093673	1964451	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX008361"	24888	"6055-19-2"	"Cyclophosphamide monohydrate"	"C6055192"	714	"NVS_NR_hER"	517792	2709398	2698675	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008361"	24888	"6055-19-2"	"Cyclophosphamide monohydrate"	"C6055192"	714	"NVS_NR_hER"	517894	2709398	2698675	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008361"	24888	"6055-19-2"	"Cyclophosphamide monohydrate"	"C6055192"	725	"NVS_NR_mERa"	517493	2710515	2699792	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008361"	24888	"6055-19-2"	"Cyclophosphamide monohydrate"	"C6055192"	750	"OT_ERa_EREGFP_0120"	115717	572788	566856	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008361"	24888	"6055-19-2"	"Cyclophosphamide monohydrate"	"C6055192"	750	"OT_ERa_EREGFP_0120"	115863	572788	566856	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008373"	23556	"68-26-8"	"Retinol"	"C68268"	2	"ACEA_T47D_80hr_Positive"	10670	1779126	1780279	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008373"	23556	"68-26-8"	"Retinol"	"C68268"	75	"ATG_ERE_CIS_up"	13799	2093666	1964458	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX008373"	23556	"68-26-8"	"Retinol"	"C68268"	746	"OT_ER_ERbERb_0480"	116663	549759	558974	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008379"	23742	"81-81-2"	"Warfarin"	"C81812"	2	"ACEA_T47D_80hr_Positive"	10336	1779127	1780278	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008379"	23742	"81-81-2"	"Warfarin"	"C81812"	75	"ATG_ERE_CIS_up"	13289	2093665	1964459	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008379"	23742	"81-81-2"	"Warfarin"	"C81812"	75	"ATG_ERE_CIS_up"	13554	2093665	1964459	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008381"	20820	"60-56-0"	"Methimazole"	"C60560"	75	"ATG_ERE_CIS_up"	13553	2093664	1964460	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008391"	44693	"553-70-8"	"Magnesium dibenzoate"	"C553708"	75	"ATG_ERE_CIS_up"	13551	2093660	1964464	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008407"	44570	"5700-49-2"	"1,2-Ethanediamine dihydriodide"	"C5700492"	117	"ATG_ERa_TRANS_up"	49922	2170061	2035986	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008415"	32654	"26644-46-2"	"Triforine"	"C26644462"	117	"ATG_ERa_TRANS_up"	49921	2170059	2035984	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008423"	44537	"1323-19-9"	"Sodium 2,4,7-tri(propan-2-yl)naphthalene-1-sulfonate"	"C1323199"	75	"ATG_ERE_CIS_up"	13157	2093654	1964470	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX008423"	44537	"1323-19-9"	"Sodium 2,4,7-tri(propan-2-yl)naphthalene-1-sulfonate"	"C1323199"	117	"ATG_ERa_TRANS_up"	49571	2170057	2035982	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX008427"	34497	"125116-23-6"	"Metconazole"	"C125116236"	2	"ACEA_T47D_80hr_Positive"	10483	1779137	1780268	11	"Borderline active"	NA	NA	"percent_activity"
"TX008427"	34497	"125116-23-6"	"Metconazole"	"C125116236"	714	"NVS_NR_hER"	517895	2709405	2698682	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008427"	34497	"125116-23-6"	"Metconazole"	"C125116236"	725	"NVS_NR_mERa"	517581	2710522	2699799	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008427"	34497	"125116-23-6"	"Metconazole"	"C125116236"	725	"NVS_NR_mERa"	517674	2710522	2699799	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008427"	34497	"125116-23-6"	"Metconazole"	"C125116236"	745	"OT_ER_ERaERb_1440"	115373	557924	536693	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008433"	27963	"30399-84-9"	"Isooctadecanoic acid"	"C30399849"	75	"ATG_ERE_CIS_up"	13550	2093652	1964472	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008433"	27963	"30399-84-9"	"Isooctadecanoic acid"	"C30399849"	117	"ATG_ERa_TRANS_up"	50169	2170055	2035980	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX008433"	27963	"30399-84-9"	"Isooctadecanoic acid"	"C30399849"	714	"NVS_NR_hER"	517826	2709406	2698683	10	"Noisy data"	NA	NA	"percent_activity"
"TX008435"	22508	"104-43-8"	"4-Dodecylphenol"	"C104438"	708	"NVS_NR_bER"	516509	2707165	2696125	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008445"	21028	"55-18-5"	"N-Nitrosodiethylamine"	"C55185"	714	"NVS_NR_hER"	517794	2709408	2698685	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008445"	21028	"55-18-5"	"N-Nitrosodiethylamine"	"C55185"	714	"NVS_NR_hER"	517827	2709408	2698685	10	"Noisy data"	NA	NA	"percent_activity"
"TX008449"	21413	"126-72-7"	"Tris(2,3-dibromopropyl) phosphate"	"C126727"	117	"ATG_ERa_TRANS_up"	49920	2170051	2035976	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008463"	20679	"76-44-8"	"Heptachlor"	"C76448"	117	"ATG_ERa_TRANS_up"	49918	2170049	2035974	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008463"	20679	"76-44-8"	"Heptachlor"	"C76448"	746	"OT_ER_ERbERb_0480"	116664	549777	558992	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008476"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	708	"NVS_NR_bER"	516330	2707169	2696129	10	"Noisy data"	NA	NA	"percent_activity"
"TX008476"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	725	"NVS_NR_mERa"	517341	2710528	2699805	10	"Noisy data"	NA	NA	"percent_activity"
"TX008486"	27268	"629-62-9"	"Pentadecane"	"C629629"	708	"NVS_NR_bER"	516284	2707170	2696130	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008488"	23907	"205-99-2"	"Benzo(b)fluoranthene"	"C205992"	725	"NVS_NR_mERa"	517177	2710530	2699807	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008488"	23907	"205-99-2"	"Benzo(b)fluoranthene"	"C205992"	744	"OT_ER_ERaERb_0480"	112928	2401190	2399941	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008488"	23907	"205-99-2"	"Benzo(b)fluoranthene"	"C205992"	745	"OT_ER_ERaERb_1440"	115416	557935	536704	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008488"	23907	"205-99-2"	"Benzo(b)fluoranthene"	"C205992"	745	"OT_ER_ERaERb_1440"	115501	557935	536704	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008488"	23907	"205-99-2"	"Benzo(b)fluoranthene"	"C205992"	747	"OT_ER_ERbERb_1440"	114878	559903	560966	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008488"	23907	"205-99-2"	"Benzo(b)fluoranthene"	"C205992"	751	"OT_ERa_EREGFP_0480"	116818	565820	568859	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008510"	24538	"1143-38-0"	"Anthralin"	"C1143380"	708	"NVS_NR_bER"	516331	2707172	2696132	10	"Noisy data"	NA	NA	"percent_activity"
"TX008510"	24538	"1143-38-0"	"Anthralin"	"C1143380"	714	"NVS_NR_hER"	517828	2709416	2698693	10	"Noisy data"	NA	NA	"percent_activity"
"TX008520"	27982	"33703-08-1"	"Hexanedioic acid, diisononyl ester"	"C33703081"	2	"ACEA_T47D_80hr_Positive"	10198	1779150	1780255	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008534"	20713	"58-93-5"	"Hydrochlorothiazide"	"C58935"	75	"ATG_ERE_CIS_up"	13375	2093636	1964488	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX008534"	20713	"58-93-5"	"Hydrochlorothiazide"	"C58935"	75	"ATG_ERE_CIS_up"	13798	2093636	1964488	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX008536"	24274	"1918-16-7"	"Propachlor"	"C1918167"	75	"ATG_ERE_CIS_up"	13374	2093635	1964489	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX008536"	24274	"1918-16-7"	"Propachlor"	"C1918167"	725	"NVS_NR_mERa"	517582	2710532	2699809	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008536"	24274	"1918-16-7"	"Propachlor"	"C1918167"	725	"NVS_NR_mERa"	517675	2710532	2699809	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008556"	22817	"1260-17-9"	"Carminic acid"	"C1260179"	117	"ATG_ERa_TRANS_up"	49917	2170035	2035960	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008556"	22817	"1260-17-9"	"Carminic acid"	"C1260179"	744	"OT_ER_ERaERb_0480"	112927	2401184	2399967	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008558"	32004	"13311-84-7"	"Flutamide"	"C13311847"	2	"ACEA_T47D_80hr_Positive"	10199	1779155	1780251	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008558"	32004	"13311-84-7"	"Flutamide"	"C13311847"	725	"NVS_NR_mERa"	517179	2710534	2699811	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008558"	32004	"13311-84-7"	"Flutamide"	"C13311847"	725	"NVS_NR_mERa"	517495	2710534	2699811	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008562"	20944	"59-87-0"	"Nitrofurazone"	"C59870"	75	"ATG_ERE_CIS_up"	13373	2093629	1964495	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX008566"	27756	"13826-35-2"	"3-Phenoxybenzenemethanol"	"C13826352"	714	"NVS_NR_hER"	517829	2709421	2698698	10	"Noisy data"	NA	NA	"percent_activity"
"TX008580"	27528	"3268-49-3"	"3-(Methylthio)propanal"	"C3268493"	742	"OT_ER_ERaERa_0480"	114953	555975	564916	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008580"	27528	"3268-49-3"	"3-(Methylthio)propanal"	"C3268493"	742	"OT_ER_ERaERa_0480"	115031	555975	564916	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008580"	27528	"3268-49-3"	"3-(Methylthio)propanal"	"C3268493"	751	"OT_ERa_EREGFP_0480"	116819	565830	568869	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008582"	21237	"50-55-5"	"Reserpine"	"C50555"	725	"NVS_NR_mERa"	517342	2710537	2699814	10	"Noisy data"	NA	NA	"percent_activity"
"TX008594"	26926	"112-72-1"	"1-Tetradecanol"	"C112721"	117	"ATG_ERa_TRANS_up"	49692	2170024	2035949	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008594"	26926	"112-72-1"	"1-Tetradecanol"	"C112721"	117	"ATG_ERa_TRANS_up"	49916	2170024	2035949	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008594"	26926	"112-72-1"	"1-Tetradecanol"	"C112721"	751	"OT_ERa_EREGFP_0480"	116820	565832	568871	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008598"	47185	"94-46-2"	"Isopentyl benzoate"	"C94462"	75	"ATG_ERE_CIS_up"	13549	2093619	1964505	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008598"	47185	"94-46-2"	"Isopentyl benzoate"	"C94462"	742	"OT_ER_ERaERa_0480"	115032	555979	564920	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008598"	47185	"94-46-2"	"Isopentyl benzoate"	"C94462"	744	"OT_ER_ERaERb_0480"	112827	2401176	2399959	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008616"	27034	"126-11-4"	"2-(Hydroxymethyl)-2-nitro-1,3-propanediol"	"C126114"	2	"ACEA_T47D_80hr_Positive"	10671	1779162	1780243	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008618"	34187	"10540-29-1"	"Tamoxifen"	"C10540291"	744	"OT_ER_ERaERb_0480"	112891	2401174	2399957	10	"Noisy data"	NA	NA	"percent_activity"
"TX008620"	47138	"98-06-6"	"tert-Butylbenzene"	"C98066"	725	"NVS_NR_mERa"	517180	2710541	2699818	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008620"	47138	"98-06-6"	"tert-Butylbenzene"	"C98066"	725	"NVS_NR_mERa"	517496	2710541	2699818	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008641"	26838	"110-27-0"	"Isopropyl tetradecanoic acid"	"C110270"	2	"ACEA_T47D_80hr_Positive"	10337	1779165	1780240	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008641"	26838	"110-27-0"	"Isopropyl tetradecanoic acid"	"C110270"	2	"ACEA_T47D_80hr_Positive"	10672	1779165	1780240	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008643"	20283	"95-83-0"	"4-Chloro-1,2-diaminobenzene"	"C95830"	75	"ATG_ERE_CIS_up"	13548	2093609	1964515	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008643"	20283	"95-83-0"	"4-Chloro-1,2-diaminobenzene"	"C95830"	117	"ATG_ERa_TRANS_up"	49691	2170012	2035937	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008643"	20283	"95-83-0"	"4-Chloro-1,2-diaminobenzene"	"C95830"	117	"ATG_ERa_TRANS_up"	49915	2170012	2035937	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008643"	20283	"95-83-0"	"4-Chloro-1,2-diaminobenzene"	"C95830"	725	"NVS_NR_mERa"	517343	2710546	2699823	10	"Noisy data"	NA	NA	"percent_activity"
"TX008648"	25595	"110-26-9"	"N,N'-Methylenebisacrylamide"	"C110269"	725	"NVS_NR_mERa"	517181	2710547	2699824	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008648"	25595	"110-26-9"	"N,N'-Methylenebisacrylamide"	"C110269"	725	"NVS_NR_mERa"	517497	2710547	2699824	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008654"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	2	"ACEA_T47D_80hr_Positive"	10761	1779169	1780236	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008654"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	714	"NVS_NR_hER"	517795	2709435	2698712	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008654"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	714	"NVS_NR_hER"	517896	2709435	2698712	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008654"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	751	"OT_ERa_EREGFP_0480"	116821	565842	568881	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008660"	21135	"842-07-9"	"C.I. Solvent Yellow 14"	"C842079"	725	"NVS_NR_mERa"	517498	2710550	2699827	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008666"	26728	"106-25-2"	"(2Z)-3,7-Dimethylocta-2,6-dien-1-ol"	"C106252"	75	"ATG_ERE_CIS_up"	13547	2093604	1964520	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008666"	26728	"106-25-2"	"(2Z)-3,7-Dimethylocta-2,6-dien-1-ol"	"C106252"	750	"OT_ERa_EREGFP_0120"	115718	572837	566905	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008672"	27246	"616-45-5"	"2-Pyrrolidinone"	"C616455"	2	"ACEA_T47D_80hr_Positive"	10673	1779172	1780234	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008672"	27246	"616-45-5"	"2-Pyrrolidinone"	"C616455"	725	"NVS_NR_mERa"	517182	2710551	2699828	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008680"	23826	"4098-71-9"	"Isophorone diisocyanate"	"C4098719"	2	"ACEA_T47D_80hr_Positive"	10338	1779173	1780232	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008682"	20845	"66-27-3"	"Methyl methanesulfonate"	"C66273"	2	"ACEA_T47D_80hr_Positive"	10674	1779174	1780231	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008682"	20845	"66-27-3"	"Methyl methanesulfonate"	"C66273"	725	"NVS_NR_mERa"	517183	2710552	2699829	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008682"	20845	"66-27-3"	"Methyl methanesulfonate"	"C66273"	725	"NVS_NR_mERa"	517499	2710552	2699829	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008684"	44202	"112-14-1"	"Octyl acetate"	"C112141"	2	"ACEA_T47D_80hr_Positive"	10339	1779175	1780230	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008684"	44202	"112-14-1"	"Octyl acetate"	"C112141"	743	"OT_ER_ERaERa_1440"	114405	551779	562962	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008702"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	714	"NVS_NR_hER"	517849	2709442	2698719	11	"Borderline active"	NA	NA	"percent_activity"
"TX008702"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	714	"NVS_NR_hER"	517957	2709442	2698719	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008702"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	714	"NVS_NR_hER"	518037	2709442	2698719	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008702"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	725	"NVS_NR_mERa"	517185	2710555	2699832	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008702"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	745	"OT_ER_ERaERb_1440"	115374	557965	536734	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008702"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	747	"OT_ER_ERbERb_1440"	114764	559933	560996	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008702"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	751	"OT_ERa_EREGFP_0480"	116822	565850	568889	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008714"	23523	"2078-54-8"	"Propofol"	"C2078548"	2	"ACEA_T47D_80hr_Positive"	10340	1779178	1780227	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008714"	23523	"2078-54-8"	"Propofol"	"C2078548"	2	"ACEA_T47D_80hr_Positive"	10402	1779178	1780227	10	"Noisy data"	NA	NA	"percent_activity"
"TX008714"	23523	"2078-54-8"	"Propofol"	"C2078548"	2	"ACEA_T47D_80hr_Positive"	10675	1779178	1780227	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008714"	23523	"2078-54-8"	"Propofol"	"C2078548"	117	"ATG_ERa_TRANS_up"	49690	2169993	2035918	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008714"	23523	"2078-54-8"	"Propofol"	"C2078548"	117	"ATG_ERa_TRANS_up"	49914	2169993	2035918	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008714"	23523	"2078-54-8"	"Propofol"	"C2078548"	745	"OT_ER_ERaERb_1440"	115502	557967	536736	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008723"	27356	"1067-53-4"	"Tris(2-methoxyethoxy)vinylsilane"	"C1067534"	2	"ACEA_T47D_80hr_Positive"	10484	1779179	1780226	11	"Borderline active"	NA	NA	"percent_activity"
"TX008723"	27356	"1067-53-4"	"Tris(2-methoxyethoxy)vinylsilane"	"C1067534"	725	"NVS_NR_mERa"	517677	2710557	2699834	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008741"	24691	"2426-08-6"	"Butyl glycidyl ether"	"C2426086"	750	"OT_ERa_EREGFP_0120"	115719	572849	566917	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008745"	29153	"120-51-4"	"Benzyl benzoate"	"C120514"	2	"ACEA_T47D_80hr_Positive"	10676	1779184	1780221	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008745"	29153	"120-51-4"	"Benzyl benzoate"	"C120514"	742	"OT_ER_ERaERa_0480"	114911	556003	564944	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008745"	29153	"120-51-4"	"Benzyl benzoate"	"C120514"	745	"OT_ER_ERaERb_1440"	115503	557973	536742	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008745"	29153	"120-51-4"	"Benzyl benzoate"	"C120514"	747	"OT_ER_ERbERb_1440"	114879	559941	561004	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008753"	27403	"1461-22-9"	"Tributyltin chloride"	"C1461229"	75	"ATG_ERE_CIS_up"	13287	2093581	1964543	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008753"	27403	"1461-22-9"	"Tributyltin chloride"	"C1461229"	75	"ATG_ERE_CIS_up"	13546	2093581	1964543	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008753"	27403	"1461-22-9"	"Tributyltin chloride"	"C1461229"	725	"NVS_NR_mERa"	517585	2710562	2699839	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008753"	27403	"1461-22-9"	"Tributyltin chloride"	"C1461229"	725	"NVS_NR_mERa"	517679	2710562	2699839	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008758"	20212	"2409-55-4"	"2-tert-Butyl-4-methylphenol"	"C2409554"	117	"ATG_ERa_TRANS_up"	49913	2169983	2035908	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008758"	20212	"2409-55-4"	"2-tert-Butyl-4-methylphenol"	"C2409554"	746	"OT_ER_ERbERb_0480"	116573	549821	559036	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008762"	25003	"583-78-8"	"2,5-Dichlorophenol"	"C583788"	2	"ACEA_T47D_80hr_Positive"	10341	1779187	1780218	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008762"	25003	"583-78-8"	"2,5-Dichlorophenol"	"C583788"	75	"ATG_ERE_CIS_up"	13286	2093579	1964545	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008762"	25003	"583-78-8"	"2,5-Dichlorophenol"	"C583788"	75	"ATG_ERE_CIS_up"	13545	2093579	1964545	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008762"	25003	"583-78-8"	"2,5-Dichlorophenol"	"C583788"	744	"OT_ER_ERaERb_0480"	112926	2401149	2399987	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008764"	20666	"556-52-5"	"Glycidol"	"C556525"	714	"NVS_NR_hER"	517830	2709452	2698729	10	"Noisy data"	NA	NA	"percent_activity"
"TX008776"	22153	"1461-25-2"	"Tetrabutyltin"	"C1461252"	75	"ATG_ERE_CIS_up"	13791	2093573	1964551	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX008776"	22153	"1461-25-2"	"Tetrabutyltin"	"C1461252"	117	"ATG_ERa_TRANS_up"	49912	2169976	2035901	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	117	"ATG_ERa_TRANS_up"	49688	2169975	2035900	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	117	"ATG_ERa_TRANS_up"	49911	2169975	2035900	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	714	"NVS_NR_hER"	517724	2709455	2698732	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	714	"NVS_NR_hER"	517850	2709455	2698732	11	"Borderline active"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	714	"NVS_NR_hER"	517959	2709455	2698732	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	714	"NVS_NR_hER"	518039	2709455	2698732	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	743	"OT_ER_ERaERa_1440"	114352	551797	562980	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	743	"OT_ER_ERaERa_1440"	114480	551797	562980	11	"Borderline active"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	744	"OT_ER_ERaERb_0480"	112826	2401144	2399996	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	746	"OT_ER_ERbERb_0480"	116574	549827	559042	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	750	"OT_ERa_EREGFP_0120"	115720	572859	566927	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	750	"OT_ERa_EREGFP_0120"	115865	572859	566927	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008780"	22413	"97-54-1"	"Isoeugenol"	"C97541"	751	"OT_ERa_EREGFP_0480"	116898	565866	568905	11	"Borderline active"	NA	NA	"percent_activity"
"TX008788"	31131	"131-18-0"	"Dipentyl phthalate"	"C131180"	75	"ATG_ERE_CIS_up"	13544	2093570	1964554	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008788"	31131	"131-18-0"	"Dipentyl phthalate"	"C131180"	117	"ATG_ERa_TRANS_up"	49687	2169973	2035898	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX008788"	31131	"131-18-0"	"Dipentyl phthalate"	"C131180"	117	"ATG_ERa_TRANS_up"	49910	2169973	2035898	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008788"	31131	"131-18-0"	"Dipentyl phthalate"	"C131180"	743	"OT_ER_ERaERa_1440"	114499	551799	562982	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008788"	31131	"131-18-0"	"Dipentyl phthalate"	"C131180"	747	"OT_ER_ERbERb_1440"	114810	559951	561014	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008788"	31131	"131-18-0"	"Dipentyl phthalate"	"C131180"	747	"OT_ER_ERbERb_1440"	114880	559951	561014	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008801"	20190	"860-22-0"	"C.I. Acid Blue 74"	"C860220"	2	"ACEA_T47D_80hr_Positive"	10342	1779195	1780210	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008801"	20190	"860-22-0"	"C.I. Acid Blue 74"	"C860220"	2	"ACEA_T47D_80hr_Positive"	10677	1779195	1780210	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008801"	20190	"860-22-0"	"C.I. Acid Blue 74"	"C860220"	75	"ATG_ERE_CIS_up"	13543	2093569	1964555	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008810"	21239	"302-79-4"	"trans-Retinoic acid"	"C302794"	746	"OT_ER_ERbERb_0480"	116595	549831	559046	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008810"	21239	"302-79-4"	"trans-Retinoic acid"	"C302794"	746	"OT_ER_ERbERb_0480"	116665	549831	559046	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008824"	21393	"112-27-6"	"Triethylene glycol"	"C112276"	725	"NVS_NR_mERa"	517188	2710572	2699849	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008830"	26904	"112-07-2"	"2-Butoxyethyl acetate"	"C112072"	2	"ACEA_T47D_80hr_Positive"	10678	1779199	1780206	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008830"	26904	"112-07-2"	"2-Butoxyethyl acetate"	"C112072"	743	"OT_ER_ERaERa_1440"	114406	551804	562987	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008836"	20106	"50-81-7"	"L-Ascorbic acid"	"C50817"	743	"OT_ER_ERaERa_1440"	114456	551806	562989	10	"Noisy data"	NA	NA	"percent_activity"
"TX008838"	22370	"57-83-0"	"Progesterone"	"C57830"	2	"ACEA_T47D_80hr_Positive"	10403	1779202	1780204	10	"Noisy data"	NA	NA	"percent_activity"
"TX008838"	22370	"57-83-0"	"Progesterone"	"C57830"	708	"NVS_NR_bER"	516348	2707216	2696176	11	"Borderline active"	NA	NA	"percent_activity"
"TX008838"	22370	"57-83-0"	"Progesterone"	"C57830"	708	"NVS_NR_bER"	516510	2707216	2696176	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008848"	26706	"104-66-5"	"1,2-Diphenoxyethane"	"C104665"	2	"ACEA_T47D_80hr_Positive"	10679	1779203	1780202	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008854"	27550	"3926-62-3"	"Sodium chloroacetate"	"C3926623"	745	"OT_ER_ERaERb_1440"	115417	557993	536762	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008854"	27550	"3926-62-3"	"Sodium chloroacetate"	"C3926623"	747	"OT_ER_ERbERb_1440"	114811	559961	561024	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008876"	25486	"51-30-9"	"Isoproterenol hydrochloride"	"C51309"	725	"NVS_NR_mERa"	517190	2710578	2699855	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008876"	25486	"51-30-9"	"Isoproterenol hydrochloride"	"C51309"	725	"NVS_NR_mERa"	517500	2710578	2699855	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008902"	27650	"7398-69-8"	"Dimethyldiallylammonium chloride"	"C7398698"	742	"OT_ER_ERaERa_0480"	114954	556027	564968	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008902"	27650	"7398-69-8"	"Dimethyldiallylammonium chloride"	"C7398698"	743	"OT_ER_ERaERa_1440"	114407	551814	562997	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008902"	27650	"7398-69-8"	"Dimethyldiallylammonium chloride"	"C7398698"	743	"OT_ER_ERaERa_1440"	114457	551814	562997	10	"Noisy data"	NA	NA	"percent_activity"
"TX008902"	27650	"7398-69-8"	"Dimethyldiallylammonium chloride"	"C7398698"	745	"OT_ER_ERaERb_1440"	115504	557998	536767	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008902"	27650	"7398-69-8"	"Dimethyldiallylammonium chloride"	"C7398698"	750	"OT_ERa_EREGFP_0120"	115802	572876	566944	10	"Noisy data"	NA	NA	"percent_activity"
"TX008906"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	117	"ATG_ERa_TRANS_up"	49569	2169952	2035877	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX008906"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	708	"NVS_NR_bER"	516349	2707222	2696182	11	"Borderline active"	NA	NA	"percent_activity"
"TX008906"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	708	"NVS_NR_bER"	516449	2707222	2696182	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008906"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	708	"NVS_NR_bER"	516511	2707222	2696182	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX008906"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	744	"OT_ER_ERaERb_0480"	112925	2401126	2400007	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008906"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	745	"OT_ER_ERaERb_1440"	115505	557999	536768	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008910"	33161	"1646-87-3"	"Aldicarb sulfoxide"	"C1646873"	117	"ATG_ERa_TRANS_up"	49908	2169951	2035876	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008932"	26908	"112-25-4"	"2-(Hexyloxy)ethanol"	"C112254"	75	"ATG_ERE_CIS_up"	13542	2093546	1964578	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX008939"	21031	"156-10-5"	"4-Nitrosodiphenylamine"	"C156105"	714	"NVS_NR_hER"	517796	2709470	2698747	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008939"	21031	"156-10-5"	"4-Nitrosodiphenylamine"	"C156105"	714	"NVS_NR_hER"	517897	2709470	2698747	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008939"	21031	"156-10-5"	"4-Nitrosodiphenylamine"	"C156105"	725	"NVS_NR_mERa"	517586	2710584	2699861	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX008966"	26694	"103-09-3"	"2-Ethylhexyl acetate"	"C103093"	2	"ACEA_T47D_80hr_Positive"	10680	1779213	1780192	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008968"	20916	"2243-62-1"	"1,5-Naphthalenediamine"	"C2243621"	743	"OT_ER_ERaERa_1440"	114458	551820	563003	10	"Noisy data"	NA	NA	"percent_activity"
"TX008982"	26564	"94-28-0"	"Triethylene glycol bis(2-ethylhexanoate)"	"C94280"	714	"NVS_NR_hER"	517898	2709472	2698749	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX008982"	26564	"94-28-0"	"Triethylene glycol bis(2-ethylhexanoate)"	"C94280"	725	"NVS_NR_mERa"	517193	2710586	2699863	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008982"	26564	"94-28-0"	"Triethylene glycol bis(2-ethylhexanoate)"	"C94280"	750	"OT_ERa_EREGFP_0120"	115722	572885	566953	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX008989"	27184	"541-02-6"	"Decamethylcyclopentasiloxane"	"C541026"	745	"OT_ER_ERaERb_1440"	115465	558008	536777	11	"Borderline active"	NA	NA	"percent_activity"
"TX009000"	27205	"556-67-2"	"Octamethylcyclotetrasiloxane"	"C556672"	725	"NVS_NR_mERa"	517194	2710587	2699864	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009002"	25297	"103-11-7"	"2-Ethylhexyl acrylate"	"C103117"	2	"ACEA_T47D_80hr_Positive"	10343	1779223	1780182	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009018"	40151	"39236-46-9"	"Imidazolidinyl urea"	"C39236469"	75	"ATG_ERE_CIS_up"	13195	2093526	1964598	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009018"	40151	"39236-46-9"	"Imidazolidinyl urea"	"C39236469"	75	"ATG_ERE_CIS_up"	13790	2093526	1964598	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009018"	40151	"39236-46-9"	"Imidazolidinyl urea"	"C39236469"	117	"ATG_ERa_TRANS_up"	49628	2169929	2035854	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009018"	40151	"39236-46-9"	"Imidazolidinyl urea"	"C39236469"	117	"ATG_ERa_TRANS_up"	50163	2169929	2035854	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009018"	40151	"39236-46-9"	"Imidazolidinyl urea"	"C39236469"	743	"OT_ER_ERaERa_1440"	114408	551831	563014	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009018"	40151	"39236-46-9"	"Imidazolidinyl urea"	"C39236469"	743	"OT_ER_ERaERa_1440"	114500	551831	563014	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009018"	40151	"39236-46-9"	"Imidazolidinyl urea"	"C39236469"	745	"OT_ER_ERaERb_1440"	115376	558015	536784	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009029"	26915	"112-42-5"	"1-Undecanol"	"C112425"	725	"NVS_NR_mERa"	517196	2710590	2699867	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009029"	26915	"112-42-5"	"1-Undecanol"	"C112425"	745	"OT_ER_ERaERb_1440"	115418	558017	536786	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009029"	26915	"112-42-5"	"1-Undecanol"	"C112425"	745	"OT_ER_ERaERb_1440"	115506	558017	536786	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009029"	26915	"112-42-5"	"1-Undecanol"	"C112425"	746	"OT_ER_ERbERb_0480"	116667	549862	559077	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009029"	26915	"112-42-5"	"1-Undecanol"	"C112425"	747	"OT_ER_ERbERb_1440"	114812	559985	561048	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009029"	26915	"112-42-5"	"1-Undecanol"	"C112425"	747	"OT_ER_ERbERb_1440"	114881	559985	561048	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	75	"ATG_ERE_CIS_up"	13194	2093522	1964602	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	75	"ATG_ERE_CIS_up"	13371	2093522	1964602	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	75	"ATG_ERE_CIS_up"	13789	2093522	1964602	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	743	"OT_ER_ERaERa_1440"	114409	551834	563017	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	743	"OT_ER_ERaERa_1440"	114501	551834	563017	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	745	"OT_ER_ERaERb_1440"	115419	558018	536787	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	750	"OT_ERa_EREGFP_0120"	115723	572896	566964	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009036"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	750	"OT_ERa_EREGFP_0120"	115803	572896	566964	10	"Noisy data"	NA	NA	"percent_activity"
"TX009038"	21956	"117-84-0"	"Dioctyl phthalate"	"C117840"	2	"ACEA_T47D_80hr_Positive"	10200	1779228	1780177	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009038"	21956	"117-84-0"	"Dioctyl phthalate"	"C117840"	725	"NVS_NR_mERa"	517197	2710591	2699868	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009038"	21956	"117-84-0"	"Dioctyl phthalate"	"C117840"	725	"NVS_NR_mERa"	517503	2710591	2699868	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009038"	21956	"117-84-0"	"Dioctyl phthalate"	"C117840"	742	"OT_ER_ERaERa_0480"	114981	556048	564989	10	"Noisy data"	NA	NA	"percent_activity"
"TX009050"	43915	"630-56-8"	"Hydroxyprogesterone caproate"	"C630568"	744	"OT_ER_ERaERb_0480"	112876	2401104	2400027	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009050"	43915	"630-56-8"	"Hydroxyprogesterone caproate"	"C630568"	744	"OT_ER_ERaERb_0480"	112924	2401104	2400027	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009050"	43915	"630-56-8"	"Hydroxyprogesterone caproate"	"C630568"	745	"OT_ER_ERaERb_1440"	115377	558021	536790	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009050"	43915	"630-56-8"	"Hydroxyprogesterone caproate"	"C630568"	746	"OT_ER_ERbERb_0480"	116617	549866	559081	11	"Borderline active"	NA	NA	"percent_activity"
"TX009050"	43915	"630-56-8"	"Hydroxyprogesterone caproate"	"C630568"	751	"OT_ERa_EREGFP_0480"	116824	565906	568945	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009062"	29761	"51580-86-0"	"Sodium dichloro-s-triazinetrione dihydrate"	"C51580860"	747	"OT_ER_ERbERb_1440"	114813	559990	561053	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009064"	22396	"480-40-0"	"Chrysin"	"C480400"	2	"ACEA_T47D_80hr_Positive"	10236	1779232	1780173	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009064"	22396	"480-40-0"	"Chrysin"	"C480400"	117	"ATG_ERa_TRANS_up"	49793	2169917	2035842	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX009064"	22396	"480-40-0"	"Chrysin"	"C480400"	725	"NVS_NR_mERa"	517198	2710595	2699872	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009064"	22396	"480-40-0"	"Chrysin"	"C480400"	742	"OT_ER_ERaERa_0480"	114955	556052	564993	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009064"	22396	"480-40-0"	"Chrysin"	"C480400"	743	"OT_ER_ERaERa_1440"	114410	551839	563022	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009070"	21244	"13292-46-1"	"Rifampicin"	"C13292461"	708	"NVS_NR_bER"	516289	2707238	2696198	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009092"	27402	"1459-93-4"	"Dimethyl isophthalate"	"C1459934"	2	"ACEA_T47D_80hr_Positive"	10344	1779236	1780169	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009092"	27402	"1459-93-4"	"Dimethyl isophthalate"	"C1459934"	2	"ACEA_T47D_80hr_Positive"	10681	1779236	1780169	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009092"	27402	"1459-93-4"	"Dimethyl isophthalate"	"C1459934"	75	"ATG_ERE_CIS_up"	13193	2093507	1964617	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009092"	27402	"1459-93-4"	"Dimethyl isophthalate"	"C1459934"	75	"ATG_ERE_CIS_up"	13788	2093507	1964617	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009092"	27402	"1459-93-4"	"Dimethyl isophthalate"	"C1459934"	117	"ATG_ERa_TRANS_up"	49905	2169910	2035835	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009097"	23796	"140-64-7"	"Pentamidine isethionate"	"C140647"	2	"ACEA_T47D_80hr_Positive"	10237	1779238	1780168	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009097"	23796	"140-64-7"	"Pentamidine isethionate"	"C140647"	117	"ATG_ERa_TRANS_up"	49792	2169908	2035833	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX009097"	23796	"140-64-7"	"Pentamidine isethionate"	"C140647"	117	"ATG_ERa_TRANS_up"	50162	2169908	2035833	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009097"	23796	"140-64-7"	"Pentamidine isethionate"	"C140647"	708	"NVS_NR_bER"	516290	2707239	2696199	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009097"	23796	"140-64-7"	"Pentamidine isethionate"	"C140647"	725	"NVS_NR_mERa"	517680	2710597	2699874	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009097"	23796	"140-64-7"	"Pentamidine isethionate"	"C140647"	750	"OT_ERa_EREGFP_0120"	115724	572907	566975	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009149"	20154	"120-32-1"	"Clorophene"	"C120321"	745	"OT_ER_ERaERb_1440"	115378	558031	536800	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009149"	20154	"120-32-1"	"Clorophene"	"C120321"	747	"OT_ER_ERbERb_1440"	114765	559999	561062	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009151"	32655	"131983-72-7"	"Triticonazole"	"C131983727"	2	"ACEA_T47D_80hr_Positive"	10345	1779242	1780163	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009151"	32655	"131983-72-7"	"Triticonazole"	"C131983727"	2	"ACEA_T47D_80hr_Positive"	10682	1779242	1780163	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009152"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	747	"OT_ER_ERbERb_1440"	114814	560002	561065	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009152"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	747	"OT_ER_ERbERb_1440"	114882	560002	561065	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009152"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	750	"OT_ERa_EREGFP_0120"	115725	572912	566980	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009152"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	750	"OT_ERa_EREGFP_0120"	115866	572912	566980	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009152"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	751	"OT_ERa_EREGFP_0480"	116825	565919	568958	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009154"	20819	"950-37-8"	"Methidathion"	"C950378"	750	"OT_ERa_EREGFP_0120"	115867	572914	566982	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009155"	32424	"104206-82-8"	"Mesotrione"	"C104206828"	2	"ACEA_T47D_80hr_Positive"	10683	1779246	1780159	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009157"	34586	"153233-91-1"	"Etoxazole"	"C153233911"	751	"OT_ERa_EREGFP_0480"	116826	565924	568963	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009190"	22421	"73-31-4"	"Melatonin"	"C73314"	2	"ACEA_T47D_80hr_Positive"	10346	1779252	1780154	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009190"	22421	"73-31-4"	"Melatonin"	"C73314"	117	"ATG_ERa_TRANS_up"	49686	2169901	2035826	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX009190"	22421	"73-31-4"	"Melatonin"	"C73314"	117	"ATG_ERa_TRANS_up"	49904	2169901	2035826	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009190"	22421	"73-31-4"	"Melatonin"	"C73314"	743	"OT_ER_ERaERa_1440"	114411	551858	563041	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009190"	22421	"73-31-4"	"Melatonin"	"C73314"	745	"OT_ER_ERaERb_1440"	115507	558042	536811	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009196"	20485	"20325-40-0"	"3,3'-Dimethoxybenzidine dihydrochloride"	"C20325400"	2	"ACEA_T47D_80hr_Positive"	10201	1779254	1780151	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009196"	20485	"20325-40-0"	"3,3'-Dimethoxybenzidine dihydrochloride"	"C20325400"	75	"ATG_ERE_CIS_up"	13787	2093495	1964629	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009196"	20485	"20325-40-0"	"3,3'-Dimethoxybenzidine dihydrochloride"	"C20325400"	725	"NVS_NR_mERa"	517349	2710603	2699880	10	"Noisy data"	NA	NA	"percent_activity"
"TX009212"	27635	"6846-50-0"	"2,2,4-Trimethyl-1,3-pentanediol diisobutyrate"	"C6846500"	725	"NVS_NR_mERa"	517200	2710606	2699883	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009212"	27635	"6846-50-0"	"2,2,4-Trimethyl-1,3-pentanediol diisobutyrate"	"C6846500"	744	"OT_ER_ERaERb_0480"	112923	2401078	2400056	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009212"	27635	"6846-50-0"	"2,2,4-Trimethyl-1,3-pentanediol diisobutyrate"	"C6846500"	750	"OT_ERa_EREGFP_0120"	115726	572925	566993	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009216"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	117	"ATG_ERa_TRANS_up"	50161	2169892	2035817	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009216"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	725	"NVS_NR_mERa"	517201	2710607	2699884	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009216"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	742	"OT_ER_ERaERa_0480"	114956	556077	565018	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009219"	27826	"23386-52-9"	"Dicyclohexyl sodium sulfosuccinate"	"C23386529"	2	"ACEA_T47D_80hr_Positive"	10347	1779259	1780147	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009219"	27826	"23386-52-9"	"Dicyclohexyl sodium sulfosuccinate"	"C23386529"	2	"ACEA_T47D_80hr_Positive"	10684	1779259	1780147	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009219"	27826	"23386-52-9"	"Dicyclohexyl sodium sulfosuccinate"	"C23386529"	75	"ATG_ERE_CIS_up"	13334	2093488	1964636	10	"Noisy data"	NA	NA	"log2_fold_induction"
"TX009219"	27826	"23386-52-9"	"Dicyclohexyl sodium sulfosuccinate"	"C23386529"	75	"ATG_ERE_CIS_up"	13786	2093488	1964636	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009219"	27826	"23386-52-9"	"Dicyclohexyl sodium sulfosuccinate"	"C23386529"	117	"ATG_ERa_TRANS_up"	49685	2169891	2035816	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX009219"	27826	"23386-52-9"	"Dicyclohexyl sodium sulfosuccinate"	"C23386529"	743	"OT_ER_ERaERa_1440"	114412	551865	563048	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009225"	20910	"55-98-1"	"Busulfan"	"C55981"	2	"ACEA_T47D_80hr_Positive"	10685	1779260	1780145	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009225"	20910	"55-98-1"	"Busulfan"	"C55981"	714	"NVS_NR_hER"	517852	2709495	2698772	11	"Borderline active"	NA	NA	"percent_activity"
"TX009225"	20910	"55-98-1"	"Busulfan"	"C55981"	714	"NVS_NR_hER"	517961	2709495	2698772	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009225"	20910	"55-98-1"	"Busulfan"	"C55981"	714	"NVS_NR_hER"	518042	2709495	2698772	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009244"	26867	"111-20-6"	"Decanedioic acid"	"C111206"	2	"ACEA_T47D_80hr_Positive"	10485	1779263	1780142	11	"Borderline active"	NA	NA	"percent_activity"
"TX009264"	27270	"629-76-5"	"1-Pentadecanol"	"C629765"	750	"OT_ERa_EREGFP_0120"	115727	572934	567002	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009264"	27270	"629-76-5"	"1-Pentadecanol"	"C629765"	751	"OT_ERa_EREGFP_0480"	116827	565941	568980	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009284"	27345	"960-71-4"	"Triphenylborane"	"C960714"	708	"NVS_NR_bER"	516394	2707255	2696215	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009284"	27345	"960-71-4"	"Triphenylborane"	"C960714"	751	"OT_ERa_EREGFP_0480"	116828	565944	568983	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009316"	20371	"80-08-0"	"Dapsone"	"C80080"	75	"ATG_ERE_CIS_up"	13154	2093464	1964660	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009316"	20371	"80-08-0"	"Dapsone"	"C80080"	750	"OT_ERa_EREGFP_0120"	115728	572943	567011	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009320"	21414	"78-42-2"	"Tris(2-ethylhexyl) phosphate"	"C78422"	2	"ACEA_T47D_80hr_Positive"	10202	1779276	1780130	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009320"	21414	"78-42-2"	"Tris(2-ethylhexyl) phosphate"	"C78422"	75	"ATG_ERE_CIS_up"	13192	2093463	1964661	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009320"	21414	"78-42-2"	"Tris(2-ethylhexyl) phosphate"	"C78422"	75	"ATG_ERE_CIS_up"	13785	2093463	1964661	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009326"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	2	"ACEA_T47D_80hr_Positive"	10203	1779277	1780128	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009326"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	117	"ATG_ERa_TRANS_up"	49684	2169865	2035790	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX009326"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	751	"OT_ERa_EREGFP_0480"	116829	565952	568991	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009328"	27593	"5216-25-1"	"4-Chlorobenzotrichloride"	"C5216251"	744	"OT_ER_ERaERb_0480"	112922	2401057	2400075	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009342"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	75	"ATG_ERE_CIS_up"	13285	2093458	1964666	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX009342"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	75	"ATG_ERE_CIS_up"	13541	2093458	1964666	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009342"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	117	"ATG_ERa_TRANS_up"	49568	2169861	2035786	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009342"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	714	"NVS_NR_hER"	518043	2709502	2698779	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009342"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	725	"NVS_NR_mERa"	517681	2710616	2699893	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009342"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	744	"OT_ER_ERaERb_0480"	112921	2401055	2400086	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009348"	26842	"110-42-9"	"Methyl decanoate"	"C110429"	2	"ACEA_T47D_80hr_Positive"	10486	1779281	1780124	11	"Borderline active"	NA	NA	"percent_activity"
"TX009348"	26842	"110-42-9"	"Methyl decanoate"	"C110429"	75	"ATG_ERE_CIS_up"	13540	2093456	1964669	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009348"	26842	"110-42-9"	"Methyl decanoate"	"C110429"	743	"OT_ER_ERaERa_1440"	114413	551887	563070	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009378"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	747	"OT_ER_ERbERb_1440"	114815	560043	561106	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009378"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	747	"OT_ER_ERbERb_1440"	114883	560043	561106	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009378"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	750	"OT_ERa_EREGFP_0120"	115548	572953	567021	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009378"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	750	"OT_ERa_EREGFP_0120"	115821	572953	567021	11	"Borderline active"	NA	NA	"percent_activity"
"TX009378"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	750	"OT_ERa_EREGFP_0120"	115888	572953	567021	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009378"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	751	"OT_ERa_EREGFP_0480"	116699	565960	568999	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009378"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	751	"OT_ERa_EREGFP_0480"	116889	565960	568999	10	"Noisy data"	NA	NA	"percent_activity"
"TX009388"	25403	"6789-88-4"	"Hexyl benzoate"	"C6789884"	2	"ACEA_T47D_80hr_Positive"	10348	1779286	1780119	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009390"	27076	"139-96-8"	"Dodecyl sulfate triethanolamine"	"C139968"	750	"OT_ERa_EREGFP_0120"	115804	572956	567024	10	"Noisy data"	NA	NA	"percent_activity"
"TX009404"	26566	"94-60-0"	"Dimethyl hexahydroterephthalate"	"C94600"	75	"ATG_ERE_CIS_up"	13539	2093440	1964684	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009404"	26566	"94-60-0"	"Dimethyl hexahydroterephthalate"	"C94600"	117	"ATG_ERa_TRANS_up"	49903	2169843	2035768	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009404"	26566	"94-60-0"	"Dimethyl hexahydroterephthalate"	"C94600"	747	"OT_ER_ERbERb_1440"	114816	560048	561111	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009412"	34361	"90823-38-4"	"Denatonium saccharide"	"C90823384"	2	"ACEA_T47D_80hr_Positive"	10349	1779290	1780115	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009412"	34361	"90823-38-4"	"Denatonium saccharide"	"C90823384"	742	"OT_ER_ERaERa_0480"	114957	556110	565051	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009412"	34361	"90823-38-4"	"Denatonium saccharide"	"C90823384"	743	"OT_ER_ERaERa_1440"	114414	551897	563080	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009412"	34361	"90823-38-4"	"Denatonium saccharide"	"C90823384"	745	"OT_ER_ERaERb_1440"	115466	558081	536850	11	"Borderline active"	NA	NA	"percent_activity"
"TX009412"	34361	"90823-38-4"	"Denatonium saccharide"	"C90823384"	751	"OT_ERa_EREGFP_0480"	116830	565966	569005	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009437"	21965	"120-82-1"	"1,2,4-Trichlorobenzene"	"C120821"	2	"ACEA_T47D_80hr_Positive"	10686	1779293	1780112	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009459"	20606	"103-23-1"	"Di(2-ethylhexyl) adipate"	"C103231"	750	"OT_ERa_EREGFP_0120"	115729	572963	567031	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009470"	24200	"108-39-4"	"m-Cresol"	"C108394"	2	"ACEA_T47D_80hr_Positive"	10687	1779295	1780111	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	2	"ACEA_T47D_80hr_Positive"	10688	1779296	1780109	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	117	"ATG_ERa_TRANS_up"	49901	2169832	2035757	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	742	"OT_ER_ERaERa_0480"	114912	556116	565057	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	742	"OT_ER_ERaERa_0480"	114994	556116	565057	11	"Borderline active"	NA	NA	"percent_activity"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	744	"OT_ER_ERaERb_0480"	112920	2401038	2400088	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	745	"OT_ER_ERaERb_1440"	115379	558087	536856	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	746	"OT_ER_ERbERb_0480"	116575	549932	559147	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009477"	26906	"112-18-5"	"N,N-Dimethyldodecan-1-amine"	"C112185"	747	"OT_ER_ERbERb_1440"	114884	560055	561118	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009481"	27134	"298-07-7"	"Bis(2-ethylhexyl) phosphate"	"C298077"	75	"ATG_ERE_CIS_up"	13284	2093427	1964697	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX009481"	27134	"298-07-7"	"Bis(2-ethylhexyl) phosphate"	"C298077"	75	"ATG_ERE_CIS_up"	13537	2093427	1964697	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009481"	27134	"298-07-7"	"Bis(2-ethylhexyl) phosphate"	"C298077"	117	"ATG_ERa_TRANS_up"	49900	2169830	2035755	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009481"	27134	"298-07-7"	"Bis(2-ethylhexyl) phosphate"	"C298077"	725	"NVS_NR_mERa"	517505	2710626	2699903	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009483"	26548	"90-72-2"	"2,4,6-Tris(dimethylaminomethyl)phenol"	"C90722"	2	"ACEA_T47D_80hr_Positive"	10762	1779299	1780106	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009483"	26548	"90-72-2"	"2,4,6-Tris(dimethylaminomethyl)phenol"	"C90722"	725	"NVS_NR_mERa"	517355	2710627	2699904	10	"Noisy data"	NA	NA	"percent_activity"
"TX009485"	26238	"75-50-3"	"Trimethylamine"	"C75503"	743	"OT_ER_ERaERa_1440"	114415	551907	563090	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009487"	20499	"127-19-5"	"N,N-Dimethylacetamide"	"C127195"	2	"ACEA_T47D_80hr_Positive"	10204	1779301	1780104	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009493"	24284	"107-98-2"	"1-Methoxy-2-propanol"	"C107982"	2	"ACEA_T47D_80hr_Positive"	10689	1779302	1780103	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009497"	26461	"78-82-0"	"2-Methylpropanenitrile"	"C78820"	2	"ACEA_T47D_80hr_Positive"	10205	1779303	1780102	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009497"	26461	"78-82-0"	"2-Methylpropanenitrile"	"C78820"	2	"ACEA_T47D_80hr_Positive"	10487	1779303	1780102	11	"Borderline active"	NA	NA	"percent_activity"
"TX009497"	26461	"78-82-0"	"2-Methylpropanenitrile"	"C78820"	2	"ACEA_T47D_80hr_Positive"	10763	1779303	1780102	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009515"	20359	"108-94-1"	"Cyclohexanone"	"C108941"	2	"ACEA_T47D_80hr_Positive"	10350	1779305	1780100	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009515"	20359	"108-94-1"	"Cyclohexanone"	"C108941"	743	"OT_ER_ERaERa_1440"	114416	551912	563095	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009515"	20359	"108-94-1"	"Cyclohexanone"	"C108941"	743	"OT_ER_ERaERa_1440"	114459	551912	563095	10	"Noisy data"	NA	NA	"percent_activity"
"TX009515"	20359	"108-94-1"	"Cyclohexanone"	"C108941"	745	"OT_ER_ERaERb_1440"	115508	558096	536865	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009535"	25355	"111-30-8"	"Glutaraldehyde"	"C111308"	708	"NVS_NR_bER"	516232	2707273	2696233	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009535"	25355	"111-30-8"	"Glutaraldehyde"	"C111308"	708	"NVS_NR_bER"	516450	2707273	2696233	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009535"	25355	"111-30-8"	"Glutaraldehyde"	"C111308"	708	"NVS_NR_bER"	516515	2707273	2696233	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009535"	25355	"111-30-8"	"Glutaraldehyde"	"C111308"	745	"OT_ER_ERaERb_1440"	115380	558097	536866	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009545"	20843	"112-63-0"	"Methyl linoleate"	"C112630"	708	"NVS_NR_bER"	516396	2707274	2696234	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009545"	20843	"112-63-0"	"Methyl linoleate"	"C112630"	714	"NVS_NR_hER"	517962	2709517	2698794	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009545"	20843	"112-63-0"	"Methyl linoleate"	"C112630"	714	"NVS_NR_hER"	518044	2709517	2698794	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009545"	20843	"112-63-0"	"Methyl linoleate"	"C112630"	751	"OT_ERa_EREGFP_0480"	116831	565984	569023	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009545"	20843	"112-63-0"	"Methyl linoleate"	"C112630"	751	"OT_ERa_EREGFP_0480"	116922	565984	569023	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009561"	21655	"109-52-4"	"Pentanoic acid"	"C109524"	2	"ACEA_T47D_80hr_Positive"	10690	1779309	1780096	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009561"	21655	"109-52-4"	"Pentanoic acid"	"C109524"	743	"OT_ER_ERaERa_1440"	114417	551916	563099	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009561"	21655	"109-52-4"	"Pentanoic acid"	"C109524"	751	"OT_ERa_EREGFP_0480"	116832	565985	569024	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009565"	28665	"68515-48-0"	"DINP branched"	"C68515480"	2	"ACEA_T47D_80hr_Positive"	10691	1779310	1780095	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009565"	28665	"68515-48-0"	"DINP branched"	"C68515480"	743	"OT_ER_ERaERa_1440"	114418	551917	563100	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009565"	28665	"68515-48-0"	"DINP branched"	"C68515480"	743	"OT_ER_ERaERa_1440"	114502	551917	563100	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009565"	28665	"68515-48-0"	"DINP branched"	"C68515480"	745	"OT_ER_ERaERb_1440"	115420	558101	536870	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009585"	29848	"108419-33-6"	"Acetic acid, C8-10-branched alkyl esters, C9-rich"	"C108419336"	2	"ACEA_T47D_80hr_Positive"	10351	1779312	1780093	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009587"	20493	"868-85-9"	"Dimethyl hydrogen phosphite"	"C868859"	2	"ACEA_T47D_80hr_Positive"	10352	1779313	1780092	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009587"	20493	"868-85-9"	"Dimethyl hydrogen phosphite"	"C868859"	2	"ACEA_T47D_80hr_Positive"	10692	1779313	1780092	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009595"	20307	"107-30-2"	"Chloromethyl methyl ether"	"C107302"	117	"ATG_ERa_TRANS_up"	49567	2169805	2035730	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009595"	20307	"107-30-2"	"Chloromethyl methyl ether"	"C107302"	117	"ATG_ERa_TRANS_up"	50160	2169805	2035730	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009607"	20415	"106-93-4"	"1,2-Dibromoethane"	"C106934"	2	"ACEA_T47D_80hr_Positive"	10353	1779317	1780088	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009621"	21029	"62-75-9"	"N-Nitrosodimethylamine"	"C62759"	708	"NVS_NR_bER"	516292	2707276	2696236	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009639"	25805	"26530-20-1"	"Octhilinone"	"C26530201"	708	"NVS_NR_bER"	516293	2707277	2696237	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009639"	25805	"26530-20-1"	"Octhilinone"	"C26530201"	708	"NVS_NR_bER"	516397	2707277	2696237	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009643"	26792	"108-44-1"	"3-Methylaniline"	"C108441"	2	"ACEA_T47D_80hr_Positive"	10693	1779321	1780084	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009649"	21800	"91-66-7"	"N,N-Diethylaniline"	"C91667"	2	"ACEA_T47D_80hr_Positive"	10354	1779322	1780083	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009649"	21800	"91-66-7"	"N,N-Diethylaniline"	"C91667"	117	"ATG_ERa_TRANS_up"	49899	2169793	2035718	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009651"	21391	"1330-78-5"	"Tricresyl phosphate"	"C1330785"	742	"OT_ER_ERaERa_0480"	114958	556144	565085	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009651"	21391	"1330-78-5"	"Tricresyl phosphate"	"C1330785"	742	"OT_ER_ERaERa_0480"	115034	556144	565085	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009651"	21391	"1330-78-5"	"Tricresyl phosphate"	"C1330785"	743	"OT_ER_ERaERa_1440"	114419	551931	563114	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009651"	21391	"1330-78-5"	"Tricresyl phosphate"	"C1330785"	745	"OT_ER_ERaERb_1440"	115421	558115	536884	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009651"	21391	"1330-78-5"	"Tricresyl phosphate"	"C1330785"	745	"OT_ER_ERaERb_1440"	115509	558115	536884	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009651"	21391	"1330-78-5"	"Tricresyl phosphate"	"C1330785"	750	"OT_ERa_EREGFP_0120"	115730	572993	567061	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009655"	20205	"85-68-7"	"Butyl benzyl phthalate"	"C85687"	725	"NVS_NR_mERa"	517204	2710634	2699911	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009655"	20205	"85-68-7"	"Butyl benzyl phthalate"	"C85687"	725	"NVS_NR_mERa"	517506	2710634	2699911	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009663"	27282	"644-97-3"	"Phenyl phosphorus dichloride"	"C644973"	725	"NVS_NR_mERa"	517587	2710635	2699912	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009663"	27282	"644-97-3"	"Phenyl phosphorus dichloride"	"C644973"	725	"NVS_NR_mERa"	517682	2710635	2699912	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009663"	27282	"644-97-3"	"Phenyl phosphorus dichloride"	"C644973"	750	"OT_ERa_EREGFP_0120"	115731	572997	567065	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009663"	27282	"644-97-3"	"Phenyl phosphorus dichloride"	"C644973"	750	"OT_ERa_EREGFP_0120"	115868	572997	567065	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009669"	20029	"107-13-1"	"Acrylonitrile"	"C107131"	750	"OT_ERa_EREGFP_0120"	115732	572998	567066	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009681"	26641	"99-63-8"	"1,3-Benzenedicarbonyl dichloride"	"C99638"	2	"ACEA_T47D_80hr_Positive"	10355	1779329	1780076	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009687"	20653	"548-62-9"	"Gentian Violet"	"C548629"	725	"NVS_NR_mERa"	517205	2710637	2699914	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009687"	20653	"548-62-9"	"Gentian Violet"	"C548629"	725	"NVS_NR_mERa"	517356	2710637	2699914	10	"Noisy data"	NA	NA	"percent_activity"
"TX009687"	20653	"548-62-9"	"Gentian Violet"	"C548629"	744	"OT_ER_ERaERb_0480"	112890	2401003	2400130	10	"Noisy data"	NA	NA	"percent_activity"
"TX009687"	20653	"548-62-9"	"Gentian Violet"	"C548629"	751	"OT_ERa_EREGFP_0480"	116833	566007	569046	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009689"	24105	"86-73-7"	"Fluorene"	"C86737"	2	"ACEA_T47D_80hr_Positive"	10238	1779331	1780074	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009689"	24105	"86-73-7"	"Fluorene"	"C86737"	2	"ACEA_T47D_80hr_Positive"	10488	1779331	1780074	11	"Borderline active"	NA	NA	"percent_activity"
"TX009689"	24105	"86-73-7"	"Fluorene"	"C86737"	2	"ACEA_T47D_80hr_Positive"	10764	1779331	1780074	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009689"	24105	"86-73-7"	"Fluorene"	"C86737"	75	"ATG_ERE_CIS_up"	13153	2093381	1964743	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009689"	24105	"86-73-7"	"Fluorene"	"C86737"	117	"ATG_ERa_TRANS_up"	50158	2169784	2035709	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009691"	24254	"85-01-8"	"Phenanthrene"	"C85018"	75	"ATG_ERE_CIS_up"	13283	2093380	1964744	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX009691"	24254	"85-01-8"	"Phenanthrene"	"C85018"	75	"ATG_ERE_CIS_up"	13536	2093380	1964744	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009691"	24254	"85-01-8"	"Phenanthrene"	"C85018"	744	"OT_ER_ERaERb_0480"	112825	2401001	2400128	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009695"	21030	"86-30-6"	"N-Nitrosodiphenylamine"	"C86306"	725	"NVS_NR_mERa"	517357	2710638	2699915	10	"Noisy data"	NA	NA	"percent_activity"
"TX009695"	21030	"86-30-6"	"N-Nitrosodiphenylamine"	"C86306"	742	"OT_ER_ERaERa_0480"	115035	556154	565095	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009695"	21030	"86-30-6"	"N-Nitrosodiphenylamine"	"C86306"	744	"OT_ER_ERaERb_0480"	112824	2401000	2400133	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009695"	21030	"86-30-6"	"N-Nitrosodiphenylamine"	"C86306"	747	"OT_ER_ERbERb_1440"	114817	560092	561155	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009695"	21030	"86-30-6"	"N-Nitrosodiphenylamine"	"C86306"	747	"OT_ER_ERbERb_1440"	114885	560092	561155	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009701"	22927	"69655-05-6"	"2',3'-Dideoxyinosine"	"C69655056"	2	"ACEA_T47D_80hr_Positive"	10694	1779334	1780070	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009703"	22934	"20830-75-5"	"Digoxin"	"C20830755"	750	"OT_ERa_EREGFP_0120"	115733	573005	567073	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009703"	22934	"20830-75-5"	"Digoxin"	"C20830755"	751	"OT_ERa_EREGFP_0480"	116834	566012	569051	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009707"	29167	"137-42-8"	"Metam-sodium"	"C137428"	2	"ACEA_T47D_80hr_Positive"	10695	1779336	1780069	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009707"	29167	"137-42-8"	"Metam-sodium"	"C137428"	747	"OT_ER_ERbERb_1440"	114818	560095	561158	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009709"	24624	"1675-54-3"	"Bisphenol A diglycidyl ether"	"C1675543"	2	"ACEA_T47D_80hr_Positive"	10489	1779337	1780068	11	"Borderline active"	NA	NA	"percent_activity"
"TX009709"	24624	"1675-54-3"	"Bisphenol A diglycidyl ether"	"C1675543"	714	"NVS_NR_hER"	518045	2709530	2698807	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009709"	24624	"1675-54-3"	"Bisphenol A diglycidyl ether"	"C1675543"	746	"OT_ER_ERbERb_0480"	116668	549974	559189	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009719"	20233	"50-14-6"	"Ergocalciferol"	"C50146"	2	"ACEA_T47D_80hr_Positive"	10356	1779339	1780066	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009719"	20233	"50-14-6"	"Ergocalciferol"	"C50146"	725	"NVS_NR_mERa"	517016	2710644	2699921	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009719"	20233	"50-14-6"	"Ergocalciferol"	"C50146"	725	"NVS_NR_mERa"	517588	2710644	2699921	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009735"	32345	"56-95-1"	"Chlorhexidine diacetate"	"C56951"	75	"ATG_ERE_CIS_up"	13782	2093369	1964756	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009741"	27200	"553-26-4"	"4,4'-Bipyridine"	"C553264"	2	"ACEA_T47D_80hr_Positive"	10206	1779341	1780065	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009741"	27200	"553-26-4"	"4,4'-Bipyridine"	"C553264"	2	"ACEA_T47D_80hr_Positive"	10490	1779341	1780065	11	"Borderline active"	NA	NA	"percent_activity"
"TX009746"	20127	"30516-87-1"	"3'-Azido-3'-deoxythymidine"	"C30516871"	745	"OT_ER_ERaERb_1440"	115422	558134	536903	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009749"	26314	"13463-41-7"	"Zinc pyrithione"	"C13463417"	2	"ACEA_T47D_80hr_Positive"	10696	1779344	1780061	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009749"	26314	"13463-41-7"	"Zinc pyrithione"	"C13463417"	714	"NVS_NR_hER"	517901	2709536	2698813	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009749"	26314	"13463-41-7"	"Zinc pyrithione"	"C13463417"	743	"OT_ER_ERaERa_1440"	114361	551951	563134	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009749"	26314	"13463-41-7"	"Zinc pyrithione"	"C13463417"	745	"OT_ER_ERaERb_1440"	115395	558135	536904	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009749"	26314	"13463-41-7"	"Zinc pyrithione"	"C13463417"	747	"OT_ER_ERbERb_1440"	114767	560103	561166	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX009749"	26314	"13463-41-7"	"Zinc pyrithione"	"C13463417"	750	"OT_ERa_EREGFP_0120"	115805	573014	567082	10	"Noisy data"	NA	NA	"percent_activity"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	2	"ACEA_T47D_80hr_Positive"	10405	1779350	1780055	10	"Noisy data"	NA	NA	"percent_activity"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	75	"ATG_ERE_CIS_up"	13781	2093359	1964765	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	117	"ATG_ERa_TRANS_up"	50156	2169762	2035687	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	708	"NVS_NR_bER"	516295	2707295	2696255	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	708	"NVS_NR_bER"	516398	2707295	2696255	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	725	"NVS_NR_mERa"	517400	2710651	2699928	11	"Borderline active"	NA	NA	"percent_activity"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	725	"NVS_NR_mERa"	517589	2710651	2699928	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009765"	22391	"520-36-5"	"Apigenin"	"C520365"	725	"NVS_NR_mERa"	517683	2710651	2699928	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009773"	44203	"112529-15-4"	"Pioglitazone hydrochloride"	"C112529154"	2	"ACEA_T47D_80hr_Positive"	10697	1779351	1780054	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009773"	44203	"112529-15-4"	"Pioglitazone hydrochloride"	"C112529154"	743	"OT_ER_ERaERa_1440"	114353	551957	563140	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009779"	22308	"446-72-0"	"Genistein"	"C446720"	725	"NVS_NR_mERa"	517360	2710655	2699932	10	"Noisy data"	NA	NA	"percent_activity"
"TX009789"	23868	"67485-29-4"	"Hydramethylnon"	"C67485294"	714	"NVS_NR_hER"	518046	2709545	2698822	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009789"	23868	"67485-29-4"	"Hydramethylnon"	"C67485294"	750	"OT_ERa_EREGFP_0120"	115734	573023	567091	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009789"	23868	"67485-29-4"	"Hydramethylnon"	"C67485294"	750	"OT_ERa_EREGFP_0120"	115869	573023	567091	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009789"	23868	"67485-29-4"	"Hydramethylnon"	"C67485294"	751	"OT_ERa_EREGFP_0480"	116835	566029	569068	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009795"	34181	"82640-04-8"	"Raloxifene hydrochloride"	"C82640048"	725	"NVS_NR_mERa"	517361	2710659	2699936	10	"Noisy data"	NA	NA	"percent_activity"
"TX009795"	34181	"82640-04-8"	"Raloxifene hydrochloride"	"C82640048"	745	"OT_ER_ERaERb_1440"	115443	558145	536914	10	"Noisy data"	NA	NA	"percent_activity"
"TX009803"	44303	"134523-03-8"	"Atorvastatin calcium"	"C134523038"	117	"ATG_ERa_TRANS_up"	49791	2169754	2035679	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX009803"	44303	"134523-03-8"	"Atorvastatin calcium"	"C134523038"	117	"ATG_ERa_TRANS_up"	50155	2169754	2035679	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX009807"	29298	"9004-82-4"	"Sodium lauryl polyoxyethylene ether sulfate"	"C9004824"	742	"OT_ER_ERaERa_0480"	115036	556178	565119	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009807"	29298	"9004-82-4"	"Sodium lauryl polyoxyethylene ether sulfate"	"C9004824"	745	"OT_ER_ERaERb_1440"	115381	558148	536917	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009811"	27072	"139-02-6"	"Sodium phenolate"	"C139026"	725	"NVS_NR_mERa"	517209	2710661	2699938	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009811"	27072	"139-02-6"	"Sodium phenolate"	"C139026"	725	"NVS_NR_mERa"	517508	2710661	2699938	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009811"	27072	"139-02-6"	"Sodium phenolate"	"C139026"	750	"OT_ERa_EREGFP_0120"	115735	573029	567097	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009811"	27072	"139-02-6"	"Sodium phenolate"	"C139026"	750	"OT_ERa_EREGFP_0120"	115870	573029	567097	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	117	"ATG_ERa_TRANS_up"	49566	2169751	2035676	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	708	"NVS_NR_bER"	516401	2707306	2696266	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	714	"NVS_NR_hER"	517853	2709550	2698827	11	"Borderline active"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	714	"NVS_NR_hER"	518048	2709550	2698827	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	743	"OT_ER_ERaERa_1440"	114420	551966	563149	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	743	"OT_ER_ERaERa_1440"	114503	551966	563149	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	745	"OT_ER_ERaERb_1440"	115382	558150	536919	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	745	"OT_ER_ERaERb_1440"	115467	558150	536919	11	"Borderline active"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	747	"OT_ER_ERbERb_1440"	114852	560118	561181	11	"Borderline active"	NA	NA	"percent_activity"
"TX009813"	20688	"77-47-4"	"Hexachlorocyclopentadiene"	"C77474"	751	"OT_ERa_EREGFP_0480"	116836	566036	569075	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009815"	47497	"119-07-3"	"Octyl decyl phthalate"	"C119073"	750	"OT_ERa_EREGFP_0120"	115736	573031	567099	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009815"	47497	"119-07-3"	"Octyl decyl phthalate"	"C119073"	751	"OT_ERa_EREGFP_0480"	116837	566037	569076	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009826"	20267	"57-74-9"	"Chlordane"	"C57749"	725	"NVS_NR_mERa"	517210	2710663	2699940	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009826"	20267	"57-74-9"	"Chlordane"	"C57749"	750	"OT_ERa_EREGFP_0120"	115737	573032	567100	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009827"	32591	"16079-88-2"	"Bromo-3-chloro-5,5-dimethylhydantoin"	"C16079882"	743	"OT_ER_ERaERa_1440"	114421	551969	563152	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009827"	32591	"16079-88-2"	"Bromo-3-chloro-5,5-dimethylhydantoin"	"C16079882"	747	"OT_ER_ERbERb_1440"	114819	560121	561184	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009855"	20262	"133-90-4"	"Chloramben"	"C133904"	750	"OT_ERa_EREGFP_0120"	115738	573036	567104	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009861"	35589	"68959-20-6"	"Disiquonium chloride "	"C68959206"	714	"NVS_NR_hER"	517799	2709553	2698830	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009861"	35589	"68959-20-6"	"Disiquonium chloride "	"C68959206"	745	"OT_ER_ERaERb_1440"	115383	558157	536926	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009863"	34260	"79-57-2"	"Oxytetracycline"	"C79572"	743	"OT_ER_ERaERa_1440"	114422	551974	563157	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009869"	21150	"62-38-4"	"Phenylmercuric acetate"	"C62384"	725	"NVS_NR_mERa"	517363	2710665	2699942	10	"Noisy data"	NA	NA	"percent_activity"
"TX009869"	21150	"62-38-4"	"Phenylmercuric acetate"	"C62384"	750	"OT_ERa_EREGFP_0120"	115806	573039	567107	10	"Noisy data"	NA	NA	"percent_activity"
"TX009882"	27608	"5915-41-3"	"Terbuthylazine"	"C5915413"	725	"NVS_NR_mERa"	517211	2710666	2699943	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009888"	41376	"24602-86-6"	"Tridemorph"	"C24602866"	750	"OT_ERa_EREGFP_0120"	115739	573042	567110	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009888"	41376	"24602-86-6"	"Tridemorph"	"C24602866"	751	"OT_ERa_EREGFP_0480"	116838	566048	569087	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009892"	47103	"1120-04-3"	"Octadecyl sulfate sodium salt"	"C1120043"	117	"ATG_ERa_TRANS_up"	49898	2169737	2035662	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009892"	47103	"1120-04-3"	"Octadecyl sulfate sodium salt"	"C1120043"	725	"NVS_NR_mERa"	517212	2710667	2699944	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009892"	47103	"1120-04-3"	"Octadecyl sulfate sodium salt"	"C1120043"	725	"NVS_NR_mERa"	517509	2710667	2699944	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009892"	47103	"1120-04-3"	"Octadecyl sulfate sodium salt"	"C1120043"	751	"OT_ERa_EREGFP_0480"	116839	566049	569088	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009922"	27932	"27323-41-7"	"Dodecylbenzene sulfonate triethanolamine (1:1)"	"C27323417"	117	"ATG_ERa_TRANS_up"	49897	2169732	2035657	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009926"	47180	"36631-30-8"	"Triisodecyl trimellitate"	"C36631308"	714	"NVS_NR_hER"	517800	2709558	2698835	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009926"	47180	"36631-30-8"	"Triisodecyl trimellitate"	"C36631308"	725	"NVS_NR_mERa"	517213	2710669	2699946	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009932"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	75	"ATG_ERE_CIS_up"	13152	2093327	1964797	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009932"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	714	"NVS_NR_hER"	517725	2709560	2698837	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009932"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	714	"NVS_NR_hER"	517854	2709560	2698837	11	"Borderline active"	NA	NA	"percent_activity"
"TX009932"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	714	"NVS_NR_hER"	517963	2709560	2698837	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009932"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	714	"NVS_NR_hER"	518049	2709560	2698837	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009932"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	746	"OT_ER_ERbERb_0480"	116669	550015	559230	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009932"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	750	"OT_ERa_EREGFP_0120"	115740	573049	567117	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	75	"ATG_ERE_CIS_up"	13282	2093326	1964798	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	75	"ATG_ERE_CIS_up"	13535	2093326	1964798	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	708	"NVS_NR_bER"	516212	2707318	2696278	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	708	"NVS_NR_bER"	516453	2707318	2696278	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	708	"NVS_NR_bER"	516518	2707318	2696278	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	725	"NVS_NR_mERa"	517012	2710672	2699949	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	725	"NVS_NR_mERa"	517590	2710672	2699949	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	750	"OT_ERa_EREGFP_0120"	115741	573050	567118	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX009934"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	750	"OT_ERa_EREGFP_0120"	115871	573050	567118	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX009936"	47178	"22047-49-0"	"2-Ethylhexyl octadecanoate"	"C22047490"	2	"ACEA_T47D_80hr_Positive"	10207	1779381	1780025	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX009936"	47178	"22047-49-0"	"2-Ethylhexyl octadecanoate"	"C22047490"	2	"ACEA_T47D_80hr_Positive"	10491	1779381	1780025	11	"Borderline active"	NA	NA	"percent_activity"
"TX009936"	47178	"22047-49-0"	"2-Ethylhexyl octadecanoate"	"C22047490"	117	"ATG_ERa_TRANS_up"	49565	2169728	2035653	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX009986"	26946	"115-95-7"	"Linalyl acetate"	"C115957"	725	"NVS_NR_mERa"	517214	2710674	2699951	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010000"	47433	"474-86-2"	"Equilin"	"C474862"	2	"ACEA_T47D_80hr_Positive"	10407	1779387	1780019	10	"Noisy data"	NA	NA	"percent_activity"
"TX010034"	40484	"66575-29-9"	"Forskolin"	"C66575299"	117	"ATG_ERa_TRANS_up"	49790	2169719	2035644	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX010040"	22828	"4291-63-8"	"Cladribine"	"C4291638"	117	"ATG_ERa_TRANS_up"	49682	2169718	2035643	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX010040"	22828	"4291-63-8"	"Cladribine"	"C4291638"	117	"ATG_ERa_TRANS_up"	49896	2169718	2035643	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010040"	22828	"4291-63-8"	"Cladribine"	"C4291638"	714	"NVS_NR_hER"	518050	2709570	2698847	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX010040"	22828	"4291-63-8"	"Cladribine"	"C4291638"	750	"OT_ERa_EREGFP_0120"	115743	573060	567128	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	117	"ATG_ERa_TRANS_up"	49789	2169716	2035641	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	742	"OT_ER_ERaERa_0480"	114959	556211	565152	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	742	"OT_ER_ERaERa_0480"	115037	556211	565152	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	745	"OT_ER_ERaERb_1440"	115424	558180	536949	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	745	"OT_ER_ERaERb_1440"	115510	558180	536949	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	746	"OT_ER_ERbERb_0480"	116596	550027	559242	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	747	"OT_ER_ERbERb_1440"	114820	560148	561211	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	747	"OT_ER_ERbERb_1440"	114887	560148	561211	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	750	"OT_ERa_EREGFP_0120"	115744	573062	567130	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010050"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	751	"OT_ERa_EREGFP_0480"	116841	566067	569106	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010065"	26241	"118-56-9"	"3,3,5-Trimethylcyclohexyl salicylate"	"C118569"	745	"OT_ER_ERaERb_1440"	115511	558182	536951	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010065"	26241	"118-56-9"	"3,3,5-Trimethylcyclohexyl salicylate"	"C118569"	747	"OT_ER_ERbERb_1440"	114821	560150	561213	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010065"	26241	"118-56-9"	"3,3,5-Trimethylcyclohexyl salicylate"	"C118569"	747	"OT_ER_ERbERb_1440"	114888	560150	561213	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010065"	26241	"118-56-9"	"3,3,5-Trimethylcyclohexyl salicylate"	"C118569"	750	"OT_ERa_EREGFP_0120"	115745	573064	567132	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010065"	26241	"118-56-9"	"3,3,5-Trimethylcyclohexyl salicylate"	"C118569"	751	"OT_ERa_EREGFP_0480"	116842	566069	569108	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010071"	22048	"525-82-6"	"Flavone"	"C525826"	75	"ATG_ERE_CIS_up"	13777	2093308	1964816	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX010090"	32537	"7173-51-5"	"Didecyldimethylammonium chloride"	"C7173515"	2	"ACEA_T47D_80hr_Positive"	10239	1779396	1780009	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX010090"	32537	"7173-51-5"	"Didecyldimethylammonium chloride"	"C7173515"	2	"ACEA_T47D_80hr_Positive"	10492	1779396	1780009	11	"Borderline active"	NA	NA	"percent_activity"
"TX010090"	32537	"7173-51-5"	"Didecyldimethylammonium chloride"	"C7173515"	714	"NVS_NR_hER"	517726	2709577	2698854	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010107"	20114	"2465-27-2"	"Auramine hydrochloride"	"C2465272"	751	"OT_ERa_EREGFP_0480"	116843	566073	569112	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010119"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	743	"OT_ER_ERaERa_1440"	114504	552004	563187	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010119"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	744	"OT_ER_ERaERb_0480"	112875	2400936	2400200	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010119"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	744	"OT_ER_ERaERb_0480"	112919	2400936	2400200	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010119"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	750	"OT_ERa_EREGFP_0120"	115746	573069	567137	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010119"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	750	"OT_ERa_EREGFP_0120"	115872	573069	567137	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010119"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	751	"OT_ERa_EREGFP_0480"	116923	566074	569113	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010127"	32315	"64359-81-5"	"4,5-Dichloro-2-octyl-3(2H)-isothiazolone"	"C64359815"	744	"OT_ER_ERaERb_0480"	112918	2400935	2400199	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010164"	29565	"85507-79-5"	"Phthalic acid, diundecyl ester, branched and linear"	"C85507795"	714	"NVS_NR_hER"	517801	2709589	2698866	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010164"	29565	"85507-79-5"	"Phthalic acid, diundecyl ester, branched and linear"	"C85507795"	714	"NVS_NR_hER"	517903	2709589	2698866	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010182"	29572	"98730-04-2"	"Benoxacor"	"C98730042"	117	"ATG_ERa_TRANS_up"	49681	2169701	2035626	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX010182"	29572	"98730-04-2"	"Benoxacor"	"C98730042"	117	"ATG_ERa_TRANS_up"	49895	2169701	2035626	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	2	"ACEA_T47D_80hr_Positive"	10240	1779404	1780001	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	2	"ACEA_T47D_80hr_Positive"	10493	1779404	1780001	11	"Borderline active"	NA	NA	"percent_activity"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	2	"ACEA_T47D_80hr_Positive"	10765	1779404	1780001	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	714	"NVS_NR_hER"	517904	2709591	2698868	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	725	"NVS_NR_mERa"	517219	2710702	2699979	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	725	"NVS_NR_mERa"	517511	2710702	2699979	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	751	"OT_ERa_EREGFP_0480"	116844	566079	569118	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010198"	47425	"1638-22-8"	"4-Butylphenol"	"C1638228"	751	"OT_ERa_EREGFP_0480"	116924	566079	569118	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010214"	27388	"1330-86-5"	"Diisooctyl adipate"	"C1330865"	2	"ACEA_T47D_80hr_Positive"	10357	1779405	1780000	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010214"	27388	"1330-86-5"	"Diisooctyl adipate"	"C1330865"	2	"ACEA_T47D_80hr_Positive"	10698	1779405	1780000	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010214"	27388	"1330-86-5"	"Diisooctyl adipate"	"C1330865"	750	"OT_ERa_EREGFP_0120"	115747	573075	567143	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010214"	27388	"1330-86-5"	"Diisooctyl adipate"	"C1330865"	750	"OT_ERa_EREGFP_0120"	115873	573075	567143	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010216"	24255	"13684-63-4"	"Phenmedipham"	"C13684634"	2	"ACEA_T47D_80hr_Positive"	10358	1779406	1779999	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010230"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	2	"ACEA_T47D_80hr_Positive"	10699	1779408	1779997	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010230"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	75	"ATG_ERE_CIS_up"	13775	2093290	1964834	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX010230"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	725	"NVS_NR_mERa"	517512	2710704	2699981	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010230"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	742	"OT_ER_ERaERa_0480"	115061	556227	565168	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX010230"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	750	"OT_ERa_EREGFP_0120"	115748	573078	567146	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010230"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	751	"OT_ERa_EREGFP_0480"	116845	566083	569122	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010234"	27721	"10081-67-1"	"4-(2-Phenylpropan-2-yl)-N-[4-(2-phenylpropan-2-yl)phenyl]aniline"	"C10081671"	725	"NVS_NR_mERa"	517686	2710706	2699983	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX010262"	20972	"67-20-9"	"Nitrofurantoin"	"C67209"	2	"ACEA_T47D_80hr_Positive"	10208	1779411	1779994	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010262"	20972	"67-20-9"	"Nitrofurantoin"	"C67209"	2	"ACEA_T47D_80hr_Positive"	10494	1779411	1779994	11	"Borderline active"	NA	NA	"percent_activity"
"TX010262"	20972	"67-20-9"	"Nitrofurantoin"	"C67209"	725	"NVS_NR_mERa"	517220	2710708	2699985	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010262"	20972	"67-20-9"	"Nitrofurantoin"	"C67209"	725	"NVS_NR_mERa"	517513	2710708	2699985	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010268"	23733	"99-66-1"	"Valproic acid"	"C99661"	2	"ACEA_T47D_80hr_Positive"	10209	1779412	1779993	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010268"	23733	"99-66-1"	"Valproic acid"	"C99661"	725	"NVS_NR_mERa"	517221	2710709	2699986	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010268"	23733	"99-66-1"	"Valproic acid"	"C99661"	725	"NVS_NR_mERa"	517514	2710709	2699986	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010268"	23733	"99-66-1"	"Valproic acid"	"C99661"	751	"OT_ERa_EREGFP_0480"	116925	566087	569126	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010280"	22320	"58-72-0"	"Triphenylethylene"	"C58720"	714	"NVS_NR_hER"	517802	2709599	2698876	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010282"	21992	"82385-42-0"	"Sodium saccharin hydrate"	"C82385420"	75	"ATG_ERE_CIS_up"	13280	2093281	1964844	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX010282"	21992	"82385-42-0"	"Sodium saccharin hydrate"	"C82385420"	75	"ATG_ERE_CIS_up"	13534	2093281	1964844	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010296"	22628	"29122-68-7"	"Atenolol"	"C29122687"	75	"ATG_ERE_CIS_up"	13149	2093277	1964847	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX010296"	22628	"29122-68-7"	"Atenolol"	"C29122687"	75	"ATG_ERE_CIS_up"	13369	2093277	1964847	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX010296"	22628	"29122-68-7"	"Atenolol"	"C29122687"	75	"ATG_ERE_CIS_up"	13774	2093277	1964847	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX010298"	22394	"491-80-5"	"Biochanin A"	"C491805"	725	"NVS_NR_mERa"	517223	2710712	2699989	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010298"	22394	"491-80-5"	"Biochanin A"	"C491805"	725	"NVS_NR_mERa"	517515	2710712	2699989	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010322"	22367	"53-16-7"	"Estrone"	"C53167"	725	"NVS_NR_mERa"	517368	2710714	2699991	10	"Noisy data"	NA	NA	"percent_activity"
"TX010324"	41981	"144-49-0"	"Fluoroacetic acid"	"C144490"	2	"ACEA_T47D_80hr_Positive"	10700	1779420	1779986	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010329"	22436	"126-00-1"	"Diphenolic acid"	"C126001"	2	"ACEA_T47D_80hr_Positive"	10408	1779421	1779984	10	"Noisy data"	NA	NA	"percent_activity"
"TX010329"	22436	"126-00-1"	"Diphenolic acid"	"C126001"	708	"NVS_NR_bER"	516521	2707361	2696321	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX010329"	22436	"126-00-1"	"Diphenolic acid"	"C126001"	742	"OT_ER_ERaERa_0480"	114913	556240	565181	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010335"	29325	"24851-98-7"	"Methyl dihydrojasmonate"	"C24851987"	2	"ACEA_T47D_80hr_Positive"	10210	1779423	1779982	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010342"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	75	"ATG_ERE_CIS_up"	13533	2093264	1964860	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010342"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	117	"ATG_ERa_TRANS_up"	49627	2169667	2035592	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX010342"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	117	"ATG_ERa_TRANS_up"	50152	2169667	2035592	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX010342"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	708	"NVS_NR_bER"	516213	2707363	2696323	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010342"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	708	"NVS_NR_bER"	516456	2707363	2696323	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX010342"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	708	"NVS_NR_bER"	516522	2707363	2696323	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX010342"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	744	"OT_ER_ERaERb_0480"	112917	2400911	2400221	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010355"	31860	"335-76-2"	"PFDA"	"C335762"	75	"ATG_ERE_CIS_up"	13190	2093262	1964863	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX010355"	31860	"335-76-2"	"PFDA"	"C335762"	75	"ATG_ERE_CIS_up"	13773	2093262	1964863	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX010355"	31860	"335-76-2"	"PFDA"	"C335762"	708	"NVS_NR_bER"	516405	2707365	2696325	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010355"	31860	"335-76-2"	"PFDA"	"C335762"	714	"NVS_NR_hER"	517905	2709608	2698885	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010358"	26446	"77-90-7"	"Acetyl tributyl citrate"	"C77907"	2	"ACEA_T47D_80hr_Positive"	10359	1779428	1779977	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010358"	26446	"77-90-7"	"Acetyl tributyl citrate"	"C77907"	742	"OT_ER_ERaERa_0480"	114960	556247	565188	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010358"	26446	"77-90-7"	"Acetyl tributyl citrate"	"C77907"	742	"OT_ER_ERaERa_0480"	114983	556247	565188	10	"Noisy data"	NA	NA	"percent_activity"
"TX010358"	26446	"77-90-7"	"Acetyl tributyl citrate"	"C77907"	750	"OT_ERa_EREGFP_0120"	115749	573098	567166	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010358"	26446	"77-90-7"	"Acetyl tributyl citrate"	"C77907"	750	"OT_ERa_EREGFP_0120"	115808	573098	567166	10	"Noisy data"	NA	NA	"percent_activity"
"TX010360"	38321	"3739-38-6"	"3-Phenoxybenzoic acid"	"C3739386"	75	"ATG_ERE_CIS_up"	13532	2093259	1964865	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010360"	38321	"3739-38-6"	"3-Phenoxybenzoic acid"	"C3739386"	117	"ATG_ERa_TRANS_up"	49891	2169662	2035587	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010369"	20537	"147-24-0"	"Diphenhydramine hydrochloride"	"C147240"	745	"OT_ER_ERaERb_1440"	115512	558218	536987	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010385"	22522	"84-69-5"	"Diisobutyl phthalate"	"C84695"	117	"ATG_ERa_TRANS_up"	49890	2169659	2035584	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010387"	37565	"55814-41-0"	"Mepronil"	"C55814410"	2	"ACEA_T47D_80hr_Positive"	10701	1779432	1779974	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010388"	20561	"72-20-8"	"Endrin"	"C72208"	746	"OT_ER_ERbERb_0480"	116597	550068	559283	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010388"	20561	"72-20-8"	"Endrin"	"C72208"	746	"OT_ER_ERbERb_0480"	116670	550068	559283	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010388"	20561	"72-20-8"	"Endrin"	"C72208"	747	"OT_ER_ERbERb_1440"	114822	560189	561252	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010388"	20561	"72-20-8"	"Endrin"	"C72208"	747	"OT_ER_ERbERb_1440"	114889	560189	561252	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010388"	20561	"72-20-8"	"Endrin"	"C72208"	750	"OT_ERa_EREGFP_0120"	115750	573103	567171	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010388"	20561	"72-20-8"	"Endrin"	"C72208"	751	"OT_ERa_EREGFP_0480"	116846	566108	569147	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010403"	26265	"3319-31-1"	"Tris(2-ethylhexyl) trimellitate"	"C3319311"	714	"NVS_NR_hER"	517855	2709613	2698890	11	"Borderline active"	NA	NA	"percent_activity"
"TX010403"	26265	"3319-31-1"	"Tris(2-ethylhexyl) trimellitate"	"C3319311"	714	"NVS_NR_hER"	518054	2709613	2698890	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX010403"	26265	"3319-31-1"	"Tris(2-ethylhexyl) trimellitate"	"C3319311"	742	"OT_ER_ERaERa_0480"	114914	556253	565194	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010405"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	75	"ATG_ERE_CIS_up"	13279	2093252	1964872	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX010405"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	75	"ATG_ERE_CIS_up"	13531	2093252	1964872	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010405"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	117	"ATG_ERa_TRANS_up"	49788	2169655	2035580	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX010405"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	745	"OT_ER_ERaERb_1440"	115425	558223	536992	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010405"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	750	"OT_ERa_EREGFP_0120"	115751	573105	567173	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010405"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	751	"OT_ERa_EREGFP_0480"	116847	566110	569149	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010423"	37303	"375-85-9"	"Perfluoroheptanoic acid"	"C375859"	75	"ATG_ERE_CIS_up"	13148	2093250	1964874	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX010423"	37303	"375-85-9"	"Perfluoroheptanoic acid"	"C375859"	117	"ATG_ERa_TRANS_up"	49889	2169653	2035578	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010538"	47590	"94-47-3"	"2-Phenylethyl benzoate"	"C94473"	744	"OT_ER_ERaERb_0480"	112823	2400897	2400237	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010538"	47590	"94-47-3"	"2-Phenylethyl benzoate"	"C94473"	746	"OT_ER_ERbERb_0480"	116576	550073	559288	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010540"	38298	"5315-79-7"	"1-Hydroxypyrene"	"C5315797"	2	"ACEA_T47D_80hr_Positive"	10495	1779439	1779966	11	"Borderline active"	NA	NA	"percent_activity"
"TX010540"	38298	"5315-79-7"	"1-Hydroxypyrene"	"C5315797"	117	"ATG_ERa_TRANS_up"	49626	2169650	2035575	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX010540"	38298	"5315-79-7"	"1-Hydroxypyrene"	"C5315797"	117	"ATG_ERa_TRANS_up"	50150	2169650	2035575	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX010540"	38298	"5315-79-7"	"1-Hydroxypyrene"	"C5315797"	744	"OT_ER_ERaERb_0480"	112916	2400896	2400235	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010554"	47592	"484-17-3"	"9-Phenanthrol"	"C484173"	708	"NVS_NR_bER"	516299	2707371	2696331	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX010554"	47592	"484-17-3"	"9-Phenanthrol"	"C484173"	714	"NVS_NR_hER"	517728	2709615	2698892	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010554"	47592	"484-17-3"	"9-Phenanthrol"	"C484173"	714	"NVS_NR_hER"	517856	2709615	2698892	11	"Borderline active"	NA	NA	"percent_activity"
"TX010554"	47592	"484-17-3"	"9-Phenanthrol"	"C484173"	714	"NVS_NR_hER"	517965	2709615	2698892	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX010554"	47592	"484-17-3"	"9-Phenanthrol"	"C484173"	714	"NVS_NR_hER"	518055	2709615	2698892	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX010554"	47592	"484-17-3"	"9-Phenanthrol"	"C484173"	725	"NVS_NR_mERa"	517369	2710725	2700002	10	"Noisy data"	NA	NA	"percent_activity"
"TX010787"	24289	"129-00-0"	"Pyrene"	"C129000"	744	"OT_ER_ERaERb_0480"	112822	2400895	2400241	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010787"	24289	"129-00-0"	"Pyrene"	"C129000"	744	"OT_ER_ERaERb_0480"	112898	2400895	2400241	11	"Borderline active"	NA	NA	"percent_activity"
"TX010787"	24289	"129-00-0"	"Pyrene"	"C129000"	746	"OT_ER_ERbERb_0480"	116671	550075	559290	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX010799"	27923	"27176-87-0"	"Dodecylbenzenesulfonic acid"	"C27176870"	117	"ATG_ERa_TRANS_up"	49888	2169647	2035572	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX010799"	27923	"27176-87-0"	"Dodecylbenzenesulfonic acid"	"C27176870"	708	"NVS_NR_bER"	516215	2707374	2696334	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX010799"	27923	"27176-87-0"	"Dodecylbenzenesulfonic acid"	"C27176870"	750	"OT_ERa_EREGFP_0120"	115549	573111	567179	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011001"	24000	"1861-32-1"	"Chlorthal-dimethyl"	"C1861321"	742	"OT_ER_ERaERa_0480"	114961	556262	565203	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011001"	24000	"1861-32-1"	"Chlorthal-dimethyl"	"C1861321"	744	"OT_ER_ERaERb_0480"	112821	2400892	2400238	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011001"	24000	"1861-32-1"	"Chlorthal-dimethyl"	"C1861321"	746	"OT_ER_ERbERb_0480"	116577	550078	559293	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011001"	24000	"1861-32-1"	"Chlorthal-dimethyl"	"C1861321"	747	"OT_ER_ERbERb_1440"	114823	560199	561262	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011001"	24000	"1861-32-1"	"Chlorthal-dimethyl"	"C1861321"	747	"OT_ER_ERbERb_1440"	114890	560199	561262	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011018"	21322	"97-77-8"	"Disulfiram"	"C97778"	750	"OT_ERa_EREGFP_0120"	115550	573114	567182	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011203"	25337	"75-12-7"	"Formamide"	"C75127"	708	"NVS_NR_bER"	516301	2707384	2696344	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011203"	25337	"75-12-7"	"Formamide"	"C75127"	742	"OT_ER_ERaERa_0480"	114962	556265	565206	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011203"	25337	"75-12-7"	"Formamide"	"C75127"	742	"OT_ER_ERaERa_0480"	115038	556265	565206	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011203"	25337	"75-12-7"	"Formamide"	"C75127"	743	"OT_ER_ERaERa_1440"	114424	552051	563234	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011203"	25337	"75-12-7"	"Formamide"	"C75127"	743	"OT_ER_ERaERa_1440"	114505	552051	563234	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011203"	25337	"75-12-7"	"Formamide"	"C75127"	745	"OT_ER_ERaERb_1440"	115513	558234	537003	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011203"	25337	"75-12-7"	"Formamide"	"C75127"	751	"OT_ERa_EREGFP_0480"	116848	566121	569160	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011207"	47633	"111-62-6"	"Ethyl oleate"	"C111626"	75	"ATG_ERE_CIS_up"	13530	2093240	1964884	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011211"	47628	"2550-40-5"	"Dicyclohexyl disulfide"	"C2550405"	742	"OT_ER_ERaERa_0480"	115039	556267	565208	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011211"	47628	"2550-40-5"	"Dicyclohexyl disulfide"	"C2550405"	750	"OT_ERa_EREGFP_0120"	115752	573118	567186	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011230"	27014	"123-96-6"	"2-Octanol"	"C123966"	2	"ACEA_T47D_80hr_Positive"	10496	1779446	1779959	11	"Borderline active"	NA	NA	"percent_activity"
"TX011230"	27014	"123-96-6"	"2-Octanol"	"C123966"	714	"NVS_NR_hER"	517729	2709629	2698906	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011230"	27014	"123-96-6"	"2-Octanol"	"C123966"	714	"NVS_NR_hER"	517857	2709629	2698906	11	"Borderline active"	NA	NA	"percent_activity"
"TX011230"	27014	"123-96-6"	"2-Octanol"	"C123966"	714	"NVS_NR_hER"	517966	2709629	2698906	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX011230"	27014	"123-96-6"	"2-Octanol"	"C123966"	714	"NVS_NR_hER"	518057	2709629	2698906	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX011230"	27014	"123-96-6"	"2-Octanol"	"C123966"	725	"NVS_NR_mERa"	517227	2710738	2700015	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011249"	22100	"645-56-7"	"4-Propylphenol"	"C645567"	2	"ACEA_T47D_80hr_Positive"	10211	1779447	1779957	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011249"	22100	"645-56-7"	"4-Propylphenol"	"C645567"	75	"ATG_ERE_CIS_up"	13772	2093234	1964890	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX011249"	22100	"645-56-7"	"4-Propylphenol"	"C645567"	743	"OT_ER_ERaERa_1440"	114425	552056	563239	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011249"	22100	"645-56-7"	"4-Propylphenol"	"C645567"	743	"OT_ER_ERaERa_1440"	114506	552056	563239	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011253"	21356	"52225-20-4"	"dl-alpha-Tocopheryl acetate"	"C52225204"	2	"ACEA_T47D_80hr_Positive"	10497	1779448	1779958	11	"Borderline active"	NA	NA	"percent_activity"
"TX011263"	40792	"58-56-0"	"Pyridoxine hydrochloride"	"C58560"	2	"ACEA_T47D_80hr_Positive"	10360	1779450	1779955	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011303"	25291	"123-05-7"	"2-Ethylhexanal"	"C123057"	2	"ACEA_T47D_80hr_Positive"	10361	1779452	1779953	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011303"	25291	"123-05-7"	"2-Ethylhexanal"	"C123057"	750	"OT_ERa_EREGFP_0120"	115753	573126	567194	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011306"	27036	"126-30-7"	"2,2-Dimethylpropane-1,3-diol"	"C126307"	714	"NVS_NR_hER"	517831	2709635	2698912	10	"Noisy data"	NA	NA	"percent_activity"
"TX011337"	47696	"61791-12-6"	"Cremophor(R) EL"	"C61791126"	75	"ATG_ERE_CIS_up"	13147	2093225	1964900	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX011337"	47696	"61791-12-6"	"Cremophor(R) EL"	"C61791126"	117	"ATG_ERa_TRANS_up"	49563	2169628	2035553	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX011337"	47696	"61791-12-6"	"Cremophor(R) EL"	"C61791126"	746	"OT_ER_ERbERb_0480"	116672	550093	559308	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011337"	47696	"61791-12-6"	"Cremophor(R) EL"	"C61791126"	747	"OT_ER_ERbERb_1440"	114824	560214	561277	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011337"	47696	"61791-12-6"	"Cremophor(R) EL"	"C61791126"	747	"OT_ER_ERbERb_1440"	114891	560214	561277	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011345"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	743	"OT_ER_ERaERa_1440"	114426	552064	563247	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011345"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	743	"OT_ER_ERaERa_1440"	114462	552064	563247	10	"Noisy data"	NA	NA	"percent_activity"
"TX011345"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	743	"OT_ER_ERaERa_1440"	114507	552064	563247	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011345"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	744	"OT_ER_ERaERb_0480"	112915	2400876	2400261	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011345"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	745	"OT_ER_ERaERb_1440"	115426	558247	537016	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011345"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	745	"OT_ER_ERaERb_1440"	115514	558247	537016	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011345"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	746	"OT_ER_ERbERb_0480"	116673	550094	559309	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011397"	24528	"8007-70-3"	"Anise oil"	"C8007703"	75	"ATG_ERE_CIS_up"	13368	2093221	1964903	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX011397"	24528	"8007-70-3"	"Anise oil"	"C8007703"	117	"ATG_ERa_TRANS_up"	49678	2169624	2035549	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX011397"	24528	"8007-70-3"	"Anise oil"	"C8007703"	117	"ATG_ERa_TRANS_up"	49886	2169624	2035549	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011397"	24528	"8007-70-3"	"Anise oil"	"C8007703"	725	"NVS_NR_mERa"	517594	2710747	2700024	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX011397"	24528	"8007-70-3"	"Anise oil"	"C8007703"	725	"NVS_NR_mERa"	517687	2710747	2700024	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX011397"	24528	"8007-70-3"	"Anise oil"	"C8007703"	742	"OT_ER_ERaERa_0480"	114915	556280	565221	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011397"	24528	"8007-70-3"	"Anise oil"	"C8007703"	743	"OT_ER_ERaERa_1440"	114354	552066	563249	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011412"	21937	"111-70-6"	"1-Heptanol"	"C111706"	2	"ACEA_T47D_80hr_Positive"	10362	1779458	1779947	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011421"	47708	"NOCAS_47708"	"Igepal CO-890"	"CNOCAS47708"	744	"OT_ER_ERaERb_0480"	112820	2400872	2400257	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011421"	47708	"NOCAS_47708"	"Igepal CO-890"	"CNOCAS47708"	745	"OT_ER_ERaERb_1440"	115384	558251	537020	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011421"	47708	"NOCAS_47708"	"Igepal CO-890"	"CNOCAS47708"	746	"OT_ER_ERbERb_0480"	116578	550098	559313	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011428"	25436	"134-31-6"	"8-Hydroxyquinoline sulfate"	"C134316"	2	"ACEA_T47D_80hr_Positive"	10498	1779461	1779944	11	"Borderline active"	NA	NA	"percent_activity"
"TX011428"	25436	"134-31-6"	"8-Hydroxyquinoline sulfate"	"C134316"	725	"NVS_NR_mERa"	517228	2710751	2700028	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011428"	25436	"134-31-6"	"8-Hydroxyquinoline sulfate"	"C134316"	747	"OT_ER_ERbERb_1440"	114825	560221	561284	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011484"	24917	"123-42-2"	"Diacetone alcohol"	"C123422"	2	"ACEA_T47D_80hr_Positive"	10212	1779464	1779941	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011488"	28774	"68609-97-2"	"C12-14-Alkyl glycidyl ether"	"C68609972"	745	"OT_ER_ERaERb_1440"	115515	558257	537026	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011490"	26789	"108-32-7"	"Propylene carbonate"	"C108327"	2	"ACEA_T47D_80hr_Positive"	10213	1779466	1779940	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011490"	26789	"108-32-7"	"Propylene carbonate"	"C108327"	2	"ACEA_T47D_80hr_Positive"	10499	1779466	1779940	11	"Borderline active"	NA	NA	"percent_activity"
"TX011492"	26943	"115-77-5"	"Pentaerythritol"	"C115775"	2	"ACEA_T47D_80hr_Positive"	10363	1779467	1779938	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011492"	26943	"115-77-5"	"Pentaerythritol"	"C115775"	2	"ACEA_T47D_80hr_Positive"	10409	1779467	1779938	10	"Noisy data"	NA	NA	"percent_activity"
"TX011551"	25216	"1321-74-0"	"Divinylbenzene"	"C1321740"	117	"ATG_ERa_TRANS_up"	49677	2169603	2035528	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX011551"	25216	"1321-74-0"	"Divinylbenzene"	"C1321740"	117	"ATG_ERa_TRANS_up"	49885	2169603	2035528	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011580"	32601	"94361-06-5"	"Cyproconazole"	"C94361065"	744	"OT_ER_ERaERb_0480"	112914	2400856	2400275	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011580"	32601	"94361-06-5"	"Cyproconazole"	"C94361065"	745	"OT_ER_ERaERb_1440"	115427	558267	537036	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011580"	32601	"94361-06-5"	"Cyproconazole"	"C94361065"	745	"OT_ER_ERaERb_1440"	115516	558267	537036	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011581"	32497	"55335-06-3"	"Triclopyr"	"C55335063"	2	"ACEA_T47D_80hr_Positive"	10364	1779476	1779929	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011581"	32497	"55335-06-3"	"Triclopyr"	"C55335063"	2	"ACEA_T47D_80hr_Positive"	10702	1779476	1779929	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011582"	35180	"584-79-2"	"Allethrin"	"C584792"	714	"NVS_NR_hER"	517803	2709649	2698926	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011582"	35180	"584-79-2"	"Allethrin"	"C584792"	725	"NVS_NR_mERa"	517230	2710756	2700033	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011582"	35180	"584-79-2"	"Allethrin"	"C584792"	725	"NVS_NR_mERa"	517518	2710756	2700033	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011585"	32493	"55219-65-3"	"Triadimenol"	"C55219653"	744	"OT_ER_ERaERb_0480"	112819	2400851	2400282	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011586"	24238	"19044-88-3"	"Oryzalin"	"C19044883"	750	"OT_ERa_EREGFP_0120"	115754	573155	567223	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011586"	24238	"19044-88-3"	"Oryzalin"	"C19044883"	751	"OT_ERa_EREGFP_0480"	116849	566160	569199	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011587"	32498	"3380-34-5"	"Triclosan"	"C3380345"	725	"NVS_NR_mERa"	517520	2710760	2700037	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011587"	32498	"3380-34-5"	"Triclosan"	"C3380345"	750	"OT_ERa_EREGFP_0120"	115755	573156	567224	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011590"	32611	"13194-48-4"	"Ethoprop"	"C13194484"	2	"ACEA_T47D_80hr_Positive"	10367	1779485	1779920	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011590"	32611	"13194-48-4"	"Ethoprop"	"C13194484"	2	"ACEA_T47D_80hr_Positive"	10704	1779485	1779920	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011591"	31864	"1763-23-1"	"PFOS"	"C1763231"	744	"OT_ER_ERaERb_0480"	112818	2400845	2400288	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011591"	31864	"1763-23-1"	"PFOS"	"C1763231"	745	"OT_ER_ERaERb_1440"	115517	558278	537047	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011592"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	742	"OT_ER_ERaERa_0480"	114963	556310	565251	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011592"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	742	"OT_ER_ERaERa_0480"	115040	556310	565251	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011592"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	744	"OT_ER_ERaERb_0480"	112817	2400844	2400292	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011592"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	746	"OT_ER_ERbERb_0480"	116674	550126	559341	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011592"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	747	"OT_ER_ERbERb_1440"	114826	560247	561310	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011592"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	750	"OT_ERa_EREGFP_0120"	115756	573161	567229	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011592"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	751	"OT_ERa_EREGFP_0480"	116850	566166	569205	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011594"	21166	"51-03-6"	"Piperonyl butoxide"	"C51036"	744	"OT_ER_ERaERb_0480"	112816	2400842	2400290	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011594"	21166	"51-03-6"	"Piperonyl butoxide"	"C51036"	746	"OT_ER_ERbERb_0480"	116675	550128	559343	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011594"	21166	"51-03-6"	"Piperonyl butoxide"	"C51036"	750	"OT_ERa_EREGFP_0120"	115757	573163	567231	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011594"	21166	"51-03-6"	"Piperonyl butoxide"	"C51036"	750	"OT_ERa_EREGFP_0120"	115874	573163	567231	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011595"	32520	"131860-33-8"	"Azoxystrobin"	"C131860338"	751	"OT_ERa_EREGFP_0480"	116851	566169	569208	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011613"	41097	"85532-75-8"	"PK 11195"	"C85532758"	750	"OT_ERa_EREGFP_0120"	115758	573167	567235	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011614"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	75	"ATG_ERE_CIS_up"	13278	2093191	1964933	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX011614"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	75	"ATG_ERE_CIS_up"	13529	2093191	1964933	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011614"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	744	"OT_ER_ERaERb_0480"	112913	2400837	2400293	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011614"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	745	"OT_ER_ERaERb_1440"	115428	558286	537055	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011614"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	745	"OT_ER_ERaERb_1440"	115518	558286	537055	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011614"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	751	"OT_ERa_EREGFP_0480"	116852	566173	569212	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011620"	20685	"319-85-7"	"beta-Hexachlorocyclohexane"	"C319857"	746	"OT_ER_ERbERb_0480"	116676	550136	559351	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011620"	20685	"319-85-7"	"beta-Hexachlorocyclohexane"	"C319857"	747	"OT_ER_ERbERb_1440"	114827	560257	561320	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011622"	47542	"117428-22-5"	"Picoxystrobin"	"C117428225"	744	"OT_ER_ERaERb_0480"	112874	2400833	2400300	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011622"	47542	"117428-22-5"	"Picoxystrobin"	"C117428225"	746	"OT_ER_ERbERb_0480"	116598	550137	559352	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011622"	47542	"117428-22-5"	"Picoxystrobin"	"C117428225"	750	"OT_ERa_EREGFP_0120"	115759	573172	567240	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011622"	47542	"117428-22-5"	"Picoxystrobin"	"C117428225"	751	"OT_ERa_EREGFP_0480"	116853	566177	569216	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011626"	32531	"116255-48-2"	"Bromuconazole"	"C116255482"	714	"NVS_NR_hER"	517967	2709661	2698938	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX011626"	32531	"116255-48-2"	"Bromuconazole"	"C116255482"	714	"NVS_NR_hER"	518059	2709661	2698938	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX011626"	32531	"116255-48-2"	"Bromuconazole"	"C116255482"	751	"OT_ERa_EREGFP_0480"	116854	566180	569219	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011627"	47540	"6344-67-8"	"3-Hydroxyfluorene"	"C6344678"	708	"NVS_NR_bER"	516406	2707418	2696378	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011627"	47540	"6344-67-8"	"3-Hydroxyfluorene"	"C6344678"	714	"NVS_NR_hER"	517730	2709662	2698939	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011627"	47540	"6344-67-8"	"3-Hydroxyfluorene"	"C6344678"	714	"NVS_NR_hER"	518060	2709662	2698939	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX011627"	47540	"6344-67-8"	"3-Hydroxyfluorene"	"C6344678"	750	"OT_ERa_EREGFP_0120"	115760	573176	567244	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011627"	47540	"6344-67-8"	"3-Hydroxyfluorene"	"C6344678"	750	"OT_ERa_EREGFP_0120"	115875	573176	567244	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011627"	47540	"6344-67-8"	"3-Hydroxyfluorene"	"C6344678"	751	"OT_ERa_EREGFP_0480"	116855	566181	569220	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011627"	47540	"6344-67-8"	"3-Hydroxyfluorene"	"C6344678"	751	"OT_ERa_EREGFP_0480"	116926	566181	569220	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011630"	47598	"41481-66-7"	"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]"	"C41481667"	744	"OT_ER_ERaERb_0480"	112912	2400826	2400309	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011631"	47594	"6149-03-7"	"Sodium 4-octylbenzenesulfonate"	"C6149037"	75	"ATG_ERE_CIS_up"	13189	2093179	1964945	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX011631"	47594	"6149-03-7"	"Sodium 4-octylbenzenesulfonate"	"C6149037"	75	"ATG_ERE_CIS_up"	13367	2093179	1964945	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX011631"	47594	"6149-03-7"	"Sodium 4-octylbenzenesulfonate"	"C6149037"	75	"ATG_ERE_CIS_up"	13771	2093179	1964945	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX011632"	40795	"7080-50-4"	"Chloramine-T trihydrate"	"C7080504"	2	"ACEA_T47D_80hr_Positive"	10368	1779507	1779897	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011632"	40795	"7080-50-4"	"Chloramine-T trihydrate"	"C7080504"	750	"OT_ERa_EREGFP_0120"	115809	573181	567249	10	"Noisy data"	NA	NA	"percent_activity"
"TX011633"	47597	"9003-11-6"	"Pluronic F-127"	"C9003116"	750	"OT_ERa_EREGFP_0120"	115761	573182	567250	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011637"	46970	"105624-86-0"	"5HPP-33"	"C105624860"	75	"ATG_ERE_CIS_up"	13770	2093174	1964950	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX011637"	46970	"105624-86-0"	"5HPP-33"	"C105624860"	751	"OT_ERa_EREGFP_0480"	116891	566190	569229	10	"Noisy data"	NA	NA	"percent_activity"
"TX011638"	43709	"4449-51-8"	"Cyclopamine"	"C4449518"	2	"ACEA_T47D_80hr_Positive"	10705	1779512	1779893	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011638"	43709	"4449-51-8"	"Cyclopamine"	"C4449518"	750	"OT_ERa_EREGFP_0120"	115762	573186	567254	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011639"	32559	"91465-08-6"	"lambda-Cyhalothrin"	"C91465086"	2	"ACEA_T47D_80hr_Positive"	10369	1779513	1779892	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011642"	34674	"125225-28-7"	"Ipconazole"	"C125225287"	2	"ACEA_T47D_80hr_Positive"	10370	1779514	1779891	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011642"	34674	"125225-28-7"	"Ipconazole"	"C125225287"	75	"ATG_ERE_CIS_up"	13769	2093170	1964954	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX011642"	34674	"125225-28-7"	"Ipconazole"	"C125225287"	117	"ATG_ERa_TRANS_up"	49674	2169573	2035498	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX011642"	34674	"125225-28-7"	"Ipconazole"	"C125225287"	117	"ATG_ERa_TRANS_up"	49882	2169573	2035498	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011642"	34674	"125225-28-7"	"Ipconazole"	"C125225287"	714	"NVS_NR_hER"	517908	2709667	2698944	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011642"	34674	"125225-28-7"	"Ipconazole"	"C125225287"	750	"OT_ERa_EREGFP_0120"	115551	573189	567257	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011653"	48167	"138472-01-2"	"FR900409"	"C138472012"	75	"ATG_ERE_CIS_up"	13528	2093168	1964956	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011655"	48178	"136042-19-8"	"FR130739"	"C136042198"	75	"ATG_ERE_CIS_up"	13277	2093167	1964957	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX011655"	48178	"136042-19-8"	"FR130739"	"C136042198"	75	"ATG_ERE_CIS_up"	13527	2093167	1964957	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011657"	48166	"102409-92-7"	"FR073317"	"C102409927"	75	"ATG_ERE_CIS_up"	13146	2093166	1964959	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX011658"	48170	"149413-74-1"	"FR150011"	"C149413741"	714	"NVS_NR_hER"	517804	2709669	2698946	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011658"	48170	"149413-74-1"	"FR150011"	"C149413741"	714	"NVS_NR_hER"	517832	2709669	2698946	10	"Noisy data"	NA	NA	"percent_activity"
"TX011659"	48172	"NOCAS_48172"	"PharmaGSID_48172"	"CNOCAS48172"	743	"OT_ER_ERaERa_1440"	114427	552130	563313	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011659"	48172	"NOCAS_48172"	"PharmaGSID_48172"	"CNOCAS48172"	751	"OT_ERa_EREGFP_0480"	116856	566200	569239	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011660"	48176	"NOCAS_48176"	"YM218"	"CNOCAS48176"	75	"ATG_ERE_CIS_up"	13188	2093163	1964962	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX011660"	48176	"NOCAS_48176"	"YM218"	"CNOCAS48176"	75	"ATG_ERE_CIS_up"	13768	2093163	1964962	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX011660"	48176	"NOCAS_48176"	"YM218"	"CNOCAS48176"	742	"OT_ER_ERaERa_0480"	114964	556345	565286	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011660"	48176	"NOCAS_48176"	"YM218"	"CNOCAS48176"	742	"OT_ER_ERaERa_0480"	115041	556345	565286	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011660"	48176	"NOCAS_48176"	"YM218"	"CNOCAS48176"	750	"OT_ERa_EREGFP_0120"	115810	573196	567264	10	"Noisy data"	NA	NA	"percent_activity"
"TX011660"	48176	"NOCAS_48176"	"YM218"	"CNOCAS48176"	750	"OT_ERa_EREGFP_0120"	115876	573196	567264	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011663"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	742	"OT_ER_ERaERa_0480"	114965	556347	565288	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011663"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	742	"OT_ER_ERaERa_0480"	115042	556347	565288	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011663"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	743	"OT_ER_ERaERa_1440"	114428	552133	563316	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011663"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	750	"OT_ERa_EREGFP_0120"	115552	573198	567266	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011663"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	751	"OT_ERa_EREGFP_0480"	116700	566203	569242	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011664"	48175	"151506-44-4"	"FR140423"	"C151506444"	742	"OT_ER_ERaERa_0480"	114966	556348	565289	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011664"	48175	"151506-44-4"	"FR140423"	"C151506444"	742	"OT_ER_ERaERa_0480"	115043	556348	565289	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011664"	48175	"151506-44-4"	"FR140423"	"C151506444"	743	"OT_ER_ERaERa_1440"	114429	552134	563317	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011664"	48175	"151506-44-4"	"FR140423"	"C151506444"	744	"OT_ER_ERaERb_0480"	112815	2400806	2400323	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011664"	48175	"151506-44-4"	"FR140423"	"C151506444"	746	"OT_ER_ERbERb_0480"	116579	550164	559379	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX011721"	20290	"50892-23-4"	"Pirinixic acid"	"C50892234"	75	"ATG_ERE_CIS_up"	13526	2093148	1964976	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX011721"	20290	"50892-23-4"	"Pirinixic acid"	"C50892234"	714	"NVS_NR_hER"	517909	2709671	2698948	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011721"	20290	"50892-23-4"	"Pirinixic acid"	"C50892234"	725	"NVS_NR_mERa"	517232	2710774	2700051	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011724"	24057	"124-40-3"	"Dimethylamine"	"C124403"	2	"ACEA_T47D_80hr_Positive"	10371	1779520	1779886	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011725"	24263	"7664-38-2"	"Phosphoric acid"	"C7664382"	747	"OT_ER_ERbERb_1440"	114853	560291	561354	11	"Borderline active"	NA	NA	"percent_activity"
"TX011725"	24263	"7664-38-2"	"Phosphoric acid"	"C7664382"	747	"OT_ER_ERbERb_1440"	114902	560291	561354	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX011725"	24263	"7664-38-2"	"Phosphoric acid"	"C7664382"	751	"OT_ERa_EREGFP_0480"	116892	566210	569249	10	"Noisy data"	NA	NA	"percent_activity"
"TX011729"	21739	"71-23-8"	"1-Propanol"	"C71238"	2	"ACEA_T47D_80hr_Positive"	10706	1779524	1779881	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011735"	34722	"210631-68-8"	"Topramezone"	"C210631688"	2	"ACEA_T47D_80hr_Positive"	10707	1779526	1779879	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011737"	47395	"166412-78-8"	"Diisononyl cyclohexane-1,2-dicarboxylate"	"C166412788"	750	"OT_ERa_EREGFP_0120"	115763	573212	567280	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011744"	28033	"53894-23-8"	"Triisononyl trimellitate"	"C53894238"	2	"ACEA_T47D_80hr_Positive"	10708	1779529	1779876	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011744"	28033	"53894-23-8"	"Triisononyl trimellitate"	"C53894238"	725	"NVS_NR_mERa"	517233	2710776	2700053	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX011744"	28033	"53894-23-8"	"Triisononyl trimellitate"	"C53894238"	725	"NVS_NR_mERa"	517521	2710776	2700053	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011745"	47533	"89-04-3"	"Trioctyl trimellitate"	"C89043"	2	"ACEA_T47D_80hr_Positive"	10709	1779530	1779875	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX011745"	47533	"89-04-3"	"Trioctyl trimellitate"	"C89043"	750	"OT_ERa_EREGFP_0120"	115764	573214	567282	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012212"	48190	"127-25-3"	"Methyl abietate"	"C127253"	75	"ATG_ERE_CIS_up"	13145	2093107	1965017	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX012212"	48190	"127-25-3"	"Methyl abietate"	"C127253"	75	"ATG_ERE_CIS_up"	13764	2093107	1965017	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012213"	33371	"96-41-3"	"Cyclopentanol"	"C96413"	2	"ACEA_T47D_80hr_Positive"	10710	1779532	1779874	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012213"	33371	"96-41-3"	"Cyclopentanol"	"C96413"	708	"NVS_NR_bER"	516407	2707430	2696390	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012215"	48211	"94-08-6"	"Ethyl 4-methylbenzoate"	"C94086"	2	"ACEA_T47D_80hr_Positive"	10711	1779533	1779872	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012215"	48211	"94-08-6"	"Ethyl 4-methylbenzoate"	"C94086"	742	"OT_ER_ERaERa_0480"	114967	556366	565307	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012216"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	742	"OT_ER_ERaERa_0480"	115044	556367	565308	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012216"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	743	"OT_ER_ERaERa_1440"	114355	552153	563336	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012216"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	743	"OT_ER_ERaERa_1440"	114463	552153	563336	10	"Noisy data"	NA	NA	"percent_activity"
"TX012216"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	744	"OT_ER_ERaERb_0480"	112814	2400787	2400346	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012216"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	745	"OT_ER_ERaERb_1440"	115468	558336	537105	11	"Borderline active"	NA	NA	"percent_activity"
"TX012216"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	746	"OT_ER_ERbERb_0480"	116677	550183	559398	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012216"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	751	"OT_ERa_EREGFP_0480"	116857	566223	569262	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012217"	48207	"838-85-7"	"Diphenyl phosphate"	"C838857"	745	"OT_ER_ERaERb_1440"	115519	558337	537106	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012218"	22523	"1085-12-7"	"Heptylparaben"	"C1085127"	708	"NVS_NR_bER"	516527	2707431	2696391	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012218"	22523	"1085-12-7"	"Heptylparaben"	"C1085127"	725	"NVS_NR_mERa"	517595	2710779	2700056	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012219"	41970	"1632-73-1"	"Fenchol"	"C1632731"	117	"ATG_ERa_TRANS_up"	49672	2169504	2035429	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012219"	41970	"1632-73-1"	"Fenchol"	"C1632731"	117	"ATG_ERa_TRANS_up"	49878	2169504	2035429	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012219"	41970	"1632-73-1"	"Fenchol"	"C1632731"	725	"NVS_NR_mERa"	517522	2710780	2700057	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012220"	27479	"2440-22-4"	"2-(2H-Benzotriazol-2-yl)-4-methylphenol"	"C2440224"	2	"ACEA_T47D_80hr_Positive"	10372	1779538	1779867	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012220"	27479	"2440-22-4"	"2-(2H-Benzotriazol-2-yl)-4-methylphenol"	"C2440224"	744	"OT_ER_ERaERb_0480"	112911	2400783	2400350	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012220"	27479	"2440-22-4"	"2-(2H-Benzotriazol-2-yl)-4-methylphenol"	"C2440224"	745	"OT_ER_ERaERb_1440"	115520	558340	537109	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	2	"ACEA_T47D_80hr_Positive"	10215	1779539	1779866	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	708	"NVS_NR_bER"	516216	2707434	2696394	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	708	"NVS_NR_bER"	516351	2707434	2696394	11	"Borderline active"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	708	"NVS_NR_bER"	516460	2707434	2696394	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	708	"NVS_NR_bER"	516528	2707434	2696394	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	714	"NVS_NR_hER"	518061	2709679	2698956	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	745	"OT_ER_ERaERb_1440"	115521	558341	537110	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012221"	22408	"143-74-8"	"Phenol red"	"C143748"	750	"OT_ERa_EREGFP_0120"	115877	573223	567291	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012222"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	2	"ACEA_T47D_80hr_Positive"	10712	1779540	1779865	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012222"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	75	"ATG_ERE_CIS_up"	13524	2093098	1965026	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012222"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	117	"ATG_ERa_TRANS_up"	49877	2169501	2035426	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012224"	38887	"2321-07-5"	"Fluorescein"	"C2321075"	2	"ACEA_T47D_80hr_Positive"	10713	1779542	1779863	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012224"	38887	"2321-07-5"	"Fluorescein"	"C2321075"	725	"NVS_NR_mERa"	517596	2710784	2700061	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012225"	48208	"89-71-4"	"Methyl 2-methylbenzoate"	"C89714"	742	"OT_ER_ERaERa_0480"	114968	556376	565317	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012227"	30307	"626-43-7"	"3,5-Dichloroaniline"	"C626437"	747	"OT_ER_ERbERb_1440"	114828	560314	561377	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012227"	30307	"626-43-7"	"3,5-Dichloroaniline"	"C626437"	747	"OT_ER_ERbERb_1440"	114892	560314	561377	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012228"	48202	"611-70-1"	"Isopropyl phenyl ketone"	"C611701"	75	"ATG_ERE_CIS_up"	13763	2093093	1965031	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012228"	48202	"611-70-1"	"Isopropyl phenyl ketone"	"C611701"	117	"ATG_ERa_TRANS_up"	50146	2169496	2035421	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012229"	48206	"79098-20-7"	"4-Chloropentylbenzene"	"C79098207"	117	"ATG_ERa_TRANS_up"	49876	2169495	2035420	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012229"	48206	"79098-20-7"	"4-Chloropentylbenzene"	"C79098207"	742	"OT_ER_ERaERa_0480"	115045	556379	565320	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012230"	47957	"1219-38-1"	"Octylparaben"	"C1219381"	708	"NVS_NR_bER"	516352	2707438	2696398	11	"Borderline active"	NA	NA	"percent_activity"
"TX012230"	47957	"1219-38-1"	"Octylparaben"	"C1219381"	708	"NVS_NR_bER"	516529	2707438	2696398	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012231"	34981	"4342-36-3"	"Tributyltin benzoate"	"C4342363"	117	"ATG_ERa_TRANS_up"	49561	2169493	2035418	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX012231"	34981	"4342-36-3"	"Tributyltin benzoate"	"C4342363"	117	"ATG_ERa_TRANS_up"	50145	2169493	2035418	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012231"	34981	"4342-36-3"	"Tributyltin benzoate"	"C4342363"	714	"NVS_NR_hER"	518062	2709684	2698961	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012231"	34981	"4342-36-3"	"Tributyltin benzoate"	"C4342363"	725	"NVS_NR_mERa"	517597	2710787	2700064	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012232"	48189	"1166-52-5"	"Dodecyl gallate"	"C1166525"	742	"OT_ER_ERaERa_0480"	115046	556382	565323	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012232"	48189	"1166-52-5"	"Dodecyl gallate"	"C1166525"	750	"OT_ERa_EREGFP_0120"	115553	573233	567301	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012234"	29133	"99-93-4"	"4-Hydroxyacetophenone"	"C99934"	75	"ATG_ERE_CIS_up"	13762	2093087	1965037	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012234"	29133	"99-93-4"	"4-Hydroxyacetophenone"	"C99934"	117	"ATG_ERa_TRANS_up"	49671	2169490	2035415	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012236"	48194	"1671-75-6"	"Heptanophenone"	"C1671756"	75	"ATG_ERE_CIS_up"	13144	2093086	1965038	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX012236"	48194	"1671-75-6"	"Heptanophenone"	"C1671756"	75	"ATG_ERE_CIS_up"	13366	2093086	1965038	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX012236"	48194	"1671-75-6"	"Heptanophenone"	"C1671756"	117	"ATG_ERa_TRANS_up"	49787	2169489	2035414	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX012237"	27877	"25550-98-5"	"Diisodecylphenyl phosphite"	"C25550985"	2	"ACEA_T47D_80hr_Positive"	10373	1779553	1779852	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012237"	27877	"25550-98-5"	"Diisodecylphenyl phosphite"	"C25550985"	117	"ATG_ERa_TRANS_up"	49670	2169488	2035413	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012237"	27877	"25550-98-5"	"Diisodecylphenyl phosphite"	"C25550985"	117	"ATG_ERa_TRANS_up"	49875	2169488	2035413	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012239"	48203	"6285-05-8"	"Ethyl 4-chlorophenyl ketone"	"C6285058"	117	"ATG_ERa_TRANS_up"	49874	2169487	2035412	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012241"	41188	"705-60-2"	"(2-Nitro-1-propenyl)benzene"	"C705602"	117	"ATG_ERa_TRANS_up"	49873	2169486	2035411	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012241"	41188	"705-60-2"	"(2-Nitro-1-propenyl)benzene"	"C705602"	750	"OT_ERa_EREGFP_0120"	115811	573239	567307	10	"Noisy data"	NA	NA	"percent_activity"
"TX012242"	48187	"199584-38-8"	"1-Methoxy-4-tert-pentylcyclohexane"	"C199584388"	75	"ATG_ERE_CIS_up"	13620	2093082	1965042	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"log2_fold_induction"
"TX012242"	48187	"199584-38-8"	"1-Methoxy-4-tert-pentylcyclohexane"	"C199584388"	75	"ATG_ERE_CIS_up"	13761	2093082	1965042	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012242"	48187	"199584-38-8"	"1-Methoxy-4-tert-pentylcyclohexane"	"C199584388"	117	"ATG_ERa_TRANS_up"	50144	2169485	2035410	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012243"	47882	"17696-62-7"	"Phenylparaben"	"C17696627"	708	"NVS_NR_bER"	516303	2707443	2696403	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012244"	29650	"1490-04-6"	"Menthol"	"C1490046"	708	"NVS_NR_bER"	516217	2707444	2696404	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012244"	29650	"1490-04-6"	"Menthol"	"C1490046"	708	"NVS_NR_bER"	516461	2707444	2696404	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012244"	29650	"1490-04-6"	"Menthol"	"C1490046"	708	"NVS_NR_bER"	516530	2707444	2696404	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012244"	29650	"1490-04-6"	"Menthol"	"C1490046"	725	"NVS_NR_mERa"	517234	2710792	2700069	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012245"	29649	"1477-55-0"	"1,3-Benzenedimethanamine"	"C1477550"	714	"NVS_NR_hER"	517910	2709690	2698967	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012245"	29649	"1477-55-0"	"1,3-Benzenedimethanamine"	"C1477550"	714	"NVS_NR_hER"	517923	2709690	2698967	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX012245"	29649	"1477-55-0"	"1,3-Benzenedimethanamine"	"C1477550"	725	"NVS_NR_mERa"	517404	2710793	2700070	11	"Borderline active"	NA	NA	"percent_activity"
"TX012245"	29649	"1477-55-0"	"1,3-Benzenedimethanamine"	"C1477550"	725	"NVS_NR_mERa"	517598	2710793	2700070	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012245"	29649	"1477-55-0"	"1,3-Benzenedimethanamine"	"C1477550"	725	"NVS_NR_mERa"	517688	2710793	2700070	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012246"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	75	"ATG_ERE_CIS_up"	13276	2093078	1965046	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012246"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	75	"ATG_ERE_CIS_up"	13523	2093078	1965046	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012246"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	708	"NVS_NR_bER"	516304	2707446	2696406	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012246"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	708	"NVS_NR_bER"	516408	2707446	2696406	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012246"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	725	"NVS_NR_mERa"	517235	2710794	2700071	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012247"	48200	"480-63-7"	"2,4,6-Trimethylbenzoic acid"	"C480637"	750	"OT_ERa_EREGFP_0120"	115554	573245	567313	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012247"	48200	"480-63-7"	"2,4,6-Trimethylbenzoic acid"	"C480637"	751	"OT_ERa_EREGFP_0480"	116701	566250	569289	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012249"	20216	"128-37-0"	"Butylated hydroxytoluene"	"C128370"	117	"ATG_ERa_TRANS_up"	50143	2169479	2035404	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012249"	20216	"128-37-0"	"Butylated hydroxytoluene"	"C128370"	750	"OT_ERa_EREGFP_0120"	115765	573246	567314	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012251"	48195	"18979-55-0"	"4-(Hexyloxy)phenol"	"C18979550"	714	"NVS_NR_hER"	518063	2709692	2698969	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012251"	48195	"18979-55-0"	"4-(Hexyloxy)phenol"	"C18979550"	742	"OT_ER_ERaERa_0480"	114916	556396	565337	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012251"	48195	"18979-55-0"	"4-(Hexyloxy)phenol"	"C18979550"	751	"OT_ERa_EREGFP_0480"	116702	566252	569291	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012252"	48199	"4344-55-2"	"4-Butyloxyaniline"	"C4344552"	117	"ATG_ERa_TRANS_up"	49786	2169477	2035402	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX012254"	48191	"13680-35-8"	"4,4'-Methylenebis(2,6-diethylaniline)"	"C13680358"	75	"ATG_ERE_CIS_up"	13522	2093072	1965052	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012254"	48191	"13680-35-8"	"4,4'-Methylenebis(2,6-diethylaniline)"	"C13680358"	742	"OT_ER_ERaERa_0480"	114969	556399	565340	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012254"	48191	"13680-35-8"	"4,4'-Methylenebis(2,6-diethylaniline)"	"C13680358"	742	"OT_ER_ERaERa_0480"	115047	556399	565340	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012254"	48191	"13680-35-8"	"4,4'-Methylenebis(2,6-diethylaniline)"	"C13680358"	744	"OT_ER_ERaERb_0480"	112869	2400755	2400378	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX012254"	48191	"13680-35-8"	"4,4'-Methylenebis(2,6-diethylaniline)"	"C13680358"	751	"OT_ERa_EREGFP_0480"	116858	566255	569294	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012255"	48209	"938-16-9"	"tert-Butyl phenyl ketone"	"C938169"	75	"ATG_ERE_CIS_up"	13275	2093071	1965053	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012255"	48209	"938-16-9"	"tert-Butyl phenyl ketone"	"C938169"	75	"ATG_ERE_CIS_up"	13521	2093071	1965053	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012255"	48209	"938-16-9"	"tert-Butyl phenyl ketone"	"C938169"	117	"ATG_ERa_TRANS_up"	49872	2169474	2035399	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012256"	47879	"117-99-7"	"2-Hydroxybenzophenone"	"C117997"	747	"OT_ER_ERbERb_1440"	114829	560338	561401	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012256"	47879	"117-99-7"	"2-Hydroxybenzophenone"	"C117997"	747	"OT_ER_ERbERb_1440"	114893	560338	561401	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012257"	32518	"1192-52-5"	"4,5-Dichloro-3H-1,2-dithiol-3-one"	"C1192525"	2	"ACEA_T47D_80hr_Positive"	10374	1779568	1779837	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012257"	32518	"1192-52-5"	"4,5-Dichloro-3H-1,2-dithiol-3-one"	"C1192525"	745	"OT_ER_ERaERb_1440"	115385	558371	537140	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012257"	32518	"1192-52-5"	"4,5-Dichloro-3H-1,2-dithiol-3-one"	"C1192525"	750	"OT_ERa_EREGFP_0120"	115766	573253	567321	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012257"	32518	"1192-52-5"	"4,5-Dichloro-3H-1,2-dithiol-3-one"	"C1192525"	750	"OT_ERa_EREGFP_0120"	115878	573253	567321	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012258"	48198	"40649-36-3"	"4-Propylcyclohexanone"	"C40649363"	75	"ATG_ERE_CIS_up"	13760	2093068	1965056	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012258"	48198	"40649-36-3"	"4-Propylcyclohexanone"	"C40649363"	117	"ATG_ERa_TRANS_up"	50142	2169471	2035396	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012258"	48198	"40649-36-3"	"4-Propylcyclohexanone"	"C40649363"	743	"OT_ER_ERaERa_1440"	114430	552189	563372	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012260"	22288	"39905-57-2"	"4-Hexyloxyaniline"	"C39905572"	75	"ATG_ERE_CIS_up"	13520	2093066	1965058	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012260"	22288	"39905-57-2"	"4-Hexyloxyaniline"	"C39905572"	742	"OT_ER_ERaERa_0480"	115048	556405	565346	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012260"	22288	"39905-57-2"	"4-Hexyloxyaniline"	"C39905572"	746	"OT_ER_ERbERb_0480"	116580	550221	559436	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012260"	22288	"39905-57-2"	"4-Hexyloxyaniline"	"C39905572"	750	"OT_ERa_EREGFP_0120"	115767	573256	567324	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012261"	48201	"5407-98-7"	"Cyclobutyl phenyl ketone"	"C5407987"	2	"ACEA_T47D_80hr_Positive"	10714	1779572	1779833	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012263"	48514	"NOCAS_48514"	"PharmaGSID_48514"	"CNOCAS48514"	117	"ATG_ERa_TRANS_up"	49871	2169466	2035391	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012263"	48514	"NOCAS_48514"	"PharmaGSID_48514"	"CNOCAS48514"	708	"NVS_NR_bER"	516305	2707451	2696411	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012263"	48514	"NOCAS_48514"	"PharmaGSID_48514"	"CNOCAS48514"	708	"NVS_NR_bER"	516409	2707451	2696411	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012263"	48514	"NOCAS_48514"	"PharmaGSID_48514"	"CNOCAS48514"	743	"OT_ER_ERaERa_1440"	114431	552194	563377	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012263"	48514	"NOCAS_48514"	"PharmaGSID_48514"	"CNOCAS48514"	745	"OT_ER_ERaERb_1440"	115429	558377	537146	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012264"	48518	"NOCAS_48518"	"PharmaGSID_48518"	"CNOCAS48518"	743	"OT_ER_ERaERa_1440"	114432	552195	563378	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012264"	48518	"NOCAS_48518"	"PharmaGSID_48518"	"CNOCAS48518"	747	"OT_ER_ERbERb_1440"	114830	560346	561409	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012265"	48513	"825643-57-0"	"PharmaGSID_48513"	"C825643570"	714	"NVS_NR_hER"	517805	2709696	2698973	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012265"	48513	"825643-57-0"	"PharmaGSID_48513"	"C825643570"	714	"NVS_NR_hER"	517911	2709696	2698973	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012265"	48513	"825643-57-0"	"PharmaGSID_48513"	"C825643570"	750	"OT_ERa_EREGFP_0120"	115768	573261	567329	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012266"	48512	"107071-66-9"	"Ro 23-7637"	"C107071669"	746	"OT_ER_ERbERb_0480"	116599	550227	559442	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012267"	48520	"625114-41-2"	"Piragliatin"	"C625114412"	75	"ATG_ERE_CIS_up"	13274	2093059	1965066	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012267"	48520	"625114-41-2"	"Piragliatin"	"C625114412"	117	"ATG_ERa_TRANS_up"	49870	2169462	2035387	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012269"	48519	"686756-87-6"	"PharmaGSID_48519"	"C686756876"	750	"OT_ERa_EREGFP_0120"	115887	573265	567333	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	117	"ATG_ERa_TRANS_up"	49669	2169458	2035383	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	117	"ATG_ERa_TRANS_up"	49869	2169458	2035383	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	708	"NVS_NR_bER"	516306	2707454	2696414	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	708	"NVS_NR_bER"	516410	2707454	2696414	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	742	"OT_ER_ERaERa_0480"	115049	556416	565357	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	744	"OT_ER_ERaERb_0480"	112813	2400738	2400395	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	745	"OT_ER_ERaERb_1440"	115386	558385	537154	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	746	"OT_ER_ERbERb_0480"	116678	550232	559447	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012271"	48509	"NOCAS_48509"	"PharmaGSID_48509"	"CNOCAS48509"	747	"OT_ER_ERbERb_1440"	114894	560353	561416	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012272"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	708	"NVS_NR_bER"	516234	2707455	2696415	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX012272"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	708	"NVS_NR_bER"	516353	2707455	2696415	11	"Borderline active"	NA	NA	"percent_activity"
"TX012272"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	708	"NVS_NR_bER"	516462	2707455	2696415	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012272"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	708	"NVS_NR_bER"	516531	2707455	2696415	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012275"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	714	"NVS_NR_hER"	517912	2709698	2698975	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012275"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	742	"OT_ER_ERaERa_0480"	114984	556420	565361	10	"Noisy data"	NA	NA	"percent_activity"
"TX012275"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	743	"OT_ER_ERaERa_1440"	114464	552206	563389	10	"Noisy data"	NA	NA	"percent_activity"
"TX012275"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	744	"OT_ER_ERaERb_0480"	112897	2400734	2400411	11	"Borderline active"	NA	NA	"percent_activity"
"TX012276"	48511	"1062243-51-9"	"PharmaGSID_48511"	"C1062243519"	708	"NVS_NR_bER"	516307	2707457	2696417	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012276"	48511	"1062243-51-9"	"PharmaGSID_48511"	"C1062243519"	725	"NVS_NR_mERa"	517689	2710799	2700076	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012276"	48511	"1062243-51-9"	"PharmaGSID_48511"	"C1062243519"	750	"OT_ERa_EREGFP_0120"	115769	573272	567340	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012512"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	742	"OT_ER_ERaERa_0480"	114970	556422	565363	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012512"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	742	"OT_ER_ERaERa_0480"	115050	556422	565363	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012512"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	743	"OT_ER_ERaERa_1440"	114508	552207	563390	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012513"	21856	"104-13-2"	"4-Butylaniline"	"C104132"	117	"ATG_ERa_TRANS_up"	49785	2169442	2035367	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX012513"	21856	"104-13-2"	"4-Butylaniline"	"C104132"	744	"OT_ER_ERaERb_0480"	112812	2400731	2400408	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012513"	21856	"104-13-2"	"4-Butylaniline"	"C104132"	746	"OT_ER_ERbERb_0480"	116679	550239	559454	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012515"	48181	"769-92-6"	"4-tert-Butylaniline"	"C769926"	117	"ATG_ERa_TRANS_up"	49784	2169440	2035365	11	"Borderline active"	NA	NA	"log2_fold_induction"
"TX012516"	47741	"132-65-0"	"Dibenzothiophene"	"C132650"	2	"ACEA_T47D_80hr_Positive"	10715	1779578	1779827	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012516"	47741	"132-65-0"	"Dibenzothiophene"	"C132650"	75	"ATG_ERE_CIS_up"	13143	2093036	1965088	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX012516"	47741	"132-65-0"	"Dibenzothiophene"	"C132650"	742	"OT_ER_ERaERa_0480"	115051	556426	565367	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012516"	47741	"132-65-0"	"Dibenzothiophene"	"C132650"	744	"OT_ER_ERaERb_0480"	112811	2400728	2400405	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012516"	47741	"132-65-0"	"Dibenzothiophene"	"C132650"	745	"OT_ER_ERaERb_1440"	115522	558394	537163	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012519"	48185	"41372-20-7"	"Apomorphine hydrochloride hydrate"	"C41372207"	2	"ACEA_T47D_80hr_Positive"	10375	1779581	1779824	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012519"	48185	"41372-20-7"	"Apomorphine hydrochloride hydrate"	"C41372207"	75	"ATG_ERE_CIS_up"	13757	2093033	1965091	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012522"	20768	"520-18-3"	"Kaempferol"	"C520183"	725	"NVS_NR_mERa"	517405	2710805	2700082	11	"Borderline active"	NA	NA	"percent_activity"
"TX012522"	20768	"520-18-3"	"Kaempferol"	"C520183"	725	"NVS_NR_mERa"	517599	2710805	2700082	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012522"	20768	"520-18-3"	"Kaempferol"	"C520183"	725	"NVS_NR_mERa"	517690	2710805	2700082	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012522"	20768	"520-18-3"	"Kaempferol"	"C520183"	743	"OT_ER_ERaERa_1440"	114356	552217	563400	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012523"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	2	"ACEA_T47D_80hr_Positive"	10376	1779585	1779820	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012523"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	2	"ACEA_T47D_80hr_Positive"	10716	1779585	1779820	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012523"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	75	"ATG_ERE_CIS_up"	13272	2093029	1965095	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012523"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	75	"ATG_ERE_CIS_up"	13518	2093029	1965095	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012523"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	745	"OT_ER_ERaERb_1440"	115431	558401	537170	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012523"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	750	"OT_ERa_EREGFP_0120"	115770	573284	567352	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012524"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	2	"ACEA_T47D_80hr_Positive"	10377	1779586	1779819	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012524"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	117	"ATG_ERa_TRANS_up"	49667	2169431	2035356	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012524"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	117	"ATG_ERa_TRANS_up"	49866	2169431	2035356	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012524"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	708	"NVS_NR_bER"	516333	2707464	2696424	10	"Noisy data"	NA	NA	"percent_activity"
"TX012524"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	714	"NVS_NR_hER"	517833	2709705	2698982	10	"Noisy data"	NA	NA	"percent_activity"
"TX012524"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	725	"NVS_NR_mERa"	517375	2710806	2700083	10	"Noisy data"	NA	NA	"percent_activity"
"TX012525"	25226	"24169-02-6"	"Econazole nitrate"	"C24169026"	2	"ACEA_T47D_80hr_Positive"	10378	1779587	1779818	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012525"	25226	"24169-02-6"	"Econazole nitrate"	"C24169026"	725	"NVS_NR_mERa"	517523	2710807	2700084	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	714	"NVS_NR_hER"	517968	2709707	2698984	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	714	"NVS_NR_hER"	518064	2709707	2698984	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	725	"NVS_NR_mERa"	517406	2710808	2700085	11	"Borderline active"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	725	"NVS_NR_mERa"	517600	2710808	2700085	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	725	"NVS_NR_mERa"	517691	2710808	2700085	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	742	"OT_ER_ERaERa_0480"	114917	556436	565377	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	743	"OT_ER_ERaERa_1440"	114509	552221	563404	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	744	"OT_ER_ERaERb_0480"	112810	2400709	2400425	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012526"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	745	"OT_ER_ERaERb_1440"	115387	558404	537173	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012527"	25429	"6088-51-3"	"6-Hydroxy-2-naphthyl disulfide"	"C6088513"	708	"NVS_NR_bER"	516463	2707467	2696427	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012527"	25429	"6088-51-3"	"6-Hydroxy-2-naphthyl disulfide"	"C6088513"	708	"NVS_NR_bER"	516532	2707467	2696427	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012527"	25429	"6088-51-3"	"6-Hydroxy-2-naphthyl disulfide"	"C6088513"	725	"NVS_NR_mERa"	517692	2710809	2700086	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012527"	25429	"6088-51-3"	"6-Hydroxy-2-naphthyl disulfide"	"C6088513"	743	"OT_ER_ERaERa_1440"	114357	552222	563405	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012528"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	2	"ACEA_T47D_80hr_Positive"	10241	1779590	1779815	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX012528"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	708	"NVS_NR_bER"	516464	2707468	2696428	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012528"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	708	"NVS_NR_bER"	516533	2707468	2696428	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012528"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	743	"OT_ER_ERaERa_1440"	114358	552223	563406	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012528"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	745	"OT_ER_ERaERb_1440"	115388	558406	537175	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012528"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	746	"OT_ER_ERbERb_0480"	116680	550254	559469	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	708	"NVS_NR_bER"	516235	2707470	2696430	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	708	"NVS_NR_bER"	516354	2707470	2696430	11	"Borderline active"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	708	"NVS_NR_bER"	516465	2707470	2696430	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	708	"NVS_NR_bER"	516534	2707470	2696430	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	714	"NVS_NR_hER"	517806	2709711	2698988	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	746	"OT_ER_ERbERb_0480"	116681	550257	559472	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	747	"OT_ER_ERbERb_1440"	114831	560377	561440	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	747	"OT_ER_ERbERb_1440"	114895	560377	561440	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012531"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	750	"OT_ERa_EREGFP_0120"	115771	573292	567360	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012532"	22364	"521-18-6"	"5alpha-Dihydrotestosterone"	"C521186"	2	"ACEA_T47D_80hr_Positive"	10411	1779594	1779812	10	"Noisy data"	NA	NA	"percent_activity"
"TX012534"	23202	"112809-51-5"	"Letrozole"	"C112809515"	714	"NVS_NR_hER"	517807	2709714	2698991	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012534"	23202	"112809-51-5"	"Letrozole"	"C112809515"	714	"NVS_NR_hER"	517914	2709714	2698991	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012534"	23202	"112809-51-5"	"Letrozole"	"C112809515"	750	"OT_ERa_EREGFP_0120"	115772	573295	567363	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012536"	36496	"797-63-7"	"Norgestrel"	"C797637"	725	"NVS_NR_mERa"	517238	2710817	2700094	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012537"	48186	"67-30-1"	"Tetrac"	"C67301"	75	"ATG_ERE_CIS_up"	13271	2093015	1965108	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX012537"	48186	"67-30-1"	"Tetrac"	"C67301"	75	"ATG_ERE_CIS_up"	13517	2093015	1965108	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012537"	48186	"67-30-1"	"Tetrac"	"C67301"	714	"NVS_NR_hER"	517915	2709717	2698994	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012537"	48186	"67-30-1"	"Tetrac"	"C67301"	725	"NVS_NR_mERa"	517239	2710818	2700095	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012537"	48186	"67-30-1"	"Tetrac"	"C67301"	725	"NVS_NR_mERa"	517524	2710818	2700095	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012537"	48186	"67-30-1"	"Tetrac"	"C67301"	743	"OT_ER_ERaERa_1440"	114434	552232	563415	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012538"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	75	"ATG_ERE_CIS_up"	13516	2093014	1965110	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012538"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	714	"NVS_NR_hER"	518065	2709718	2698995	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012538"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	725	"NVS_NR_mERa"	517240	2710819	2700096	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012538"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	725	"NVS_NR_mERa"	517525	2710819	2700096	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012538"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	744	"OT_ER_ERaERb_0480"	112809	2400705	2400427	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012538"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	745	"OT_ER_ERaERb_1440"	115389	558416	537185	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012538"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	750	"OT_ERa_EREGFP_0120"	115555	573299	567367	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012539"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	2	"ACEA_T47D_80hr_Positive"	10217	1779601	1779804	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012539"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	708	"NVS_NR_bER"	516466	2707478	2696438	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012539"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	708	"NVS_NR_bER"	516536	2707478	2696438	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012539"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	750	"OT_ERa_EREGFP_0120"	115773	573300	567368	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012539"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	750	"OT_ERa_EREGFP_0120"	115879	573300	567368	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012539"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	751	"OT_ERa_EREGFP_0480"	116859	566305	569344	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012540"	20618	"102676-31-3"	"Fadrozole hydrochloride"	"C102676313"	725	"NVS_NR_mERa"	517241	2710821	2700098	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012541"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	708	"NVS_NR_bER"	516412	2707480	2696440	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012541"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	714	"NVS_NR_hER"	517742	2709721	2698998	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX012541"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	714	"NVS_NR_hER"	517969	2709721	2698998	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012541"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	742	"OT_ER_ERaERa_0480"	114972	556451	565392	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012541"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	743	"OT_ER_ERaERa_1440"	114435	552236	563419	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012541"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	746	"OT_ER_ERbERb_0480"	116683	550267	559482	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012541"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	750	"OT_ERa_EREGFP_0120"	115774	573302	567370	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012543"	21087	"604-75-1"	"Oxazepam"	"C604751"	2	"ACEA_T47D_80hr_Positive"	10379	1779605	1779800	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012543"	21087	"604-75-1"	"Oxazepam"	"C604751"	75	"ATG_ERE_CIS_up"	13187	2093009	1965115	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX012543"	21087	"604-75-1"	"Oxazepam"	"C604751"	75	"ATG_ERE_CIS_up"	13756	2093009	1965115	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012543"	21087	"604-75-1"	"Oxazepam"	"C604751"	117	"ATG_ERa_TRANS_up"	49625	2169412	2035337	7	"Only one conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX012543"	21087	"604-75-1"	"Oxazepam"	"C604751"	117	"ATG_ERa_TRANS_up"	50139	2169412	2035337	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012543"	21087	"604-75-1"	"Oxazepam"	"C604751"	743	"OT_ER_ERaERa_1440"	114436	552238	563421	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012545"	45232	"51-24-1"	"Tiratricol"	"C51241"	744	"OT_ER_ERaERb_0480"	112807	2400688	2400452	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012545"	45232	"51-24-1"	"Tiratricol"	"C51241"	750	"OT_ERa_EREGFP_0120"	115880	573306	567374	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012546"	48210	"93-99-2"	"Phenyl benzoate"	"C93992"	117	"ATG_ERa_TRANS_up"	49865	2169409	2035334	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012546"	48210	"93-99-2"	"Phenyl benzoate"	"C93992"	744	"OT_ER_ERaERb_0480"	112808	2400689	2400446	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012546"	48210	"93-99-2"	"Phenyl benzoate"	"C93992"	746	"OT_ER_ERbERb_0480"	116684	550272	559487	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012548"	36112	"95-38-5"	"1H-Imidazole-1-ethanol, 2-(8-heptadecenyl)-4,5-dihydro-"	"C95385"	745	"OT_ER_ERaERb_1440"	115390	558426	537195	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012548"	36112	"95-38-5"	"1H-Imidazole-1-ethanol, 2-(8-heptadecenyl)-4,5-dihydro-"	"C95385"	746	"OT_ER_ERbERb_0480"	116685	550274	559489	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012548"	36112	"95-38-5"	"1H-Imidazole-1-ethanol, 2-(8-heptadecenyl)-4,5-dihydro-"	"C95385"	747	"OT_ER_ERbERb_1440"	114766	560394	561457	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX012549"	48204	"70568-60-4"	"4-Butylcyclohexanol"	"C70568604"	75	"ATG_ERE_CIS_up"	13142	2093003	1965121	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX012549"	48204	"70568-60-4"	"4-Butylcyclohexanol"	"C70568604"	75	"ATG_ERE_CIS_up"	13755	2093003	1965121	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012549"	48204	"70568-60-4"	"4-Butylcyclohexanol"	"C70568604"	117	"ATG_ERa_TRANS_up"	49864	2169406	2035331	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012550"	48188	"106-45-6"	"4-Thiocresol"	"C106456"	75	"ATG_ERE_CIS_up"	13515	2093002	1965122	12	"Borderline inactive"	NA	NA	"log2_fold_induction"
"TX012550"	48188	"106-45-6"	"4-Thiocresol"	"C106456"	117	"ATG_ERa_TRANS_up"	50138	2169405	2035330	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX012551"	20197	"22260-51-1"	"Bromocriptine mesylate"	"C22260511"	708	"NVS_NR_bER"	516309	2707484	2696444	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012551"	20197	"22260-51-1"	"Bromocriptine mesylate"	"C22260511"	725	"NVS_NR_mERa"	517017	2710826	2700103	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"TX012551"	20197	"22260-51-1"	"Bromocriptine mesylate"	"C22260511"	725	"NVS_NR_mERa"	517407	2710826	2700103	11	"Borderline active"	NA	NA	"percent_activity"
"TX012551"	20197	"22260-51-1"	"Bromocriptine mesylate"	"C22260511"	725	"NVS_NR_mERa"	517601	2710826	2700103	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012551"	20197	"22260-51-1"	"Bromocriptine mesylate"	"C22260511"	725	"NVS_NR_mERa"	517693	2710826	2700103	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX012552"	48184	"2919-66-6"	"Melengestrol acetate"	"C2919666"	725	"NVS_NR_mERa"	517602	2710827	2700104	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX012552"	48184	"2919-66-6"	"Melengestrol acetate"	"C2919666"	745	"OT_ER_ERaERb_1440"	115432	558430	537199	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX012553"	48522	"NOCAS_48522"	"HMR1171 trifluoroacetate (1:1)"	"CNOCAS48522"	745	"OT_ER_ERaERb_1440"	115524	558431	537200	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX012553"	48522	"NOCAS_48522"	"HMR1171 trifluoroacetate (1:1)"	"CNOCAS48522"	751	"OT_ERa_EREGFP_0480"	116861	566319	569358	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX014395"	21233	"16423-68-0"	"FD&C Red 3"	"C16423680"	75	"ATG_ERE_CIS_up"	13139	2092867	1965257	6	"Only highest conc above baseline, active"	NA	NA	"log2_fold_induction"
"TX014395"	21233	"16423-68-0"	"FD&C Red 3"	"C16423680"	75	"ATG_ERE_CIS_up"	13742	2092867	1965257	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX101640"	20209	"94-26-8"	"Butylparaben"	"C94268"	708	"NVS_NR_bER"	516537	2707491	2696451	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX103073"	20374	"72-55-9"	"p,p'-DDE"	"C72559"	751	"OT_ERa_EREGFP_0480"	116863	566339	569378	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX104423"	37714	"1987-50-4"	"4-Heptylphenol"	"C1987504"	750	"OT_ERa_EREGFP_0120"	115777	573338	567406	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX104423"	37714	"1987-50-4"	"4-Heptylphenol"	"C1987504"	751	"OT_ERa_EREGFP_0480"	116864	566343	569382	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX104423"	37714	"1987-50-4"	"4-Heptylphenol"	"C1987504"	751	"OT_ERa_EREGFP_0480"	116927	566343	569382	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX104886"	40716	"5349-51-9"	"4-(2-Methylbutan-2-yl)cyclohexanol"	"C5349519"	746	"OT_ER_ERbERb_0480"	116581	550305	559520	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX105444"	40722	"2433-14-9"	"4-Cyclohexylcyclohexanol"	"C2433149"	742	"OT_ER_ERaERa_0480"	114919	556491	565432	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX105444"	40722	"2433-14-9"	"4-Cyclohexylcyclohexanol"	"C2433149"	751	"OT_ERa_EREGFP_0480"	116866	566347	569386	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX105684"	22474	"50-22-6"	"Corticosterone"	"C50226"	117	"ATG_ERa_TRANS_up"	49652	2169105	2035030	8	"Multiple points above baseline, inactive"	NA	NA	"log2_fold_induction"
"TX106008"	20337	"50-41-9"	"Clomiphene citrate"	"C50419"	742	"OT_ER_ERaERa_0480"	114986	556496	565437	10	"Noisy data"	NA	NA	"percent_activity"
"TX107238"	23902	"56-55-3"	"Benz(a)anthracene"	"C56553"	745	"OT_ER_ERaERb_1440"	115433	558469	537238	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX107238"	23902	"56-55-3"	"Benz(a)anthracene"	"C56553"	751	"OT_ERa_EREGFP_0480"	116868	566357	569396	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX108422"	36515	"57-85-2"	"Testosterone propionate"	"C57852"	750	"OT_ERa_EREGFP_0120"	115779	573356	567424	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX108476"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	2	"ACEA_T47D_80hr_Positive"	10423	1779651	1781721	10	"Noisy data"	NA	NA	"percent_activity"
"TX108618"	34187	"10540-29-1"	"Tamoxifen"	"C10540291"	743	"OT_ER_ERaERa_1440"	114468	552293	563476	10	"Noisy data"	NA	NA	"percent_activity"
"TX108838"	22370	"57-83-0"	"Progesterone"	"C57830"	750	"OT_ERa_EREGFP_0120"	115780	573360	567428	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX109795"	34181	"82640-04-8"	"Raloxifene hydrochloride"	"C82640048"	742	"OT_ER_ERaERa_0480"	114987	556516	565457	10	"Noisy data"	NA	NA	"percent_activity"
"TX109795"	34181	"82640-04-8"	"Raloxifene hydrochloride"	"C82640048"	743	"OT_ER_ERaERa_1440"	114469	552301	563484	10	"Noisy data"	NA	NA	"percent_activity"
"TX110322"	22367	"53-16-7"	"Estrone"	"C53167"	743	"OT_ER_ERaERa_1440"	114470	552304	563487	10	"Noisy data"	NA	NA	"percent_activity"
"TX110322"	22367	"53-16-7"	"Estrone"	"C53167"	745	"OT_ER_ERaERb_1440"	115451	558487	537256	10	"Noisy data"	NA	NA	"percent_activity"
"TX111585"	32493	"55219-65-3"	"Triadimenol"	"C55219653"	725	"NVS_NR_mERa"	517257	2710879	2700156	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX112521"	48182	"712-50-5"	"Cyclohexylphenylketone"	"C712505"	745	"OT_ER_ERaERb_1440"	115529	558492	537261	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX112533"	22369	"129453-61-8"	"Fulvestrant"	"C129453618"	708	"NVS_NR_bER"	516355	2707544	2696504	11	"Borderline active"	NA	NA	"percent_activity"
"TX112533"	22369	"129453-61-8"	"Fulvestrant"	"C129453618"	708	"NVS_NR_bER"	516542	2707544	2696504	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX112533"	22369	"129453-61-8"	"Fulvestrant"	"C129453618"	743	"OT_ER_ERaERa_1440"	114471	552312	563495	10	"Noisy data"	NA	NA	"percent_activity"
"TX112533"	22369	"129453-61-8"	"Fulvestrant"	"C129453618"	745	"OT_ER_ERaERb_1440"	115452	558495	537264	10	"Noisy data"	NA	NA	"percent_activity"
"TX112535"	37094	"68392-35-8"	"4-Hydroxytamoxifen"	"C68392358"	743	"OT_ER_ERaERa_1440"	114472	552313	563496	10	"Noisy data"	NA	NA	"percent_activity"
"TX112535"	37094	"68392-35-8"	"4-Hydroxytamoxifen"	"C68392358"	745	"OT_ER_ERaERb_1440"	115453	558496	537265	10	"Noisy data"	NA	NA	"percent_activity"
"TX112536"	36496	"797-63-7"	"Norgestrel"	"C797637"	708	"NVS_NR_bER"	516356	2707546	2696506	11	"Borderline active"	NA	NA	"percent_activity"
"TX112536"	36496	"797-63-7"	"Norgestrel"	"C797637"	708	"NVS_NR_bER"	516543	2707546	2696506	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"TX112536"	36496	"797-63-7"	"Norgestrel"	"C797637"	745	"OT_ER_ERaERb_1440"	115531	558497	537266	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX112536"	36496	"797-63-7"	"Norgestrel"	"C797637"	747	"OT_ER_ERbERb_1440"	114838	560465	561528	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX112542"	33562	"52806-53-8"	"Hydroxyflutamide"	"C52806538"	2	"ACEA_T47D_80hr_Positive"	10219	1779683	1781689	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX112545"	45232	"51-24-1"	"Tiratricol"	"C51241"	751	"OT_ERa_EREGFP_0480"	116873	566387	569426	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX202687"	33923	"32809-16-8"	"Procymidone"	"C32809168"	2	"ACEA_T47D_80hr_Positive"	10767	1779694	1781678	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX202769"	20770	"143-50-0"	"Kepone"	"C143500"	746	"OT_ER_ERbERb_0480"	116602	550358	559573	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX205098"	40707	"33228-44-3"	"4-Pentylaniline"	"C33228443"	725	"NVS_NR_mERa"	517263	2710909	2700186	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX205798"	20576	"57-63-6"	"17alpha-Ethinylestradiol"	"C57636"	2	"ACEA_T47D_80hr_Positive"	10432	1779706	1781666	10	"Noisy data"	NA	NA	"percent_activity"
"TX206008"	20337	"50-41-9"	"Clomiphene citrate"	"C50419"	2	"ACEA_T47D_80hr_Positive"	10385	1779709	1781663	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX206008"	20337	"50-41-9"	"Clomiphene citrate"	"C50419"	743	"OT_ER_ERaERa_1440"	114473	552341	563524	10	"Noisy data"	NA	NA	"percent_activity"
"TX206008"	20337	"50-41-9"	"Clomiphene citrate"	"C50419"	745	"OT_ER_ERaERb_1440"	115456	558524	537293	10	"Noisy data"	NA	NA	"percent_activity"
"TX208327"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	743	"OT_ER_ERaERa_1440"	114359	552348	563531	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX208327"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	751	"OT_ERa_EREGFP_0480"	116880	566419	569458	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX208327"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	751	"OT_ERa_EREGFP_0480"	116930	566419	569458	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX208838"	22370	"57-83-0"	"Progesterone"	"C57830"	751	"OT_ERa_EREGFP_0480"	116882	566425	569464	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX210322"	22367	"53-16-7"	"Estrone"	"C53167"	747	"OT_ER_ERbERb_1440"	114848	560515	561578	10	"Noisy data"	NA	NA	"percent_activity"
"TX212517"	24882	"66-81-9"	"Cycloheximide"	"C66819"	714	"NVS_NR_hER"	517972	2709843	2699120	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX212530"	34192	"10161-33-8"	"17beta-Trenbolone"	"C10161338"	745	"OT_ER_ERaERb_1440"	115394	558553	537322	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX212532"	22364	"521-18-6"	"5alpha-Dihydrotestosterone"	"C521186"	708	"NVS_NR_bER"	516317	2707604	2696564	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX212536"	36496	"797-63-7"	"Norgestrel"	"C797637"	743	"OT_ER_ERaERa_1440"	114442	552374	563557	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"TX212545"	45232	"51-24-1"	"Tiratricol"	"C51241"	742	"OT_ER_ERaERa_0480"	114924	556591	565532	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX311585"	32493	"55219-65-3"	"Triadimenol"	"C55219653"	2	"ACEA_T47D_80hr_Positive"	10723	1779756	1781616	12	"Borderline inactive"	NA	NA	"percent_activity"
"TX311591"	31864	"1763-23-1"	"PFOS"	"C1763231"	117	"ATG_ERa_TRANS_up"	50097	2168985	2034910	16	"Hit-call potentially confounded by overfitting"	NA	NA	"log2_fold_induction"
"TX511591"	31864	"1763-23-1"	"PFOS"	"C1763231"	714	"NVS_NR_hER"	517733	2709860	2699137	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"TX511591"	31864	"1763-23-1"	"PFOS"	"C1763231"	714	"NVS_NR_hER"	517974	2709860	2699137	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"TX511591"	31864	"1763-23-1"	"PFOS"	"C1763231"	714	"NVS_NR_hER"	518072	2709860	2699137	17	"Biochemical assay with < 50% efficacy"	NA	NA	"percent_activity"
"Tox21_300004"	40701	"77-93-0"	"Triethyl citrate"	"C77930"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224116	1056318	799791	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300004"	40701	"77-93-0"	"Triethyl citrate"	"C77930"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224902	1056318	799791	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300006"	21206	"57-55-6"	"1,2-Propylene glycol"	"C57556"	785	"Tox21_ERa_BLA_Agonist_ratio"	201869	1097651	915264	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300009"	22529	"99-76-3"	"Methylparaben"	"C99763"	788	"Tox21_ERa_LUC_BG1_Agonist"	259412	1192308	608069	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300009"	22529	"99-76-3"	"Methylparaben"	"C99763"	788	"Tox21_ERa_LUC_BG1_Agonist"	260591	1192308	608069	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300012"	20350	"120-71-8"	"2-Methoxy-5-methylaniline"	"C120718"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224903	1056326	799799	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300013"	21774	"83-32-9"	"Acenaphthene"	"C83329"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236472	974714	841788	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300014"	23878	"120-12-7"	"Anthracene"	"C120127"	788	"Tox21_ERa_LUC_BG1_Agonist"	258344	1192313	608074	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300015"	20716	"123-31-9"	"Hydroquinone"	"C123319"	785	"Tox21_ERa_BLA_Agonist_ratio"	201870	1097660	915273	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300017"	23792	"99-99-0"	"4-Nitrotoluene"	"C99990"	785	"Tox21_ERa_BLA_Agonist_ratio"	201871	1097662	915275	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300018"	20431	"106-46-7"	"1,4-Dichlorobenzene"	"C106467"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223857	1056332	799805	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300019"	20605	"104-76-7"	"2-Ethyl-1-hexanol"	"C104767"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224904	1056333	799806	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300019"	20605	"104-76-7"	"2-Ethyl-1-hexanol"	"C104767"	788	"Tox21_ERa_LUC_BG1_Agonist"	257741	1192318	608079	1	"Row-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_300019"	20605	"104-76-7"	"2-Ethyl-1-hexanol"	"C104767"	788	"Tox21_ERa_LUC_BG1_Agonist"	257865	1192318	608079	4	"Col-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_300019"	20605	"104-76-7"	"2-Ethyl-1-hexanol"	"C104767"	788	"Tox21_ERa_LUC_BG1_Agonist"	260592	1192318	608079	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300023"	21106	"87-86-5"	"Pentachlorophenol"	"C87865"	785	"Tox21_ERa_BLA_Agonist_ratio"	201872	1097668	915281	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300023"	21106	"87-86-5"	"Pentachlorophenol"	"C87865"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224117	1056337	799810	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300023"	21106	"87-86-5"	"Pentachlorophenol"	"C87865"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237861	974724	841798	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300024"	20121	"26628-22-8"	"Sodium azide"	"C26628228"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224905	1056338	799811	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300024"	20121	"26628-22-8"	"Sodium azide"	"C26628228"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225167	1056338	799811	9	"Potential pintool carryover"	0.333333333333333	"proportion"	"percent_activity"
"Tox21_300024"	20121	"26628-22-8"	"Sodium azide"	"C26628228"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237862	974725	841799	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300027"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	788	"Tox21_ERa_LUC_BG1_Agonist"	258345	1192326	608087	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300027"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	788	"Tox21_ERa_LUC_BG1_Agonist"	259413	1192326	608087	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300027"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	788	"Tox21_ERa_LUC_BG1_Agonist"	260593	1192326	608087	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300027"	25895	"101-54-2"	"N-Phenyl-1,4-benzenediamine"	"C101542"	788	"Tox21_ERa_LUC_BG1_Agonist"	261577	1192326	608087	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300031"	24087	"110-80-5"	"2-Ethoxyethanol"	"C110805"	785	"Tox21_ERa_BLA_Agonist_ratio"	201873	1097676	915289	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300035"	21426	"57-13-6"	"Urea"	"C57136"	788	"Tox21_ERa_LUC_BG1_Agonist"	260594	1192334	608095	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300036"	20507	"121-69-7"	"N,N-Dimethylaniline"	"C121697"	785	"Tox21_ERa_BLA_Agonist_ratio"	200676	1097681	915294	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300036"	20507	"121-69-7"	"N,N-Dimethylaniline"	"C121697"	788	"Tox21_ERa_LUC_BG1_Agonist"	257866	1192335	608096	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300040"	20439	"120-83-2"	"2,4-Dichlorophenol"	"C120832"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224906	1056354	799827	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300045"	20293	"532-27-4"	"2-Chloroacetophenone"	"C532274"	785	"Tox21_ERa_BLA_Agonist_ratio"	202728	1097690	915303	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300047"	22331	"89-72-5"	"2-(Butan-2-yl)phenol"	"C89725"	788	"Tox21_ERa_LUC_BG1_Agonist"	259414	1192346	608107	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300048"	20921	"91-59-8"	"2-Naphthylamine"	"C91598"	785	"Tox21_ERa_BLA_Agonist_ratio"	200677	1097693	915306	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300048"	20921	"91-59-8"	"2-Naphthylamine"	"C91598"	788	"Tox21_ERa_LUC_BG1_Agonist"	259415	1192347	608108	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300048"	20921	"91-59-8"	"2-Naphthylamine"	"C91598"	788	"Tox21_ERa_LUC_BG1_Agonist"	260595	1192347	608108	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300050"	20759	"78-59-1"	"Isophorone"	"C78591"	785	"Tox21_ERa_BLA_Agonist_ratio"	201874	1097695	915308	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300050"	20759	"78-59-1"	"Isophorone"	"C78591"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237177	974751	841825	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300052"	21993	"132-64-9"	"Dibenzofuran"	"C132649"	788	"Tox21_ERa_LUC_BG1_Agonist"	258346	1192351	608112	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300052"	21993	"132-64-9"	"Dibenzofuran"	"C132649"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236473	974753	841827	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300053"	23877	"90-04-0"	"2-Anisidine"	"C90040"	788	"Tox21_ERa_LUC_BG1_Agonist"	260596	1192352	608113	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300055"	26307	"87-62-7"	"2,6-Dimethylaniline"	"C87627"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236390	974756	841830	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300056"	22536	"599-64-4"	"4-Cumylphenol"	"C599644"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237178	974757	841831	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300056"	22536	"599-64-4"	"4-Cumylphenol"	"C599644"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237863	974757	841831	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300058"	21961	"119-61-9"	"Benzophenone"	"C119619"	785	"Tox21_ERa_BLA_Agonist_ratio"	201875	1097703	915316	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300058"	21961	"119-61-9"	"Benzophenone"	"C119619"	785	"Tox21_ERa_BLA_Agonist_ratio"	202729	1097703	915316	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300058"	21961	"119-61-9"	"Benzophenone"	"C119619"	788	"Tox21_ERa_LUC_BG1_Agonist"	258347	1192357	608118	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300060"	21201	"121-79-9"	"Propyl gallate"	"C121799"	788	"Tox21_ERa_LUC_BG1_Agonist"	258595	1192359	608120	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300061"	21653	"110-62-3"	"Pentanal"	"C110623"	785	"Tox21_ERa_BLA_Agonist_ratio"	201876	1097706	915319	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300062"	21832	"99-97-8"	"N,N,4-Trimethylaniline"	"C99978"	788	"Tox21_ERa_LUC_BG1_Agonist"	258348	1192361	608122	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300063"	34287	"104-67-6"	"5-Heptyldihydro-2(3H)-furanone"	"C104676"	785	"Tox21_ERa_BLA_Agonist_ratio"	201877	1097708	915321	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300063"	34287	"104-67-6"	"5-Heptyldihydro-2(3H)-furanone"	"C104676"	788	"Tox21_ERa_LUC_BG1_Agonist"	259416	1192362	608123	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300065"	40111	"105-54-4"	"Ethyl butyrate"	"C105544"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224118	1056379	799852	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300067"	20375	"50-29-3"	"p,p'-DDT"	"C50293"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224907	1056381	799854	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300067"	20375	"50-29-3"	"p,p'-DDT"	"C50293"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225626	1056381	799854	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300075"	26029	"4418-26-2"	"Sodium dehydroacetate"	"C4418262"	788	"Tox21_ERa_LUC_BG1_Agonist"	258349	1192374	608135	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300075"	26029	"4418-26-2"	"Sodium dehydroacetate"	"C4418262"	788	"Tox21_ERa_LUC_BG1_Agonist"	261578	1192374	608135	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300078"	21946	"112-30-1"	"1-Decanol"	"C112301"	788	"Tox21_ERa_LUC_BG1_Agonist"	260597	1192377	608138	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300079"	26076	"1401-55-4"	"Tannic acid"	"C1401554"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224908	1056393	799866	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300079"	26076	"1401-55-4"	"Tannic acid"	"C1401554"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225627	1056393	799866	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300082"	40788	"121-00-6"	"2-tert-Butyl-4-methoxyphenol"	"C121006"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237864	974783	841857	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300086"	22332	"99-71-8"	"4-(Butan-2-yl)phenol"	"C99718"	785	"Tox21_ERa_BLA_Agonist_ratio"	201878	1097731	915344	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300086"	22332	"99-71-8"	"4-(Butan-2-yl)phenol"	"C99718"	788	"Tox21_ERa_LUC_BG1_Agonist"	259417	1192385	608146	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300086"	22332	"99-71-8"	"4-(Butan-2-yl)phenol"	"C99718"	788	"Tox21_ERa_LUC_BG1_Agonist"	260598	1192385	608146	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300088"	21771	"80-46-6"	"4-(2-Methylbutan-2-yl)phenol"	"C80466"	785	"Tox21_ERa_BLA_Agonist_ratio"	201879	1097733	915346	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300088"	21771	"80-46-6"	"4-(2-Methylbutan-2-yl)phenol"	"C80466"	785	"Tox21_ERa_BLA_Agonist_ratio"	202730	1097733	915346	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300088"	21771	"80-46-6"	"4-(2-Methylbutan-2-yl)phenol"	"C80466"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237865	974789	841863	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300090"	26974	"120-95-6"	"2,4-Bis(2-methylbutan-2-yl)phenol"	"C120956"	785	"Tox21_ERa_BLA_Agonist_ratio"	201880	1097735	915348	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300090"	26974	"120-95-6"	"2,4-Bis(2-methylbutan-2-yl)phenol"	"C120956"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224909	1056404	799877	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300092"	27494	"2687-25-4"	"2,3-Diaminotoluene"	"C2687254"	788	"Tox21_ERa_LUC_BG1_Agonist"	260599	1192391	608152	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300092"	27494	"2687-25-4"	"2,3-Diaminotoluene"	"C2687254"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237179	974793	841867	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300092"	27494	"2687-25-4"	"2,3-Diaminotoluene"	"C2687254"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237866	974793	841867	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300093"	24261	"732-11-6"	"Phosmet"	"C732116"	788	"Tox21_ERa_LUC_BG1_Agonist"	260600	1192392	608153	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300094"	24081	"145-73-3"	"Endothal"	"C145733"	785	"Tox21_ERa_BLA_Agonist_ratio"	201881	1097739	915352	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300094"	24081	"145-73-3"	"Endothal"	"C145733"	788	"Tox21_ERa_LUC_BG1_Agonist"	259418	1192393	608154	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300094"	24081	"145-73-3"	"Endothal"	"C145733"	788	"Tox21_ERa_LUC_BG1_Agonist"	260601	1192393	608154	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300098"	20770	"143-50-0"	"Kepone"	"C143500"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224429	1056412	799885	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300101"	20068	"117-79-3"	"2-Aminoanthraquinone"	"C117793"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236565	974802	841876	3	"Col-wise effect, decreased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_300101"	20068	"117-79-3"	"2-Aminoanthraquinone"	"C117793"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237379	974802	841876	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300102"	35152	"116-25-6"	"1-(Hydroxymethyl)-5,5-dimethylhydantoin"	"C116256"	788	"Tox21_ERa_LUC_BG1_Agonist"	258350	1192401	608162	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300103"	20221	"98-54-4"	"4-tert-Butylphenol"	"C98544"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223858	1056417	799890	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300103"	20221	"98-54-4"	"4-tert-Butylphenol"	"C98544"	788	"Tox21_ERa_LUC_BG1_Agonist"	259419	1192402	608163	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300103"	20221	"98-54-4"	"4-tert-Butylphenol"	"C98544"	788	"Tox21_ERa_LUC_BG1_Agonist"	260602	1192402	608163	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300104"	21164	"110-85-0"	"Piperazine"	"C110850"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236474	974805	841879	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300106"	21485	"121-91-5"	"1,3-Benzenedicarboxylic acid"	"C121915"	788	"Tox21_ERa_LUC_BG1_Agonist"	260603	1192405	608166	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300107"	21986	"126-73-8"	"Tributyl phosphate"	"C126738"	788	"Tox21_ERa_LUC_BG1_Agonist"	258351	1192406	608167	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300109"	20374	"72-55-9"	"p,p'-DDE"	"C72559"	785	"Tox21_ERa_BLA_Agonist_ratio"	201882	1097754	915367	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300109"	20374	"72-55-9"	"p,p'-DDE"	"C72559"	788	"Tox21_ERa_LUC_BG1_Agonist"	259420	1192408	608169	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300109"	20374	"72-55-9"	"p,p'-DDE"	"C72559"	788	"Tox21_ERa_LUC_BG1_Agonist"	260604	1192408	608169	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300111"	26691	"102-76-1"	"Triacetin"	"C102761"	788	"Tox21_ERa_LUC_BG1_Agonist"	258352	1192410	608171	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_300111"	26691	"102-76-1"	"Triacetin"	"C102761"	788	"Tox21_ERa_LUC_BG1_Agonist"	261579	1192410	608171	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300112"	20634	"51-21-8"	"5-Fluorouracil"	"C51218"	785	"Tox21_ERa_BLA_Agonist_ratio"	201883	1097757	915370	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300112"	20634	"51-21-8"	"5-Fluorouracil"	"C51218"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237180	974813	841887	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300113"	27131	"288-88-0"	"1H-1,2,4-Triazole"	"C288880"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236630	974814	841888	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300114"	26602	"96-76-4"	"2,4-Di-tert-butylphenol"	"C96764"	788	"Tox21_ERa_LUC_BG1_Agonist"	258353	1192413	608174	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300116"	20512	"79-44-7"	"Dimethylcarbamoyl chloride"	"C79447"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236391	974817	841891	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300117"	21834	"100-02-7"	"4-Nitrophenol"	"C100027"	785	"Tox21_ERa_BLA_Agonist_ratio"	201884	1097762	915375	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300117"	21834	"100-02-7"	"4-Nitrophenol"	"C100027"	788	"Tox21_ERa_LUC_BG1_Agonist"	260605	1192416	608177	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300123"	24097	"111-76-2"	"2-Butoxyethanol"	"C111762"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236392	974824	841898	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300125"	20140	"532-32-1"	"Sodium benzoate"	"C532321"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236393	974826	841900	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300127"	22519	"59-30-3"	"Folic acid"	"C59303"	785	"Tox21_ERa_BLA_Agonist_ratio"	201885	1097772	915385	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300127"	22519	"59-30-3"	"Folic acid"	"C59303"	788	"Tox21_ERa_LUC_BG1_Agonist"	258354	1192426	608187	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300128"	42390	"3811-73-2"	"Sodium (2-pyridylthio)-N-oxide"	"C3811732"	785	"Tox21_ERa_BLA_Agonist_ratio"	201886	1097773	915386	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300128"	42390	"3811-73-2"	"Sodium (2-pyridylthio)-N-oxide"	"C3811732"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236760	974829	841903	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300129"	21217	"58-14-0"	"Pyrimethamine"	"C58140"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236761	974830	841904	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300130"	20869	"101-61-1"	"4,4'-Methylenebis(N,N-dimethylaniline)"	"C101611"	785	"Tox21_ERa_BLA_Agonist_ratio"	201887	1097775	915388	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300133"	21094	"101-80-4"	"4,4'-Oxydianiline"	"C101804"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224910	1056447	799920	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300133"	21094	"101-80-4"	"4,4'-Oxydianiline"	"C101804"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225628	1056447	799920	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300135"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	788	"Tox21_ERa_LUC_BG1_Agonist"	259421	1192434	608195	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300135"	20392	"131-17-9"	"Diallyl phthalate"	"C131179"	788	"Tox21_ERa_LUC_BG1_Agonist"	260606	1192434	608195	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300139"	20498	"120-61-6"	"Dimethyl terephthalate"	"C120616"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224911	1056453	799926	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300140"	21238	"108-46-3"	"Resorcinol"	"C108463"	788	"Tox21_ERa_LUC_BG1_Agonist"	259849	1192439	608200	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300141"	22422	"101-77-9"	"4,4'-Methylenedianiline"	"C101779"	788	"Tox21_ERa_LUC_BG1_Agonist"	258355	1192440	608201	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300142"	26684	"101-86-0"	"2-Benzylideneoctanal"	"C101860"	788	"Tox21_ERa_LUC_BG1_Agonist"	258356	1192441	608202	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300142"	26684	"101-86-0"	"2-Benzylideneoctanal"	"C101860"	788	"Tox21_ERa_LUC_BG1_Agonist"	261580	1192441	608202	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300143"	20402	"95-80-7"	"2,4-Diaminotoluene"	"C95807"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224912	1056457	799930	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300144"	20663	"56-81-5"	"Glycerol"	"C56815"	788	"Tox21_ERa_LUC_BG1_Agonist"	259722	1192443	608204	9	"Potential pintool carryover"	0.333333333333333	"proportion"	"percent_activity"
"Tox21_300147"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	785	"Tox21_ERa_BLA_Agonist_ratio"	201888	1097792	915405	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300147"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	788	"Tox21_ERa_LUC_BG1_Agonist"	258357	1192446	608207	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300147"	27921	"27138-31-4"	"Di(propylene glycol) dibenzoate"	"C27138314"	788	"Tox21_ERa_LUC_BG1_Agonist"	261581	1192446	608207	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300149"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225629	1056463	799936	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300149"	26031	"151-21-3"	"Sodium dodecyl sulfate"	"C151213"	788	"Tox21_ERa_LUC_BG1_Agonist"	259422	1192448	608209	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300151"	29874	"49562-28-9"	"Fenofibrate"	"C49562289"	785	"Tox21_ERa_BLA_Agonist_ratio"	202731	1097796	915409	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300151"	29874	"49562-28-9"	"Fenofibrate"	"C49562289"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236762	974852	841926	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300153"	20257	"120-80-9"	"Catechol"	"C120809"	785	"Tox21_ERa_BLA_Agonist_ratio"	201202	1097798	915411	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300153"	20257	"120-80-9"	"Catechol"	"C120809"	788	"Tox21_ERa_LUC_BG1_Agonist"	260607	1192452	608213	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300154"	41847	"109-43-3"	"Dibutyl decanedioate"	"C109433"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224913	1056468	799941	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300155"	23632	"87-69-4"	"L-Tartaric acid"	"C87694"	785	"Tox21_ERa_BLA_Agonist_ratio"	201889	1097800	915413	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300156"	20939	"139-13-9"	"Nitrilotriacetic acid"	"C139139"	785	"Tox21_ERa_BLA_Agonist_ratio"	201890	1097801	915414	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300158"	35341	"77-48-5"	"1,3-Dibromo-5,5-dimethylhydantoin"	"C77485"	788	"Tox21_ERa_LUC_BG1_Agonist"	258358	1192457	608218	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300159"	20570	"6381-77-7"	"Sodium erythorbate (1:1)"	"C6381777"	788	"Tox21_ERa_LUC_BG1_Agonist"	260608	1192458	608219	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300161"	24143	"822-06-0"	"1,6-Diisocyanatohexane"	"C822060"	785	"Tox21_ERa_BLA_Agonist_ratio"	201891	1097806	915419	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300162"	21821	"96-29-7"	"2-Butanone oxime"	"C96297"	788	"Tox21_ERa_LUC_BG1_Agonist"	260609	1192461	608222	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300165"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	788	"Tox21_ERa_LUC_BG1_Agonist"	260610	1192464	608225	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300165"	25068	"84-75-3"	"Dihexyl phthalate"	"C84753"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236475	974866	841940	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300170"	20647	"98-01-1"	"Furfural"	"C98011"	785	"Tox21_ERa_BLA_Agonist_ratio"	201892	1097815	915428	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300172"	20040	"309-00-2"	"Aldrin"	"C309002"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237181	974873	841947	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300173"	24376	"1929-77-7"	"Vernolate"	"C1929777"	788	"Tox21_ERa_LUC_BG1_Agonist"	260611	1192472	608233	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300175"	24086	"563-12-2"	"Ethion"	"C563122"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224914	1056489	799962	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300175"	24086	"563-12-2"	"Ethion"	"C563122"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225630	1056489	799962	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300176"	44643	"3033-77-0"	"N,N,N-Trimethyl(oxiran-2-yl)methanaminium chloride"	"C3033770"	785	"Tox21_ERa_BLA_Agonist_ratio"	201893	1097821	915434	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300176"	44643	"3033-77-0"	"N,N,N-Trimethyl(oxiran-2-yl)methanaminium chloride"	"C3033770"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223947	1056490	799963	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300176"	44643	"3033-77-0"	"N,N,N-Trimethyl(oxiran-2-yl)methanaminium chloride"	"C3033770"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225212	1056490	799963	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300180"	20143	"65-85-0"	"Benzoic acid"	"C65850"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224915	1056494	799967	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300183"	21780	"84-66-2"	"Diethyl phthalate"	"C84662"	788	"Tox21_ERa_LUC_BG1_Agonist"	260612	1192482	608243	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300184"	24985	"118-52-5"	"1,3-Dichloro-5,5-dimethylhydantoin"	"C118525"	785	"Tox21_ERa_BLA_Agonist_ratio"	201894	1097829	915442	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300186"	24359	"95-95-4"	"2,4,5-Trichlorophenol"	"C95954"	785	"Tox21_ERa_BLA_Agonist_ratio"	201895	1097831	915444	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300186"	24359	"95-95-4"	"2,4,5-Trichlorophenol"	"C95954"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225631	1056500	799973	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300189"	21386	"88-06-2"	"2,4,6-Trichlorophenol"	"C88062"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236394	974890	841964	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300191"	20373	"72-54-8"	"p,p'-DDD"	"C72548"	785	"Tox21_ERa_BLA_Agonist_ratio"	201896	1097836	915449	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300191"	20373	"72-54-8"	"p,p'-DDD"	"C72548"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225632	1056505	799978	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300192"	47167	"79-16-3"	"N-Methylacetamide"	"C79163"	788	"Tox21_ERa_LUC_BG1_Agonist"	260613	1192491	608252	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300193"	20755	"54-85-3"	"Isoniazid"	"C54853"	785	"Tox21_ERa_BLA_Agonist_ratio"	201897	1097838	915451	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300194"	26261	"13674-87-8"	"Tris(1,3-dichloro-2-propyl)phosphate"	"C13674878"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224430	1056508	799981	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300195"	22731	"298-46-4"	"Carbamazepine"	"C298464"	785	"Tox21_ERa_BLA_Agonist_ratio"	201898	1097840	915453	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300197"	33058	"584-13-4"	"4-Amino-1,2,4-triazole"	"C584134"	788	"Tox21_ERa_LUC_BG1_Agonist"	259423	1192496	608257	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300197"	33058	"584-13-4"	"4-Amino-1,2,4-triazole"	"C584134"	788	"Tox21_ERa_LUC_BG1_Agonist"	260614	1192496	608257	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300198"	22442	"77-40-7"	"Bisphenol B"	"C77407"	785	"Tox21_ERa_BLA_Agonist_ratio"	201899	1097843	915456	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300198"	22442	"77-40-7"	"Bisphenol B"	"C77407"	785	"Tox21_ERa_BLA_Agonist_ratio"	202732	1097843	915456	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300198"	22442	"77-40-7"	"Bisphenol B"	"C77407"	788	"Tox21_ERa_LUC_BG1_Agonist"	258359	1192497	608258	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300198"	22442	"77-40-7"	"Bisphenol B"	"C77407"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237867	974899	841973	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300200"	24107	"59756-60-4"	"Fluridone"	"C59756604"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237868	974901	841975	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300201"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225633	1056515	799988	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300201"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	788	"Tox21_ERa_LUC_BG1_Agonist"	259424	1192500	608261	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300201"	20867	"838-88-0"	"4,4'-Methylenebis(2-methylaniline)"	"C838880"	788	"Tox21_ERa_LUC_BG1_Agonist"	260615	1192500	608261	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300202"	47246	"139340-56-0"	"Darbufelone mesylate"	"C139340560"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236763	974903	841977	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300203"	47248	"NOCAS_47248"	"CI-1018"	"CNOCAS47248"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237869	974904	841978	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300204"	47249	"221246-12-4"	"Fandosentan potassium salt"	"C221246124"	788	"Tox21_ERa_LUC_BG1_Agonist"	259425	1192503	608264	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300205"	47251	"145742-28-5"	"CP-122721"	"C145742285"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236764	974906	841980	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300206"	47252	"186392-65-4"	"Ingliforib"	"C186392654"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224431	1056520	799993	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300207"	47253	"199171-88-5"	"CP-401387"	"C199171885"	785	"Tox21_ERa_BLA_Agonist_ratio"	201900	1097852	915465	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300207"	47253	"199171-88-5"	"CP-401387"	"C199171885"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237182	974908	841982	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300208"	47254	"220860-50-4"	"CP-457920"	"C220860504"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237870	974909	841983	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300209"	47255	"NOCAS_47255"	"CP-465394"	"CNOCAS47255"	788	"Tox21_ERa_LUC_BG1_Agonist"	260616	1192508	608269	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300210"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225634	1056524	799997	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300210"	47257	"127308-82-1"	"Zamifenacin"	"C127308821"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237871	974911	841985	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300211"	47316	"461023-63-2"	"Aplaviroc hydrochloride"	"C461023632"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225635	1056525	799998	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300211"	47316	"461023-63-2"	"Aplaviroc hydrochloride"	"C461023632"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237872	974912	841986	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300212"	47320	"180084-01-9"	"SB236057A"	"C180084019"	785	"Tox21_ERa_BLA_Agonist_ratio"	200544	1097857	915470	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300214"	47325	"NOCAS_47325"	"SB413217A"	"CNOCAS47325"	788	"Tox21_ERa_LUC_BG1_Agonist"	258596	1192513	608274	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300214"	47325	"NOCAS_47325"	"SB413217A"	"CNOCAS47325"	788	"Tox21_ERa_LUC_BG1_Agonist"	259915	1192513	608274	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300214"	47325	"NOCAS_47325"	"SB413217A"	"CNOCAS47325"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237183	974915	841989	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300216"	47322	"200940-23-4"	"SB243213A"	"C200940234"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224916	1056530	800003	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300217"	47318	"139149-55-6"	"SB202235"	"C139149556"	785	"Tox21_ERa_BLA_Agonist_ratio"	201901	1097862	915475	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300217"	47318	"139149-55-6"	"SB202235"	"C139149556"	788	"Tox21_ERa_LUC_BG1_Agonist"	259426	1192516	608277	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300219"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	785	"Tox21_ERa_BLA_Agonist_ratio"	201902	1097864	915477	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300219"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237873	974920	841994	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300219"	47313	"263553-33-9"	"GW473178E methyl benzene sulphonic acid"	"C263553339"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238041	974920	841994	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300220"	47312	"864283-48-7"	"GSK232420A"	"C864283487"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237874	974921	841995	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300221"	47324	"219790-72-4"	"SB281832"	"C219790724"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237184	974922	841996	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300222"	47315	"444610-91-7"	"PharmaGSID_47315"	"C444610917"	785	"Tox21_ERa_BLA_Agonist_ratio"	202733	1097867	915480	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300222"	47315	"444610-91-7"	"PharmaGSID_47315"	"C444610917"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237875	974923	841997	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300223"	47327	"313994-79-5"	"MK-578"	"C313994795"	785	"Tox21_ERa_BLA_Agonist_ratio"	201903	1097868	915481	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300224"	47328	"NOCAS_47328"	"MK-274"	"CNOCAS47328"	785	"Tox21_ERa_BLA_Agonist_ratio"	201904	1097869	915482	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300225"	47330	"NOCAS_47330"	"PharmaGSID_47330"	"CNOCAS47330"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225975	1056539	800012	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300225"	47330	"NOCAS_47330"	"PharmaGSID_47330"	"CNOCAS47330"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237876	974926	842000	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300226"	47331	"331623-06-4"	"MK-547"	"C331623064"	785	"Tox21_ERa_BLA_Agonist_ratio"	201905	1097871	915484	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300226"	47331	"331623-06-4"	"MK-547"	"C331623064"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225976	1056540	800013	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300227"	47338	"262376-75-0"	"HMR1426"	"C262376750"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224432	1056541	800014	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300227"	47338	"262376-75-0"	"HMR1426"	"C262376750"	788	"Tox21_ERa_LUC_BG1_Agonist"	259916	1192526	608287	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300230"	47342	"NOCAS_47342"	"SR125047"	"CNOCAS47342"	785	"Tox21_ERa_BLA_Agonist_ratio"	202734	1097875	915488	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300230"	47342	"NOCAS_47342"	"SR125047"	"CNOCAS47342"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236765	974931	842005	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300231"	47344	"159138-81-5"	"Cariporide mesylate"	"C159138815"	788	"Tox21_ERa_LUC_BG1_Agonist"	258597	1192530	608291	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300233"	47347	"155990-20-8"	"SR271425"	"C155990208"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225636	1056547	800020	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300233"	47347	"155990-20-8"	"SR271425"	"C155990208"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236566	974934	842008	3	"Col-wise effect, decreased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_300233"	47347	"155990-20-8"	"SR271425"	"C155990208"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237380	974934	842008	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300234"	47348	"742693-38-5"	"SSR504734"	"C742693385"	785	"Tox21_ERa_BLA_Agonist_ratio"	201906	1097879	915492	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300234"	47348	"742693-38-5"	"SSR504734"	"C742693385"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224433	1056548	800021	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300234"	47348	"742693-38-5"	"SSR504734"	"C742693385"	788	"Tox21_ERa_LUC_BG1_Agonist"	259427	1192533	608294	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300234"	47348	"742693-38-5"	"SSR504734"	"C742693385"	788	"Tox21_ERa_LUC_BG1_Agonist"	260617	1192533	608294	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300234"	47348	"742693-38-5"	"SSR504734"	"C742693385"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236766	974935	842009	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300236"	47353	"NOCAS_47353"	"SSR241586"	"CNOCAS47353"	785	"Tox21_ERa_BLA_Agonist_ratio"	201203	1097881	915494	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300236"	47353	"NOCAS_47353"	"SSR241586"	"CNOCAS47353"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236767	974937	842011	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300237"	47355	"189003-92-7"	"Trelanserin"	"C189003927"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225637	1056551	800024	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300237"	47355	"189003-92-7"	"Trelanserin"	"C189003927"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237877	974938	842012	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300239"	47357	"288104-79-0"	"Surinabant"	"C288104790"	785	"Tox21_ERa_BLA_Agonist_ratio"	201907	1097884	915497	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300239"	47357	"288104-79-0"	"Surinabant"	"C288104790"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236768	974940	842014	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300240"	47358	"439687-69-1"	"Nelivaptan"	"C439687691"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224434	1056554	800027	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300240"	47358	"439687-69-1"	"Nelivaptan"	"C439687691"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236476	974941	842015	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300240"	47358	"439687-69-1"	"Nelivaptan"	"C439687691"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237878	974941	842015	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300241"	47359	"298198-52-4"	"SSR180711"	"C298198524"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236395	974942	842016	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300242"	47360	"929601-09-2"	"SR58611"	"C929601092"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237879	974943	842017	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300243"	47362	"NOCAS_47362"	"SSR150106"	"CNOCAS47362"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224917	1056557	800030	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300243"	47362	"NOCAS_47362"	"SSR150106"	"CNOCAS47362"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225638	1056557	800030	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300243"	47362	"NOCAS_47362"	"SSR150106"	"CNOCAS47362"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236769	974944	842018	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300245"	47364	"NOCAS_47364"	"SSR103800"	"CNOCAS47364"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237880	974946	842020	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300246"	47366	"NOCAS_47366"	"SAR115740"	"CNOCAS47366"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237881	974947	842021	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300248"	47369	"221671-62-1"	"SR146131"	"C221671621"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237882	974949	842023	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300249"	47371	"725228-45-5"	"AVE5638"	"C725228455"	785	"Tox21_ERa_BLA_Agonist_ratio"	202735	1097894	915507	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300249"	47371	"725228-45-5"	"AVE5638"	"C725228455"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237185	974950	842024	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300249"	47371	"725228-45-5"	"AVE5638"	"C725228455"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237883	974950	842024	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300250"	47372	"478263-98-8"	"AVE3295"	"C478263988"	785	"Tox21_ERa_BLA_Agonist_ratio"	202736	1097895	915508	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300250"	47372	"478263-98-8"	"AVE3295"	"C478263988"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225277	1056564	800037	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300251"	47374	"NOCAS_47374"	"SSR161421"	"CNOCAS47374"	785	"Tox21_ERa_BLA_Agonist_ratio"	201908	1097896	915509	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300254"	47377	"NOCAS_47377"	"AVE6324"	"CNOCAS47377"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236770	974955	842029	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300255"	47379	"NOCAS_47379"	"SSR126768"	"CNOCAS47379"	785	"Tox21_ERa_BLA_Agonist_ratio"	202737	1097900	915513	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300257"	47385	"NOCAS_47385"	"SAR377142"	"CNOCAS47385"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237884	974958	842032	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300258"	47387	"NOCAS_47387"	"SAR102779"	"CNOCAS47387"	788	"Tox21_ERa_LUC_BG1_Agonist"	259428	1192557	608318	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300258"	47387	"NOCAS_47387"	"SAR102779"	"CNOCAS47387"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236771	974959	842033	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300259"	47389	"NOCAS_47389"	"SAR150640"	"CNOCAS47389"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224435	1056573	800046	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300260"	47391	"1068967-96-3"	"SAR102608"	"C1068967963"	785	"Tox21_ERa_BLA_Agonist_ratio"	200545	1097905	915518	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300260"	47391	"1068967-96-3"	"SAR102608"	"C1068967963"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225639	1056574	800047	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300260"	47391	"1068967-96-3"	"SAR102608"	"C1068967963"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237885	974961	842035	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300263"	47335	"851916-42-2"	"MK-812"	"C851916422"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238042	974964	842038	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300264"	47337	"1061517-62-1"	"PharmaGSID_47337"	"C1061517621"	785	"Tox21_ERa_BLA_Agonist_ratio"	202738	1097909	915522	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300265"	37208	"15307-79-6"	"Diclofenac sodium"	"C15307796"	788	"Tox21_ERa_LUC_BG1_Agonist"	260618	1192564	608325	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300266"	20740	"53-86-1"	"Indomethacin"	"C53861"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225640	1056580	800053	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300266"	20740	"53-86-1"	"Indomethacin"	"C53861"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236477	974967	842041	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300267"	29879	"65277-42-1"	"Ketoconazole"	"C65277421"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224119	1056581	800054	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300268"	20784	"75330-75-5"	"Lovastatin"	"C75330755"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225641	1056582	800055	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300268"	20784	"75330-75-5"	"Lovastatin"	"C75330755"	788	"Tox21_ERa_LUC_BG1_Agonist"	259429	1192567	608328	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300269"	20822	"59-05-2"	"Methotrexate"	"C59052"	785	"Tox21_ERa_BLA_Agonist_ratio"	201909	1097914	915527	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300269"	20822	"59-05-2"	"Methotrexate"	"C59052"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224918	1056583	800056	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300269"	20822	"59-05-2"	"Methotrexate"	"C59052"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237186	974970	842044	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300272"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	785	"Tox21_ERa_BLA_Agonist_ratio"	201204	1097917	915530	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300272"	40713	"1034-01-1"	"Octyl gallate"	"C1034011"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224436	1056586	800059	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300274"	21301	"54965-24-1"	"Tamoxifen citrate"	"C54965241"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225213	1056588	800061	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300275"	23652	"154-42-7"	"6-Thioguanine"	"C154427"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236396	974976	842050	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300275"	23652	"154-42-7"	"6-Thioguanine"	"C154427"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237187	974976	842050	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300276"	20970	"1836-75-5"	"Nitrofen"	"C1836755"	785	"Tox21_ERa_BLA_Agonist_ratio"	200546	1097921	915534	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300276"	20970	"1836-75-5"	"Nitrofen"	"C1836755"	785	"Tox21_ERa_BLA_Agonist_ratio"	200678	1097921	915534	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300276"	20970	"1836-75-5"	"Nitrofen"	"C1836755"	785	"Tox21_ERa_BLA_Agonist_ratio"	202447	1097921	915534	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300277"	20336	"637-07-0"	"Clofibrate"	"C637070"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236397	974978	842052	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300278"	24059	"119-93-7"	"3,3'-Dimethylbenzidine"	"C119937"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237188	974979	842053	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300279"	20894	"90-94-8"	"Michler's ketone"	"C90948"	785	"Tox21_ERa_BLA_Agonist_ratio"	201910	1097924	915537	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300279"	20894	"90-94-8"	"Michler's ketone"	"C90948"	788	"Tox21_ERa_LUC_BG1_Agonist"	259430	1192578	608339	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300279"	20894	"90-94-8"	"Michler's ketone"	"C90948"	788	"Tox21_ERa_LUC_BG1_Agonist"	260619	1192578	608339	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300280"	21209	"51-52-5"	"6-Propyl-2-thiouracil"	"C51525"	788	"Tox21_ERa_LUC_BG1_Agonist"	260620	1192579	608340	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300281"	20541	"57-41-0"	"5,5-Diphenylhydantoin"	"C57410"	785	"Tox21_ERa_BLA_Agonist_ratio"	201911	1097926	915539	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300281"	20541	"57-41-0"	"5,5-Diphenylhydantoin"	"C57410"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225642	1056595	800068	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300281"	20541	"57-41-0"	"5,5-Diphenylhydantoin"	"C57410"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237886	974982	842056	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300282"	21125	"77-09-8"	"Phenolphthalein"	"C77098"	785	"Tox21_ERa_BLA_Agonist_ratio"	201912	1097927	915540	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300282"	21125	"77-09-8"	"Phenolphthalein"	"C77098"	785	"Tox21_ERa_BLA_Agonist_ratio"	202739	1097927	915540	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300282"	21125	"77-09-8"	"Phenolphthalein"	"C77098"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237381	974983	842057	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300285"	21218	"117-39-5"	"Quercetin"	"C117395"	785	"Tox21_ERa_BLA_Agonist_ratio"	201205	1097930	915543	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300285"	21218	"117-39-5"	"Quercetin"	"C117395"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224437	1056599	800072	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300287"	23556	"68-26-8"	"Retinol"	"C68268"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225643	1056601	800074	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300287"	23556	"68-26-8"	"Retinol"	"C68268"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237189	974988	842062	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300288"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	785	"Tox21_ERa_BLA_Agonist_ratio"	200547	1097933	915546	1	"Row-wise effect, increased signal"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300288"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	785	"Tox21_ERa_BLA_Agonist_ratio"	200679	1097933	915546	4	"Col-wise effect, increased signal"	0.377777777777778	"proportion"	"percent_activity"
"Tox21_300288"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225214	1056602	800075	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300288"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225278	1056602	800075	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300288"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	788	"Tox21_ERa_LUC_BG1_Agonist"	257867	1192587	608348	4	"Col-wise effect, increased signal"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300288"	20573	"50-28-2"	"17beta-Estradiol"	"C50282"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237887	974989	842063	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300291"	27982	"33703-08-1"	"Hexanedioic acid, diisononyl ester"	"C33703081"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224919	1056605	800078	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300294"	22817	"1260-17-9"	"Carminic acid"	"C1260179"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237190	974995	842069	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300294"	22817	"1260-17-9"	"Carminic acid"	"C1260179"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237888	974995	842069	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300296"	20164	"3296-90-0"	"2,2-Bis(bromomethyl)-1,3-propanediol"	"C3296900"	788	"Tox21_ERa_LUC_BG1_Agonist"	260621	1192595	608356	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300297"	21135	"842-07-9"	"C.I. Solvent Yellow 14"	"C842079"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237191	974998	842072	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300300"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	785	"Tox21_ERa_BLA_Agonist_ratio"	201913	1097945	915558	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300300"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	785	"Tox21_ERa_BLA_Agonist_ratio"	202740	1097945	915558	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300300"	20069	"97-56-3"	"2-Amino-5-azotoluene"	"C97563"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236567	975001	842075	3	"Col-wise effect, decreased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_300302"	30698	"10016-20-3"	"alpha-Cyclodextrin"	"C10016203"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224120	1056616	800089	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300302"	30698	"10016-20-3"	"alpha-Cyclodextrin"	"C10016203"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224920	1056616	800089	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300303"	22413	"97-54-1"	"Isoeugenol"	"C97541"	788	"Tox21_ERa_LUC_BG1_Agonist"	258598	1192602	608363	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300304"	31131	"131-18-0"	"Dipentyl phthalate"	"C131180"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224921	1056618	800091	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300305"	21239	"302-79-4"	"trans-Retinoic acid"	"C302794"	785	"Tox21_ERa_BLA_Agonist_ratio"	201914	1097950	915563	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300305"	21239	"302-79-4"	"trans-Retinoic acid"	"C302794"	785	"Tox21_ERa_BLA_Agonist_ratio"	202741	1097950	915563	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300305"	21239	"302-79-4"	"trans-Retinoic acid"	"C302794"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225215	1056619	800092	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300305"	21239	"302-79-4"	"trans-Retinoic acid"	"C302794"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237192	975006	842080	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300306"	21393	"112-27-6"	"Triethylene glycol"	"C112276"	788	"Tox21_ERa_LUC_BG1_Agonist"	259431	1192605	608366	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300306"	21393	"112-27-6"	"Triethylene glycol"	"C112276"	788	"Tox21_ERa_LUC_BG1_Agonist"	260622	1192605	608366	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300307"	22370	"57-83-0"	"Progesterone"	"C57830"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224438	1056621	800094	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300307"	22370	"57-83-0"	"Progesterone"	"C57830"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236772	975008	842082	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300310"	27924	"27178-16-1"	"Diisodecyl hexanedioate"	"C27178161"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224922	1056624	800097	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300310"	27924	"27178-16-1"	"Diisodecyl hexanedioate"	"C27178161"	788	"Tox21_ERa_LUC_BG1_Agonist"	258360	1192609	608370	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300310"	27924	"27178-16-1"	"Diisodecyl hexanedioate"	"C27178161"	788	"Tox21_ERa_LUC_BG1_Agonist"	261582	1192609	608370	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300312"	23796	"140-64-7"	"Pentamidine isethionate"	"C140647"	785	"Tox21_ERa_BLA_Agonist_ratio"	201915	1097957	915570	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300314"	34695	"8018-01-7"	"Mancozeb"	"C8018017"	788	"Tox21_ERa_LUC_BG1_Agonist"	259432	1192612	608373	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300315"	20485	"20325-40-0"	"3,3'-Dimethoxybenzidine dihydrochloride"	"C20325400"	785	"Tox21_ERa_BLA_Agonist_ratio"	201916	1097959	915572	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300315"	20485	"20325-40-0"	"3,3'-Dimethoxybenzidine dihydrochloride"	"C20325400"	785	"Tox21_ERa_BLA_Agonist_ratio"	202742	1097959	915572	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300315"	20485	"20325-40-0"	"3,3'-Dimethoxybenzidine dihydrochloride"	"C20325400"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224439	1056628	800101	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300315"	20485	"20325-40-0"	"3,3'-Dimethoxybenzidine dihydrochloride"	"C20325400"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237889	975015	842089	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300316"	27635	"6846-50-0"	"2,2,4-Trimethyl-1,3-pentanediol diisobutyrate"	"C6846500"	785	"Tox21_ERa_BLA_Agonist_ratio"	200680	1097960	915573	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300317"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	785	"Tox21_ERa_BLA_Agonist_ratio"	200681	1097961	915574	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300317"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	788	"Tox21_ERa_LUC_BG1_Agonist"	258361	1192615	608376	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300317"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	788	"Tox21_ERa_LUC_BG1_Agonist"	259433	1192615	608376	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300317"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	788	"Tox21_ERa_LUC_BG1_Agonist"	260623	1192615	608376	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300317"	29241	"2772-45-4"	"2,4-Bis(1-methyl-1-phenylethyl)phenol"	"C2772454"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236773	975017	842091	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300320"	20887	"91-62-3"	"6-Methylquinoline"	"C91623"	785	"Tox21_ERa_BLA_Agonist_ratio"	200682	1097964	915577	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300321"	21414	"78-42-2"	"Tris(2-ethylhexyl) phosphate"	"C78422"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224923	1056634	800107	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300322"	27625	"6422-86-2"	"Bis(2-ethylhexyl) terephthalate"	"C6422862"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224924	1056635	800108	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300324"	47528	"58394-64-2"	"Benzyloctyl adipate"	"C58394642"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224925	1056636	800109	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300324"	47528	"58394-64-2"	"Benzyloctyl adipate"	"C58394642"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225644	1056636	800109	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300324"	47528	"58394-64-2"	"Benzyloctyl adipate"	"C58394642"	788	"Tox21_ERa_LUC_BG1_Agonist"	257868	1192621	608382	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300324"	47528	"58394-64-2"	"Benzyloctyl adipate"	"C58394642"	788	"Tox21_ERa_LUC_BG1_Agonist"	259850	1192621	608382	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300325"	27991	"36653-82-4"	"1-Hexadecanol"	"C36653824"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224121	1056637	800110	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300325"	27991	"36653-82-4"	"1-Hexadecanol"	"C36653824"	788	"Tox21_ERa_LUC_BG1_Agonist"	259434	1192622	608383	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300325"	27991	"36653-82-4"	"1-Hexadecanol"	"C36653824"	788	"Tox21_ERa_LUC_BG1_Agonist"	260624	1192622	608383	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300328"	20582	"91-53-2"	"Ethoxyquin"	"C91532"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236478	975027	842101	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300329"	23977	"95-49-8"	"2-Chlorotoluene"	"C95498"	785	"Tox21_ERa_BLA_Agonist_ratio"	201918	1097972	915585	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300330"	47527	"66456-53-9"	"Adipic acid, polypropyleneglycol, laurate"	"C66456539"	785	"Tox21_ERa_BLA_Agonist_ratio"	201919	1097973	915586	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300330"	47527	"66456-53-9"	"Adipic acid, polypropyleneglycol, laurate"	"C66456539"	785	"Tox21_ERa_BLA_Agonist_ratio"	202743	1097973	915586	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300330"	47527	"66456-53-9"	"Adipic acid, polypropyleneglycol, laurate"	"C66456539"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224926	1056642	800115	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300331"	47526	"91082-17-6"	"C10-21 sulfonic acids phenyl esters"	"C91082176"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224927	1056643	800116	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300332"	20209	"94-26-8"	"Butylparaben"	"C94268"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224441	1056644	800117	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300332"	20209	"94-26-8"	"Butylparaben"	"C94268"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225279	1056644	800117	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300333"	27218	"579-66-8"	"2,6-Diethylaniline"	"C579668"	788	"Tox21_ERa_LUC_BG1_Agonist"	260625	1192630	608391	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300337"	21643	"124-13-0"	"Octanal"	"C124130"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225645	1056649	800122	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300339"	20877	"90-12-0"	"1-Methylnaphthalene"	"C90120"	785	"Tox21_ERa_BLA_Agonist_ratio"	201920	1097982	915595	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300342"	21600	"111-14-8"	"Heptanoic acid"	"C111148"	788	"Tox21_ERa_LUC_BG1_Agonist"	259435	1192639	608400	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300342"	21600	"111-14-8"	"Heptanoic acid"	"C111148"	788	"Tox21_ERa_LUC_BG1_Agonist"	260626	1192639	608400	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300344"	21605	"124-04-9"	"Hexanedioic acid"	"C124049"	785	"Tox21_ERa_BLA_Agonist_ratio"	201921	1097987	915600	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300346"	24814	"106-43-4"	"4-Chlorotoluene"	"C106434"	785	"Tox21_ERa_BLA_Agonist_ratio"	201922	1097989	915602	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300349"	36299	"7378-99-6"	"N,N-Dimethyloctylamine"	"C7378996"	788	"Tox21_ERa_LUC_BG1_Agonist"	260627	1192646	608407	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300350"	25152	"106-65-0"	"Dimethyl succinate"	"C106650"	788	"Tox21_ERa_LUC_BG1_Agonist"	259436	1192647	608408	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300350"	25152	"106-65-0"	"Dimethyl succinate"	"C106650"	788	"Tox21_ERa_LUC_BG1_Agonist"	260628	1192647	608408	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300355"	20654	"105-87-3"	"Geranyl acetate"	"C105873"	788	"Tox21_ERa_LUC_BG1_Agonist"	259437	1192652	608413	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300355"	20654	"105-87-3"	"Geranyl acetate"	"C105873"	788	"Tox21_ERa_LUC_BG1_Agonist"	260629	1192652	608413	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300356"	26900	"112-00-5"	"Dodecyltrimethylammonium chloride"	"C112005"	785	"Tox21_ERa_BLA_Agonist_ratio"	201923	1097999	915612	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300357"	20699	"136-77-6"	"4-Hexylresorcinol"	"C136776"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224442	1056669	800142	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300359"	21419	"73-22-3"	"l-Tryptophan"	"C73223"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236398	975058	842132	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300360"	27263	"628-63-7"	"Pentyl acetate"	"C628637"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224122	1056672	800145	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300360"	27263	"628-63-7"	"Pentyl acetate"	"C628637"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224928	1056672	800145	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300360"	27263	"628-63-7"	"Pentyl acetate"	"C628637"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225168	1056672	800145	9	"Potential pintool carryover"	0.333333333333333	"proportion"	"percent_activity"
"Tox21_300360"	27263	"628-63-7"	"Pentyl acetate"	"C628637"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225646	1056672	800145	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300361"	21754	"77-71-4"	"5,5-Dimethylhydantoin"	"C77714"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236631	975060	842134	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300362"	26640	"99-62-7"	"1,3-Diisopropylbenzene"	"C99627"	788	"Tox21_ERa_LUC_BG1_Agonist"	260630	1192659	608420	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300364"	21575	"75-99-0"	"Dalapon"	"C75990"	785	"Tox21_ERa_BLA_Agonist_ratio"	201924	1098007	915620	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300364"	21575	"75-99-0"	"Dalapon"	"C75990"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225977	1056676	800149	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300364"	21575	"75-99-0"	"Dalapon"	"C75990"	788	"Tox21_ERa_LUC_BG1_Agonist"	257869	1192661	608422	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300368"	42209	"4455-26-9"	"N-Methyldioctylamine"	"C4455269"	785	"Tox21_ERa_BLA_Agonist_ratio"	201925	1098011	915624	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300368"	42209	"4455-26-9"	"N-Methyldioctylamine"	"C4455269"	788	"Tox21_ERa_LUC_BG1_Agonist"	260631	1192665	608426	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300374"	42206	"2687-96-9"	"1-Dodecyl-2-pyrrolidinone"	"C2687969"	785	"Tox21_ERa_BLA_Agonist_ratio"	201926	1098017	915630	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300374"	42206	"2687-96-9"	"1-Dodecyl-2-pyrrolidinone"	"C2687969"	788	"Tox21_ERa_LUC_BG1_Agonist"	259438	1192671	608432	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300374"	42206	"2687-96-9"	"1-Dodecyl-2-pyrrolidinone"	"C2687969"	788	"Tox21_ERa_LUC_BG1_Agonist"	260632	1192671	608432	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300374"	42206	"2687-96-9"	"1-Dodecyl-2-pyrrolidinone"	"C2687969"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237890	975073	842147	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300376"	42416	"1191-50-0"	"Sodium myristyl sulfate"	"C1191500"	785	"Tox21_ERa_BLA_Agonist_ratio"	201927	1098019	915632	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300376"	42416	"1191-50-0"	"Sodium myristyl sulfate"	"C1191500"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225647	1056688	800161	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300377"	32646	"4151-50-2"	"Sulfluramid"	"C4151502"	785	"Tox21_ERa_BLA_Agonist_ratio"	201928	1098020	915633	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300377"	32646	"4151-50-2"	"Sulfluramid"	"C4151502"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224123	1056689	800162	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300377"	32646	"4151-50-2"	"Sulfluramid"	"C4151502"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225280	1056689	800162	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300382"	40112	"106-30-9"	"Ethyl heptanoate"	"C106309"	785	"Tox21_ERa_BLA_Agonist_ratio"	202744	1098025	915638	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300385"	41248	"88-58-4"	"2,5-Di-tert-butylbenzene-1,4-diol"	"C88584"	785	"Tox21_ERa_BLA_Agonist_ratio"	201930	1098028	915641	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300386"	42423	"126-14-7"	"Sucrose octaacetate"	"C126147"	785	"Tox21_ERa_BLA_Agonist_ratio"	201931	1098029	915642	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300387"	25133	"99-51-4"	"1,2-Dimethyl-4-nitrobenzene"	"C99514"	788	"Tox21_ERa_LUC_BG1_Agonist"	260633	1192684	608445	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300389"	27397	"1338-43-8"	"Sorbitan, mono-(9Z)-9-octadecenoate"	"C1338438"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224929	1056701	800174	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300390"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	785	"Tox21_ERa_BLA_Agonist_ratio"	202745	1098033	915646	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300390"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	788	"Tox21_ERa_LUC_BG1_Agonist"	258362	1192687	608448	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300390"	44581	"96-70-8"	"2-tert-Butyl-4-ethylphenol"	"C96708"	788	"Tox21_ERa_LUC_BG1_Agonist"	261583	1192687	608448	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300391"	27050	"128-04-1"	"Sodium dimethyldithiocarbamate"	"C128041"	785	"Tox21_ERa_BLA_Agonist_ratio"	201932	1098034	915647	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300392"	44564	"3855-32-1"	"2,6,10-Trimethyl-2,6,10-triazaundecane"	"C3855321"	785	"Tox21_ERa_BLA_Agonist_ratio"	201933	1098035	915648	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300392"	44564	"3855-32-1"	"2,6,10-Trimethyl-2,6,10-triazaundecane"	"C3855321"	788	"Tox21_ERa_LUC_BG1_Agonist"	258363	1192689	608450	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300394"	31862	"307-24-4"	"PFHxA"	"C307244"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224930	1056706	800179	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300395"	37185	"19774-82-4"	"Amiodarone hydrochloride"	"C19774824"	785	"Tox21_ERa_BLA_Agonist_ratio"	201934	1098038	915651	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300395"	37185	"19774-82-4"	"Amiodarone hydrochloride"	"C19774824"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225648	1056707	800180	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300396"	37709	"3871-99-6"	"PFHS-K"	"C3871996"	785	"Tox21_ERa_BLA_Agonist_ratio"	201935	1098039	915652	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300400"	23581	"79902-63-9"	"Simvastatin"	"C79902639"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225649	1056712	800185	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300400"	23581	"79902-63-9"	"Simvastatin"	"C79902639"	788	"Tox21_ERa_LUC_BG1_Agonist"	260634	1192697	608458	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300402"	37712	"27955-94-8"	"4,4',4-Ethane-1,1,1-triyltriphenol"	"C27955948"	785	"Tox21_ERa_BLA_Agonist_ratio"	201936	1098045	915658	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300402"	37712	"27955-94-8"	"4,4',4-Ethane-1,1,1-triyltriphenol"	"C27955948"	788	"Tox21_ERa_LUC_BG1_Agonist"	257742	1192699	608460	1	"Row-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_300402"	37712	"27955-94-8"	"4,4',4-Ethane-1,1,1-triyltriphenol"	"C27955948"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237382	975101	842175	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300404"	32514	"643-79-8"	"1,2-Benzenedicarboxaldehyde"	"C643798"	785	"Tox21_ERa_BLA_Agonist_ratio"	201938	1098047	915660	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300404"	32514	"643-79-8"	"1,2-Benzenedicarboxaldehyde"	"C643798"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224443	1056716	800189	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300404"	32514	"643-79-8"	"1,2-Benzenedicarboxaldehyde"	"C643798"	788	"Tox21_ERa_LUC_BG1_Agonist"	259439	1192701	608462	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300404"	32514	"643-79-8"	"1,2-Benzenedicarboxaldehyde"	"C643798"	788	"Tox21_ERa_LUC_BG1_Agonist"	260635	1192701	608462	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300405"	20137	"92-87-5"	"Benzidine"	"C92875"	788	"Tox21_ERa_LUC_BG1_Agonist"	258364	1192702	608463	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300405"	20137	"92-87-5"	"Benzidine"	"C92875"	788	"Tox21_ERa_LUC_BG1_Agonist"	261584	1192702	608463	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300407"	21456	"2783-94-0"	"FD&C Yellow 6"	"C2783940"	785	"Tox21_ERa_BLA_Agonist_ratio"	201939	1098050	915663	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300408"	24431	"1646-75-9"	"Aldicarb oxime"	"C1646759"	785	"Tox21_ERa_BLA_Agonist_ratio"	201940	1098051	915664	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300408"	24431	"1646-75-9"	"Aldicarb oxime"	"C1646759"	788	"Tox21_ERa_LUC_BG1_Agonist"	258365	1192705	608466	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300408"	24431	"1646-75-9"	"Aldicarb oxime"	"C1646759"	788	"Tox21_ERa_LUC_BG1_Agonist"	261585	1192705	608466	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300411"	32620	"86479-06-3"	"Hexaflumuron"	"C86479063"	788	"Tox21_ERa_LUC_BG1_Agonist"	259917	1192708	608469	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300412"	38939	"754-91-6"	"PFOSA"	"C754916"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236774	975111	842185	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300413"	20576	"57-63-6"	"17alpha-Ethinylestradiol"	"C57636"	785	"Tox21_ERa_BLA_Agonist_ratio"	200548	1098056	915669	1	"Row-wise effect, increased signal"	0.488888888888889	"proportion"	"percent_activity"
"Tox21_300413"	20576	"57-63-6"	"17alpha-Ethinylestradiol"	"C57636"	785	"Tox21_ERa_BLA_Agonist_ratio"	200683	1098056	915669	4	"Col-wise effect, increased signal"	0.733333333333333	"proportion"	"percent_activity"
"Tox21_300413"	20576	"57-63-6"	"17alpha-Ethinylestradiol"	"C57636"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224931	1056725	800198	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300413"	20576	"57-63-6"	"17alpha-Ethinylestradiol"	"C57636"	788	"Tox21_ERa_LUC_BG1_Agonist"	257870	1192710	608471	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_300413"	20576	"57-63-6"	"17alpha-Ethinylestradiol"	"C57636"	788	"Tox21_ERa_LUC_BG1_Agonist"	258366	1192710	608471	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300413"	20576	"57-63-6"	"17alpha-Ethinylestradiol"	"C57636"	788	"Tox21_ERa_LUC_BG1_Agonist"	261410	1192710	608471	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300415"	29871	"23593-75-1"	"Clotrimazole"	"C23593751"	785	"Tox21_ERa_BLA_Agonist_ratio"	201941	1098058	915671	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300415"	29871	"23593-75-1"	"Clotrimazole"	"C23593751"	785	"Tox21_ERa_BLA_Agonist_ratio"	202746	1098058	915671	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300415"	29871	"23593-75-1"	"Clotrimazole"	"C23593751"	788	"Tox21_ERa_LUC_BG1_Agonist"	259440	1192712	608473	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300415"	29871	"23593-75-1"	"Clotrimazole"	"C23593751"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236479	975114	842188	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300416"	21358	"1156-19-0"	"Tolazamide"	"C1156190"	788	"Tox21_ERa_LUC_BG1_Agonist"	258367	1192713	608474	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300416"	21358	"1156-19-0"	"Tolazamide"	"C1156190"	788	"Tox21_ERa_LUC_BG1_Agonist"	261586	1192713	608474	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300418"	24066	"528-29-0"	"1,2-Dinitrobenzene"	"C528290"	788	"Tox21_ERa_LUC_BG1_Agonist"	258599	1192715	608476	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300418"	24066	"528-29-0"	"1,2-Dinitrobenzene"	"C528290"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236399	975117	842191	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300420"	41623	"15310-01-7"	"Benodanil"	"C15310017"	788	"Tox21_ERa_LUC_BG1_Agonist"	260636	1192717	608478	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300421"	20207	"88-85-7"	"Dinoseb"	"C88857"	785	"Tox21_ERa_BLA_Agonist_ratio"	201942	1098064	915677	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300422"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224932	1056734	800207	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300422"	24157	"33820-53-0"	"Isopropalin"	"C33820530"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225650	1056734	800207	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300426"	47258	"124378-77-4"	"Enadoline"	"C124378774"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236632	975125	842199	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300427"	47259	"149062-75-9"	"PharmaGSID_47259"	"C149062759"	788	"Tox21_ERa_LUC_BG1_Agonist"	258368	1192724	608485	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300427"	47259	"149062-75-9"	"PharmaGSID_47259"	"C149062759"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236480	975126	842200	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300429"	47262	"207736-05-8"	"CI-1029"	"C207736058"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225651	1056741	800214	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300431"	47264	"171866-31-2"	"CP-283097"	"C171866312"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237383	975130	842204	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300433"	47266	"230954-09-3"	"CP-544439"	"C230954093"	785	"Tox21_ERa_BLA_Agonist_ratio"	201943	1098076	915689	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300433"	47266	"230954-09-3"	"CP-544439"	"C230954093"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237891	975132	842206	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300434"	47267	"NOCAS_47267"	"CP-642931"	"CNOCAS47267"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237193	975133	842207	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300435"	47268	"104795-68-8"	"CI-959"	"C104795688"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224444	1056747	800220	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300435"	47268	"104795-68-8"	"CI-959"	"C104795688"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225216	1056747	800220	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300435"	47268	"104795-68-8"	"CI-959"	"C104795688"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237446	975134	842208	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300436"	47270	"253450-09-8"	"Besonprodil"	"C253450098"	788	"Tox21_ERa_LUC_BG1_Agonist"	258369	1192733	608494	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300436"	47270	"253450-09-8"	"Besonprodil"	"C253450098"	788	"Tox21_ERa_LUC_BG1_Agonist"	261587	1192733	608494	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300436"	47270	"253450-09-8"	"Besonprodil"	"C253450098"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237892	975135	842209	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300437"	47271	"676116-04-4"	"PD 0343701"	"C676116044"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236633	975136	842210	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300438"	47272	"249296-43-3"	"CJ-013610"	"C249296433"	785	"Tox21_ERa_BLA_Agonist_ratio"	201944	1098081	915694	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300438"	47272	"249296-43-3"	"CJ-013610"	"C249296433"	785	"Tox21_ERa_BLA_Agonist_ratio"	202747	1098081	915694	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300438"	47272	"249296-43-3"	"CJ-013610"	"C249296433"	788	"Tox21_ERa_LUC_BG1_Agonist"	258370	1192735	608496	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300440"	47276	"194098-25-4"	"CP-409092"	"C194098254"	788	"Tox21_ERa_LUC_BG1_Agonist"	259441	1192737	608498	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300440"	47276	"194098-25-4"	"CP-409092"	"C194098254"	788	"Tox21_ERa_LUC_BG1_Agonist"	260637	1192737	608498	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300441"	47277	"361343-19-3"	"Elzasonan"	"C361343193"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236775	975140	842214	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300442"	47278	"214535-77-0"	"CP-457677"	"C214535770"	785	"Tox21_ERa_BLA_Agonist_ratio"	201945	1098085	915698	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300443"	47279	"261947-38-0"	"CP-532623"	"C261947380"	785	"Tox21_ERa_BLA_Agonist_ratio"	201946	1098086	915699	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300444"	47280	"289716-94-5"	"CP-607366"	"C289716945"	785	"Tox21_ERa_BLA_Agonist_ratio"	201947	1098087	915700	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300444"	47280	"289716-94-5"	"CP-607366"	"C289716945"	788	"Tox21_ERa_LUC_BG1_Agonist"	258371	1192741	608502	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300444"	47280	"289716-94-5"	"CP-607366"	"C289716945"	788	"Tox21_ERa_LUC_BG1_Agonist"	261588	1192741	608502	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300444"	47280	"289716-94-5"	"CP-607366"	"C289716945"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236776	975143	842217	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300447"	47283	"368832-42-2"	"CP-728663"	"C368832422"	785	"Tox21_ERa_BLA_Agonist_ratio"	201948	1098090	915703	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300451"	47287	"197077-55-7"	"UK-333747"	"C197077557"	788	"Tox21_ERa_LUC_BG1_Agonist"	259918	1192748	608509	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300452"	47288	"203942-49-8"	"UK-337312"	"C203942498"	785	"Tox21_ERa_BLA_Agonist_ratio"	200684	1098095	915708	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300452"	47288	"203942-49-8"	"UK-337312"	"C203942498"	785	"Tox21_ERa_BLA_Agonist_ratio"	201206	1098095	915708	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300452"	47288	"203942-49-8"	"UK-337312"	"C203942498"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224933	1056764	800237	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300452"	47288	"203942-49-8"	"UK-337312"	"C203942498"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236777	975151	842225	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300453"	47289	"215297-27-1"	"UK-343664"	"C215297271"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225652	1056765	800238	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300454"	47290	"402910-27-4"	"UK-416244"	"C402910274"	785	"Tox21_ERa_BLA_Agonist_ratio"	201949	1098097	915710	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300454"	47290	"402910-27-4"	"UK-416244"	"C402910274"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236778	975153	842227	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300456"	47292	"NOCAS_47292"	"PD 0200347"	"CNOCAS47292"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236400	975155	842229	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300456"	47292	"NOCAS_47292"	"PD 0200347"	"CNOCAS47292"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236634	975155	842229	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300457"	47294	"668981-02-0"	"CP-863187"	"C668981020"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224445	1056769	800242	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300458"	47295	"291305-06-1"	"UK-373911"	"C291305061"	785	"Tox21_ERa_BLA_Agonist_ratio"	201950	1098101	915714	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300458"	47295	"291305-06-1"	"UK-373911"	"C291305061"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236779	975157	842231	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300460"	47297	"134002-60-1"	"CP-085958"	"C134002601"	785	"Tox21_ERa_BLA_Agonist_ratio"	200685	1098103	915716	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300461"	47299	"NOCAS_47299"	"CP-422935"	"CNOCAS47299"	785	"Tox21_ERa_BLA_Agonist_ratio"	201951	1098104	915717	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300463"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	785	"Tox21_ERa_BLA_Agonist_ratio"	201952	1098106	915719	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300463"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225653	1056775	800248	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300463"	47303	"179465-71-5"	"CJ-013790"	"C179465715"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236780	975162	842236	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300464"	47304	"135080-03-4"	"CP-100829"	"C135080034"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237893	975163	842237	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300465"	47305	"NOCAS_47305"	"CP-608039"	"CNOCAS47305"	785	"Tox21_ERa_BLA_Agonist_ratio"	201953	1098108	915721	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300466"	47306	"290352-28-2"	"CP-634384"	"C290352282"	788	"Tox21_ERa_LUC_BG1_Agonist"	258372	1192763	608524	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300466"	47306	"290352-28-2"	"CP-634384"	"C290352282"	788	"Tox21_ERa_LUC_BG1_Agonist"	261589	1192763	608524	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300467"	47307	"501027-49-2"	"PD-0333941"	"C501027492"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224446	1056779	800252	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300468"	47308	"158081-99-3"	"CP-105696"	"C158081993"	785	"Tox21_ERa_BLA_Agonist_ratio"	201954	1098111	915724	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300468"	47308	"158081-99-3"	"CP-105696"	"C158081993"	785	"Tox21_ERa_BLA_Agonist_ratio"	202748	1098111	915724	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300468"	47308	"158081-99-3"	"CP-105696"	"C158081993"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237894	975167	842241	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300469"	47309	"162706-14-1"	"UK-156819"	"C162706141"	788	"Tox21_ERa_LUC_BG1_Agonist"	258373	1192766	608527	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300469"	47309	"162706-14-1"	"UK-156819"	"C162706141"	788	"Tox21_ERa_LUC_BG1_Agonist"	261590	1192766	608527	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300470"	23719	"97322-87-7"	"Troglitazone"	"C97322877"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224447	1056782	800255	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300471"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	785	"Tox21_ERa_BLA_Agonist_ratio"	201955	1098114	915727	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300471"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224448	1056783	800256	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300471"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225281	1056783	800256	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300471"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236401	975170	842244	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300471"	47349	"NOCAS_47349"	"AVE8488"	"CNOCAS47349"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236481	975170	842244	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300472"	47381	"NOCAS_47381"	"AVE8923"	"CNOCAS47381"	785	"Tox21_ERa_BLA_Agonist_ratio"	201207	1098115	915728	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300472"	47381	"NOCAS_47381"	"AVE8923"	"CNOCAS47381"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236781	975171	842245	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300474"	24051	"1445-75-6"	"Diisopropyl methylphosphonate"	"C1445756"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224047	1056786	800259	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300475"	34150	"52-86-8"	"Haloperidol"	"C52868"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237895	975174	842248	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300476"	41691	"35256-85-0"	"Butam"	"C35256850"	788	"Tox21_ERa_LUC_BG1_Agonist"	261591	1192773	608534	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300478"	24729	"10605-21-7"	"Carbendazim"	"C10605217"	785	"Tox21_ERa_BLA_Agonist_ratio"	201956	1098121	915734	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300478"	24729	"10605-21-7"	"Carbendazim"	"C10605217"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224934	1056790	800263	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300478"	24729	"10605-21-7"	"Carbendazim"	"C10605217"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225654	1056790	800263	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300480"	24104	"206-44-0"	"Fluoranthene"	"C206440"	785	"Tox21_ERa_BLA_Agonist_ratio"	200549	1098123	915736	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300480"	24104	"206-44-0"	"Fluoranthene"	"C206440"	788	"Tox21_ERa_LUC_BG1_Agonist"	258374	1192777	608538	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300480"	24104	"206-44-0"	"Fluoranthene"	"C206440"	788	"Tox21_ERa_LUC_BG1_Agonist"	261592	1192777	608538	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300481"	26214	"101-20-2"	"Triclocarban"	"C101202"	785	"Tox21_ERa_BLA_Agonist_ratio"	201957	1098124	915737	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300481"	26214	"101-20-2"	"Triclocarban"	"C101202"	785	"Tox21_ERa_BLA_Agonist_ratio"	202749	1098124	915737	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300481"	26214	"101-20-2"	"Triclocarban"	"C101202"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225282	1056793	800266	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300481"	26214	"101-20-2"	"Triclocarban"	"C101202"	788	"Tox21_ERa_LUC_BG1_Agonist"	259442	1192778	608539	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300484"	27441	"1843-05-6"	"Octabenzone"	"C1843056"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224935	1056796	800269	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300484"	27441	"1843-05-6"	"Octabenzone"	"C1843056"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225655	1056796	800269	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300484"	27441	"1843-05-6"	"Octabenzone"	"C1843056"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237194	975183	842257	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300484"	27441	"1843-05-6"	"Octabenzone"	"C1843056"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237896	975183	842257	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300485"	27195	"544-76-3"	"Hexadecane"	"C544763"	788	"Tox21_ERa_LUC_BG1_Agonist"	259919	1192782	608543	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300487"	32113	"107534-96-3"	"Tebuconazole"	"C107534963"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225656	1056799	800272	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300487"	32113	"107534-96-3"	"Tebuconazole"	"C107534963"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237195	975186	842260	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300487"	32113	"107534-96-3"	"Tebuconazole"	"C107534963"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237897	975186	842260	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300488"	24891	"69-74-9"	"Cytarabine hydrochloride"	"C69749"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237196	975187	842261	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300489"	32523	"2634-33-5"	"1,2-Benzisothiazolin-3-one"	"C2634335"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224936	1056801	800274	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300489"	32523	"2634-33-5"	"1,2-Benzisothiazolin-3-one"	"C2634335"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225657	1056801	800274	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300489"	32523	"2634-33-5"	"1,2-Benzisothiazolin-3-one"	"C2634335"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237197	975188	842262	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300489"	32523	"2634-33-5"	"1,2-Benzisothiazolin-3-one"	"C2634335"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237898	975188	842262	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300491"	20811	"7487-94-7"	"Mercuric chloride"	"C7487947"	785	"Tox21_ERa_BLA_Agonist_ratio"	201958	1098134	915747	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300491"	20811	"7487-94-7"	"Mercuric chloride"	"C7487947"	785	"Tox21_ERa_BLA_Agonist_ratio"	202750	1098134	915747	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300491"	20811	"7487-94-7"	"Mercuric chloride"	"C7487947"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224449	1056803	800276	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300492"	20710	"122-66-7"	"1,2-Diphenylhydrazine"	"C122667"	788	"Tox21_ERa_LUC_BG1_Agonist"	260638	1192789	608550	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300494"	21427	"51-79-6"	"Urethane"	"C51796"	788	"Tox21_ERa_LUC_BG1_Agonist"	258375	1192791	608552	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300495"	20123	"103-33-3"	"Azobenzene"	"C103333"	788	"Tox21_ERa_LUC_BG1_Agonist"	259443	1192792	608553	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300496"	22959	"577-11-7"	"Docusate sodium"	"C577117"	785	"Tox21_ERa_BLA_Agonist_ratio"	201959	1098139	915752	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300496"	22959	"577-11-7"	"Docusate sodium"	"C577117"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224450	1056808	800281	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300496"	22959	"577-11-7"	"Docusate sodium"	"C577117"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237899	975195	842269	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300498"	27522	"3147-75-9"	"Octrizole"	"C3147759"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225658	1056810	800283	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300500"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	785	"Tox21_ERa_BLA_Agonist_ratio"	201960	1098143	915756	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300500"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	785	"Tox21_ERa_BLA_Agonist_ratio"	202751	1098143	915756	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300500"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224451	1056812	800285	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300500"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237198	975199	842273	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300500"	20510	"57-97-6"	"7,12-Dimethylbenz(a)anthracene"	"C57976"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237900	975199	842273	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300504"	21952	"115-86-6"	"Triphenyl phosphate"	"C115866"	785	"Tox21_ERa_BLA_Agonist_ratio"	201961	1098147	915760	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300506"	25219	"25155-30-0"	"Sodium dodecylbenzenesulfonate"	"C25155300"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224452	1056818	800291	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300507"	24930	"496-72-0"	"3,4-Diaminotoluene"	"C496720"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224453	1056819	800292	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300510"	40694	"136-60-7"	"Butyl benzoate"	"C136607"	788	"Tox21_ERa_LUC_BG1_Agonist"	258376	1192807	608568	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300510"	40694	"136-60-7"	"Butyl benzoate"	"C136607"	788	"Tox21_ERa_LUC_BG1_Agonist"	261593	1192807	608568	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300511"	22472	"104-51-8"	"Butylbenzene"	"C104518"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225659	1056823	800296	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300511"	22472	"104-51-8"	"Butylbenzene"	"C104518"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225978	1056823	800296	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300512"	23927	"101-55-3"	"p-Bromodiphenyl ether"	"C101553"	788	"Tox21_ERa_LUC_BG1_Agonist"	260639	1192809	608570	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300517"	24827	"69-09-0"	"Chlorpromazine hydrochloride"	"C69090"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236782	975216	842290	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300518"	24112	"72178-02-0"	"Fomesafen"	"C72178020"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224937	1056830	800303	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300520"	21254	"94-59-7"	"Safrole"	"C94597"	788	"Tox21_ERa_LUC_BG1_Agonist"	259444	1192817	608578	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300521"	47535	"82469-79-2"	"Butyryl trihexyl citrate"	"C82469792"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224938	1056833	800306	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300523"	47537	"2432-87-3"	"Dioctyl succinate"	"C2432873"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224939	1056835	800308	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300523"	47537	"2432-87-3"	"Dioctyl succinate"	"C2432873"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237199	975222	842296	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300524"	47538	"6624-73-3"	"Pentane-1,5-diyl dibenzoate"	"C6624733"	788	"Tox21_ERa_LUC_BG1_Agonist"	259445	1192821	608582	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300524"	47538	"6624-73-3"	"Pentane-1,5-diyl dibenzoate"	"C6624733"	788	"Tox21_ERa_LUC_BG1_Agonist"	260640	1192821	608582	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300526"	20465	"56-53-1"	"Diethylstilbestrol"	"C56531"	785	"Tox21_ERa_BLA_Agonist_ratio"	200550	1098169	915782	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300526"	20465	"56-53-1"	"Diethylstilbestrol"	"C56531"	785	"Tox21_ERa_BLA_Agonist_ratio"	200686	1098169	915782	4	"Col-wise effect, increased signal"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_300526"	20465	"56-53-1"	"Diethylstilbestrol"	"C56531"	788	"Tox21_ERa_LUC_BG1_Agonist"	257743	1192823	608584	1	"Row-wise effect, increased signal"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300526"	20465	"56-53-1"	"Diethylstilbestrol"	"C56531"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236482	975225	842299	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300527"	21392	"102-71-6"	"Triethanolamine"	"C102716"	785	"Tox21_ERa_BLA_Agonist_ratio"	201962	1098170	915783	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300530"	28666	"68515-49-1"	"1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich"	"C68515491"	785	"Tox21_ERa_BLA_Agonist_ratio"	201963	1098173	915786	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300530"	28666	"68515-49-1"	"1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich"	"C68515491"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224940	1056842	800315	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300532"	20820	"60-56-0"	"Methimazole"	"C60560"	788	"Tox21_ERa_LUC_BG1_Agonist"	259851	1192829	608590	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300533"	21028	"55-18-5"	"N-Nitrosodiethylamine"	"C55185"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236604	975232	842306	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300534"	20679	"76-44-8"	"Heptachlor"	"C76448"	788	"Tox21_ERa_LUC_BG1_Agonist"	259446	1192831	608592	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300534"	20679	"76-44-8"	"Heptachlor"	"C76448"	788	"Tox21_ERa_LUC_BG1_Agonist"	260641	1192831	608592	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300535"	27268	"629-62-9"	"Pentadecane"	"C629629"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236402	975234	842308	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300536"	32004	"13311-84-7"	"Flutamide"	"C13311847"	785	"Tox21_ERa_BLA_Agonist_ratio"	201964	1098179	915792	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300536"	32004	"13311-84-7"	"Flutamide"	"C13311847"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224941	1056848	800321	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300536"	32004	"13311-84-7"	"Flutamide"	"C13311847"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225660	1056848	800321	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300536"	32004	"13311-84-7"	"Flutamide"	"C13311847"	788	"Tox21_ERa_LUC_BG1_Agonist"	258377	1192833	608594	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300536"	32004	"13311-84-7"	"Flutamide"	"C13311847"	788	"Tox21_ERa_LUC_BG1_Agonist"	261594	1192833	608594	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300537"	21237	"50-55-5"	"Reserpine"	"C50555"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225927	1056849	800322	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300537"	21237	"50-55-5"	"Reserpine"	"C50555"	788	"Tox21_ERa_LUC_BG1_Agonist"	257871	1192834	608595	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300537"	21237	"50-55-5"	"Reserpine"	"C50555"	788	"Tox21_ERa_LUC_BG1_Agonist"	259447	1192834	608595	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300537"	21237	"50-55-5"	"Reserpine"	"C50555"	788	"Tox21_ERa_LUC_BG1_Agonist"	260642	1192834	608595	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300537"	21237	"50-55-5"	"Reserpine"	"C50555"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236783	975236	842310	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300538"	26926	"112-72-1"	"1-Tetradecanol"	"C112721"	785	"Tox21_ERa_BLA_Agonist_ratio"	201965	1098181	915794	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300539"	34187	"10540-29-1"	"Tamoxifen"	"C10540291"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224048	1056851	800324	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300539"	34187	"10540-29-1"	"Tamoxifen"	"C10540291"	788	"Tox21_ERa_LUC_BG1_Agonist"	259448	1192836	608597	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300540"	47138	"98-06-6"	"tert-Butylbenzene"	"C98066"	785	"Tox21_ERa_BLA_Agonist_ratio"	200687	1098183	915796	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300541"	21256	"599-79-1"	"Sulfasalazine"	"C599791"	785	"Tox21_ERa_BLA_Agonist_ratio"	201966	1098184	915797	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300541"	21256	"599-79-1"	"Sulfasalazine"	"C599791"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224942	1056853	800326	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300543"	27403	"1461-22-9"	"Tributyltin chloride"	"C1461229"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224049	1056855	800328	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300544"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224454	1056856	800329	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300544"	37706	"2795-39-3"	"PFOS-K"	"C2795393"	788	"Tox21_ERa_LUC_BG1_Agonist"	259449	1192841	608602	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300549"	21956	"117-84-0"	"Dioctyl phthalate"	"C117840"	785	"Tox21_ERa_BLA_Agonist_ratio"	201967	1098192	915805	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300549"	21956	"117-84-0"	"Dioctyl phthalate"	"C117840"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224943	1056861	800334	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300550"	21244	"13292-46-1"	"Rifampicin"	"C13292461"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225661	1056862	800335	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300550"	21244	"13292-46-1"	"Rifampicin"	"C13292461"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236483	975249	842323	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300552"	26689	"102-60-3"	"N,N,N',N'-Tetrakis(2-Hydroxypropyl)ethylenediamine"	"C102603"	785	"Tox21_ERa_BLA_Agonist_ratio"	201968	1098194	915807	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300553"	27270	"629-76-5"	"1-Pentadecanol"	"C629765"	788	"Tox21_ERa_LUC_BG1_Agonist"	259450	1192849	608610	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300553"	27270	"629-76-5"	"1-Pentadecanol"	"C629765"	788	"Tox21_ERa_LUC_BG1_Agonist"	260643	1192849	608610	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300556"	20105	"134-03-2"	"Sodium L-ascorbate"	"C134032"	788	"Tox21_ERa_LUC_BG1_Agonist"	260644	1192852	608613	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300558"	20371	"80-08-0"	"Dapsone"	"C80080"	785	"Tox21_ERa_BLA_Agonist_ratio"	201969	1098200	915813	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300558"	20371	"80-08-0"	"Dapsone"	"C80080"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223859	1056869	800342	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300559"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224944	1056870	800343	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300559"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	788	"Tox21_ERa_LUC_BG1_Agonist"	258378	1192855	608616	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300559"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	788	"Tox21_ERa_LUC_BG1_Agonist"	261595	1192855	608616	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300559"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237200	975257	842331	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300559"	27041	"126-86-3"	"2,4,7,9-Tetramethyl-5-decyne-4,7-diol"	"C126863"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237901	975257	842331	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300560"	27593	"5216-25-1"	"4-Chlorobenzotrichloride"	"C5216251"	788	"Tox21_ERa_LUC_BG1_Agonist"	258379	1192856	608617	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_300560"	27593	"5216-25-1"	"4-Chlorobenzotrichloride"	"C5216251"	788	"Tox21_ERa_LUC_BG1_Agonist"	261596	1192856	608617	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300561"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	785	"Tox21_ERa_BLA_Agonist_ratio"	201970	1098203	915816	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300561"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	785	"Tox21_ERa_BLA_Agonist_ratio"	202448	1098203	915816	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300561"	26081	"79-94-7"	"3,3',5,5'-Tetrabromobisphenol A"	"C79947"	785	"Tox21_ERa_BLA_Agonist_ratio"	202752	1098203	915816	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300564"	20606	"103-23-1"	"Di(2-ethylhexyl) adipate"	"C103231"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224945	1056875	800348	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300564"	20606	"103-23-1"	"Di(2-ethylhexyl) adipate"	"C103231"	788	"Tox21_ERa_LUC_BG1_Agonist"	257872	1192860	608621	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300564"	20606	"103-23-1"	"Di(2-ethylhexyl) adipate"	"C103231"	788	"Tox21_ERa_LUC_BG1_Agonist"	261597	1192860	608621	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300565"	27856	"25265-71-8"	"Dipropylene glycol"	"C25265718"	785	"Tox21_ERa_BLA_Agonist_ratio"	201971	1098207	915820	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300565"	27856	"25265-71-8"	"Dipropylene glycol"	"C25265718"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225662	1056876	800349	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300566"	25805	"26530-20-1"	"Octhilinone"	"C26530201"	785	"Tox21_ERa_BLA_Agonist_ratio"	202753	1098208	915821	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300566"	25805	"26530-20-1"	"Octhilinone"	"C26530201"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224455	1056877	800350	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300566"	25805	"26530-20-1"	"Octhilinone"	"C26530201"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237902	975264	842338	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300567"	42219	"103-65-1"	"Propylbenzene"	"C103651"	785	"Tox21_ERa_BLA_Agonist_ratio"	201972	1098209	915822	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300568"	26792	"108-44-1"	"3-Methylaniline"	"C108441"	785	"Tox21_ERa_BLA_Agonist_ratio"	201973	1098210	915823	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300569"	21800	"91-66-7"	"N,N-Diethylaniline"	"C91667"	788	"Tox21_ERa_LUC_BG1_Agonist"	258600	1192865	608626	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300570"	27983	"34590-94-8"	"Propanol, 1(or 2)-(2-methoxymethylethoxy)-"	"C34590948"	788	"Tox21_ERa_LUC_BG1_Agonist"	260645	1192866	608627	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300573"	24254	"85-01-8"	"Phenanthrene"	"C85018"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236403	975271	842345	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300574"	21030	"86-30-6"	"N-Nitrosodiphenylamine"	"C86306"	788	"Tox21_ERa_LUC_BG1_Agonist"	260646	1192870	608631	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300576"	29055	"84852-15-3"	"4-Nonylphenol, branched"	"C84852153"	785	"Tox21_ERa_BLA_Agonist_ratio"	200551	1098218	915831	1	"Row-wise effect, increased signal"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300576"	29055	"84852-15-3"	"4-Nonylphenol, branched"	"C84852153"	788	"Tox21_ERa_LUC_BG1_Agonist"	258380	1192872	608633	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300576"	29055	"84852-15-3"	"4-Nonylphenol, branched"	"C84852153"	788	"Tox21_ERa_LUC_BG1_Agonist"	261598	1192872	608633	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300576"	29055	"84852-15-3"	"4-Nonylphenol, branched"	"C84852153"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237903	975274	842348	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300582"	24845	"64-86-8"	"Colchicine"	"C64868"	785	"Tox21_ERa_BLA_Agonist_ratio"	201974	1098224	915837	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300582"	24845	"64-86-8"	"Colchicine"	"C64868"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224946	1056893	800366	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300582"	24845	"64-86-8"	"Colchicine"	"C64868"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225663	1056893	800366	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300582"	24845	"64-86-8"	"Colchicine"	"C64868"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237201	975280	842354	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300582"	24845	"64-86-8"	"Colchicine"	"C64868"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237904	975280	842354	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300584"	44203	"112529-15-4"	"Pioglitazone hydrochloride"	"C112529154"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225664	1056895	800368	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300584"	44203	"112529-15-4"	"Pioglitazone hydrochloride"	"C112529154"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237905	975282	842356	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300585"	22308	"446-72-0"	"Genistein"	"C446720"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237384	975283	842357	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300586"	20267	"57-74-9"	"Chlordane"	"C57749"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224456	1056897	800370	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300586"	20267	"57-74-9"	"Chlordane"	"C57749"	788	"Tox21_ERa_LUC_BG1_Agonist"	259451	1192882	608643	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300586"	20267	"57-74-9"	"Chlordane"	"C57749"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236784	975284	842358	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300592"	20895	"2385-85-5"	"Mirex"	"C2385855"	785	"Tox21_ERa_BLA_Agonist_ratio"	201975	1098234	915847	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300593"	27932	"27323-41-7"	"Dodecylbenzene sulfonate triethanolamine (1:1)"	"C27323417"	785	"Tox21_ERa_BLA_Agonist_ratio"	201976	1098235	915848	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300593"	27932	"27323-41-7"	"Dodecylbenzene sulfonate triethanolamine (1:1)"	"C27323417"	788	"Tox21_ERa_LUC_BG1_Agonist"	258381	1192889	608650	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300593"	27932	"27323-41-7"	"Dodecylbenzene sulfonate triethanolamine (1:1)"	"C27323417"	788	"Tox21_ERa_LUC_BG1_Agonist"	261599	1192889	608650	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300594"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	785	"Tox21_ERa_BLA_Agonist_ratio"	201977	1098236	915849	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300594"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224457	1056905	800378	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300594"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237202	975292	842366	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300594"	20299	"510-15-6"	"Chlorobenzilate"	"C510156"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237906	975292	842366	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300596"	22828	"4291-63-8"	"Cladribine"	"C4291638"	785	"Tox21_ERa_BLA_Agonist_ratio"	201978	1098238	915851	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300596"	22828	"4291-63-8"	"Cladribine"	"C4291638"	788	"Tox21_ERa_LUC_BG1_Agonist"	258382	1192892	608653	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300596"	22828	"4291-63-8"	"Cladribine"	"C4291638"	788	"Tox21_ERa_LUC_BG1_Agonist"	261600	1192892	608653	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300598"	32537	"7173-51-5"	"Didecyldimethylammonium chloride"	"C7173515"	785	"Tox21_ERa_BLA_Agonist_ratio"	202754	1098240	915853	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300599"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	785	"Tox21_ERa_BLA_Agonist_ratio"	201979	1098241	915854	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300599"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224458	1056910	800383	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300599"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	788	"Tox21_ERa_LUC_BG1_Agonist"	258383	1192895	608656	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300599"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	788	"Tox21_ERa_LUC_BG1_Agonist"	259452	1192895	608656	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300599"	22777	"169590-42-5"	"Celecoxib"	"C169590425"	788	"Tox21_ERa_LUC_BG1_Agonist"	260647	1192895	608656	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300600"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224947	1056911	800384	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300600"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225665	1056911	800384	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300600"	26697	"103-24-2"	"Bis(2-ethylhexyl) nonanedioate"	"C103242"	788	"Tox21_ERa_LUC_BG1_Agonist"	259453	1192896	608657	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300606"	47553	"2058-94-8"	"Perfluoroundecanoic acid"	"C2058948"	785	"Tox21_ERa_BLA_Agonist_ratio"	201980	1098248	915861	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300609"	47565	"2043-57-4"	"1H,1H,2H,2H-Perfluorooctyl iodide"	"C2043574"	785	"Tox21_ERa_BLA_Agonist_ratio"	201981	1098251	915864	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300612"	22522	"84-69-5"	"Diisobutyl phthalate"	"C84695"	788	"Tox21_ERa_LUC_BG1_Agonist"	259454	1192908	608669	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300613"	20561	"72-20-8"	"Endrin"	"C72208"	788	"Tox21_ERa_LUC_BG1_Agonist"	259455	1192909	608670	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300613"	20561	"72-20-8"	"Endrin"	"C72208"	788	"Tox21_ERa_LUC_BG1_Agonist"	260648	1192909	608670	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300613"	20561	"72-20-8"	"Endrin"	"C72208"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237203	975311	842385	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300613"	20561	"72-20-8"	"Endrin"	"C72208"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237907	975311	842385	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300614"	26265	"3319-31-1"	"Tris(2-ethylhexyl) trimellitate"	"C3319311"	785	"Tox21_ERa_BLA_Agonist_ratio"	201982	1098256	915869	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300614"	26265	"3319-31-1"	"Tris(2-ethylhexyl) trimellitate"	"C3319311"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224948	1056925	800398	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300614"	26265	"3319-31-1"	"Tris(2-ethylhexyl) trimellitate"	"C3319311"	788	"Tox21_ERa_LUC_BG1_Agonist"	261601	1192910	608671	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300615"	47576	"486-56-6"	"Cotinine"	"C486566"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236404	975313	842387	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300616"	37303	"375-85-9"	"Perfluoroheptanoic acid"	"C375859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224949	1056927	800400	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300616"	37303	"375-85-9"	"Perfluoroheptanoic acid"	"C375859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225666	1056927	800400	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300617"	38298	"5315-79-7"	"1-Hydroxypyrene"	"C5315797"	785	"Tox21_ERa_BLA_Agonist_ratio"	202755	1098259	915872	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300618"	47592	"484-17-3"	"9-Phenanthrol"	"C484173"	785	"Tox21_ERa_BLA_Agonist_ratio"	202472	1098260	915873	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300620"	41097	"85532-75-8"	"PK 11195"	"C85532758"	785	"Tox21_ERa_BLA_Agonist_ratio"	201983	1098262	915875	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300620"	41097	"85532-75-8"	"PK 11195"	"C85532758"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225667	1056931	800404	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300621"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225668	1056932	800405	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300621"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	788	"Tox21_ERa_LUC_BG1_Agonist"	259456	1192917	608678	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300621"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	788	"Tox21_ERa_LUC_BG1_Agonist"	260649	1192917	608678	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300621"	24126	"1024-57-3"	"Heptachlor epoxide"	"C1024573"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237204	975319	842393	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300622"	22345	"789-02-6"	"o,p'-DDT"	"C789026"	785	"Tox21_ERa_BLA_Agonist_ratio"	200688	1098264	915877	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300622"	22345	"789-02-6"	"o,p'-DDT"	"C789026"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225669	1056933	800406	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300623"	20249	"1563-66-2"	"Carbofuran"	"C1563662"	788	"Tox21_ERa_LUC_BG1_Agonist"	258384	1192919	608680	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300623"	20249	"1563-66-2"	"Carbofuran"	"C1563662"	788	"Tox21_ERa_LUC_BG1_Agonist"	261602	1192919	608680	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300624"	20685	"319-85-7"	"beta-Hexachlorocyclohexane"	"C319857"	785	"Tox21_ERa_BLA_Agonist_ratio"	201984	1098266	915879	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300624"	20685	"319-85-7"	"beta-Hexachlorocyclohexane"	"C319857"	788	"Tox21_ERa_LUC_BG1_Agonist"	257744	1192920	608681	1	"Row-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_300624"	20685	"319-85-7"	"beta-Hexachlorocyclohexane"	"C319857"	788	"Tox21_ERa_LUC_BG1_Agonist"	258385	1192920	608681	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300624"	20685	"319-85-7"	"beta-Hexachlorocyclohexane"	"C319857"	788	"Tox21_ERa_LUC_BG1_Agonist"	261603	1192920	608681	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300625"	47542	"117428-22-5"	"Picoxystrobin"	"C117428225"	785	"Tox21_ERa_BLA_Agonist_ratio"	201985	1098267	915880	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300626"	43938	"2528-16-7"	"Monobenzyl phthalate"	"C2528167"	788	"Tox21_ERa_LUC_BG1_Agonist"	260650	1192922	608683	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300627"	22588	"54-62-6"	"4-Aminofolic acid"	"C54626"	785	"Tox21_ERa_BLA_Agonist_ratio"	201986	1098269	915882	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300627"	22588	"54-62-6"	"4-Aminofolic acid"	"C54626"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224950	1056938	800411	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300627"	22588	"54-62-6"	"4-Aminofolic acid"	"C54626"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237205	975325	842399	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300629"	47598	"41481-66-7"	"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]"	"C41481667"	785	"Tox21_ERa_BLA_Agonist_ratio"	201987	1098271	915884	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300629"	47598	"41481-66-7"	"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]"	"C41481667"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224459	1056940	800413	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300629"	47598	"41481-66-7"	"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]"	"C41481667"	788	"Tox21_ERa_LUC_BG1_Agonist"	259457	1192925	608686	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300629"	47598	"41481-66-7"	"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]"	"C41481667"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236785	975327	842401	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300630"	47394	"330198-91-9"	"Fully acetylated glycerol monoester on 12-Hydroxystearic acid (85%); Fully acetylated glycerol monostearate represents (10%)"	"C330198919"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224951	1056941	800414	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300632"	43709	"4449-51-8"	"Cyclopamine"	"C4449518"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237908	975330	842404	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300633"	20501	"1095-90-5"	"Methadone hydrochloride"	"C1095905"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236405	975331	842405	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300638"	47395	"166412-78-8"	"Diisononyl cyclohexane-1,2-dicarboxylate"	"C166412788"	785	"Tox21_ERa_BLA_Agonist_ratio"	201988	1098280	915893	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300638"	47395	"166412-78-8"	"Diisononyl cyclohexane-1,2-dicarboxylate"	"C166412788"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224952	1056949	800422	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300638"	47395	"166412-78-8"	"Diisononyl cyclohexane-1,2-dicarboxylate"	"C166412788"	788	"Tox21_ERa_LUC_BG1_Agonist"	259458	1192934	608695	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300638"	47395	"166412-78-8"	"Diisononyl cyclohexane-1,2-dicarboxylate"	"C166412788"	788	"Tox21_ERa_LUC_BG1_Agonist"	259723	1192934	608695	9	"Potential pintool carryover"	0.333333333333333	"proportion"	"percent_activity"
"Tox21_300638"	47395	"166412-78-8"	"Diisononyl cyclohexane-1,2-dicarboxylate"	"C166412788"	788	"Tox21_ERa_LUC_BG1_Agonist"	260651	1192934	608695	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300639"	28033	"53894-23-8"	"Triisononyl trimellitate"	"C53894238"	785	"Tox21_ERa_BLA_Agonist_ratio"	201989	1098281	915894	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300639"	28033	"53894-23-8"	"Triisononyl trimellitate"	"C53894238"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224953	1056950	800423	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300639"	28033	"53894-23-8"	"Triisononyl trimellitate"	"C53894238"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225670	1056950	800423	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300640"	47533	"89-04-3"	"Trioctyl trimellitate"	"C89043"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224124	1056951	800424	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300640"	47533	"89-04-3"	"Trioctyl trimellitate"	"C89043"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224954	1056951	800424	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300640"	47533	"89-04-3"	"Trioctyl trimellitate"	"C89043"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225928	1056951	800424	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300644"	32572	"23031-36-9"	"Prallethrin"	"C23031369"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224460	1056955	800428	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300645"	35957	"68359-37-5"	"Cyfluthrin"	"C68359375"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223770	1056956	800429	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300645"	35957	"68359-37-5"	"Cyfluthrin"	"C68359375"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224955	1056956	800429	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300645"	35957	"68359-37-5"	"Cyfluthrin"	"C68359375"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225671	1056956	800429	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300645"	35957	"68359-37-5"	"Cyfluthrin"	"C68359375"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237206	975343	842417	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300650"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	785	"Tox21_ERa_BLA_Agonist_ratio"	201990	1098292	915905	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300650"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	785	"Tox21_ERa_BLA_Agonist_ratio"	202756	1098292	915905	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300650"	32390	"60168-88-9"	"Fenarimol"	"C60168889"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237207	975348	842422	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300651"	32651	"51707-55-2"	"Thidiazuron"	"C51707552"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236787	975349	842423	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300655"	24211	"15299-99-7"	"Napropamide"	"C15299997"	785	"Tox21_ERa_BLA_Agonist_ratio"	201991	1098297	915910	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300656"	22325	"2971-36-0"	"2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane"	"C2971360"	785	"Tox21_ERa_BLA_Agonist_ratio"	201992	1098298	915911	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300657"	20560	"115-29-7"	"Endosulfan"	"C115297"	785	"Tox21_ERa_BLA_Agonist_ratio"	201993	1098299	915912	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300657"	20560	"115-29-7"	"Endosulfan"	"C115297"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225673	1056968	800441	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300658"	20620	"55-38-9"	"Fenthion"	"C55389"	788	"Tox21_ERa_LUC_BG1_Agonist"	259460	1192954	608715	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300658"	20620	"55-38-9"	"Fenthion"	"C55389"	788	"Tox21_ERa_LUC_BG1_Agonist"	260652	1192954	608715	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300672"	41274	"941-69-5"	"1-Phenyl-1H-pyrrole-2,5-dione"	"C941695"	785	"Tox21_ERa_BLA_Agonist_ratio"	202757	1098314	915927	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300672"	41274	"941-69-5"	"1-Phenyl-1H-pyrrole-2,5-dione"	"C941695"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224461	1056983	800456	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300672"	41274	"941-69-5"	"1-Phenyl-1H-pyrrole-2,5-dione"	"C941695"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236788	975370	842444	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300674"	21151	"90-43-7"	"2-Phenylphenol"	"C90437"	788	"Tox21_ERa_LUC_BG1_Agonist"	259461	1192970	608731	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300674"	21151	"90-43-7"	"2-Phenylphenol"	"C90437"	788	"Tox21_ERa_LUC_BG1_Agonist"	260653	1192970	608731	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300676"	34232	"101-10-0"	"Cloprop"	"C101100"	788	"Tox21_ERa_LUC_BG1_Agonist"	260655	1192972	608733	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300683"	41252	"128-95-0"	"1,4-Diaminoanthraquinone"	"C128950"	785	"Tox21_ERa_BLA_Agonist_ratio"	201995	1098325	915938	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300684"	34653	"79983-71-4"	"Hexaconazole"	"C79983714"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224462	1056995	800468	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300685"	34948	"112410-23-8"	"Tebufenozide"	"C112410238"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224463	1056996	800469	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300686"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224464	1056997	800470	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300686"	41247	"120-46-7"	"1,3-Diphenyl-1,3-propanedione"	"C120467"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237386	975384	842458	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300691"	22292	"52645-53-1"	"Permethrin"	"C52645531"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224956	1057002	800475	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300694"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	785	"Tox21_ERa_BLA_Agonist_ratio"	202758	1098336	915949	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300694"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224125	1057005	800478	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300694"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	788	"Tox21_ERa_LUC_BG1_Agonist"	259463	1192990	608751	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300694"	34210	"29091-21-2"	"Prodiamine"	"C29091212"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236790	975392	842466	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300695"	21248	"83-79-4"	"Rotenone"	"C83794"	785	"Tox21_ERa_BLA_Agonist_ratio"	201997	1098337	915950	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300696"	24159	"82558-50-7"	"Isoxaben"	"C82558507"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225674	1057007	800480	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300697"	34961	"111988-49-9"	"Thiacloprid"	"C111988499"	785	"Tox21_ERa_BLA_Agonist_ratio"	201998	1098339	915952	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300701"	24234	"27314-13-2"	"Norflurazon"	"C27314132"	788	"Tox21_ERa_LUC_BG1_Agonist"	259464	1192997	608758	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300701"	24234	"27314-13-2"	"Norflurazon"	"C27314132"	788	"Tox21_ERa_LUC_BG1_Agonist"	260657	1192997	608758	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300705"	32376	"87674-68-8"	"Dimethenamid"	"C87674688"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224126	1057016	800489	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300705"	32376	"87674-68-8"	"Dimethenamid"	"C87674688"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237208	975403	842477	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300705"	32376	"87674-68-8"	"Dimethenamid"	"C87674688"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237909	975403	842477	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300706"	23951	"5234-68-4"	"Carboxin"	"C5234684"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224127	1057017	800490	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300706"	23951	"5234-68-4"	"Carboxin"	"C5234684"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225675	1057017	800490	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300706"	23951	"5234-68-4"	"Carboxin"	"C5234684"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225929	1057017	800490	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300708"	24048	"43222-48-6"	"Difenzoquat metilsulfate"	"C43222486"	788	"Tox21_ERa_LUC_BG1_Agonist"	257873	1193004	608765	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300708"	24048	"43222-48-6"	"Difenzoquat metilsulfate"	"C43222486"	788	"Tox21_ERa_LUC_BG1_Agonist"	259465	1193004	608765	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300708"	24048	"43222-48-6"	"Difenzoquat metilsulfate"	"C43222486"	788	"Tox21_ERa_LUC_BG1_Agonist"	259852	1193004	608765	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300716"	32640	"95737-68-1"	"Pyriproxyfen"	"C95737681"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225676	1057027	800500	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300718"	24266	"29232-93-7"	"Pirimiphos-methyl"	"C29232937"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224128	1057029	800502	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300718"	24266	"29232-93-7"	"Pirimiphos-methyl"	"C29232937"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225677	1057029	800502	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300720"	24151	"35554-44-0"	"Imazalil"	"C35554440"	785	"Tox21_ERa_BLA_Agonist_ratio"	201999	1098362	915975	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300720"	24151	"35554-44-0"	"Imazalil"	"C35554440"	785	"Tox21_ERa_BLA_Agonist_ratio"	202759	1098362	915975	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300723"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	785	"Tox21_ERa_BLA_Agonist_ratio"	202000	1098365	915978	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300723"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	785	"Tox21_ERa_BLA_Agonist_ratio"	202760	1098365	915978	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300723"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237209	975421	842495	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300723"	32690	"173584-44-6"	"Indoxacarb"	"C173584446"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237910	975421	842495	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300724"	32354	"105512-06-9"	"Clodinafop-propargyl mixt."	"C105512069"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225284	1057035	800508	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300730"	20407	"333-41-5"	"Diazinon"	"C333415"	788	"Tox21_ERa_LUC_BG1_Agonist"	259466	1193026	608787	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300732"	24163	"330-55-2"	"Linuron"	"C330552"	785	"Tox21_ERa_BLA_Agonist_ratio"	202001	1098374	915987	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300732"	24163	"330-55-2"	"Linuron"	"C330552"	788	"Tox21_ERa_LUC_BG1_Agonist"	259467	1193028	608789	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300733"	32329	"741-58-2"	"Bensulide"	"C741582"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224466	1057044	800517	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300744"	34282	"122-88-3"	"4-Chlorophenoxyacetic acid"	"C122883"	785	"Tox21_ERa_BLA_Agonist_ratio"	202003	1098386	915999	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300749"	40362	"50-65-7"	"Niclosamide"	"C50657"	785	"Tox21_ERa_BLA_Agonist_ratio"	202004	1098391	916004	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300749"	40362	"50-65-7"	"Niclosamide"	"C50657"	785	"Tox21_ERa_BLA_Agonist_ratio"	202761	1098391	916004	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300749"	40362	"50-65-7"	"Niclosamide"	"C50657"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236407	975447	842521	1	"Row-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_300752"	32464	"41198-08-7"	"Profenofos"	"C41198087"	785	"Tox21_ERa_BLA_Agonist_ratio"	202005	1098394	916007	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300752"	32464	"41198-08-7"	"Profenofos"	"C41198087"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224467	1057063	800536	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300754"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	785	"Tox21_ERa_BLA_Agonist_ratio"	200552	1098396	916009	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300754"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	785	"Tox21_ERa_BLA_Agonist_ratio"	200689	1098396	916009	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300754"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236408	975452	842526	1	"Row-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_300754"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236569	975452	842526	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300754"	21409	"76-87-9"	"Triphenyltin hydroxide"	"C76879"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237387	975452	842526	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300759"	41275	"142-18-7"	"1-Monolaurin"	"C142187"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224469	1057070	800543	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300761"	24235	"85509-19-9"	"Flusilazole"	"C85509199"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224470	1057072	800545	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300761"	24235	"85509-19-9"	"Flusilazole"	"C85509199"	788	"Tox21_ERa_LUC_BG1_Agonist"	259468	1193057	608818	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300764"	41978	"101463-69-8"	"Flufenoxuron"	"C101463698"	785	"Tox21_ERa_BLA_Agonist_ratio"	202006	1098406	916019	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300767"	20508	"75-60-5"	"Dimethylarsinic acid"	"C75605"	788	"Tox21_ERa_LUC_BG1_Agonist"	260658	1193063	608824	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300772"	20243	"133-06-2"	"Captan"	"C133062"	785	"Tox21_ERa_BLA_Agonist_ratio"	202009	1098414	916027	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300774"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224961	1057085	800558	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300774"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225680	1057085	800558	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300774"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237212	975472	842546	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300774"	23899	"1861-40-1"	"Benfluralin"	"C1861401"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237912	975472	842546	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300779"	32605	"51338-27-3"	"Diclofop-methyl"	"C51338273"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224962	1057090	800563	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300779"	32605	"51338-27-3"	"Diclofop-methyl"	"C51338273"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225681	1057090	800563	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300781"	41250	"14233-37-5"	"1,4-Bis(N-isopropylamino)anthraquinone"	"C14233375"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237214	975479	842553	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300781"	41250	"14233-37-5"	"1,4-Bis(N-isopropylamino)anthraquinone"	"C14233375"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237914	975479	842553	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300782"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	785	"Tox21_ERa_BLA_Agonist_ratio"	202011	1098424	916037	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300782"	37541	"1031-07-8"	"Endosulfan sulfate"	"C1031078"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225682	1057093	800566	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300785"	32667	"66230-04-4"	"Esfenvalerate"	"C66230044"	785	"Tox21_ERa_BLA_Agonist_ratio"	202012	1098427	916040	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300785"	32667	"66230-04-4"	"Esfenvalerate"	"C66230044"	788	"Tox21_ERa_LUC_BG1_Agonist"	259470	1193081	608842	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300786"	32562	"113-48-4"	"MGK-264"	"C113484"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224472	1057097	800570	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300786"	32562	"113-48-4"	"MGK-264"	"C113484"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237915	975484	842558	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300788"	34492	"120116-88-3"	"Cyazofamid"	"C120116883"	785	"Tox21_ERa_BLA_Agonist_ratio"	202013	1098430	916043	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300790"	24175	"57837-19-1"	"Metalaxyl"	"C57837191"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236636	975488	842562	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300791"	32365	"1194-65-6"	"Dichlobenil"	"C1194656"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236637	975489	842563	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300795"	32548	"114369-43-6"	"Fenbuconazole"	"C114369436"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224473	1057106	800579	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300799"	41265	"2425-77-6"	"2-Hexyl-1-decanol"	"C2425776"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224964	1057110	800583	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300799"	41265	"2425-77-6"	"2-Hexyl-1-decanol"	"C2425776"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236410	975497	842571	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300801"	20242	"2425-06-1"	"Captafol"	"C2425061"	785	"Tox21_ERa_BLA_Agonist_ratio"	202014	1098443	916056	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300801"	20242	"2425-06-1"	"Captafol"	"C2425061"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236411	975499	842573	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300802"	24316	"34014-18-1"	"Tebuthiuron"	"C34014181"	788	"Tox21_ERa_LUC_BG1_Agonist"	260661	1193098	608859	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300805"	24276	"2312-35-8"	"Propargite"	"C2312358"	785	"Tox21_ERa_BLA_Agonist_ratio"	202016	1098447	916060	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300805"	24276	"2312-35-8"	"Propargite"	"C2312358"	785	"Tox21_ERa_BLA_Agonist_ratio"	202763	1098447	916060	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300805"	24276	"2312-35-8"	"Propargite"	"C2312358"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236412	975503	842577	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300805"	24276	"2312-35-8"	"Propargite"	"C2312358"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238047	975503	842577	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300806"	34816	"6923-22-4"	"Monocrotophos"	"C6923224"	785	"Tox21_ERa_BLA_Agonist_ratio"	202017	1098448	916061	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300807"	24272	"7287-19-6"	"Prometryn"	"C7287196"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236413	975505	842579	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300807"	24272	"7287-19-6"	"Prometryn"	"C7287196"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237916	975505	842579	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300808"	34877	"53112-28-0"	"Pyrimethanil"	"C53112280"	788	"Tox21_ERa_LUC_BG1_Agonist"	259473	1193104	608865	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300808"	34877	"53112-28-0"	"Pyrimethanil"	"C53112280"	788	"Tox21_ERa_LUC_BG1_Agonist"	260662	1193104	608865	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300811"	24259	"2310-17-0"	"Phosalone"	"C2310170"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225683	1057122	800595	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300811"	24259	"2310-17-0"	"Phosalone"	"C2310170"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236638	975509	842583	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300811"	24259	"2310-17-0"	"Phosalone"	"C2310170"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237917	975509	842583	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300824"	34625	"361377-29-9"	"Fluoxastrobin"	"C361377299"	785	"Tox21_ERa_BLA_Agonist_ratio"	202019	1098466	916079	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300826"	20794	"12427-38-2"	"Maneb"	"C12427382"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238048	975524	842598	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300827"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224967	1057138	800611	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300827"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237215	975525	842599	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300827"	24241	"42874-03-3"	"Oxyfluorfen"	"C42874033"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237918	975525	842599	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300829"	41514	"21662-09-9"	"(4Z)-4-Decenal"	"C21662099"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224968	1057140	800613	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300830"	24338	"23564-05-8"	"Thiophanate-methyl"	"C23564058"	785	"Tox21_ERa_BLA_Agonist_ratio"	202020	1098472	916085	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300831"	24317	"5902-51-2"	"Terbacil"	"C5902512"	785	"Tox21_ERa_BLA_Agonist_ratio"	202021	1098473	916086	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300836"	35288	"33956-49-9"	"Codlelure"	"C33956499"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237919	975534	842608	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300838"	20426	"99-30-9"	"Dicloran"	"C99309"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236791	975536	842610	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300840"	20449	"62-73-7"	"Dichlorvos"	"C62737"	785	"Tox21_ERa_BLA_Agonist_ratio"	202022	1098482	916095	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300840"	20449	"62-73-7"	"Dichlorvos"	"C62737"	788	"Tox21_ERa_LUC_BG1_Agonist"	260663	1193136	608897	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300842"	21976	"122-99-6"	"2-Phenoxyethanol"	"C122996"	785	"Tox21_ERa_BLA_Agonist_ratio"	202023	1098484	916097	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300844"	34881	"124495-18-7"	"Quinoxyfen"	"C124495187"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224474	1057155	800628	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300845"	24209	"300-76-5"	"Naled"	"C300765"	788	"Tox21_ERa_LUC_BG1_Agonist"	259474	1193141	608902	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300845"	24209	"300-76-5"	"Naled"	"C300765"	788	"Tox21_ERa_LUC_BG1_Agonist"	260664	1193141	608902	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300854"	20247	"63-25-2"	"Carbaryl"	"C63252"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224969	1057165	800638	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300859"	24280	"60207-90-1"	"Propiconazole"	"C60207901"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224475	1057170	800643	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300860"	21389	"52-68-6"	"Trichlorfon"	"C52686"	785	"Tox21_ERa_BLA_Agonist_ratio"	202024	1098502	916115	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300861"	22018	"298-04-4"	"Disulfoton"	"C298044"	788	"Tox21_ERa_LUC_BG1_Agonist"	258386	1193157	608918	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300863"	32470	"31218-83-4"	"Propetamphos"	"C31218834"	785	"Tox21_ERa_BLA_Agonist_ratio"	202025	1098505	916118	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300863"	32470	"31218-83-4"	"Propetamphos"	"C31218834"	788	"Tox21_ERa_LUC_BG1_Agonist"	259475	1193159	608920	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300864"	32519	"135158-54-2"	"Acibenzolar-S-methyl"	"C135158542"	788	"Tox21_ERa_LUC_BG1_Agonist"	258387	1193160	608921	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300864"	32519	"135158-54-2"	"Acibenzolar-S-methyl"	"C135158542"	788	"Tox21_ERa_LUC_BG1_Agonist"	259476	1193160	608921	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300864"	32519	"135158-54-2"	"Acibenzolar-S-methyl"	"C135158542"	788	"Tox21_ERa_LUC_BG1_Agonist"	260665	1193160	608921	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300865"	24154	"36734-19-7"	"Iprodione"	"C36734197"	788	"Tox21_ERa_LUC_BG1_Agonist"	258388	1193161	608922	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300865"	24154	"36734-19-7"	"Iprodione"	"C36734197"	788	"Tox21_ERa_LUC_BG1_Agonist"	259477	1193161	608922	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300865"	24154	"36734-19-7"	"Iprodione"	"C36734197"	788	"Tox21_ERa_LUC_BG1_Agonist"	260666	1193161	608922	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300866"	32500	"68694-11-1"	"Triflumizole"	"C68694111"	785	"Tox21_ERa_BLA_Agonist_ratio"	202026	1098508	916121	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300866"	32500	"68694-11-1"	"Triflumizole"	"C68694111"	785	"Tox21_ERa_BLA_Agonist_ratio"	202449	1098508	916121	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300866"	32500	"68694-11-1"	"Triflumizole"	"C68694111"	785	"Tox21_ERa_BLA_Agonist_ratio"	202764	1098508	916121	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300866"	32500	"68694-11-1"	"Triflumizole"	"C68694111"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225219	1057177	800650	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300867"	24245	"40487-42-1"	"Pendimethalin"	"C40487421"	788	"Tox21_ERa_LUC_BG1_Agonist"	259478	1193163	608924	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300867"	24245	"40487-42-1"	"Pendimethalin"	"C40487421"	788	"Tox21_ERa_LUC_BG1_Agonist"	260667	1193163	608924	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300871"	32525	"149877-41-8"	"Bifenazate"	"C149877418"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236792	975569	842643	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300875"	41298	"695-06-7"	"gamma-Caprolactone"	"C695067"	785	"Tox21_ERa_BLA_Agonist_ratio"	202029	1098517	916130	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300875"	41298	"695-06-7"	"gamma-Caprolactone"	"C695067"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223860	1057186	800659	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300875"	41298	"695-06-7"	"gamma-Caprolactone"	"C695067"	788	"Tox21_ERa_LUC_BG1_Agonist"	258389	1193171	608932	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300876"	29221	"1702-17-6"	"Clopyralid"	"C1702176"	788	"Tox21_ERa_LUC_BG1_Agonist"	258390	1193172	608933	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300879"	32637	"123312-89-0"	"Pymetrozine"	"C123312890"	788	"Tox21_ERa_LUC_BG1_Agonist"	258391	1193175	608936	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300881"	35423	"571-58-4"	"1,4-Dimethylnaphthalene"	"C571584"	785	"Tox21_ERa_BLA_Agonist_ratio"	202031	1098523	916136	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300881"	35423	"571-58-4"	"1,4-Dimethylnaphthalene"	"C571584"	788	"Tox21_ERa_LUC_BG1_Agonist"	258393	1193177	608938	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300881"	35423	"571-58-4"	"1,4-Dimethylnaphthalene"	"C571584"	788	"Tox21_ERa_LUC_BG1_Agonist"	259920	1193177	608938	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300882"	24002	"39515-41-8"	"Fenpropathrin"	"C39515418"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224476	1057193	800666	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300882"	24002	"39515-41-8"	"Fenpropathrin"	"C39515418"	788	"Tox21_ERa_LUC_BG1_Agonist"	258632	1193178	608939	7	"Only one conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300882"	24002	"39515-41-8"	"Fenpropathrin"	"C39515418"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237920	975580	842654	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300886"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	785	"Tox21_ERa_BLA_Agonist_ratio"	200553	1098528	916141	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300886"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	785	"Tox21_ERa_BLA_Agonist_ratio"	202765	1098528	916141	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300886"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	788	"Tox21_ERa_LUC_BG1_Agonist"	259479	1193182	608943	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300886"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	788	"Tox21_ERa_LUC_BG1_Agonist"	260668	1193182	608943	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300886"	23897	"43121-43-3"	"Triadimefon"	"C43121433"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237216	975584	842658	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300887"	40363	"83657-24-3"	"Diniconazole"	"C83657243"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224477	1057198	800671	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300890"	20442	"94-75-7"	"2,4-Dichlorophenoxyacetic acid"	"C94757"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224972	1057201	800674	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300892"	23998	"52315-07-8"	"Cypermethrin"	"C52315078"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224973	1057203	800676	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300892"	23998	"52315-07-8"	"Cypermethrin"	"C52315078"	788	"Tox21_ERa_LUC_BG1_Agonist"	258394	1193188	608949	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300893"	22341	"1610-18-0"	"Prometon"	"C1610180"	788	"Tox21_ERa_LUC_BG1_Agonist"	259480	1193189	608950	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300893"	22341	"1610-18-0"	"Prometon"	"C1610180"	788	"Tox21_ERa_LUC_BG1_Agonist"	260670	1193189	608950	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300894"	42424	"59-40-5"	"Sulfaquinoxaline"	"C59405"	788	"Tox21_ERa_LUC_BG1_Agonist"	258603	1193190	608951	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300896"	32344	"54593-83-8"	"Chlorethoxyfos"	"C54593838"	788	"Tox21_ERa_LUC_BG1_Agonist"	258395	1193192	608953	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300897"	34303	"81406-37-3"	"Fluroxypyr-meptyl"	"C81406373"	788	"Tox21_ERa_LUC_BG1_Agonist"	258396	1193193	608954	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300898"	32550	"111812-58-9"	"Fenpyroximate (Z,E)"	"C111812589"	785	"Tox21_ERa_BLA_Agonist_ratio"	202032	1098540	916153	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300898"	32550	"111812-58-9"	"Fenpyroximate (Z,E)"	"C111812589"	788	"Tox21_ERa_LUC_BG1_Agonist"	258397	1193194	608955	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_300898"	32550	"111812-58-9"	"Fenpyroximate (Z,E)"	"C111812589"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236605	975596	842670	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300898"	32550	"111812-58-9"	"Fenpyroximate (Z,E)"	"C111812589"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237388	975596	842670	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300900"	32577	"79538-32-2"	"Tefluthrin"	"C79538322"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224974	1057211	800684	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300900"	32577	"79538-32-2"	"Tefluthrin"	"C79538322"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225687	1057211	800684	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300900"	32577	"79538-32-2"	"Tefluthrin"	"C79538322"	788	"Tox21_ERa_LUC_BG1_Agonist"	260671	1193196	608957	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300901"	34270	"104098-48-8"	"Imazapic"	"C104098488"	788	"Tox21_ERa_LUC_BG1_Agonist"	259481	1193197	608958	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300904"	23881	"74115-24-5"	"Clofentezine"	"C74115245"	788	"Tox21_ERa_LUC_BG1_Agonist"	259482	1193200	608961	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300904"	23881	"74115-24-5"	"Clofentezine"	"C74115245"	788	"Tox21_ERa_LUC_BG1_Agonist"	260672	1193200	608961	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300905"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	785	"Tox21_ERa_BLA_Agonist_ratio"	202033	1098547	916160	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300905"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	785	"Tox21_ERa_BLA_Agonist_ratio"	202766	1098547	916160	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300905"	21788	"88-30-2"	"3-Trifluoromethyl-4-nitrophenol"	"C88302"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225688	1057216	800689	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300906"	32613	"122-14-5"	"Fenitrothion"	"C122145"	785	"Tox21_ERa_BLA_Agonist_ratio"	202034	1098548	916161	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300906"	32613	"122-14-5"	"Fenitrothion"	"C122145"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223861	1057217	800690	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300907"	34357	"103055-07-8"	"Lufenuron"	"C103055078"	785	"Tox21_ERa_BLA_Agonist_ratio"	202035	1098549	916162	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300907"	34357	"103055-07-8"	"Lufenuron"	"C103055078"	788	"Tox21_ERa_LUC_BG1_Agonist"	257874	1193203	608964	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300907"	34357	"103055-07-8"	"Lufenuron"	"C103055078"	788	"Tox21_ERa_LUC_BG1_Agonist"	259483	1193203	608964	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300907"	34357	"103055-07-8"	"Lufenuron"	"C103055078"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237217	975605	842679	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300911"	34545	"110488-70-5"	"Dimethomorph"	"C110488705"	785	"Tox21_ERa_BLA_Agonist_ratio"	202036	1098553	916166	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300916"	24216	"1929-82-4"	"Nitrapyrin"	"C1929824"	788	"Tox21_ERa_LUC_BG1_Agonist"	259484	1193212	608973	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300916"	24216	"1929-82-4"	"Nitrapyrin"	"C1929824"	788	"Tox21_ERa_LUC_BG1_Agonist"	260675	1193212	608973	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300917"	21995	"134-62-3"	"DEET"	"C134623"	788	"Tox21_ERa_LUC_BG1_Agonist"	258401	1193213	608974	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300917"	21995	"134-62-3"	"DEET"	"C134623"	788	"Tox21_ERa_LUC_BG1_Agonist"	259921	1193213	608974	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_300918"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224975	1057229	800702	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300918"	21395	"1582-09-8"	"Trifluralin"	"C1582098"	788	"Tox21_ERa_LUC_BG1_Agonist"	258402	1193214	608975	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300919"	20370	"1596-84-5"	"Daminozide"	"C1596845"	785	"Tox21_ERa_BLA_Agonist_ratio"	202037	1098561	916174	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300919"	20370	"1596-84-5"	"Daminozide"	"C1596845"	788	"Tox21_ERa_LUC_BG1_Agonist"	258403	1193215	608976	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_300920"	22253	"10453-86-8"	"Resmethrin"	"C10453868"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224478	1057231	800704	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300924"	32547	"2593-15-9"	"Etridiazole"	"C2593159"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223863	1057235	800708	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300925"	24242	"76738-62-0"	"Paclobutrazol"	"C76738620"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237219	975623	842697	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300925"	24242	"76738-62-0"	"Paclobutrazol"	"C76738620"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237921	975623	842697	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300927"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	785	"Tox21_ERa_BLA_Agonist_ratio"	202767	1098569	916182	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300927"	42243	"110-25-8"	"Oleyl sarcosine"	"C110258"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237220	975625	842699	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300929"	20122	"86-50-0"	"Azinphos-methyl"	"C86500"	785	"Tox21_ERa_BLA_Agonist_ratio"	202038	1098571	916184	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300929"	20122	"86-50-0"	"Azinphos-methyl"	"C86500"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225689	1057240	800713	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300929"	20122	"86-50-0"	"Azinphos-methyl"	"C86500"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236793	975627	842701	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300930"	23871	"33089-61-1"	"Amitraz"	"C33089611"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237221	975628	842702	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300930"	23871	"33089-61-1"	"Amitraz"	"C33089611"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237922	975628	842702	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300943"	32581	"156052-68-5"	"Zoxamide"	"C156052685"	785	"Tox21_ERa_BLA_Agonist_ratio"	202039	1098585	916198	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300943"	32581	"156052-68-5"	"Zoxamide"	"C156052685"	785	"Tox21_ERa_BLA_Agonist_ratio"	202768	1098585	916198	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300943"	32581	"156052-68-5"	"Zoxamide"	"C156052685"	788	"Tox21_ERa_LUC_BG1_Agonist"	260677	1193239	609000	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300943"	32581	"156052-68-5"	"Zoxamide"	"C156052685"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237390	975641	842715	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300945"	34742	"NOCAS_34742"	"Milbemectin (mixture of 70% Milbemcin A4, 30% Milbemycin A3)"	"CNOCAS34742"	785	"Tox21_ERa_BLA_Agonist_ratio"	200690	1098587	916200	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_300947"	40372	"133855-98-8"	"Epoxiconazole"	"C133855988"	785	"Tox21_ERa_BLA_Agonist_ratio"	202041	1098589	916202	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300947"	40372	"133855-98-8"	"Epoxiconazole"	"C133855988"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224479	1057258	800731	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300951"	42494	"1067-25-0"	"Trimethoxypropylsilane"	"C1067250"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224977	1057262	800735	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300955"	32553	"62924-70-3"	"Flumetralin"	"C62924703"	785	"Tox21_ERa_BLA_Agonist_ratio"	202042	1098597	916210	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300958"	32355	"81777-89-1"	"Clomazone"	"C81777891"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225690	1057269	800742	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300958"	32355	"81777-89-1"	"Clomazone"	"C81777891"	788	"Tox21_ERa_LUC_BG1_Agonist"	259485	1193254	609015	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300958"	32355	"81777-89-1"	"Clomazone"	"C81777891"	788	"Tox21_ERa_LUC_BG1_Agonist"	260678	1193254	609015	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300959"	34773	"116714-46-6"	"Novaluron"	"C116714466"	785	"Tox21_ERa_BLA_Agonist_ratio"	202043	1098601	916214	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300959"	34773	"116714-46-6"	"Novaluron"	"C116714466"	785	"Tox21_ERa_BLA_Agonist_ratio"	202769	1098601	916214	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300965"	32482	"96182-53-5"	"Tebupirimfos"	"C96182535"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224129	1057276	800749	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_300965"	32482	"96182-53-5"	"Tebupirimfos"	"C96182535"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224978	1057276	800749	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300970"	21337	"148-79-8"	"Thiabendazole"	"C148798"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237391	975668	842742	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_300980"	21781	"84-74-2"	"Dibutyl phthalate"	"C84742"	788	"Tox21_ERa_LUC_BG1_Agonist"	259486	1193276	609037	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300988"	20450	"115-32-2"	"Dicofol"	"C115322"	785	"Tox21_ERa_BLA_Agonist_ratio"	202049	1098630	916243	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300988"	20450	"115-32-2"	"Dicofol"	"C115322"	785	"Tox21_ERa_BLA_Agonist_ratio"	202770	1098630	916243	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300988"	20450	"115-32-2"	"Dicofol"	"C115322"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224480	1057299	800772	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300988"	20450	"115-32-2"	"Dicofol"	"C115322"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236794	975686	842760	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300994"	32532	"128639-02-1"	"Carfentrazone-ethyl"	"C128639021"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225692	1057305	800778	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300994"	32532	"128639-02-1"	"Carfentrazone-ethyl"	"C128639021"	788	"Tox21_ERa_LUC_BG1_Agonist"	259488	1193290	609051	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300994"	32532	"128639-02-1"	"Carfentrazone-ethyl"	"C128639021"	788	"Tox21_ERa_LUC_BG1_Agonist"	260680	1193290	609051	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_300995"	34956	"112281-77-3"	"Tetraconazole"	"C112281773"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224481	1057306	800779	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_300998"	20855	"298-00-0"	"Methyl parathion"	"C298000"	785	"Tox21_ERa_BLA_Agonist_ratio"	202050	1098640	916253	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300998"	20855	"298-00-0"	"Methyl parathion"	"C298000"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224979	1057309	800782	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_300998"	20855	"298-00-0"	"Methyl parathion"	"C298000"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225693	1057309	800782	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301001"	34665	"81334-34-1"	"Imazapyr"	"C81334341"	785	"Tox21_ERa_BLA_Agonist_ratio"	202051	1098643	916256	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301007"	34664	"114311-32-9"	"Imazamox"	"C114311329"	785	"Tox21_ERa_BLA_Agonist_ratio"	202053	1098649	916262	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301007"	34664	"114311-32-9"	"Imazamox"	"C114311329"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224133	1057318	800791	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301009"	34818	"35575-96-3"	"Azamethiphos"	"C35575963"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237923	975707	842781	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301017"	32649	"7696-12-0"	"Tetramethrin"	"C7696120"	785	"Tox21_ERa_BLA_Agonist_ratio"	202054	1098659	916272	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301021"	20112	"1912-24-9"	"Atrazine"	"C1912249"	785	"Tox21_ERa_BLA_Agonist_ratio"	202055	1098663	916276	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301024"	34586	"153233-91-1"	"Etoxazole"	"C153233911"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224483	1057335	800808	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301026"	21975	"122-39-4"	"Diphenylamine"	"C122394"	785	"Tox21_ERa_BLA_Agonist_ratio"	202056	1098668	916281	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301029"	34503	"122008-85-9"	"Cyhalofop-butyl"	"C122008859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224980	1057340	800813	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301029"	34503	"122008-85-9"	"Cyhalofop-butyl"	"C122008859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225694	1057340	800813	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301032"	23990	"21725-46-2"	"Cyanazine"	"C21725462"	788	"Tox21_ERa_LUC_BG1_Agonist"	260681	1193328	609089	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301035"	42379	"1112-39-6"	"Dimethoxydimethylsilane"	"C1112396"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224981	1057346	800819	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301038"	34223	"119168-77-3"	"Tebufenpyrad"	"C119168773"	785	"Tox21_ERa_BLA_Agonist_ratio"	202060	1098680	916293	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301038"	34223	"119168-77-3"	"Tebufenpyrad"	"C119168773"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236416	975736	842810	1	"Row-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_301038"	34223	"119168-77-3"	"Tebufenpyrad"	"C119168773"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236639	975736	842810	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301042"	32549	"126833-17-8"	"Fenhexamid"	"C126833178"	785	"Tox21_ERa_BLA_Agonist_ratio"	201209	1098684	916297	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301042"	32549	"126833-17-8"	"Fenhexamid"	"C126833178"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224484	1057353	800826	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301044"	39336	"28434-00-6"	"S-Bioallethrin"	"C28434006"	785	"Tox21_ERa_BLA_Agonist_ratio"	202061	1098686	916299	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301045"	22455	"131-11-3"	"Dimethyl phthalate"	"C131113"	785	"Tox21_ERa_BLA_Agonist_ratio"	200554	1098687	916300	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301047"	32580	"141517-21-7"	"Trifloxystrobin"	"C141517217"	785	"Tox21_ERa_BLA_Agonist_ratio"	202062	1098689	916302	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301047"	32580	"141517-21-7"	"Trifloxystrobin"	"C141517217"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224052	1057358	800831	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301049"	32398	"131341-86-1"	"Fludioxonil"	"C131341861"	788	"Tox21_ERa_LUC_BG1_Agonist"	259490	1193345	609106	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301049"	32398	"131341-86-1"	"Fludioxonil"	"C131341861"	788	"Tox21_ERa_LUC_BG1_Agonist"	259724	1193345	609106	9	"Potential pintool carryover"	0.333333333333333	"proportion"	"percent_activity"
"Tox21_301049"	32398	"131341-86-1"	"Fludioxonil"	"C131341861"	788	"Tox21_ERa_LUC_BG1_Agonist"	260682	1193345	609106	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301059"	34930	"98886-44-3"	"Fosthiazate"	"C98886443"	785	"Tox21_ERa_BLA_Agonist_ratio"	202063	1098701	916314	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301059"	34930	"98886-44-3"	"Fosthiazate"	"C98886443"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236640	975757	842831	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301059"	34930	"98886-44-3"	"Fosthiazate"	"C98886443"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238117	975757	842831	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301060"	21105	"82-68-8"	"Pentachloronitrobenzene"	"C82688"	785	"Tox21_ERa_BLA_Agonist_ratio"	202064	1098702	916315	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301061"	32555	"103361-09-7"	"Flumioxazin"	"C103361097"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224982	1057372	800845	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301061"	32555	"103361-09-7"	"Flumioxazin"	"C103361097"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225695	1057372	800845	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301064"	20160	"82657-04-3"	"Bifenthrin"	"C82657043"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224984	1057375	800848	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301064"	20160	"82657-04-3"	"Bifenthrin"	"C82657043"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225696	1057375	800848	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301064"	20160	"82657-04-3"	"Bifenthrin"	"C82657043"	788	"Tox21_ERa_LUC_BG1_Agonist"	259491	1193360	609121	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301064"	20160	"82657-04-3"	"Bifenthrin"	"C82657043"	788	"Tox21_ERa_LUC_BG1_Agonist"	260683	1193360	609121	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301064"	20160	"82657-04-3"	"Bifenthrin"	"C82657043"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236796	975762	842836	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301069"	38795	"1873-88-7"	"1,1,1,3,5,5,5-Heptamethyltrisiloxane"	"C1873887"	785	"Tox21_ERa_BLA_Agonist_ratio"	202066	1098711	916324	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301072"	32647	"21564-17-0"	"2-(Thiocyanomethylthio)benzothiazole"	"C21564170"	785	"Tox21_ERa_BLA_Agonist_ratio"	202067	1098714	916327	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301072"	32647	"21564-17-0"	"2-(Thiocyanomethylthio)benzothiazole"	"C21564170"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237924	975770	842844	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301073"	32552	"142459-58-3"	"Flufenacet"	"C142459583"	785	"Tox21_ERa_BLA_Agonist_ratio"	202068	1098715	916328	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301073"	32552	"142459-58-3"	"Flufenacet"	"C142459583"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225697	1057384	800857	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301076"	32600	"113136-77-9"	"Cyclanilide"	"C113136779"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238050	975774	842848	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301077"	21385	"133-07-3"	"Folpet"	"C133073"	785	"Tox21_ERa_BLA_Agonist_ratio"	202069	1098719	916332	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301077"	21385	"133-07-3"	"Folpet"	"C133073"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236641	975775	842849	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_301077"	21385	"133-07-3"	"Folpet"	"C133073"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238051	975775	842849	13	"Includes potential chemical plate interlace points"	0.2	"proportion"	"percent_activity"
"Tox21_301078"	23914	"141-66-2"	"Dicrotophos"	"C141662"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236642	975776	842850	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301085"	34612	"69806-50-4"	"Fluazifop-butyl"	"C69806504"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224985	1057396	800869	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301085"	34612	"69806-50-4"	"Fluazifop-butyl"	"C69806504"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237222	975783	842857	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301085"	34612	"69806-50-4"	"Fluazifop-butyl"	"C69806504"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237925	975783	842857	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301088"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224485	1057399	800872	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301088"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236418	975786	842860	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301088"	34401	"69327-76-0"	"Buprofezin"	"C69327760"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236797	975786	842860	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301090"	32573	"96489-71-3"	"Pyridaben"	"C96489713"	785	"Tox21_ERa_BLA_Agonist_ratio"	202071	1098732	916345	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301090"	32573	"96489-71-3"	"Pyridaben"	"C96489713"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224054	1057401	800874	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301090"	32573	"96489-71-3"	"Pyridaben"	"C96489713"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236419	975788	842862	1	"Row-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_301091"	32645	"122836-35-5"	"Sulfentrazone"	"C122836355"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238052	975789	842863	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301093"	34590	"161326-34-7"	"Fenamidone"	"C161326347"	785	"Tox21_ERa_BLA_Agonist_ratio"	202072	1098735	916348	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301093"	34590	"161326-34-7"	"Fenamidone"	"C161326347"	785	"Tox21_ERa_BLA_Agonist_ratio"	202772	1098735	916348	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301093"	34590	"161326-34-7"	"Fenamidone"	"C161326347"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236420	975791	842865	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301093"	34590	"161326-34-7"	"Fenamidone"	"C161326347"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238054	975791	842865	13	"Includes potential chemical plate interlace points"	0.2	"proportion"	"percent_activity"
"Tox21_301094"	34634	"68157-60-8"	"Forchlorfenuron"	"C68157608"	785	"Tox21_ERa_BLA_Agonist_ratio"	202073	1098736	916349	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301094"	34634	"68157-60-8"	"Forchlorfenuron"	"C68157608"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236421	975792	842866	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301094"	34634	"68157-60-8"	"Forchlorfenuron"	"C68157608"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236643	975792	842866	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301094"	34634	"68157-60-8"	"Forchlorfenuron"	"C68157608"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238055	975792	842866	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301095"	22109	"706-14-9"	"gamma-Decanolactone"	"C706149"	785	"Tox21_ERa_BLA_Agonist_ratio"	202074	1098737	916350	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301095"	22109	"706-14-9"	"gamma-Decanolactone"	"C706149"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236644	975793	842867	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301096"	34627	"69377-81-7"	"Fluroxypyr"	"C69377817"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224986	1057407	800880	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301098"	41567	"141-22-0"	"9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-"	"C141220"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237926	975796	842870	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301102"	21332	"137-26-8"	"Thiram"	"C137268"	785	"Tox21_ERa_BLA_Agonist_ratio"	202075	1098744	916357	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301102"	21332	"137-26-8"	"Thiram"	"C137268"	788	"Tox21_ERa_LUC_BG1_Agonist"	259493	1193398	609159	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301110"	32372	"119446-68-3"	"Difenoconazole"	"C119446683"	785	"Tox21_ERa_BLA_Agonist_ratio"	202077	1098752	916365	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301110"	32372	"119446-68-3"	"Difenoconazole"	"C119446683"	785	"Tox21_ERa_BLA_Agonist_ratio"	202773	1098752	916365	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301112"	34580	"26225-79-6"	"Ethofumesate"	"C26225796"	785	"Tox21_ERa_BLA_Agonist_ratio"	202078	1098754	916367	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301112"	34580	"26225-79-6"	"Ethofumesate"	"C26225796"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238056	975810	842884	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301114"	34609	"120068-37-3"	"Fipronil"	"C120068373"	785	"Tox21_ERa_BLA_Agonist_ratio"	202079	1098756	916369	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301126"	41237	"99-86-5"	"alpha-Terpinene"	"C99865"	785	"Tox21_ERa_BLA_Agonist_ratio"	202081	1098768	916381	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301126"	41237	"99-86-5"	"alpha-Terpinene"	"C99865"	788	"Tox21_ERa_LUC_BG1_Agonist"	260686	1193422	609183	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301127"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	788	"Tox21_ERa_LUC_BG1_Agonist"	259494	1193423	609184	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301127"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	788	"Tox21_ERa_LUC_BG1_Agonist"	260687	1193423	609184	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301127"	34456	"87818-31-3"	"Cinmethylin"	"C87818313"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237928	975825	842899	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301129"	22043	"499-83-2"	"2,6-Pyridinedicarboxylic acid"	"C499832"	785	"Tox21_ERa_BLA_Agonist_ratio"	202082	1098771	916384	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301129"	22043	"499-83-2"	"2,6-Pyridinedicarboxylic acid"	"C499832"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224987	1057440	800913	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301130"	32638	"175013-18-0"	"Pyraclostrobin"	"C175013180"	785	"Tox21_ERa_BLA_Agonist_ratio"	200691	1098772	916385	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301130"	32638	"175013-18-0"	"Pyraclostrobin"	"C175013180"	785	"Tox21_ERa_BLA_Agonist_ratio"	202083	1098772	916385	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301132"	34864	"181274-15-7"	"Propoxycarbazone-sodium"	"C181274157"	788	"Tox21_ERa_LUC_BG1_Agonist"	259497	1193428	609189	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301133"	34928	"148477-71-8"	"Spirodiclofen"	"C148477718"	785	"Tox21_ERa_BLA_Agonist_ratio"	202084	1098775	916388	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301134"	24085	"16672-87-0"	"Ethephon"	"C16672870"	788	"Tox21_ERa_LUC_BG1_Agonist"	260690	1193430	609191	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301135"	24315	"88671-89-0"	"Myclobutanil"	"C88671890"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237223	975833	842907	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301135"	24315	"88671-89-0"	"Myclobutanil"	"C88671890"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237929	975833	842907	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301139"	20764	"101-21-3"	"Chlorpropham"	"C101213"	788	"Tox21_ERa_LUC_BG1_Agonist"	259498	1193435	609196	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301143"	20440	"120-36-5"	"Dichlorprop"	"C120365"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224988	1057454	800927	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301144"	34588	"131807-57-3"	"Famoxadone"	"C131807573"	785	"Tox21_ERa_BLA_Agonist_ratio"	202085	1098786	916399	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301149"	21804	"94-09-7"	"Benzocaine"	"C94097"	785	"Tox21_ERa_BLA_Agonist_ratio"	202086	1098791	916404	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301150"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224486	1057461	800934	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301150"	32379	"97886-45-8"	"Dithiopyr"	"C97886458"	788	"Tox21_ERa_LUC_BG1_Agonist"	259499	1193446	609207	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301152"	20292	"107-20-0"	"Chloroacetaldehyde"	"C107200"	788	"Tox21_ERa_LUC_BG1_Agonist"	258405	1193448	609209	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301153"	32683	"7786-34-7"	"Mevinphos"	"C7786347"	785	"Tox21_ERa_BLA_Agonist_ratio"	202087	1098795	916408	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301153"	32683	"7786-34-7"	"Mevinphos"	"C7786347"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224989	1057464	800937	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301153"	32683	"7786-34-7"	"Mevinphos"	"C7786347"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225698	1057464	800937	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301153"	32683	"7786-34-7"	"Mevinphos"	"C7786347"	788	"Tox21_ERa_LUC_BG1_Agonist"	258406	1193449	609210	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301154"	34962	"153719-23-4"	"Thiamethoxam"	"C153719234"	788	"Tox21_ERa_LUC_BG1_Agonist"	259500	1193450	609211	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301155"	24337	"28249-77-6"	"Thiobencarb"	"C28249776"	788	"Tox21_ERa_LUC_BG1_Agonist"	259501	1193451	609212	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301155"	24337	"28249-77-6"	"Thiobencarb"	"C28249776"	788	"Tox21_ERa_LUC_BG1_Agonist"	260691	1193451	609212	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301156"	21086	"23135-22-0"	"Oxamyl"	"C23135220"	785	"Tox21_ERa_BLA_Agonist_ratio"	202088	1098798	916411	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301156"	21086	"23135-22-0"	"Oxamyl"	"C23135220"	788	"Tox21_ERa_LUC_BG1_Agonist"	260692	1193452	609213	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301161"	20479	"60-51-5"	"Dimethoate"	"C60515"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224990	1057472	800945	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301166"	32392	"66441-23-4"	"Fenoxaprop-ethyl"	"C66441234"	785	"Tox21_ERa_BLA_Agonist_ratio"	202090	1098808	916421	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301166"	32392	"66441-23-4"	"Fenoxaprop-ethyl"	"C66441234"	788	"Tox21_ERa_LUC_BG1_Agonist"	258407	1193462	609223	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301169"	42325	"104-45-0"	"4-Propylanisole"	"C104450"	785	"Tox21_ERa_BLA_Agonist_ratio"	200555	1098811	916424	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301169"	42325	"104-45-0"	"4-Propylanisole"	"C104450"	788	"Tox21_ERa_LUC_BG1_Agonist"	258410	1193465	609226	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301169"	42325	"104-45-0"	"4-Propylanisole"	"C104450"	788	"Tox21_ERa_LUC_BG1_Agonist"	261604	1193465	609226	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301170"	23900	"17804-35-2"	"Benomyl"	"C17804352"	785	"Tox21_ERa_BLA_Agonist_ratio"	202091	1098812	916425	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301170"	23900	"17804-35-2"	"Benomyl"	"C17804352"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224991	1057481	800954	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301170"	23900	"17804-35-2"	"Benomyl"	"C17804352"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225699	1057481	800954	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301170"	23900	"17804-35-2"	"Benomyl"	"C17804352"	788	"Tox21_ERa_LUC_BG1_Agonist"	258411	1193466	609227	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_301170"	23900	"17804-35-2"	"Benomyl"	"C17804352"	788	"Tox21_ERa_LUC_BG1_Agonist"	261605	1193466	609227	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301171"	21922	"110-73-6"	"2-(Ethylamino)ethanol"	"C110736"	788	"Tox21_ERa_LUC_BG1_Agonist"	258412	1193467	609228	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301177"	32551	"79622-59-6"	"Fluazinam"	"C79622596"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236798	975875	842949	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301178"	26513	"85-40-5"	"1,2,3,6-Tetrahydrophthalimide"	"C85405"	788	"Tox21_ERa_LUC_BG1_Agonist"	259725	1193474	609235	9	"Potential pintool carryover"	0.333333333333333	"proportion"	"percent_activity"
"Tox21_301179"	24270	"67747-09-5"	"Prochloraz"	"C67747095"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225701	1057490	800963	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301179"	24270	"67747-09-5"	"Prochloraz"	"C67747095"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237224	975877	842951	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301179"	24270	"67747-09-5"	"Prochloraz"	"C67747095"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237930	975877	842951	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301181"	20089	"101-05-3"	"Anilazine"	"C101053"	788	"Tox21_ERa_LUC_BG1_Agonist"	260696	1193477	609238	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301184"	40222	"199119-58-9"	"Trifloxysulfuron-sodium"	"C199119589"	788	"Tox21_ERa_LUC_BG1_Agonist"	258414	1193480	609241	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301184"	40222	"199119-58-9"	"Trifloxysulfuron-sodium"	"C199119589"	788	"Tox21_ERa_LUC_BG1_Agonist"	261606	1193480	609241	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301185"	32601	"94361-06-5"	"Cyproconazole"	"C94361065"	788	"Tox21_ERa_LUC_BG1_Agonist"	258415	1193481	609242	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_301185"	32601	"94361-06-5"	"Cyproconazole"	"C94361065"	788	"Tox21_ERa_LUC_BG1_Agonist"	261607	1193481	609242	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301188"	41426	"110-87-2"	"3,4-Dihydro-2H-pyran"	"C110872"	788	"Tox21_ERa_LUC_BG1_Agonist"	259507	1193484	609245	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301191"	34465	"210880-92-5"	"Clothianidin"	"C210880925"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237931	975889	842963	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301192"	32513	"85264-33-1"	"(3,5-Dimethyl-1H-pyrazol-1-yl)methanol"	"C85264331"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223865	1057503	800976	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301193"	34855	"79241-46-6"	"Fluazifop-P-butyl"	"C79241466"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224993	1057504	800977	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301193"	34855	"79241-46-6"	"Fluazifop-P-butyl"	"C79241466"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237225	975891	842965	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301196"	21907	"109-77-3"	"Propanedinitrile"	"C109773"	788	"Tox21_ERa_LUC_BG1_Agonist"	260700	1193492	609253	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	785	"Tox21_ERa_BLA_Agonist_ratio"	202096	1098844	916457	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223868	1057513	800986	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223949	1057513	800986	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225220	1057513	800986	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	788	"Tox21_ERa_LUC_BG1_Agonist"	259508	1193498	609259	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	788	"Tox21_ERa_LUC_BG1_Agonist"	260701	1193498	609259	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236799	975900	842974	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301202"	22162	"1689-84-5"	"Bromoxynil"	"C1689845"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237447	975900	842974	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_301208"	41954	"106-68-3"	"3-Octanone"	"C106683"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223869	1057519	800992	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301208"	41954	"106-68-3"	"3-Octanone"	"C106683"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224995	1057519	800992	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301209"	32393	"72490-01-8"	"Fenoxycarb"	"C72490018"	785	"Tox21_ERa_BLA_Agonist_ratio"	202097	1098851	916464	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301209"	32393	"72490-01-8"	"Fenoxycarb"	"C72490018"	785	"Tox21_ERa_BLA_Agonist_ratio"	202774	1098851	916464	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301209"	32393	"72490-01-8"	"Fenoxycarb"	"C72490018"	788	"Tox21_ERa_LUC_BG1_Agonist"	259510	1193505	609266	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301210"	41889	"4712-55-4"	"Diphenyl phosphite"	"C4712554"	785	"Tox21_ERa_BLA_Agonist_ratio"	202098	1098852	916465	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301214"	35175	"525-79-1"	"Kinetin"	"C525791"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223771	1057525	800998	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301216"	40776	"654055-01-3"	"Morin hydrate"	"C654055013"	788	"Tox21_ERa_LUC_BG1_Agonist"	259511	1193512	609273	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301216"	40776	"654055-01-3"	"Morin hydrate"	"C654055013"	788	"Tox21_ERa_LUC_BG1_Agonist"	260702	1193512	609273	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301234"	44865	"18924-66-8"	"2,2'-(Tetradecylimino)diethanol"	"C18924668"	785	"Tox21_ERa_BLA_Agonist_ratio"	202102	1098876	916489	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301234"	44865	"18924-66-8"	"2,2'-(Tetradecylimino)diethanol"	"C18924668"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236800	975932	843006	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301236"	42171	"1541-81-7"	"4-Dodecylmorpholine"	"C1541817"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224135	1057547	801020	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301274"	44818	"3913-02-8"	"2-Butyloctan-1-ol"	"C3913028"	785	"Tox21_ERa_BLA_Agonist_ratio"	202106	1098916	916529	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301288"	29677	"7631-86-9"	"Silica"	"C7631869"	785	"Tox21_ERa_BLA_Agonist_ratio"	202109	1098930	916543	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301307"	32630	"1214-39-7"	"N-Benzyladenine"	"C1214397"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237228	976005	843079	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301307"	32630	"1214-39-7"	"N-Benzyladenine"	"C1214397"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237935	976005	843079	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301310"	42490	"2031-67-6"	"Triethoxymethylsilane"	"C2031676"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225002	1057621	801094	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301310"	42490	"2031-67-6"	"Triethoxymethylsilane"	"C2031676"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225705	1057621	801094	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301323"	42299	"99-89-8"	"4-Isopropylphenol"	"C99898"	788	"Tox21_ERa_LUC_BG1_Agonist"	259517	1193619	609380	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301323"	42299	"99-89-8"	"4-Isopropylphenol"	"C99898"	788	"Tox21_ERa_LUC_BG1_Agonist"	260712	1193619	609380	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301326"	42130	"587-85-9"	"Diphenylmercury(II)"	"C587859"	785	"Tox21_ERa_BLA_Agonist_ratio"	202112	1098968	916581	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301326"	42130	"587-85-9"	"Diphenylmercury(II)"	"C587859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225003	1057637	801110	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301326"	42130	"587-85-9"	"Diphenylmercury(II)"	"C587859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225706	1057637	801110	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301326"	42130	"587-85-9"	"Diphenylmercury(II)"	"C587859"	788	"Tox21_ERa_LUC_BG1_Agonist"	259519	1193622	609383	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301326"	42130	"587-85-9"	"Diphenylmercury(II)"	"C587859"	788	"Tox21_ERa_LUC_BG1_Agonist"	260714	1193622	609383	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301336"	42154	"493-52-7"	"Methyl red"	"C493527"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224491	1057647	801120	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301342"	27412	"1559-34-8"	"3,6,9,12-Tetraoxahexadecan-1-ol"	"C1559348"	788	"Tox21_ERa_LUC_BG1_Agonist"	260718	1193638	609399	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301342"	27412	"1559-34-8"	"3,6,9,12-Tetraoxahexadecan-1-ol"	"C1559348"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238057	976040	843114	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301358"	32675	"35400-43-2"	"Sulprofos"	"C35400432"	788	"Tox21_ERa_LUC_BG1_Agonist"	260720	1193654	609415	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301372"	42273	"2934-05-6"	"2,4-Diisopropylphenol"	"C2934056"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237230	976070	843144	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301372"	42273	"2934-05-6"	"2,4-Diisopropylphenol"	"C2934056"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237938	976070	843144	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301374"	41962	"78-07-9"	"Ethyltriethoxysilane"	"C78079"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225711	1057685	801158	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301377"	42038	"5870-93-9"	"Heptyl butanoate"	"C5870939"	788	"Tox21_ERa_LUC_BG1_Agonist"	260724	1193673	609434	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301378"	42074	"499-75-2"	"Isopropyl-o-cresol"	"C499752"	788	"Tox21_ERa_LUC_BG1_Agonist"	259526	1193674	609435	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301379"	41125	"7681-82-5"	"Sodium iodide"	"C7681825"	785	"Tox21_ERa_BLA_Agonist_ratio"	200557	1099021	916634	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301379"	41125	"7681-82-5"	"Sodium iodide"	"C7681825"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223871	1057690	801163	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301383"	42276	"94-71-3"	"2-Ethoxyphenol"	"C94713"	788	"Tox21_ERa_LUC_BG1_Agonist"	259527	1193679	609440	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301383"	42276	"94-71-3"	"2-Ethoxyphenol"	"C94713"	788	"Tox21_ERa_LUC_BG1_Agonist"	260725	1193679	609440	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301388"	20834	"598-55-0"	"Methyl carbamate"	"C598550"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237231	976086	843160	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301450"	42369	"81-88-9"	"Rhodamine B"	"C81889"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224497	1057761	801234	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301450"	42369	"81-88-9"	"Rhodamine B"	"C81889"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237943	976148	843222	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301456"	22381	"84-16-2"	"meso-Hexestrol"	"C84162"	785	"Tox21_ERa_BLA_Agonist_ratio"	200559	1099098	916711	1	"Row-wise effect, increased signal"	0.122222222222222	"proportion"	"percent_activity"
"Tox21_301456"	22381	"84-16-2"	"meso-Hexestrol"	"C84162"	785	"Tox21_ERa_BLA_Agonist_ratio"	200695	1099098	916711	4	"Col-wise effect, increased signal"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_301456"	22381	"84-16-2"	"meso-Hexestrol"	"C84162"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223774	1057767	801240	1	"Row-wise effect, increased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_301461"	35616	"824-39-5"	"Sodium 2-nitrophenolate"	"C824395"	785	"Tox21_ERa_BLA_Agonist_ratio"	202124	1099103	916716	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301478"	22353	"92-04-6"	"2-Chloro-4-phenylphenol"	"C92046"	785	"Tox21_ERa_BLA_Agonist_ratio"	202126	1099120	916733	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301478"	22353	"92-04-6"	"2-Chloro-4-phenylphenol"	"C92046"	785	"Tox21_ERa_BLA_Agonist_ratio"	202778	1099120	916733	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301478"	22353	"92-04-6"	"2-Chloro-4-phenylphenol"	"C92046"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225716	1057789	801262	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301479"	41728	"2870-32-8"	"C.I. Direct Yellow 12"	"C2870328"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225009	1057790	801263	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301479"	41728	"2870-32-8"	"C.I. Direct Yellow 12"	"C2870328"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225717	1057790	801263	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301483"	44576	"77-89-4"	"Acetyltriethyl citrate"	"C77894"	788	"Tox21_ERa_LUC_BG1_Agonist"	259535	1193779	609540	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301483"	44576	"77-89-4"	"Acetyltriethyl citrate"	"C77894"	788	"Tox21_ERa_LUC_BG1_Agonist"	260738	1193779	609540	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301502"	26035	"2492-26-4"	"Sodium 2-mercaptobenzothiolate"	"C2492264"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236422	976200	843274	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301507"	42454	"589-68-4"	"Tetradecanoic acid, 2,3-dihydroxypropyl ester"	"C589684"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225011	1057818	801291	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301507"	42454	"589-68-4"	"Tetradecanoic acid, 2,3-dihydroxypropyl ester"	"C589684"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225720	1057818	801291	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301525"	44663	"3734-67-6"	"C.I. Acid Red 1"	"C3734676"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237233	976223	843297	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301525"	44663	"3734-67-6"	"C.I. Acid Red 1"	"C3734676"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237945	976223	843297	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301530"	40747	"68-96-2"	"17alpha-Hydroxyprogesterone"	"C68962"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224056	1057841	801314	4	"Col-wise effect, increased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_301530"	40747	"68-96-2"	"17alpha-Hydroxyprogesterone"	"C68962"	788	"Tox21_ERa_LUC_BG1_Agonist"	260743	1193826	609587	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301530"	40747	"68-96-2"	"17alpha-Hydroxyprogesterone"	"C68962"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237947	976228	843302	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301534"	41422	"87-01-4"	"7-(Dimethylamino)-4-methylcoumarin"	"C87014"	785	"Tox21_ERa_BLA_Agonist_ratio"	200561	1099176	916789	1	"Row-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_301534"	41422	"87-01-4"	"7-(Dimethylamino)-4-methylcoumarin"	"C87014"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225223	1057845	801318	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_301538"	41726	"2610-11-9"	"C.I. Direct Red 81 disodium salt"	"C2610119"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225012	1057849	801322	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301542"	44536	"13171-00-1"	"1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone"	"C13171001"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237235	976240	843314	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301542"	44536	"13171-00-1"	"1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone"	"C13171001"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237948	976240	843314	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301544"	41293	"120-65-0"	"2-((Dimethylamino)methyl)phenol"	"C120650"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223775	1057855	801328	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301544"	41293	"120-65-0"	"2-((Dimethylamino)methyl)phenol"	"C120650"	788	"Tox21_ERa_LUC_BG1_Agonist"	259538	1193840	609601	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301545"	35010	"129-06-6"	"Sodium warfarin"	"C129066"	785	"Tox21_ERa_BLA_Agonist_ratio"	202132	1099187	916800	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301548"	37714	"1987-50-4"	"4-Heptylphenol"	"C1987504"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225721	1057859	801332	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301555"	41530	"139-88-8"	"7-Ethyl-2-methyl-4-undecanolsulfate, sodium salt"	"C139888"	788	"Tox21_ERa_LUC_BG1_Agonist"	260746	1193851	609612	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301559"	32309	"1929-73-3"	"2,4-D-Butotyl"	"C1929733"	788	"Tox21_ERa_LUC_BG1_Agonist"	258422	1193855	609616	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_301559"	32309	"1929-73-3"	"2,4-D-Butotyl"	"C1929733"	788	"Tox21_ERa_LUC_BG1_Agonist"	261413	1193855	609616	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_301561"	41794	"99607-70-2"	"Cloquintocet-mexyl"	"C99607702"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225722	1057872	801345	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301565"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	785	"Tox21_ERa_BLA_Agonist_ratio"	202136	1099207	916820	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301565"	32348	"3691-35-8"	"Chlorophacinone"	"C3691358"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224140	1057876	801349	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301570"	32688	"26002-80-2"	"Phenothrin"	"C26002802"	788	"Tox21_ERa_LUC_BG1_Agonist"	261609	1193866	609627	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301571"	34601	"67564-91-4"	"(2R,6S)-Fenpropimorph"	"C67564914"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237238	976269	843343	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301571"	34601	"67564-91-4"	"(2R,6S)-Fenpropimorph"	"C67564914"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237951	976269	843343	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301577"	32431	"87392-12-9"	"S-Metolachlor"	"C87392129"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225724	1057888	801361	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301577"	32431	"87392-12-9"	"S-Metolachlor"	"C87392129"	788	"Tox21_ERa_LUC_BG1_Agonist"	261135	1193873	609634	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_301577"	32431	"87392-12-9"	"S-Metolachlor"	"C87392129"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237239	976275	843349	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301577"	32431	"87392-12-9"	"S-Metolachlor"	"C87392129"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237952	976275	843349	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301579"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	785	"Tox21_ERa_BLA_Agonist_ratio"	202138	1099221	916834	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301579"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	785	"Tox21_ERa_BLA_Agonist_ratio"	202780	1099221	916834	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301579"	32533	"122453-73-0"	"Chlorfenapyr"	"C122453730"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225014	1057890	801363	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301580"	34324	"14816-18-3"	"Phoxim"	"C14816183"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223951	1057891	801364	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301581"	37539	"959-98-8"	"Endosulfan I"	"C959988"	785	"Tox21_ERa_BLA_Agonist_ratio"	202139	1099223	916836	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301581"	37539	"959-98-8"	"Endosulfan I"	"C959988"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224502	1057892	801365	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301581"	37539	"959-98-8"	"Endosulfan I"	"C959988"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237953	976279	843353	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301589"	34165	"63612-50-0"	"Nilutamide"	"C63612500"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225015	1057900	801373	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301589"	34165	"63612-50-0"	"Nilutamide"	"C63612500"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225725	1057900	801373	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301604"	22366	"50-27-1"	"Estriol"	"C50271"	785	"Tox21_ERa_BLA_Agonist_ratio"	200562	1099246	916859	1	"Row-wise effect, increased signal"	0.355555555555556	"proportion"	"percent_activity"
"Tox21_301604"	22366	"50-27-1"	"Estriol"	"C50271"	785	"Tox21_ERa_BLA_Agonist_ratio"	200696	1099246	916859	4	"Col-wise effect, increased signal"	0.2	"proportion"	"percent_activity"
"Tox21_301604"	22366	"50-27-1"	"Estriol"	"C50271"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225983	1057915	801388	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301604"	22366	"50-27-1"	"Estriol"	"C50271"	788	"Tox21_ERa_LUC_BG1_Agonist"	257746	1193900	609661	1	"Row-wise effect, increased signal"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_301604"	22366	"50-27-1"	"Estriol"	"C50271"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237955	976302	843376	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301635"	40716	"5349-51-9"	"4-(2-Methylbutan-2-yl)cyclohexanol"	"C5349519"	788	"Tox21_ERa_LUC_BG1_Agonist"	260756	1193931	609692	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301637"	37749	"4638-48-6"	"5-Chlorosalicylanilide"	"C4638486"	785	"Tox21_ERa_BLA_Agonist_ratio"	202142	1099279	916892	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301637"	37749	"4638-48-6"	"5-Chlorosalicylanilide"	"C4638486"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225017	1057948	801421	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301643"	28022	"51632-16-7"	"1-(Bromomethyl)-3-phenoxybenzene"	"C51632167"	785	"Tox21_ERa_BLA_Agonist_ratio"	202782	1099285	916898	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301643"	28022	"51632-16-7"	"1-(Bromomethyl)-3-phenoxybenzene"	"C51632167"	788	"Tox21_ERa_LUC_BG1_Agonist"	261610	1193939	609700	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301654"	41709	"5850-86-2"	"C.I. Acid Orange 8, monosodium salt"	"C5850862"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237959	976352	843426	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301667"	41653	"4707-47-5"	"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate"	"C4707475"	785	"Tox21_ERa_BLA_Agonist_ratio"	202143	1099309	916922	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301667"	41653	"4707-47-5"	"Methyl 2,4-dihydroxy-3,6-dimethylbenzoate"	"C4707475"	788	"Tox21_ERa_LUC_BG1_Agonist"	260761	1193963	609724	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301699"	40707	"33228-44-3"	"4-Pentylaniline"	"C33228443"	788	"Tox21_ERa_LUC_BG1_Agonist"	259548	1193995	609756	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301699"	40707	"33228-44-3"	"4-Pentylaniline"	"C33228443"	788	"Tox21_ERa_LUC_BG1_Agonist"	260762	1193995	609756	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301751"	32648	"22248-79-9"	"Z-Tetrachlorvinphos"	"C22248799"	785	"Tox21_ERa_BLA_Agonist_ratio"	202152	1099393	917006	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301751"	32648	"22248-79-9"	"Z-Tetrachlorvinphos"	"C22248799"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237960	976449	843523	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301757"	42086	"59227-89-3"	"Laurocapram"	"C59227893"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225018	1058068	801541	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301757"	42086	"59227-89-3"	"Laurocapram"	"C59227893"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225730	1058068	801541	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301766"	41639	"827-21-4"	"Benzenesulfonic acid, 2,4-dimethyl-, sodium salt"	"C827214"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223952	1058077	801550	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301769"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	785	"Tox21_ERa_BLA_Agonist_ratio"	202155	1099411	917024	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301769"	40611	"27306-78-1"	"Silwet L77"	"C27306781"	785	"Tox21_ERa_BLA_Agonist_ratio"	202789	1099411	917024	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301775"	44833	"80-27-3"	"Terpinyl propionate"	"C80273"	785	"Tox21_ERa_BLA_Agonist_ratio"	202156	1099417	917030	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301778"	32484	"3383-96-8"	"Temephos"	"C3383968"	785	"Tox21_ERa_BLA_Agonist_ratio"	202157	1099420	917033	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301778"	32484	"3383-96-8"	"Temephos"	"C3383968"	785	"Tox21_ERa_BLA_Agonist_ratio"	202790	1099420	917033	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301778"	32484	"3383-96-8"	"Temephos"	"C3383968"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236812	976476	843550	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301791"	44902	"27253-33-4"	"Calcium neodecanoate"	"C27253334"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225733	1058102	801575	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301833"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225985	1058144	801617	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_301833"	48122	"63449-41-2"	"C8-18-Alkydimethylbenzyl ammonium chlorides"	"C63449412"	788	"Tox21_ERa_LUC_BG1_Agonist"	259557	1194129	609890	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301837"	20814	"72-33-3"	"Mestranol"	"C72333"	785	"Tox21_ERa_BLA_Agonist_ratio"	200564	1099479	917092	1	"Row-wise effect, increased signal"	0.288888888888889	"proportion"	"percent_activity"
"Tox21_301837"	20814	"72-33-3"	"Mestranol"	"C72333"	785	"Tox21_ERa_BLA_Agonist_ratio"	200698	1099479	917092	4	"Col-wise effect, increased signal"	0.0888888888888889	"proportion"	"percent_activity"
"Tox21_301837"	20814	"72-33-3"	"Mestranol"	"C72333"	788	"Tox21_ERa_LUC_BG1_Agonist"	257748	1194133	609894	1	"Row-wise effect, increased signal"	0.0888888888888889	"proportion"	"percent_activity"
"Tox21_301837"	20814	"72-33-3"	"Mestranol"	"C72333"	788	"Tox21_ERa_LUC_BG1_Agonist"	261414	1194133	609894	13	"Includes potential chemical plate interlace points"	0.2	"proportion"	"percent_activity"
"Tox21_301841"	23322	"84371-65-3"	"Mifepristone"	"C84371653"	785	"Tox21_ERa_BLA_Agonist_ratio"	202164	1099483	917096	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301841"	23322	"84371-65-3"	"Mifepristone"	"C84371653"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225849	1058152	801625	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_301841"	23322	"84371-65-3"	"Mifepristone"	"C84371653"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236814	976539	843613	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_301854"	34518	"13684-56-5"	"Desmedipham"	"C13684565"	788	"Tox21_ERa_LUC_BG1_Agonist"	258429	1194150	609911	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_301854"	34518	"13684-56-5"	"Desmedipham"	"C13684565"	788	"Tox21_ERa_LUC_BG1_Agonist"	261415	1194150	609911	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_301870"	42491	"2761-24-2"	"Triethoxypentylsilane"	"C2761242"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225027	1058181	801654	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301870"	42491	"2761-24-2"	"Triethoxypentylsilane"	"C2761242"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225739	1058181	801654	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301875"	20337	"50-41-9"	"Clomiphene citrate"	"C50419"	785	"Tox21_ERa_BLA_Agonist_ratio"	202167	1099517	917130	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301875"	20337	"50-41-9"	"Clomiphene citrate"	"C50419"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236492	976573	843647	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301937"	41208	"58846-77-8"	"Decyl beta-D-glucopyranoside"	"C58846778"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225746	1058248	801721	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301941"	34576	"2491-38-5"	"2-Bromo-4-hydroxyacetophenone"	"C2491385"	788	"Tox21_ERa_LUC_BG1_Agonist"	260785	1194237	609998	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301943"	23216	"6893-02-3"	"3,5,3'-Triiodothyronine"	"C6893023"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225032	1058254	801727	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301943"	23216	"6893-02-3"	"3,5,3'-Triiodothyronine"	"C6893023"	788	"Tox21_ERa_LUC_BG1_Agonist"	259566	1194239	610000	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301943"	23216	"6893-02-3"	"3,5,3'-Triiodothyronine"	"C6893023"	788	"Tox21_ERa_LUC_BG1_Agonist"	260786	1194239	610000	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301948"	41424	"13254-34-7"	"2,6-Dimethyl-2-heptanol"	"C13254347"	785	"Tox21_ERa_BLA_Agonist_ratio"	202174	1099590	917203	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301950"	41200	"94-91-7"	"N,N'-Disalicylidene-1,2-diaminopropane"	"C94917"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236495	976648	843722	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_301951"	24944	"35691-65-7"	"1,2-Dibromo-2,4-dicyanobutane"	"C35691657"	785	"Tox21_ERa_BLA_Agonist_ratio"	202175	1099593	917206	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301951"	24944	"35691-65-7"	"1,2-Dibromo-2,4-dicyanobutane"	"C35691657"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237965	976649	843723	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_301966"	42169	"5116-94-9"	"Monotridecyl phosphate"	"C5116949"	788	"Tox21_ERa_LUC_BG1_Agonist"	259568	1194262	610023	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_301967"	29653	"1762-95-4"	"Thiocyanic acid, ammonium salt"	"C1762954"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225851	1058278	801751	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302012"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	788	"Tox21_ERa_LUC_BG1_Agonist"	259570	1194308	610069	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302012"	40708	"33228-45-4"	"4-Hexylaniline"	"C33228454"	788	"Tox21_ERa_LUC_BG1_Agonist"	260791	1194308	610069	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302013"	41604	"540-18-1"	"Pentyl butyrate"	"C540181"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223781	1058324	801797	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302013"	41604	"540-18-1"	"Pentyl butyrate"	"C540181"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223953	1058324	801797	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302021"	38696	"93-89-0"	"Ethyl benzoate"	"C93890"	788	"Tox21_ERa_LUC_BG1_Agonist"	260792	1194317	610078	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302039"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	785	"Tox21_ERa_BLA_Agonist_ratio"	202182	1099681	917294	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302039"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	788	"Tox21_ERa_LUC_BG1_Agonist"	259572	1194335	610096	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302039"	35214	"3391-86-4"	"1-Octen-3-ol"	"C3391864"	788	"Tox21_ERa_LUC_BG1_Agonist"	260797	1194335	610096	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302055"	23745	"58-86-6"	"D-Xylose"	"C58866"	788	"Tox21_ERa_LUC_BG1_Agonist"	260798	1194351	610112	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302055"	23745	"58-86-6"	"D-Xylose"	"C58866"	788	"Tox21_ERa_LUC_BG1_Agonist"	261418	1194351	610112	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302065"	34317	"8001-54-5"	"Benzalkonium chloride"	"C8001545"	785	"Tox21_ERa_BLA_Agonist_ratio"	202186	1099707	917320	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302065"	34317	"8001-54-5"	"Benzalkonium chloride"	"C8001545"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224145	1058376	801849	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302065"	34317	"8001-54-5"	"Benzalkonium chloride"	"C8001545"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225931	1058376	801849	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302065"	34317	"8001-54-5"	"Benzalkonium chloride"	"C8001545"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238118	976763	843837	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302080"	41682	"115-39-9"	"Bromophenol blue"	"C115399"	785	"Tox21_ERa_BLA_Agonist_ratio"	200567	1099722	917335	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302080"	41682	"115-39-9"	"Bromophenol blue"	"C115399"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223876	1058391	801864	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302080"	41682	"115-39-9"	"Bromophenol blue"	"C115399"	788	"Tox21_ERa_LUC_BG1_Agonist"	259857	1194376	610137	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302085"	21233	"16423-68-0"	"FD&C Red 3"	"C16423680"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237257	976783	843857	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302085"	21233	"16423-68-0"	"FD&C Red 3"	"C16423680"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237968	976783	843857	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302087"	23296	"61-73-4"	"Methylene blue"	"C61734"	785	"Tox21_ERa_BLA_Agonist_ratio"	202191	1099729	917342	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302087"	23296	"61-73-4"	"Methylene blue"	"C61734"	788	"Tox21_ERa_LUC_BG1_Agonist"	259574	1194383	610144	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302087"	23296	"61-73-4"	"Methylene blue"	"C61734"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236818	976785	843859	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302088"	38881	"633-96-5"	"C.I. Acid Orange 7"	"C633965"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237258	976786	843860	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302088"	38881	"633-96-5"	"C.I. Acid Orange 7"	"C633965"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237969	976786	843860	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302091"	41721	"8004-92-0"	"C.I. Acid Yellow 3 disodium salt"	"C8004920"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225040	1058402	801875	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302092"	40343	"5437-45-6"	"Benzyl bromoacetate"	"C5437456"	788	"Tox21_ERa_LUC_BG1_Agonist"	258436	1194388	610149	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302092"	40343	"5437-45-6"	"Benzyl bromoacetate"	"C5437456"	788	"Tox21_ERa_LUC_BG1_Agonist"	259928	1194388	610149	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_302101"	42418	"3026-63-9"	"Sodium tridecyl sulfate"	"C3026639"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224513	1058412	801885	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302101"	42418	"3026-63-9"	"Sodium tridecyl sulfate"	"C3026639"	788	"Tox21_ERa_LUC_BG1_Agonist"	259575	1194397	610158	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302110"	41661	"611-20-1"	"Benzonitrile, 2-hydroxy-"	"C611201"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223783	1058421	801894	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302110"	41661	"611-20-1"	"Benzonitrile, 2-hydroxy-"	"C611201"	788	"Tox21_ERa_LUC_BG1_Agonist"	259576	1194406	610167	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302133"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	785	"Tox21_ERa_BLA_Agonist_ratio"	202192	1099775	917388	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302133"	36588	"26027-38-3"	"Polyoxyethylene(10)nonylphenyl ether"	"C26027383"	785	"Tox21_ERa_BLA_Agonist_ratio"	202800	1099775	917388	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302134"	27191	"542-92-7"	"1,3-Cyclopentadiene"	"C542927"	788	"Tox21_ERa_LUC_BG1_Agonist"	259580	1194430	610191	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302134"	27191	"542-92-7"	"1,3-Cyclopentadiene"	"C542927"	788	"Tox21_ERa_LUC_BG1_Agonist"	260804	1194430	610191	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302134"	27191	"542-92-7"	"1,3-Cyclopentadiene"	"C542927"	788	"Tox21_ERa_LUC_BG1_Agonist"	261420	1194430	610191	13	"Includes potential chemical plate interlace points"	0.2	"proportion"	"percent_activity"
"Tox21_302137"	22489	"140-10-3"	"Cinnamic acid"	"C140103"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237260	976835	843909	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302152"	25234	"17372-87-1"	"Eosin"	"C17372871"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225988	1058463	801936	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302152"	25234	"17372-87-1"	"Eosin"	"C17372871"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237261	976850	843924	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302152"	25234	"17372-87-1"	"Eosin"	"C17372871"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237971	976850	843924	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302152"	25234	"17372-87-1"	"Eosin"	"C17372871"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238119	976850	843924	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302161"	22679	"58-85-5"	"Biotin"	"C58855"	788	"Tox21_ERa_LUC_BG1_Agonist"	259581	1194457	610218	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302161"	22679	"58-85-5"	"Biotin"	"C58855"	788	"Tox21_ERa_LUC_BG1_Agonist"	260809	1194457	610218	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302171"	22437	"500-38-9"	"Nordihydroguaiaretic acid"	"C500389"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224515	1058482	801955	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302171"	22437	"500-38-9"	"Nordihydroguaiaretic acid"	"C500389"	788	"Tox21_ERa_LUC_BG1_Agonist"	261421	1194467	610228	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302171"	22437	"500-38-9"	"Nordihydroguaiaretic acid"	"C500389"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237263	976869	843943	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302172"	44390	"6610-29-3"	"N-Methylhydrazinecarbothioamide"	"C6610293"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225288	1058483	801956	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_302172"	44390	"6610-29-3"	"N-Methylhydrazinecarbothioamide"	"C6610293"	788	"Tox21_ERa_LUC_BG1_Agonist"	259582	1194468	610229	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302198"	44487	"5137-55-3"	"Methyltrioctylammonium chloride"	"C5137553"	785	"Tox21_ERa_BLA_Agonist_ratio"	200700	1099840	917453	4	"Col-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_302198"	44487	"5137-55-3"	"Methyltrioctylammonium chloride"	"C5137553"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224146	1058509	801982	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302198"	44487	"5137-55-3"	"Methyltrioctylammonium chloride"	"C5137553"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225048	1058509	801982	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302198"	44487	"5137-55-3"	"Methyltrioctylammonium chloride"	"C5137553"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225755	1058509	801982	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302215"	44578	"827-19-0"	"Sodium 2,5-dimethylbenzenesulfonate"	"C827190"	785	"Tox21_ERa_BLA_Agonist_ratio"	200701	1099857	917470	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302215"	44578	"827-19-0"	"Sodium 2,5-dimethylbenzenesulfonate"	"C827190"	785	"Tox21_ERa_BLA_Agonist_ratio"	203252	1099857	917470	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"Tox21_302215"	44578	"827-19-0"	"Sodium 2,5-dimethylbenzenesulfonate"	"C827190"	788	"Tox21_ERa_LUC_BG1_Agonist"	257876	1194511	610272	4	"Col-wise effect, increased signal"	0.0888888888888889	"proportion"	"percent_activity"
"Tox21_302215"	44578	"827-19-0"	"Sodium 2,5-dimethylbenzenesulfonate"	"C827190"	788	"Tox21_ERa_LUC_BG1_Agonist"	259727	1194511	610272	9	"Potential pintool carryover"	0.333333333333333	"proportion"	"percent_activity"
"Tox21_302215"	44578	"827-19-0"	"Sodium 2,5-dimethylbenzenesulfonate"	"C827190"	788	"Tox21_ERa_LUC_BG1_Agonist"	259859	1194511	610272	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302215"	44578	"827-19-0"	"Sodium 2,5-dimethylbenzenesulfonate"	"C827190"	788	"Tox21_ERa_LUC_BG1_Agonist"	261677	1194511	610272	15	"Gain AC50 < lowest conc & loss AC50 < mean conc"	NA	NA	"percent_activity"
"Tox21_302217"	40352	"39300-45-3"	"Dinocap"	"C39300453"	785	"Tox21_ERa_BLA_Agonist_ratio"	202196	1099859	917472	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302217"	40352	"39300-45-3"	"Dinocap"	"C39300453"	785	"Tox21_ERa_BLA_Agonist_ratio"	202802	1099859	917472	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302218"	32412	"81405-85-8"	"Imazmethabenz"	"C81405858"	788	"Tox21_ERa_LUC_BG1_Agonist"	260811	1194514	610275	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302225"	44538	"13301-61-6"	"C.I. Disperse Orange 37"	"C13301616"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225049	1058536	802009	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302225"	44538	"13301-61-6"	"C.I. Disperse Orange 37"	"C13301616"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225756	1058536	802009	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302233"	42190	"2605-79-0"	"N,N-Dimethyldecylamine oxide"	"C2605790"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236500	976931	844005	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302251"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	785	"Tox21_ERa_BLA_Agonist_ratio"	202200	1099893	917506	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302251"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237266	976949	844023	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302251"	32558	"143390-89-0"	"Kresoxim-methyl"	"C143390890"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237977	976949	844023	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302270"	36515	"57-85-2"	"Testosterone propionate"	"C57852"	785	"Tox21_ERa_BLA_Agonist_ratio"	200568	1099912	917525	1	"Row-wise effect, increased signal"	0.0777777777777778	"proportion"	"percent_activity"
"Tox21_302270"	36515	"57-85-2"	"Testosterone propionate"	"C57852"	785	"Tox21_ERa_BLA_Agonist_ratio"	200703	1099912	917525	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302270"	36515	"57-85-2"	"Testosterone propionate"	"C57852"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223954	1058581	802054	3	"Col-wise effect, decreased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_302270"	36515	"57-85-2"	"Testosterone propionate"	"C57852"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225229	1058581	802054	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302270"	36515	"57-85-2"	"Testosterone propionate"	"C57852"	788	"Tox21_ERa_LUC_BG1_Agonist"	257749	1194566	610327	1	"Row-wise effect, increased signal"	0.0555555555555556	"proportion"	"percent_activity"
"Tox21_302270"	36515	"57-85-2"	"Testosterone propionate"	"C57852"	788	"Tox21_ERa_LUC_BG1_Agonist"	257877	1194566	610327	4	"Col-wise effect, increased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_302271"	44537	"1323-19-9"	"Sodium 2,4,7-tri(propan-2-yl)naphthalene-1-sulfonate"	"C1323199"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225761	1058582	802055	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302273"	34497	"125116-23-6"	"Metconazole"	"C125116236"	785	"Tox21_ERa_BLA_Agonist_ratio"	202804	1099915	917528	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302273"	34497	"125116-23-6"	"Metconazole"	"C125116236"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224517	1058584	802057	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302273"	34497	"125116-23-6"	"Metconazole"	"C125116236"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238120	976971	844045	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302276"	27963	"30399-84-9"	"Isooctadecanoic acid"	"C30399849"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225053	1058587	802060	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302290"	41484	"3681-71-8"	"(3Z)-3-Hexenyl acetate"	"C3681718"	788	"Tox21_ERa_LUC_BG1_Agonist"	260815	1194586	610347	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302294"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225054	1058605	802078	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302294"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	788	"Tox21_ERa_LUC_BG1_Agonist"	258441	1194590	610351	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302294"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	788	"Tox21_ERa_LUC_BG1_Agonist"	259586	1194590	610351	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302294"	36288	"5333-42-6"	"2-Octyl-1-dodecanol"	"C5333426"	788	"Tox21_ERa_LUC_BG1_Agonist"	260816	1194590	610351	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302296"	44202	"112-14-1"	"Octyl acetate"	"C112141"	788	"Tox21_ERa_LUC_BG1_Agonist"	260818	1194592	610353	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302303"	47033	"17465-86-0"	"gamma-Cyclodextrin"	"C17465860"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225056	1058614	802087	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302311"	36933	"16893-85-9"	"Sodium hexafluorosilicate"	"C16893859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225058	1058622	802095	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302311"	36933	"16893-85-9"	"Sodium hexafluorosilicate"	"C16893859"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225762	1058622	802095	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302330"	22526	"94-18-8"	"Benzylparaben"	"C94188"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224520	1058641	802114	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302335"	22396	"480-40-0"	"Chrysin"	"C480400"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224521	1058646	802119	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302347"	25403	"6789-88-4"	"Hexyl benzoate"	"C6789884"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225932	1058658	802131	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302358"	20516	"57-14-7"	"1,1-Dimethylhydrazine"	"C57147"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225992	1058669	802142	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302359"	25469	"123-51-3"	"Isopentyl alcohol"	"C123513"	788	"Tox21_ERa_LUC_BG1_Agonist"	257752	1194655	610416	1	"Row-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_302359"	25469	"123-51-3"	"Isopentyl alcohol"	"C123513"	788	"Tox21_ERa_LUC_BG1_Agonist"	257878	1194655	610416	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_302361"	29167	"137-42-8"	"Metam-sodium"	"C137428"	788	"Tox21_ERa_LUC_BG1_Agonist"	260822	1194657	610418	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302363"	32345	"56-95-1"	"Chlorhexidine diacetate"	"C56951"	785	"Tox21_ERa_BLA_Agonist_ratio"	202805	1100005	917618	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302363"	32345	"56-95-1"	"Chlorhexidine diacetate"	"C56951"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236822	977061	844135	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302369"	34181	"82640-04-8"	"Raloxifene hydrochloride"	"C82640048"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224058	1058680	802153	4	"Col-wise effect, increased signal"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302369"	34181	"82640-04-8"	"Raloxifene hydrochloride"	"C82640048"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225857	1058680	802153	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302369"	34181	"82640-04-8"	"Raloxifene hydrochloride"	"C82640048"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236606	977067	844141	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_302372"	45191	"66357-35-5"	"Ranitidine"	"C66357355"	788	"Tox21_ERa_LUC_BG1_Agonist"	258444	1194668	610429	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302373"	44303	"134523-03-8"	"Atorvastatin calcium"	"C134523038"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224147	1058684	802157	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302373"	44303	"134523-03-8"	"Atorvastatin calcium"	"C134523038"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224524	1058684	802157	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302373"	44303	"134523-03-8"	"Atorvastatin calcium"	"C134523038"	788	"Tox21_ERa_LUC_BG1_Agonist"	259590	1194669	610430	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302374"	29298	"9004-82-4"	"Sodium lauryl polyoxyethylene ether sulfate"	"C9004824"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224525	1058685	802158	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302374"	29298	"9004-82-4"	"Sodium lauryl polyoxyethylene ether sulfate"	"C9004824"	788	"Tox21_ERa_LUC_BG1_Agonist"	259591	1194670	610431	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302379"	35589	"68959-20-6"	"Disiquonium chloride "	"C68959206"	785	"Tox21_ERa_BLA_Agonist_ratio"	202475	1100021	917634	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_302379"	35589	"68959-20-6"	"Disiquonium chloride "	"C68959206"	788	"Tox21_ERa_LUC_BG1_Agonist"	259592	1194675	610436	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302379"	35589	"68959-20-6"	"Disiquonium chloride "	"C68959206"	788	"Tox21_ERa_LUC_BG1_Agonist"	260823	1194675	610436	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302384"	47103	"1120-04-3"	"Octadecyl sulfate sodium salt"	"C1120043"	785	"Tox21_ERa_BLA_Agonist_ratio"	202216	1100026	917639	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302386"	34700	"3653-48-3"	"MCPA-sodium"	"C3653483"	788	"Tox21_ERa_LUC_BG1_Agonist"	259593	1194682	610443	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302386"	34700	"3653-48-3"	"MCPA-sodium"	"C3653483"	788	"Tox21_ERa_LUC_BG1_Agonist"	260824	1194682	610443	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302388"	27891	"26264-06-2"	"Calcium dodecylbenzene sulfonate"	"C26264062"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224526	1058699	802172	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302399"	40484	"66575-29-9"	"Forskolin"	"C66575299"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225230	1058710	802183	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302399"	40484	"66575-29-9"	"Forskolin"	"C66575299"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236507	977097	844171	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302409"	32315	"64359-81-5"	"4,5-Dichloro-2-octyl-3(2H)-isothiazolone"	"C64359815"	785	"Tox21_ERa_BLA_Agonist_ratio"	202217	1100051	917664	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302418"	29565	"85507-79-5"	"Phthalic acid, diundecyl ester, branched and linear"	"C85507795"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225067	1058729	802202	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302422"	27388	"1330-86-5"	"Diisooctyl adipate"	"C1330865"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225068	1058733	802206	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302422"	27388	"1330-86-5"	"Diisooctyl adipate"	"C1330865"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225769	1058733	802206	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302423"	26178	"2244-21-5"	"Potassium dichloroisocyanurate"	"C2244215"	788	"Tox21_ERa_LUC_BG1_Agonist"	260829	1194719	610480	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302423"	26178	"2244-21-5"	"Potassium dichloroisocyanurate"	"C2244215"	788	"Tox21_ERa_LUC_BG1_Agonist"	261612	1194719	610480	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302426"	22628	"29122-68-7"	"Atenolol"	"C29122687"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223788	1058737	802210	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302427"	23380	"68-22-4"	"Norethindrone"	"C68224"	785	"Tox21_ERa_BLA_Agonist_ratio"	200571	1100069	917682	1	"Row-wise effect, increased signal"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302427"	23380	"68-22-4"	"Norethindrone"	"C68224"	785	"Tox21_ERa_BLA_Agonist_ratio"	203101	1100069	917682	13	"Includes potential chemical plate interlace points"	0.144444444444444	"proportion"	"percent_activity"
"Tox21_302427"	23380	"68-22-4"	"Norethindrone"	"C68224"	788	"Tox21_ERa_LUC_BG1_Agonist"	257753	1194723	610484	1	"Row-wise effect, increased signal"	0.0777777777777778	"proportion"	"percent_activity"
"Tox21_302427"	23380	"68-22-4"	"Norethindrone"	"C68224"	788	"Tox21_ERa_LUC_BG1_Agonist"	257879	1194723	610484	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302431"	37565	"55814-41-0"	"Mepronil"	"C55814410"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236508	977129	844203	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302434"	32531	"116255-48-2"	"Bromuconazole"	"C116255482"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225770	1058745	802218	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302460"	47127	"16587-71-6"	"4-(tert-Pentyl)-cyclohexanone"	"C16587716"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237274	977158	844232	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302461"	47185	"94-46-2"	"Isopentyl benzoate"	"C94462"	788	"Tox21_ERa_LUC_BG1_Agonist"	257754	1194757	610518	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302499"	47597	"9003-11-6"	"Pluronic F-127"	"C9003116"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236645	977197	844271	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302499"	47597	"9003-11-6"	"Pluronic F-127"	"C9003116"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237278	977197	844271	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302499"	47597	"9003-11-6"	"Pluronic F-127"	"C9003116"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237983	977197	844271	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302531"	47708	"NOCAS_47708"	"Igepal CO-890"	"CNOCAS47708"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237280	977229	844303	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302538"	44175	"8000-34-8"	"Clove leaf oil"	"C8000348"	785	"Tox21_ERa_BLA_Agonist_ratio"	202239	1100180	917793	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302543"	47696	"61791-12-6"	"Cremophor(R) EL"	"C61791126"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225079	1058854	802327	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302576"	47205	"83834-59-7"	"2-Ethylhexyl trans-4-methoxycinnamate"	"C83834597"	788	"Tox21_ERa_LUC_BG1_Agonist"	259601	1194872	610633	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302576"	47205	"83834-59-7"	"2-Ethylhexyl trans-4-methoxycinnamate"	"C83834597"	788	"Tox21_ERa_LUC_BG1_Agonist"	260841	1194872	610633	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302586"	47429	"2392-39-4"	"Dexamethasone sodium phosphate"	"C2392394"	785	"Tox21_ERa_BLA_Agonist_ratio"	202247	1100228	917841	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302586"	47429	"2392-39-4"	"Dexamethasone sodium phosphate"	"C2392394"	788	"Tox21_ERa_LUC_BG1_Agonist"	259603	1194882	610643	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302596"	47451	"6359-82-6"	"Acid Yellow 11"	"C6359826"	785	"Tox21_ERa_BLA_Agonist_ratio"	202248	1100238	917851	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302603"	47497	"119-07-3"	"Octyl decyl phthalate"	"C119073"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225082	1058914	802387	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302605"	47517	"68515-75-3"	"Hexanedioic acid, di-C7-9-branched and linear alkyl esters"	"C68515753"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225083	1058916	802389	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302622"	47590	"94-47-3"	"2-Phenylethyl benzoate"	"C94473"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223790	1058933	802406	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302641"	47433	"474-86-2"	"Equilin"	"C474862"	785	"Tox21_ERa_BLA_Agonist_ratio"	200572	1100283	917896	1	"Row-wise effect, increased signal"	0.244444444444444	"proportion"	"percent_activity"
"Tox21_302641"	47433	"474-86-2"	"Equilin"	"C474862"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225232	1058952	802425	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302641"	47433	"474-86-2"	"Equilin"	"C474862"	788	"Tox21_ERa_LUC_BG1_Agonist"	257755	1194937	610698	1	"Row-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_302642"	22100	"645-56-7"	"4-Propylphenol"	"C645567"	785	"Tox21_ERa_BLA_Agonist_ratio"	202264	1100284	917897	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302642"	22100	"645-56-7"	"4-Propylphenol"	"C645567"	788	"Tox21_ERa_LUC_BG1_Agonist"	259609	1194938	610699	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302642"	22100	"645-56-7"	"4-Propylphenol"	"C645567"	788	"Tox21_ERa_LUC_BG1_Agonist"	260850	1194938	610699	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302650"	47180	"36631-30-8"	"Triisodecyl trimellitate"	"C36631308"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223879	1058961	802434	2	"Row-wise effect, decreased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_302650"	47180	"36631-30-8"	"Triisodecyl trimellitate"	"C36631308"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225086	1058961	802434	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302655"	32619	"112226-61-6"	"Halofenozide"	"C112226616"	785	"Tox21_ERa_BLA_Agonist_ratio"	202269	1100297	917910	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302664"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	785	"Tox21_ERa_BLA_Agonist_ratio"	202270	1100306	917919	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302664"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	785	"Tox21_ERa_BLA_Agonist_ratio"	202813	1100306	917919	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302664"	21113	"8006-90-4"	"Peppermint oil"	"C8006904"	788	"Tox21_ERa_LUC_BG1_Agonist"	258446	1194960	610721	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302670"	47712	"68917-18-0"	"Cornmint oil"	"C68917180"	788	"Tox21_ERa_LUC_BG1_Agonist"	259611	1194966	610727	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302670"	47712	"68917-18-0"	"Cornmint oil"	"C68917180"	788	"Tox21_ERa_LUC_BG1_Agonist"	260854	1194966	610727	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302732"	20190	"860-22-0"	"C.I. Acid Blue 74"	"C860220"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237284	977430	844504	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302732"	20190	"860-22-0"	"C.I. Acid Blue 74"	"C860220"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237992	977430	844504	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302737"	21240	"127-47-9"	"Retinol acetate"	"C127479"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225092	1059048	802521	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302748"	21415	"122-20-3"	"Triisopropanolamine"	"C122203"	788	"Tox21_ERa_LUC_BG1_Agonist"	259626	1195044	610805	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302748"	21415	"122-20-3"	"Triisopropanolamine"	"C122203"	788	"Tox21_ERa_LUC_BG1_Agonist"	260874	1195044	610805	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302750"	20359	"108-94-1"	"Cyclohexanone"	"C108941"	788	"Tox21_ERa_LUC_BG1_Agonist"	257882	1195046	610807	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302751"	20889	"622-97-9"	"4-Methylstyrene"	"C622979"	788	"Tox21_ERa_LUC_BG1_Agonist"	259628	1195047	610808	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302761"	20379	"53-43-0"	"Dehydroepiandrosterone"	"C53430"	785	"Tox21_ERa_BLA_Agonist_ratio"	200574	1100403	918016	1	"Row-wise effect, increased signal"	0.377777777777778	"proportion"	"percent_activity"
"Tox21_302761"	20379	"53-43-0"	"Dehydroepiandrosterone"	"C53430"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225234	1059072	802545	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302761"	20379	"53-43-0"	"Dehydroepiandrosterone"	"C53430"	788	"Tox21_ERa_LUC_BG1_Agonist"	257757	1195057	610818	1	"Row-wise effect, increased signal"	0.311111111111111	"proportion"	"percent_activity"
"Tox21_302768"	21793	"90-15-3"	"1-Naphthol"	"C90153"	788	"Tox21_ERa_LUC_BG1_Agonist"	257758	1195064	610825	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302768"	21793	"90-15-3"	"1-Naphthol"	"C90153"	788	"Tox21_ERa_LUC_BG1_Agonist"	259860	1195064	610825	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302781"	21666	"544-63-8"	"Tetradecanoic acid"	"C544638"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225781	1059092	802565	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302784"	20652	"25812-30-0"	"Gemfibrozil"	"C25812300"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225783	1059095	802568	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302790"	20144	"119-53-9"	"Benzoin"	"C119539"	788	"Tox21_ERa_LUC_BG1_Agonist"	259631	1195086	610847	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302792"	25216	"1321-74-0"	"Divinylbenzene"	"C1321740"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237998	977490	844564	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302793"	22525	"5153-25-3"	"2-Ethylhexylparaben"	"C5153253"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224535	1059104	802577	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302793"	22525	"5153-25-3"	"2-Ethylhexylparaben"	"C5153253"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237999	977491	844565	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302798"	20511	"612-82-8"	"3,3'-Dimethylbenzidine dihydrochloride"	"C612828"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237292	977496	844570	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302798"	20511	"612-82-8"	"3,3'-Dimethylbenzidine dihydrochloride"	"C612828"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238000	977496	844570	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302802"	20278	"97-00-7"	"1-Chloro-2,4-dinitrobenzene"	"C97007"	785	"Tox21_ERa_BLA_Agonist_ratio"	202283	1100444	918057	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302804"	20372	"53-19-0"	"o,p'-DDD"	"C53190"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224536	1059115	802588	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302822"	21031	"156-10-5"	"4-Nitrosodiphenylamine"	"C156105"	785	"Tox21_ERa_BLA_Agonist_ratio"	202286	1100464	918077	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302822"	21031	"156-10-5"	"4-Nitrosodiphenylamine"	"C156105"	785	"Tox21_ERa_BLA_Agonist_ratio"	202820	1100464	918077	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302822"	21031	"156-10-5"	"4-Nitrosodiphenylamine"	"C156105"	788	"Tox21_ERa_LUC_BG1_Agonist"	259632	1195118	610879	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302822"	21031	"156-10-5"	"4-Nitrosodiphenylamine"	"C156105"	788	"Tox21_ERa_LUC_BG1_Agonist"	260876	1195118	610879	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302823"	20969	"79-24-3"	"Nitroethane"	"C79243"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223880	1059134	802607	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_302839"	21815	"95-76-1"	"3,4-Dichloroaniline"	"C95761"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224149	1059150	802623	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302839"	21815	"95-76-1"	"3,4-Dichloroaniline"	"C95761"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225096	1059150	802623	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302839"	21815	"95-76-1"	"3,4-Dichloroaniline"	"C95761"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225784	1059150	802623	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302843"	22409	"80-09-1"	"4,4'-Sulfonyldiphenol"	"C80091"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237293	977541	844615	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302852"	22405	"131-57-7"	"2-Hydroxy-4-methoxybenzophenone"	"C131577"	785	"Tox21_ERa_BLA_Agonist_ratio"	202288	1100494	918107	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302852"	22405	"131-57-7"	"2-Hydroxy-4-methoxybenzophenone"	"C131577"	785	"Tox21_ERa_BLA_Agonist_ratio"	202821	1100494	918107	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302852"	22405	"131-57-7"	"2-Hydroxy-4-methoxybenzophenone"	"C131577"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224151	1059163	802636	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302855"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224154	1059166	802639	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302855"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237294	977553	844627	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302855"	21234	"4548-53-2"	"FD&C Red 4"	"C4548532"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238001	977553	844627	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302868"	21199	"1114-71-2"	"Pebulate"	"C1114712"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224157	1059179	802652	5	"Includes potential flare region points"	0.2	"proportion"	"percent_activity"
"Tox21_302868"	21199	"1114-71-2"	"Pebulate"	"C1114712"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225885	1059179	802652	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302869"	20091	"142-04-1"	"Aniline hydrochloride"	"C142041"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224158	1059180	802653	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302869"	20091	"142-04-1"	"Aniline hydrochloride"	"C142041"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225099	1059180	802653	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302869"	20091	"142-04-1"	"Aniline hydrochloride"	"C142041"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225787	1059180	802653	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302869"	20091	"142-04-1"	"Aniline hydrochloride"	"C142041"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225994	1059180	802653	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302876"	20828	"150-76-5"	"4-Methoxyphenol"	"C150765"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237295	977574	844648	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302881"	21853	"103-76-4"	"1-Piperazineethanol"	"C103764"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224160	1059192	802665	5	"Includes potential flare region points"	0.222222222222222	"proportion"	"percent_activity"
"Tox21_302881"	21853	"103-76-4"	"1-Piperazineethanol"	"C103764"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225100	1059192	802665	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302881"	21853	"103-76-4"	"1-Piperazineethanol"	"C103764"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225862	1059192	802665	13	"Includes potential chemical plate interlace points"	0.2	"proportion"	"percent_activity"
"Tox21_302882"	21388	"93-76-5"	"2,4,5-Trichlorophenoxyacetic acid"	"C93765"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224161	1059193	802666	5	"Includes potential flare region points"	0.222222222222222	"proportion"	"percent_activity"
"Tox21_302882"	21388	"93-76-5"	"2,4,5-Trichlorophenoxyacetic acid"	"C93765"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225788	1059193	802666	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302882"	21388	"93-76-5"	"2,4,5-Trichlorophenoxyacetic acid"	"C93765"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225863	1059193	802666	13	"Includes potential chemical plate interlace points"	0.2	"proportion"	"percent_activity"
"Tox21_302884"	22391	"520-36-5"	"Apigenin"	"C520365"	785	"Tox21_ERa_BLA_Agonist_ratio"	200577	1100526	918139	1	"Row-wise effect, increased signal"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302884"	22391	"520-36-5"	"Apigenin"	"C520365"	785	"Tox21_ERa_BLA_Agonist_ratio"	201162	1100526	918139	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302884"	22391	"520-36-5"	"Apigenin"	"C520365"	788	"Tox21_ERa_LUC_BG1_Agonist"	257759	1195180	610941	1	"Row-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_302884"	22391	"520-36-5"	"Apigenin"	"C520365"	788	"Tox21_ERa_LUC_BG1_Agonist"	258450	1195180	610941	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302884"	22391	"520-36-5"	"Apigenin"	"C520365"	788	"Tox21_ERa_LUC_BG1_Agonist"	259863	1195180	610941	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302884"	22391	"520-36-5"	"Apigenin"	"C520365"	788	"Tox21_ERa_LUC_BG1_Agonist"	261425	1195180	610941	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302885"	22479	"90-00-6"	"2-Ethylphenol"	"C90006"	788	"Tox21_ERa_LUC_BG1_Agonist"	258451	1195181	610942	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302885"	22479	"90-00-6"	"2-Ethylphenol"	"C90006"	788	"Tox21_ERa_LUC_BG1_Agonist"	259634	1195181	610942	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302885"	22479	"90-00-6"	"2-Ethylphenol"	"C90006"	788	"Tox21_ERa_LUC_BG1_Agonist"	261426	1195181	610942	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302886"	21391	"1330-78-5"	"Tricresyl phosphate"	"C1330785"	788	"Tox21_ERa_LUC_BG1_Agonist"	258452	1195182	610943	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302893"	22153	"1461-25-2"	"Tetrabutyltin"	"C1461252"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236429	977591	844665	1	"Row-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_302898"	21243	"989-38-8"	"Rhodamine 6G"	"C989388"	785	"Tox21_ERa_BLA_Agonist_ratio"	202823	1100540	918153	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302898"	21243	"989-38-8"	"Rhodamine 6G"	"C989388"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224166	1059209	802682	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302898"	21243	"989-38-8"	"Rhodamine 6G"	"C989388"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225864	1059209	802682	13	"Includes potential chemical plate interlace points"	0.222222222222222	"proportion"	"percent_activity"
"Tox21_302898"	21243	"989-38-8"	"Rhodamine 6G"	"C989388"	788	"Tox21_ERa_LUC_BG1_Agonist"	258453	1195194	610955	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302901"	22394	"491-80-5"	"Biochanin A"	"C491805"	785	"Tox21_ERa_BLA_Agonist_ratio"	201163	1100543	918156	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302901"	22394	"491-80-5"	"Biochanin A"	"C491805"	788	"Tox21_ERa_LUC_BG1_Agonist"	258456	1195197	610958	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302901"	22394	"491-80-5"	"Biochanin A"	"C491805"	788	"Tox21_ERa_LUC_BG1_Agonist"	261429	1195197	610958	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302901"	22394	"491-80-5"	"Biochanin A"	"C491805"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237409	977599	844673	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_302909"	20093	"20265-97-8"	"4-Methoxyaniline hydrochloride"	"C20265978"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224168	1059220	802693	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302909"	20093	"20265-97-8"	"4-Methoxyaniline hydrochloride"	"C20265978"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225889	1059220	802693	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302909"	20093	"20265-97-8"	"4-Methoxyaniline hydrochloride"	"C20265978"	788	"Tox21_ERa_LUC_BG1_Agonist"	259636	1195205	610966	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302912"	20043	"97-59-6"	"Allantoin"	"C97596"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224171	1059223	802696	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302912"	20043	"97-59-6"	"Allantoin"	"C97596"	788	"Tox21_ERa_LUC_BG1_Agonist"	258457	1195208	610969	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302912"	20043	"97-59-6"	"Allantoin"	"C97596"	788	"Tox21_ERa_LUC_BG1_Agonist"	261430	1195208	610969	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302913"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	788	"Tox21_ERa_LUC_BG1_Agonist"	258458	1195209	610970	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302913"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	788	"Tox21_ERa_LUC_BG1_Agonist"	260879	1195209	610970	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302913"	21062	"930-55-2"	"N-Nitrosopyrrolidine"	"C930552"	788	"Tox21_ERa_LUC_BG1_Agonist"	261431	1195209	610970	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302922"	21997	"140-31-8"	"1-(2-Aminoethyl)piperazine"	"C140318"	788	"Tox21_ERa_LUC_BG1_Agonist"	259638	1195218	610979	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302926"	22421	"73-31-4"	"Melatonin"	"C73314"	788	"Tox21_ERa_LUC_BG1_Agonist"	258461	1195222	610983	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302926"	22421	"73-31-4"	"Melatonin"	"C73314"	788	"Tox21_ERa_LUC_BG1_Agonist"	259639	1195222	610983	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302926"	22421	"73-31-4"	"Melatonin"	"C73314"	788	"Tox21_ERa_LUC_BG1_Agonist"	260881	1195222	610983	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302926"	22421	"73-31-4"	"Melatonin"	"C73314"	788	"Tox21_ERa_LUC_BG1_Agonist"	261433	1195222	610983	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302929"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225103	1059240	802713	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302929"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	788	"Tox21_ERa_LUC_BG1_Agonist"	258464	1195225	610986	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302929"	21792	"90-02-8"	"Salicylaldehyde"	"C90028"	788	"Tox21_ERa_LUC_BG1_Agonist"	261436	1195225	610986	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302930"	20575	"140-67-0"	"Estragole"	"C140670"	788	"Tox21_ERa_LUC_BG1_Agonist"	258465	1195226	610987	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302930"	20575	"140-67-0"	"Estragole"	"C140670"	788	"Tox21_ERa_LUC_BG1_Agonist"	261437	1195226	610987	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302931"	21863	"105-53-3"	"Diethyl propanedioate"	"C105533"	788	"Tox21_ERa_LUC_BG1_Agonist"	258466	1195227	610988	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302931"	21863	"105-53-3"	"Diethyl propanedioate"	"C105533"	788	"Tox21_ERa_LUC_BG1_Agonist"	261615	1195227	610988	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302937"	20737	"120-72-9"	"Indole"	"C120729"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237301	977635	844709	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302938"	22171	"2016-57-1"	"1-Decanamine"	"C2016571"	788	"Tox21_ERa_LUC_BG1_Agonist"	260883	1195234	610995	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302939"	20307	"107-30-2"	"Chloromethyl methyl ether"	"C107302"	788	"Tox21_ERa_LUC_BG1_Agonist"	258467	1195235	610996	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302939"	20307	"107-30-2"	"Chloromethyl methyl ether"	"C107302"	788	"Tox21_ERa_LUC_BG1_Agonist"	259640	1195235	610996	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302939"	20307	"107-30-2"	"Chloromethyl methyl ether"	"C107302"	788	"Tox21_ERa_LUC_BG1_Agonist"	260884	1195235	610996	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302939"	20307	"107-30-2"	"Chloromethyl methyl ether"	"C107302"	788	"Tox21_ERa_LUC_BG1_Agonist"	261616	1195235	610996	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302940"	21984	"124-22-1"	"1-Dodecanamine"	"C124221"	788	"Tox21_ERa_LUC_BG1_Agonist"	258468	1195236	610997	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302940"	21984	"124-22-1"	"1-Dodecanamine"	"C124221"	788	"Tox21_ERa_LUC_BG1_Agonist"	261438	1195236	610997	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302941"	20366	"427-51-0"	"Cyproterone acetate"	"C427510"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224539	1059252	802725	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302941"	20366	"427-51-0"	"Cyproterone acetate"	"C427510"	788	"Tox21_ERa_LUC_BG1_Agonist"	258469	1195237	610998	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302941"	20366	"427-51-0"	"Cyproterone acetate"	"C427510"	788	"Tox21_ERa_LUC_BG1_Agonist"	259641	1195237	610998	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302941"	20366	"427-51-0"	"Cyproterone acetate"	"C427510"	788	"Tox21_ERa_LUC_BG1_Agonist"	260885	1195237	610998	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302941"	20366	"427-51-0"	"Cyproterone acetate"	"C427510"	788	"Tox21_ERa_LUC_BG1_Agonist"	261439	1195237	610998	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302943"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	785	"Tox21_ERa_BLA_Agonist_ratio"	202476	1100585	918198	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_302943"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224540	1059254	802727	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302943"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	788	"Tox21_ERa_LUC_BG1_Agonist"	258471	1195239	611000	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302943"	21138	"106-50-3"	"1,4-Benzenediamine"	"C106503"	788	"Tox21_ERa_LUC_BG1_Agonist"	261441	1195239	611000	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302945"	21483	"122-78-1"	"Phenylacetaldehyde"	"C122781"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225794	1059256	802729	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302945"	21483	"122-78-1"	"Phenylacetaldehyde"	"C122781"	788	"Tox21_ERa_LUC_BG1_Agonist"	258473	1195241	611002	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302951"	20029	"107-13-1"	"Acrylonitrile"	"C107131"	788	"Tox21_ERa_LUC_BG1_Agonist"	260886	1195247	611008	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302952"	20352	"135-20-6"	"Cupferron"	"C135206"	788	"Tox21_ERa_LUC_BG1_Agonist"	258474	1195248	611009	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302952"	20352	"135-20-6"	"Cupferron"	"C135206"	788	"Tox21_ERa_LUC_BG1_Agonist"	261618	1195248	611009	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302953"	21931	"111-27-3"	"1-Hexanol"	"C111273"	788	"Tox21_ERa_LUC_BG1_Agonist"	258475	1195249	611010	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_302953"	21931	"111-27-3"	"1-Hexanol"	"C111273"	788	"Tox21_ERa_LUC_BG1_Agonist"	261619	1195249	611010	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302956"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	785	"Tox21_ERa_BLA_Agonist_ratio"	201165	1100598	918211	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302956"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	785	"Tox21_ERa_BLA_Agonist_ratio"	202297	1100598	918211	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302956"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	785	"Tox21_ERa_BLA_Agonist_ratio"	202826	1100598	918211	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302956"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	788	"Tox21_ERa_LUC_BG1_Agonist"	258478	1195252	611013	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302956"	20466	"105-55-5"	"N,N'-Diethylthiourea"	"C105555"	788	"Tox21_ERa_LUC_BG1_Agonist"	261444	1195252	611013	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302957"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	785	"Tox21_ERa_BLA_Agonist_ratio"	201166	1100599	918212	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302957"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	785	"Tox21_ERa_BLA_Agonist_ratio"	202298	1100599	918212	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302957"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225292	1059268	802741	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_302957"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	788	"Tox21_ERa_LUC_BG1_Agonist"	258479	1195253	611014	5	"Includes potential flare region points"	0.2	"proportion"	"percent_activity"
"Tox21_302957"	20621	"51630-58-1"	"Fenvalerate"	"C51630581"	788	"Tox21_ERa_LUC_BG1_Agonist"	261445	1195253	611014	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302958"	20106	"50-81-7"	"L-Ascorbic acid"	"C50817"	788	"Tox21_ERa_LUC_BG1_Agonist"	258480	1195254	611015	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302958"	20106	"50-81-7"	"L-Ascorbic acid"	"C50817"	788	"Tox21_ERa_LUC_BG1_Agonist"	261620	1195254	611015	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302958"	20106	"50-81-7"	"L-Ascorbic acid"	"C50817"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237303	977656	844730	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302958"	20106	"50-81-7"	"L-Ascorbic acid"	"C50817"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238005	977656	844730	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302963"	21390	"96-18-4"	"1,2,3-Trichloropropane"	"C96184"	788	"Tox21_ERa_LUC_BG1_Agonist"	258481	1195259	611020	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302963"	21390	"96-18-4"	"1,2,3-Trichloropropane"	"C96184"	788	"Tox21_ERa_LUC_BG1_Agonist"	261621	1195259	611020	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302965"	20107	"22839-47-0"	"Aspartame"	"C22839470"	788	"Tox21_ERa_LUC_BG1_Agonist"	258483	1195261	611022	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302965"	20107	"22839-47-0"	"Aspartame"	"C22839470"	788	"Tox21_ERa_LUC_BG1_Agonist"	261446	1195261	611022	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302966"	21602	"57-10-3"	"Hexadecanoic acid"	"C57103"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225104	1059277	802750	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302966"	21602	"57-10-3"	"Hexadecanoic acid"	"C57103"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225795	1059277	802750	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302966"	21602	"57-10-3"	"Hexadecanoic acid"	"C57103"	788	"Tox21_ERa_LUC_BG1_Agonist"	258484	1195262	611023	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302966"	21602	"57-10-3"	"Hexadecanoic acid"	"C57103"	788	"Tox21_ERa_LUC_BG1_Agonist"	261447	1195262	611023	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302967"	21413	"126-72-7"	"Tris(2,3-dibromopropyl) phosphate"	"C126727"	785	"Tox21_ERa_BLA_Agonist_ratio"	202300	1100609	918222	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302967"	21413	"126-72-7"	"Tris(2,3-dibromopropyl) phosphate"	"C126727"	788	"Tox21_ERa_LUC_BG1_Agonist"	258485	1195263	611024	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302967"	21413	"126-72-7"	"Tris(2,3-dibromopropyl) phosphate"	"C126727"	788	"Tox21_ERa_LUC_BG1_Agonist"	261448	1195263	611024	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302968"	22123	"818-61-1"	"2-Hydroxyethyl acrylate"	"C818611"	788	"Tox21_ERa_LUC_BG1_Agonist"	258486	1195264	611025	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302968"	22123	"818-61-1"	"2-Hydroxyethyl acrylate"	"C818611"	788	"Tox21_ERa_LUC_BG1_Agonist"	261449	1195264	611025	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302972"	21959	"118-79-6"	"2,4,6-Tribromophenol"	"C118796"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224541	1059283	802756	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_302972"	21959	"118-79-6"	"2,4,6-Tribromophenol"	"C118796"	788	"Tox21_ERa_LUC_BG1_Agonist"	259642	1195268	611029	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302977"	21224	"6459-94-5"	"C.I. Acid Red 114"	"C6459945"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225106	1059288	802761	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302977"	21224	"6459-94-5"	"C.I. Acid Red 114"	"C6459945"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225797	1059288	802761	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302980"	21777	"83-88-5"	"Riboflavin"	"C83885"	788	"Tox21_ERa_LUC_BG1_Agonist"	258492	1195276	611037	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302980"	21777	"83-88-5"	"Riboflavin"	"C83885"	788	"Tox21_ERa_LUC_BG1_Agonist"	261451	1195276	611037	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_302986"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225108	1059297	802770	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_302986"	21977	"123-07-9"	"4-Ethylphenol"	"C123079"	788	"Tox21_ERa_LUC_BG1_Agonist"	260889	1195282	611043	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_302992"	22480	"620-17-7"	"3-Ethylphenol"	"C620177"	788	"Tox21_ERa_LUC_BG1_Agonist"	258496	1195288	611049	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_302992"	22480	"620-17-7"	"3-Ethylphenol"	"C620177"	788	"Tox21_ERa_LUC_BG1_Agonist"	261628	1195288	611049	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302993"	22436	"126-00-1"	"Diphenolic acid"	"C126001"	788	"Tox21_ERa_LUC_BG1_Agonist"	258497	1195289	611050	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302993"	22436	"126-00-1"	"Diphenolic acid"	"C126001"	788	"Tox21_ERa_LUC_BG1_Agonist"	261629	1195289	611050	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302994"	22254	"13071-79-9"	"Terbufos"	"C13071799"	788	"Tox21_ERa_LUC_BG1_Agonist"	258498	1195290	611051	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_302994"	22254	"13071-79-9"	"Terbufos"	"C13071799"	788	"Tox21_ERa_LUC_BG1_Agonist"	261454	1195290	611051	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303009"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225111	1059320	802793	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303009"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225801	1059320	802793	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303009"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	788	"Tox21_ERa_LUC_BG1_Agonist"	259648	1195305	611066	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303009"	20381	"52918-63-5"	"Deltamethrin"	"C52918635"	788	"Tox21_ERa_LUC_BG1_Agonist"	260893	1195305	611066	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303013"	21824	"97-23-4"	"Dichlorophen"	"C97234"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236830	977711	844785	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303019"	21082	"1936-15-8"	"C.I. Acid Orange 10"	"C1936158"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223960	1059330	802803	3	"Col-wise effect, decreased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_303029"	20494	"756-79-6"	"Dimethyl methylphosphonate"	"C756796"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224172	1059340	802813	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303030"	21655	"109-52-4"	"Pentanoic acid"	"C109524"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223963	1059341	802814	3	"Col-wise effect, decreased signal"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303030"	21655	"109-52-4"	"Pentanoic acid"	"C109524"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224173	1059341	802814	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303031"	20425	"117-80-6"	"Dichlone"	"C117806"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223882	1059342	802815	2	"Row-wise effect, decreased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303031"	20425	"117-80-6"	"Dichlone"	"C117806"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223964	1059342	802815	3	"Col-wise effect, decreased signal"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303031"	20425	"117-80-6"	"Dichlone"	"C117806"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224059	1059342	802815	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303031"	20425	"117-80-6"	"Dichlone"	"C117806"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224174	1059342	802815	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303031"	20425	"117-80-6"	"Dichlone"	"C117806"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225239	1059342	802815	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303036"	24274	"1918-16-7"	"Propachlor"	"C1918167"	785	"Tox21_ERa_BLA_Agonist_ratio"	202304	1100678	918291	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303038"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	785	"Tox21_ERa_BLA_Agonist_ratio"	201216	1100680	918293	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303038"	27061	"135-19-3"	"2-Naphthalenol"	"C135193"	788	"Tox21_ERa_LUC_BG1_Agonist"	260896	1195334	611095	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303044"	24255	"13684-63-4"	"Phenmedipham"	"C13684634"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225113	1059355	802828	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303044"	24255	"13684-63-4"	"Phenmedipham"	"C13684634"	788	"Tox21_ERa_LUC_BG1_Agonist"	259931	1195340	611101	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303044"	24255	"13684-63-4"	"Phenmedipham"	"C13684634"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236575	977742	844816	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303046"	24598	"118-58-1"	"Benzyl salicylate"	"C118581"	788	"Tox21_ERa_LUC_BG1_Agonist"	259650	1195342	611103	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303046"	24598	"118-58-1"	"Benzyl salicylate"	"C118581"	788	"Tox21_ERa_LUC_BG1_Agonist"	260898	1195342	611103	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303047"	24046	"311-45-5"	"Paraoxon"	"C311455"	785	"Tox21_ERa_BLA_Agonist_ratio"	202305	1100689	918302	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303047"	24046	"311-45-5"	"Paraoxon"	"C311455"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237307	977745	844819	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303047"	24046	"311-45-5"	"Paraoxon"	"C311455"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238007	977745	844819	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303050"	22934	"20830-75-5"	"Digoxin"	"C20830755"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223965	1059361	802834	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303050"	22934	"20830-75-5"	"Digoxin"	"C20830755"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225240	1059361	802834	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303050"	22934	"20830-75-5"	"Digoxin"	"C20830755"	788	"Tox21_ERa_LUC_BG1_Agonist"	259652	1195346	611107	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303050"	22934	"20830-75-5"	"Digoxin"	"C20830755"	788	"Tox21_ERa_LUC_BG1_Agonist"	260900	1195346	611107	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303053"	25003	"583-78-8"	"2,5-Dichlorophenol"	"C583788"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223966	1059364	802837	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303067"	25306	"16219-75-3"	"5-Ethylidene-2-norbornene"	"C16219753"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225114	1059378	802851	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303070"	27282	"644-97-3"	"Phenyl phosphorus dichloride"	"C644973"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236430	977768	844842	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303074"	26285	"120-14-9"	"Veratraldehyde"	"C120149"	788	"Tox21_ERa_LUC_BG1_Agonist"	259654	1195370	611131	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303074"	26285	"120-14-9"	"Veratraldehyde"	"C120149"	788	"Tox21_ERa_LUC_BG1_Agonist"	260902	1195370	611131	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303075"	25892	"90-30-2"	"N-Phenyl-1-naphthylamine"	"C90302"	785	"Tox21_ERa_BLA_Agonist_ratio"	202308	1100717	918330	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303075"	25892	"90-30-2"	"N-Phenyl-1-naphthylamine"	"C90302"	785	"Tox21_ERa_BLA_Agonist_ratio"	202831	1100717	918330	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303089"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	785	"Tox21_ERa_BLA_Agonist_ratio"	202456	1100731	918344	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303089"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	788	"Tox21_ERa_LUC_BG1_Agonist"	257761	1195385	611146	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303089"	27142	"328-84-7"	"1,2-Dichloro-4-(trifluoromethyl)benzene"	"C328847"	788	"Tox21_ERa_LUC_BG1_Agonist"	259864	1195385	611146	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303099"	27356	"1067-53-4"	"Tris(2-methoxyethoxy)vinylsilane"	"C1067534"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225115	1059410	802883	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303110"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225117	1059421	802894	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303110"	26698	"103-34-4"	"4,4'-Dithiodimorpholine"	"C103344"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225804	1059421	802894	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303111"	25857	"66-71-7"	"1,10-Phenanthroline"	"C66717"	785	"Tox21_ERa_BLA_Agonist_ratio"	202309	1100753	918366	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303112"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	788	"Tox21_ERa_LUC_BG1_Agonist"	260904	1195408	611169	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303112"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236513	977810	844884	2	"Row-wise effect, decreased signal"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303112"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236576	977810	844884	3	"Col-wise effect, decreased signal"	0.2	"proportion"	"percent_activity"
"Tox21_303112"	27292	"683-18-1"	"Dibutyltin dichloride"	"C683181"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237414	977810	844884	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303132"	25021	"84-61-7"	"Dicyclohexyl phthalate"	"C84617"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224542	1059443	802916	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303132"	25021	"84-61-7"	"Dicyclohexyl phthalate"	"C84617"	788	"Tox21_ERa_LUC_BG1_Agonist"	259656	1195428	611189	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303132"	25021	"84-61-7"	"Dicyclohexyl phthalate"	"C84617"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237309	977830	844904	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303137"	27304	"753-73-1"	"Dimethyltin dichloride"	"C753731"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225805	1059448	802921	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303138"	24049	"35367-38-5"	"Diflubenzuron"	"C35367385"	788	"Tox21_ERa_LUC_BG1_Agonist"	259657	1195434	611195	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303138"	24049	"35367-38-5"	"Diflubenzuron"	"C35367385"	788	"Tox21_ERa_LUC_BG1_Agonist"	260906	1195434	611195	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303144"	27550	"3926-62-3"	"Sodium chloroacetate"	"C3926623"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225119	1059455	802928	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303171"	26838	"110-27-0"	"Isopropyl tetradecanoic acid"	"C110270"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225121	1059482	802955	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303171"	26838	"110-27-0"	"Isopropyl tetradecanoic acid"	"C110270"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225806	1059482	802955	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303171"	26838	"110-27-0"	"Isopropyl tetradecanoic acid"	"C110270"	788	"Tox21_ERa_LUC_BG1_Agonist"	259658	1195467	611228	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303171"	26838	"110-27-0"	"Isopropyl tetradecanoic acid"	"C110270"	788	"Tox21_ERa_LUC_BG1_Agonist"	260907	1195467	611228	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303172"	24176	"126-98-7"	"Methacrylonitrile"	"C126987"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225122	1059483	802956	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303176"	27527	"3194-55-6"	"1,2,5,6,9,10-Hexabromocyclododecane"	"C3194556"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238009	977874	844948	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303184"	27540	"3622-84-2"	"N-Butylbenzenesulfonamide"	"C3622842"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224176	1059495	802968	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303184"	27540	"3622-84-2"	"N-Butylbenzenesulfonamide"	"C3622842"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225124	1059495	802968	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303184"	27540	"3622-84-2"	"N-Butylbenzenesulfonamide"	"C3622842"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237311	977882	844956	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303186"	26171	"29385-43-1"	"Tolyltriazole"	"C29385431"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224178	1059497	802970	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303187"	25101	"99-07-0"	"3-Dimethylaminophenol"	"C99070"	785	"Tox21_ERa_BLA_Agonist_ratio"	202310	1100829	918442	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303187"	25101	"99-07-0"	"3-Dimethylaminophenol"	"C99070"	788	"Tox21_ERa_LUC_BG1_Agonist"	259659	1195483	611244	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303187"	25101	"99-07-0"	"3-Dimethylaminophenol"	"C99070"	788	"Tox21_ERa_LUC_BG1_Agonist"	260909	1195483	611244	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303201"	24704	"98-51-1"	"4-tert-Butyltoluene"	"C98511"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224181	1059512	802985	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_303203"	26298	"108-38-3"	"1,3-Dimethylbenzene"	"C108383"	785	"Tox21_ERa_BLA_Agonist_ratio"	201168	1100845	918458	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303205"	26314	"13463-41-7"	"Zinc pyrithione"	"C13463417"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236431	977903	844977	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303212"	26102	"117-08-8"	"Tetrachlorophthalic anhydride"	"C117088"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223798	1059523	802996	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303212"	26102	"117-08-8"	"Tetrachlorophthalic anhydride"	"C117088"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224182	1059523	802996	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303212"	26102	"117-08-8"	"Tetrachlorophthalic anhydride"	"C117088"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225127	1059523	802996	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303212"	26102	"117-08-8"	"Tetrachlorophthalic anhydride"	"C117088"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225808	1059523	802996	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303213"	27345	"960-71-4"	"Triphenylborane"	"C960714"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225809	1059524	802997	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303214"	26789	"108-32-7"	"Propylene carbonate"	"C108327"	788	"Tox21_ERa_LUC_BG1_Agonist"	259662	1195510	611271	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303222"	25662	"122-57-6"	"Methyl styryl ketone"	"C122576"	788	"Tox21_ERa_LUC_BG1_Agonist"	260911	1195518	611279	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303228"	27433	"1760-24-3"	"N-[3-(Trimethoxysilyl)propyl]ethane-1,2-diamine"	"C1760243"	788	"Tox21_ERa_LUC_BG1_Agonist"	259664	1195524	611285	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303228"	27433	"1760-24-3"	"N-[3-(Trimethoxysilyl)propyl]ethane-1,2-diamine"	"C1760243"	788	"Tox21_ERa_LUC_BG1_Agonist"	260912	1195524	611285	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303229"	26080	"100-21-0"	"Terephthalic acid"	"C100210"	785	"Tox21_ERa_BLA_Agonist_ratio"	202311	1100871	918484	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303229"	26080	"100-21-0"	"Terephthalic acid"	"C100210"	788	"Tox21_ERa_LUC_BG1_Agonist"	258503	1195525	611286	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303232"	24586	"95-16-9"	"Benzothiazole"	"C95169"	788	"Tox21_ERa_LUC_BG1_Agonist"	258505	1195528	611289	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303232"	24586	"95-16-9"	"Benzothiazole"	"C95169"	788	"Tox21_ERa_LUC_BG1_Agonist"	259666	1195528	611289	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303232"	24586	"95-16-9"	"Benzothiazole"	"C95169"	788	"Tox21_ERa_LUC_BG1_Agonist"	260913	1195528	611289	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303234"	27414	"1563-38-8"	"2,3-Dihydro-2,2-dimethyl-7-benzofuranol"	"C1563388"	788	"Tox21_ERa_LUC_BG1_Agonist"	260914	1195530	611291	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303240"	25688	"110-91-8"	"Morpholine"	"C110918"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223800	1059551	803024	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303245"	26922	"112-60-7"	"Tetraethylene glycol"	"C112607"	788	"Tox21_ERa_LUC_BG1_Agonist"	258508	1195541	611302	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303246"	24263	"7664-38-2"	"Phosphoric acid"	"C7664382"	785	"Tox21_ERa_BLA_Agonist_ratio"	201169	1100888	918501	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303246"	24263	"7664-38-2"	"Phosphoric acid"	"C7664382"	788	"Tox21_ERa_LUC_BG1_Agonist"	258509	1195542	611303	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303246"	24263	"7664-38-2"	"Phosphoric acid"	"C7664382"	788	"Tox21_ERa_LUC_BG1_Agonist"	259933	1195542	611303	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303247"	23602	"110-15-6"	"Butanedioic acid"	"C110156"	788	"Tox21_ERa_LUC_BG1_Agonist"	258510	1195543	611304	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303253"	25292	"94-96-2"	"2-Ethyl-1,3-hexanediol"	"C94962"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223801	1059564	803037	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303253"	25292	"94-96-2"	"2-Ethyl-1,3-hexanediol"	"C94962"	788	"Tox21_ERa_LUC_BG1_Agonist"	260919	1195549	611310	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303253"	25292	"94-96-2"	"2-Ethyl-1,3-hexanediol"	"C94962"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236516	977951	845025	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303254"	27094	"142-16-5"	"Bis(2-ethylhexyl) maleate"	"C142165"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225130	1059565	803038	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303254"	27094	"142-16-5"	"Bis(2-ethylhexyl) maleate"	"C142165"	788	"Tox21_ERa_LUC_BG1_Agonist"	260920	1195550	611311	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303256"	25427	"75-86-5"	"2-Hydroxy-2-methylpropanenitrile"	"C75865"	788	"Tox21_ERa_LUC_BG1_Agonist"	258512	1195552	611313	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303256"	25427	"75-86-5"	"2-Hydroxy-2-methylpropanenitrile"	"C75865"	788	"Tox21_ERa_LUC_BG1_Agonist"	259934	1195552	611313	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303256"	25427	"75-86-5"	"2-Hydroxy-2-methylpropanenitrile"	"C75865"	788	"Tox21_ERa_LUC_BG1_Agonist"	261634	1195552	611313	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303257"	26811	"108-98-5"	"Benzenethiol"	"C108985"	788	"Tox21_ERa_LUC_BG1_Agonist"	258513	1195553	611314	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303257"	26811	"108-98-5"	"Benzenethiol"	"C108985"	788	"Tox21_ERa_LUC_BG1_Agonist"	261455	1195553	611314	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303259"	27246	"616-45-5"	"2-Pyrrolidinone"	"C616455"	785	"Tox21_ERa_BLA_Agonist_ratio"	202313	1100901	918514	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303259"	27246	"616-45-5"	"2-Pyrrolidinone"	"C616455"	785	"Tox21_ERa_BLA_Agonist_ratio"	202832	1100901	918514	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303259"	27246	"616-45-5"	"2-Pyrrolidinone"	"C616455"	788	"Tox21_ERa_LUC_BG1_Agonist"	258515	1195555	611316	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303269"	24284	"107-98-2"	"1-Methoxy-2-propanol"	"C107982"	788	"Tox21_ERa_LUC_BG1_Agonist"	258517	1195565	611326	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303271"	24834	"14371-10-9"	"(2E)-3-Phenylprop-2-enal"	"C14371109"	788	"Tox21_ERa_LUC_BG1_Agonist"	258519	1195567	611328	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303271"	24834	"14371-10-9"	"(2E)-3-Phenylprop-2-enal"	"C14371109"	788	"Tox21_ERa_LUC_BG1_Agonist"	261635	1195567	611328	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303273"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	785	"Tox21_ERa_BLA_Agonist_ratio"	202315	1100915	918528	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303273"	27461	"2231-57-4"	"Thiocarbazide"	"C2231574"	788	"Tox21_ERa_LUC_BG1_Agonist"	258521	1195569	611330	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303282"	27258	"625-55-8"	"Isopropyl formate"	"C625558"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223803	1059593	803066	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303282"	27258	"625-55-8"	"Isopropyl formate"	"C625558"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225132	1059593	803066	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303282"	27258	"625-55-8"	"Isopropyl formate"	"C625558"	788	"Tox21_ERa_LUC_BG1_Agonist"	260925	1195578	611339	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303286"	26799	"108-77-0"	"2,4,6-Trichloro-s-triazine"	"C108770"	785	"Tox21_ERa_BLA_Agonist_ratio"	202316	1100928	918541	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303286"	26799	"108-77-0"	"2,4,6-Trichloro-s-triazine"	"C108770"	788	"Tox21_ERa_LUC_BG1_Agonist"	258526	1195582	611343	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303287"	25478	"108-21-4"	"Isopropyl acetate"	"C108214"	788	"Tox21_ERa_LUC_BG1_Agonist"	258527	1195583	611344	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303296"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223804	1059607	803080	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303296"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225133	1059607	803080	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303296"	24676	"141-32-2"	"Butyl acrylate"	"C141322"	788	"Tox21_ERa_LUC_BG1_Agonist"	259670	1195592	611353	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303298"	27036	"126-30-7"	"2,2-Dimethylpropane-1,3-diol"	"C126307"	785	"Tox21_ERa_BLA_Agonist_ratio"	202317	1100940	918553	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303298"	27036	"126-30-7"	"2,2-Dimethylpropane-1,3-diol"	"C126307"	785	"Tox21_ERa_BLA_Agonist_ratio"	202834	1100940	918553	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303298"	27036	"126-30-7"	"2,2-Dimethylpropane-1,3-diol"	"C126307"	788	"Tox21_ERa_LUC_BG1_Agonist"	258530	1195594	611355	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303301"	26647	"99-96-7"	"4-Hydroxybenzoic acid"	"C99967"	788	"Tox21_ERa_LUC_BG1_Agonist"	260927	1195597	611358	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303304"	26879	"111-49-9"	"Hexamethyleneimine"	"C111499"	788	"Tox21_ERa_LUC_BG1_Agonist"	260929	1195600	611361	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303305"	27153	"460-00-4"	"1-Bromo-4-fluorobenzene"	"C460004"	788	"Tox21_ERa_LUC_BG1_Agonist"	260930	1195601	611362	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303309"	26706	"104-66-5"	"1,2-Diphenoxyethane"	"C104665"	788	"Tox21_ERa_LUC_BG1_Agonist"	259673	1195605	611366	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303309"	26706	"104-66-5"	"1,2-Diphenoxyethane"	"C104665"	788	"Tox21_ERa_LUC_BG1_Agonist"	260932	1195605	611366	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303313"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	785	"Tox21_ERa_BLA_Agonist_ratio"	202318	1100955	918568	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303313"	25300	"1241-94-7"	"2-Ethylhexyl diphenyl phosphate"	"C1241947"	788	"Tox21_ERa_LUC_BG1_Agonist"	260934	1195609	611370	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303315"	24624	"1675-54-3"	"Bisphenol A diglycidyl ether"	"C1675543"	788	"Tox21_ERa_LUC_BG1_Agonist"	259674	1195611	611372	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303315"	24624	"1675-54-3"	"Bisphenol A diglycidyl ether"	"C1675543"	788	"Tox21_ERa_LUC_BG1_Agonist"	260936	1195611	611372	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303318"	26694	"103-09-3"	"2-Ethylhexyl acetate"	"C103093"	788	"Tox21_ERa_LUC_BG1_Agonist"	260938	1195614	611375	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303322"	25506	"463-40-1"	"Linolenic acid"	"C463401"	785	"Tox21_ERa_BLA_Agonist_ratio"	202319	1100964	918577	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303322"	25506	"463-40-1"	"Linolenic acid"	"C463401"	788	"Tox21_ERa_LUC_BG1_Agonist"	259865	1195618	611379	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303325"	26118	"119-64-2"	"Tetralin"	"C119642"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223806	1059636	803109	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303325"	26118	"119-64-2"	"Tetralin"	"C119642"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223886	1059636	803109	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303325"	26118	"119-64-2"	"Tetralin"	"C119642"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225134	1059636	803109	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303326"	25291	"123-05-7"	"2-Ethylhexanal"	"C123057"	788	"Tox21_ERa_LUC_BG1_Agonist"	260940	1195622	611383	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303328"	25102	"109-55-7"	"3-(Dimethylamino)propylamine"	"C109557"	788	"Tox21_ERa_LUC_BG1_Agonist"	260942	1195624	611385	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303334"	25864	"156-43-4"	"4-Ethoxyaniline"	"C156434"	788	"Tox21_ERa_LUC_BG1_Agonist"	260943	1195630	611391	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303344"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225135	1059655	803128	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303344"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225811	1059655	803128	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303344"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237313	978042	845116	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303344"	48507	"NOCAS_48507"	"PharmaGSID_48507"	"CNOCAS48507"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238011	978042	845116	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303346"	25816	"144-62-7"	"Oxalic acid"	"C144627"	788	"Tox21_ERa_LUC_BG1_Agonist"	260944	1195642	611403	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303349"	48174	"174185-16-1"	"FR167356"	"C174185161"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237314	978047	845121	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303352"	48506	"588941-45-1"	"PharmaGSID_48506"	"C588941451"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224545	1059663	803136	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303352"	48506	"588941-45-1"	"PharmaGSID_48506"	"C588941451"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238012	978050	845124	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303353"	48181	"769-92-6"	"4-tert-Butylaniline"	"C769926"	788	"Tox21_ERa_LUC_BG1_Agonist"	258626	1195649	611410	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303354"	25429	"6088-51-3"	"6-Hydroxy-2-naphthyl disulfide"	"C6088513"	785	"Tox21_ERa_BLA_Agonist_ratio"	202480	1100996	918609	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303357"	48199	"4344-55-2"	"4-Butyloxyaniline"	"C4344552"	785	"Tox21_ERa_BLA_Agonist_ratio"	203234	1100998	918611	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303358"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	785	"Tox21_ERa_BLA_Agonist_ratio"	200705	1100999	918612	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303358"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	785	"Tox21_ERa_BLA_Agonist_ratio"	202457	1100999	918612	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303358"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	785	"Tox21_ERa_BLA_Agonist_ratio"	203235	1100999	918612	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303358"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225242	1059668	803141	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303358"	38864	"88-24-4"	"2,2'-Methylenebis(ethyl-6-tert-butylphenol)"	"C88244"	788	"Tox21_ERa_LUC_BG1_Agonist"	257885	1195653	611414	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303359"	29572	"98730-04-2"	"Benoxacor"	"C98730042"	785	"Tox21_ERa_BLA_Agonist_ratio"	202320	1101000	918613	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303359"	29572	"98730-04-2"	"Benoxacor"	"C98730042"	785	"Tox21_ERa_BLA_Agonist_ratio"	203236	1101000	918613	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303359"	29572	"98730-04-2"	"Benoxacor"	"C98730042"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225136	1059669	803142	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303359"	29572	"98730-04-2"	"Benoxacor"	"C98730042"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238013	978056	845130	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303360"	27926	"27193-86-8"	"Dodecylphenol"	"C27193868"	785	"Tox21_ERa_BLA_Agonist_ratio"	200706	1101001	918614	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303360"	27926	"27193-86-8"	"Dodecylphenol"	"C27193868"	785	"Tox21_ERa_BLA_Agonist_ratio"	203237	1101001	918614	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303360"	27926	"27193-86-8"	"Dodecylphenol"	"C27193868"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223968	1059670	803143	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303363"	20768	"520-18-3"	"Kaempferol"	"C520183"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224546	1059672	803145	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303367"	25886	"121-39-1"	"Ethyl 3-phenylglycidate"	"C121391"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237315	978063	845137	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303367"	25886	"121-39-1"	"Ethyl 3-phenylglycidate"	"C121391"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238014	978063	845137	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303370"	30606	"55589-62-3"	"Acesulfame potassium"	"C55589623"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225137	1059679	803152	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303391"	25226	"24169-02-6"	"Econazole nitrate"	"C24169026"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224547	1059697	803170	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303392"	27721	"10081-67-1"	"4-(2-Phenylpropan-2-yl)-N-[4-(2-phenylpropan-2-yl)phenyl]aniline"	"C10081671"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238015	978085	845159	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303397"	29262	"4130-42-1"	"2,6-Di-tert-butyl-4-ethylphenol"	"C4130421"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237316	978090	845164	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303406"	32518	"1192-52-5"	"4,5-Dichloro-3H-1,2-dithiol-3-one"	"C1192525"	785	"Tox21_ERa_BLA_Agonist_ratio"	202835	1101042	918655	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303406"	32518	"1192-52-5"	"4,5-Dichloro-3H-1,2-dithiol-3-one"	"C1192525"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225812	1059711	803184	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303407"	48519	"686756-87-6"	"PharmaGSID_48519"	"C686756876"	785	"Tox21_ERa_BLA_Agonist_ratio"	202322	1101043	918656	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303407"	48519	"686756-87-6"	"PharmaGSID_48519"	"C686756876"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224548	1059712	803185	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303407"	48519	"686756-87-6"	"PharmaGSID_48519"	"C686756876"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236835	978099	845173	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303411"	48184	"2919-66-6"	"Melengestrol acetate"	"C2919666"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225813	1059716	803189	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303411"	48184	"2919-66-6"	"Melengestrol acetate"	"C2919666"	788	"Tox21_ERa_LUC_BG1_Agonist"	259676	1195701	611462	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303423"	32559	"91465-08-6"	"lambda-Cyhalothrin"	"C91465086"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225140	1059728	803201	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303423"	32559	"91465-08-6"	"lambda-Cyhalothrin"	"C91465086"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225814	1059728	803201	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303430"	47957	"1219-38-1"	"Octylparaben"	"C1219381"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224550	1059735	803208	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303433"	41141	"129298-91-5"	"TNP-470"	"C129298915"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225141	1059738	803211	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303433"	41141	"129298-91-5"	"TNP-470"	"C129298915"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225815	1059738	803211	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303433"	41141	"129298-91-5"	"TNP-470"	"C129298915"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225997	1059738	803211	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303433"	41141	"129298-91-5"	"TNP-470"	"C129298915"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237318	978125	845199	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303439"	25055	"122-62-3"	"Bis(2-ethylhexyl) decanedioate"	"C122623"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225142	1059743	803216	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303441"	48176	"NOCAS_48176"	"YM218"	"CNOCAS48176"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225143	1059745	803218	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303444"	21356	"52225-20-4"	"dl-alpha-Tocopheryl acetate"	"C52225204"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225144	1059748	803221	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303444"	21356	"52225-20-4"	"dl-alpha-Tocopheryl acetate"	"C52225204"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225816	1059748	803221	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303446"	21856	"104-13-2"	"4-Butylaniline"	"C104132"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225145	1059750	803223	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303446"	21856	"104-13-2"	"4-Butylaniline"	"C104132"	788	"Tox21_ERa_LUC_BG1_Agonist"	260945	1195735	611496	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303449"	33161	"1646-87-3"	"Aldicarb sulfoxide"	"C1646873"	785	"Tox21_ERa_BLA_Agonist_ratio"	202323	1101084	918697	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303458"	22523	"1085-12-7"	"Heptylparaben"	"C1085127"	785	"Tox21_ERa_BLA_Agonist_ratio"	202481	1101093	918706	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303458"	22523	"1085-12-7"	"Heptylparaben"	"C1085127"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224551	1059762	803235	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303462"	28665	"68515-48-0"	"DINP branched"	"C68515480"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225146	1059766	803239	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303471"	48195	"18979-55-0"	"4-(Hexyloxy)phenol"	"C18979550"	785	"Tox21_ERa_BLA_Agonist_ratio"	202324	1101106	918719	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303471"	48195	"18979-55-0"	"4-(Hexyloxy)phenol"	"C18979550"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224552	1059775	803248	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303472"	21175	"9005-65-6"	"Polysorbate 80"	"C9005656"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224183	1059776	803249	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303472"	21175	"9005-65-6"	"Polysorbate 80"	"C9005656"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225147	1059776	803249	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303472"	21175	"9005-65-6"	"Polysorbate 80"	"C9005656"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225817	1059776	803249	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303473"	48206	"79098-20-7"	"4-Chloropentylbenzene"	"C79098207"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224184	1059777	803250	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303473"	48206	"79098-20-7"	"4-Chloropentylbenzene"	"C79098207"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225148	1059777	803250	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303474"	48170	"149413-74-1"	"FR150011"	"C149413741"	785	"Tox21_ERa_BLA_Agonist_ratio"	200578	1101109	918722	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303474"	48170	"149413-74-1"	"FR150011"	"C149413741"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224185	1059778	803251	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303474"	48170	"149413-74-1"	"FR150011"	"C149413741"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238016	978165	845239	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303475"	27713	"9004-96-0"	"Polyoxyethylene monoleate"	"C9004960"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225149	1059779	803252	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303475"	27713	"9004-96-0"	"Polyoxyethylene monoleate"	"C9004960"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225818	1059779	803252	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303476"	48211	"94-08-6"	"Ethyl 4-methylbenzoate"	"C94086"	785	"Tox21_ERa_BLA_Agonist_ratio"	203238	1101111	918724	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303477"	23159	"96-83-3"	"Iopanoic acid"	"C96833"	788	"Tox21_ERa_LUC_BG1_Agonist"	259935	1195766	611527	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303480"	48185	"41372-20-7"	"Apomorphine hydrochloride hydrate"	"C41372207"	785	"Tox21_ERa_BLA_Agonist_ratio"	202838	1101114	918727	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303486"	27656	"7659-86-1"	"2-Ethylhexyl sulfanylacetate"	"C7659861"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224188	1059789	803262	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303486"	27656	"7659-86-1"	"2-Ethylhexyl sulfanylacetate"	"C7659861"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225150	1059789	803262	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303486"	27656	"7659-86-1"	"2-Ethylhexyl sulfanylacetate"	"C7659861"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225820	1059789	803262	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303487"	48189	"1166-52-5"	"Dodecyl gallate"	"C1166525"	785	"Tox21_ERa_BLA_Agonist_ratio"	200579	1101121	918734	1	"Row-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303487"	48189	"1166-52-5"	"Dodecyl gallate"	"C1166525"	785	"Tox21_ERa_BLA_Agonist_ratio"	201217	1101121	918734	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303487"	48189	"1166-52-5"	"Dodecyl gallate"	"C1166525"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224189	1059790	803263	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303487"	48189	"1166-52-5"	"Dodecyl gallate"	"C1166525"	786	"Tox21_ERa_BLA_Antagonist_ratio"	226000	1059790	803263	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303497"	22589	"125-84-8"	"Aminoglutethimide"	"C125848"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224190	1059799	803272	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303497"	22589	"125-84-8"	"Aminoglutethimide"	"C125848"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225151	1059799	803272	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303497"	22589	"125-84-8"	"Aminoglutethimide"	"C125848"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225822	1059799	803272	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303497"	22589	"125-84-8"	"Aminoglutethimide"	"C125848"	788	"Tox21_ERa_LUC_BG1_Agonist"	260946	1195784	611545	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303498"	41970	"1632-73-1"	"Fenchol"	"C1632731"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224191	1059800	803273	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303499"	48172	"NOCAS_48172"	"PharmaGSID_48172"	"CNOCAS48172"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224192	1059801	803274	5	"Includes potential flare region points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_303499"	48172	"NOCAS_48172"	"PharmaGSID_48172"	"CNOCAS48172"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225823	1059801	803274	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303499"	48172	"NOCAS_48172"	"PharmaGSID_48172"	"CNOCAS48172"	788	"Tox21_ERa_LUC_BG1_Agonist"	261459	1195786	611547	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303499"	48172	"NOCAS_48172"	"PharmaGSID_48172"	"CNOCAS48172"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236837	978188	845262	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303499"	48172	"NOCAS_48172"	"PharmaGSID_48172"	"CNOCAS48172"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237453	978188	845262	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303501"	21087	"604-75-1"	"Oxazepam"	"C604751"	788	"Tox21_ERa_LUC_BG1_Agonist"	258534	1195788	611549	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303504"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	785	"Tox21_ERa_BLA_Agonist_ratio"	203134	1101137	918750	13	"Includes potential chemical plate interlace points"	0.244444444444444	"proportion"	"percent_activity"
"Tox21_303504"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224553	1059806	803279	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303504"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	788	"Tox21_ERa_LUC_BG1_Agonist"	261463	1195791	611552	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_303504"	48168	"129299-90-7"	"Fabesetron hydrochloride"	"C129299907"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236838	978193	845267	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303510"	21460	"17924-92-4"	"Zearalenone"	"C17924924"	788	"Tox21_ERa_LUC_BG1_Agonist"	257886	1195797	611558	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303511"	29124	"95-93-2"	"1,2,4,5-Tetramethylbenzene"	"C95932"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225825	1059813	803286	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303511"	29124	"95-93-2"	"1,2,4,5-Tetramethylbenzene"	"C95932"	788	"Tox21_ERa_LUC_BG1_Agonist"	260947	1195798	611559	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303513"	25143	"526-75-0"	"2,3-Dimethylphenol"	"C526750"	788	"Tox21_ERa_LUC_BG1_Agonist"	260948	1195800	611561	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303513"	25143	"526-75-0"	"2,3-Dimethylphenol"	"C526750"	788	"Tox21_ERa_LUC_BG1_Agonist"	261466	1195800	611561	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303517"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	785	"Tox21_ERa_BLA_Agonist_ratio"	201171	1101150	918763	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303517"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	785	"Tox21_ERa_BLA_Agonist_ratio"	203136	1101150	918763	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_303517"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225294	1059819	803292	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303517"	48505	"NOCAS_48505"	"PharmaGSID_48505"	"CNOCAS48505"	788	"Tox21_ERa_LUC_BG1_Agonist"	261468	1195804	611565	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303518"	48511	"1062243-51-9"	"PharmaGSID_48511"	"C1062243519"	785	"Tox21_ERa_BLA_Agonist_ratio"	202326	1101151	918764	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303518"	48511	"1062243-51-9"	"PharmaGSID_48511"	"C1062243519"	785	"Tox21_ERa_BLA_Agonist_ratio"	203102	1101151	918764	13	"Includes potential chemical plate interlace points"	0.311111111111111	"proportion"	"percent_activity"
"Tox21_303518"	48511	"1062243-51-9"	"PharmaGSID_48511"	"C1062243519"	788	"Tox21_ERa_LUC_BG1_Agonist"	261469	1195805	611566	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303521"	47633	"111-62-6"	"Ethyl oleate"	"C111626"	785	"Tox21_ERa_BLA_Agonist_ratio"	203185	1101153	918766	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303525"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	788	"Tox21_ERa_LUC_BG1_Agonist"	259678	1195811	611572	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303525"	37262	"1434-54-4"	"Pregnenolone carbonitrile"	"C1434544"	788	"Tox21_ERa_LUC_BG1_Agonist"	260949	1195811	611572	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303526"	27877	"25550-98-5"	"Diisodecylphenyl phosphite"	"C25550985"	788	"Tox21_ERa_LUC_BG1_Agonist"	259679	1195812	611573	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303529"	48204	"70568-60-4"	"4-Butylcyclohexanol"	"C70568604"	785	"Tox21_ERa_BLA_Agonist_ratio"	203186	1101161	918774	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303529"	48204	"70568-60-4"	"4-Butylcyclohexanol"	"C70568604"	788	"Tox21_ERa_LUC_BG1_Agonist"	258538	1195815	611576	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303529"	48204	"70568-60-4"	"4-Butylcyclohexanol"	"C70568604"	788	"Tox21_ERa_LUC_BG1_Agonist"	261323	1195815	611576	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303530"	27868	"25360-10-5"	"tert-Nonanethiol"	"C25360105"	788	"Tox21_ERa_LUC_BG1_Agonist"	258539	1195816	611577	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303530"	27868	"25360-10-5"	"tert-Nonanethiol"	"C25360105"	788	"Tox21_ERa_LUC_BG1_Agonist"	259680	1195816	611577	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303530"	27868	"25360-10-5"	"tert-Nonanethiol"	"C25360105"	788	"Tox21_ERa_LUC_BG1_Agonist"	260950	1195816	611577	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303530"	27868	"25360-10-5"	"tert-Nonanethiol"	"C25360105"	788	"Tox21_ERa_LUC_BG1_Agonist"	261472	1195816	611577	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303533"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	785	"Tox21_ERa_BLA_Agonist_ratio"	203137	1101164	918777	13	"Includes potential chemical plate interlace points"	0.222222222222222	"proportion"	"percent_activity"
"Tox21_303533"	26259	"13674-84-5"	"Tris(2-chloroisopropyl)phosphate"	"C13674845"	788	"Tox21_ERa_LUC_BG1_Agonist"	261324	1195818	611579	13	"Includes potential chemical plate interlace points"	0.222222222222222	"proportion"	"percent_activity"
"Tox21_303535"	27837	"24800-44-0"	"Tripropylene glycol"	"C24800440"	785	"Tox21_ERa_BLA_Agonist_ratio"	203139	1101166	918779	13	"Includes potential chemical plate interlace points"	0.222222222222222	"proportion"	"percent_activity"
"Tox21_303535"	27837	"24800-44-0"	"Tripropylene glycol"	"C24800440"	788	"Tox21_ERa_LUC_BG1_Agonist"	261474	1195820	611581	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303538"	48516	"NOCAS_48516"	"PharmaGSID_48516"	"CNOCAS48516"	788	"Tox21_ERa_LUC_BG1_Agonist"	259681	1195823	611584	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303540"	30060	"594-20-7"	"2,2-Dichloropropane"	"C594207"	788	"Tox21_ERa_LUC_BG1_Agonist"	258541	1195825	611586	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303540"	30060	"594-20-7"	"2,2-Dichloropropane"	"C594207"	788	"Tox21_ERa_LUC_BG1_Agonist"	260952	1195825	611586	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303540"	30060	"594-20-7"	"2,2-Dichloropropane"	"C594207"	788	"Tox21_ERa_LUC_BG1_Agonist"	261475	1195825	611586	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303543"	48194	"1671-75-6"	"Heptanophenone"	"C1671756"	788	"Tox21_ERa_LUC_BG1_Agonist"	258544	1195828	611589	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303543"	48194	"1671-75-6"	"Heptanophenone"	"C1671756"	788	"Tox21_ERa_LUC_BG1_Agonist"	261478	1195828	611589	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303544"	45232	"51-24-1"	"Tiratricol"	"C51241"	785	"Tox21_ERa_BLA_Agonist_ratio"	202328	1101175	918788	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303544"	45232	"51-24-1"	"Tiratricol"	"C51241"	785	"Tox21_ERa_BLA_Agonist_ratio"	203240	1101175	918788	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303544"	45232	"51-24-1"	"Tiratricol"	"C51241"	788	"Tox21_ERa_LUC_BG1_Agonist"	258545	1195829	611590	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303544"	45232	"51-24-1"	"Tiratricol"	"C51241"	788	"Tox21_ERa_LUC_BG1_Agonist"	261479	1195829	611590	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303545"	27875	"25496-72-4"	"Glyceryl monooleate"	"C25496724"	785	"Tox21_ERa_BLA_Agonist_ratio"	203188	1101176	918789	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303545"	27875	"25496-72-4"	"Glyceryl monooleate"	"C25496724"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225153	1059845	803318	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303545"	27875	"25496-72-4"	"Glyceryl monooleate"	"C25496724"	788	"Tox21_ERa_LUC_BG1_Agonist"	260954	1195830	611591	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303545"	27875	"25496-72-4"	"Glyceryl monooleate"	"C25496724"	788	"Tox21_ERa_LUC_BG1_Agonist"	261326	1195830	611591	13	"Includes potential chemical plate interlace points"	0.2	"proportion"	"percent_activity"
"Tox21_303549"	48191	"13680-35-8"	"4,4'-Methylenebis(2,6-diethylaniline)"	"C13680358"	785	"Tox21_ERa_BLA_Agonist_ratio"	203241	1101179	918792	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303552"	27833	"24549-06-2"	"2-Ethyl-6-methylaniline"	"C24549062"	785	"Tox21_ERa_BLA_Agonist_ratio"	202329	1101182	918795	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303552"	27833	"24549-06-2"	"2-Ethyl-6-methylaniline"	"C24549062"	788	"Tox21_ERa_LUC_BG1_Agonist"	258546	1195836	611597	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303554"	48178	"136042-19-8"	"FR130739"	"C136042198"	788	"Tox21_ERa_LUC_BG1_Agonist"	258548	1195838	611599	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303554"	48178	"136042-19-8"	"FR130739"	"C136042198"	788	"Tox21_ERa_LUC_BG1_Agonist"	260956	1195838	611599	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303554"	48178	"136042-19-8"	"FR130739"	"C136042198"	788	"Tox21_ERa_LUC_BG1_Agonist"	261480	1195838	611599	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303555"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	785	"Tox21_ERa_BLA_Agonist_ratio"	202330	1101185	918798	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303555"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	785	"Tox21_ERa_BLA_Agonist_ratio"	202839	1101185	918798	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303555"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	788	"Tox21_ERa_LUC_BG1_Agonist"	258549	1195839	611600	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303555"	48183	"78473-71-9"	"Enterolactone"	"C78473719"	788	"Tox21_ERa_LUC_BG1_Agonist"	261481	1195839	611600	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303556"	34997	"81741-28-8"	"Tributyltetradecylphosphonium chloride"	"C81741288"	788	"Tox21_ERa_LUC_BG1_Agonist"	258550	1195840	611601	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303556"	34997	"81741-28-8"	"Tributyltetradecylphosphonium chloride"	"C81741288"	788	"Tox21_ERa_LUC_BG1_Agonist"	261482	1195840	611601	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303557"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	785	"Tox21_ERa_BLA_Agonist_ratio"	202331	1101187	918800	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303557"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225154	1059856	803329	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303557"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225826	1059856	803329	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303557"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	788	"Tox21_ERa_LUC_BG1_Agonist"	258551	1195841	611602	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303557"	48196	"2396-68-1"	"4-tert-Butylbenzenethiol"	"C2396681"	788	"Tox21_ERa_LUC_BG1_Agonist"	261483	1195841	611602	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303558"	42061	"125-12-2"	"Isobornyl acetate"	"C125122"	788	"Tox21_ERa_LUC_BG1_Agonist"	260957	1195842	611603	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303558"	42061	"125-12-2"	"Isobornyl acetate"	"C125122"	788	"Tox21_ERa_LUC_BG1_Agonist"	261484	1195842	611603	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303560"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	785	"Tox21_ERa_BLA_Agonist_ratio"	203242	1101190	918803	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303560"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	788	"Tox21_ERa_LUC_BG1_Agonist"	261329	1195844	611605	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303560"	22678	"90357-06-5"	"Bicalutamide"	"C90357065"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238019	978246	845320	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303561"	48193	"1625-91-8"	"4,4'-Di-tert-butylbiphenyl"	"C1625918"	785	"Tox21_ERa_BLA_Agonist_ratio"	203243	1101191	918804	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303562"	29154	"120-92-3"	"Cyclopentanone"	"C120923"	785	"Tox21_ERa_BLA_Agonist_ratio"	203244	1101192	918805	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303564"	48209	"938-16-9"	"tert-Butyl phenyl ketone"	"C938169"	785	"Tox21_ERa_BLA_Agonist_ratio"	202332	1101194	918807	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303564"	48209	"938-16-9"	"tert-Butyl phenyl ketone"	"C938169"	785	"Tox21_ERa_BLA_Agonist_ratio"	202840	1101194	918807	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303564"	48209	"938-16-9"	"tert-Butyl phenyl ketone"	"C938169"	788	"Tox21_ERa_LUC_BG1_Agonist"	258552	1195848	611609	5	"Includes potential flare region points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303566"	22411	"118-82-1"	"4,4'-Methylenebis(2,6-di-t-butylphenol)"	"C118821"	788	"Tox21_ERa_LUC_BG1_Agonist"	258554	1195850	611611	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303566"	22411	"118-82-1"	"4,4'-Methylenebis(2,6-di-t-butylphenol)"	"C118821"	788	"Tox21_ERa_LUC_BG1_Agonist"	261639	1195850	611611	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303568"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	785	"Tox21_ERa_BLA_Agonist_ratio"	202334	1101198	918811	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303568"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	788	"Tox21_ERa_LUC_BG1_Agonist"	258556	1195852	611613	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303568"	22607	"120511-73-1"	"Anastrozole"	"C120511731"	788	"Tox21_ERa_LUC_BG1_Agonist"	261486	1195852	611613	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303569"	30307	"626-43-7"	"3,5-Dichloroaniline"	"C626437"	788	"Tox21_ERa_LUC_BG1_Agonist"	258557	1195853	611614	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303569"	30307	"626-43-7"	"3,5-Dichloroaniline"	"C626437"	788	"Tox21_ERa_LUC_BG1_Agonist"	261487	1195853	611614	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303570"	22408	"143-74-8"	"Phenol red"	"C143748"	788	"Tox21_ERa_LUC_BG1_Agonist"	261640	1195854	611615	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303571"	27756	"13826-35-2"	"3-Phenoxybenzenemethanol"	"C13826352"	785	"Tox21_ERa_BLA_Agonist_ratio"	201218	1101201	918814	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303571"	27756	"13826-35-2"	"3-Phenoxybenzenemethanol"	"C13826352"	788	"Tox21_ERa_LUC_BG1_Agonist"	261641	1195855	611616	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303572"	23202	"112809-51-5"	"Letrozole"	"C112809515"	785	"Tox21_ERa_BLA_Agonist_ratio"	203245	1101202	918815	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303572"	23202	"112809-51-5"	"Letrozole"	"C112809515"	788	"Tox21_ERa_LUC_BG1_Agonist"	261330	1195856	611617	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_303573"	26943	"115-77-5"	"Pentaerythritol"	"C115775"	785	"Tox21_ERa_BLA_Agonist_ratio"	203246	1101203	918816	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303574"	29320	"21245-02-3"	"2-Ethylhexyl 4-(dimethylamino)benzoate"	"C21245023"	785	"Tox21_ERa_BLA_Agonist_ratio"	202335	1101204	918817	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303576"	48512	"107071-66-9"	"Ro 23-7637"	"C107071669"	788	"Tox21_ERa_LUC_BG1_Agonist"	258559	1195860	611621	5	"Includes potential flare region points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303576"	48512	"107071-66-9"	"Ro 23-7637"	"C107071669"	788	"Tox21_ERa_LUC_BG1_Agonist"	261488	1195860	611621	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303577"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	788	"Tox21_ERa_LUC_BG1_Agonist"	258560	1195861	611622	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303577"	37745	"87-18-3"	"4-tert-Butylphenyl salicylate"	"C87183"	788	"Tox21_ERa_LUC_BG1_Agonist"	261489	1195861	611622	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303578"	27479	"2440-22-4"	"2-(2H-Benzotriazol-2-yl)-4-methylphenol"	"C2440224"	785	"Tox21_ERa_BLA_Agonist_ratio"	202336	1101208	918821	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303578"	27479	"2440-22-4"	"2-(2H-Benzotriazol-2-yl)-4-methylphenol"	"C2440224"	788	"Tox21_ERa_LUC_BG1_Agonist"	261490	1195862	611623	13	"Includes potential chemical plate interlace points"	0.177777777777778	"proportion"	"percent_activity"
"Tox21_303578"	27479	"2440-22-4"	"2-(2H-Benzotriazol-2-yl)-4-methylphenol"	"C2440224"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237417	978264	845338	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303582"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	785	"Tox21_ERa_BLA_Agonist_ratio"	203190	1101212	918825	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303582"	21770	"79-95-8"	"2,2',6,6'-Tetrachlorobisphenol A"	"C79958"	788	"Tox21_ERa_LUC_BG1_Agonist"	261331	1195866	611627	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303583"	29210	"1118-46-3"	"Butyltin trichloride"	"C1118463"	785	"Tox21_ERa_BLA_Agonist_ratio"	203191	1101213	918826	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303583"	29210	"1118-46-3"	"Butyltin trichloride"	"C1118463"	788	"Tox21_ERa_LUC_BG1_Agonist"	261332	1195867	611628	13	"Includes potential chemical plate interlace points"	0.133333333333333	"proportion"	"percent_activity"
"Tox21_303586"	48518	"NOCAS_48518"	"PharmaGSID_48518"	"CNOCAS48518"	785	"Tox21_ERa_BLA_Agonist_ratio"	202842	1101216	918829	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303586"	48518	"NOCAS_48518"	"PharmaGSID_48518"	"CNOCAS48518"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237418	978272	845346	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303587"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	785	"Tox21_ERa_BLA_Agonist_ratio"	202337	1101217	918830	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303587"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	788	"Tox21_ERa_LUC_BG1_Agonist"	258562	1195871	611632	5	"Includes potential flare region points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303587"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	788	"Tox21_ERa_LUC_BG1_Agonist"	260960	1195871	611632	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303587"	20409	"53-70-3"	"Dibenz(a,h)anthracene"	"C53703"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237320	978273	845347	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303591"	29290	"7785-26-4"	"(-)-alpha-Pinene"	"C7785264"	788	"Tox21_ERa_LUC_BG1_Agonist"	261645	1195875	611636	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303592"	29698	"7775-27-1"	"Sodium persulfate"	"C7775271"	788	"Tox21_ERa_LUC_BG1_Agonist"	261646	1195876	611637	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303595"	48210	"93-99-2"	"Phenyl benzoate"	"C93992"	785	"Tox21_ERa_BLA_Agonist_ratio"	203192	1101225	918838	13	"Includes potential chemical plate interlace points"	0.155555555555556	"proportion"	"percent_activity"
"Tox21_303596"	27793	"17796-82-6"	"N-(Cyclohexylthio)phthalimide"	"C17796826"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223887	1059895	803368	2	"Row-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303596"	27793	"17796-82-6"	"N-(Cyclohexylthio)phthalimide"	"C17796826"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224554	1059895	803368	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303596"	27793	"17796-82-6"	"N-(Cyclohexylthio)phthalimide"	"C17796826"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225295	1059895	803368	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_303596"	27793	"17796-82-6"	"N-(Cyclohexylthio)phthalimide"	"C17796826"	786	"Tox21_ERa_BLA_Antagonist_ratio"	226005	1059895	803368	16	"Hit-call potentially confounded by overfitting"	NA	NA	"percent_activity"
"Tox21_303596"	27793	"17796-82-6"	"N-(Cyclohexylthio)phthalimide"	"C17796826"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237321	978282	845356	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303596"	27793	"17796-82-6"	"N-(Cyclohexylthio)phthalimide"	"C17796826"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238020	978282	845356	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303599"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	785	"Tox21_ERa_BLA_Agonist_ratio"	202338	1101229	918842	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303599"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	785	"Tox21_ERa_BLA_Agonist_ratio"	202843	1101229	918842	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303599"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225892	1059898	803371	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303599"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	788	"Tox21_ERa_LUC_BG1_Agonist"	259688	1195883	611644	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303599"	22446	"2467-02-9"	"Bisphenol F"	"C2467029"	788	"Tox21_ERa_LUC_BG1_Agonist"	260962	1195883	611644	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303600"	29661	"3452-97-9"	"3,5,5-Trimethyl-1-hexanol"	"C3452979"	788	"Tox21_ERa_LUC_BG1_Agonist"	260963	1195884	611645	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303601"	48513	"825643-57-0"	"PharmaGSID_48513"	"C825643570"	785	"Tox21_ERa_BLA_Agonist_ratio"	201220	1101231	918844	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303601"	48513	"825643-57-0"	"PharmaGSID_48513"	"C825643570"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236840	978287	845361	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303602"	29133	"99-93-4"	"4-Hydroxyacetophenone"	"C99934"	788	"Tox21_ERa_LUC_BG1_Agonist"	260964	1195886	611647	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303603"	21639	"124-19-6"	"Nonanal"	"C124196"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225155	1059902	803375	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303603"	21639	"124-19-6"	"Nonanal"	"C124196"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225865	1059902	803375	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303610"	41188	"705-60-2"	"(2-Nitro-1-propenyl)benzene"	"C705602"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224064	1059909	803382	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303610"	41188	"705-60-2"	"(2-Nitro-1-propenyl)benzene"	"C705602"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224555	1059909	803382	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303610"	41188	"705-60-2"	"(2-Nitro-1-propenyl)benzene"	"C705602"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225867	1059909	803382	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303610"	41188	"705-60-2"	"(2-Nitro-1-propenyl)benzene"	"C705602"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237419	978296	845370	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303613"	20618	"102676-31-3"	"Fadrozole hydrochloride"	"C102676313"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224067	1059912	803385	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303613"	20618	"102676-31-3"	"Fadrozole hydrochloride"	"C102676313"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225870	1059912	803385	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303614"	48188	"106-45-6"	"4-Thiocresol"	"C106456"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224068	1059913	803386	4	"Col-wise effect, increased signal"	0.0888888888888889	"proportion"	"percent_activity"
"Tox21_303614"	48188	"106-45-6"	"4-Thiocresol"	"C106456"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225156	1059913	803386	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303614"	48188	"106-45-6"	"4-Thiocresol"	"C106456"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225827	1059913	803386	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303614"	48188	"106-45-6"	"4-Thiocresol"	"C106456"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225871	1059913	803386	13	"Includes potential chemical plate interlace points"	0.111111111111111	"proportion"	"percent_activity"
"Tox21_303614"	48188	"106-45-6"	"4-Thiocresol"	"C106456"	788	"Tox21_ERa_LUC_BG1_Agonist"	257888	1195898	611659	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303616"	23192	"50-21-5"	"Lactic acid"	"C50215"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223972	1059915	803388	3	"Col-wise effect, decreased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303616"	23192	"50-21-5"	"Lactic acid"	"C50215"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224070	1059915	803388	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303616"	23192	"50-21-5"	"Lactic acid"	"C50215"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225245	1059915	803388	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303639"	41306	"131-55-5"	"2,2',4,4'-Tetrahydroxybenzophenone"	"C131555"	785	"Tox21_ERa_BLA_Agonist_ratio"	200707	1101269	918882	4	"Col-wise effect, increased signal"	0.0222222222222222	"proportion"	"percent_activity"
"Tox21_303641"	37717	"1478-61-1"	"Bisphenol AF"	"C1478611"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238024	978327	845401	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303642"	22474	"50-22-6"	"Corticosterone"	"C50226"	785	"Tox21_ERa_BLA_Agonist_ratio"	200580	1101272	918885	1	"Row-wise effect, increased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303642"	22474	"50-22-6"	"Corticosterone"	"C50226"	788	"Tox21_ERa_LUC_BG1_Agonist"	259690	1195926	611687	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303642"	22474	"50-22-6"	"Corticosterone"	"C50226"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238025	978328	845402	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303644"	22377	"57-91-0"	"17alpha-Estradiol"	"C57910"	785	"Tox21_ERa_BLA_Agonist_ratio"	200581	1101273	918886	1	"Row-wise effect, increased signal"	0.2	"proportion"	"percent_activity"
"Tox21_303644"	22377	"57-91-0"	"17alpha-Estradiol"	"C57910"	785	"Tox21_ERa_BLA_Agonist_ratio"	200708	1101273	918886	4	"Col-wise effect, increased signal"	0.0666666666666667	"proportion"	"percent_activity"
"Tox21_303644"	22377	"57-91-0"	"17alpha-Estradiol"	"C57910"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225246	1059942	803415	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303644"	22377	"57-91-0"	"17alpha-Estradiol"	"C57910"	788	"Tox21_ERa_LUC_BG1_Agonist"	257762	1195927	611688	1	"Row-wise effect, increased signal"	0.0777777777777778	"proportion"	"percent_activity"
"Tox21_303644"	22377	"57-91-0"	"17alpha-Estradiol"	"C57910"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236842	978329	845403	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_303646"	22439	"81-90-3"	"Phenolphthalin"	"C81903"	788	"Tox21_ERa_LUC_BG1_Agonist"	260967	1195928	611689	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303647"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225159	1059944	803417	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303647"	33836	"104-40-5"	"4-Nonylphenol"	"C104405"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225831	1059944	803417	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303648"	29246	"2943-75-1"	"Triethoxyoctylsilane"	"C2943751"	788	"Tox21_ERa_LUC_BG1_Agonist"	259691	1195930	611691	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303650"	22310	"486-66-8"	"Daidzein"	"C486668"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225832	1059946	803419	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303651"	22367	"53-16-7"	"Estrone"	"C53167"	785	"Tox21_ERa_BLA_Agonist_ratio"	200582	1101278	918891	1	"Row-wise effect, increased signal"	0.277777777777778	"proportion"	"percent_activity"
"Tox21_303651"	22367	"53-16-7"	"Estrone"	"C53167"	785	"Tox21_ERa_BLA_Agonist_ratio"	200709	1101278	918891	4	"Col-wise effect, increased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303651"	22367	"53-16-7"	"Estrone"	"C53167"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225247	1059947	803420	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303651"	22367	"53-16-7"	"Estrone"	"C53167"	788	"Tox21_ERa_LUC_BG1_Agonist"	257763	1195932	611693	1	"Row-wise effect, increased signal"	0.144444444444444	"proportion"	"percent_activity"
"Tox21_303651"	22367	"53-16-7"	"Estrone"	"C53167"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237323	978334	845408	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303652"	24882	"66-81-9"	"Cycloheximide"	"C66819"	785	"Tox21_ERa_BLA_Agonist_ratio"	202341	1101279	918892	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303652"	24882	"66-81-9"	"Cycloheximide"	"C66819"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223973	1059948	803421	3	"Col-wise effect, decreased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303654"	34192	"10161-33-8"	"17beta-Trenbolone"	"C10161338"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224071	1059950	803423	4	"Col-wise effect, increased signal"	0.0333333333333333	"proportion"	"percent_activity"
"Tox21_303654"	34192	"10161-33-8"	"17beta-Trenbolone"	"C10161338"	788	"Tox21_ERa_LUC_BG1_Agonist"	257764	1195935	611696	1	"Row-wise effect, increased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303654"	34192	"10161-33-8"	"17beta-Trenbolone"	"C10161338"	788	"Tox21_ERa_LUC_BG1_Agonist"	257889	1195935	611696	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303654"	34192	"10161-33-8"	"17beta-Trenbolone"	"C10161338"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236517	978337	845411	2	"Row-wise effect, decreased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303654"	34192	"10161-33-8"	"17beta-Trenbolone"	"C10161338"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237324	978337	845411	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303654"	34192	"10161-33-8"	"17beta-Trenbolone"	"C10161338"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238026	978337	845411	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_303655"	22364	"521-18-6"	"5alpha-Dihydrotestosterone"	"C521186"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225248	1059951	803424	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303656"	22369	"129453-61-8"	"Fulvestrant"	"C129453618"	785	"Tox21_ERa_BLA_Agonist_ratio"	202342	1101283	918896	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303656"	22369	"129453-61-8"	"Fulvestrant"	"C129453618"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224072	1059952	803425	4	"Col-wise effect, increased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303657"	37094	"68392-35-8"	"4-Hydroxytamoxifen"	"C68392358"	785	"Tox21_ERa_BLA_Agonist_ratio"	202343	1101284	918897	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303657"	37094	"68392-35-8"	"4-Hydroxytamoxifen"	"C68392358"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236518	978340	845414	2	"Row-wise effect, decreased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303658"	36496	"797-63-7"	"Norgestrel"	"C797637"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223974	1059954	803427	3	"Col-wise effect, decreased signal"	0.0111111111111111	"proportion"	"percent_activity"
"Tox21_303658"	36496	"797-63-7"	"Norgestrel"	"C797637"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224073	1059954	803427	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303658"	36496	"797-63-7"	"Norgestrel"	"C797637"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225249	1059954	803427	10	"Noisy data"	NA	NA	"percent_activity"
"Tox21_303658"	36496	"797-63-7"	"Norgestrel"	"C797637"	788	"Tox21_ERa_LUC_BG1_Agonist"	257890	1195939	611700	4	"Col-wise effect, increased signal"	0.0444444444444444	"proportion"	"percent_activity"
"Tox21_303659"	33562	"52806-53-8"	"Hydroxyflutamide"	"C52806538"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225160	1059955	803428	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_303659"	33562	"52806-53-8"	"Hydroxyflutamide"	"C52806538"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225833	1059955	803428	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400002"	40371	"140-56-7"	"Fenaminosulf"	"C140567"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224074	1059957	803430	4	"Col-wise effect, increased signal"	0.00592592592592593	"proportion"	"percent_activity"
"Tox21_400002"	40371	"140-56-7"	"Fenaminosulf"	"C140567"	788	"Tox21_ERa_LUC_BG1_Agonist"	257891	1195942	611703	4	"Col-wise effect, increased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400004"	23113	"90-05-1"	"2-Methoxyphenol"	"C90051"	785	"Tox21_ERa_BLA_Agonist_ratio"	200583	1101290	918903	1	"Row-wise effect, increased signal"	0.00317460317460317	"proportion"	"percent_activity"
"Tox21_400004"	23113	"90-05-1"	"2-Methoxyphenol"	"C90051"	785	"Tox21_ERa_BLA_Agonist_ratio"	200710	1101290	918903	4	"Col-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400006"	20730	"148-24-3"	"8-Hydroxyquinoline"	"C148243"	785	"Tox21_ERa_BLA_Agonist_ratio"	202344	1101292	918905	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400008"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225161	1059963	803436	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400008"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225835	1059963	803436	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400008"	24986	"80-07-9"	"4,4'-Dichlorodiphenyl sulfone"	"C80079"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236432	978350	845424	1	"Row-wise effect, increased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400009"	25049	"111-77-3"	"Diethylene glycol monomethyl ether"	"C111773"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236433	978351	845425	1	"Row-wise effect, increased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400010"	21126	"92-84-2"	"Phenothiazine"	"C92842"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236434	978352	845426	1	"Row-wise effect, increased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	785	"Tox21_ERa_BLA_Agonist_ratio"	200585	1101297	918910	1	"Row-wise effect, increased signal"	0.0103703703703704	"proportion"	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	785	"Tox21_ERa_BLA_Agonist_ratio"	200711	1101297	918910	4	"Col-wise effect, increased signal"	0.0103703703703704	"proportion"	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224557	1059966	803439	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225296	1059966	803439	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	788	"Tox21_ERa_LUC_BG1_Agonist"	257765	1195951	611712	1	"Row-wise effect, increased signal"	0.00742942050520059	"proportion"	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	788	"Tox21_ERa_LUC_BG1_Agonist"	257892	1195951	611712	4	"Col-wise effect, increased signal"	0.00742942050520059	"proportion"	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	788	"Tox21_ERa_LUC_BG1_Agonist"	258563	1195951	611712	5	"Includes potential flare region points"	0.160475482912333	"proportion"	"percent_activity"
"Tox21_400011"	22360	"140-66-9"	"4-(1,1,3,3-Tetramethylbutyl)phenol"	"C140669"	788	"Tox21_ERa_LUC_BG1_Agonist"	261003	1195951	611712	13	"Includes potential chemical plate interlace points"	0.105497771173848	"proportion"	"percent_activity"
"Tox21_400014"	25881	"95-54-5"	"1,2-Phenylenediamine"	"C95545"	785	"Tox21_ERa_BLA_Agonist_ratio"	202845	1101300	918913	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400014"	25881	"95-54-5"	"1,2-Phenylenediamine"	"C95545"	788	"Tox21_ERa_LUC_BG1_Agonist"	259693	1195954	611715	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400014"	25881	"95-54-5"	"1,2-Phenylenediamine"	"C95545"	788	"Tox21_ERa_LUC_BG1_Agonist"	260969	1195954	611715	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400015"	22312	"1806-26-4"	"4-Octylphenol"	"C1806264"	785	"Tox21_ERa_BLA_Agonist_ratio"	200587	1101301	918914	1	"Row-wise effect, increased signal"	0.0133333333333333	"proportion"	"percent_activity"
"Tox21_400015"	22312	"1806-26-4"	"4-Octylphenol"	"C1806264"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223890	1059970	803443	2	"Row-wise effect, decreased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400015"	22312	"1806-26-4"	"4-Octylphenol"	"C1806264"	788	"Tox21_ERa_LUC_BG1_Agonist"	257766	1195955	611716	1	"Row-wise effect, increased signal"	0.00594353640416048	"proportion"	"percent_activity"
"Tox21_400017"	25023	"77-73-6"	"Dicyclopentadiene"	"C77736"	785	"Tox21_ERa_BLA_Agonist_ratio"	200588	1101303	918916	1	"Row-wise effect, increased signal"	0.00317460317460317	"proportion"	"percent_activity"
"Tox21_400019"	24460	"60-09-3"	"4-Aminoazobenzene"	"C60093"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236577	978361	845435	3	"Col-wise effect, decreased signal"	0.00477707006369427	"proportion"	"percent_activity"
"Tox21_400023"	37752	"744-45-6"	"Diphenyl isophthalate"	"C744456"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223808	1059978	803451	1	"Row-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400023"	37752	"744-45-6"	"Diphenyl isophthalate"	"C744456"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224075	1059978	803451	4	"Col-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400023"	37752	"744-45-6"	"Diphenyl isophthalate"	"C744456"	788	"Tox21_ERa_LUC_BG1_Agonist"	257767	1195963	611724	1	"Row-wise effect, increased signal"	0.00636942675159236	"proportion"	"percent_activity"
"Tox21_400023"	37752	"744-45-6"	"Diphenyl isophthalate"	"C744456"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236578	978365	845439	3	"Col-wise effect, decreased signal"	0.00636942675159236	"proportion"	"percent_activity"
"Tox21_400024"	20119	"446-86-6"	"Azathioprine"	"C446866"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224076	1059979	803452	4	"Col-wise effect, increased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400024"	20119	"446-86-6"	"Azathioprine"	"C446866"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225162	1059979	803452	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400024"	20119	"446-86-6"	"Azathioprine"	"C446866"	788	"Tox21_ERa_LUC_BG1_Agonist"	257768	1195964	611725	1	"Row-wise effect, increased signal"	0.00445765230312036	"proportion"	"percent_activity"
"Tox21_400024"	20119	"446-86-6"	"Azathioprine"	"C446866"	788	"Tox21_ERa_LUC_BG1_Agonist"	257893	1195964	611725	4	"Col-wise effect, increased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400024"	20119	"446-86-6"	"Azathioprine"	"C446866"	788	"Tox21_ERa_LUC_BG1_Agonist"	259694	1195964	611725	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400024"	20119	"446-86-6"	"Azathioprine"	"C446866"	788	"Tox21_ERa_LUC_BG1_Agonist"	260970	1195964	611725	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400028"	21928	"111-15-9"	"2-Ethoxyethyl acetate"	"C111159"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236580	978370	845444	3	"Col-wise effect, decreased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400029"	20453	"60-57-1"	"Dieldrin"	"C60571"	785	"Tox21_ERa_BLA_Agonist_ratio"	202346	1101315	918928	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400029"	20453	"60-57-1"	"Dieldrin"	"C60571"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223892	1059984	803457	2	"Row-wise effect, decreased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400029"	20453	"60-57-1"	"Dieldrin"	"C60571"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225836	1059984	803457	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400029"	20453	"60-57-1"	"Dieldrin"	"C60571"	788	"Tox21_ERa_LUC_BG1_Agonist"	259696	1195969	611730	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400029"	20453	"60-57-1"	"Dieldrin"	"C60571"	788	"Tox21_ERa_LUC_BG1_Agonist"	260972	1195969	611730	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400029"	20453	"60-57-1"	"Dieldrin"	"C60571"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237325	978371	845445	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400029"	20453	"60-57-1"	"Dieldrin"	"C60571"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238027	978371	845445	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400030"	20295	"106-47-8"	"4-Chloroaniline"	"C106478"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224077	1059985	803458	4	"Col-wise effect, increased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400032"	24065	"99-65-0"	"1,3-Dinitrobenzene"	"C99650"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223893	1059987	803460	2	"Row-wise effect, decreased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400032"	24065	"99-65-0"	"1,3-Dinitrobenzene"	"C99650"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236436	978374	845448	1	"Row-wise effect, increased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400032"	24065	"99-65-0"	"1,3-Dinitrobenzene"	"C99650"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236520	978374	845448	2	"Row-wise effect, decreased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400033"	24489	"2835-95-2"	"5-Amino-2-methylphenol"	"C2835952"	785	"Tox21_ERa_BLA_Agonist_ratio"	200589	1101319	918932	1	"Row-wise effect, increased signal"	0.00444444444444444	"proportion"	"percent_activity"
"Tox21_400033"	24489	"2835-95-2"	"5-Amino-2-methylphenol"	"C2835952"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236437	978375	845449	1	"Row-wise effect, increased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400034"	27236	"602-01-7"	"2,3-Dinitrotoluene"	"C602017"	785	"Tox21_ERa_BLA_Agonist_ratio"	200590	1101320	918933	1	"Row-wise effect, increased signal"	0.00444444444444444	"proportion"	"percent_activity"
"Tox21_400034"	27236	"602-01-7"	"2,3-Dinitrotoluene"	"C602017"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236521	978376	845450	2	"Row-wise effect, decreased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400035"	20944	"59-87-0"	"Nitrofurazone"	"C59870"	788	"Tox21_ERa_LUC_BG1_Agonist"	259697	1195975	611736	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400035"	20944	"59-87-0"	"Nitrofurazone"	"C59870"	788	"Tox21_ERa_LUC_BG1_Agonist"	259730	1195975	611736	9	"Potential pintool carryover"	0.0222882615156018	"proportion"	"percent_activity"
"Tox21_400035"	20944	"59-87-0"	"Nitrofurazone"	"C59870"	788	"Tox21_ERa_LUC_BG1_Agonist"	260973	1195975	611736	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400035"	20944	"59-87-0"	"Nitrofurazone"	"C59870"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236522	978377	845451	2	"Row-wise effect, decreased signal"	0.00148588410104012	"proportion"	"percent_activity"
"Tox21_400035"	20944	"59-87-0"	"Nitrofurazone"	"C59870"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236843	978377	845451	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_400037"	20283	"95-83-0"	"4-Chloro-1,2-diaminobenzene"	"C95830"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223809	1059992	803465	1	"Row-wise effect, increased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400037"	20283	"95-83-0"	"4-Chloro-1,2-diaminobenzene"	"C95830"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237326	978379	845453	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400037"	20283	"95-83-0"	"4-Chloro-1,2-diaminobenzene"	"C95830"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238028	978379	845453	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400038"	25595	"110-26-9"	"N,N'-Methylenebisacrylamide"	"C110269"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224078	1059993	803466	4	"Col-wise effect, increased signal"	0.00317460317460317	"proportion"	"percent_activity"
"Tox21_400038"	25595	"110-26-9"	"N,N'-Methylenebisacrylamide"	"C110269"	788	"Tox21_ERa_LUC_BG1_Agonist"	259698	1195978	611739	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400038"	25595	"110-26-9"	"N,N'-Methylenebisacrylamide"	"C110269"	788	"Tox21_ERa_LUC_BG1_Agonist"	260974	1195978	611739	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400038"	25595	"110-26-9"	"N,N'-Methylenebisacrylamide"	"C110269"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236438	978380	845454	1	"Row-wise effect, increased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400040"	20916	"2243-62-1"	"1,5-Naphthalenediamine"	"C2243621"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238029	978382	845456	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400041"	25178	"102-06-7"	"1,3-Diphenylguanidine"	"C102067"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223810	1059996	803469	1	"Row-wise effect, increased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400042"	24657	"627-18-9"	"3-Bromo-1-propanol"	"C627189"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223811	1059997	803470	1	"Row-wise effect, increased signal"	0.00317460317460317	"proportion"	"percent_activity"
"Tox21_400046"	20154	"120-32-1"	"Clorophene"	"C120321"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224559	1060001	803474	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_400046"	20154	"120-32-1"	"Clorophene"	"C120321"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238031	978388	845462	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400047"	32655	"131983-72-7"	"Triticonazole"	"C131983727"	785	"Tox21_ERa_BLA_Agonist_ratio"	200591	1101333	918946	1	"Row-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400047"	32655	"131983-72-7"	"Triticonazole"	"C131983727"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238032	978389	845463	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400048"	20791	"121-75-5"	"Malathion"	"C121755"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223894	1060003	803476	2	"Row-wise effect, decreased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400048"	20791	"121-75-5"	"Malathion"	"C121755"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224079	1060003	803476	4	"Col-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400050"	32424	"104206-82-8"	"Mesotrione"	"C104206828"	788	"Tox21_ERa_LUC_BG1_Agonist"	257895	1195990	611751	4	"Col-wise effect, increased signal"	0.00318471337579618	"proportion"	"percent_activity"
"Tox21_400051"	37707	"29420-49-3"	"PFBS-K"	"C29420493"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224080	1060006	803479	4	"Col-wise effect, increased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400053"	27198	"550-44-7"	"N-Methylphthalimide"	"C550447"	785	"Tox21_ERa_BLA_Agonist_ratio"	200592	1101339	918952	1	"Row-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400053"	27198	"550-44-7"	"N-Methylphthalimide"	"C550447"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223976	1060008	803481	3	"Col-wise effect, decreased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400058"	33664	"58-18-4"	"17-Methyltestosterone"	"C58184"	785	"Tox21_ERa_BLA_Agonist_ratio"	200593	1101344	918957	1	"Row-wise effect, increased signal"	0.00952380952380952	"proportion"	"percent_activity"
"Tox21_400058"	33664	"58-18-4"	"17-Methyltestosterone"	"C58184"	788	"Tox21_ERa_LUC_BG1_Agonist"	257769	1195998	611759	1	"Row-wise effect, increased signal"	0.0222929936305732	"proportion"	"percent_activity"
"Tox21_400058"	33664	"58-18-4"	"17-Methyltestosterone"	"C58184"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237454	978400	845474	11	"Borderline active"	NA	NA	"percent_activity"
"Tox21_400059"	22048	"525-82-6"	"Flavone"	"C525826"	785	"Tox21_ERa_BLA_Agonist_ratio"	202847	1101345	918958	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400059"	22048	"525-82-6"	"Flavone"	"C525826"	788	"Tox21_ERa_LUC_BG1_Agonist"	259731	1195999	611760	9	"Potential pintool carryover"	0.0238853503184713	"proportion"	"percent_activity"
"Tox21_400059"	22048	"525-82-6"	"Flavone"	"C525826"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236523	978401	845475	2	"Row-wise effect, decreased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400074"	35180	"584-79-2"	"Allethrin"	"C584792"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223895	1060029	803502	2	"Row-wise effect, decreased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400074"	35180	"584-79-2"	"Allethrin"	"C584792"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223977	1060029	803502	3	"Col-wise effect, decreased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400075"	20827	"72-43-5"	"Methoxychlor"	"C72435"	785	"Tox21_ERa_BLA_Agonist_ratio"	202348	1101361	918974	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400075"	20827	"72-43-5"	"Methoxychlor"	"C72435"	785	"Tox21_ERa_BLA_Agonist_ratio"	202848	1101361	918974	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400075"	20827	"72-43-5"	"Methoxychlor"	"C72435"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223815	1060030	803503	1	"Row-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400077"	32493	"55219-65-3"	"Triadimenol"	"C55219653"	785	"Tox21_ERa_BLA_Agonist_ratio"	200594	1101363	918976	1	"Row-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400077"	32493	"55219-65-3"	"Triadimenol"	"C55219653"	788	"Tox21_ERa_LUC_BG1_Agonist"	259699	1196017	611778	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400077"	32493	"55219-65-3"	"Triadimenol"	"C55219653"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237329	978419	845493	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400077"	32493	"55219-65-3"	"Triadimenol"	"C55219653"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238036	978419	845493	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400078"	24238	"19044-88-3"	"Oryzalin"	"C19044883"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224081	1060033	803506	4	"Col-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400078"	24238	"19044-88-3"	"Oryzalin"	"C19044883"	789	"Tox21_ERa_LUC_BG1_Antagonist"	237330	978420	845494	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400078"	24238	"19044-88-3"	"Oryzalin"	"C19044883"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238037	978420	845494	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400079"	32498	"3380-34-5"	"Triclosan"	"C3380345"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236844	978421	845495	6	"Only highest conc above baseline, active"	NA	NA	"percent_activity"
"Tox21_400080"	24035	"94-82-6"	"2,4-DB"	"C94826"	785	"Tox21_ERa_BLA_Agonist_ratio"	200712	1101366	918979	4	"Col-wise effect, increased signal"	0.00317460317460317	"proportion"	"percent_activity"
"Tox21_400081"	24102	"22224-92-6"	"Fenamiphos"	"C22224926"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236440	978423	845497	1	"Row-wise effect, increased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400081"	24102	"22224-92-6"	"Fenamiphos"	"C22224926"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238038	978423	845497	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400083"	31864	"1763-23-1"	"PFOS"	"C1763231"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236441	978425	845499	1	"Row-wise effect, increased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400084"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	786	"Tox21_ERa_BLA_Antagonist_ratio"	225164	1060039	803512	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400084"	20607	"117-81-7"	"Di(2-ethylhexyl) phthalate"	"C117817"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236442	978426	845500	1	"Row-wise effect, increased signal"	0.00159235668789809	"proportion"	"percent_activity"
"Tox21_400085"	24109	"66332-96-5"	"Flutolanil"	"C66332965"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238039	978427	845501	12	"Borderline inactive"	NA	NA	"percent_activity"
"Tox21_400086"	21166	"51-03-6"	"Piperonyl butoxide"	"C51036"	786	"Tox21_ERa_BLA_Antagonist_ratio"	224082	1060041	803514	4	"Col-wise effect, increased signal"	0.00158730158730159	"proportion"	"percent_activity"
"Tox21_400087"	32520	"131860-33-8"	"Azoxystrobin"	"C131860338"	785	"Tox21_ERa_BLA_Agonist_ratio"	202349	1101373	918986	8	"Multiple points above baseline, inactive"	NA	NA	"percent_activity"
"Tox21_400087"	32520	"131860-33-8"	"Azoxystrobin"	"C131860338"	789	"Tox21_ERa_LUC_BG1_Antagonist"	236443	978429	845503	1	"Row-wise effect, increased signal"	0.00796178343949045	"proportion"	"percent_activity"
"Tox21_400088"	20182	"80-05-7"	"Bisphenol A"	"C80057"	785	"Tox21_ERa_BLA_Agonist_ratio"	200595	1101374	918987	1	"Row-wise effect, increased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400088"	20182	"80-05-7"	"Bisphenol A"	"C80057"	785	"Tox21_ERa_BLA_Agonist_ratio"	200713	1101374	918987	4	"Col-wise effect, increased signal"	0.00592592592592593	"proportion"	"percent_activity"
"Tox21_400088"	20182	"80-05-7"	"Bisphenol A"	"C80057"	786	"Tox21_ERa_BLA_Antagonist_ratio"	223978	1060043	803516	3	"Col-wise effect, decreased signal"	0.00148148148148148	"proportion"	"percent_activity"
"Tox21_400088"	20182	"80-05-7"	"Bisphenol A"	"C80057"	788	"Tox21_ERa_LUC_BG1_Agonist"	257770	1196028	611789	1	"Row-wise effect, increased signal"	0.0193164933135215	"proportion"	"percent_activity"
"Tox21_400088"	20182	"80-05-7"	"Bisphenol A"	"C80057"	788	"Tox21_ERa_LUC_BG1_Agonist"	257898	1196028	611789	4	"Col-wise effect, increased signal"	0.011887072808321	"proportion"	"percent_activity"
"Tox21_400088"	20182	"80-05-7"	"Bisphenol A"	"C80057"	789	"Tox21_ERa_LUC_BG1_Antagonist"	238040	978430	845504	12	"Borderline inactive"	NA	NA	"percent_activity"
